<SEC-DOCUMENT>0001193125-18-193489.txt : 20180615
<SEC-HEADER>0001193125-18-193489.hdr.sgml : 20180615
<ACCEPTANCE-DATETIME>20180615060437
ACCESSION NUMBER:		0001193125-18-193489
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		30
FILED AS OF DATE:		20180615
DATE AS OF CHANGE:		20180615

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Neuronetics, Inc.
		CENTRAL INDEX KEY:			0001227636
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1209

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-225307
		FILM NUMBER:		18900668

	BUSINESS ADDRESS:	
		STREET 1:		3222 PHOENIXVILLE PIKE
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355
		BUSINESS PHONE:		877-600-7555

	MAIL ADDRESS:	
		STREET 1:		3222 PHOENIXVILLE PIKE
		CITY:			MALVERN
		STATE:			PA
		ZIP:			19355

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEURONETICS INC
		DATE OF NAME CHANGE:	20030416
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>d542432ds1a.htm
<DESCRIPTION>S-1/A
<TEXT>
<HTML><HEAD>
<TITLE>S-1/A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>As filed with the Securities and Exchange Commission on June 15,
2018 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Registration No.&nbsp;333-225307 </B></FONT></P>
<P STYLE="font-size:1px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="line-height:2px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #465361">&nbsp;</P>
<P STYLE="line-height:2px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #465361">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5" COLOR="#465361"><B>UNITED STATES
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5" COLOR="#465361"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Washington, D.C. 20549 </B></FONT></P> <P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center>
<P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P></center>  <P STYLE="margin-top:2px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="5" COLOR="#465361"><B>AMENDMENT NO. 1 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5" COLOR="#465361"><B>TO </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5" COLOR="#465361"><B>FORM <FONT STYLE="white-space:nowrap">S-1</FONT> </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5" COLOR="#465361"><B>REGISTRATION STATEMENT </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>UNDER </I></B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>THE SECURITIES ACT OF
1933 </I></B></FONT></P> <P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P></center>
<P STYLE="margin-top:2px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Exact name of registrant as specified in its charter) </B></FONT></P> <P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Delaware</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>3841</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>33-1051425</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(State or other jurisdiction of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>incorporation or organization)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(Primary Standard Industrial</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Classification Code Number)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(I.R.S. Employer</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Identification Number)</B></FONT></P></TD></TR>
</TABLE> <P STYLE="margin-top:2px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>3222 Phoenixville Pike </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Malvern, Pennsylvania 19355 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(610) <FONT STYLE="white-space:nowrap">640-4202</FONT> </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(Address, including zip code, and telephone number, including area code, of registrant&#146;s principal executive offices) </B></FONT></P>
<P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P></center>
<P STYLE="margin-top:2px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Chris Thatcher </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>President and Chief Executive Officer </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Neuronetics, Inc. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>3222 Phoenixville Pike </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Malvern,
Pennsylvania 19355 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(610) <FONT STYLE="white-space:nowrap">640-4202</FONT> </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(Name, address, including zip code, and telephone number, including area code, of agent for service) </B></FONT></P>
<P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P></center>
<P STYLE="margin-top:2px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Copies to: </I></B></FONT></P> <P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Divakar Gupta</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Joshua A. Kaufman</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Jeffrey Libson</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Brandon
Fenn</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Cooley LLP</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>1114 Avenue of the Americas</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>New York, New
York 10036</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(212) <FONT STYLE="white-space:nowrap">479-6000</FONT></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>B. Shayne Kennedy</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Brian J. Cuneo</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Drew Capurro</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Latham&nbsp;&amp; Watkins
LLP</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>650 Town Center Drive</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Costa Mesa, California 92626</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(714) <FONT
STYLE="white-space:nowrap">540-1235</FONT></B></FONT></P></TD></TR>
</TABLE> <P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P></center>
<P STYLE="margin-top:2px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Approximate date of commencement of proposed sale to the public: </B>As soon as practicable after this registration statement is
declared effective. </FONT></P> <P STYLE="margin-top:2px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">If any of the securities being registered on this form are to be offered on a delayed or continuous basis
pursuant to Rule 415 under the Securities Act of 1933, check the following box.&nbsp;&nbsp;&nbsp;&nbsp;&#9744; </FONT></P> <P STYLE="margin-top:2px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">If this form is
filed to register additional securities for an offering pursuant to Rule 462(b)&nbsp;under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the
same offering.&nbsp;&nbsp;&nbsp;&nbsp;&#9744; </FONT></P> <P STYLE="margin-top:2px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">If this form is a post-effective amendment filed pursuant to
Rule&nbsp;462(c)&nbsp;under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&nbsp;&nbsp;&#9744; </FONT></P>
<P STYLE="margin-top:2px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">If this form is a post-effective amendment filed pursuant to Rule&nbsp;462(d)&nbsp;under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&nbsp;&nbsp;&#9744; </FONT></P> <P STYLE="margin-top:2px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting
company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company,&#148; and &#147;emerging growth company&#148; in Rule
<FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </FONT></P> <P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="65%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="1%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Large&nbsp;accelerated&nbsp;filer</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&#9744;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Accelerated&nbsp;filer</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&#9744;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Non-accelerated filer</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&#9746;&nbsp;(Do&nbsp;not&nbsp;check&nbsp;if&nbsp;a&nbsp;smaller&nbsp;reporting&nbsp;company)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Smaller&nbsp;reporting&nbsp;company</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&#9744;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Emerging&nbsp;growth&nbsp;company</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&#9746;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:2px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>If an emerging growth company, indicate by check mark if the registrant has elected not to use the
extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&nbsp;&nbsp;</B>&#9744;<B></B><B> </B></FONT></P>
<P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P></center>
<P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:2px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>CALCULATION OF REGISTRATION FEE </B></FONT></P>
<P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>


<TR STYLE="font-size:1px">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE="border-top:1px solid #465361">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Title of Each Class of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Securities To Be Registered</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #465361; BORDER-TOP:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount<BR></B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>to be<BR>Registered<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #465361; BORDER-TOP:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Proposed<BR>Maximum<BR>Offering Price<BR>Per Share<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #465361; BORDER-TOP:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #465361">
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Proposed<BR>Maximum<BR>Aggregate</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Offering&nbsp;Price<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #465361; BORDER-TOP:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount&nbsp;of</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Registration&nbsp;
Fee<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)(4)</SUP></B></FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #465361"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Common Stock, $0.01 par value per share</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #465361; BORDER-TOP:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">5,750,000</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #465361; BORDER-TOP:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$16.00</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #465361; BORDER-TOP:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$92,000,000</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #465361; BORDER-TOP:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$11,454</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE="border-top:1px solid #465361">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE="border-top:1px solid #465361">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Includes 750,000 shares that the underwriters have the option to purchase. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Estimated solely for the purposes of calculating the registration fee pursuant to Rule 457(a) under the Securities Act, as amended.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Calculated pursuant to Rule 457(a) based on an estimate of the proposed maximum aggregate offering price. </FONT></P></TD></TR></TABLE>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">The Registrant previously paid $10,738.13 in connection with the original filing of this Registration Statement on May&nbsp;31, 2018.
</FONT></P></TD></TR></TABLE>  <P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P></center>
<P STYLE="margin-top:2px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until
the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933 or until the registration statement shall
become effective on such date as the Commission, acting pursuant to said Section&nbsp;8(a), may determine. </B></FONT></P> <P STYLE="font-size:3px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:0px;border-bottom:0.5pt solid #465361">&nbsp;</P> <P STYLE="line-height:2px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #465361">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g56n78.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g30q00.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></FONT></P>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="85%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Page</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_1">Prospectus Summary</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_2">Risk Factors</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_3">Special Note Regarding Forward-Looking Statements</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_3a">Implications of Being an Emerging Growth Company </A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">56</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_4">Market, Industry and Other Data</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">57</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_5">Use of Proceeds</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_6">Dividend Policy</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">59</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_7">Capitalization</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_8">Dilution</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">62</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_9">Selected Financial Data</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_10">Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations
</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR></TABLE>
</DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="85%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Page</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_11">Business</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">88</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_12">Management</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">126</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_13">Executive and Director Compensation</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">135</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_14">Certain Relationships and Related Party Transactions</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">151</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_15">Principal Stockholders</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">154</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_16">Description of Capital Stock</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">157</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_17">Shares Eligible for Future Sale</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">163</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_18">Material U.S. Federal Income Tax Consequences to <FONT STYLE="white-space:nowrap">Non-U.S.
</FONT> Holders</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">166</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_19">Underwriting</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">170</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_20">Legal Matters</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">177</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_21">Experts</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">177</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_21a">Where You Can Find More Information </A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">177</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><A HREF="#toc542432_22">Index to Financial Statements</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><FONT STYLE="white-space:nowrap">F-1</FONT></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE>  </div><div style="clear:both; height:0px; font-size:0px">&nbsp;</div>
 <P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px">&nbsp;</P><center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P></center>
 <P STYLE="margin-top:10px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Until &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018 (25 days after the
date of this prospectus), all dealers that buy, sell or trade shares of our common stock, whether or not participating in this offering, may be required to deliver a prospectus. This delivery requirement is in addition to the obligation of dealers
to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. </B></FONT></P>  <P STYLE="margin-top:10px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We
have not, and the underwriters have not, authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by or on behalf of us or to which we have
referred you. We and the underwriters take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. This prospectus is an offer to sell only the shares offered hereby, but only
under circumstances and in jurisdictions where it is lawful to do so. The information contained in this prospectus or in any applicable free writing prospectus is current only as of its date, regardless of its time of delivery or any sale of shares
of our common stock. Our business, financial condition, results of operations and prospects may have changed since that date. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>TRADEMARKS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have received trademark
registration for Neuronetics and NeuroStar in the United States and Japan, as well as TrakStar, SenStar Treatment Assist, SenStar, MT Assist and NeuroStar TMS Therapy in the United States. This prospectus contains references to our trademarks and to
trademarks belonging to other entities. Solely for convenience, trademark and trade names referred to in this prospectus, including logos, artwork and other visual displays, may appear without the <FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT> or &#153; symbols, but such references are not intended to indicate, in any way, that we will not
assert, to the fullest extent under applicable law, our rights to these trademarks and trade names. All other trademarks, trade names and service marks appearing in this prospectus are the property of their respective owners. We do not intend our
use or display of other companies&#146; trade names or trademarks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>INVESTORS OUTSIDE OF THE UNITED STATES </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have not, and
the underwriters have not, done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside of the United
States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of our common stock and the distribution of this prospectus outside of the United States.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">i </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1pt solid #465361;BORDER-LEFT:1pt solid #465361;BORDER-RIGHT:1pt solid #465361;BORDER-TOP:1pt solid #465361;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_1"></A>PROSPECTUS SUMMARY </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>This summary highlights information contained elsewhere in this prospectus. This summary does not contain all of the information you
should consider before investing in our common stock. You should read this entire prospectus carefully, especially &#147;Risk Factors,&#148; &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148; and
our financial statements and the related notes thereto appearing at the end of this prospectus, before making an investment decision. As used in this prospectus, unless the context otherwise requires, references to &#147;we,&#148; &#147;us,&#148;
&#147;our&#148; and &#147;the Company&#148; refer to Neuronetics, Inc. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Neuronetics </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of
life for patients who suffer from psychiatric disorders. Our first commercial product, the NeuroStar Advanced Therapy System, is a <FONT STYLE="white-space:nowrap">non-invasive</FONT> and <FONT STYLE="white-space:nowrap">non-systemic</FONT>
office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, <FONT STYLE="white-space:nowrap">MRI-strength</FONT> magnetic field that induces electrical currents designed to stimulate specific areas of the brain
associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, to treat adult patients with major depressive disorder, or MDD, that have failed to achieve satisfactory improvement from prior antidepressant
medication in the current episode. NeuroStar Advanced Therapy is safe, clinically effective, reproducible and precise and is supported by the largest clinical data set of any competing TMS system. We believe we are the market leader in TMS therapy
based on our U.S. installed base of 781&nbsp;active NeuroStar Advanced Therapy Systems in approximately 615 psychiatrist offices and the estimated 50,000&nbsp;patients treated with approximately 1.8&nbsp;million of our treatment sessions. We
generated revenues of $40.4 million for the year ended December 31, 2017 and $10.2 million for the three months ended March 31, 2018. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">MDD is a mood disorder characterized by the presence of one or both of two major diagnostic criteria: a depressed mood or loss of interest in pleasure that continues for at least two
weeks. The presence of at least one of these diagnostic symptoms must be accompanied by several of the following additional symptoms: sleep disturbance, changes in appetite, sexual dysfunction, anxiety, fatigue, difficulty concentrating and suicidal
thinking. MDD is a recurrent disease and follows a fluctuating course over an individual&#146;s lifetime, with periods of remission and relapse. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Initial treatment options for MDD often consist of antidepressant medication prescribed by a primary care physician. Although a variety of antidepressant drugs are available, drug therapy
has two primary limitations: limited effectiveness and treatment-emergent side effects. These limitations were demonstrated in the Sequenced Treatment Alternatives to Relieve Depression, or STAR*D study, a large clinical trial funded by the U.S.
National Institute of Mental Health, or NIMH, that enrolled more than 4,000 adult MDD patients at 41 clinical sites to examine the outcomes to a sequenced series of antidepressant medication attempts that mimicked best practices. In the study,
approximately 28% and 21% of patients achieved remission in their first and second medication attempts, respectively. Many patients taking antidepressant medications experience intolerable or troubling side effects that contribute to a delay or
failure in attaining an effective or optimal antidepressant dose, poor patient treatment adherence or discontinuation of treatment therapy. TMS is considered to be an appropriate alternative for the treatment of MDD patients who have failed to
achieve satisfactory improvement from prior antidepressant medication. The effectiveness of TMS depends on the psychiatrist&#146;s ability to deliver a precise amount of magnetic pulses to a specific area of the brain in a manner that can be
consistently repeated during each treatment session. We believe that competing TMS systems have significant limitations that have limited their adoption. </FONT></P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1pt solid #465361;BORDER-LEFT:1pt solid #465361;BORDER-RIGHT:1pt solid #465361;BORDER-TOP:1pt solid #465361;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to
treat patients who suffer from MDD and to address many of the key limitations of existing treatment options. We believe our therapy provides our psychiatrist customers and their patients with several benefits, including clinically demonstrated
response and remission with durable results, a demonstrated safety profile with limited treatment-emergent side effects and high patient adherence. Additionally, our therapy was designed to provide a precise and reproducible office-based therapy
that is also efficient and convenient. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We couple our product&#146;s clinical benefits with significant practice development
resources, on-site clinical training, reimbursement and service support to help our psychiatrist customers develop a successful NeuroStar Advanced Therapy practice. We also provide cloud-based practice management solutions that enhance convenience
for both psychiatrists and patients. Based on our commercial data, we believe psychiatrists can recoup their initial capital investment in our system by providing a standard course of treatment to approximately 12&nbsp;patients. We believe
psychiatrists can generate approximately $7,500 to $10,000 of revenue per patient for a standard course of treatment, which may provide meaningful incremental income to their practices. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of March&nbsp;31, 2018, we had an installed base of 781&nbsp;active systems in the United States. We currently sell our products in the United States through our direct sales and
customer support team, which was comprised of 126 people as of March&nbsp;31, 2018. Our sales force primarily targets 15,100 psychiatrists at 3,600 high-decile psychiatric practices that we estimate, based on data from Symphony Health and our own
internal estimates, treat approximately 33% of the total MDD patients in the United States who meet our labeled indication and are insured. Patients are reimbursed by Medicare and the vast majority of commercial payors in the United States for
treatment sessions utilizing our system. We generate revenues primarily from initial capital sales of our systems and recurring treatment sessions. For the year ended December&nbsp;31, 2017, we generated revenues of $40.4&nbsp;million, which
represented an increase of 18% compared to the prior year. For the year ended December 31, 2017, U.S. revenues were $39.9 million, which represented an increase of 26% compared to the prior year. Revenues from treatment sessions represented 71% of
our U.S. revenues for the year ended December 31, 2017 compared to 78% of our U.S. revenues for the prior year. For the three months ended March 31, 2018, we generated revenues of $10.2 million, which represented an increase of 35% compared to the
same period in the prior year. For the three months ended March 31, 2018, our U.S. revenues were $10.0 million, which represented an increase of 35% compared to the same period in the prior year. Revenues from treatment sessions represented 72% of
our U.S. revenues for the three months ended March 31, 2018, compared to 78% of our U.S. revenues for the same period in the prior year. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Market Overview </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The World Health Organization, or WHO,
estimates that there are over 300&nbsp;million people in the world living with depression and ranks MDD as the single largest contributor to global disability and a major contributor to suicide worldwide. According to a study published in the
<I>Journal of Clinical Psychiatry, </I>the economic burden of the disease was estimated to be $210&nbsp;billion in 2010 in the United States. Based on U.S. Census Bureau data and a study published in the <I>Journal of the American Medical
Association</I><I>,</I> we estimate that approximately 21&nbsp;million people in the United States suffer from MDD annually. Of these people, we estimate approximately 13.3&nbsp;million are adults aged 22&nbsp;to 70 years, of whom an estimated
7.6&nbsp;million, based on data from the <I>Journal of the American Medical Association,</I> are being treated by a psychiatrist. We estimate, based on data from the STAR*D study, that approximately 5.5&nbsp;million of these patients have failed to
achieve remission of their MDD from their prior antidepressant medication therapy and that approximately </FONT></P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1pt solid #465361;BORDER-LEFT:1pt solid #465361;BORDER-RIGHT:1pt solid #465361;BORDER-TOP:1pt solid #465361;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
3.8 million of those patients have commercial insurance or Medicare coverage for the NeuroStar Advanced Therapy. As a result, based on our expected revenues for a standard course of treatment, we
believe our total annual addressable market opportunity for treatment sessions in the United States is approximately $9.6 billion. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In Japan, the country with the third highest aggregate healthcare expenditures worldwide according to Deloitte, we estimate, based on data from the National Center for Biotechnology
Information that approximately 2.4&nbsp;million adults suffer from MDD and approximately 655,000 of these adults are being treated for their MDD by a psychiatrist. We estimate, based on data from the STAR*D study, that approximately 475,000 of these
patients, all of whom are covered by Japan&#146;s single payor healthcare system, have failed to achieve remission of their MDD from prior antidepressant medication therapy. As a result, we believe our total addressable market opportunity for
treatment sessions in Japan is over $1.0&nbsp;billion, assuming psychiatrist reimbursement levels per treatment course per patient are similar to those in the United States. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Current Treatments for MDD and Their Limitations </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The most
common form of treatment for MDD is antidepressant medication with or without psychotherapy. During the initial treatment course, a patient may experience uncomfortable side effects and it is common for a patient and the primary care physician to
spend time testing several different medications before arriving at a medication regimen that provides symptom relief and is tolerable. If initial treatment approaches do not adequately relieve a patient&#146;s symptoms, a primary care physician
will often make a referral for consultation with a psychiatrist trained in psychopharmacology. There are a wide array of options that a psychiatrist may consider as second line therapies. For example, a psychiatrist may recommend either combining
two or more antidepressant medications or using a second medication such as an atypical antipsychotic that is not an antidepressant along with the initial antidepressant medication to augment the efficacy of such antidepressant, which is referred to
as augmentation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">TMS is another second line therapy and differs from drug therapy approaches by inducing electrical currents
designed to stimulate specific areas of the brain associated with mood.&nbsp;This stimulation triggers a cascading electro-chemical effect that can pass along the neuronal circuit and reach into the deeper structures of the brain that also regulate
mood. This action changes the connections among these structures in a manner that improves the activity of the neuronal circuit and results in an improvement in mood. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">More aggressive options, which are associated with greater medical risk, are sometimes considered for patients that require later stages of treatment and include electroconvulsive therapy,
for the most critical MDD patients and vagus nerve stimulation, which is considered the most invasive treatment option currently approved by the FDA for MDD patients who have proven to be severely treatment resistant. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Limitations of Current Therapies </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Antidepressant Therapy </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Although a variety of
antidepressant medications are available for the treatment of MDD, antidepressant therapy has two primary limitations: limited efficacy and treatment-emergent side effects that interfere with patient adherence to the prescribed treatment regimen.
These limitations were demonstrated in the STAR*D study, which demonstrated that nearly three-fourths of patients did not benefit from initial antidepressant medication therapy with a selective serotonin reuptake
</FONT></P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1pt solid #465361;BORDER-LEFT:1pt solid #465361;BORDER-RIGHT:1pt solid #465361;BORDER-TOP:1pt solid #465361;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
inhibitor, and these patients remained symptomatic and functionally impaired. The likelihood of achieving remission from a medication regimen was limited and declined with each successive
augmentation attempt. The study showed that the likelihood of discontinuing treatment due to treatment-emergent side effects increased with each incremental course of medication, with approximately 41% of patients who progressed to the fourth
monotherapy treatment attempt subsequently discontinuing drug treatment. The severity of side effects generally increase as a patient proceeds from initial drug treatment to combination or augmented drug treatments. Later stage treatment options,
such as first-generation antidepressants and antipsychotics, have potentially more serious and life threatening side effects and intolerability. The discontinuation of treatment can also result in severe side effects. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Transcranial Magnetic Stimulation </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">While TMS has been demonstrated to be a safe and effective treatment alternative for patients suffering from MDD, we believe that most TMS systems have experienced limited adoption for
several reasons, including: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">challenges in delivering precise and reproducible treatments; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">lack of clinical data from randomized outcome and other trials; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">lack of cloud-based practice management system; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">lack of comfort and convenience; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">lack of customer support and practice development resources. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We believe a significant market opportunity exists for a TMS system that can address the shortcomings of second line antidepressant
medications and competing TMS systems. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Our Solution </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We designed the NeuroStar Advanced Therapy as a <FONT STYLE="white-space:nowrap">non-invasive</FONT> and non-systemic therapeutic alternative for patients who suffer from MDD. NeuroStar
Advanced Therapy is an <FONT STYLE="white-space:nowrap">in-office</FONT> treatment that has been cleared to be performed in as little as 19 minutes (but may take up to 39&nbsp;minutes due to patient sensitivity or at the discretion of the treating
psychiatrist) per session and is performed while the patient is awake, alert and is seated and reclined comfortably in the treatment chair. A course of treatment consists of sessions administered for five days a week for up to six weeks. During the
first treatment session, two essential steps are performed. First, the patient&#146;s cortex is mapped with the NeuroStar Treatment Coil to identify the motor cortex. Once the specific location on the motor cortex is found, the second step involves
the use of a proprietary software algorithm, which assists the psychiatrist in estimating the physiologically appropriate magnetic field intensity for each treatment session. After these two steps are performed, the location of the motor cortex then
also serves as a reference point to enable the psychiatrist to properly position the NeuroStar Treatment Coil over the prefrontal cortex, resting the coil lightly in contact with the patient&#146;s scalp. Accuracy of positioning of the treatment
coil for treatment is assured by use of the NeuroStar Advanced Therapy System&#146;s three-dimensional positioning device. Once the coil is properly positioned, the device delivers NeuroStar Advanced Therapy using a highly targeted, pulsed magnetic
field to stimulate cortical neurons. Our therapy provides targeted stimulation of the prefrontal cortex and engages the neuronal circuitry connected to this region that is known to be involved in the regulation of mood. </FONT></P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1pt solid #465361;BORDER-LEFT:1pt solid #465361;BORDER-RIGHT:1pt solid #465361;BORDER-TOP:1pt solid #465361;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We believe our solution addresses the key limitations of existing MDD
treatment options and that NeuroStar Advanced Therapy provides the following principal benefits to our psychiatrist customers and their patients: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Clinically demonstrated safety, efficacy, response and remission with durable results.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>The safety
and efficacy of our therapy has been demonstrated in two large sham-controlled trials. The results of a real-world clinical trial in patients who failed to achieve satisfactory improvement from antidepressant medication treatment demonstrated that
58% of patients responded to treatment, and 37% achieved remission. The majority of patients in this trial also participated in a <FONT STYLE="white-space:nowrap">12-month</FONT> <FONT STYLE="white-space:nowrap">follow-up</FONT> phase at the
conclusion of which the response rate in these patients was 68% and the remission rate was 45%. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Demonstrated safety profile with limited treatment-emergent side effects and high patient
adherence.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The adverse events discontinuation rate in our sham-controlled clinical studies has been approximately 5%. For single medication treatment in the STAR*D study, the adverse events discontinuation rate was 9%
to 41%. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Precise and reproducible office-based therapy.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>Patients receive NeuroStar Advanced Therapy in a
psychiatrist&#146;s office without the need for general anesthesia or sedation. Our system is designed to deliver the recommended TMS treatment dose to the indicated location consistently. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Efficient and convenient treatment for the patient and the psychiatrist.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>We have developed and
deployed the shortest duration FDA-cleared treatment for MDD using TMS therapy.<B><I> </I></B>Once a psychiatrist has established a patient&#146;s coordinates during the initial treatment session, a trained member of the office staff under the
supervision of the psychiatrist may administer subsequent treatment sessions. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Unique cloud-based practice management system.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>Our TrakStar practice management system captures
all treatment relevant information, and the encrypted information can be downloaded to any system in a psychiatrist&#146;s network in order to make it convenient for a patient to receive care and increase scheduling flexibility.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Comprehensive customer support and practice development resources</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;We believe that we offer the
most comprehensive practice support services among all TMS system providers to help our psychiatrist customers operationalize and grow their TMS service line. We provide our customers with significant marketing support to increase referring
physician and potential patient awareness. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Our Strengths </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are focused on improving the quality of life for patients who suffer from psychiatric disorders. We believe that the
following strengths will allow us to build our business and potentially expand our market opportunity. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>A market leader in TMS therapy.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;We believe we are the market leader in TMS therapy based on our
U.S. installed base of 781 active NeuroStar Advanced Therapy Systems in approximately 615 psychiatrist offices, the estimated 50,000 patients treated with over 1.8&nbsp;million of our treatment sessions, and our $40.4 million and $10.2&nbsp;million
in revenues in 2017 and the three months ended March 31, 2018, respectively. We believe these factors provide us meaningful competitive advantages by creating significant barriers to entry to other TMS providers. </FONT></P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1pt solid #465361;BORDER-LEFT:1pt solid #465361;BORDER-RIGHT:1pt solid #465361;BORDER-TOP:1pt solid #465361;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Significant body of clinical data and key opinion leader support.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The safety, efficacy and
durability of our therapy is supported by what we believe is the largest clinical data set of any TMS system. We have also established strong relationships with key opinion leaders within the psychiatric community who help us to educate
psychiatrists from around the world on innovative treatment modalities such as TMS therapy. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Proprietary technology with a broad IP portfolio.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;As of March&nbsp;31, 2018, we owned or licensed
30 issued or allowed U.S. patents, 49 issued or allowed foreign patents, seven pending U.S. patent applications and 14 pending foreign patent applications. We believe this patent portfolio is substantially larger than that of any of our TMS system
competitors. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Extensive reimbursement coverage and experience.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Based on our estimates, over 65 major private
insurers in the United States, including the top 25 largest private insurers, have adopted coverage policies for reimbursement of NeuroStar Advanced Therapy, representing approximately 205 million covered lives or about 95% of the total private
payor covered lives in the United States. In addition, our therapy is eligible for reimbursement from Medicare. Our reimbursement team has assisted our customers to conduct more than 20,000 benefits investigations. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Potential to enhance psychiatrist practice economics.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>Based on our commercial data, we believe
our<B> </B>psychiatrist customers can generate approximately $7,500 to $10,000 of revenues per patient for a standard course of treatment using our system and can recoup their capital investment in our system by treating approximately 12 patients.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Our Strategy </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our goal is to maintain and extend our leadership position in TMS therapy for patients with psychiatric disorders. The key elements of our strategy include: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">improve customer targeting and expand our direct sales and customer support team to accelerate growth; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">increase utilization of our new and existing installed base of our systems; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">expand our international market opportunities; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">pursue pipeline development of our therapy for additional indications. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Risks Associated with Our Business </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our ability to implement our business strategy is subject to numerous risks and uncertainties. You should carefully consider all of the information set forth in this prospectus and, in
particular, the information under the heading &#147;Risk Factors,&#148; beginning on page 12 of this prospectus, prior to making an investment in our common stock. These risks include, among others, the following: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">we have incurred losses in the past and may be unable to achieve or sustain profitability in the future; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">we rely generally on the sale of our NeuroStar Advanced Therapy System and treatment sessions to generate revenues;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">if coverage is unavailable or reimbursement from third-party payors for treatments using our products significantly declines,
psychiatrists may be reluctant to use our products; </FONT></P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1pt solid #465361;BORDER-LEFT:1pt solid #465361;BORDER-RIGHT:1pt solid #465361;BORDER-TOP:1pt solid #465361;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">psychiatrists and patients may be slow to adopt and use TMS therapies, including because our therapies must be administered up to five
times a week for six weeks in a psychiatrist&#146;s office; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our success depends in part upon patient satisfaction with the effectiveness of our NeuroStar Advanced Therapy System;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">we operate in a very competitive environment and if we are unable to compete successfully against our existing or potential
competitors, our sales and operating results may be negatively affected; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">if we are unable to successfully expand our sales and customer support team and adequately address our customers&#146; needs, it could
negatively impact sales and market acceptance of our products and we may never generate sufficient revenues to achieve or sustain profitability; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">security and privacy breaches may expose us to liability and harm our reputation and business; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our products and operations are subject to extensive government regulation and oversight both in the United States and abroad, and our
failure to comply with applicable requirements could harm our business. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Corporate Information
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We were incorporated in Delaware in April of 2003. Our principal executive offices are located at 3222&nbsp;Phoenixville
Pike, Malvern, Pennsylvania 19355, and our telephone number is (610) <FONT STYLE="white-space:nowrap">640-4202.</FONT> Our website address is <I>www.neurostar.com</I>. The information contained on, or accessible through, our website is not
incorporated by reference into this prospectus, and you should not consider any information contained in, or that can be accessed through, our website as part of this prospectus or in deciding whether to purchase our common stock. </FONT></P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1pt solid #465361;BORDER-LEFT:1pt solid #465361;BORDER-RIGHT:1pt solid #465361;BORDER-TOP:1pt solid #465361;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>THE OFFERING </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="80%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="45%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Issuer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Neuronetics, Inc.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Common stock offered by us</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,000,000 shares (or 5,750,000 shares if the underwriters exercise their option to purchase additional shares in full).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Common stock to be outstanding after this offering</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16,245,558 shares (or 16,995,558 shares if the underwriters exercise their option to purchase additional shares in full).</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Option to purchase additional shares of common stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The underwriters have a <FONT STYLE="white-space:nowrap">30-day</FONT> option to purchase up to 750,000 additional shares of common stock from us.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Use of proceeds</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We intend to use the net proceeds from this offering to fund the further commercialization and marketing of our NeuroStar Advanced Therapy System, primarily through
expansion of our sales, customer support and practice development teams; to fund research and development activities, which may include hardware and software product development and enhancements of our NeuroStar Advanced Therapy System and clinical
development expenses relating to additional indications; and for general corporate purposes, including general and administrative expenses and working capital. See &#147;Use of Proceeds.&#148;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Directed share program</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">At our request, the underwriters have reserved up to 250,000 shares of common stock, or approximately 5% of the shares offered by this prospectus, for sale at the
initial public offering price, to our directors, officers and current investors. Shares purchased by our directors and officers will be subject to the 180-day lock-up restriction described in the &#147;Underwriting&#148; section of this prospectus.
The number of shares of common stock available for sale to the general public will be reduced to the extent these parties purchase such reserved shares. Any reserved shares that are not purchased under this program will be offered by the
underwriters to the general public on the same terms as the other shares offered by this prospectus.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Risk factors</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">You may read the &#147;Risk Factors&#148; section of this prospectus beginning on page&nbsp;12 and other information included in this prospectus for a discussion of
factors that you should consider carefully before deciding to invest in our common stock.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Proposed Nasdaq Global Market symbol</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#147;STIM&#148;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1pt solid #465361;BORDER-LEFT:1pt solid #465361;BORDER-RIGHT:1pt solid #465361;BORDER-TOP:1pt solid #465361;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <center> <P STYLE="line-height:6px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P></center>  <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The number of shares of our common stock to be outstanding after this offering is based on 11,245,558 shares of our common stock outstanding as of March&nbsp;31, 2018, which includes
12,823 shares of unvested restricted stock. The number of shares of common stock outstanding as of March&nbsp;31, 2018 excludes: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,669,144 shares of common stock issuable upon the exercise of stock options outstanding as of March&nbsp;31, 2018, with a
weighted-average exercise price of $2.63 per share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">224,703 shares of common stock issuable upon the exercise of stock options granted after March&nbsp;31, 2018, with a weighted-average
exercise price of $7.54 per share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">105,095 shares of common stock issuable upon the exercise of warrants outstanding as of March&nbsp;31, 2018 to purchase shares of
convertible preferred stock that will become warrants to purchase shares of common stock upon the closing of this offering, at a weighted-average exercise price of $11.03 per share; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">46,670 shares of common stock reserved for future issuance under our Amended and Restated 2003 Stock Incentive Plan, as amended, or
2003 Plan; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,334,315 shares of common stock reserved for future issuance under the 2018 Plan, and shares that become available under the 2018 Plan
pursuant to provisions that automatically increase the share reserve under the 2018 Plan each year; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">243,699 shares of common stock reserved for future issuance under our 2018 Employee Stock Purchase Plan, or 2018 ESPP, and shares that
become available under the 2018 ESPP pursuant to provisions that automatically increase the share reserve under the 2018 ESPP each year. </FONT></P></TD></TR></TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Unless otherwise indicated, this prospectus reflects and assumes the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">a 0.0345-for-1 reverse split for our common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the automatic conversion of all outstanding shares of our convertible preferred stock into 10,994,280 shares of our common stock, which
will occur upon the closing of this offering; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the automatic conversion of all outstanding warrants to purchase shares of convertible preferred stock into warrants to purchase common
stock; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">no exercise of outstanding options or warrants or settlement of restricted stock units; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the filing of our amended and restated certificate of incorporation, which will occur upon the closing of this offering; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">no exercise by the underwriters of their option to purchase up to 750,000 additional shares of our common stock.
</FONT></P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1pt solid #465361;BORDER-LEFT:1pt solid #465361;BORDER-RIGHT:1pt solid #465361;BORDER-TOP:1pt solid #465361;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>SUMMARY FINANCIAL DATA </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following tables set forth, for the periods and as of the dates indicated, a summary of our historical financial
data. The statements of operations data for the years ended December&nbsp;31, 2016 and 2017 are derived from our audited financial statements appearing at the end of this prospectus. The statements of operations data for the three months ended March
31, 2017 and 2018 and the balance sheet data as of March 31, 2018 are derived from our unaudited interim financial statements appearing at the end of this prospectus. We have prepared our unaudited interim financial statements on the same basis as
our audited financial statements and have included, in our opinion, all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the financial information set forth in those statements. You should read this
data together with the more detailed information contained in our audited financial statements and the related notes thereto and in &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; included
elsewhere in this prospectus. Our historical results are not necessarily indicative of the results that should be expected in the future. Our interim results are not necessarily indicative of results to be expected for the full year ending December
31, 2018, or any other period. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="59%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Years
ended</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December 31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Three&nbsp;Months ended<BR>March 31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2016&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in&nbsp;thousands,&nbsp;except&nbsp;per&nbsp;share&nbsp;data)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Statements of Operations Data</U>:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">40,433</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,526</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,152</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,632</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,538</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,457</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gross Profit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">27,606</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30,801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,695</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Operating expenses:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">21,794</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">27,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,306</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,109</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,926</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,572</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,642</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,636</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,937</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,555</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">36,943</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">44,409</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,976</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Loss from Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(9,337</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(13,608</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(3,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(4,605</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other (income) expense:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Interest expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,835</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,808</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">921</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other (income) expense, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">62</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(357</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(11,234</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(16,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(4,514</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(5,497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net loss per share of common stock outstanding, basic and diluted</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(76.95</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(86.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(27.03</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(24.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Weighted-average common shares outstanding, basic and diluted</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">146</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">186</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">226</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma net loss per share of common stock outstanding, basic and diluted (unaudited)</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(0.49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma weighted-average common shares outstanding, basic and diluted (unaudited)</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,601</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,220</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">See &#147;Note 11. Loss per Share&#148; in our audited and unaudited interim financial statements included elsewhere in this prospectus
for an explanation of the method used to calculate the historical and pro forma basic and diluted net loss per common share. </FONT></P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1pt solid #465361;BORDER-LEFT:1pt solid #465361;BORDER-RIGHT:1pt solid #465361;BORDER-TOP:1pt solid #465361;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>As of March 31, 2018 </B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Actual</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Pro&nbsp;
forma<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Pro&nbsp;forma&nbsp;as<BR>Adjusted<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Balance Sheet Data</U>:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash and cash equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">87,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Working capital</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">19,522</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">19,522</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">86,272</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">32,016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">32,016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">97,372</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Long-term debt, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">485</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total stockholders&#146; (deficit) equity</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(197,974</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(10,353</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">56,397</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE>  <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Data presented on a pro forma basis to give effect to (i)&nbsp;the automatic conversion of all outstanding shares of our convertible
preferred stock into an aggregate of 10,994,280 shares of common stock and (ii)&nbsp;the automatic conversion of outstanding warrants to purchase shares of our convertible preferred stock into warrants to purchase shares of our common stock, each of
which will occur upon the closing of this offering. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Data presented on a pro forma as adjusted basis to give further effect to our issuance and sale of 5,000,000 shares of common stock in
this offering at an assumed initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering
expenses payable by us. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Each $1.00 increase (decrease) in the assumed initial public
offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted amount of each of cash and cash equivalents, working capital, total
assets and total stockholders&#146; equity (deficit) by $4.7&nbsp;million, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and
commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of 1,000,000 shares in the number of shares offered by us at the assumed initial public offering price would increase (decrease) the pro forma as adjusted
amount of each of cash and cash equivalents, working capital, total assets and total stockholders&#146; equity (deficit) by $14.0&nbsp;million. The pro forma as adjusted information discussed above is illustrative only and will be adjusted based on
the actual initial public offering price and other terms of our initial public offering determined at pricing. </FONT></P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_2"></A>RISK FACTORS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Investing in our common stock involves a high degree of risk. You should carefully consider the risks and uncertainties described
below and the other information contained in this prospectus before deciding whether to invest in our common stock. The occurrence of any of the events or developments described below could harm our business, financial condition, results of
operations and prospects. As a result, the market price of our common stock could decline, and you may lose all or part of your investment.</I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Risks Related to Our Business and Industry </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We have
incurred losses in the past and may be unable to achieve or sustain profitability in the future. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have incurred net
losses since inception, including net losses of $11.2&nbsp;million, $16.1&nbsp;million and $5.5&nbsp;million for the years ended December&nbsp;31, 2016 and 2017 and the three months ended March 31, 2018, respectively. As a result of ongoing losses,
as of March&nbsp;31, 2018, we had an accumulated deficit of $202.4&nbsp;million. We expect to continue to incur significant sales and marketing, product development, regulatory and other expenses as we continue to expand our marketing efforts to
increase adoption of our products and expand existing relationships with our customers, to obtain regulatory clearances or approvals for our products in additional countries and for additional indications, and to develop new products or add new
features to our existing products. In addition, our general and administrative expenses will increase following this offering due to the additional costs associated with being a public company. The net losses we incur may fluctuate significantly
from quarter to quarter. We will need to generate significant additional revenues to achieve and sustain profitability, and even if we achieve profitability, we cannot be sure that we will remain profitable for any substantial period of time. Our
failure to achieve or maintain profitability could negatively impact the value of our common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We rely on the sale
of our NeuroStar Advanced Therapy System and treatment sessions to generate revenues. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">At present, we rely on the sale
of our NeuroStar Advanced Therapy System and treatment sessions to generate revenues, and we expect to generate substantially all of our revenues in the foreseeable future from sales of these and any related products. Because the market for TMS
therapy is still developing and contains a limited number of market participants, sales of our products could be negatively impacted by unfavorable market reactions to our or other TMS devices. If the use of our or other TMS therapies results in
serious adverse events, or such products malfunction or are misused, patients and psychiatrists may attribute such negative events to TMS therapy generally, which may adversely affect market adoption of our products. Additionally, if patients
undergoing treatment with a NeuroStar Advanced Therapy System perceive the benefits to be inadequate or adverse events too numerous or severe compared to the relevant rates of alternative TMS therapies or pharmaceutical options, it will be difficult
to demonstrate the value of our NeuroStar Advanced Therapy System to patients and psychiatrists. As a result, demand for and the use of our NeuroStar Advanced Therapy System may decline or may not increase at the pace or to the levels we expect.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If coverage is unavailable or reimbursement from third-party payors for treatments using our products significantly
declines, psychiatrists may be reluctant to use our products. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the United States, sales of our products will depend,
in part, on the extent to which the treatment sessions using our products are covered and reimbursed by third-party payors, including private insurers and government healthcare programs. Even if a third-party payor covers a particular treatment that
uses our products, the resulting reimbursement rate may not be adequate to cover a provider&#146;s cost to purchase our products or ensure such purchase is profitable for the provider. Further, patients who are treated
<FONT STYLE="white-space:nowrap">in-office</FONT> for a medical condition generally rely on third-party payors to reimburse all or part of the costs associated with the treatment and may be unwilling to undergo such treatment in the absence of
coverage and adequate reimbursement, or due to large annual deductibles associated with certain health insurance plans. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Reimbursement by a third-party payor may depend upon a number of factors, including the
third-party payor&#146;s determination that a treatment is neither experimental nor investigational, safe, effective, and medically necessary, appropriate for the specific patient, cost-effective, supported by peer-reviewed medical journals and
included in clinical practice guidelines. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the United States, there is no uniform policy of coverage and reimbursement
among third-party payors. Third-party payors often rely upon Medicare coverage policies and payment limitations in setting their own reimbursement policies, but also have their own methods and approval process apart from Medicare coverage and
reimbursement determinations. Therefore, coverage and reimbursement for treatments can differ significantly from payor to payor. Decisions regarding the extent of coverage and amount of reimbursement to be provided for an <FONT
STYLE="white-space:nowrap">in-office</FONT> treatment is made on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">plan-by-plan</FONT></FONT> basis. One payor&#146;s determination to provide coverage for a specific treatment does
not assure that other payors will also provide coverage, and adequate reimbursement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, the federal government and
state legislatures have continued to implement cost containment programs, including price controls and restrictions on coverage and reimbursement. To contain costs, governmental healthcare programs and third-party payors are increasingly challenging
the price, scrutinizing the medical necessity and reviewing the cost-effectiveness of medical treatments. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Outside of the
United States, reimbursement systems vary significantly by country. Many foreign markets, including Japan, have government-managed healthcare systems that govern reimbursement for psychiatric treatments and procedures. Additionally, some foreign
reimbursement systems provide for limited payments in a given period and therefore result in extended payment periods. If adequate levels of reimbursement from third-party payors outside of the United States are not obtained, international sales of
our products may not materialize or grow significantly. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The marketability of our products may suffer if the government and
third-party payors fail to provide adequate coverage and reimbursement. Even if favorable coverage and reimbursement status is attained, less favorable coverage policies and reimbursement rates may be implemented in the future. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If we are unable to adequately train psychiatrists and other treatment providers on the safe and appropriate use of our products,
we may be unable to achieve our expected growth. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">There is a learning process involved for treatment providers to
become proficient in the use of our products, which requires us to spend considerable time and resources for training. It is critical to the success of our commercialization efforts to train a sufficient number of psychiatrists and to provide them
with adequate, ongoing instruction and training in the use of our products. This training process generally requires psychiatrists to review and study product materials, engage in multi-day, hands-on training sessions for up to four hours a day and
participate in a multi-day observational period prior to treating patients independently. This training process may also take longer than expected or be more complicated than the psychiatrists or their personnel are comfortable with and may
therefore affect our ability to increase sales. Convincing psychiatrists to dedicate the time and energy necessary for adequate training is challenging, and we may not be successful in these efforts. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Psychiatrists and patients may be slow to adopt and use TMS therapies. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">TMS therapy is an emerging treatment option for patients suffering from MDD. As a result, psychiatrist and patient awareness of TMS
therapy as a treatment option for MDD, and experience with TMS therapies, is limited. Our success depends in large part on our ability to educate and train psychiatrist and patients, and successfully demonstrate the safety, tolerability, ease of
use, efficacy, cost effectiveness and other merits of our NeuroStar Advanced Therapy System. We have been engaging in an active marketing campaign to raise awareness of our NeuroStar Advanced Therapy System and its benefits among psychiatrists, but
we cannot assure you that these efforts will be successful or that they will not </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">13 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
prove to be cost-prohibitive. Some psychiatrists may also find the initial patient set up and the subsequent procedures for future treatment sessions to be difficult or complicated, or could be
wary of the initial investment required for the purchase of the NeuroStar Advanced Therapy System, which may impact their decision to purchase or use the NeuroStar Advanced Therapy System as part of their practice. Similarly, psychiatrists may find
it difficult to hire additional staff, allocate sufficient space or operationalize our NeuroStar Advanced Therapy System, which could slow its adoption. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, psychiatrists may not derive sufficient cash flow from using the NeuroStar Advanced Therapy Systems due to their own practice economics or otherwise. Failure to achieve
economic benefits from the purchase or use of the NeuroStar Advanced Therapy System would adversely affect our customers&#146; purchase of treatment sessions. These factors could also reduce the number of procedures performed using our NeuroStar
Advanced Therapy System, and if we do not facilitate the utilization of our products by our customers, our revenues and results of operations could be harmed. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, in January 2018, we completed enrollment in a multicenter, prospective, randomized, sham controlled, double-blind pivotal clinical trial to evaluate our NeuroStar Advanced
Therapy System to treat adolescents with MDD. Based on a preliminary analysis we conducted in the second quarter of 2018, the primary endpoint in the initial phase of the ongoing trial was not met. These clinical trial results may have a potential
adverse impact on the market perception of our NeuroStar Advanced Therapy System. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our success depends in part upon
patient satisfaction with the effectiveness of our NeuroStar Advanced Therapy System. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In order to generate repeat and
referral business, patients must be satisfied with the effectiveness of our NeuroStar Advanced Therapy System. Clinical studies demonstrate that, in order to be effective, our products must be used for a period of four to six weeks, and require a
patient to return to a psychiatrist&#146;s office five days a week during that period in order to receive the recommended course of treatment. Since patients who achieve response or remission using our therapy will obtain these results gradually
over this treatment period, their perception of their results may vary depending on their compliance with the prescribed treatment course. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We train our psychiatrist customers to select the appropriate patient candidates for treatment using the NeuroStar Advanced Therapy System, explain to their patients the time-period over
which the results from a treatment course can be expected to occur, and measure the success of treatments using medical guidelines. However, our psychiatrist customers may not select appropriate patient candidates for NeuroStar Advanced Therapy
treatment, which may produce results that may not meet patients&#146; expectations. In addition, the efficacy of treatment is dependent on proper patient set up at the initial treatment session and duplication of that set up at future treatment
sessions. To the extent psychiatrists do not make the proper measurements for a specific patient or use the same procedures at each treatment session, it could result in variability of the treatment efficacy and results for the patient. If patients
are not satisfied with the results of our NeuroStar Advanced Therapy System, our reputation and future sales will suffer. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We operate in a very competitive environment and if we are unable to compete successfully against our existing or potential
competitors, our sales and operating results may be negatively affected. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our currently marketed products are, and any
future products we develop and commercialize will be, subject to intense competition. The industry in which we operate is subject to rapid change and is highly sensitive to the introduction of new products or other market activities of current or
new industry participants. Our ability to compete successfully will depend on our ability to develop products that reach the market in a timely manner, to receive adequate coverage and reimbursement from third-party payors, and to successfully
demonstrate to psychiatrists and patients the merits of our products compared to those of our competitors. If we are not successful in convincing others of the merits of our </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
products or educating them on the use of our products, they may not use our products or use them effectively and we may be unable to increase our sales. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have competitors that sell other forms of TMS therapy, including Brainsway, Magstim Magventure, CloudTMS and Nexstim, that compete
directly with the NeuroStar Advanced Therapy System. Competing TMS therapy companies may develop treatments that can be administered for shorter time periods, that have improved efficacy when compared to our products, or that require a less
significant investment of resources from psychiatrists. We also face competition from pharmaceutical and other companies that develop competitive products, such as antidepressant medications. Our commercial opportunity could be reduced or eliminated
if these competitors develop and commercialize antidepressant medications or other treatments that are safer or more effective than the NeuroStar Advanced Therapy System. At any time, these and other potential market entrants may develop treatment
alternatives that may render our products uncompetitive. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, our competitors may have more established distribution
networks than we do, or may be acquired by enterprises that have more established distribution networks than we do. Our competitors may also develop and patent processes or products earlier than we can or obtain domestic or international regulatory
clearances or approvals for competing products more rapidly than we can, which could impair our ability to develop and commercialize similar products. We also compete with our competitors in acquiring technologies and technology licenses
complementary to our products or advantageous to our business. In addition, we compete with our competitors to engage the services of independent distributors outside the United States, both those presently working with us and those with whom we
hope to work as we expand. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We may face difficulties encountered by companies in new and evolving markets.
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In assessing our prospects, you must consider the risks and difficulties frequently encountered by companies in new
and evolving markets. These risks include our ability to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">manage rapidly changing and expanding operations; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">increase awareness of our brand and strengthen customer loyalty; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">successfully execute our business and marketing strategy; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">respond effectively to competitive pressures and developments; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">continue to develop and enhance our products and products in development; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">obtain regulatory clearance or approval to commercialize new products and enhance our existing products; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">refrain from infringing on the intellectual property rights of others, and maintaining appropriate legal policies and procedures;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">expand our presence in existing and commence operations in new international markets; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">attract, retain and motivate qualified personnel. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If we are unable to successfully expand our sales and customer support team and adequately address our customers&#146; needs, it could negatively impact sales and market acceptance
of our products and we may never generate sufficient revenues to achieve or sustain profitability. </I></B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of
March&nbsp;31, 2018, our sales organization consisted of five independent distributors in five countries, and 126 professionals on our sales and customer support team. Our operating results are directly dependent upon the sales and marketing efforts
of our sales and customer support team and our independent third party distributors outside of the United States. If our employees or our independent distributors fail to adequately promote, market and sell our products, our sales could
significantly decrease. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, our future sales will largely depend on our ability to increase our
marketing efforts and adequately address our customers&#146; needs. We believe it is necessary to expand our sales force, including by hiring additional sales representatives or distributors with specific technical backgrounds that can support our
customers&#146; needs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As we launch new products, expand our product offerings to new indications and increase our marketing
efforts with respect to existing products, we will need to expand the reach of our marketing and sales networks. Our future success will depend largely on our ability to continue to hire, train, retain and motivate skilled employees, and
distributors with significant technical knowledge in various areas. New hires require training and take time to achieve full productivity. If we fail to train new hires adequately, or if we experience high turnover in our sales force in the future,
new hires may not become as productive as may be necessary to maintain or increase our sales. If we are unable to expand our sales and marketing capabilities domestically and internationally, we may be unable to effectively commercialize our
products. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>The loss of our senior management or our inability to attract and retain highly skilled executives,
salespeople and product development personnel could negatively impact our business. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our success depends on the skills,
experience and performance of the members of our executive management team. The individual and collective efforts of these employees will be important as we continue to develop our products and as we expand our commercial activities. We believe that
it is challenging to identify individuals with the requisite skills to serve in many of our key positions, and the loss or incapacity of existing members of our executive management team could negatively impact our operations. Other than our Chief
Executive Officer, we do not maintain key man life insurance with any of our employees. The existence of our Chief Executive Officer&#146;s employment agreement does not guarantee our retention of our Chief Executive Officer for any period of time.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our commercial, supply chain and research and development programs and operations depend on our ability to attract and retain
highly skilled managers, salespeople and product development and customer training personnel. We may be unable to attract or retain qualified managers, salespeople or product development and customer training personnel in the future due to the
competition for qualified personnel in the medical treatment and device fields. We also face competition from universities and public and private research institutions in recruiting and retaining highly qualified scientific personnel. Recruiting and
retention difficulties can limit our ability to support our commercial, supply chain and research and development programs. The loss of key employees, the failure of any key employee to perform or our inability to attract and retain skilled
employees, as needed, or an inability to effectively plan for and implement a succession plan for key employees could harm our business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our long-term growth depends on our ability to commercialize our approved products for current and future indications and to develop and commercialize additional products through our
research and development efforts. If we fail to do so we may be unable to compete effectively. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In order to increase
our future revenues, we must successfully enhance our existing product offerings and introduce new products in response to changing customer demands and competitive pressures and technologies. Our industry is characterized by intense competition,
including from lower-cost competitors, rapid technological changes, new product introductions and enhancements and evolving industry standards. We also face competition from large pharmaceutical companies with greater capital. Our business prospects
depend in part on our ability to develop and commercialize new products and applications for our technology, including in new markets that develop as a result of technological, pharmaceutical and scientific advances, while improving the performance
and cost-effectiveness of our products. New pharmaceutical products, technologies, techniques or other products could emerge that might offer better combinations of price and performance than our products. It is important that we anticipate changes
in technology and market demand, as well as psychiatrist practices to successfully </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
develop, obtain clearance or approval, if required, and successfully introduce new, enhanced and competitive technologies to meet our prospective customers&#146; needs on a timely and
cost-effective basis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We might be unable to successfully further commercialize or develop or obtain regulatory clearances or
approvals to market new products or our existing products for additional indications. For example, our NeuroStar Advanced Therapy System did not meet the primary endpoint in the initial phase of the clinical trial of adolescents with MDD. While we
intend to complete the remaining phases of this clinical trial, in light of these results we are unlikely to seek clearance for this indication. Additionally, these products and any future products, even if cleared, might not be accepted by
psychiatrists or the third-party payors who reimburse for the procedures performed with our products. The success of any new product offering or enhancement to an existing product will depend on numerous additional factors, including our ability to:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">properly identify and anticipate clinician and patient needs; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">demonstrate the benefits associated with the use or our products when compared to the products and devices of our competitors;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">develop and introduce new products or product enhancements in a timely manner; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">adequately protect our intellectual property and avoid infringing upon the intellectual property rights of third parties;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">demonstrate the safety and efficacy of new products; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">obtain the necessary regulatory clearances or approvals for new products or product enhancements. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If we do not develop and obtain regulatory clearances or approvals for new products or indications or product enhancements in time to
meet market demand, or if there is insufficient demand for these products or enhancements, our results of operations will suffer. Our research and development efforts may require a substantial investment of time and resources before we are
adequately able to determine the commercial viability of a new product, technology, material or other innovation. In addition, even if we are able to develop enhancements or new generations of our products successfully, these enhancements or new
generations of products may not produce sales in excess of the costs of development and they may be quickly rendered obsolete by changing customer preferences or the introduction by our competitors of products embodying new technologies or features.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Nevertheless, we must carefully manage our introduction of new products. If potential customers believe such products will
offer enhanced features or be sold for a more attractive price, they may delay purchases until such products are available. We may also have excess or obsolete inventory as we transition to new products, and we have limited experience in managing
product transitions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We rely on single-source suppliers for some components used in our NeuroStar Advanced Therapy
System and on a single manufacturer for the assembly of our NeuroStar Advanced Therapy System, and we may be unable to find replacements or immediately transition to alternative parties for these components. </I></B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We rely on single-source suppliers for some components used in our NeuroStar Advanced Therapy System, and we do not have long-term supply
contracts with these suppliers. Furthermore, we rely on a single manufacturer for the assembly of the mobile console and patient positioning system used in our NeuroStar Advanced Therapy System. For us to be successful, our suppliers and contract
manufacturer must be able to provide us with components in substantial quantities, in compliance with regulatory requirements, in accordance with agreed upon specifications, at acceptable costs and on a timely basis. While these suppliers have
generally met our demand requirements on a timely basis in the past, their </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">17 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
ability and willingness to continue to do so going forward may be limited for several reasons, including our lack of long-term agreements with those suppliers, our relative importance as a
customer of those suppliers, or, as applicable, their ability to produce the components for or provide assembly services to manufacture our NeuroStar Advanced Therapy System. An interruption in our commercial operations could occur if we encounter
delays or difficulties in securing these components or manufactured products, if we cannot obtain an acceptable substitute. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Any transition to a new supplier or contract manufacturer could be time-consuming and expensive, may result in interruptions in our
operations and product delivery, could affect the performance specifications of our NeuroStar Advanced Therapy System or could require that we modify its design. If we are required to change our contract manufacturer, we will be required to verify
that the new manufacturer maintains facilities, procedures and operations that comply with our quality and applicable regulatory requirements, which could further impede our ability to manufacture our products in a timely manner. If the change in
manufacturer results in a significant change to any product, a new 510(k) clearance from the FDA or similar non-U.S. regulatory authorization may be necessary before we implement the change, which could cause a substantial delay. We cannot assure
you that we will be able to identify and engage alternative suppliers or contract manufacturers on similar terms or without delay. Furthermore, our contract manufacturer could require us to move to a different production facility. The occurrence of
any of these events could harm our ability to meet the demand for our NeuroStar Advanced Therapy System in a timely and cost-effective manner. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We may be unable to manage our anticipated growth effectively, which could make it difficult to execute our business strategy. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have been growing rapidly and have a relatively short history of operating as a commercial company. For example, our revenues grew from
$34.2&nbsp;million for the year ended December&nbsp;31, 2016 to $40.4&nbsp;million for the year ended December&nbsp;31, 2017, and from $7.5 million for the three months ended March 31, 2017 to $10.2 million for the three months ended March 31, 2018.
We intend to continue to grow our business operations and may experience periods of rapid growth and expansion. This anticipated growth could create a strain on our organizational, administrative and operational infrastructure, including our supply
chain operations, quality control, technical support and customer service, sales force management and general and financial administration. We may be unable to maintain the quality, or delivery timelines, of our products or customer service or
satisfy customer demand if our business grows too rapidly. Our ability to manage our growth properly will require us to continue to improve our operational, financial and management controls, and our reporting systems and procedures. We may
implement new enterprise software systems in a number of areas affecting a broad range of business processes and functional areas. The time and resources required to implement these new systems is uncertain and failure to complete this in a timely
and efficient manner could harm our business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As our commercial operations and sales volume grow, we will need to continue to
increase our workflow capacity for our supply chain, customer service, training and education personnel, billing, accounting reporting and general process improvements and expand our internal quality assurance program, among other things. Because
our products require us to devote significant resources to training our customers on the use, and educating our customers on the benefits, of our products, we will be required to expand these personnel as we increase our sales efforts. We may not
successfully implement these increases in scale or the expansion of our personnel, which could harm our business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We
rely and in the future expect to rely on a network of third-party distributors to market and distribute our products internationally, and if we are unable to maintain and expand this network, we may be unable to generate anticipated sales.
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We rely, and expect to rely in the future, on a network of third-party distributors to market and distribute our
products in international markets. We currently sell our products in five countries outside </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">18 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
of the United States and plan to market and sell our products through our exclusive distribution agreement in Japan once we attain reimbursement approval. We are assessing the opportunity to
continue expanding into other international markets. We may face significant challenges and risks in managing a geographically dispersed distribution network. We have limited ability to control any third-party distributors. Our distributors may be
unable to successfully market and sell our products and may not devote sufficient time and resources to support the marketing, sales, education and training efforts that we believe enable the products to develop, achieve or sustain market
acceptance. Additionally, in some international jurisdictions, we rely on our distributors to manage the regulatory process, while complying with all applicable rules and regulations, and we are dependent on their ability to do so effectively. In
addition, if a dispute arises with a distributor or if a distributor is terminated by us or goes out of business, it may take time to locate an alternative distributor, to seek appropriate regulatory approvals and to train new personnel to market
our products, and our ability to sell those systems in the region formerly serviced by such terminated distributor could be harmed. Any of these factors could reduce our revenues from affected markets, increase our costs in those markets or damage
our reputation. In addition, i<B></B>f<B></B> an independent distributor were to depart and be retained by one of our competitors, we may be unable to prevent that distributor from helping competitors solicit business from our existing customers,
which could further adversely affect our sales. As a result of our reliance on third-party distributors, we may be subject to disruptions and increased costs due to factors beyond our control, including labor strikes, third-party error and other
issues. If the services of any of these third-party distributors become unsatisfactory, we may experience delays in meeting our customers&#146; demands and we may be unable to find a suitable replacement on a timely basis or on commercially
reasonable terms. Any failure to deliver products in a timely manner may damage our reputation and could cause us to lose potential customers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We face risks associated with our international business. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We currently market and sell our products in five countries outside of the United States, including Japan, and plan to market and sell our products through our exclusive distribution
agreement in Japan. Once we attain satisfactory reimbursement approval, we expect that sales of our NeuroStar Advanced Therapy System in Japan will increase. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The sale and shipment of our products across international borders, as well as the purchase of components and products from international sources, subjects us to extensive U.S. and other
foreign governmental trade, import and export and customs regulations and laws. Compliance with these regulations and laws is costly and exposes us to penalties for <FONT STYLE="white-space:nowrap">non-compliance.</FONT> We expect our international
activities will be dynamic over the foreseeable future as we continue to pursue opportunities in international markets. Our international business operations are subject to a variety of risks, including: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">difficulties in staffing and managing foreign and geographically dispersed operations, to the extent we establish <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> operations; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">differing and multiple payor reimbursement regimes, government payors or patient <FONT STYLE="white-space:nowrap">self-pay</FONT>
systems; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">difficulties in determining and creating the proper sales pathway in new, international markets; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">compliance with various U.S. and international laws, including export control laws and the U.S. Foreign Corrupt Practices Act of 1977,
or the FCPA, and anti-money laundering laws; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">differing regulatory requirements for obtaining clearances or approvals to market our products; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">changes in, or uncertainties relating to, foreign rules and regulations that may impact our ability to sell our products, perform
services or repatriate profits to the United States; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">19 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">tariffs and trade barriers, export regulations, sanctions and other regulatory and contractual limitations on our ability to sell our
products in certain foreign markets; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">potential adverse tax consequences, including imposition of limitations on or increase of withholding and other taxes on remittances
and other payments by foreign subsidiaries or joint ventures; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">imposition of differing labor laws and standards; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">armed conflicts or economic, political or social instability in foreign countries and regions; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">fluctuations in foreign currency exchange rates; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">an inability, or reduced ability, to protect our intellectual property, including any effect of compulsory licensing imposed by
government action; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">availability of government subsidies or other incentives that benefit competitors in their local markets that are not available to us.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are assessing the opportunity to expand into other international markets. However, our expansion plans
may not be realized, or if realized, may not be successful. We expect each market to have particular regulatory hurdles to overcome, and future developments in these markets, including the uncertainty relating to governmental policies and
regulations, could harm our business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our employees, consultants, distributors and other commercial partners may engage
in misconduct or other improper activities, including <FONT STYLE="white-space:nowrap">non-compliance</FONT> with regulatory standards and requirements. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are exposed to the risk that our employees, consultants, distributors and other commercial partners may engage in inappropriate, fraudulent or illegal activity. Misconduct by these
parties could include intentional, reckless or negligent conduct or other unauthorized activities that violate the regulations of the FDA and other U.S. healthcare regulators, as well as <FONT STYLE="white-space:nowrap">non-U.S.</FONT> regulators,
including by violating laws requiring the reporting of true, complete and accurate information to such regulators, manufacturing standards, healthcare fraud and abuse laws and regulations in the United States and abroad or laws that require the
true, complete and accurate reporting of financial information or data. In particular, sales, marketing and business arrangements in the healthcare industry, including the sale of medical devices, are subject to extensive laws and regulations
intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive
programs and other business arrangements. It is not always possible to identify and deter misconduct by our employees, distributors and other third parties, and the precautions we take to detect and prevent this activity may not be effective in
controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. These risks may be more pronounced, and we may find
that the processes and policies we have implemented are not effective at preventing misconduct. If any actions are instituted against us and we are not successful in defending ourselves or asserting our rights, those actions could result in the
imposition of significant fines or other sanctions, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, individual imprisonment, disgorgement, possible exclusion from participation in government
healthcare programs, additional reporting obligations and oversight if we becomes subject to a corporate integrity agreement or other agreement to resolve allegations of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these laws,
contractual damages, reputational harm, diminished profits and future earnings and the curtailment of our operations. Whether or not we are successful in defending against such actions or investigations, we could incur substantial costs, including
legal fees, and divert the attention of management in defending ourselves against any of these claims or investigations. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We rely in part on third parties to conduct our clinical trials. If these third
parties fail to perform their duties on time or as expected, we may not be able to obtain regulatory approval for additional indications that we may seek for the NeuroStar Advanced Therapy System. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our clinical trials are managed by our own staff and personnel, but we rely in part upon certain third-parties, including clinical trial
sites, medical institutions, clinical research organizations, or CROs, and private practices, for, among other things, site monitoring, statistical work and electronic data capture in our clinical trials.&nbsp;Nevertheless, we are responsible for
ensuring that each of our clinical trials is conducted in accordance with applicable protocols, and legal, regulatory and scientific standards, including current good clinical practices, or cGCPs, which are regulations and guidelines enforced by the
FDA and comparable foreign regulatory authorities for clinical trials.&nbsp;If we or any such third parties fail to comply with applicable cGCPs, the clinical data generated in such trials may be deemed unreliable and the FDA or comparable foreign
regulatory authorities may require us to perform additional clinical trials before approving a marketing application for any particular indication. In addition, if such third parties do not devote sufficient time and resources to our clinical trials
or otherwise carry out their contractual duties or obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they assist in obtaining is compromised due to the failure to adhere to our
clinical protocols, regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated, and we may not be able to obtain regulatory approval for or successfully commercialize our product candidates in a
specified indication. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If product liability lawsuits are brought against us, our business may be harmed, and we may be
required to pay damages that exceed our insurance coverage. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our business exposes us to potential product liability
claims that are inherent in the testing, manufacture and sale of medical devices for the treatment of MDD. Our treatments are designed for patients who suffer from significant psychiatric disorders, and these patients are more likely to experience
significant adverse health outcomes, which could increase the risk of product liability lawsuits. Furthermore, if psychiatrists are not sufficiently trained in the use of our products, they may misuse or ineffectively use our products, which may
result in unsatisfactory patient outcomes. We could become the subject of product liability lawsuits alleging that component failures, malfunctions, manufacturing flaws, design defects or inadequate disclosure of product-related risks or
product-related information resulted in an unsafe condition or injury to patients. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Regardless of the merit or eventual
outcome, product liability claims may result in: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">decreased demand for our products; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">injury to our reputation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">significant litigation costs; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">substantial monetary awards to or costly settlements with patients; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">product recalls; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">material defense costs; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">loss of revenues; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the inability to commercialize new products or product candidates; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">diversion of management attention from pursuing our business strategy. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our existing product liability insurance coverage may be inadequate to protect us from any liabilities we might incur. If a product
liability claim or series of claims is brought against us for uninsured liabilities or in excess of our insurance coverage, our business could suffer. Any product liability claim brought </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">21 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
against us, with or without merit, could result in the increase of our product liability insurance rates or the inability to secure coverage in the future. In addition, a recall of some of our
products, whether or not the result of a product liability claim, could result in significant costs and loss of customers. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our insurance policies protect us only from some business risks, which will leave us exposed to significant uninsured liabilities.
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We do not carry insurance for all categories of risk that our business may encounter. Some of the policies we
currently maintain include general liability, cybersecurity liability, employee benefits liability, property, umbrella, workers&#146; compensation, products and clinical trial liability and directors&#146; and officers&#146; insurance. We do not
know, however, if these policies will provide us with adequate levels of coverage. Any significant uninsured liability may require us to pay substantial amounts, which would adversely affect our cash position and results of operations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We bear the risk of warranty claims on our products. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We bear the risk of warranty claims on the products we supply for two years from the date of delivery. We have a warranty reserve of $0.6&nbsp;million at March&nbsp;31, 2018. There can be
no assurance that we will not face increased claims in the future. We may not be successful in claiming recovery under any warranty or indemnity provided to us by our suppliers or vendors in the event of a successful warranty claim against us by a
customer or that any recovery from such vendor or supplier would be adequate. In addition, warranty claims brought by our customers related to third-party components may arise after our ability to bring corresponding warranty claims against such
suppliers expires, which could result in costs to us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We could be negatively impacted by violations of applicable
anti-corruption laws or violations of our internal policies designed to ensure ethical business practices. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We operate
in a number of countries throughout the world, including in countries that do not have as strong a commitment to anti-corruption and ethical behavior that is required by U.S. laws or by our corporate policies. We are subject to the risk that we, our
U.S. employees or any future employees or consultants located in other jurisdictions or any third parties such as our distributors that we engage to do work on our behalf in foreign countries may take action determined to be in violation of
anti-corruption laws in any jurisdiction in which we conduct business, including the FCPA. The FCPA generally prohibits covered entities and their intermediaries from engaging in bribery or making other prohibited payments, offers or promises to
foreign officials for the purpose of obtaining or retaining business or other advantages. In addition, the FCPA imposes recordkeeping and internal controls requirements on publicly traded corporations and their foreign affiliates, which are intended
to, among other things, prevent the diversion of corporate funds to the payment of bribes and other improper payments, and to prevent the establishment of &#147;off books&#148; slush funds from which such improper payments can be made. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We will face significant risks if we fail to comply with the FCPA and other laws that prohibit improper payments, offers or promises of
payment to foreign governments and their officials and political parties by us and other business entities for the purpose of obtaining or retaining business or other advantages. In many foreign countries, particularly in countries with developing
economies, it may be a local custom that businesses operating in such countries engage in business practices that are prohibited by the FCPA or other laws and regulations. We have implemented or are in the process of implementing company policies
relating to compliance with the FCPA and similar laws. However, such policies may not be effective at preventing all potential FCPA or other violations. Although our agreements with our international distributors state our expectations for our
distributors&#146; compliance with U.S. laws, including the FCPA, and provide us with various remedies upon any <FONT STYLE="white-space:nowrap">non-compliance,</FONT> including the ability to terminate the agreement, our distributors may not comply
with U.S. laws, including the FCPA. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">22 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
Any violation of the FCPA or any similar anti-corruption law or regulation could result in substantial fines, sanctions, civil and/or criminal penalties and curtailment of operations in certain
jurisdictions and might harm our business, financial condition or results of operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If we experience significant
disruptions in our information technology systems, our business may be adversely affected. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We depend on our
information technology systems for the efficient functioning of our business, including for our TrakStar system and accounting, data storage, compliance, purchasing and inventory management. We do not have redundant systems at this time. While we
will attempt to mitigate interruptions, we may experience difficulties in implementing upgrades to our information technology systems, which would impact our business operations, or experience difficulties in operating our business during the
upgrade, either of which could disrupt our operations, including our ability to provide customers with data on patient outcomes, track the usage of our products, timely ship and track product orders, project inventory requirements, manage our supply
chain and otherwise adequately service our customers or disrupt our customers&#146; ability to access patient data or use our products for treatments. In the event we experience significant disruptions as a result of the current implementation of
our information technology systems, we may be unable to repair our systems in an efficient and timely manner. Accordingly, such events may disrupt or reduce the efficiency of our entire operation and have a material adverse effect on our results of
operations and cash flows. Currently we carry business interruption coverage to mitigate any potential losses, but we cannot be certain that such potential losses will not exceed our policy limits. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are increasingly dependent on sophisticated information technology for our infrastructure. Our information systems require an ongoing
commitment of significant resources to maintain, protect and enhance existing systems. Failure to maintain or protect our information systems and data integrity effectively could have a materially adverse effect on our business. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Performance issues, service interruptions or price increases by our shipping carriers could adversely affect our business and harm
our reputation and ability to provide our services on a timely basis. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Expedited, reliable shipping is essential to our
operations. We rely heavily on providers of transport services for reliable and secure <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-to-point</FONT></FONT> transport of our products to our customers and for tracking of
these shipments. Should a carrier encounter delivery performance issues such as loss, damage or destruction of any systems, it would be costly to replace such systems in a timely manner and such occurrences may damage our reputation and lead to
decreased demand for our products and increased cost and expense to our business. In addition, any significant increase in shipping rates could adversely affect our operating margins and results of operations. Similarly, strikes, severe weather,
natural disasters or other service interruptions affecting delivery services we use would adversely affect our ability to process orders for our products on a timely basis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Security and privacy breaches may expose us to liability and harm our reputation and business. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As part of our business we receive and process information about our customers, partners and their patients, including protected health information, or PHI, and we may store or contract
with third parties to store our customers&#146; data, including PHI. PHI, a subset of individually identifiable information, is regulated at the federal level by the Health Insurance Portability and Accountability Act, or HIPAA, as amended by the
Health Information and Technology for Economic and Clinical Health Act of 2009, or HITECH, and by various laws at the state level, as more fully described below. We are required to safeguard PHI in accordance with HIPAA and, as a business associate,
we are also directly liable for compliance with HIPAA. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">While we implemented security measures relating to our NeuroStar
Advanced Therapy System and TrakStar database, specifically, and our operations, generally, those measures may not prevent security </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">23 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
breaches that could harm our business. Advances in computer capabilities, inadequate technology or facility security measures or other factors may result in a compromise or breach of our systems
and the data and PHI we store and process. Our security measures may be breached as a result of actions by third parties or employee error or malfeasance. A party who is able to circumvent our security measures or exploit inadequacies in our
security measures, could, among other things, misappropriate proprietary information, including information about our customers and their patients, cause the loss or disclosure of some or all of this information, cause interruptions in our or our
customers&#146; operations or expose our customers to computer viruses or other disruptions or vulnerabilities. Any compromise of our systems or the data we store or process could implicate reporting requirements under HIPAA, result in a loss of
confidence in the security of our software, damage our reputation, disrupt our business, lead to legal liability and adversely affect our results of operations. Moreover, a compromise of our systems could remain undetected for an extended period of
time, exacerbating the impact of that compromise. Actual or perceived vulnerabilities may lead to claims against us by our customers, their patients or other third parties, including the federal and state governments. While our customer agreements
typically contain provisions that seek to limit our liability, there is no assurance these provisions will be enforceable and effective under applicable law. In addition, the cost and operational consequences of implementing further data protection
measures could be significant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Employment litigation and unfavorable publicity could negatively affect our future
business. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Employees may, from time to time, bring lawsuits against us regarding injury, creating a hostile work place,
discrimination, wage and hour, sexual harassment and other employment issues. In recent years there has been an increase in the number of discrimination and harassment claims generally. Coupled with the expansion of social media platforms and
similar devices that allow individuals access to a broad audience, these claims have had a significant negative impact on some businesses. Companies that have faced employment or harassment related lawsuits have had to terminate management or other
key personnel, and have suffered reputational harm that has negatively impacted their sales. If we were to face any employment related claims, our business could be negatively affected. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>The recently passed comprehensive tax reform bill could adversely affect our business and financial condition. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">On December&nbsp;22, 2017, President Trump signed into law new legislation, (Pub. L. <FONT STYLE="white-space:nowrap">115-97),</FONT> commonly referred to as the Tax Cuts and Jobs Act of
2017, that significantly revises the Internal Revenue Code of 1986, as amended.&nbsp;The newly enacted federal income tax law, among other things, contains significant changes to corporate taxation, including reduction of the corporate tax rate from
a top marginal rate of 35% to a flat rate of 21%, limitation of the tax deduction for interest expense to 30% of adjusted earnings (except for certain small businesses), limitation of the deduction for net operating losses to 80% of current year
taxable income and elimination of net operating loss carrybacks, one time taxation of offshore earnings at reduced rates regardless of whether they are repatriated, elimination of U.S. tax on foreign earnings (subject to certain important
exceptions), immediate deductions for certain new investments instead of deductions for depreciation expense over time, and modifying or repealing many business deductions and credits.&nbsp;Notwithstanding the reduction in the corporate income tax
rate, the overall impact of the new federal tax law is uncertain and our business and financial condition could be adversely affected.&nbsp;In addition, it is uncertain how various states will respond to the newly enacted federal tax law.&nbsp;The
impact of this tax reform on holders of our common stock is also uncertain and could be adverse.&nbsp;We urge our stockholders to consult with their legal and tax advisors with respect to this legislation and the potential tax consequences of
investing in or holding our common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our effective tax rate may fluctuate, and we may incur obligations in tax
jurisdictions in excess of accrued amounts. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are subject to taxation in numerous U.S. states and territories. As a
result, our effective tax rate is derived from a combination of applicable tax rates in the various places that we operate. In preparing </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">24 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
our financial statements, we estimate the amount of tax that will become payable in each of such places. Nevertheless, our effective tax rate may be different than experienced in the past due to
numerous factors, including passage of the newly enacted federal income tax law, changes in the mix of our profitability from state to state, the results of examinations and audits of our tax filings, our inability to secure or sustain acceptable
agreements with tax authorities, changes in accounting for income taxes and changes in tax laws. Any of these factors could cause us to experience an effective tax rate significantly different from previous periods or our current expectations and
may result in tax obligations in excess of amounts accrued in our financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our operations are vulnerable
to interruption or loss due to natural or other disasters, power loss, strikes and other events beyond our control. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">A
major earthquake, fire or other disaster, such as a major flood, seasonal storms, or terrorist attack affecting our facilities, or those of our third-party manufacturers or suppliers, could significantly disrupt our or their operations, and delay or
prevent product shipment or installation during the time required to repair, rebuild or replace our third-party manufacturers or suppliers&#146; damaged manufacturing facilities. These delays could be lengthy and costly. If any of our
manufacturers&#146;, suppliers&#146; or customers&#146; facilities are negatively impacted by a disaster, shipments of our products could be delayed. Additionally, customers may delay purchases of our products until operations return to normal. Even
if we are able to quickly respond to a disaster, the ongoing effects of the disaster could create some uncertainty in the operations of our business. In addition, our or their facilities may be subject to a shortage of available electrical power and
other energy supplies. Any shortages may increase our costs for power and energy supplies or could result in blackouts, which could disrupt the operations of our affected facilities and harm our business. In addition, concerns about terrorism, the
effects of a terrorist attack, political turmoil or an outbreak of epidemic diseases could have a negative effect on our operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We may seek to grow our business through acquisitions or investments in new or complementary businesses, products or technologies, through the licensing of products or technologies
from third parties. The failure to manage acquisitions, investments, licenses or other strategic alliances, or the failure to integrate them with our existing business, could harm our business. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our success depends in part on our ability to continually enhance and broaden our product offerings in response to changing customer
demands, competitive pressures, technologies and market pressures. Accordingly, from time to time we may consider opportunities to acquire, make investments in or license other technologies, products and businesses that may enhance our capabilities,
complement our current products or expand the breadth of our markets or customer base. Potential and completed acquisitions, strategic investments, licenses and other alliances involve numerous risks, including: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">difficulty assimilating or integrating acquired or licensed technologies, products or business operations;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">issues maintaining uniform standards, procedures, controls and policies; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">unanticipated costs associated with acquisitions or strategic alliances, including the assumption of unknown or contingent liabilities
and the incurrence of debt or future write-offs of intangible assets or goodwill; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">diversion of management&#146;s attention from our core business and disruption of ongoing operations; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">adverse effects on existing business relationships with suppliers, distributors and customers; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">risks associated with entering new markets in which we have limited or no experience; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">potential losses related to investments in other companies; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">potential loss of key employees of the acquired businesses; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">increased legal and accounting compliance costs. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">25 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We do not know if we will be able to identify acquisitions or strategic relationships
we deem suitable, whether we will be able to successfully complete any such transactions on favorable terms or at all or whether we will be able to successfully integrate any acquired business, product or technology into our business or retain any
key personnel, suppliers or distributors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Foreign acquisitions involve unique risks in addition to those mentioned above,
including those related to integration of operations across different cultures, languages and legal and regulatory environments, currency risks and the particular economic, political and regulatory risks associated with specific countries.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">To finance any acquisitions, investments or strategic alliances, we may choose to issue shares of our common stock or other
equity-linked securities as consideration, which could dilute the ownership of our stockholders. Additional funds may not be available on terms that are favorable to us, or at all. If the price of our common stock is low or volatile, we may be
unable to consummate any acquisitions, investments or strategic alliances using our stock as consideration. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Risks Related
to Intellectual Property </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If we are not able to obtain and enforce patent protection for our technologies, products,
or product candidates, development and commercialization of our products and product candidates may be adversely affected. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our commercial success will depend in part on our success in obtaining and maintaining issued patents and other intellectual property rights in the United States and elsewhere and
protecting our proprietary technology. If we do not adequately protect our intellectual property and proprietary technology, competitors may be able to use our technologies and erode or negate any competitive advantage we may have, which could harm
our business and ability to achieve profitability. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have applied, and we intend to continue applying, for patents covering
aspects of our technologies that we deem appropriate. However, the patent process is expensive and time consuming, and we may not be able to apply for patents on certain aspects of our current or future products and other technologies in a timely
fashion, at a reasonable cost, in all jurisdictions, or at all, and any potential patent coverage we obtain may not be sufficient to prevent substantial competition. As of March&nbsp;31, 2018, we owned or licensed 30 issued or allowed U.S. patents
and 49 issued or allowed foreign patents and we owned or licensed seven pending U.S. patent applications and 14 pending foreign patent applications. Assuming all required fees are paid, issued U.S. patents owned by us will expire between 2019 and
2027. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We cannot offer any assurances about which, if any, patents will issue or whether any issued patents will be found
invalid and unenforceable or will be threatened by third parties. Any patent applications we file may be challenged and may not result in issued patents or may be invalidated or narrowed in scope after they are issued. We also cannot provide any
assurances that any of our patents have, or that any of our pending patent applications that mature into issued patents will include, claims with a scope sufficient to protect and provide exclusivity for our products, any additional features we
develop for our products or any new products. Other parties may have designed around our claims or developed technologies that may be related or competitive to our platform, may have filed or may file patent applications and may have received or may
receive patents that overlap or conflict with our patent applications, either by claiming the same methods or devices or by claiming subject matter that could dominate our patent position. Any successful opposition to these patents or any other
patents owned by or, if applicable in the future, licensed to us could deprive us of rights necessary for the practice of our technologies or the successful commercialization of any products or product candidates that we may develop. Since patent
applications in the US and most other countries are confidential for a period of time after filing, we cannot be certain that we or our licensors were the first to file any patent application related to our
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">26 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
technologies, products, or product candidates. Furthermore, an interference proceeding can be provoked by a third party or instituted by the United States Patent and Trademark Office, or the
USPTO, to determine who was the first to invent any of the subject matter covered by the patent claims of our applications for any application with an effective filing date before March&nbsp;16, 2013. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The patent positions of medical device companies, including our patent position, may involve complex legal and factual questions, and,
therefore, the scope, validity and enforceability of any patent claims that we may obtain cannot be predicted with certainty. Patents, if issued, may be challenged, deemed unenforceable, invalidated or circumvented. Once granted, patents may remain
open to opposition, interference, <FONT STYLE="white-space:nowrap">re-examination,</FONT> post-grant review, inter partes review, nullification or derivation action in court or before patent offices or similar proceedings for a given period after
allowance or grant, during which time third parties can raise objections against such initial grant. Proceedings challenging our patents, which may continue for a protracted period of time, could result in either loss of the patent or denial of the
patent application or loss or reduction in the scope of one or more of the claims of the patent or patent application. In addition, such proceedings may be costly. Thus, any patents that we may own may not provide any protection against competitors.
Furthermore, an adverse decision in an interference proceeding can result in a third party receiving the patent right sought by us, which in turn could affect our ability to commercialize our products. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Furthermore, though an issued patent is presumed valid and enforceable, its issuance is not conclusive as to its validity or its
enforceability and it may not provide us with adequate proprietary protection or competitive advantages against competitors with similar products. Competitors may also be able to design around our patents. Other parties may develop and obtain patent
protection for alternative and possibly more effective technologies, designs or methods. We may be unable to prevent the unauthorized disclosure or use of our technical knowledge or trade secrets by consultants, suppliers, vendors, former employees
and current employees. The laws of some foreign countries do not protect our proprietary rights to the same extent as the laws of the United States, and we may encounter significant problems in protecting our proprietary rights in these countries.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our ability to enforce our patent rights depends on our ability to detect infringement. It may be difficult to detect
infringers who do not advertise the components that are used in their products. Moreover, it may be difficult or impossible to obtain evidence of infringement in a competitor&#146;s or potential competitor&#146;s product. We may not prevail in any
lawsuits that we initiate and the damages or other remedies awarded if we were to prevail may not be commercially meaningful. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, proceedings to enforce or defend our patents could put our patents at risk of being invalidated, held unenforceable or
interpreted narrowly. Such proceedings could also provoke third parties to assert claims against us, including that some or all of the claims in one or more of our patents are invalid or otherwise unenforceable. If any of our patents covering our
products are invalidated or found unenforceable, or if a court found that valid, enforceable patents held by third parties covered one or more of our products, our competitive position could be harmed or we could be required to incur significant
expenses to enforce or defend our rights. If we initiate lawsuits to protect or enforce our patents, or litigate against third party claims, such proceedings would be expensive and would divert the attention of our management and technical
personnel. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The degree of future protection for our proprietary rights is uncertain, and we cannot ensure that: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">any of our patents, or any of our pending patent applications, if issued, or those of our licensors, will include claims having a scope
sufficient to protect our products; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">any of our pending patent applications or those of our licensors may issue as patents; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">27 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">others will not or may not be able to make, use, offer to sell, or sell products that are the same as or similar to our own but that
are not covered by the claims of the patents that we own or license; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">we will be able to successfully commercialize our products on a substantial scale, if approved, before the relevant patents that we own
or license expire; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">we were the first to make the inventions covered by each of the patents and pending patent applications that we own or license;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">we or our licensors were the first to file patent applications for these inventions; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">others will not develop similar or alternative technologies that do not infringe the patents we own or license;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">any of the patents we own or license will be found to ultimately be valid and enforceable; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">any patents issued to us or our licensors will provide a basis for an exclusive market for our commercially viable products or will
provide us with any competitive advantages; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">a third party may not challenge the patents we own or license and, if challenged, a court would hold that such patents are valid,
enforceable and infringed; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">we may develop or <FONT STYLE="white-space:nowrap">in-license</FONT> additional proprietary technologies that are patentable;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the patents of others will not have an adverse effect on our business; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our competitors do not conduct research and development activities in countries where we do not have enforceable patent rights and then
use the information learned from such activities to develop competitive products for sale in our major commercial markets; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">we will develop additional proprietary technologies or products that are separately patentable; or </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our commercial activities or products will not infringe upon the patents of others. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Where we obtain licenses from or collaborate with third parties, in some circumstances, we may not have the right to control the
preparation, filing and prosecution of patent applications, or to maintain the patents, covering technology that we license from third parties, or such activities, if controlled by us, may require the input of such third parties. We may also require
the cooperation of our licensors and collaborators to enforce any licensed patent rights, and such cooperation may not be provided. Therefore, these patents and applications may not be prosecuted and enforced in a manner consistent with the best
interests of our business. Moreover, if we do obtain necessary licenses, we will likely have obligations under those licenses, and any failure to satisfy those obligations could give our licensor the right to terminate the license. Termination of a
necessary license, or expiration of licensed patents or patent applications, could have a material adverse impact on our business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our inability to effectively protect our proprietary technologies could harm our competitive position. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Although our competitors have utilized and are expected to continue utilizing technologies similar to ours, our success will depend upon our ability to protect and continue to develop
proprietary technologies and products and to defend any advantages afforded to us relative to our competitors. If we do not protect our intellectual property adequately, competitors may be able to use our technologies and thereby erode any
competitive advantages we may have. For example, patents for our core technology will begin to expire in the United States in 2024, and our patents outside of the United States are expected to remain in effect until between 2024 and 2035. We will be
able to protect our proprietary rights from unauthorized use by third parties only to the extent that our proprietary technologies are covered by valid and enforceable patents or are effectively maintained as trade secrets. We have
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">28 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
agreements with our employees and selected consultants that obligate them to assign their inventions to us. If the employees and consultants who are parties to these agreements breach or violate
the terms of these agreements, including by refusing or being unavailable to sign assignments, oaths, declarations or other documents, we may not have adequate remedies for any such breach or violation, and we could lose our rights in inventions
through such breaches or violations. Furthermore, it is possible that technology relevant to our business will be independently developed by a person that is not a party to such an agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>The lives of our patents may not be sufficient to effectively protect our products and business. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Patents have a limited lifespan. In the US, the natural expiration of a patent is generally 20 years after its first effective <FONT STYLE="white-space:nowrap">non-provisional</FONT>
filing date. Although various extensions may be available, the life of a patent, and the protection it affords, is limited. Even if patents covering our technologies, products, or product candidates are obtained, once the patent life has expired, we
may be open to competition. Patents covering some of our core technology have expired or will expire within the next five years. In addition, although upon issuance in the United States a patent&#146;s life can be increased based on certain delays
caused by the USPTO, this increase can be reduced or eliminated based on certain delays caused by the patent applicant during patent prosecution. If we do not have sufficient patent life to protect our technologies, products, and product candidates,
our business and results of operations will be adversely affected. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Litigation or other proceedings or third-party
claims of intellectual property infringement could require us to spend significant time and money and could prevent us from selling our products. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our commercial success will depend in part on not infringing the patents or violating the other proprietary rights of others. We cannot assure you that our operations do not, or will not
in the future, infringe existing or future patents. Our activities may be subject to claims that we infringe or otherwise violate patents owned or controlled by third parties. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Numerous U.S. and foreign patents and pending patent applications exist in our market that are owned by third parties. Our competitors in both the United States and abroad, many of which
have substantially greater resources and have made substantial investments in patent portfolios and competing technologies, may have applied for or obtained or may in the future apply for and obtain, patents that will prevent, limit or otherwise
interfere with our ability to make, use and sell our products. We do not always conduct independent reviews of pending patent applications of and patents issued to third parties. Patent applications in the United States and elsewhere are typically
published approximately 18 months after the earliest filing for which priority is claimed, with such earliest filing date being commonly referred to as the priority date. Certain U.S. applications that will not be filed outside the U.S. can remain
confidential until patents issue. In addition, patent applications in the United States and elsewhere can be pending for many years before issuance, or unintentionally abandoned patents or applications can be revived. Furthermore, pending patent
applications that have been published can, subject to certain limitations, be later amended in a manner that could cover our technologies, our products or the use of our products. As such, there may be applications of others now pending or recently
revived patents of which we are unaware. These applications may later result in issued patents, or the revival of previously abandoned patents, that will prevent, limit or otherwise interfere with our ability to make, use or sell our products.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the
patent&#146;s prosecution history and can involve other factors such as expert opinion. Our interpretation of the relevance or the scope of claims in a patent or a pending application may be incorrect, which may negatively impact our ability to
market our products. Further, we may incorrectly determine that our technologies, products, or product candidates are not covered by a third party patent or may incorrectly predict whether a third party&#146;s pending patent application will issue
with claims of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
relevant scope. Our determination of the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect, which may negatively impact our ability to
develop and market our products or product candidates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Significant litigation regarding patent rights occurs in our industry.
Third parties may, in the future, assert claims that we are employing their proprietary technology without authorization, including claims from competitors or from <FONT STYLE="white-space:nowrap">non-practicing</FONT> entities that have no relevant
product revenue and against whom our own patent portfolio may have no deterrent effect. As we continue to commercialize our products in their current or updated forms, launch new products and enter new markets, we expect competitors may claim that
one or more of our products infringe their intellectual property rights as part of business strategies designed to impede our successful commercialization and entry into new markets. The large number of patents, the rapid rate of new patent
applications and issuances, the complexities of the technology involved, and the uncertainty of litigation may increase the risk of business resources and management&#146;s attention being diverted to patent litigation. Although we are presently
unaware of any such third-party claims, in the future, we may receive letters or other threats or claims from third parties inviting us to take licenses under, or alleging that we infringe, their patents. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Moreover, we may become party to future adversarial proceedings regarding our patent portfolio or the patents of third parties. Such
proceedings could include supplemental examination or contested post-grant proceedings such as review, reexamination, interference or derivation proceedings before the U.S. Patent and Trademark Office and challenges in U.S. District Court. Patents
may be subjected to opposition, post-grant review or comparable proceedings lodged in various foreign, both national and regional, patent offices. The legal threshold for initiating litigation or contested proceedings may be low, so that even
lawsuits or proceedings with a low probability of success might be initiated. Litigation and contested proceedings can also be expensive and time-consuming, regardless of the merit of the claims, and our adversaries in these proceedings may have the
ability to dedicate substantially greater resources to prosecuting these legal actions than we can. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Any lawsuits resulting
from such allegations could subject us to significant liability for damages and invalidate our proprietary rights. Any potential intellectual property litigation also could force us to do one or more of the following: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">stop making, selling or using products or technologies that allegedly infringe the asserted intellectual property;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">lose the opportunity to license our technology to others or to collect royalty payments based upon successful protection and assertion
of our intellectual property rights against others; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">incur significant legal expenses; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">pay substantial damages or royalties to the party whose intellectual property rights we may be found to be infringing, including
enhanced damages if we are found to have willfully infringed or misappropriated such rights; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">pay the attorney&#146;s fees and costs of litigation to the party whose intellectual property rights we may be found to be infringing;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">redesign those products that contain the allegedly infringing intellectual property, which could be costly, disruptive and infeasible;
and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">attempt to obtain a license to the relevant intellectual property from third parties, which may not be available on reasonable terms or
at all, or from third parties who may attempt to license rights that they do not have. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Any litigation or claim against us, even those without merit, may cause us to incur
substantial costs, and could place a significant strain on our financial resources, divert the attention of management from our core business and harm our reputation. If we are found to infringe the intellectual property rights of third parties, we
could be required to pay substantial damages (which may be increased up to three times of awarded damages) and/or substantial royalties and could be prevented from selling our products unless we obtain a license or are able to redesign our products
to avoid infringement. Any such license may not be available on reasonable terms, if at all, and there can be no assurance that we would be able to redesign our products in a way that would not infringe the intellectual property rights of others.
Even if such licenses are available, we could incur substantial costs related to royalty payments for licenses obtained from third parties, which could negatively affect our gross margins, and the rights may be
<FONT STYLE="white-space:nowrap">non-exclusive,</FONT> which could give our competitors access to the same technology or intellectual property rights licensed to us. We could encounter delays in product introductions while we attempt to develop
alternative methods or products. If we fail to obtain any required licenses or make any necessary changes to our products or technologies, we may have to withdraw existing products from the market or may be unable to commercialize one or more of our
products. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If we collaborate with third parties in the development of technology in the future, our collaborators may not
properly maintain or defend our intellectual property rights or may use our proprietary information in such a way as to invite litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to
litigation or potential liability. Further, collaborators may infringe the intellectual property rights of third parties, which may expose us to litigation and potential liability. Also, we may be obligated under our agreements with our
collaborators, licensors, suppliers and others to indemnify and hold them harmless for damages arising from intellectual property infringement by us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, we generally indemnify our customers and international distributors with respect to infringement by our products of the proprietary rights of third parties. Third parties may
assert infringement claims against our customers or distributors. These claims may require us to initiate or defend protracted and costly litigation on behalf of our customers or distributors, regardless of the merits of these claims. If any of
these claims succeed or settle, we may be forced to pay damages or settlement payments on behalf of our customers or distributors or may be required to obtain licenses for the products they use. If we cannot obtain all necessary licenses on
commercially reasonable terms, our customers may be forced to stop using our products. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If we are unable to protect the
confidentiality of our trade secrets, our business and competitive position could be harmed. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition to patent
protection, we also rely upon copyright and trade secret protection, unpatented <FONT STYLE="white-space:nowrap">know-how</FONT> and continuing technological innovation to develop and maintain our competitive position, which we seek to protect
through <FONT STYLE="white-space:nowrap">non-disclosure</FONT> agreements and invention assignment agreements with our employees, consultants and third parties, to protect our confidential and proprietary information. In addition to contractual
measures, we try to protect the confidential nature of our proprietary information using commonly accepted physical and technological security measures. Such measures may not provide adequate protection for our proprietary information, for example,
in the case of misappropriation of a trade secret by an employee, consultant, customer or third party with authorized access. Our security measures may not prevent an employee, consultant or customer from misappropriating our trade secrets and
providing them to a competitor, and recourse we take against such misconduct may not provide an adequate remedy to protect our interests fully. Monitoring unauthorized uses and disclosures is difficult, and we do not know whether the steps we have
taken to protect our proprietary technologies will be effective. Unauthorized parties may also attempt to copy or reverse engineer certain aspects of our products that we consider proprietary. Enforcing a claim that a party illegally disclosed or
misappropriated a trade secret can be difficult, expensive and time-consuming, </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">31 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
and the outcome is unpredictable. Even though we use commonly accepted security measures, the criteria for protection of trade secrets can vary among different jurisdictions. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, trade secrets may be independently developed by others in a manner that could prevent legal recourse by us. Trade secrets
will over time be disseminated within the industry through independent development, the publication of journal articles and the movement of personnel skilled in the art from company to company or academic to industry scientific positions. Though our
agreements with third parties typically restrict the ability of our advisors, employees, collaborators, licensors, suppliers, third-party contractors and consultants to publish data potentially relating to our trade secrets, our agreements may
contain certain limited publication rights. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent such competitor from using that technology or information to compete
with us, which could harm our competitive position. Because from time to time we expect to rely on third parties in the development, manufacture, and distribution of our products and provision of our services, we must, at times, share trade secrets
with them. Despite employing the contractual and other security precautions described above, the need to share trade secrets increases the risk that such trade secrets become known by our competitors, are inadvertently incorporated into the
technology of others, or are disclosed or used in violation of these agreements. If any of our confidential or proprietary information, such as our trade secrets, were to be disclosed or misappropriated, or if any such information was independently
developed by a competitor, our business and competitive position could be harmed. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We may be unable to enforce our
intellectual property rights throughout the world. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The laws of some foreign countries do not protect intellectual
property rights to the same extent as the laws of the United States. Many companies have encountered significant problems in protecting and defending intellectual property rights in certain foreign jurisdictions. These challenges can be caused by
the absence or inconsistency of the application of rules and methods for the establishment and enforcement of intellectual property rights outside of the United States. In addition, the legal systems of some countries, particularly developing
countries, do not favor the enforcement of patents and other intellectual property protection, especially those relating to healthcare. This could make it difficult for us to stop infringement of our foreign patents, or the misappropriation of our
other intellectual property rights. For example, some foreign countries have compulsory licensing laws under which a patent owner must grant licenses to third parties. In addition, some countries limit the enforceability of patents against third
parties, including government agencies or government contractors. In these countries, patents may provide limited or no benefit. Patent protection must ultimately be sought on a
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, which is an expensive and time-consuming process with uncertain outcomes. Accordingly, we may choose not to seek patent protection in certain
countries, and we will not have the benefit of patent protection in such countries. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Proceedings to enforce our patent rights
in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business. Accordingly, our efforts to protect our intellectual property rights in such countries may be inadequate. In
addition, changes in the law and legal decisions by courts in the United States and foreign countries may affect our ability to obtain adequate protection for our technology and the enforcement of our intellectual property. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Further, the standards applied by the USPTO and foreign patent offices in granting patents are not always applied uniformly or
predictably. As such, we do not know the degree of future protection that we will have on our technologies, products, and product candidates. While we will endeavor to try to protect our technologies, products, and product candidates with
intellectual property rights such as patents, as appropriate, the process of obtaining patents is time-consuming, expensive and sometimes unpredictable. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">32 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Third parties may assert ownership or commercial rights to inventions we develop.
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Third parties may in the future make claims challenging the inventorship or ownership of our intellectual property,
including studies we commission or reports on the efficacy of our products. In addition, we may face claims by third parties that our agreements with employees, contractors or consultants obligating them to assign intellectual property to us are
ineffective or in conflict with prior or competing contractual obligations of assignment, which could result in ownership disputes regarding intellectual property we have developed or will develop and interfere with our ability to capture the
commercial value of such intellectual property. Litigation may be necessary to resolve an ownership dispute, and if we are not successful, we may be precluded from using certain intellectual property or may lose our exclusive rights in that
intellectual property. Either outcome could harm our business and competitive position. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Third parties may assert that
our employees or consultants have wrongfully used or disclosed confidential information or misappropriated trade secrets. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We employ individuals who previously worked with other companies, including our competitors or potential competitors. Although we try to ensure that our employees and consultants do not
use the proprietary information or <FONT STYLE="white-space:nowrap">know-how</FONT> of others in their work for us, we may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or
disclosed intellectual property, including trade secrets or other proprietary information, of a former employer or other third party. Litigation may be necessary to defend against these claims. If we fail in defending any such claims or settling
those claims, in addition to paying monetary damages or a settlement payment, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs
and be a distraction to management and other employees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Changes in U.S. patent law could diminish the value of patents
in general, thereby impairing our ability to protect our products. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our patent rights may be affected by developments
or uncertainty in the patent statute, patent case law or USPTO rules and regulations. There are a number of recent changes to the patent laws that may have a significant impact on our ability to protect our technology and enforce our intellectual
property rights. For example, the United States has recently enacted and is currently implementing the America Invents Act of 2011, a wide-ranging patent reform legislation. These changes include provisions that affect the way patent applications
will be prosecuted and may also affect patent litigation. As an example, the first to file provisions, which became effective March 2013, mean that the party that is first to file in the United States generally is awarded the patent rights,
regardless of who invented first. This could have a negative impact on some of our IP and could increase uncertainties surrounding obtaining and enforcement or defense of our issued patents. Further, the U.S. Supreme Court has ruled on several
patent cases in recent years, either narrowing the scope of patent protection available in certain circumstances or weakening the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to
obtain future patents, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the U.S. Congress, the federal courts and the U.S. Patent and Trademark Office, the laws and
regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents or future patents. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent
agencies, and our patent protection could be reduced or eliminated for <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these requirements. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions during the patent process. Periodic
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">33 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
maintenance fees, renewal fees, annuity fees and various other governmental fees on patents and/or applications will be due to be paid to the USPTO and various governmental patent agencies
outside of the US in several stages over the lifetime of the patents and/or applications. We employ reputable professionals and rely on such third parties to help us comply with these requirements and effect payment of these fees with respect to the
patents and patent applications that we own, and if we <FONT STYLE="white-space:nowrap">in-license</FONT> intellectual property we may have to rely upon our licensors to comply with these requirements and effect payment of these fees with respect to
any patents and patent applications that we license. In many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. However, there are situations in which noncompliance can result
in abandonment or lapse of a patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, competitors might be able to enter the market earlier than would otherwise have been
the case. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If we fail to comply with our obligations under license or technology agreements with third parties, we may
be required to pay damages and we could lose license rights that are critical to our business. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We license certain
intellectual property, and in the future we may enter into additional agreements that provide us with licenses to valuable intellectual property or technology. These licenses impose various payment obligations on us. If we fail to comply with any of
these obligations, we may be required to pay damages and the licensor may have the right to terminate the license. Termination by the licensor could cause us to lose valuable rights, and could prevent us from distributing our products, or inhibit
our ability to commercialize future products. Our business could suffer if any current or future licenses terminate, if the licensors fail to abide by the terms of the license, if the licensors fail to enforce licensed patents against infringing
third parties, if the licensed patents or other rights are found to be invalid or unenforceable, or if we are unable to enter into necessary licenses on acceptable terms. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Any collaboration arrangements that we may enter into in the future may not be successful, which could adversely affect our ability to develop and commercialize our products.
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Any future collaborations that we enter into may not be successful. The success of our collaboration arrangements will
depend heavily on the efforts and activities of our collaborators. Collaborations are subject to numerous risks, which may include that: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">collaborators have significant discretion in determining the efforts and resources that they will apply to collaborations;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">collaborators may not pursue development and commercialization of our products or may elect not to continue or renew development or
commercialization programs based on trial or test results, changes in their strategic focus due to the acquisition of competitive products, availability of funding or other external factors, such as a business combination that diverts resources or
creates competing priorities; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our
products or product candidates; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">a collaborator with marketing, manufacturing and distribution rights to one or more products may not commit sufficient resources to or
otherwise not perform satisfactorily in carrying out these activities; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">we could grant exclusive rights to our collaborators that would prevent us from collaborating with others;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual property or proprietary
information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">disputes may arise between us and a collaborator that causes the delay or termination of the research, development or commercialization
of our current or future products or that results in costly litigation or arbitration that diverts management attention and resources; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">collaborations may be terminated, and, if terminated, may result in a need for additional capital to pursue further development or
commercialization of the applicable current or future products; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">collaborators may own or <FONT STYLE="white-space:nowrap">co-own</FONT> intellectual property covering our products that results from
our collaborating with them, and in such cases, we would not have the exclusive right to develop or commercialize such intellectual property; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">a collaborator&#146;s sales and marketing activities or other operations may not be in compliance with applicable laws resulting in
civil or criminal proceedings. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If our trademarks and trade names are not adequately protected, then
we may not be able to build name recognition in our markets of interest and our business may be adversely affected. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our trademarks or trade names may be challenged, infringed, circumvented or declared generic or descriptive determined to be infringing on
other marks. We may not be able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we need for name recognition by potential partners or customers in our markets of interest. During trademark
registration proceedings, we may receive rejections. Although we would be given an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, in the USPTO and in comparable agencies in many foreign
jurisdictions, third parties are given an opportunity to oppose pending trademark applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not
survive such proceedings. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected. We may license our trademarks and trade names to
third parties, such as distributors. Though these license agreements may provide guidelines for how our trademarks and trade names may be used, a breach of these agreements or misuse of our trademarks and tradenames by our licensees may jeopardize
our rights in or diminish the goodwill associated with our trademarks and trade names. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Risks Related to Our Capital
Structure </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We may need to raise additional capital to fund our existing commercial operations, develop and
commercialize new products and expand our operations. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Based on our current business plan, we believe that our current
cash and cash equivalents as of March&nbsp;31, 2018, availability of borrowing under our credit facility, anticipated cash receipts from sales of our products and net proceeds from this offering will be sufficient to meet our anticipated cash
requirements through at least the next 24 months. If our available cash balances, potential future borrowing capacity, net proceeds from this offering and anticipated cash flow from operations are insufficient to satisfy our liquidity requirements,
including because of lower demand for our products as a result of the risks described in this prospectus, we may seek to sell common or preferred equity or debt securities, enter into an additional credit facility or another form of third-party
funding or seek other debt financing. Our present and future funding requirements will depend on many other factors, including: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our ability to achieve revenue growth and improve operating margins; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our ability to improve or maintain coverage and reimbursement arrangements with domestic third-party and government payors;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our rate of progress in establishing coverage and reimbursement arrangements from international commercial third-party and government
payors, particularly in Japan; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">35 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the cost of expanding our operations and offerings, including our sales and marketing efforts; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our rate of progress in, and cost of the sales and marketing activities associated with, establishing adoption of our products and
maintaining or improving our sales to our current customers; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the cost of research and development activities, including research and development relating to additional indications;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the effect of competing technological and market developments; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">costs related to international expansion; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the potential cost of and delays in product development as a result of any regulatory oversight applicable to our products.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We may also consider raising additional capital in the future to expand our business, to pursue strategic
investments, to take advantage of financing opportunities or for other reasons, including to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">expand our sales and marketing efforts to increase market adoption of our products and address competitive developments;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">fund development and marketing efforts of any future products or additional features to then-current products;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">acquire, license or invest in new technologies; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">provide for supply and inventory costs associated with plans to accommodate potential increases in demand for our products
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">acquire or invest in complementary businesses or assets; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">finance capital expenditures and general and administrative expenses. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Additional capital may not be available to us at such times or in the amounts we need. Even if capital is available, it might be
available only on unfavorable terms. Any issuance of additional equity or equity-linked securities could be dilutive to our existing stockholders, and any new equity securities could have rights, preferences and privileges superior to those of
holders of our common stock, including the shares of common stock sold in this offering. Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt, pay dividends, repurchase our stock,
make investments and engage in merger, consolidation or asset sale transactions. If we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish or license some rights to our
technologies or products, on terms that are not favorable to us. If access to sufficient capital is not available as and when needed, our business will be materially impaired and we may be required to cease operations, curtail one or more product
development or commercialization programs, significantly reduce expenses, sell assets, seek a merger or joint venture partner, file for protection from creditors or liquidate all our assets. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our ability to use net operating losses to offset future taxable income may be subject to limitations. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of December&nbsp;31, 2017, we had federal and state net operating loss carryforwards of $167.4&nbsp;million and $96.4&nbsp;million, respectively. The federal and state net operating
loss carryforwards will begin to expire, if not utilized, beginning in 2023 and 2020, respectively. These net operating loss carryforwards could expire unused and be unavailable to offset future income tax liabilities. Under the newly enacted
federal income tax law, federal net operating losses incurred in 2018 and in future years may be carried forward indefinitely, but the deductibility of such federal net operating losses is limited.&nbsp;It is uncertain how various states will
respond to the newly enacted federal tax law. In addition, under Section&nbsp;382 of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">36 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
the Internal Revenue Code of 1986, as amended, and corresponding provisions of state law, if a corporation undergoes an &#147;ownership change,&#148; which is generally defined as a greater than
50% change, by value, in its equity ownership over a three-year period, the corporation&#146;s ability to use its <FONT STYLE="white-space:nowrap">pre-change</FONT> net operating loss carryforwards and other
<FONT STYLE="white-space:nowrap">pre-change</FONT> tax attributes to offset its post-change income or taxes may be limited. In connection with this offering, it is possible that we will experience an ownership change limitation. We may experience
ownership changes in the future as a result of subsequent shifts in our stock ownership, some of which may be outside of our control. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it
would harm our future operating results by effectively increasing our future tax obligations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>The terms of our credit
facility place restrictions on our operating and financial flexibility. If we raise additional capital through debt financing, the terms of any new debt could further restrict our ability to operate our business. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have a $35.0&nbsp;million credit facility with Oxford Finance&nbsp;LLC, or Oxford, that is secured by a lien covering substantially all
of our assets, excluding intellectual property. As of March&nbsp;31, 2018, the outstanding principal balance under the credit facility was $30.0&nbsp;million. The credit facility contains customary covenants and events of default applicable to us.
The affirmative covenants include, among others, a covenant that requires us to achieve at least 75% of our trailing 12-month forecasted revenues, as measured each month in accordance with a forecast that we provided to Oxford upon signing the
agreement and future forecasts that we are required to deliver to the lenders each year for the life of the credit facility. The negative covenants include, among others, restrictions on us transferring collateral, changing businesses, engaging in
mergers or acquisitions, incurring additional indebtedness and encumbering collateral. If we default under the credit facility, Oxford may accelerate all of our repayment obligations and take control of our pledged assets, potentially requiring us
to renegotiate our agreement on terms less favorable to us or to immediately cease operations. Further, if we are liquidated, Oxford&#146;s right to repayment would be senior to the rights of the holders of our common stock to receive any proceeds
from the liquidation. Oxford could declare a default upon the occurrence of any event that it interprets as a material adverse effect as defined under the credit facility, thereby requiring us to repay the loan immediately or to attempt to reverse
the declaration of default through negotiation or litigation. Any declaration by Oxford of an event of default could significantly harm our business and prospects and could cause the price of our common stock to decline. If we raise any additional
debt financing, the terms of such additional debt could further restrict our operating and financial flexibility. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Risks
Related to Government Regulation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our products and operations are subject to extensive government regulation and
oversight both in the United States and abroad, and our failure to comply with applicable requirements could harm our business. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We and our products are subject to extensive regulation in the United States and elsewhere, including by the FDA and its foreign counterparts. The FDA and foreign regulatory agencies
regulate, among other things, with respect to medical devices: design, development and manufacturing; testing, labeling, content and language of instructions for use and storage; clinical trials; product safety; marketing, sales and distribution;
premarket clearance and approval; record keeping procedures; advertising and promotion; recalls and field safety corrective actions; post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to
recur, could lead to death or serious injury; post-market approval studies; and product import and export. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The regulations to
which we are subject are complex and have tended to become more stringent over time. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated sales.
The FDA enforces these regulatory requirements through periodic unannounced inspections. We do not know whether we will pass any </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">37 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
future FDA inspections. Failure to comply with applicable regulations could jeopardize our ability to sell our products and result in enforcement actions such as: warning letters; fines;
injunctions; civil penalties; termination of distribution; recalls or seizures of products; delays in the introduction of products into the market; total or partial suspension of production; refusal to grant future clearances or approvals;
withdrawals or suspensions of current clearances or approvals, resulting in prohibitions on sales of our products; and in the most serious cases, criminal penalties. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We may not receive the necessary clearances or approvals for our future products, and failure to timely obtain necessary clearances or approvals for our future products would
adversely affect our ability to grow our business. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">An element of our strategy is to continue to upgrade our products,
add new features and expand clearance or approval of our current products to new indications. In the United States, before we can market a new medical device, or a new use of, new claim for or significant modification to an existing product, we must
first receive either clearance under Section&nbsp;510(k) of the Federal Food, Drug, and Cosmetic Act, or the FDCA, or approval of a premarket approval application, or PMA, from the FDA, unless an exemption applies. In the 510(k) clearance process,
before a device may be marketed, the FDA must determine that a proposed device is &#147;substantially equivalent&#148; to a legally-marketed &#147;predicate&#148; device, which includes a device that has been previously cleared through the 510(k)
process, a device that was legally marketed prior to May&nbsp;28, 1976 <FONT STYLE="white-space:nowrap">(pre-amendments</FONT> device), a device that was originally on the U.S. market pursuant to an approved PMA and later down-classified, or a
510(k)-exempt device. To be &#147;substantially equivalent,&#148; the proposed device must have the same intended use as the predicate device, and either have the same technological characteristics as the predicate device or have different
technological characteristics and not raise different questions of safety or effectiveness than the predicate device. Clinical data are sometimes required to support substantial equivalence. In the PMA process, the FDA must determine that a proposed
device is safe and effective for its intended use based, in part, on extensive data, including, but not limited to, technical, <FONT STYLE="white-space:nowrap">pre-clinical,</FONT> clinical trial, manufacturing and labeling data. Our ability to
successfully obtain clearance for any new indications will be dependent on us submitting data as to the successful completion of clinical trials evidencing safety and efficacy. The PMA process is typically required for devices that are deemed to
pose the greatest risk, such as life-sustaining, life-supporting or implantable devices. However, some devices are automatically subject to the PMA pathway regardless of the level of risk they pose because they have not previously been classified
into a lower risk class by the FDA. Manufacturers of these devices may request that FDA review such devices in accordance with the <I>de novo</I> classification procedure, which allows a manufacturer whose novel device would otherwise require the
submission and approval of a PMA prior to marketing to request down-classification of the device on the basis that the device presents low or moderate risk. <I></I>If the FDA agrees with the down classification, the applicant will then receive
authorization to market the device. This device type can then be used as a predicate device for future 510(k) submissions. We initially received marketing authorization of our device through the <I>de novo </I>classification process, and we have
made changes to our system through subsequent 510(k) clearances. The process of obtaining regulatory clearances or approvals, or completing the <I>de novo </I>classification process, to market a medical device can be costly and time consuming, and
we may not be able to successfully obtain <FONT STYLE="white-space:nowrap">pre-market</FONT> reviews on a timely basis, if at all. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Modifications to products that are approved through a PMA application generally require FDA approval. Similarly, certain modifications made to products cleared through a 510(k) or
authorized through the <I>de novo</I> classification process may require a new 510(k) clearance. Each of the PMA approval, <I>de novo </I>classification and the 510(k) clearance processes can be expensive, lengthy and uncertain. The FDA&#146;s
510(k) clearance process usually takes from three to 12 months, but can last longer. The process of obtaining a PMA is much more costly and uncertain than the 510(k) clearance process and generally takes from one to three years, or even longer, from
the time the application is filed with the FDA. In addition, a PMA generally requires the performance of one or more clinical trials. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">38 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
Despite the time, effort and cost, a device may not be approved or cleared by the FDA. Any delay or failure to obtain necessary regulatory approvals or clearances could harm our business.
Furthermore, even if we are granted regulatory clearances or approvals, they may include significant limitations on the indicated uses for the device, which may limit the market for the device. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Any modifications to our existing products may require new 510(k) clearance; however, future modifications may be subject to the
substantially more costly, time-consuming and uncertain PMA process. If the FDA requires us to go through a lengthier, more rigorous examination for future products or modifications to existing products than we had expected, product introductions or
modifications could be delayed or canceled, which could cause our sales to decline. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The FDA can delay, limit or deny
clearance or approval of a device for many reasons, including: we may be unable to demonstrate to the FDA&#146;s satisfaction that the product or modification is substantially equivalent to the proposed predicate device or safe and effective for its
intended use; the data from our <FONT STYLE="white-space:nowrap">pre-clinical</FONT> studies and clinical trials may be insufficient to support clearance or approval, where required; and the manufacturing process or facilities we use may not meet
applicable requirements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Even if granted, a 510(k) clearance, <I>de novo </I>classification, or PMA approval imposes
substantial restrictions on how our devices may be marketed or sold, and the FDA continues to place considerable restrictions on our products and operations. For example, the manufacture of medical devices must comply with the FDA&#146;s Quality
System Regulation, or QSR. In addition, manufacturers must register their manufacturing facilities, list the products with the FDA, and comply with requirements relating to labeling, marketing, complaint handling, adverse event and medical device
reporting, reporting of corrections and removals, and import and export. The FDA monitors compliance with the QSR and these other requirements through periodic inspections. If our facilities or those of our manufacturers or suppliers are found to be
in violation of applicable laws and regulations, or if we or our manufacturers or suppliers fail to take satisfactory corrective action in response to an adverse inspection, the regulatory authority could take enforcement action, including any of
the following sanctions: untitled letters, warning letters, fines, injunctions, consent decrees and civil penalties; customer notifications or repair, replacement, refunds, detention or seizure of our products; operating restrictions or partial
suspension or total shutdown of production; refusing or delaying requests for 510(k) marketing clearance or PMA approvals of new products or modified products; withdrawing 510(k) marketing clearances or PMA approvals that have already been granted;
refusing to provide Certificates for Foreign Government; refusing to grant export approval for our products; or pursuing criminal prosecution. Any of these sanctions could impair our ability to produce our products in a cost-effective and timely
manner in order to meet our customers&#146; demands, and could have a material adverse effect on our reputation, business, results of operations and financial condition. We may also be required to bear other costs or take other actions that may have
a negative impact on our sales and our ability to generate profits. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, the FDA may change its clearance and
approval policies, adopt additional regulations or revise existing regulations, or take other actions, which may prevent or delay approval or clearance of our future products under development or impact our ability to modify our currently cleared
products on a timely basis. Such policy or regulatory changes could impose additional requirements upon us that could delay our ability to obtain new 510(k) clearances, increase the costs of compliance or restrict our ability to maintain our current
clearances. We also cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative or executive action, either in the United States or abroad. For example, certain policies of the
Trump administration may impact our business and industry. Namely, the Trump administration has taken several executive actions, including the issuance of a number of Executive Orders, that could impose significant burdens on, or otherwise
materially delay, the FDA&#146;s ability to engage in routine regulatory and oversight activities such as implementing statutes through rulemaking, issuance of guidance, and review and approval of marketing applications. It is difficult to predict
how these executive actions, including the Executive </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">39 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
Orders, will be implemented, and the extent to which they will impact the FDA&#146;s ability to exercise its regulatory authority. If these executive actions impose constraints on FDA&#146;s
ability to engage in oversight and implementation activities in the normal course, our business may be negatively impacted. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In order to sell our products in member countries of the EEA our products must comply with the essential requirements of the EU Medical
Devices Directive (Council Directive 93/42/EEC). Compliance with these requirements is a prerequisite to be able to affix the CE Mark to our products, without which they cannot be sold or marketed in the EEA. To demonstrate compliance with the
essential requirements we must undergo a conformity assessment procedure, which varies according to the type of medical device and its classification. Except for <FONT STYLE="white-space:nowrap">low-risk</FONT> medical devices (Class I <FONT
STYLE="white-space:nowrap">non-sterile,</FONT> <FONT STYLE="white-space:nowrap">non-measuring</FONT> devices), where the manufacturer can issue an EC Declaration of Conformity based on a self-assessment of the conformity of its products with the
essential requirements of the EU Medical Devices Directive, a conformity assessment procedure requires the intervention of an organization accredited by a Member State of the EEA to conduct conformity assessments, or a Notified Body. Depending on
the relevant conformity assessment procedure, the Notified Body would typically audit and examine the technical file and the quality system for the manufacture, design and final inspection of our devices. The Notified Body issues a certificate of
conformity following successful completion of a conformity assessment procedure conducted in relation to the medical device and its manufacturer and their conformity with the essential requirements. This certificate entitles the manufacturer to
affix the CE Mark to its medical devices after having prepared and signed a related EC Declaration of Conformity. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As a
general rule, demonstration of conformity of medical devices and their manufacturers with the essential requirements must be based, among other things, on the evaluation of clinical data supporting the safety and performance of the products during
normal conditions of use. Specifically, a manufacturer must demonstrate that the device achieves its intended performance during normal conditions of use, that the known and foreseeable risks, and any adverse events, are minimized and acceptable
when weighed against the benefits of its intended performance, and that any claims made about the performance and safety of the device are supported by suitable evidence. If we fail to remain in compliance with applicable European laws and
directives, we would be unable to continue to affix the CE Mark to our surgical systems, which would prevent us from selling them within the EEA. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We or our distributors will also need to obtain regulatory approval in other foreign jurisdictions in which we plan to market and sell our products, and we or they may not obtain such
approvals as necessary to commercialize our products in those territories. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Modifications to our products may require
new 510(k) clearances or PMA approvals, and may require us to cease marketing or recall the modified products until clearances are obtained. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Any modification to a 510(k)-cleared product that could significantly affect its safety or effectiveness, or that would constitute a major change in its intended use, design or
manufacture, requires a new 510(k) clearance or, possibly, approval of a PMA. The FDA requires every manufacturer to make this determination in the first instance, but the FDA may review any manufacturer&#146;s decision. The FDA may not agree with
our decisions regarding whether new clearances or approvals are necessary. We have made modifications to our products in the past and have determined based on our review of the applicable FDA regulations and guidance that in certain instances new
510(k) clearances were not required. We may make similar modifications or add additional features in the future that we believe do not require a new 510(k) clearance or approval of a PMA. If the FDA disagrees with our determination and requires us
to submit new 510(k) notifications or PMAs for modifications to our previously cleared products for which we have concluded that new clearances or approvals are unnecessary, we may be required to cease marketing or to recall the modified product
until we obtain clearance or approval, and we may be subject to significant regulatory fines or penalties. In addition, the FDA may not approve or clear our products for the indications that are necessary or desirable for successful
commercialization or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">40 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
could require clinical trials to support any modifications. Any delay or failure in obtaining required clearances or approvals would adversely affect our ability to introduce new or enhanced
products in a timely manner, which in turn would harm our future growth. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our products must be manufactured in
accordance with federal and state regulations, and we could be forced to recall our installed systems or terminate production if we fail to comply with these regulations. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The methods used in, and the facilities used for, the manufacture of our products must comply with the FDA&#146;s Quality System Regulation, or QSR, which is a complex regulatory scheme
that covers the procedures and documentation of the design, testing, production, process controls, quality assurance, labeling, packaging, handling, storage, distribution, installation, servicing and shipping of medical devices. Furthermore, we are
required to verify that our suppliers maintain facilities, procedures and operations that comply with our quality standards and applicable regulatory requirements. The FDA enforces the QSR through periodic announced or unannounced inspections of
medical device manufacturing facilities, which may include the facilities of subcontractors. Our products are also subject to similar state regulations and various laws and regulations of foreign countries governing manufacturing. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We or our third-party manufacturers may not take the necessary steps to comply with applicable regulations, which could cause delays in
the delivery of our products. In addition, failure to comply with applicable FDA requirements or later discovery of previously unknown problems with our products or manufacturing processes could result in, among other things: warning letters or
untitled letters; fines, injunctions or civil penalties; suspension or withdrawal of approvals or clearances; seizures or recalls of our products; total or partial suspension of production or distribution; administrative or judicially imposed
sanctions; the FDA&#146;s refusal to grant pending or future clearances or approvals for our products; clinical holds; refusal to permit the import or export of our products; and criminal prosecution of us or our employees. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Any of these actions could significantly and negatively impact supply of our products. If any of these events occurs, our reputation
could be harmed, we could be exposed to product liability claims and we could lose customers and suffer reduced revenues and increased costs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If treatment guidelines for the psychiatric conditions we are targeting change or the standard of care evolves, we may need to redesign and seek new marketing authorization from the
FDA for one or more of our products. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If treatment guidelines for the psychiatric conditions we are targeting or the
standard of care for such conditions evolves, we may need to redesign the applicable product and seek new clearances or approvals from the FDA. Our 510(k) clearances from the FDA are based on current treatment guidelines. If treatment guidelines
change so that different treatments become desirable, the clinical utility of one or more of our products could be diminished and our business could suffer. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>The misuse or <FONT STYLE="white-space:nowrap">off-label</FONT> use of our products may harm our reputation in the marketplace, result in injuries that lead to product liability
suits or result in costly investigations, fines or sanctions by regulatory bodies if we are deemed to have engaged in the promotion of these uses, any of which could be costly to our business. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our product has been authorized for marketing by the FDA for a specific indication. We train our commercial organization and distributors
outside the United States to not promote our products for uses outside of the <FONT STYLE="white-space:nowrap">FDA-cleared</FONT> indications for use, known as <FONT STYLE="white-space:nowrap">&#147;off-label</FONT> uses.&#148; We cannot, however,
prevent a psychiatrist from using our products <FONT STYLE="white-space:nowrap">off-label,</FONT> when in the psychiatrist&#146;s independent professional medical judgment he or she deems it appropriate. There may be increased risk of injury to
patients if psychiatrists attempt to use our products <FONT STYLE="white-space:nowrap">off-label.</FONT> Furthermore, the use of our products for indications </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">41 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
other than those cleared by the FDA or approved by any foreign regulatory body may not effectively treat such conditions, which could harm our reputation in the marketplace among psychiatrists
and patients. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If the FDA or any foreign regulatory body determines that our promotional materials or training constitute
promotion of an <FONT STYLE="white-space:nowrap">off-label</FONT> use, it could request that we modify our training or promotional materials or subject us to regulatory or enforcement actions, including the issuance or imposition of an untitled
letter, which is used for violators that do not necessitate a warning letter, injunction, seizure, civil fine or criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action under other
regulatory authority. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our products may cause or contribute to adverse medical events that we are required to report to
the FDA, and if we fail to do so, we would be subject to sanctions that could harm our reputation, business, financial condition and results of operations. The discovery of serious safety issues with our products, or a recall of our products either
voluntarily or at the direction of the FDA or another governmental authority, could have a negative impact on us. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We
are subject to the FDA&#146;s medical device reporting regulations and similar foreign regulations, which require us to report to the FDA when we receive or become aware of information that reasonably suggests that one or more of our products may
have caused or contributed to a death or serious injury or malfunctioned in a way that, if the malfunction were to recur, it could cause or contribute to a death or serious injury. The timing of our obligation to report is triggered by the date we
become aware of the adverse event as well as the nature of the event. We may fail to report adverse events of which we become aware within the prescribed timeframe. We may also fail to recognize that we have become aware of a reportable adverse
event, especially if it is not reported to us as an adverse event or if it is an adverse event that is unexpected or removed in time from the use of the product. If we fail to comply with our reporting obligations, the FDA could take action,
including warning letters, untitled letters, administrative actions, criminal prosecution, imposition of civil monetary penalties, revocation of our device clearance, seizure of our products or delay in clearance of future products. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The FDA and foreign regulatory bodies have the authority to require the recall of commercialized products in the event of material
deficiencies or defects in design or manufacture of a product or in the event that a product poses an unacceptable risk to health. The FDA&#146;s authority to require a recall must be based on a finding that there is reasonable probability that the
device could cause serious injury or death. We may also choose to voluntarily recall a product if any material deficiency is found. A government-mandated or voluntary recall by us could occur as a result of an unacceptable risk to health, component
failures, malfunctions, manufacturing defects, labeling or design deficiencies, packaging defects or other deficiencies or failures to comply with applicable regulations. Product defects or other errors may occur in the future. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Depending on the corrective action we take to redress a product&#146;s deficiencies or defects, the FDA may require, or we may decide,
that we will need to obtain new approvals or clearances for the device before we may market or distribute the corrected device. Seeking such approvals or clearances may delay our ability to replace the recalled devices in a timely manner. Moreover,
if we do not adequately address problems associated with our devices, we may face additional regulatory enforcement action, including FDA warning letters, product seizure, injunctions, administrative penalties or civil or criminal fines. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Companies are required to maintain certain records of recalls and corrections, even if they are not reportable to the FDA. We may
initiate voluntary withdrawals or corrections for our products in the future that we determine do not require notification of the FDA. If the FDA disagrees with our determinations, it could require us to report those actions as recalls and we may be
subject to enforcement action. A future recall announcement could harm our reputation with customers, potentially lead to product liability claims against us and negatively affect our sales. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">42 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Any adverse event involving our products could result in voluntary corrective actions,
such as recalls or customer notifications, or agency action, such as inspection, mandatory recall or other enforcement action. Any corrective action, whether voluntary or involuntary, as well as defending ourselves in a lawsuit, would require the
dedication of our time and capital, distract management from operating our business and may harm our reputation and financial results. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If we or our distributors do not obtain and maintain international regulatory registrations or approvals for our products, we will be unable to market and sell our products outside
of the United States. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales of our products outside of the United States are subject to foreign regulatory
requirements that vary widely from country to country. In addition, the FDA regulates exports of medical devices from the United States. While the regulations of some countries may not impose barriers to marketing and selling our products or only
require notification, others require that we or our distributors obtain the approval of a specified regulatory body. Complying with foreign regulatory requirements, including obtaining registrations or approvals, can be expensive and time-consuming,
and we or our distributors may not receive regulatory approvals in each country in which we plan to market our products or we may be unable to do so on a timely basis. The time required to obtain registrations or approvals, if required by other
countries, may be longer than that required for FDA clearance, and requirements for such registrations, clearances or approvals may significantly differ from FDA requirements. If we modify our products, we or our distributors may need to apply for
additional regulatory approvals before we are permitted to sell the modified product. In addition, we may not continue to meet the quality and safety standards required to maintain the authorizations that we or our distributors have received. If we
or our distributors are unable to maintain our authorizations in a particular country, we will no longer be able to sell the applicable product in that country. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Regulatory clearance or approval by the FDA does not ensure clearance or approval by regulatory authorities in other countries, and clearance or approval by one or more foreign regulatory
authorities does not ensure clearance or approval by regulatory authorities in other foreign countries or by the FDA. However, a failure or delay in obtaining regulatory clearance or approval in one country may have a negative effect on the
regulatory process in others. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We are subject to certain federal, state and foreign fraud and abuse laws, health
information privacy and security laws and transparency laws, which, if violated, could subject us to substantial penalties. Additionally, any challenge to or investigation into our practices under these laws could cause adverse publicity and be
costly to respond to, and thus could harm our business. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">There are numerous U.S. federal and state, as well as foreign,
laws pertaining to healthcare fraud and abuse, including anti-kickback, false claims and physician transparency laws. Our business practices and relationships with providers and patients are subject to scrutiny under these laws. We may also be
subject to patient information privacy and security regulation by both the federal government and the states and foreign jurisdictions in which we conduct our business. The healthcare laws and regulations that may affect our ability to operate
include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting,
offering, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of a good or service, for which payment may be made, in
whole or in part, under federal healthcare programs, such as Medicare and Medicaid. The term &#147;remuneration&#148; has been broadly interpreted to include anything of value. The intent standard under the federal Anti-Kickback Statute was amended
by the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010, or PPACA, to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or
specific intent to violate it, in order to have committed a violation. Moreover, the government may assert that a claim including items or services </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">43 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the federal civil and criminal false claims laws and civil monetary penalties laws, including the federal civil False Claims Act, which
prohibit, among other things, individuals or entities from knowingly presenting, or causing to be presented, false, fictitious or fraudulent claims for payment from Medicare, Medicaid or other federal healthcare programs, and knowingly making, using
or causing to be made or used a false record or statement material to a false or fraudulent claim to avoid, decrease or conceal an obligation to pay money to the federal government. Private individuals can bring False Claims Act &#147;qui tam&#148;
actions, on behalf of the government and such individuals, commonly known as &#147;whistleblowers,&#148; and may share in amounts paid by the entity to the government in fines or settlement. Companies have been prosecuted under the False Claims Act
in connection with alleged <FONT STYLE="white-space:nowrap">off-label</FONT> promotion of devices and allegedly providing free products to customers with the expectation that the customers would bill federal health care programs for the product. As
a result of a modification made by the Fraud Enforcement and Recovery Act of 2009, a claim includes &#147;any request or demand&#148; for money or property presented to the U.S. government. In addition, manufacturers can be held liable under the
False Claims Act even when they do not submit claims directly to government payors if they are deemed to &#147;cause&#148; the submission of false or fraudulent claims; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">HIPAA, which created additional federal criminal statutes that prohibit, among other things, executing or attempting to execute a
scheme to defraud any healthcare benefit program, including private third-party payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, and
knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statements or representations, or making or using any false writing or document knowing the same to contain any
materially false, fictitious or fraudulent statement or entry in connection with the delivery of, or payment for, healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual
knowledge of the statute or specific intent to violate it to have committed a violation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the federal Physician Payments Sunshine Act under PPACA which requires certain manufacturers of drugs, devices, biologics and medical
supplies for which payment is available under Medicare, Medicaid or the Children&#146;s Health Insurance Program (with certain exceptions) to report annually to the United States Department of Health and Human Services, Centers for Medicare and
Medicaid Services, information related to payments and other transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and teaching hospitals, and applicable manufacturers and group
purchasing organizations, as well as ownership and investment interests held by physicians and their immediate family members; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">HIPAA, as amended by HITECH, and their respective implementing regulations, which imposes privacy, security transmission and breach
reporting obligations with respect to individually identifiable health information, including PHI, upon entities subject to the law, such as health plans, healthcare clearinghouses and certain healthcare providers, and their respective business
associates that perform services on their behalf that involve individually identifiable health information, including PHI. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and criminal penalties directly
applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the HIPAA laws and seek attorneys&#146; fees and costs associated with pursuing federal
civil actions; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">analogous state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may
apply to items or services reimbursed by any </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">44 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
third-party payor, including commercial insurers or patients; state laws that require device companies to comply with the industry&#146;s voluntary compliance guidelines and the applicable
compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state and local laws that require the licensure of sales representatives; state
laws that require device manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures and pricing information; data privacy and security laws and
regulations in foreign jurisdictions that may be more stringent than those in the United States (such as the European Union, which adopted the General Data Protection Regulation, which will become effective in May 2018); state laws governing the
privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts; and state laws related to insurance fraud in the
case of claims involving private insurers. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">These laws and regulations, among other things, constrain our
business, marketing and other promotional activities by limiting the kinds of financial arrangements, including sales programs, we may have with psychiatrists or other potential purchasers of our products. We have also entered into consulting
agreements with physicians, which are subject to these laws. Further, while we do not submit claims and our customers will make the ultimate decision on how to submit claims, we may provide reimbursement guidance and support regarding our products.
Due to the breadth of these laws, the narrowness of statutory exceptions and regulatory safe harbors available, and the range of interpretations to which they are subject, it is possible that some of our current or future practices might be
challenged under one or more of these laws. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">To enforce compliance with healthcare regulatory laws, certain enforcement bodies
have recently increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Responding to
investigations can be <FONT STYLE="white-space:nowrap">time-and</FONT> resource-consuming and can divert management&#146;s attention from the business. Any such investigation or settlement could increase our costs or otherwise have an adverse effect
on our business. Even an unsuccessful challenge or investigation into our practices could cause adverse publicity, and be costly to respond to. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If our operations are found to be in violation of any of the healthcare laws or regulations described above or any other healthcare regulations that apply to us, we may be subject to
penalties, including administrative, civil and criminal penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs, such as Medicare and Medicaid, imprisonment, additional reporting obligations and
oversight if we becomes subject to a corporate integrity agreement or other agreement to resolve allegations of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these laws, reputational harm, and the curtailment or restructuring of our
operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Healthcare policy changes, including recently enacted legislation reforming the U.S. healthcare system,
could harm our cash flows, financial condition and results of operations. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">From time to time, legislation is drafted
and introduced in Congress that could significantly change the statutory provisions governing the regulation of medical devices. In addition, FDA regulations and guidance are often revised or reinterpreted by the FDA in ways that may significantly
affect our business and our products. Any new statutes, regulations, revisions, or reinterpretations of existing regulations may impose additional costs, lengthen review times of any future products, or make it more difficult to manufacture, market
or distribute our products. We cannot determine what effect changes in regulations, statutes, legal interpretation or policies, when and if promulgated, enacted or adopted may have on our business in the future. <B><I></I></B> </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">45 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For example, in March 2010, the PPACA was enacted in the United States, which made a
number of substantial changes in the way healthcare is financed by both governmental and private insurers. Among other ways in which it may impact our business, the PPACA: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">imposes an annual excise tax of 2.3% on any entity that manufactures or imports medical devices offered for sale in the United States,
with limited exceptions (described in more detail below), although the effective rate paid may be lower. Under the Consolidated Appropriations Act of 2016 and due to subsequent legislative amendment, the excise tax has been suspended through
December&nbsp;31, 2019; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">establishes a new Patient-Centered Outcomes Research Institute to oversee and identify priorities in comparative clinical effectiveness
research in an effort to coordinate and develop such research; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">implements payment system reforms including a national pilot program on payment bundling to encourage hospitals, psychiatrists and
other providers to improve the coordination, quality and efficiency of certain healthcare services through bundled payment models; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">expands the eligibility criteria for Medicaid programs. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Some of the provisions of the PPACA have yet to be implemented, and there have been judicial and Congressional challenges to certain aspects of the PPACA, as well as recent efforts by the
Trump administration to repeal or replace certain aspects of the PPACA. Since January 2017, President Trump has signed two Executive Orders designed to delay the implementation of certain provisions of the PPACA or otherwise circumvent some of the
requirements for health insurance mandated by the PPACA. Concurrently, Congress has considered legislation that would repeal or repeal and replace all or part of the PPACA. While Congress has not passed comprehensive repeal legislation, two bills
affecting the implementation of certain taxes under the PPACA have been signed into law. The Tax Cuts and Jobs Act of 2017 includes a provision repealing, effective January&nbsp;1, 2019, the <FONT STYLE="white-space:nowrap">tax-based</FONT> shared
responsibility payment imposed by the PPACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#147;individual mandate.&#148; Additionally, on January&nbsp;22, 2018,
President Trump signed a continuing resolution on appropriations for fiscal year 2018 that delayed the implementation of certain PPACA-mandated fees, including delaying imposition of the medical device excise tax on
<FONT STYLE="white-space:nowrap">non-exempt</FONT> medical devices through December&nbsp;31, 2019. As a result, there is significant uncertainty regarding future healthcare reform and its impact on our operations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. On August&nbsp;2, 2011,
the Budget Control Act of 2011 was signed into law, which, among other things, created the Joint Select Committee on Deficit Reduction to recommend to Congress proposals for spending reductions. The Joint Select Committee did not achieve a targeted
deficit reduction of at least $1.2 trillion for the years 2013 through 2021, triggering the legislation&#146;s automatic reduction to several government programs. On January&nbsp;2, 2013, the American Taxpayer Relief Act of 2012 was signed into law,
which, among other things, reduced Medicare payments to several types of providers, including hospitals, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Recently there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products,
which has resulted in several U.S. Congressional inquiries and proposed federal legislation designed to, among other things, bring more transparency to product pricing, reduce the cost of certain products under Medicare, review the relationship
between pricing and manufacturer patient programs, and reform government program reimbursement methodologies. At the state level, individual states in the United States are also increasingly passing legislation and
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">46 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
implementing regulations designed to control product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure
and transparency measures. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We expect additional state and federal healthcare reform measures to be adopted in the future, any
of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our products or additional pricing pressure. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Risks Related to This Offering and Ownership of Our Common Stock </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We will incur significant costs as a result of operating as a public company and our management expects to devote substantial time to public company compliance programs.
</I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As a public company, we will incur significant legal, accounting and other expenses due to our compliance with
regulations and disclosure obligations applicable to us, including compliance with the Sarbanes-Oxley Act, as well as rules implemented by the Securities and Exchange Commission, or the SEC, and Nasdaq. Our management and other personnel will devote
a substantial amount of time to these compliance programs and monitoring of public company reporting obligations and as a result of the corporate governance and executive compensation related rules, regulations and guidelines promulgated under the
Dodd-Frank Wall Street Reform and Consumer Protection Act, and further regulations and disclosure obligations expected in the future, we will likely need to devote additional time and costs to comply with such compliance programs and rules. These
rules and regulations will cause us to incur significant legal and financial compliance costs and will make some activities more time-consuming and costly. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>The price of our common stock may be volatile, and you may be unable to resell your shares at or above the initial public offering price. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Prior to this offering, there was no public market for shares of our common stock. The initial public offering price for the shares of our
common stock sold in this offering will be determined by negotiation between the underwriters and us. This price may not reflect the market price of our common stock following this offering. You may be unable to sell your shares of common stock at
or above the initial public offering price due to fluctuations in the market price of our common stock. In addition, the trading price of our common stock may be highly volatile and could be subject to wide fluctuations in response to various
factors, some of which are beyond our control. Factors that could cause volatility in the market price of our common stock include, but are not limited to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the actual or anticipated fluctuations in our financial condition and operating results; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the actual or anticipated changes in our growth rate; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the commercial success and market acceptance of our products; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the success of our competitors in developing or commercializing products; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">media exposure of our products or of those of others in our industry; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our ability to commercialize or obtain regulatory approvals for our products, or delays in commercializing or obtaining regulatory
approvals; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, collaborations or capital
commitments; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the addition or departure of key personnel; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">product liability claims; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">general prevailing economic, industry and market conditions, including factors unrelated to our operating performance or the operating
performance of our competitors; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">47 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">business disruptions caused by earthquakes, fires or other natural disasters; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">disputes or other developments concerning our intellectual property or other proprietary rights, including litigation;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the FDA or other U.S. or foreign regulatory actions affecting us or the healthcare or medical device industry;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">healthcare reform measures in the United States; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">sales of our common stock by us or our stockholders in the future; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the timing and amount of our investments in the growth of our business; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">inability to obtain additional funding; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">future sales or issuances of equity or debt securities by us; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">failure to meet or exceed financial estimates and projections of the investment community or that we provide to the public; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the issuance of new or changed securities analysts&#146; reports or recommendations regarding us. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, the stock markets in general, and the markets for companies like ours in particular, have from time to time experienced
extreme volatility that has been often unrelated to the operating performance of the issuer. A certain degree of stock price volatility can be attributed to being a newly public company. These broad market and industry fluctuations may negatively
impact the price or liquidity of our common stock, regardless of our operating performance. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Moreover, because of these
fluctuations, comparing our operating results on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">period-to-period</FONT></FONT> basis may not be meaningful. You should not rely on our past results as an indication of our future
performance. This variability and unpredictability could also result in our failing to meet the expectations of industry or financial analysts or investors for any period. If our revenues or operating results fall below the expectations of analysts
or investors or below any forecasts we may provide to the market, or if the forecasts we provide to the market are below the expectations of analysts or investors, the price of our common stock could decline substantially. Such a stock price decline
could occur even when we have met any previously publicly stated revenues or earnings forecasts that we may provide. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We
may be subject to securities litigation, which is expensive and could divert our management&#146;s attention. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the
past, companies that have experienced volatility in the market price of their securities have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Regardless of the merits or the ultimate
results of such litigation, securities litigation brought against us could result in substantial costs and divert our management&#146;s attention from other business concerns. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We are an &#147;emerging growth company&#148; and the reduced disclosure requirements applicable to emerging growth companies could make our common stock less attractive to
investors. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are an &#147;emerging growth company,&#148; as defined in the JOBS Act. We may remain an emerging growth
company until as late as December&nbsp;31, 2023, though we may cease to be an emerging growth company earlier under certain circumstances, including (i)&nbsp;if the market value of our common stock that is held by
<FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700&nbsp;million as of any June&nbsp;30, in which case we would cease to be an emerging growth company as of the following December&nbsp;31, or (ii)&nbsp;if our gross revenues exceeds
$1.07&nbsp;billion in any fiscal year. &#147;Emerging growth companies&#148; may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies, including not being required to comply with the
auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">48 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously
approved. Investors could find our common stock less attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our
stock price may be more volatile. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, Section&nbsp;102 of the JOBS Act also provides that an emerging growth company
can take advantage of the extended transition period provided in Section&nbsp;7(a)(2)(B) of the Securities Act of 1933, as amended, or the Securities Act, for complying with new or revised accounting standards. An emerging growth company can
therefore delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We are choosing not to &#147;opt out&#148; of such extended transition period, and as a result, we will not comply with
new or revised accounting standards on the relevant dates on which adoption of such standards is required for <FONT STYLE="white-space:nowrap">non-emerging</FONT> growth companies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Future sales of our common stock or securities convertible or exchangeable for our common stock may cause our stock price to decline. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If our existing stockholders or optionholders sell, or indicate an intention to sell, substantial amounts of our common stock in the
public market after the <FONT STYLE="white-space:nowrap">lock-up</FONT> and legal restrictions on resale discussed in this prospectus lapse, the price of our common stock could decline. The perception in the market that these sales may occur could
also cause the price of our common stock to decline. Based on shares of common stock outstanding as of March&nbsp;31, 2018, upon the completion of this offering, we will have outstanding a total of 16,245,558 shares of common stock. Of these shares,
the shares of common stock sold by us in this offering, plus any shares sold upon exercise of the underwriters&#146; option to purchase additional shares of common stock, will be freely tradable without restriction, unless held by our affiliates, in
the public market immediately following this offering. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After the <FONT STYLE="white-space:nowrap">lock-up</FONT>
agreements entered in connection with this offering expire, shares of common stock covered by those agreements will be eligible for sale in the public market, subject in certain instances to volume limitations under Rule 144 under the Securities
Act, with respect to shares held by directors, executive officers and other affiliates. Piper Jaffray&nbsp;&amp; Co. may, in its sole discretion, permit our directors, our executive officers and other stockholders and the holders of our outstanding
options or warrants who are subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements to sell shares prior to the expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements. Sales of these shares, or perceptions
that they will be sold, could cause the price of our common stock to decline. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, based on the number of shares
subject to outstanding awards under the 2003 Plan, or available for issuance thereunder, as of March&nbsp;31, 2018, and including the initial reserve under the 2018 Plan, shares of common stock that are either subject to outstanding options,
outstanding but subject to vesting or reserved for future issuance under the 2018 Plan will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, the
<FONT STYLE="white-space:nowrap">lock-up</FONT> agreements and Rule 144 and Rule 701 under the Securities Act. We also plan to file a registration statement permitting shares of common stock issued in the future pursuant to the 2018 Plan to be
freely resold by plan participants in the public market, subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements, applicable vesting schedules and, for shares held by directors, executive officers and other affiliates, volume
limitations under Rule 144 under the Securities Act. The 2018 Plan contains provisions for the annual increase of the number of shares reserved for issuance under such plan, as described elsewhere in this prospectus, which shares we also intend to
register. If the shares we may issue from time to time under the 2018 Plan are sold, or if it is perceived that they will be sold, by the award recipients in the public market, the price of our common stock could decline. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Approximately 11,099,375&nbsp;shares of common stock will be entitled to rights with respect to registration under the Securities Act,
subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above. Such registration would </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">49 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
result in these shares becoming fully tradable without restriction under the Securities Act when the applicable registration statement is declared effective. Sales of such shares could cause the
price of our common stock to decline. See &#147;Description of Capital Stock&#151;Registration Rights&#148; for additional information. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our reported financial results may be adversely affected by changes in accounting principles generally accepted in the United States. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Generally accepted accounting principles in the United States, or U.S. GAAP, are subject to interpretation by the Financial Accounting
Standards Board, or FASB, the U.S. Securities and Exchange Commission, or SEC, and various bodies formed to promulgate and interpret appropriate accounting principles. A change in these principles or interpretations could have a significant effect
on our reported financial results, and could affect the reporting of transactions completed before the announcement of a change. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In particular, in May 2014, the FASB issued Accounting Standards Update, or ASU, <FONT STYLE="white-space:nowrap">No.&nbsp;2014-09,</FONT> Revenue from Contracts with Customers (Topic
606), which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition. The core principle of ASU <FONT STYLE="white-space:nowrap">2014-09</FONT> is that an entity should recognize revenue to depict the transfer of promised
goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. As an &#147;emerging growth company,&#148; the JOBS Act allows us to delay adoption of
new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. We have elected to use this extended transition period under the JOBS Act with respect to ASU <FONT
STYLE="white-space:nowrap">2014-09,</FONT> which will result in ASU <FONT STYLE="white-space:nowrap">2014-09</FONT> becoming applicable to us after we cease to be an emerging growth company, unless we choose to adopt it beforehand. We are currently
evaluating the impact that ASU <FONT STYLE="white-space:nowrap">2014-09</FONT> may have on our financial reporting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If
there is no viable public market for our common stock, you may be unable to sell your shares at or above the initial public offering price. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Prior to this offering there has been no public market for shares of our common stock. Although we expect our common stock will be approved for listing on the Nasdaq Global Market, an
active trading market for our shares may never develop or be sustained following this offering. You may be unable to sell your shares quickly or at the market price if trading in shares of our common stock is not active. The initial public offering
price for our common stock will be determined through negotiations with the underwriters, and the negotiated price may not be indicative of the market price of the common stock after the offering. As a result of these and other factors, you may be
unable to resell your shares of our common stock at or above the initial public offering price. Further, an inactive market may also impair our ability to raise capital by selling shares of our common stock and may impair our ability to enter into
strategic partnerships or acquire companies or products by using our shares of common stock or other equity-linked securities as consideration. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Investors in this offering will suffer immediate and substantial dilution of their investment. </I></B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If you purchase common stock in this offering, you will pay more for your shares than our pro forma as adjusted net tangible book value per share. Based upon an assumed initial public
offering price of $15.00&nbsp;per share, the midpoint of the price range set forth on the cover page of this prospectus, you will incur immediate and substantial dilution of $11.53&nbsp;per share, representing the difference between our assumed
initial public offering price and our pro forma as adjusted net tangible book value per share as of March&nbsp;31, 2018. Based upon the assumed initial public offering price of $15.00&nbsp;per share, purchasers of common stock in this offering will
have contributed approximately 29% of the aggregate purchase price paid by all purchasers of our stock and will own approximately 31% of our common stock outstanding after this offering. To the extent outstanding stock options or warrants are
exercised, new investors may incur further dilution. For information on how the foregoing amounts were calculated, see the section titled &#147;Dilution.&#148; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">50 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our sales volumes and our results of operations may fluctuate over the course of
the year. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have experienced and may continue to experience meaningful variability in our sales and gross profit
among quarters. A number of factors over which we have limited control, such as seasonal variations in revenues, may contribute to fluctuations in our financial results. In the first quarter, our results can be impacted by severe weather and by the
resetting of annual U.S. patient healthcare insurance plan deductibles, which may cause delays in patients seeking NeuroStar Advanced Therapy treatments. Historically, we have seen a sequential decline in third quarter revenues, which we believe is
attributable to summer vacation plans of psychiatrists and patients. In addition, the fourth quarter has consistently been a strong revenue quarter on a sequential basis primarily due to U.S. psychiatrists&#146; historical timing for capital
expenditures and patients&#146; needs to exhaust remaining balances in flexible spending accounts. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Additional factors that we
expect may contribute to variability in our sales and gross profit over the course of the year include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the growth or decline of our installed system base; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the unpredictability of future sales by our international distributors, including our exclusive distributor in Japan;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the demand for, and pricing of, our products and the products of our competitors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the timing of or failure to obtain regulatory clearances or approvals for other products, indications or treatments; or
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the costs, benefits and timing of new product introductions. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We will have broad discretion in the use of the net proceeds from this offering and may invest or spend the proceeds in ways which
you do not agree or that may not be effective. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We discuss our plan for the use of the net proceeds of this offering in
the section titled &#147;Use of Proceeds.&#148; However, our management will have broad discretion over the use of the net proceeds from this offering. Because of the number and variability of factors that will determine our use of such proceeds,
you may not agree with how we allocate or spend the proceeds from this offering. We may pursue additional domestic and international sales and marketing efforts, commercialization and product development strategies, clinical trials, regulatory
approvals or collaborations that decrease the market value of our common stock and that increase our losses. You will not have the opportunity, as part of your investment decision, to assess whether we are using the net proceeds appropriately and
you will be relying on the judgment of our management regarding the use of these net proceeds. Our failure to allocate and spend the net proceeds from this offering effectively could harm our business, financial condition and results of operations.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our principal stockholders and management own a significant percentage of our stock and will be able to exert control
over matters subject to stockholder approval. </I></B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Excluding any shares that may be purchased in this offering,
including pursuant to the directed share program or otherwise, our officers and directors, together with holders of 5% or more of our outstanding common stock before this offering and their respective affiliates, will beneficially own approximately
81.0% of our common stock. Accordingly, these stockholders will continue to have an influence over the outcome of corporate actions requiring stockholder approval, including the election of directors, mergers, consolidation or sale of all or
substantially all of our assets or any other significant corporate transaction. The interests of these stockholders may not be the same as or may even conflict with your interests. For example, these stockholders could attempt to delay or prevent a
change in control of the company, even if such a change in control would benefit our other stockholders, which could deprive our stockholders of an opportunity to receive a premium for their common stock as part of a sale of the company or our
assets and might affect the prevailing price of our common stock. The </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">51 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
significant concentration of stock ownership may negatively impact the price of our common stock due to investors&#146; perception that conflicts of interest may exist or arise. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>As a result of becoming a public company, we will be obligated to develop and maintain proper and effective internal controls over
financial reporting and any failure to maintain the adequacy of these internal controls may adversely affect investor confidence in our company and the value of our common stock. </I></B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">To comply with the requirements of being a public company, we expect to undertake various actions, including implementing new internal controls and procedures and hiring new accounting or
internal finance staff. The Sarbanes-Oxley Act requires that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing to develop and refine our disclosure controls and other procedures
that are designed to ensure that information required to be disclosed by us in the reports that we file with the SEC is recorded, processed, summarized and reported within the time periods specified in SEC rules and regulations, and that information
required to be disclosed in reports under the Securities Exchange Act of 1934, or the Exchange Act, is communicated to our principal executive and financial officers. Our current controls and any new controls that we develop may become inadequate
and weaknesses in our internal control over financial reporting may be discovered in the future. Any failure to develop or maintain effective controls when we become subject to this requirement could negatively impact the results of periodic
management evaluations and annual independent registered public accounting firm attestation reports regarding the effectiveness of our internal control over financial reporting that we will be required to include in our periodic reports we will file
with the SEC under Section&nbsp;404 of the Sarbanes-Oxley Act, harm our operating results, cause us to fail to meet our reporting obligations or result in a restatement of our prior period financial statements. In the event that we are not able to
demonstrate compliance with the Sarbanes-Oxley Act, that our internal control over financial reporting is perceived as inadequate or that we are unable to produce timely or accurate financial statements, investors may lose confidence in our
operating results and the price of our common stock could decline. In addition, if we are unable to continue to meet these requirements, we may be unable to remain listed on the Nasdaq Global Market. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our independent registered public accounting firm will not be required to formally attest to the effectiveness of our internal control
over financial reporting until the later of our second annual report or the first annual report required to be filed with the SEC following the date we are no longer an &#147;emerging growth company,&#148; as defined in the JOBS Act, depending on
whether we choose to rely on certain exemptions set forth in the JOBS Act. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Provisions of our amended and restated
charter documents or Delaware law could delay or prevent an acquisition of the company, even if the acquisition would be beneficial to our stockholders, which could make it more difficult for you to change management. </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Provisions in our amended and restated certificate of incorporation and our amended and restated bylaws that will become effective upon
the completion of this offering may discourage, delay or prevent a merger, acquisition or other change in control that stockholders may consider favorable, including transactions in which stockholders might otherwise receive a premium for their
shares. In addition, these provisions may frustrate or prevent any attempt by our stockholders to replace or remove our current management by making it more difficult to replace or remove our board of directors. These provisions include: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">a prohibition on stockholder action through written consent; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">no cumulative voting in the election of directors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of the board of directors
or the resignation, death or removal of a director; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">52 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">a requirement that special meetings of stockholders be called only by the board of directors, the chairman of the board of directors,
the chief executive officer or, in the absence of a chief executive officer, the president; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">an advance notice requirement for stockholder proposals and nominations; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the authority of our board of directors to issue blank-check preferred stock with such terms as our board of directors may determine;
and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">a requirement of approval of not less than 66 2/3% of all outstanding shares of our capital stock entitled to vote to amend any bylaws
by stockholder action, or to amend specific provisions of our amended and restated certificate of incorporation. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, Delaware law prohibits a publicly held Delaware corporation from engaging in a business combination with an interested stockholder, generally a person who, together with its
affiliates, owns, or within the last three years has owned, 15% or more of our voting stock, for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is
approved in a prescribed manner. Accordingly, Delaware law may discourage, delay or prevent a change in control of our company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Provisions in our charter documents and other provisions of Delaware law could limit the price that investors are willing to pay in the
future for shares of our common stock. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Our amended and restated certificate of incorporation provides that the
Court of Chancery of the State of Delaware and the federal district courts of the United States of America will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders&#146; ability
to obtain a favorable judicial forum for disputes with us or our directors, officers or employees. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our amended and
restated certificate of incorporation that will become effective upon the completion of this offering provides that the Court of Chancery of the State of Delaware is the exclusive forum for (i)&nbsp;any derivative action or proceeding brought on our
behalf, (ii)&nbsp;any action asserting a claim of breach of a fiduciary duty or other wrongdoing by any of our directors, officers, employees or agents to us or our stockholders, (iii)&nbsp;any action asserting a claim arising pursuant to any
provision of the DGCL or our amended and restated certificate of incorporation or amended and restated bylaws, (iv)&nbsp;any action to interpret, apply, enforce or determine the validity of our amended and restated certificate of incorporation or
amended and restated bylaws or (v)&nbsp;any action asserting a claim governed by the internal affairs doctrine. Our amended and restated certificate of incorporation further provides that the federal district courts of the United States of America
will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. These exclusive forum provisions may limit a stockholder&#146;s ability to bring a claim in a judicial forum that it finds
favorable for disputes with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and other employees. Some companies that adopted a similar federal district court forum selection
provision are currently subject to a suit in the Chancery Court of Delaware by stockholders who assert that the provision is not enforceable. If a court were to find either choice of forum provision contained in our amended and restated certificate
of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>We do not anticipate paying any cash dividends on our common stock in the foreseeable future; therefore, capital appreciation, if
any, of our common stock will be your sole source of gain for the foreseeable future. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have never declared or paid
any cash dividends on our common stock and do not intend to do so in the foreseeable future. We currently intend to retain all available funds and any future earnings to finance the growth and development of our business. In addition, the terms of
our credit agreements contain, and the terms of any future credit agreements we may enter into may contain, terms prohibiting </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">53 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
or limiting the amount of dividends that may be declared or paid on our common stock. As a result, capital appreciation, if any, of our common stock will be your sole source of gain for the
foreseeable future. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>If securities or industry analysts do not publish research, or publish inaccurate or unfavorable
research, about our business, our stock price and trading volume could decline. </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If a trading market for our common
stock develops, it will depend, in part, on the research and reports that securities or industry analysts publish about us or our business. Securities and industry analysts do not currently, and may never, publish research on the company. If no
securities or industry analysts commence coverage of the company, the price for our common stock could be negatively impacted. In the event securities or industry analysts initiate coverage, if one or more of the analysts who cover us downgrade our
common stock or publish inaccurate or unfavorable research about our business, our stock price could decline. In addition, if our operating results fail to meet the forecast of analysts, our stock price could decline. If one or more of these
analysts cease coverage of the company or fail to publish reports on us regularly, demand for our common stock could decrease, which might cause our stock price and trading volume to decline. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">54 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_3"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING
STATEMENTS </B></FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">This prospectus contains forward-looking statements. All statements other than statements of historical
facts contained in this prospectus, including statements regarding our future results of operations and financial position, business strategy, current and prospective products, product approvals, research and development costs, current and
prospective collaborations, timing and likelihood of success, plans and objectives of management for future operations, future results of current and anticipated products, are forward-looking statements. These statements involve known and unknown
risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements.
</FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In some cases, you can identify forward-looking statements by terms such as &#147;may,&#148; &#147;will,&#148;
&#147;should,&#148; &#147;expect,&#148; &#147;plan,&#148; &#147;anticipate,&#148; &#147;could,&#148; &#147;intend,&#148; &#147;target,&#148; &#147;project,&#148; &#147;contemplates,&#148; &#147;believes,&#148; &#147;estimates,&#148;
&#147;predicts,&#148; &#147;potential&#148; or &#147;continue&#148; or the negative of these terms or other similar expressions. The forward-looking statements in this prospectus are only predictions. We have based these forward-looking statements
largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements speak only as of the date of this
prospectus and are subject to a number of risks, uncertainties and assumptions described under the sections in this prospectus entitled &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results
of Operations&#148; and elsewhere in this prospectus. The events and circumstances reflected in our forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking
statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may emerge from time to time, and it is not possible for us to predict all risk factors and uncertainties. Except as required by applicable law, we do
not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">55 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_3a"></A>IMPLICATIONS OF BEING AN EMERGING GROWTH
COMPANY </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We qualify as an &#147;emerging growth company,&#148; as defined in the Jumpstart Our Business
Startups Act of 2012, or the JOBS Act. An emerging growth company may take advantage of certain exemptions from certain reporting requirements and other burdens that are otherwise applicable generally to public companies that are not emerging growth
companies. These exemptions include, but are not limited to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reduced obligations with respect to financial data, including presenting only two years of audited financial statements and only two
years of selected financial data in the Registration Statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> of which this prospectus is a part;</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">an exception from compliance with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act of 2002, as
amended, or the Sarbanes-Oxley Act;</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reduced disclosure about our executive and director compensation arrangements in our periodic reports, proxy statements and
registration statements; and</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">exemptions from the requirements of holding <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory votes on executive and
director compensation or golden parachute arrangements. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We may take advantage of these exemptions for up to
five years or such earlier time that we no longer qualify as an emerging growth company. We would cease to qualify as an emerging growth company if we have more than $1.07&nbsp;billion in annual revenues, we are deemed to be a &#147;large
accelerated filer&#148; under the rules of the U.S. Securities and Exchange Commission, or SEC, which means the market value of our common stock that is held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700&nbsp;million or we
issue more than $1.0&nbsp;billion of <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt over a three-year period. We may choose to take advantage of some but not all of these reduced reporting burdens. For example, we may take advantage of
the exemption from auditor attestation on the effectiveness of our internal control over financial reporting. We have taken advantage of certain reduced reporting burdens in this prospectus. To the extent that we take advantage of these reduced
reporting requirements, the information that we provide stockholders may be different than you might obtain from other public companies in which you hold equity interests. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards until such time as those standards apply to private companies. We have
elected to avail ourselves of this exemption from new or revised accounting standards and, therefore, we will not be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">56 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_4"></A>MARKET, INDUSTRY AND OTHER DATA
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Unless otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we
operate, including our general expectations and market position, market opportunity and market size, is based on information from our own management estimates and research, as well as from industry and general publications and research, surveys and
studies conducted by third parties. Management estimates are derived from publicly available information, the study we commissioned Symphony Health to conduct in order to guide and inform our market strategy, our knowledge of our industry and
assumptions based on such information and knowledge, which we believe to be reasonable. This data involves a number of assumptions and limitations, and you are encouraged not to give undue weight to such estimates. While we believe the market
position, market opportunity and market size information included in this prospectus is generally reliable, such information is inherently imprecise. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, assumptions and estimates of our and our industry&#146;s future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors,
including those described in the section entitled &#147;Risk Factors.&#148; These and other factors could cause our future performance to differ materially from our assumptions and estimates. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">57 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_5"></A>USE OF PROCEEDS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We estimate that the net proceeds from our issuance and sale of 5,000,000 shares of our common stock in this offering will be
approximately $66.8 million (or $77.2 million if the underwriters exercise in full their option to purchase additional shares), assuming an initial public offering price of $15.00<B> </B>per share, which is the midpoint of the price range set forth
on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each $1.00 increase (decrease) in the assumed initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus,
would increase (decrease) the net proceeds to us from this offering by $4.7<B> </B>million, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts
and commissions and estimated offering expenses payable by us. Each increase (decrease) of 1,000,000 in the number of shares we are offering would increase (decrease) the net proceeds to us from this offering by $14.0 million, assuming the assumed
initial public offering price of $15.00 per share stays the same, and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of March&nbsp;31, 2018, we had cash and cash equivalents of $20.4&nbsp;million. We intend to use the net proceeds from this offering, together with our existing cash and cash
equivalents, as follows: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">approximately $25.0&nbsp;million to fund the further commercialization and marketing of our NeuroStar Advanced Therapy System,
primarily through expansion of sales, customer support and practice development teams; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">approximately $17.0 million to fund research and development activities, which may include hardware and software product development
and enhancements of our NeuroStar Advanced Therapy System and clinical development expenses relating to additional indications, which may include bipolar depression, post-traumatic stress disorder and potential other clinical indications yet to be
determined; and </FONT></P></TD></TR></TABLE>  <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the balance for general corporate purposes, including general and administrative expenses and working capital.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our expected use of net proceeds from this offering represents our current intentions based upon our
present plans and business condition. As of the date of this prospectus, we cannot predict with complete certainty all of the particular uses for the net proceeds to be received upon the completion of this offering or the actual amounts that we will
spend on the uses set forth above. We believe opportunities may exist from time to time to expand our current business through the acquisition or <FONT STYLE="white-space:nowrap">in-license</FONT> of complementary businesses, technologies or
intellectual property. While we have no current agreements for any specific acquisitions or <FONT STYLE="white-space:nowrap">in-licenses</FONT> at this time, we may use a portion of the net proceeds for these purposes. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The amounts and timing of our actual expenditures will depend on numerous factors, including the results of our sales and marketing
expansion efforts, the progress of our clinical trials and other development efforts for our NeuroStar Advanced Therapy System and the amount of cash used in our operations. We therefore cannot estimate with certainty the amount of net proceeds to
be used for the purposes described above. For example, at this stage of development, it is not possible to predict the total costs associated with completing the clinical development and approval process of the NeuroStar Advanced Therapy System or a
similar product for the treatment of post-traumatic stress disorder, bipolar depression or any other indication. We may find it necessary or advisable to use the net proceeds for other purposes, and we will have broad discretion in the application
of the net proceeds. Pending the uses described above, we plan to invest the net proceeds from this offering in short-term, interest-bearing obligations, investment-grade instruments, certificates of deposit or direct or guaranteed obligations of
the U.S. government. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">58 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_6"></A>DIVIDEND POLICY </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have never declared or paid, and do not anticipate declaring or paying, in the foreseeable future, any cash dividends on our common
stock. We currently intend to retain all available funds and any future earnings to support our operations and finance the growth and development of our business. In addition, under the terms of our loan and security agreement with Oxford Finance
LLC we may not declare or pay any cash dividends or distributions, subject to certain exceptions, without the consent of Oxford Finance LLC. Any future determination related to our dividend policy will be made at the discretion of our board of
directors and will depend upon, among other factors, our results of operations, financial condition, capital requirements, the consent of Oxford Finance LLC, other contractual restrictions, business prospects and other factors our board of directors
may deem relevant. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">59 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_7"></A>CAPITALIZATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table sets forth our cash and cash equivalents and capitalization as of March&nbsp;31, 2018: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">on an actual basis; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">on a pro forma basis to give effect to (i)&nbsp;the automatic conversion of all outstanding shares of our convertible preferred stock
into an aggregate of 10,994,280 shares of common stock, which will occur upon the closing of this offering; (ii)&nbsp;the automatic conversion of outstanding warrants to purchase shares of our convertible preferred stock into warrants to purchase
shares of our common stock, which will occur upon the closing of this offering; and (iii)&nbsp;the effectiveness of our amended and restated certificate of incorporation; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">on a pro forma as adjusted basis to give further effect to our issuance and sale of 5,000,000 shares of common stock in this offering
at an assumed initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting underwriting discounts and commissions and estimated offering expenses payable
by us. </FONT></P></TD></TR></TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">You should read this information in conjunction with our audited and unaudited interim
financial statements and the related notes thereto appearing at the end of this prospectus, the &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; section and other financial information contained
in this prospectus. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>As of March 31, 2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Actual</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Pro forma</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Pro forma<BR>as&nbsp;Adjusted<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in thousands, except share and per share<BR>data)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash and cash equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">87,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Long-term debt, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">485</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock: $0.01 par value: actual: 308,593,088&nbsp;shares authorized, issuable in series;
304,958,337&nbsp;shares issued and outstanding; aggregate liquidation value of $108,324; pro forma and pro forma as adjusted: no shares authorized, issued or outstanding and no liquidation value</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Stockholders&#146; (deficit) equity:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Preferred stock, $0.01 par value: actual: no shares authorized, issued or outstanding; pro forma and pro forma as
adjusted: 10,000,000&nbsp;shares authorized; no shares issued or outstanding</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Common stock, $0.01 par value: actual: 413,917,786&nbsp;shares authorized; 251,278&nbsp;shares issued and
outstanding; pro forma: 200,000,000&nbsp;shares authorized; 11,245,558&nbsp;shares issued and outstanding; pro forma as adjusted: 200,000,000&nbsp;shares authorized; 16,245,558&nbsp;shares issued and outstanding</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">112</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">162</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Additional paid-in capital</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,466</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">191,978</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">258,678</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accumulated deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(202,443</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(202,443</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(202,443</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total stockholders&#146; (deficit) equity</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(197,974</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(10,353</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">56,397</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total capitalization</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">19,450</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">19,450</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">86,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Each $1.00 increase (decrease) in the assumed initial public offering price of $15.00 per share, which is the midpoint of the price
range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted amount of each of cash and cash </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">60 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">
equivalents, additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital and total stockholders&#146; equity by $4.7&nbsp;million, assuming that the number of shares offered by us, as set
forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each increase (decrease) of 1,000,000 shares in the number of shares
offered by us at the assumed initial public offering price would increase (decrease) the pro forma as adjusted amount of each of cash and cash equivalents, additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital and total
stockholders&#146; equity by $14.0&nbsp;million. </FONT></TD></TR></TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The number of shares of common stock outstanding as of
March&nbsp;31, 2018, after giving effect to the conversion of all outstanding shares of our convertible preferred stock into common stock upon the closing of this offering, excludes: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,669,144 shares of common stock issuable upon the exercise of stock options outstanding as of March&nbsp;31, 2018, with a
weighted-average exercise price of $2.63 per share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">224,703 shares of common stock issuable upon the exercise of stock options granted after March&nbsp;31, 2018, with a weighted-average
exercise price of $7.54 per share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">105,095 shares of common stock issuable upon the exercise of warrants outstanding as of March&nbsp;31, 2018 to purchase shares of
convertible preferred stock that will become warrants to purchase shares of common stock upon the closing of this offering, at a weighted-average exercise price of $11.03 per share; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">46,670 shares of common stock reserved for future issuance under our 2003 Plan; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,334,315 shares of common stock reserved for future issuance under the 2018 Plan and shares that become available under the 2018 Plan
pursuant to provisions that automatically increase the share reserve under the 2018 Plan each year; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">243,699 shares of common stock reserved for issuance under the 2018 ESPP and shares that become available under the 2018 ESPP pursuant
to provisions that automatically increase the share reserve under the 2018 ESPP each year. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">61 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_8"></A>DILUTION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of March&nbsp;31, 2018, we had a historical net tangible book deficit of $198.0 million, or $787.87 per share of common stock. Our
historical net tangible book deficit per share represents total tangible assets less total liabilities and convertible preferred stock, which is not included within stockholders&#146; deficit, divided by the number of shares of our common stock
outstanding as of March&nbsp;31, 2018. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our pro forma net tangible book deficit as of March&nbsp;31, 2018 was $10.4 million,
or $0.92 per share of our common stock. Pro forma net tangible book deficit per share represents total tangible assets less total liabilities, divided by the number of shares of our common stock outstanding as of March&nbsp;31, 2018, after giving
effect to (i)&nbsp;the automatic conversion of all outstanding shares of our convertible preferred stock into an aggregate of 10,994,280 shares of common stock upon the closing of this offering and (ii)&nbsp;the reclassification of our convertible
preferred stock warrant liability to additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital upon the automatic conversion of outstanding warrants to purchase shares of our convertible preferred stock into warrants to purchase shares of
our common stock, which will occur upon the closing of this offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After giving further effect to the receipt of the net
proceeds from our sale of 5,000,000 shares of common stock in this offering at an assumed initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, and after deducting
underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible book value as of March&nbsp;31, 2018 would have been $56.4 million, or $3.47 per share. This amount represents an immediate
increase in pro forma net tangible book value of $4.39 per share to our existing stockholders and immediate dilution of $11.53 per share to new investors in this offering. We determine dilution by subtracting the pro forma as adjusted net tangible
book value per share after this offering from the amount of cash that a new investor paid for a share of common stock in this offering. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table illustrates this dilution to new investors on a per share basis: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="74%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Assumed initial public offering price per share</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Historical net tangible book deficit per share of common stock as of March&nbsp;31, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(787.87</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Decrease in net tangible book deficit per share of common stock attributable to pro forma
adjustments</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">786.95</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma net tangible book deficit per share of common stock as of March&nbsp;31, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(0.92</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Increase in net tangible book value per share of common stock attributable to this offering</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.39</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma as adjusted net tangible book value per share of common stock after this offering</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.47</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Dilution per share of common stock to new investors participating in this offering</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11.53</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each $1.00 increase (decrease) in the assumed initial public offering price of $15.00 per share,
which is the midpoint of the price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted net tangible book value per share after this offering by $0.29, and dilution in pro forma net tangible book
value per share to new investors by $0.71, assuming that the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting underwriting discounts and commissions and estimated offering
expenses payable by us. An increase of 1,000,000 shares in the number of shares we are offering would increase the pro forma as </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">62 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
adjusted net tangible book value per share after this offering by $0.61 and decrease the dilution per share to new investors participating in this offering by $0.61, assuming no change in the
assumed initial public offering price per share and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. A decrease of 1,000,000 shares in the number of shares we are offering would decrease the pro
forma as adjusted net tangible book value per share after this offering by $0.69 and increase the dilution per share to new investors participating in this offering by $0.69, assuming no change in the assumed initial public offering price per share
and after deducting underwriting discounts and commissions and estimated offering expenses payable by us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If the underwriters
exercise in full their option to purchase additional shares of our common stock, the pro forma as adjusted net tangible book value after this offering would be $3.93 per share, the increase in pro forma net tangible book value per share would be
$0.46 and the dilution per share to new investors would be $11.07 per share, in each case assuming an initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes, as of March&nbsp;31, 2018 on the pro forma as adjusted basis described above, the differences
between the number of shares purchased from us, the total consideration paid to us in cash and the average price per share that existing stockholders and investors in this offering paid for such shares. The calculation below is based on an assumed
initial public offering price of $15.00 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, before deducting underwriting discounts and commissions and estimated offering expenses payable by us.
</FONT></P>  <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Shares Purchased</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Total&nbsp;Consideration</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Average&nbsp;Price</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Per Share</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Number</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Existing stockholders</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,245,558</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">179,519,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">71</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15.96</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Investors in this offering</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">75,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16,245,558</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">245,519,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15.67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>   <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">A $1.00 increase or decrease in the assumed initial public offering price of $15.00 per share,
the midpoint of the range listed on the cover of this prospectus, would increase or decrease, respectively, total consideration paid by investors in this offering and total consideration paid by all stockholders by $5.0&nbsp;million, assuming that
the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If the
underwriters exercise their option to purchase additional shares of our common stock in full: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the percentage of shares of common stock held by existing stockholders will decrease to approximately 66% of the total number of shares
of our common stock outstanding after this offering; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the number of shares held by new investors will increase to 5,750,000, or approximately 34% of the total number of shares of our common
stock outstanding after this offering. </FONT></P></TD></TR></TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The foregoing tables and calculations are based on the number
of shares of our common stock outstanding as of March&nbsp;31, 2018, after giving effect to the conversion of all outstanding shares of our convertible preferred stock into common stock upon the closing of this offering, and excludes: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,669,144 shares of common stock issuable upon the exercise of stock options outstanding as of March&nbsp;31, 2018, with a
weighted-average exercise price of $2.63 per share; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">224,703 shares of common stock issuable upon the exercise of stock options granted after March&nbsp;31, 2018, with a weighted-average
exercise price of $7.54 per share; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">63 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">105,095 shares of common stock issuable upon the exercise of warrants outstanding as of March&nbsp;31, 2018 to purchase shares of
convertible preferred stock that will become warrants to purchase shares of common stock upon the closing of this offering, at a weighted-average exercise price of $11.03 per share; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">46,670 shares of common stock reserved for future issuance under our 2003 Plan; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,334,315 shares of common stock reserved for future issuance under the 2018 Plan, and shares that become available under the 2018 Plan
pursuant to provisions that automatically increase the share reserve under the 2018 Plan each year; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">243,699 shares of common stock reserved for issuance under the 2018 ESPP, and shares that become available under the 2018 ESPP pursuant
to provisions that automatically increase the share reserve under the ESPP each year. </FONT></P></TD></TR></TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">To the extent
any of our outstanding options or warrants is exercised, there will be further dilution to new investors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We may choose to
raise additional capital through the sale of equity or equity-linked securities due to market conditions or strategic considerations for our current or future development and commercialization plans. To the extent that we issue additional shares of
common stock or other equity or equity-linked securities in the future, there will be further dilution to our stockholders. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">64 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_9"></A>SELECTED FINANCIAL DATA </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following tables set forth, for the periods and as of the dates indicated, our selected historical financial data. The statements of
operations data for the years ended December&nbsp;31, 2016 and 2017 and the balance sheet data as of December&nbsp;31, 2016 and 2017 are derived from our audited financial statements appearing at the end of this prospectus. The statements of
operations data for the three months ended March 31, 2017 and 2018 and the balance sheet data as of March 31, 2018 are derived from our unaudited interim financial statements appearing at the end of this prospectus. We have prepared our unaudited
interim financial statements on the same basis as our audited financial statements and have included, in our opinion, all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the financial information
set forth in those statements. You should read this data together with the more detailed information contained in our audited financial statements and the related notes thereto and in &#147;Management&#146;s Discussion and Analysis of Financial
Condition and Results of Operations&#148; included elsewhere in this prospectus. Our historical results are not necessarily indicative of the results that should be expected in the future. Our interim results are not necessarily indicative of
results to be expected for the full year ending December 31, 2018, or any other period. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Years&nbsp;ended&nbsp;December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Three&nbsp;Months&nbsp;ended</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2016&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in&nbsp;thousands,&nbsp;except&nbsp;per&nbsp;share&nbsp;data)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Statements of Operations Data:</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">40,433</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,526</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,152</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,632</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,538</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,457</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gross Profit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">27,606</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30,801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,695</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Operating expenses:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">21,794</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">27,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,306</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,109</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,926</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,572</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,642</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,636</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,937</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,555</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">36,943</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">44,409</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,976</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Loss from Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(9,337</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(13,608</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(3,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(4,605</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other (income) expense:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Interest expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,835</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,808</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">921</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other (income) expense, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">62</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(357</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(11,234</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(16,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(4,514</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(5,497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net loss per share of common stock outstanding, basic and diluted</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(76.95</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(86.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(27.03</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(24.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Weighted-average common shares outstanding, basic and diluted</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">146</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">186</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">226</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma net loss per share of common stock outstanding, basic and diluted (unaudited)</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(0.49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma weighted-average common shares outstanding, basic and diluted (unaudited)</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,601</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,220</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>See &#147;Note 11. Loss per Share&#148; in our audited and
unaudited interim financial statements included elsewhere in this prospectus for an explanation of the method used to calculate the historical and pro forma basic and diluted net loss per common share. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">65 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>As&nbsp;of&nbsp;December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>As&nbsp;of&nbsp;March&nbsp;31,</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2018</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Balance Sheet Data:</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash and cash equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;&nbsp;17,040</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;&nbsp;29,147</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;&nbsp;20,354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Working capital</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,582</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">25,011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">19,522</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">24,798</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">38,938</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">32,016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Long-term debt, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15,647</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,556</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">459</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">478</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">485</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">172,311</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accumulated deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(180,887</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(196,946</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(202,443</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total stockholders&#146; deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(177,124</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(192,652</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(197,974</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">66 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_10"></A>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>The following discussion and analysis of our financial condition and
results of operations should be read in conjunction with our audited financial statements and related notes thereto and other financial information included elsewhere in this prospectus. In addition to historical financial information, some of the
information contained in the following discussion and analysis contains forward-looking statements that involve risks, uncertainties and assumptions. You should review the &#145;&#145;Risk Factors&#146;&#146; section of this prospectus for a
discussion of important factors that could cause our actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. </I></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Overview </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of
life for patients who suffer from psychiatric disorders. Our first commercial product, the NeuroStar Advanced Therapy System, is a <FONT STYLE="white-space:nowrap">non-invasive</FONT> and <FONT STYLE="white-space:nowrap">non-systemic</FONT>
office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, <FONT STYLE="white-space:nowrap">MRI-strength</FONT> magnetic field that induces electrical currents designed to stimulate specific areas of the brain
associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, to treat adult patients with major depressive disorder, or MDD, that have failed to achieve satisfactory improvement from prior antidepressant
medication in the current MDD episode. NeuroStar Advanced Therapy is safe, clinically effective, reproducible and precise and we believe is supported by the largest clinical data set of any competing TMS system. We believe we are the market leader
in TMS therapy based on our U.S. installed base of 781 active NeuroStar Advanced Therapy Systems in approximately 615 psychiatrist offices and the estimated 50,000 patients treated with approximately 1.8&nbsp;million treatment sessions. We generated
revenues of $40.4 million for the year ended December 31, 2017 and $10.2 million for the three months ended March 31, 2018. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We designed the NeuroStar Advanced Therapy as a <FONT STYLE="white-space:nowrap">non-invasive</FONT> therapeutic alternative to treat
patients who suffer from MDD and to address many of the key limitations of existing treatment options. We generate revenues from initial capital sales of our systems, recurring treatment sessions and from service and repair and extended warranty
contracts. We derive the majority of our revenues from our recurring treatment sessions, which represented 71% of our U.S. revenues for the year ended December&nbsp;31, 2017. Revenues from our NeuroStar Advanced Therapy Systems represented 25% of
our U.S. revenues for the same period. For the three months ended March 31, 2018, revenues from treatment sessions and NeuroStar Advanced Therapy Systems represented 72% and 24% of our U.S. revenues, respectively. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We currently sell our NeuroStar Advanced Therapy System and recurring treatment sessions in the United States through our direct sales
and customer support team, which was comprised of 126&nbsp;people as of March&nbsp;31, 2018. Our sales force primarily targets 15,100 psychiatrists at 3,600 high-decile psychiatric practices that we estimate, based on data from Symphony Health and
our own internal estimates, treat approximately 33% of the total MDD patients in the United States who meet our labeled indication and are insured. We expect to continue to expand our direct sales and customer support team to further penetrate the
market by demonstrating the benefits of our NeuroStar Advanced Therapy to psychiatrists and their MDD patients. Some of our customers have and may purchase more than one NeuroStar Advanced Therapy System. Based on our commercial data, we believe
psychiatrists can recoup their initial capital investment in our system by providing a standard course of treatment to approximately 12&nbsp;patients. We believe psychiatrists can generate approximately $7,500 to $10,000 of revenue per patient for a
standard course of treatment, which may provide meaningful incremental income to their practices. We have a diverse customer base of psychiatrists in group psychiatric practices in the United States. No single customer accounted for more than 7% of
our revenues in each of 2016 and 2017 or for </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">67 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
more than 8% of our revenues for the three months ended March 31, 2018. Patients are reimbursed by Medicare and the vast majority of commercial payors in the United States for treatment sessions
utilizing our NeuroStar Advanced Therapy System. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We market our products in a few select markets outside the United States
through independent distributors. International revenues represented 1% of our total revenues for the year ended December&nbsp;31, 2017 and 2% of our total revenues for the three months ended March 31, 2018. In October 2017, we entered into an
exclusive distribution agreement with Teijin Pharma Limited, or Teijin, for the distribution of our NeuroStar Advanced Therapy Systems and treatment sessions to customers who will treat patients with MDD in Japan. We received Shonin approval for our
system in Japan in September 2017, and we plan to work with Teijin to obtain reimbursement or approval for NeuroStar Advanced Therapy in Japan in 2018. We expect our international revenues to increase as a percentage of our total revenues as we grow
our presence in Japan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our research and development efforts are focused on the following: hardware and software product
developments and enhancements of our NeuroStar Advanced Therapy System and clinical development relating to additional indications, which may include bipolar depression and post-traumatic stress disorder. We outsource the manufacture of components
of our NeuroStar Advanced Therapy Systems that are produced to our specifications, and individual components are either shipped directly from our third-party contract manufacturers to our customers or consolidated into pallets at our Malvern,
Pennsylvania facility prior to shipment. Final installation of these systems occurs at the customer site. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Revenues increased
by $6.2&nbsp;million, or 18%, from $34.2&nbsp;million for the year ended December&nbsp;31, 2016 to $40.4&nbsp;million for the year ended December&nbsp;31, 2017. For the year ended December 31, 2017, our U.S. revenues were $39.9&nbsp;million,
compared to $31.6 million for the year ended December 31, 2016, which represented an increase of 26% period over period. Revenues increased by $2.6 million, or 35%, from $7.5&nbsp;million for the three months ended March&nbsp;31, 2017 to
$10.2&nbsp;million for the three months ended March&nbsp;31, 2018. For the three months ended March 31, 2018, our U.S. revenues were $10.0&nbsp;million, compared to $7.4 million for the three months ended March 31, 2017, which represented an
increase of 35% period over period. Due to the seasonality of our sales, during the first quarter of each year, we typically experience reduced revenues compared to our other quarters. We incurred net losses of $16.1&nbsp;million and $5.5 million
for the year ended December&nbsp;31, 2017 and the three months ended March 31, 2018, respectively. We expect to continue to incur losses for the next several years as we expand our commercial organization to support our planned sales growth and
while continuing to invest in our pipeline indications. As of March&nbsp;31, 2018, we had an accumulated deficit of $202.4&nbsp;million. Our primary sources of capital to date have been from private placements of our convertible preferred
securities, borrowings under our credit facilities and sales of our products. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Components of Our Results of Operations
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Revenues </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">To date, we have generated revenues primarily from the capital portion of our business and related sales and rentals of the NeuroStar Advanced Therapy System and the recurring revenues
from our sale of treatment sessions in the United States. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I><U>NeuroStar Advanced Therapy System
Revenues</U></I></B>.&nbsp;&nbsp;&nbsp;&nbsp;NeuroStar Advanced Therapy System revenues consist primarily of a capital component, including upgrades to the equipment attributable to the initial sale of the system. NeuroStar Advanced Therapy Systems
can be purchased outright or on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rent-to-own</FONT></FONT> basis by certain customers. We had an installed base of 647 and 752 active NeuroStar Advanced Therapy Systems as of
December&nbsp;31, 2016 and December&nbsp;31, 2017, respectively. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">68 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I><U>Treatment Session Revenues</U></I></B>.&nbsp;&nbsp;&nbsp;&nbsp;Treatment
session revenues primarily include sales of NeuroStar Treatment Sessions and SenStar treatment links. The NeuroStar Treatment Sessions are access codes that are delivered electronically in the United States. The SenStar treatment links are
disposable units containing <FONT STYLE="white-space:nowrap">single-use</FONT> access codes that are sold and used outside the United States. Access codes are purchased separately by our customers, primarily on an
<FONT STYLE="white-space:nowrap">as-needed</FONT> basis, and are required by the NeuroStar Advanced Therapy System in order to deliver treatment sessions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I><U>Other Revenues</U></I></B>.&nbsp;&nbsp;&nbsp;&nbsp;Other revenues are derived primarily from service and repair and extended warranty contracts with our existing customers.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We refer you to the section titled &#147;Critical Accounting Policies and Use of Estimates&#151;Revenue Recognition&#148;
appearing elsewhere in this prospectus for additional information regarding how we account for revenues. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The United States
represented 99% of our total revenues in 2017, and our sales in this region have been generated by our direct sales force. Outside the United States, our sales are made through local third-party distributors. International revenues were 8% for the
year ended December 31, 2016, compared with 1% for the year ended December 31, 2017. In 2017, we terminated our relationship with our Japanese distributor in anticipation of entering into a new distribution agreement with Teijin, which significantly
impacted our international sales for the year. We expect that both our United States and international revenues will increase in the near term as we continue to expand the installed base of NeuroStar Advanced Therapy Systems and increase the related
patient utilization in the United States, as well as grow our presence in Japan. We expect our revenues to be positively impacted to the extent our direct sales force is successful in increasing the rate of adoption and utilization of treatment with
TMS Therapy as an alternative to other MDD treatments. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Cost of Revenues and Gross Margin </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of revenues primarily consists of the costs of components and products purchased from our third-party contract manufacturers of our
NeuroStar Advanced Therapy Systems as well as the cost of treatment packs for individual treatment sessions. We use third-party contract manufacturing partners to produce the components for and assemble the completed NeuroStar Advanced Therapy
Systems. Cost of revenues also includes costs related to personnel, royalties, warranty, shipping, and our operations and field service departments. We expect our cost of revenues to increase in absolute dollars as and to the extent our revenues
grow. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our gross profit is calculated by subtracting our cost of revenues from our revenues. We calculate our gross margin as
our gross profit divided by our revenues. Our gross margin has been and will continue to be affected by a variety of factors, primarily product sales mix, pricing and third-party contract manufacturing costs. Our gross margins on revenues from sales
of NeuroStar Advanced Therapy Systems are lower than our gross margins on revenues from sales of treatment sessions and, as a result, the sales mix between NeuroStar Advanced Therapy Systems and treatment sessions can affect the gross margin in any
reporting period. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Sales and Marketing Expenses </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing expenses consist of market research and commercial activities related to the sale of our NeuroStar Advanced Therapy Systems and treatment sessions and salaries and
related benefits, sales commissions and share-based compensation for employees focused on these efforts. Other significant sales and marketing costs include conferences and trade shows, promotional and marketing activities, including direct and
online marketing, practice support programs, television and radio media campaigns, travel and training expenses. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">69 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We anticipate a significant increase in headcount in our commercial organization and in
expenses in executing on our growth initiatives as we continue to expand our business in the United States and internationally. As a result, we expect our sales and marketing expenses to continue to increase in absolute dollars. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>General and Administrative Expenses </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">General and administrative expenses consist primarily of personnel expenses, including salaries and related benefits, share-based compensation and travel expenses, for employees in
executive, finance, information technology, legal and human resource functions. General and administrative expenses also include the cost of insurance, outside legal fees, accounting and other consulting services, audit fees from our independent
registered public accounting firm, board of directors fees and other administrative costs, such as corporate facility costs, including rent, utilities, depreciation and maintenance not otherwise included in cost of revenues. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We anticipate that our general and administrative expenses will increase in absolute dollars because of an expanded infrastructure and an
increased headcount. We anticipate higher corporate infrastructure costs including, but not limited to, accounting, legal, human resources, consulting and investor relations fees, listing fees on the Nasdaq Global Market, costs associated with
Securities and Exchange Commission, or SEC, reporting and compliance, as well as increased director and officer insurance premiums, as a result of becoming a public company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Research and Development Expenses </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development
expenses consist primarily of personnel expenses, including salaries and related benefits and share-based compensation for employees in clinical development, product development, regulatory and quality assurance functions, as well as expenses
associated with outsourced professional scientific development services and costs of investigative sites and consultants that conduct our preclinical and clinical development programs. We typically use our employee, consultant and infrastructure
resources across our research and development programs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We plan to incur research and development expenses for the near
future as we expect to continue our development of TMS Therapy for the treatment of additional patient populations and new indications, which may include bipolar depression, post-traumatic stress disorder and potential other clinical indications yet
to be determined, as well as for various hardware and software development projects. As a result, we expect our research and development expenses to continue to increase in absolute dollars. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Interest Expense </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Interest expense consists of cash
interest payable under our credit facility and <FONT STYLE="white-space:nowrap">non-cash</FONT> interest attributable to the accrual of final payment fees and the amortization of deferred financing costs related to our indebtedness. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Other (Income) Expense, Net </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other (income) expense, net consists primarily of the fair value remeasurement related to our outstanding convertible preferred stock warrants, which are accounted for as a liability and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">marked-to-market</FONT></FONT> at each reporting period, as well as gains and losses on the disposal of fixed assets and interest income earned on our money market account balances.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">70 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Results of Operations </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Comparison of the Three Months ended March 31, 2017 and 2018 </I></B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="54%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Three&nbsp;Months&nbsp;ended<BR>March 31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Increase / (Decrease)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Dollars</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Percentage</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in thousands, except percentages)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,526</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,152</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,626</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,538</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,457</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">919</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gross Profit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,695</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,707</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gross Margin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Operating expenses:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,306</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,109</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,642</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,636</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">994</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,555</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(473</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,976</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,324</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Loss from Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(3,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(4,605</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">617</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other (income) expense:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Interest expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">921</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">371</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other income, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(4,514</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(5,497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">983</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Revenues by Geography<BR>Three Months ended March 31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>%&nbsp;of&nbsp;Revenues</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>%&nbsp;of&nbsp;Revenues</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in thousands, except percentages)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">United States</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,394</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,972</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">International</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">132</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,526</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,152</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>U.S. Revenues by Product Category<BR></B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Three Months ended March 31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>%&nbsp;of&nbsp;Revenues</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>%&nbsp;of&nbsp;Revenues</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in thousands, except percentages)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">NeuroStar Advanced Therapy System</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,321</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,373</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Treatment sessions</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,749</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,240</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">72</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">324</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">359</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total U.S. revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,394</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,972</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Revenues </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total revenues increased by $2.6 million, or 35%, from $7.5 million for the three months ended March&nbsp;31, 2017 to $10.2 million for the three months ended March 31, 2018. Revenues in
the United&nbsp;States increased </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">71 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
by $2.6 million from the three months ended March 31, 2017 compared to the three months ended March&nbsp;31, 2018 due to higher unit sales of both NeuroStar Advanced Therapy Systems and treatment
sessions. International revenues increased slightly for the three months ended March 31, 2018 compared to the three months ended March 31, 2017, primarily due to the recognition of deferred revenue related to the upfront and milestone payments
received in 2017 under our distribution agreement with Teijin for Japan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Revenues in the United States increased by $2.6
million, or 35%, from $7.4 million for the three months ended March 31, 2017 to $10.0 million for the three months ended March 31, 2018. NeuroStar Advanced Therapy System revenues in the United States grew by $1.1 million, or 80%, in the three
months ended March 31, 2018 compared to the three months ended March 31, 2017, based on 74% higher unit volume and 6% higher average selling prices. NeuroStar Advanced Therapy System revenues represented 18% and 24% of U.S. revenues for the three
months ended March 31, 2017 and 2018, respectively. We believe the growth in NeuroStar Advanced Therapy System revenues between these two periods was the result of the efforts of our expanded commercial organization and increased marketing efforts.
As of March 31, 2018, we had an installed base of 781 active systems in the United States, compared to 671 as of March 31, 2017. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Treatment session revenues in the United States represented 78% and 72% of total revenues in the United States for the three months ended March 31, 2017 and 2018, respectively, and
increased by 26% from the three months ended March 31, 2017 to the three months ended March 31, 2018. The increase in United States treatment session revenues was primarily the result of a 30% increase in the number of treatment sessions performed.
This was offset by a 4% decline in average selling price due to certain volume pricing discounts within our existing customer base. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Cost of Revenues and Gross Margin </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of revenues
increased by $0.9 million, or 60%, from $1.5 million for the three months ended March&nbsp;31, 2017 to $2.5 million for the three months ended March 31, 2018. The increase was primarily due to increased NeuroStar Advanced Therapy System sales
becoming a larger portion of the sales mix. Gross margin decreased from 80% for the three months ended March 31, 2017 to 76% for the three months ended March 31, 2018. The decrease was due to the higher mix of NeuroStar Advanced Therapy System
revenues in the three months ended March 31, 2018 in relation to treatment session revenues, as well as the reduction in the average selling price of our treatment sessions contributed to the decline in gross margin. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Sales and Marketing Expenses </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing expenses increased by $1.8 million, or 29%, from $6.3 million for the three months ended March 31, 2017 to $8.1 million for the three months ended March 31, 2018. The
increase was primarily due to increased personnel costs as a result of our sales and marketing expansion activities, as well as higher marketing expenses and sales commission costs, consistent with our growth in revenues. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>General and Administrative Expenses </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">General and administrative expenses increased by $1.0 million, or 61%, from $1.6 million for the three months ended March 31, 2017 to $2.6 million for the three months ended March 31,
2018. The increase was primarily due to an increase in personnel and legal, accounting and other professional services expenses required to support the growth of our business and to ready the infrastructure for public company reporting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Research and Development Expenses </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development expenses decreased $0.5 million, or 23%, from $2.0 million for the three months ended March 31, 2017 to $1.6 million for the three months ended March 31, 2018. The
decrease was primarily due to declines in spending relating to our adolescent study, which were partially offset by expenses relating to the launch of the next generation of our NeuroStar Advanced Therapy System and TrakStar practice management
system. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">72 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Interest Expense </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Interest expense increased $0.4 million, or 67%, from $0.6 million for the three months ended March&nbsp;31, 2017 to $0.9 million for the three months ended March 31, 2018, primarily as a
result of higher cash interest expenses related to the $10.0 million increase during 2017 in principal borrowings under our $35.0 million credit facility and higher non-cash interest expenses accrued in connection with the final payment fees due to
the lender under the agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Other (Income) Expense, Net </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other (income) expense, net, which includes the change in the fair value of the liability related to our outstanding convertible preferred stock warrants, was unchanged in total for the
three months ended March 31, 2018 compared to the three months ended March 31, 2017. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Comparison of the Years ended
December&nbsp;31, 2016 and 2017 </I></B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Years&nbsp;ended&nbsp;December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Increase/(Decrease)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Dollars</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Percentage</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in thousands, except percentages)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">40,433</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,205</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,632</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gross Profit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">27,606</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30,801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,195</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gross Margin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">81</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Operating expenses:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">21,794</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">27,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,106</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">28</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,926</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,572</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,646</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,937</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(286</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">36,943</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">44,409</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,466</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Loss from Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(9,337</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(13,608</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,271</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">46</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other (income) expense:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Interest expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,835</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,808</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">973</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">53</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other (income) expense, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">62</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(357</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(419</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(11,234</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(16,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,825</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Calculation is not meaningful. </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Revenues by Geography<BR>Years ended December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>%&nbsp;of&nbsp;Revenues</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>%&nbsp;of&nbsp;Revenues</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in thousands, except percentages)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">United States</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">31,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">92</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">39,853</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">99</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">International</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,651</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">580</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">40,433</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>U.S. Revenues by Product Category</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Years ended December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>%&nbsp;of&nbsp;Revenues</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>%&nbsp;of&nbsp;Revenues</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in thousands, except percentages)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">NeuroStar Advanced Therapy System</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,694</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,120</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Treatment sessions</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">24,630</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">28,391</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">71</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,253</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,342</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total U.S. revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">31,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">39,853</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">73 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Revenues </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total revenues increased by $6.2&nbsp;million, or 18%, from $34.2&nbsp;million for the year ended December&nbsp;31, 2016 to $40.4&nbsp;million for the year ended December&nbsp;31, 2017.
Revenues in the United States increased by $8.3&nbsp;million from 2016 to 2017 due to higher unit sales of both NeuroStar Advanced Therapy Systems and treatment sessions. International revenues declined by $2.1&nbsp;million primarily due to the
transition of our Japanese distributor during the fourth quarter of 2016. During the fourth quarter of 2017, we entered into an exclusive distribution agreement with Teijin, which we believe will allow us to increase our revenues in Japan once we
obtain reimbursement in that country. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Revenues in the United States increased by $8.3 million, or 26%, from $31.6 million for
the year ended December 31, 2016 to $39.9 million for the year ended December 31, 2017. NeuroStar Advanced Therapy System revenues in the United States grew by $4.4 million from 2016 to 2017, or 78%, based on 64% higher unit volume and 14% higher
average selling prices. NeuroStar Advanced Therapy System revenues represented 18% and 25% of U.S. revenues for 2016 and 2017, respectively. We believe the growth in NeuroStar Advanced Therapy System revenues between the two periods was the result
of the efforts of our expanded sales and customer support team to place additional systems. Treatment sessions revenues in the United States increased by $3.8 million from 2016 to 2017, primarily due to an increase in the installed base of NeuroStar
Advanced Therapy Systems. Treatment sessions revenues represented 78% and 71% of U.S. revenues for 2016 and 2017, respectively. The increase in treatment session revenues in the United States was primarily the result of a 24% increase in the number
of treatment sessions performed. This was offset by a 9% decline in average selling price due to certain volume pricing discounts within our existing customer base. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Cost of Revenues and Gross Margin </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of revenues
increased by $3.0&nbsp;million, or 45%, from $6.6&nbsp;million for the year ended December&nbsp;31, 2016 to $9.6&nbsp;million for the year ended December&nbsp;31, 2017. The increase was primarily due to increased NeuroStar Advanced Therapy System
sales becoming a larger portion of the sales mix. Gross margin was 76% for the year ended December&nbsp;31, 2017 compared to 81% for the year ended December&nbsp;31, 2016. The decrease in gross margin was primarily due to the higher mix of NeuroStar
Advanced Therapy System revenues in 2017 in relation to treatment sessions revenues and the reduction in the average selling price of our treatment sessions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Sales and Marketing Expenses </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing expenses
increased by $6.1&nbsp;million, or 28%, from $21.8&nbsp;million for the year ended December&nbsp;31, 2016 to $27.9&nbsp;million for the year ended December&nbsp;31, 2017. The increase was primarily due to increased personnel costs as a result of our
sales and marketing expansion activities, as well as higher marketing expenses and sales commission costs, consistent with our growth in revenues. During 2017, we added 15 new sales territories and undertook several marketing projects to support our
expansion plans, including increasing our presence at trade shows, expanding our media campaigns and enhancing our practice support program to include patient starter kits. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>General and Administrative Expenses </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">General and
administrative expenses increased by $1.7&nbsp;million, or 24%, from $6.9&nbsp;million for the year ended December&nbsp;31, 2016 to $8.6&nbsp;million for the year ended December&nbsp;31, 2017. The increase was primarily due to an increase in
personnel and legal, accounting and other professional services expenses required to support the growth of our business and ready the infrastructure for public company reporting. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Research and Development Expenses </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development
expenses decreased $0.3&nbsp;million, or 3%, from $8.2&nbsp;million for the year ended December&nbsp;31, 2016 to $7.9&nbsp;million for the year ended December&nbsp;31, 2017. The decrease was primarily
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">74 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
due to declines in spending relating to our adolescent study, which were partially offset by expenses relating to the launch of the next generation of our NeuroStar Advanced Therapy System and
TrakStar practice management system. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Interest Expense </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Interest expense increased $1.0&nbsp;million, or 53%, from $1.8&nbsp;million for the year ended December&nbsp;31, 2016 to $2.8&nbsp;million for the year ended December&nbsp;31, 2017,
primarily as a result of higher cash interest expenses related to the increase in principal borrowings under our $35.0&nbsp;million credit facility and higher <FONT STYLE="white-space:nowrap">non-cash</FONT> interest expenses accrued in connection
with final payment fees due to the lender under the agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Other (Income) Expense, Net </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The fair value remeasurement of the liability related to our outstanding convertible preferred stock warrants decreased by
$0.3&nbsp;million during the year ended December&nbsp;31, 2017 as a result of the change in the fair value of our Series E and Series F convertible preferred stock during 2017. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Quarterly Results of Operations </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following
tables set forth our unaudited quarterly results of operations for each quarter in the years ended December&nbsp;31, 2016 and 2017 and the first quarter of 2018. We have prepared the unaudited quarterly results of operations on a consistent basis
with our audited annual financial statements included elsewhere in this prospectus. In the opinion of management, the unaudited quarterly results of operations reflect all adjustments, consisting only of normal and recurring adjustments, necessary
for a fair presentation. The unaudited quarterly results of operations should be read in conjunction with our audited annual financial statements and related notes thereto included elsewhere in this prospectus. Unaudited interim results of
historical periods are not necessarily indicative of the results to be expected for a full year, or for any other period. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="34" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Three Months ended</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31,<BR>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>June&nbsp;30,<BR>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>September&nbsp;30,<BR>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,<BR>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31,<BR>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>June&nbsp;30,<BR>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>September&nbsp;30,<BR>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,<BR>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31,<BR>2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="34" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in thousands, except percentages)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">6,857</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">9,276</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">8,280</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">9,815</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">7,526</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">10,308</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">10,491</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">12,108</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">10,152</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Cost of revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,357</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,667</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,429</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">2,169</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,538</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">2,501</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">2,636</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">2,957</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">2,457</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Gross Profit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">5,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">7,609</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">6,851</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">7,646</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">5,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">7,807</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">7,855</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">9,151</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">7,695</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Gross<I> </I>Margin</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">82</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">83</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">78</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Operating expenses:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Sales and marketing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">4,472</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">4,982</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">5,289</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">7,051</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">6,306</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">6,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">6,566</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">8,628</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">8,109</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,553</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,765</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,635</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,973</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,642</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,837</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">2,256</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">2,837</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">2,636</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">2,163</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,885</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">2,217</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">2,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">2,147</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,843</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,919</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">1,555</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">7,983</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">8,910</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">8,809</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">11,241</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">9,976</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">10,384</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">10,665</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">13,384</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">12,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Loss from Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(2,483</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(1,301</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(1,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(3,595</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(3,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(2,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(2,810</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(4,233</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(4,605</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Other (income) expense:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Interest expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">410</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">411</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">459</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">555</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">711</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">807</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">740</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">921</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Other (income) expense, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(135</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">104</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">117</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(420</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:4.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Net Loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(2,758</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(1,816</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(2,393</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(4,267</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(4,514</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(2,868</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(3,753</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(4,924</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">(5,497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">75 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Seasonality </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our business has historically been affected by seasonality. In the first quarter, our results can be impacted by severe weather and by the resetting of annual U.S. patient healthcare
insurance plan deductibles, which may cause delays in patients seeking NeuroStar Advanced Therapy treatments. Historically, we have seen a sequential decline in third quarter revenues, which we believe is attributable to summer vacation plans of
psychiatrists and patients. In addition, the fourth quarter has consistently been a strong revenue quarter on a sequential basis primarily due to U.S. psychiatrists&#146; historical timing for capital expenditures and patients&#146; needs to exhaust
remaining balances in their flexible spending accounts. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Liquidity and Capital Resources </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Overview </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of March 31, 2018, we had cash and cash equivalents of $20.4 million and an accumulated deficit of $202.4 million, compared to cash and
cash equivalents of $29.1&nbsp;million and an accumulated deficit of $196.9&nbsp;million as of December 31, 2017. We incurred negative cash flows from operating activities of $8.5&nbsp;million and $11.1&nbsp;million for the years ended
December&nbsp;31, 2016 and 2017, respectively. We incurred negative cash flows from operating activities of $6.7 million and $8.3 million for the three months ended March 31, 2017 and 2018, respectively. We have incurred operating losses since our
inception, and we anticipate that our operating losses will continue in the near term as we seek to expand our sales and marketing initiatives to support our growth in existing and new markets and invest funds in additional research and development
activities. Our primary sources of capital to date have been from private placements of our convertible preferred securities, borrowings under our credit facilities and sales of our products. Through March&nbsp;31, 2018, we raised
$178.9&nbsp;million from private placements of our convertible preferred securities and at such date we had $30.0&nbsp;million of borrowings outstanding under our credit facility, which matures in March 2022 and has $5.0&nbsp;million of additional
capacity, subject to the achievement of $45.0&nbsp;million of trailing twelve month revenues in 2018, which is currently expected to occur in 2018. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We expect our revenues and expenses to increase in connection with our <FONT STYLE="white-space:nowrap">on-going</FONT> activities, particularly as we continue to execute on our growth
strategy, including expansion of our sales and customer support teams. Furthermore, following the completion of this offering, we expect to incur additional costs as a public company. Based on our current business plan, we believe that our cash and
cash equivalents as of March&nbsp;31, 2018, availability of borrowing under our credit facility, anticipated cash receipts from sales of our products and net proceeds from this offering will be sufficient to meet our anticipated cash requirements
through at least the next 24 months. However, if these sources are insufficient to satisfy our liquidity requirements, we may seek to sell additional common or preferred equity or debt securities, or enter into a new credit facility. If we raise
additional funds by issuing equity or equity-linked securities, our stockholders would experience dilution and any new equity securities could have rights, preferences and privileges superior to those of holders of our common stock, including the
shares of common stock sold in this offering. Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt. We cannot be assured that additional equity, equity-linked or debt financing will
be available on terms favorable to us or our stockholders, or at all. It is also possible that we may allocate significant amounts of capital towards products or technologies for which market demand is lower than expected and, as a result, abandon
such efforts. If we are unable to obtain adequate financing when we require it, or if we obtain financing on terms which are not favorable to us, or if we expend capital on products or technologies that are unsuccessful, our ability to continue to
support our business growth and to respond to business challenges could be significantly limited, or we may be required to delay the development, commercialization and marketing of our products. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our current and future funding requirements will depend on many factors, including: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our ability to achieve revenue growth and improve operating margins; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">76 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our ability to improve or maintain coverage and reimbursement arrangements with domestic third-party and government payors;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our rate of progress in establishing coverage and reimbursement arrangements from international commercial third-party and government
payors, particularly in Japan; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the cost of expanding our operations and offerings, including our sales and marketing efforts; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our rate of progress in, and cost of the sales and marketing activities associated with, establishing adoption of our products and
maintaining or improving our sales to our current customers; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the cost of research and development activities, including research and development relating to additional indications, which may
include bipolar depression and PTSD; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the effect of competing technological and market developments; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">costs related to international expansion; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the potential cost of and delays in product development as a result of any regulatory oversight applicable to our products.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Cash Flows </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table sets forth a summary of our cash flows for the years ended December&nbsp;31, 2016 and 2017 and the three months ended March 31, 2017 and 2018: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="55%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Years&nbsp;ended&nbsp;December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Three&nbsp;Months&nbsp;ended<BR>March&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2016&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Cash Used in Operating Activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(8,541</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(11,144</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(6,685</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(8,297</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Cash Used in Investing Activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(324</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(594</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(84</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(297</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Cash Provided by (Used in) Financing Activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,896</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">23,845</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,985</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net (Decrease) Increase in Cash and Cash Equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(3,969</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12,107</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(2,784</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(8,793</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Net Cash Used in Operating Activities </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net cash used in operating activities for the three months ended March 31, 2018 was $8.3 million, consisting primarily of a net loss of $5.5 million and a decrease in net operating
liabilities of $3.4&nbsp;million, partially offset by non-cash charges of $0.6 million. The decrease in net operating liabilities was primarily due to a decrease in accrued expenses as a result of first quarter 2018 payments of 2017 incentive
compensation and commissions accrued as of December 31, 2017. Non-cash charges consisted of depreciation and amortization, non-cash interest expense, share-based compensation, the cost of rental units purchased by customers and the change in the
fair value of the liability related to our outstanding convertible preferred stock warrants. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net cash used in operating
activities for the three months ended March 31, 2017 was $6.7 million, consisting primarily of a net loss of $4.5 million and a decrease in net operating liabilities of $2.5&nbsp;million, partially offset by non-cash charges of $0.3 million. The
decrease in net operating liabilities was primarily due to a decrease in accrued expenses as a result of first quarter 2017 payments of 2016 incentive compensation and commissions accrued as of December 31, 2016. Non-cash charges consisted of
depreciation and amortization, non-cash interest expense, share-based compensation and the change in the fair value of the liability related to our outstanding convertible preferred stock warrants. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">77 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net cash used in operating activities for 2017 was $11.1&nbsp;million, consisting
primarily of a net loss of $16.1&nbsp;million, offset by an increase in net operating liabilities of $3.2&nbsp;million and <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $1.8&nbsp;million. The increase in net operating liabilities was
primarily due to an increase in deferred revenue representing the initial payment and first milestone payment received in accordance with our Japanese distribution agreement as well as expanding commercial and research activities. <FONT
STYLE="white-space:nowrap">Non-cash</FONT> charges consisted of depreciation and amortization, <FONT STYLE="white-space:nowrap">non-cash</FONT> interest expense, share-based compensation, the cost of rental units purchased by customers and the
change in the fair value of the liability related to our outstanding convertible preferred stock warrants. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net cash used in
operating activities for 2016 was $8.5&nbsp;million, consisting primarily of a net loss of $11.2&nbsp;million, offset by an increase in net operating liabilities of $1.4&nbsp;million and <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of
$1.3&nbsp;million. The increase in net operating liabilities was primarily due to increases in accounts payable and accrued expenses, offset by an increase in inventory primarily due
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">rent-to-own</FONT></FONT> units from one large customer. <FONT STYLE="white-space:nowrap">Non-cash</FONT> charges consisted of depreciation and amortization, <FONT
STYLE="white-space:nowrap">non-cash</FONT> interest expense, share-based compensation and the change in the fair value of the liability related to our outstanding convertible preferred stock warrants. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Net Cash Used in Investing Activities </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net cash used in investing activities for the three months ended March 31, 2018 was $0.3 million, compared to net cash used in investing activities for the three months ended March 31,
2017 of $0.1&nbsp;million, in each case attributable to purchases of property and equipment and capitalized software costs. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net cash used in investing activities for 2017 was $0.6&nbsp;million, compared to net cash used in investing activities for 2016 of
$0.3&nbsp;million, in each case attributable to purchases of property and equipment and capitalized software costs in 2017. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Net Cash Provided by (Used in) Financing Activities </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net cash used in financing activates for the three months ended March 31, 2018 was $0.2 million, consisting primarily of $0.2 million of payments of initial public offering costs, slightly
offset by cash proceeds from the exercises of stock options. Net cash provided by financing activities for the three months ended March 31, 2017 was $4.0 million, consisting of $5.0 million of borrowings under our current credit facility, offset by
payment of $1.0 million of deferred debt issuance costs incurred in connection with our March 2017 amendment to our $35.0 million credit facility. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net cash provided by financing activities for 2017 was $23.8&nbsp;million, consisting of $14.8&nbsp;million of net proceeds from the issuance of Series G convertible preferred stock and
$10.0&nbsp;million of borrowings under our current credit facility, offset by payment of $1.0&nbsp;million of deferred debt issuance costs incurred in connection with our March 2017 amended credit facility. Net cash provided by financing activities
for 2016 was $4.9&nbsp;million, consisting primarily of $5.0&nbsp;million of borrowings under our previous credit facility, offset by payment of the related deferred debt issuance costs incurred in connection with a March 2016 amendment. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Indebtedness </I></B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Current $35.0&nbsp;Million Credit Facility </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In March 2017,
we entered into a new loan and security agreement with Oxford Finance LLC, or Oxford, for a credit facility that replaced our previous $25.0&nbsp;million credit facility with Oxford and which allows us to borrow up to $35.0&nbsp;million in three
tranches of term loans: a Term A Loan in the amount of $25.0&nbsp;million, which was drawn down immediately upon closing in March 2017, a Term B </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">78 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
Loan in the amount of $5.0&nbsp;million, which was drawn down in December 2017, and a Term C Loan in the amount of $5.0&nbsp;million, which will become available to us upon the achievement of
$45.0&nbsp;million of trailing twelve month revenues in 2018, which we expect to achieve in 2018. Each term loan accrues interest from the date of borrowing through the date of repayment at a floating per annum rate of interest, which resets monthly
and is equal to the greater of 8.15% or the 30 day U.S. LIBOR rate on the last business day of the month plus 7.38%. At the date of each borrowing, we are required to issue to Oxford warrants to purchase our Series F or later series of convertible
preferred stock or, if we are a public company at the date of borrowing, warrants to purchase our common stock, with a seven year term and in an amount equal to 3.95% of the first $5.0&nbsp;million of each tranche borrowed. The credit facility
matures and all amounts borrowed thereunder are due on March&nbsp;1, 2022. As of March&nbsp;31, 2018, we had borrowed and had outstanding an aggregate of $30.0&nbsp;million of principal under our credit facility. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Term A Loan features an interest-only period through March 2019, during which time we are required to make monthly interest payments,
after which time we are required to make monthly payments of principal and interest based on a <FONT STYLE="white-space:nowrap">36-month</FONT> amortization schedule. However, if $45.0&nbsp;million of trailing twelve month revenues is achieved in
2018, the interest-only period can be extended for an additional 12 months through March 2020 and the amortization period then becomes 24 months. In connection with the drawdown of the Term A Loan, we issued to the lender a warrant to purchase
588,498 shares of our Series F convertible preferred stock, which has an exercise price of $0.3356 per share and which expires in March 2024. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Term B Loan features an interest-only period through March 2019, during which time we are required to make monthly interest payments, after which time we are required to make monthly
payments of principal and interest based on a <FONT STYLE="white-space:nowrap">36-month</FONT> amortization schedule. However, if $45.0&nbsp;million of trailing twelve month revenues is achieved in 2018, then the interest-only period can be extended
for an additional 12 months through March 2020 and the amortization period then becomes 24 months. In connection with the drawdown of the Term B Loan, we issued to the lender a warrant to purchase 588,498 shares of our Series F convertible preferred
stock, which has an exercise price of $0.3356 per share and which expires in December 2024. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition to principal and
interest payments due under the credit facility, we are required to make final payment fees to the lender due upon the earlier of prepayment or maturity of each tranche, which are equal to 8%, 7% and 6.5% of the principal amounts of the Term A, Term
B and Term C Loans, respectively, except that if the interest-only periods on the Term A and Term B Loans are extended then the final payment fees increase to 8.5%, 7.5% and 7% of the principal amounts of the Term A, Term B and Term C Loans,
respectively. We accrue the estimated final payment fees using the effective interest rate, with a charge to <FONT STYLE="white-space:nowrap">non-cash</FONT> interest expense, over the term of borrowing for each tranche. As of both December 31, 2017
and March 31, 2018, the effective interest rates for the Term A and Term B Loans were 10.7% and 11.6%, respectively. If we prepay our term loans prior to their respective scheduled maturities, we will also be required to make prepayment fees to the
lender equal to 3% if prepaid on or before the first anniversary of funding, 2% if prepaid after the first and on or before the second anniversary of funding or 1% if prepaid after the second anniversary of funding of the principal amounts borrowed.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our obligations under the credit facility are secured by a first priority security interest in substantially all of our
assets, other than our intellectual property. We have agreed not to pledge or otherwise encumber any of our intellectual property. The loan and security agreement related to our credit facility includes a financial maintenance covenant that requires
us to achieve at least 75% of our trailing 12-month forecasted revenues, as measured each month in accordance with a forecast that we provided to Oxford upon signing the agreement and future forecasts that we are required to deliver to the lenders
each year for the life of the credit facility, as well as customary affirmative and negative covenants. We were in compliance with all of the covenants under our credit facility as of March&nbsp;31, 2018. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">79 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The loan and security agreement related to our credit facility contains events of
default, including, without limitation, events of default upon: (i)&nbsp;failure to make payment pursuant to the terms of the agreement; (ii)&nbsp;violation of covenants; (iii)&nbsp;material adverse changes to our business; (iv)&nbsp;attachment or
levy on our assets or judicial restraint on our business; (v)&nbsp;insolvency; (vi) significant judgments, orders or decrees for payments by us not covered by insurance; (vii)&nbsp;incorrectness of representations and warranties;
(viii)&nbsp;incurrence of subordinated debt; (ix)&nbsp;revocation of governmental approvals necessary for us to conduct our business; and (x)&nbsp;failure by us to maintain a valid and perfected lien on the collateral securing the borrowing.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Based on a <FONT STYLE="white-space:nowrap">36-month</FONT> amortization of the outstanding principal amounts of the Term A
and Term B Loans beginning on April&nbsp;1, 2019 as discussed above, the following table sets forth by year our required future principal payments (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:18pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Year:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Principal<BR>Payments</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2019</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2020</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2021</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2022</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total principal payments</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We currently anticipate that we will extend the interest-only periods on the Term A and Term B Loans upon
achieving $45.0&nbsp;million of trailing twelve month revenues, which is currently expected to occur in 2018. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Previous
$25.0&nbsp;Million Credit Facility </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Prior to March 2017, we had a $25.0&nbsp;million credit facility in place with Oxford,
which we entered into in February 2014 and which allowed us to borrow up to $25.0&nbsp;million in three tranches of term loans: a Term A Loan in the amount of $15.0&nbsp;million, a Term B Loan in the amount of $5.0&nbsp;million, and a Term C Loan in
the amount of $5.0&nbsp;million, which was never drawn down. Each term loan accrued interest at per annum rates ranging from 8.5% to 8.9%. This facility featured an interest-only period on all tranches through March 2017, and we were also required
to issue convertible preferred stock warrants to the lender at the time of borrowing of each tranche. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We accrued final
payment fees using the effective interest rate, with a charge to <FONT STYLE="white-space:nowrap">non-cash</FONT> interest expense, over the term of borrowing and until our entry into our current credit facility in March 2017, at which time we paid
the lender $1.0&nbsp;million in satisfaction of all final payment fee liabilities due under the prior credit facility. As of December 31, 2016, the effective interest rates for the previous Term A and Term B Loans were 10.4% and 11.6%, respectively.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We evaluated whether our current credit facility entered into in March 2017 represented a debt modification or extinguishment
in accordance with ASC <FONT STYLE="white-space:nowrap">470-50,</FONT> Debt&#151;Modifications and Extinguishments. Upon determining that the change in cash flows between the previous and current credit facilities was not greater than 10%, we
accounted for the transaction as a debt modification. As of March 2017, the unamortized balance of deferred financing costs incurred in connection with the $25.0&nbsp;million credit facility, and certain additional deferred financing costs incurred
in connection with entry into our current credit facility, are being amortized to interest expense through March 2022 utilizing the effective interest method. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For the three months ended March&nbsp;31, 2017, we recognized interest expense of $0.6&nbsp;million, of which $0.5&nbsp;million was cash and $0.1&nbsp;million was non-cash interest expense
related to the amortization of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">80 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
deferred financing costs and accrual of final payment fees. For the three months ended March&nbsp;31, 2018, we recognized interest expense of $0.9&nbsp;million, of which $0.7&nbsp;million was
cash and $0.2&nbsp;million was non-cash interest expense related to the amortization of deferred financing costs and accrual of final payment fees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For the year ended December&nbsp;31, 2016, we recognized interest expense of $1.8&nbsp;million, of which $1.4&nbsp;million was cash and $0.4&nbsp;million was
<FONT STYLE="white-space:nowrap">non-cash</FONT> interest expense related to the amortization of deferred financing costs and accrual of final payment fees. For the year ended December&nbsp;31, 2017, we recognized interest expense of
$2.8&nbsp;million, of which $2.1&nbsp;million was cash and $0.7&nbsp;million was <FONT STYLE="white-space:nowrap">non-cash</FONT> interest expense related to the amortization of deferred financing costs and accrual of final payment fees. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><FONT STYLE="white-space:nowrap">Off-Balance</FONT> Sheet Arrangements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We do not maintain any <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements, partnerships or other relationships with unconsolidated entities, often referred to as
structured finance or special-purpose entities, which are established for the purpose of facilitating <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements or other contractually narrow or limited purposes. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Commitments and Contractual Obligations </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table sets forth a summary of our contractual obligations as of December&nbsp;31, 2017, which have not materially changed as of March 31, 2018: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="44%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Payments Due by Period</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Less&nbsp;than<BR>1 Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>1 to 3<BR>Years</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>3 to 5<BR>Years</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>More&nbsp;than<BR>5 Years</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Principal payments on <FONT STYLE="white-space:nowrap">long-term</FONT> debt</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">17,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Interest and lender fees on <FONT STYLE="white-space:nowrap">long-term</FONT> debt</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,630</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,034</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,089</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,753</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Operating leases</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">490</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,107</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">88</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,685</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,120</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">22,641</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15,677</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">41,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Interest payable reflects the rate in effect as of December&nbsp;31, 2017. The interest rate on borrowings under the credit facility is
variable and resets monthly. Lender fees reflect final payment fees due assuming no extension of the interest-only period. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>Reflects obligations primarily related to our office and
warehouse/storage leases in Malvern, PA. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Distribution Agreement with Teijin Pharma Limited
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In October 2017, we entered into a seven and a half year distribution agreement with Teijin Pharma Limited, or Teijin, for
the exclusive distribution of our NeuroStar Advanced Therapy System to customers who will treat patients with MDD in Japan. Under the distribution agreement, Teijin is generally restricted from selling competing products in Japan. Our distribution
agreement provides that we will have primary responsibility for obtaining reimbursement approval for use of NeuroStar Advanced Therapy System for the treatment of MDD in Japan, and Teijin will promote the sales of NeuroStar Advanced Therapy System
for treatment of MDD in Japan. We have agreed to provide sales and technical support training to Teijin for our NeuroStar Advanced Therapy Systems. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Teijin is required to purchase minimum dollar values of NeuroStar Advanced Therapy Systems and treatment sessions from us following reimbursement approval by the Japanese Ministry of
Health, Labour and Welfare, or JMHLW, for TMS treatment for MDD (or, if such approval requires certified training on the NeuroStar Advanced Therapy System by a third party, then upon the first psychiatrist being issued his or her training
certification). </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">81 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In 2017, under our distribution agreement with Teijin, we received an upfront payment
of $0.75&nbsp;million and a milestone payment of $2.0&nbsp;million following JMHLW&#146;s approval of marketing the NeuroStar Advanced Therapy System for the treatment of MDD in Japan. These upfront and milestone payments have been deferred and are
being recognized as revenue over the seven and one half year term of the agreement. Teijin is required to pay us a milestone payment tied to JMHLW issuing reimbursement for use of our products for the treatment of MDD in Japan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The distribution agreement is scheduled to expire on March&nbsp;31, 2025, subject to earlier termination if we or Teijin breach the
agreement, Teijin fails to maintain distributor-level permits and approvals, Teijin fails to purchase from us specified dollar values of its sales forecasts, reimbursement for treatment of MDD using the NeuroStar Advanced Therapy System is not
obtained from JMHLW by specified dates or such reimbursement is below specified minimums, Teijin reasonably believes that it is not commercially reasonable to continue distributing the NeuroStar Advanced Therapy System in Japan or bankruptcy related
events occur. The term of the distribution agreement will be automatically extended for two years unless either party gives the other party at least two years&#146; prior written of notice of <FONT STYLE="white-space:nowrap">non-renewal,</FONT>
except that we cannot decline to renew the agreement if Teijin has purchased 100% of its sales forecasts over the term of the agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Executive Employment Agreements </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are party to an
employment agreement and offer letters with certain members of our executive team that provide for severance and other payments following termination of their employment for various reasons. We refer you to the &#147;Executive and Director
Compensation&#148; section of this prospectus for a more complete description of our executive employment agreements. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Quantitative and Qualitative Disclosures about Market Risk </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our cash is held on deposit in demand accounts at a large financial institution in amounts in excess of the Federal Deposit Insurance Corporation, or FDIC, insurance coverage limit of
$250,000 per depositor, per FDIC-insured bank, per ownership category. We have reviewed the financial statements of this institution and believe it has sufficient assets and liquidity to conduct its operations in the ordinary course of business with
little or no credit risk to us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Financial instruments that potentially subject us to concentrations of credit risk
principally consist of cash equivalents and accounts receivable. We limit our credit risk associated with cash equivalents by placing investments in highly-rated money market funds. We limit our credit risk with respect to accounts receivable by
performing credit evaluations when deemed necessary, but we do not require collateral to secure amounts owed to us by our customers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As discussed above in the section of this prospectus titled &#147;&#151;Liquidity and Capital Resources&#151;Indebtedness,&#148; our credit facility bears interest at a floating per annum
rate of interest, which resets monthly and is equal to the greater of 8.15% or the 30 day U.S. LIBOR rate on the last business day of the month plus 7.38%. As a result, we are exposed to risks from changes in interest rates. We believe that a one
point increase in interest rates would result in an approximate $0.2 million increase to our interest expense for the year ended December&nbsp;31, 2017. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Inflationary factors, such as increases in our cost of revenues and operating expenses, may adversely affect our operating results. Although we do not believe inflation has had a material
impact on our financial condition, results of operations or cash flows to date, a high rate of inflation in the future may have an adverse effect on our ability to maintain and increase our gross margin or decrease our operating expenses as a
percentage of our revenues if our selling prices of our products do not increase as much or more than our costs increase. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We
do not currently have any exposure to foreign currency fluctuations and do not engage in any hedging activities as part of our normal course of business. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">82 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Critical Accounting Policies and Use of Estimates </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The preparation of our financial statements in accordance with accounting principles generally accepted in the United States, or GAAP, and
the rules and regulations of the SEC requires us to make estimates and assumptions, based on judgments considered reasonable, which affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date
of the financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates and assumptions on historical experience, known trends and events and various other factors that we believe to be
reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Although we believe our estimates and assumptions are
reasonable when made, they are based upon information available to us at the time they are made. We evaluate our estimates and assumptions on an ongoing basis and, if necessary, make adjustments. Due to the risks and uncertainties involved in our
business and evolving market conditions, and given the subjective element of the estimates and assumptions made, actual results may differ from estimated results. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We define our critical accounting policies as those accounting policies that are most important to the portrayal of our financial condition and results of operations and require our most
difficult and subjective judgments. While our significant accounting policies are more fully described in &#147;Note 3. Summary of Significant Accounting Policies&#148; in our audited financial statements and related notes thereto appearing
elsewhere in this prospectus, we believe the following discussion addresses our most critical accounting policies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Revenue
Recognition </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Revenue is recognized when title and risk of ownership has been transferred, provided that persuasive evidence
of an arrangement exists, the price is fixed and determinable and collectability is reasonably assured. Transfer of title and risk of ownership occurs when the product is shipped or transferred to the customer. We sell to end users in the United
States and to third-party distributors outside the United States and do not provide return rights. Sales to distributors outside the United States are made in U.S. dollars. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our NeuroStar Advanced Therapy System sales in the United States typically have post sale obligations of installation and training. These obligations are fulfilled after product shipment,
and we defer recognizing revenue until installation occurs. In accordance with the accounting guidance related to multiple element arrangements, we defer the fair value attributable to the post shipment training and recognize such revenue when the
obligation is fulfilled. We base the fair value of the training using stand-alone service rates. Our sales to our third-party distributors outside the United States do not have these post-sale obligations. Our consumable single use and accessory
products have no post sale obligations and no return rights. Revenue from the sales of these products are recognized upon delivery. Revenue attributable to the NeuroStar Advanced Therapy Systems purchased on a rent-to-own basis are accounted for as
operating leases and revenue is recognized on a straight-line basis over the term of the lease. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, we provide a one
to <FONT STYLE="white-space:nowrap">two-year</FONT> warranty for systems sold in the United States. Terms of product warranty differ amongst our third-party distributors outside the United States, but are generally three years or less. We provide
for the estimated cost to repair or replace products under any warranty at the time of sale. We also offer our customers in the United States annual service contracts. Revenue from the sale of annual service contracts is recognized on a straight
line basis over the period of the applicable contract. We also earn revenue from customers from services outside of their warranty term or annual service contracts. Such service revenue is recognized as the services are provided. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We had deferred revenue of $1.3&nbsp;million, $1.6&nbsp;million and $1.2 million at December&nbsp;31, 2016 and 2017 and March 31, 2018,
respectively, primarily related to training, warranty and rent to own units. During </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">83 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
the fourth quarter of 2017, we entered into an exclusive Distribution Agreement with Teijin Pharma Limited, which we expect will allow us to increase deliveries to Japan. In connection with the
Distribution Agreement, we received an upfront payment as well as the first milestone payment, which are being recognized as revenue over the seven and a half-year term of the agreement. The last milestone payment is due upon achieving reimbursement
approval in Japan. At December&nbsp;31, 2017 and March&nbsp;31, 2018, we had $2.7&nbsp;million and $2.6 million in deferred revenue, respectively, related to this agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Share-based Compensation </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We recognize the grant-date fair
value of share-based awards issued as compensation as expense on a straight-line basis over the requisite service period, which is generally the vesting period of the award. The fair value of restricted stock awards is based on a determination by
the board of directors of the estimated fair value of the common stock at the date of grant. The fair value of stock options is estimated at the time of grant using the Black-Scholes option pricing model, which requires the use of inputs and
assumptions, the most critical of which is the estimated fair value of our common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We expect the amount of share-based
compensation expense recognized for stock options and restricted stock awards to increase for future awards in future periods due to the potential increase in both the value of our common stock and the size of our company in terms of headcount.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Stock Options Granted </I></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We recognized de minimis and $0.1&nbsp;million of share-based compensation expense related to stock options during the three months ended March&nbsp;31, 2017 and 2018, respectively. As of
March&nbsp;31, 2018, we had $2.0&nbsp;million of total unrecognized compensation cost related to non-vested stock options which we expect to recognize over a weighted-average period of 3.3 years. The weighted-average grant-date fair value of stock
options granted during the three months ended March&nbsp;31, 2018 was estimated at $2.90 per option. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We recognized
$0.2&nbsp;million and $0.4&nbsp;million of share-based compensation expense related to stock options during the years ended December&nbsp;31, 2016 and 2017, respectively. As of December&nbsp;31, 2017, we had $1.4&nbsp;million of total unrecognized
compensation cost related to <FONT STYLE="white-space:nowrap">non-vested</FONT> stock options which we expect to recognize over a weighted-average period of 3.2 years. The weighted-average grant-date fair value of stock options granted during the
years ended December&nbsp;31, 2016 and 2017 was estimated at $1.16 and $1.45 per option, respectively. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">84 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes by grant date the number of shares of common stock
underlying stock options granted from January&nbsp;1, 2017 through the date of this prospectus, as well as the associated per share exercise price and the estimated fair value per share of our common stock as determined by our board of directors as
of the grant date: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="36%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:39pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Grant Date</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Number&nbsp;of&nbsp;Shares<BR>Subject to<BR>Options Granted</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>(in thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Exercise&nbsp;Price<BR>per Share of<BR>Common&nbsp;Stock</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Estimated<BR>Fair&nbsp;Value<BR>per&nbsp;Share of<BR>Common&nbsp;Stock</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Estimated&nbsp;Fair<BR>Value&nbsp;per&nbsp;Share&nbsp;of<BR>Common Stock<BR>Option
Award</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">February&nbsp;6, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">322</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">February&nbsp;14, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">April&nbsp;12, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">109</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">July&nbsp;20, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">349</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1.16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">September&nbsp;22, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">October&nbsp;19, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">97</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">December&nbsp;6, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">December&nbsp;7, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">January 24, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">106</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">March 16, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">171</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">April 25, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5.22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5.22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">April 25, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5.22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5.22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">June 8, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">106</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6.24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE>   <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Based on an assumed initial public offering price of $15.00 per share, the midpoint of the price
range set forth on the cover page of this prospectus, the intrinsic value of vested and unvested stock options outstanding as of June 8, 2018 was $18.1 million and $16.1 million, respectively. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Restricted Stock Awards Granted </I></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">To date, we have granted restricted stock awards only to an independent member of our board of directors and only as compensation for board service. We granted the independent director
restricted stock awards of 42,316 shares at an estimated grant-date fair value of $2.03 per share on July&nbsp;20, 2016 and 10,937 shares at an estimated grant-date fair value of $4.06 per share on October&nbsp;19, 2017. We recognized
$0.1&nbsp;million of share-based compensation expense related to restricted stock awards during the year ended December&nbsp;31, 2017, with a de minimis amount recognized during the three months ended March 31, 2018. As of March&nbsp;31, 2018, we
had minimal unrecognized compensation cost related to <FONT STYLE="white-space:nowrap">non-vested</FONT> restricted stock awards which we expect to recognize over a weighted-average period of 1.3 years. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Valuation of Common Stock </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">All options to purchase shares of our common stock are granted with an exercise price per share equal to or greater than the estimated fair value per share of our common stock on the date
of grant, based on the information known to us on the date of grant. Prior to this offering, on each grant date, the fair values of the shares of common stock underlying our stock options were estimated on each grant date by our board of directors,
based on information known to us at the date of grant. In order to determine the estimated fair value of our common stock, our board of directors considered, among other things, contemporaneous valuations of our preferred and common stock prepared
by an unrelated third-party valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants 2013 Practice Guide, <I>Valuation of Privately-Held-Company Equity Securities Issued as Compensation</I>.
Given the absence of a public trading market for our capital stock, our board of directors exercised reasonable judgment and considered a number of objective and subjective factors to determine the best estimate of the fair value of our preferred
and common stock, including: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">contemporaneous third-party valuations of our preferred and common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the prices, rights, preferences and privileges of our preferred stock relative to the common stock; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">85 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our business, financial condition and results of operations, including related industry trends affecting our operations;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the likelihood of achieving a liquidity event, such as an initial public offering or the sale of our company, given prevailing market
conditions; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the lack of marketability of our preferred and common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the market performance of comparable publicly traded companies; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">United States and global economic and capital market conditions and outlook. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After the closing of this offering, our board of directors will determine the per share fair value of our common stock based on the
closing price of our common stock as reported by the Nasdaq Global Market on the date of grant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Internal Controls over
Financial Reporting </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our management is responsible for establishing and maintaining adequate internal control over
financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. generally
accepted accounting principles. As a result of becoming a public company, we will be required, under Section&nbsp;404 of the Sarbanes-Oxley Act, to furnish a report by management on, among other things, the effectiveness of our internal control over
financial reporting beginning with our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2019. This assessment will need to include disclosure of any material weaknesses identified by our
management in our internal control over financial reporting. The SEC defines a material weakness as a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a
material misstatement of a company&#146;s annual or interim financial statements will not be detected or prevented on a timely basis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In accordance with the provisions of the Sarbanes-Oxley Act, neither we nor our independent registered public accounting firm has performed an evaluation of our internal control over
financial reporting during any period included in this prospectus. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>JOBS Act Accounting Election </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are an &#147;emerging growth company,&#148; as defined in the Jumpstart Our Business Startups Act of 2012, or JOBS Act, and are
eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. Section&nbsp;107 of the JOBS Act provides that an emerging growth company can
take advantage of the extended transition period provided in Section&nbsp;7(a)(2)(B) of the Securities Act of 1933, or Securities Act, for complying with new or revised accounting standards issued subsequent to the enactment of the JOBS Act until
such time as those standards apply to private companies. Section&nbsp;107 of the JOBS Act provides that we can elect to opt out of the extended transition period at any time, which election is irrevocable. We have elected to avail ourselves of this
exemption from complying with new or revised accounting standards and, therefore, will not be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are in the process of evaluating the benefits of relying on other exemptions and reduced reporting requirements under the JOBS Act.
Subject to certain conditions, as an emerging growth company, we may rely on certain of these exemptions, including without limitation (i)&nbsp;providing an auditor&#146;s attestation report on our system of internal controls over financial
reporting pursuant to Section&nbsp;404(b) of the Sarbanes-Oxley Act and (ii)&nbsp;complying with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">86 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
auditor&#146;s report providing additional information about the audit and the financial statements, known as the auditor discussion and analysis. We will remain an emerging growth company until
the earlier of (a)&nbsp;the last day of the fiscal year in which we have total annual gross revenue of $1.07&nbsp;billion or more; (b)&nbsp;the last day of the fiscal year following the fifth anniversary of the date of the completion of this
offering; (c)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in nonconvertible debt during the previous six years; or (d)&nbsp;the date on which we are deemed to be a large accelerated filer under the rules of the SEC. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Recent Accounting Pronouncements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We refer you to &#147;Note 4. Recent Accounting Pronouncements&#148; in our audited financial statements and related notes thereto included elsewhere in this prospectus. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">87 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_11"></A>BUSINESS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Overview </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of
life for patients who suffer from psychiatric disorders. Our first commercial product, the NeuroStar Advanced Therapy System, is a <FONT STYLE="white-space:nowrap">non-invasive</FONT> and <FONT STYLE="white-space:nowrap">non-systemic</FONT>
office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, <FONT STYLE="white-space:nowrap">MRI-strength</FONT> magnetic field that induces electrical currents designed to stimulate specific areas of the brain
associated with mood. The system is cleared by the United States Food and Drug Administration, or FDA, to treat adult patients with major depressive disorder, or MDD, that have failed to achieve satisfactory improvement from prior antidepressant
medication in the current MDD episode. NeuroStar Advanced Therapy is safe, clinically effective, reproducible and precise and we believe is supported by the largest clinical data set of any competing TMS system. We believe we are the market leader
in TMS therapy based on our U.S. installed base of 781 active NeuroStar Advanced Therapy Systems in approximately 615 psychiatrist offices and the estimated 50,000&nbsp;patients treated with approximately 1.8&nbsp;million treatment sessions. We
generated revenues of $40.4 million for the year ended December&nbsp;31, 2017 and $10.2 million for the three months ended March 31, 2018. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">MDD is a mood disorder characterized by the presence of one or both of two major diagnostic criteria: a depressed mood or loss of interest in pleasure that continues for at least two
weeks. The presence of at least one of these diagnostic symptoms must be accompanied by several of the following additional symptoms: sleep disturbance, changes in appetite, sexual dysfunction, anxiety, fatigue, difficulty concentrating and suicidal
thinking. MDD is a recurrent disease and follows a fluctuating course over an individual&#146;s lifetime, with periods of remission and relapse. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The World Health Organization, or WHO, ranks MDD as the single largest contributor to global disability and a major contributor to suicide worldwide. According to a study published in the
<I>Journal of Clinical Psychiatry</I>, the economic burden of the disease was estimated to be $210&nbsp;billion in 2010 in the United States, including outpatient and inpatient medical costs, pharmacy costs, suicide related costs and workplace
costs. A study published in <I>Psychological Medicine</I> reported a global incidence rate of MDD is 3.0% and the WHO estimates that there are over 300 million people in the world living with depression. Based on U.S. Census Bureau data and a study
published in the <I>Journal of the American Medical Association,</I> we estimate that approximately 21&nbsp;million people in the United States suffer from MDD annually. Of these people, we estimate approximately 13.3&nbsp;million are adults aged 22
to 70 years, of whom an estimated 7.6&nbsp;million, based on data from the <I>Journal of the American Medical Association</I>, are being treated by a psychiatrist. We estimate, based on data from the Sequenced Treatment Alternatives to Relieve
Depression, or the STAR*D study, that approximately 5.5&nbsp;million of these patients have failed to achieve remission of their MDD from their prior antidepressant medication therapy and that approximately 3.8&nbsp;million of those patients have
commercial insurance or Medicare coverage for NeuroStar Advanced Therapy. As a result, based on our expected revenues for a standard course of treatment, we believe our total annual addressable market opportunity for treatment sessions in the United
States is approximately $9.6&nbsp;billion. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Initial treatment options for MDD often consist of antidepressant medication
prescribed by a primary care physician. Although a variety of antidepressant medications are available, drug therapy has two primary limitations: limited effectiveness and treatment-emergent side effects. These limitations were demonstrated in the
STAR*D study, a large clinical trial funded by the U.S. National Institute of Mental Health, or NIMH, that enrolled more than 4,000 adult MDD patients at 41 clinical sites to examine the outcomes to a sequenced series of antidepressant medication
attempts that mimicked best practices. In the study, approximately 28% and 21% of patients achieved remission in their first and second medication attempts, respectively. Many patients taking antidepressant medications experience intolerable or
troubling side effects that contribute to a delay or failure in attaining an effective or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">88 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
optimal antidepressant dose, poor patient treatment adherence or discontinuation of treatment therapy. The likelihood of achieving remission is limited and declines with each successive
medication attempt. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">TMS is considered to be an appropriate therapy for the treatment of MDD patients who have failed to
achieve satisfactory improvement from prior antidepressant medication. TMS is typically performed as an office-based procedure using a capital equipment system designed to deliver the magnetic pulses necessary to stimulate the specific areas of the
brain associated with mood. A course of treatment typically requires treatment sessions five times a week for up to six weeks that can last from 19 to as long as 45 minutes per session. The effectiveness of TMS depends on the psychiatrist&#146;s
ability to deliver a precise amount of magnetic pulses to a specific area of the brain in a manner that can be consistently repeated during each treatment session. While TMS has been demonstrated to be a safe and effective treatment alternative for
patients suffering from MDD, we believe that competing TMS systems have experienced limited adoption because of their lack of the following: the ability to reproduce consistent treatments, significant clinical data from randomized outcome trials,
practice development resources and a cloud-based practice management system. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We designed the NeuroStar Advanced Therapy as a <FONT
STYLE="white-space:nowrap">non-invasive</FONT> therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options. We believe our NeuroStar Advanced Therapy provides our
psychiatrist customers and their patients with several benefits, including clinically demonstrated response and remission with durable results, a demonstrated safety profile with limited treatment-emergent side effects and high patient adherence.
Additionally, NeuroStar Advanced Therapy was designed to provide a precise and reproducible office-based therapy that is also efficient and convenient. Our therapy is delivered without general anesthesia or sedation, enabling the patient to drive
and resume normal activities immediately following each treatment session. We couple our product&#146;s clinical benefits with significant practice development resources, on-site clinical training and reimbursement and service support to help our
psychiatrist customers develop a successful NeuroStar Advanced Therapy practice. We also provide cloud-based practice management solutions that enhance convenience for both psychiatrists and patients. Based on our commercial data, we believe
psychiatrists can recoup their initial capital investment in our system by providing a standard course of treatment to approximately 12 patients, assuming these patients receive reimbursement from Medicare or commercial insurance at rates that are
similar to what our customers have observed for existing and prior patients. We believe psychiatrists can generate approximately $7,500 to $10,000 of revenue per patient for a standard course of treatment, which may provide meaningful incremental
income to their practices. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The safety, effectiveness and durability of NeuroStar Advanced Therapy is supported by a large
clinical data set published in 23 articles in peer-reviewed medical journals, including from 11 clinical studies that have collectively enrolled more than 900 adult patients suffering from MDD. In a 307&nbsp;patient, naturalistic, prospective,
observational trial conducted at 42 U.S. clinical sites in patients who had tried and failed to receive relief from one or more medication trials in their current MDD episode, following an acute course of NeuroStar Advanced Therapy, 58% of patients
responded, which means they achieved a clinically meaningful reduction in symptoms, and 37% achieved remission. Response and remission were maintained over a <FONT STYLE="white-space:nowrap">12-month</FONT> period for a majority of these patients.
In the STAR*D study approximately 28% and 21% of patients achieved remission in their first and second medication trials, respectively. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our growth strategy includes expanding our commercialization efforts in the United States, expanding international opportunities and pursuing pipeline development of our therapy for
additional indications. Outside the United States, our products have received marketing authorizations in the European Union and Japan. Our initial international commercial focus is Japan, which has the third largest healthcare spend globally. We
recently entered into an exclusive distribution agreement with Teijin Pharma Limited, or Teijin, a leading Japanese healthcare company, to further expand our commercialization efforts in this </FONT></P>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">89 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
market. We are also evaluating the use of enhancements to our NeuroStar Advanced Therapy System to treat additional indications, which may include bipolar depression and post-traumatic stress
disorder. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of March&nbsp;31, 2018, we had an installed base of 781 active NeuroStar Advanced Therapy Systems in the
United States. We currently sell our NeuroStar Advanced Therapy System and recurring treatment sessions in the United States through our direct sales and customer support team, which was comprised of 126 people as of March&nbsp;31, 2018. Our sales
force primarily targets 3,600 high-decile psychiatric practices that we estimate, based on data from Symphony Health and our own internal estimates, treat approximately 33% of the total MDD patients in the United States who meet our labeled
indication and are insured. Patients are reimbursed by Medicare and the vast majority of commercial payors in the United States for treatment sessions utilizing our NeuroStar Advanced Therapy System. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We generate revenues from initial capital sales of our systems, sales of our recurring treatment sessions and from service and repair and
extended warranty contracts. For the year ended December&nbsp;31, 2017, we generated revenues of $40.4&nbsp;million and had a net loss of $16.1&nbsp;million. Our revenues increased 18% during the year ended December&nbsp;31, 2017 compared to the
year ended December&nbsp;31, 2016. For the year ended December&nbsp;31, 2017, our U.S. revenues were $39.9 million, compared to $31.6 million for the year ended December&nbsp;31, 2016, which represented an increase of 26% compared to the prior
period. Revenues from treatment sessions represented 71% of our U.S. revenues for the year ended December 31, 2017 compared to 78% of our U.S. revenues for the prior year. For the three months ended March 31, 2018, we generated revenues of $10.2
million, which represented an increase of 35% compared to the same period in the prior year. For the three months ended March 31, 2018, U.S. revenues were $10.0&nbsp;million, which represented an increase of 35% compared to the same period in the
prior year. Revenues from treatment sessions represented 72% of our U.S. revenues for the three months ended March 31, 2018, compared to 78% of our U.S. revenues for the same period in the prior year. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Market Opportunity and Major Depressive Disorder </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Market Opportunity </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The WHO estimates that there are over
300&nbsp;million people in the world living with depression and ranks MDD as the single largest contributor to global disability and a major contributor to suicide worldwide. In the United States, the economic burden of the disease was estimated by
the <I>Journal of Clinical Psychiatry</I> to be $210&nbsp;billion in 2010, including outpatient and inpatient medical costs, pharmacy costs, suicide related costs and workplace costs. There were approximately 333&nbsp;million antidepressant
medication prescriptions written in the United States in 2017, representing pharmaceutical sales totaling $5.0&nbsp;billion, according to IMS Health. Based on U.S. Census Bureau data and a study published in the <I>Journal of the American Medical
Association, </I>we estimate that approximately 21&nbsp;million people in the United States suffer from MDD annually. Of these people, we estimate approximately 13.3&nbsp;million are adults aged 22 to 70 years, of whom an estimated 7.6&nbsp;million,
based on data from the <I>Journal of the American Medical Association</I>, are being treated by a psychiatrist. We estimate, based on data from the STAR*D study, that approximately 5.5 million of these patients have failed to achieve remission of
their MDD from their prior antidepressant medication therapy and that approximately 3.8 million of those patients have commercial insurance or Medicare coverage for the NeuroStar Advanced Therapy. As a result, based on our expected revenues for a
standard course of treatment, we believe our total annual addressable market opportunity for treatment sessions in the United States is approximately $9.6 billion. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In Japan, the country with the third highest aggregate healthcare expenditures worldwide according to Deloitte, we estimate, based on data from the National Center for Biotechnology and
Information, that approximately 2.4&nbsp;million adults suffer from MDD and approximately 655,000 of these adults are being treated for their MDD by a psychiatrist. We estimate, based on data from the STAR*D study, that approximately 475,000 of
these patients, all of whom are covered by Japan&#146;s single payor healthcare system, have failed to achieve remission of their MDD from prior antidepressant medication therapy and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">90 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
are candidates for treatment with NeuroStar Advanced Therapy. As a result, we believe our total addressable market opportunity for treatment sessions in Japan is over $1.0 billion, assuming
psychiatrist reimbursement levels per treatment course per patient are similar to those in the United States. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Major
Depressive Disorder </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Disease Overview </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">MDD is a mood disorder characterized by the presence of one or both of two major diagnostic criteria that continues for at least two weeks: a depressed mood or loss of interest in
pleasure. The presence of at least one of these diagnostic symptoms must be accompanied by several of the following additional symptoms, for a total of five or more symptoms: sleep disturbance, changes in appetite, sexual dysfunction, anxiety,
fatigue, difficulty concentrating and suicidal thinking. In order to be diagnosed with MDD, a patient must display symptoms that are present most of the day, nearly every day, for at least two weeks. A diagnosis of MDD is established by clinical
interview and an assessment of whether a patient reports a collection of symptoms defined in the American Psychiatric Association&#146;s <I>Diagnostic</I> <I>and Statistical Manual of Mental Disorders, fifth edition</I>, or <FONT
STYLE="white-space:nowrap">DSM-5.</FONT> The severity of a patient&#146;s symptoms is typically measured by a standardized rating scale from a self-reported questionnaire, such as the Patient Health
<FONT STYLE="white-space:nowrap">Questionnaire-9,</FONT> or PHQ-9, or from an observer-dependent interview, such as the Hamilton Depression Rating Scale, or HAMD. Based in part on these rating scale measures, MDD can be graded on a continuum from
mild to severe. The symptoms of the disease may result in role impairment, which refers to a loss of functioning or enjoyment in work, or impairment of household relationships and/or social roles. MDD is often accompanied by, or comorbid with, other
mental disorders, with an estimated three-fourths of patients with recurrent MDD suffering from another psychiatric illness or substance abuse disorder. MDD patients also have an increased risk of death from suicide and other more typical causes,
such as heart disease. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">MDD is a recurrent disease and follows a fluctuating course over an individual&#146;s lifetime, with
periods of remission and relapse. If an initial episode of MDD is resolved, the return of depressive symptoms during the first nine months thereafter is referred to as a relapse of the illness and is generally considered to be part of the same
depressive episode. When depressive symptoms return more than 12 months after the initial episode of MDD is resolved, it is considered to be a recurrence of the illness and is deemed a new and distinct episode. A response to treatment is commonly
measured as a clinically significant decrease in symptoms on a standardized rating scale from baseline scores. When a patient shows no or nearly no symptoms, the patient is referred to as being in remission. An average episode of MDD lasts
approximately four to eight months and approximately three-fourths of all patients who experience an episode of MDD will experience recovery within a year. However, experiencing one episode of MDD places an individual at an estimated 50% risk of
experiencing an additional episode of MDD. Approximately 80% of those individuals who have experienced two episodes of MDD will experience an additional episode. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Neuroscience of MDD </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The exact causes of MDD are not known
but, as with many psychiatric disorders, a variety of factors may be involved, including the physical and chemical characteristics of the brain, hormonal changes, genetics, acute life events, chronic stress, childhood exposure to adversity and other
environmental factors. Researchers have identified a network in the brain that affects a person&#146;s mood, which can play a significant role in MDD and includes the prefrontal cortex, the anterior cingulate cortex and the limbic brain structures.
The basic unit of organization in this network of the brain is the neuron, a specialized cell that responds to both chemical and electrical signals. The release of chemical messengers, or neurotransmitters, in the brain occurs across synapses, or
the space between neurons. This release of neurotransmitters results in changes in the electrical properties of the receiving neuron, which in turn triggers a cascade of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">neuron-to-neuron</FONT></FONT> electro-chemical reactions along a pathway of the brain referred to as a neuronal circuit. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">91 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following diagram depicts the chemical reactions across the neuronal network:
</FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Neurotransmission Mechanism </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g07s21.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">This communication process across different regions of the brain is ordinarily self-regulated by
feedback mechanisms that instruct the originating neuron to stop releasing the neurotransmitter and start reabsorbing it into the cell, a process called reabsorption or reuptake. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In people with MDD, however, this complex system of neuronal communication does not function properly. Receptors may be either oversensitive or insensitive to a specific neurotransmitter,
causing their response to its release to be excessive or inadequate. The signal might also be weakened if the originating cell produces too little of a neurotransmitter or if an overly efficient reuptake process reabsorbs too much of the
neurotransmitter before the molecules have the chance to bind to the receptors on other neurons. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">One of the most important
discoveries in neuroscience has been the recognition that improper regulation of one or more of the three major neurotransmitters, serotonin, norepinephrine and dopamine, plays a key role in a patient&#146;s depression. This understanding has guided
psychiatric drug development and the treatment of depression for more than three decades by placing a major focus on targeting chemically-based mechanisms. The relatively recent introduction of TMS as a targeted, circuit-based treatment option has
reintroduced the importance of electrical mechanisms in restoring proper function to neuronal pathways to treat depression. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Current Treatment Landscape </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>First Line Therapy </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the United States, an initial
diagnosis of adult MDD is typically made by the patient&#146;s primary care physician. Upon diagnosis, the most common form of treatment is antidepressant medication, which may or may not be accompanied by psychotherapy. The physician typically
discusses a number of different treatment options and then designs a treatment plan tailored to the patient&#146;s specific symptoms, personal preferences and the psychiatric services that are available near the patient&#146;s home. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The most commonly prescribed antidepressant medications are selective serotonin reuptake inhibitors, or SSRIs. SSRIs primarily affect the
levels and activity of serotonin in the brain and attempt to address depression by blocking the reuptake of this neurotransmitter, thereby making more serotonin available. During the initial treatment course, a patient may experience uncomfortable
side effects and it is common for a patient and the primary care physician to spend time testing different medications within the same and different chemical classes before arriving at a medication regimen that provides symptom relief and is
tolerable. Different classes of antidepressant medications may also work on different </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">92 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
combinations of underlying neurotransmitters. For example, serotonin norepinephrine reuptake inhibitors, or SNRIs, work by blocking the reuptake of both serotonin and norepinephrine. Other
medications may have more diverse effects on all three major neurotransmitters. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Depression-focused psychotherapies are a
commonly recommended treatment option for MDD and are generally used in conjunction with an antidepressant medication. The two most well studied and commonly available psychotherapy techniques include cognitive behavioral therapy and interpersonal
psychotherapy. These are interactive therapies between a trained professional and a patient. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Second Line
Therapy </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If initial treatment approaches do not adequately relieve a patient&#146;s symptoms, a primary care physician will
often make a referral for consultation with a psychiatrist trained in psychopharmacology. There are a wide array of options that a psychiatrist may consider as second line therapies after an initial treatment has failed. For example, a psychiatrist
may recommend either combining two or more antidepressant medications, which is referred to as combination therapy, or using a second medication such as an atypical antipsychotic that is not an antidepressant along with the initial antidepressant
medication to augment the efficacy of such antidepressant, which is referred to as augmentation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Another second line therapy
is TMS, which is considered to be an appropriate alternative for the treatment of a patient with MDD who has failed to achieve satisfactory improvement from prior antidepressant medication in the current MDD episode.&nbsp;TMS differs from drug
therapy approaches by using a pulsed, <FONT STYLE="white-space:nowrap">MRI-strength</FONT> magnetic field to induce electrical currents designed to stimulate specific areas of the brain associated with mood.&nbsp;The target for brain stimulation is
the prefrontal cortex, which serves as a starting point to regulate the neuronal circuitry connected to this region of the brain. This stimulation triggers a cascading electro-chemical effect that can pass along the neuronal circuit and reach into
the deeper structures of the brain that also regulate mood. This action changes the connections among these structures in a manner that improves the activity of the neuronal circuit and results in an improvement in mood. TMS is typically performed
as an office-based procedure using a piece of capital equipment designed to deliver the magnetic pulses necessary to stimulate the neurons.&nbsp;A course of treatment typically requires treatment sessions five times a week for up to six weeks that
can last from 19 to as long as 45 minutes per session. The effectiveness of TMS therapy depends on the psychiatrist&#146;s ability to deliver a precise amount of magnetic pulses to a specific area of the brain in a manner that can be consistently
repeated during each treatment session.</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Later Stage Treatment Options </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">More aggressive options, which are associated with greater medical risk, are sometimes considered for patients that require later stages
of treatment and include electroconvulsive therapy, or ECT, and vagus nerve stimulation, or VNS. ECT is a hospital-based treatment approach that is usually reserved for the most critical MDD patients and is considered most frequently in instances
where the patient is experiencing catatonia, acute suicidal behaviors requiring inpatient hospitalization or psychotic symptoms. ECT involves the direct application of high voltage electrical current to the surface of the head and must be
administered under anesthesia in a controlled hospital setting. VNS is considered the most invasive treatment option currently approved by the FDA for MDD patients who have proven to be severely treatment resistant. VNS involves the surgical
implantation of an electrode wrapped around the vagus nerve, which travels through the neck near the carotid artery, and utilizes a pulse generator that is separately implanted under the skin near the patient&#146;s collarbone. The pulse generator
sends electrical impulses to the electrode throughout the day with the goal of modifying the regions of the brain known to be involved in the regulation of mood. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">93 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">A general overview of the treatment sequence for a patient with MDD is shown in the
diagram below. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:1px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g00o02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Limitations of Current Therapies </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Antidepressant medication therapy </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Although a variety of antidepressant medications are available for the treatment of MDD, antidepressant therapy has two primary limitations: limited efficacy and treatment-emergent side
effects that interfere with patient adherence to the prescribed treatment regimen. These limitations were demonstrated in the STAR*D study. This study was sponsored by the NIMH and enrolled more than 4,000 adult patients at 41 clinical sites,
including outpatients with nonpsychotic MDD. The trial examined the outcomes to a sequenced series of antidepressant medication treatment options that mimicked best practices. Patients whose depression did not remit after the initial treatment trial
of using a single-medication SSRI treatment were able to participate in a sequence of up to three treatment trials. The progression that followed included switching to a different class and more complex combination and augmentation treatments for
patients who were unable to achieve remission with each of the trials. Brain stimulation techniques, including ECT and VNS, were not examined in this study. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U></U></B><B><I><U>Limited Efficacy</U></I></B><B><U></U></B>.&nbsp;&nbsp;&nbsp;&nbsp;In the STAR*D study, approximately 28% and
21% of patients achieved remission in their first and second medication attempts, respectively. The likelihood of achieving remission from a medication regimen was limited and declined with each successive augmentation attempt. For patients that had
three prior treatment attempts, only approximately 7% achieved remission in response to the fourth monotherapy treatment option used in that </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">94 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
study. The following figure depicts the percentage of patients who achieved remission at each stage of monotherapy treatment in the STAR*D study based on analysis of HAMD scores:
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:1px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g30p52.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U></U></B><B><I><U>Treatment-Emergent Side Effects</U></I></B><B><U></U></B>.&nbsp;&nbsp;&nbsp;&nbsp;The STAR*D study showed that
the likelihood of discontinuing treatment due to treatment-emergent side effects increased with each incremental course of medication. According to the study and as shown in the figure below, approximately 41% of patients who progressed to the
fourth monotherapy treatment attempt subsequently discontinued drug treatment. Many patients taking antidepressant medications experience intolerable or troubling side effects that contribute to a delay or failure in attaining an effective or
optimal antidepressant dose and often result in poor patient treatment adherence or discontinuation of therapy. These side effects include sexual dysfunction, drowsiness, fatigue, weight gain and nausea. The severity of side effects generally
increase as a patient proceeds from initial drug treatment to combination or augmented drug treatments. Later stage treatment options, such as first-generation antidepressants and antipsychotics, have potentially more serious side effects and
intolerability, with the risk of potential fatal overdose. The discontinuation of treatment can also result in severe side effects, including dizziness, nausea, lethargy, headache, anxiety and agitation that can last for extended periods.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:1px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g79s79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Since the publication of the STAR*D study results, additional drug therapies have been introduced,
including most prominently atypical antipsychotics, which are used as augmentation agents for patients with partial or <FONT STYLE="white-space:nowrap">non-response</FONT> to initial antidepressant medications given alone. Unfortunately, these
augmentation treatments have not significantly improved overall MDD patient response rates and have also introduced additional side effects. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">95 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Depression-Focused Psychotherapies </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Antidepressant medication therapy for MDD is often administered along with a recommendation for a depression-focused psychotherapy. While
these treatment options have demonstrated efficacy in some clinical studies, they also are associated with limitations in practice. For instance, the experience level of the therapist may significantly affect the treatment outcome. Additionally, in
order to access these treatments, patients usually require a referral to a psychotherapist who may be located at a different clinical site than their treating psychiatrist. Psychotherapy requires a commitment by a patient to numerous treatment
sessions in order to potentially achieve significant improvement, with a typical treatment regimen consisting of 16 sessions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Later Stage Treatment Options </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Both ECT and VNS have
significant drawbacks. ECT requires general anesthesia and is administered in a controlled hospital setting with access to emergency resuscitation equipment. ECT is typically administered three times per week for up to 12 treatments, with some
patients requiring as many as 20&nbsp;treatments. ECT patients may experience confusion and memory loss, the two most common side effects of ECT treatments, immediately following a treatment session. Other side effects may include nausea, headache,
jaw pain, muscle ache, hypertension and hypotension and life threatening complications including adverse reactions to anesthesia, arrhythmias, ischemia or prolonged seizures. Because of the potentially disabling side effects of ECT, the patient is
typically unable to work for the duration of the course of treatment. VNS is considered the most invasive treatment option currently approved by the FDA for MDD patients who have proven to be severely treatment resistant. VNS includes surgical
related risks, such as infection or local damage to the recurrent laryngeal nerve, which may lead to permanent voice alteration. Other drawbacks of VNS include the development of cardiac arrhythmias and the periodic repeat surgeries required to
replace the pulse generator battery. Finally, reimbursement for the implantation and ongoing monitoring of the VNS device remains problematic, limiting access to the procedure for most patients. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Transcranial Magnetic Stimulation </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">While TMS has been demonstrated to be a safe and effective treatment alternative for patients suffering from MDD, we believe that most TMS systems have experienced limited adoption for
several reasons, including: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Challenges in delivering precise and reproducible treatments</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;We believe the design and technology
of most TMS systems makes it difficult for psychiatrists to reliably administer precise and reproducible treatments during each treatment session.&nbsp;Notably, most TMS systems do not provide the psychiatrist with the ability to stabilize the
patient&#146;s head during treatment. If a slight separation of the TMS treatment coil from the patient&#146;s head occurs, it may reduce the magnetic field in the patient&#146;s brain, resulting in the delivery of a lower dose than what was
prescribed. Most TMS systems are unable to track the number of pulses not delivered as a result of this separation and therefore may not administer the prescribed dose. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Lack of clinical data from randomized outcome and other trials.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>Most TMS providers have not
conducted, and their systems have not been the subject of, significant clinical trials or naturalistic studies to demonstrate their effectiveness. As a result, when selling their products most TMS providers must rely on smaller or more general
studies or clinical trials that were conducted using other TMS systems or the NeuroStar Advanced Therapy System, which may present a barrier to adoption by psychiatrists and patients. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Lack of cloud-based practice management system</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;Many psychiatrists and psychiatrist practice
groups operate in multiple locations and may use multiple TMS devices. Most TMS systems, however, only allow for the storage of patient data and treatment information on a local computer. Unless connected through an inter or intra-office network,
psychiatrists may not be able to access patient treatment data and information regarding the use of the TMS </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">96 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
system. Moreover, this can create logistical challenges when psychiatrists seek to treat the patient at multiple locations or on multiple systems at the same location.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Lack of comfort and convenience</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;Most TMS systems are adaptations of research devices that have
been repurposed.&nbsp;As a result, they frequently lack the ergonomic and other human factors that provide comfort and convenience and that are important for improving the patient experience and acceptance of the treatment. Other TMS systems may
also require treatment to be administered for up to 45 minutes per treatment session. Some TMS systems require patients to wear a cap that fits firmly around the head and/or utilizes a chin strap that is attached from one ear to the other, which
patients may consider uncomfortable. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Lack of customer support and practice development resources.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>Many psychiatrists are not accustomed
to implementing a piece of capital equipment into their practice. As a result, we believe they need multi-day, on-site training for themselves and their staff, marketing and reimbursement support, and help determining the allocation of office space
and proper roles of staff for the use of TMS systems. We believe that most TMS providers do not provide comprehensive clinical support and practice development resources that are necessary to operationalize a TMS service line into their practice.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Our Solution </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We designed the NeuroStar Advanced Therapy as a <FONT STYLE="white-space:nowrap">non-invasive</FONT> and <FONT STYLE="white-space:nowrap">non-systemic</FONT> therapeutic alternative for
patients who suffer from MDD. We believe our solution addresses the key limitations of existing MDD treatment options and that NeuroStar Advanced Therapy provides the following principal benefits to our psychiatrist customers and their patients:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Clinically demonstrated safety, efficacy, response and remission with durable results.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>The safety
and efficacy of NeuroStar Advanced Therapy has been demonstrated in two large prospective, multisite, randomized, sham-controlled trials. In addition, the efficacy of NeuroStar Advanced Therapy has been demonstrated in a multisite, real world,
open-label, clinical trial in which patients who failed to achieve satisfactory improvement from antidepressant medication treatment in their current episode of MDD received an acute treatment course of TMS therapy. Overall, the results of this
trial demonstrated that 58% of patients responded to treatment, and 37% achieved remission. In this trial, similar response and remission rates were observed across patients with a wide range of prior drug treatment attempts. The majority of
patients in this trial also participated in a <FONT STYLE="white-space:nowrap">12-month</FONT> <FONT STYLE="white-space:nowrap">follow-up</FONT> phase at the conclusion of which the clinician-assessed response rate in these patients was 68% and
remission rate was 45%. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Demonstrated safety profile with limited treatment-emergent side effects and high patient
adherence.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;NeuroStar Advanced Therapy has a demonstrated safety profile without the systemic side effects typically experienced with antidepressant medications. The adverse events discontinuation rate in our
sham-controlled clinical studies has been approximately 5%. For single medication treatment in the STAR*D Study, the adverse events discontinuation rate was 9% to 41%. The most common side effect associated with NeuroStar Advanced Therapy is
transient, localized pain or discomfort at or near the treatment location. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Precise and reproducible office-based therapy.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>Patients receive NeuroStar Advanced Therapy for
five days a week for up to six weeks in a psychiatrist&#146;s office without the need for general anesthesia or sedation. The NeuroStar Advanced Therapy System&#146;s proprietary components and software are designed to deliver the recommended TMS
treatment dose to the indicated location on the patient&#146;s prefrontal cortex consistently. The treatment location is determined with a three-dimensional, laser-guided, <FONT STYLE="white-space:nowrap">six-point</FONT> coordinate system. The
SenStar Connect is a proprietary component of the device designed to ensure our NeuroStar Treatment Coil is functioning properly and positioned against a patient&#146;s head. SenStar
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">97 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
Connect provides continuous real-time feedback to the clinician throughout the course of treatment and it tracks lost pulses during each treatment session and provides the clinician with the
opportunity to readminister any lost pulses at the end of the treatment, all of which helps to ensure that a patient receives the prescribed dose of NeuroStar Advanced Therapy. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Efficient and convenient treatment for the patient and the psychiatrist.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>We have developed and
deployed one of the shortest duration treatment for MDD using TMS approved by the FDA, with each treatment cleared to be performed in as little as 19 minutes (but may take up to 39 minutes due to patient sensitivity or at the discretion of the
treating psychiatrist).<B><I> </I></B>Our therapy is delivered while a patient is awake and alert, enabling the patient to drive a vehicle and resume normal activities immediately following each treatment session. The NeuroStar Advanced Therapy
System was designed for patient and psychiatrist convenience by establishing a proprietary software system, which we refer to as MT Assist, that allows the psychiatrist to determine the proper dose and motor threshold unique to each patient. After
the initial treatment session, the NeuroStar Advanced Therapy System records the treatment coordinates so they do not need to be <FONT STYLE="white-space:nowrap">re-identified</FONT> in future treatments. Once a psychiatrist has established the
patient&#146;s coordinates during the initial treatment session, a trained member of the office staff under the supervision of the psychiatrist may administer subsequent treatment sessions. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Unique cloud-based practice management system.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>Our TrakStar practice management system captures
all treatment relevant information, and the encrypted information can be downloaded to any NeuroStar Advanced Therapy System in a psychiatrist&#146;s network in order to make it convenient for a patient to receive care and increase scheduling
flexibility. Patients do not need to be treated by the same NeuroStar Advanced Therapy System for each treatment session, and therefore psychiatrists who own multiple systems do not need to schedule patients to specific devices. A treating
psychiatrist can download a patient&#146;s encrypted information from TrakStar and analyze it real-time from their laptop, mobile phone or tablet. TrakStar also manages the inventory of purchased treatment sessions, which can be replenished by an
office administrator online at any time. We expect the next version of TrakStar will also enable remote software updates, diagnostics and troubleshooting and performance monitoring to maintain industry-leading up time. TrakStar also captures and
records daily system utilization, office productivity and patient outcomes. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Comprehensive customer support and practice development resources</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;We believe that we offer the
most comprehensive practice support services among all TMS system providers to help our psychiatrist customers operationalize and grow their TMS service line. We provide our customers with marketing support, such as tools to increase awareness with
referring psychiatrists, providing customizable advertising materials designed to educate patients within an existing practice and in the local community, and through our digital marketing campaign, which is comprised of paid search, display
advertising, social media and public relations. Our clinical practice consultants focus their efforts on helping psychiatrist customers implement our six step Practice Success Program, which includes practice management planning, patient
identification, staff training on practice roles, patient consult training, outcomes data analysis, practice marketing, public relations strategies and other support services. Our reimbursement managers help our psychiatrist customers to understand
how they can navigate all issues regarding the insurance reimbursement process, including investigation of benefits, prior authorizations and claims documentation. Our field service engineers are responsible for maintenance, repairs and installation
of upgrades of our systems, and typically provide a response within 24 hours of a service call. This responsiveness has allowed us to realize over 99% uptime of our installed base. Finally, we also offer our customers a 24/7 support hotline to
respond to medical information inquiries and technical questions that arise. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">98 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We believe these characteristics address the limitations of antidepressant medications
and competing TMS systems and as a result make our NeuroStar Advanced Therapy the most attractive <FONT STYLE="white-space:nowrap">non-invasive</FONT> therapeutic alternative for our psychiatrist customers when they treat patients who suffer from
MDD. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Our Strengths </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are focused on improving the quality of life for patients who suffer from psychiatric disorders, including MDD. Our executive team on average has 20 years of experience in healthcare,
developing and commercializing innovative medical technology products. We believe that our focus and experience in treating patients with MDD, combined with the following strengths, will allow us to build our business and potentially expand our
market opportunity: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>A market leader in TMS therapy.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;We believe we are the market leader in TMS therapy based on our
U.S. installed base of 781 active NeuroStar Advanced Therapy Systems in approximately 615 psychiatrist offices and the estimated 50,000 patients treated with over 1.8&nbsp;million treatment sessions. We generated revenues of $40.4 million for the
year ended December 31, 2017 and $10.2 million for the three months ended March 31, 2018. We believe this commercial scale, combined with our investments in comprehensive practice support services and an experienced direct sales and customer support
team provides us meaningful competitive advantages by creating significant barriers to entry to other TMS providers. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Significant body of clinical data and key opinion leader support.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The safety, efficacy and
durability of NeuroStar Advanced Therapy is supported by what we believe is the largest clinical data set of any TMS system. Our therapy has been the subject of 11 clinical studies that have collectively enrolled more than 900 patients suffering
from MDD. The results of these studies have been published in 23 articles in peer reviewed medical journals. We have also established strong relationships with key opinion leaders within the psychiatric community, who help us to educate
psychiatrists from around the world on innovative treatment modalities such as TMS therapy. These key opinion leaders also help inform our clinical development programs. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Proprietary technology with a broad IP portfolio.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>Our NeuroStar Advanced Therapy incorporates
several key proprietary technologies that are designed to ensure the precise delivery and repeatability of our therapy in the clinical setting. As of March&nbsp;31, 2018, we owned or licensed 30 issued or allowed U.S. patents, 49 issued or allowed
foreign patents, seven pending U.S. patent applications, and 14 pending foreign patent applications. We believe this patent portfolio is substantially larger than that of any competing TMS companies. This portfolio covers key aspects of our
technology, including contact sensing, MT Assist and our iron core magnet that allows high patient throughput. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Extensive reimbursement coverage and experience.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;NeuroStar Advanced Therapy is a well-established
treatment option for patients with MDD and is reimbursed by many commercial payors and Medicare contractors in the United States. We estimate that, over 65 major private insurers in the United States, including the top 25 largest private insurers,
have adopted coverage policies for reimbursement of NeuroStar Advanced Therapy, representing approximately 205&nbsp;million covered lives or about 95% of the total private payor covered lives in the United States. TMS treatment sessions using
NeuroStar Advanced Therapy are also eligible for reimbursement for all Medicare regions, representing an additional 58.5&nbsp;million covered lives in the United States in as of January 2018. In addition, our reimbursement team has significant
experience working with our psychiatrist customers to help them navigate the reimbursement process. Our reimbursement team has assisted our customers to conduct more than 20,000 benefits investigations, and have helped approximately 50,000 patients
gain access to our therapy. We are also in the process of obtaining reimbursement coverage for NeuroStar Advanced Therapy in Japan, which we expect to receive in 2018. In April 2018 we received approval to submit reimbursement dossiers with the
Japanese Ministry of Health, Labour and Welfare, or JMHLW. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">99 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Potential to enhance psychiatrist practice economics.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>Based on our commercial data, we believe
our<B> </B>psychiatrist customers can generate between approximately $7,500 to $10,000 of revenues per patient for a standard course of treatment using the NeuroStar Advanced Therapy System, and can recoup their capital investment in our system by
treating approximately 12&nbsp;patients, assuming these patients receive reimbursement from Medicare or commercial insurance at levels that are similar to what our customers have observed for existing and prior patients. We believe that subsequent
treatments using our system may significantly increase practice economics for our psychiatrist customers. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Our Strategy </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our goal is to maintain and extend our leadership position in TMS therapy for patients with psychiatric disorders. The key elements of our strategy include: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Improve customer targeting and expand our direct sales and customer support team to accelerate
growth.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>To capture new psychiatrist customers, we plan to expand our specialized, direct sales organization that targets MDD treating psychiatric practices that accept reimbursement from private insurance and Medicare.
Symphony Health estimates that there are approximately 26,300 group and solo practice sites in the United States with psychiatrists that prescribe antidepressant medications. Our direct sales force primarily targets psychiatrists at 3,600 of these
practice sites, referred to as high-decile practices, which, based on data from Symphony Health and our own internal estimates, we estimate treat approximately 2.5&nbsp;million patients, representing 33% of the total MDD patients in the United
States. We estimate that approximately 1.2 million of these patients have failed prior antidepressant medication attempts in the current MDD episode and are covered by insurance that will provide reimbursement based on this medical status, resulting
in a targeted total addressable market of approximately $3.0&nbsp;billion. After nearly doubling the number of our business development managers in the last twelve months, we intend to continue to expand our team of 34 business development managers
and seven inside sales representatives that are responsible for driving new customer acquisitions. To reach our target practices, we also plan to expand our advertising efforts, both online and through more traditional approaches, such as targeting
leading psychiatric journals, practice outreach and education through monthly webcasts, attendance at key psychiatric trade shows and sponsoring clinical symposiums and product theaters. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Increase utilization of our new and existing installed base of NeuroStar Advanced Therapy
Systems.</I></B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B>We plan to expand our sales and customer support team to increase the number of patients treated by our existing installed base of 781 active NeuroStar Advanced Therapy Systems in the United States and
any additional systems that we sell in the future. We intend to hire additional clinical training consultants to our existing team of eight who will focus on the ongoing training of our psychiatrist customers and their staff in order to allow our
existing team of 28 clinical practice consultants to focus exclusively on helping increase patient utilization of NeuroStar Advanced Therapy in a practice. Our clinical practice consultants focus their efforts on helping psychiatrist customers
implement our six step Practice Success Program. We intend to make further investments in marketing tools, like our marketing portal, which consists of customizable practice development and advertisement materials all of which are designed to drive
patient awareness within an existing practice and in the local community. We recently concluded a three-week national television advertising campaign designed to increase patient awareness of NeuroStar Advanced Therapy. We also plan to invest
further in our direct to consumer marketing programs, primarily through digital marketing, which is comprised of paid search, display advertising, social media and public relations to our psychiatrist customers. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Expand our international market opportunities.</I></B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B>We primarily sell our products within the
United States and also sell our products through distributors in Japan, Saudi Arabia, The </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
United Arab Emirates, Singapore, the Republic of Korea and Australia. Our products have received regulatory approval in the European Union and Japan and we plan to primarily focus our commercial
efforts outside of the United States on Japan. We plan to work with Teijin to obtain reimbursement approval for the NeuroStar Advanced Therapy System in 2018, and to provide sales, marketing and clinical support to ensure our commercial success. We
will continue to opportunistically evaluate additional markets outside the United States and Japan for commercial expansion. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Pursue enhancements of our NeuroStar Advanced Therapy System and pipeline development for additional
indications.</I></B><B>&nbsp;&nbsp;&nbsp;&nbsp;</B>We plan to continue our research and development efforts to enhance the hardware and software components of our NeuroStar Advanced Therapy System for the treatment of MDD and other psychiatric
disorders.<B> </B>We also plan to evaluate the use of enhancements to our NeuroStar Advanced Therapy System to treat other psychiatric disorders, which may include bipolar depression and post-traumatic stress disorder, or PTSD.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>The NeuroStar Advanced Therapy System </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Product </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our NeuroStar Advanced Therapy System is comprised
of the NeuroStar Mobile Console, Patient Positioning System, NeuroStar Treatment Coil and TrakStar practice management system. NeuroStar Treatment Sessions and SenStar Treatment Links, which we refer to as treatment sessions, represent the
consumable portion of the NeuroStar Advanced Therapy Treatment System. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>NeuroStar Mobile Console and Patient Positioning
System </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our NeuroStar Mobile Console and Patient Positioning System are comprised of the following components: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center">


<IMG SRC="g542432g91q20.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1. <B><I>LCD touch screen</I></B> <B><I>and graphical user interface</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;Our LCD touch
screen and graphical user interface provide the operator clear visual directions for sequencing the TMS treatment. User confirmation is required on critical steps to ensure accuracy.</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2. <B><I>Patient Positioning
System</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;The patented patient positioning system includes an electromechanically controlled chair to recline the patient during treatment and a three-dimensional positioning device that uses laser alignment and six
calibrated coordinates to accurately position the patient&#146;s head during treatment.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3. <B><I>Gantry Arm</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;The gantry arm mechanically counterbalances the NeuroStar Treatment Coil and allows the operator to consistently move and place it into
position. Once in position, electromechanical brakes stabilize the NeuroStar Treatment Coil and gantry arm.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4. <B><I>Mobile Console.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The mobile console houses the embedded computer and power electronics responsible
for generating the prescribed pulse sequence.</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">101 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>NeuroStar Treatment Coil </I></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="91%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top">


<IMG SRC="g542432g64a43.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our proprietary NeuroStar Treatment Coil produces the magnetic field that induces the electric current at the prescribed treatment site. The iron core in our
NeuroStar Treatment Coil provides efficient energy conversion and management of the magnetic field. This allows our NeuroStar Treatment Coil to function at higher operating power and lower temperatures. Our NeuroStar Treatment Coil assembly includes
a small fan and sensor to assist in cooling, and temperature tracking, and ensure patient comfort and safety. This temperature management feature allows for short intervals between treatment sessions. The coil face is set at a <FONT
STYLE="white-space:nowrap">140-degree</FONT> angle to conform with the patient&#146;s head to ensure contact across the magnet face.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>SenStar </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">SenStar is a thin, flexible electronic circuit, as shown in the figure below, that functions in both the treatment delivery and procedure fee management for our NeuroStar Advanced Therapy
System. Embedded in each SenStar is a magnetic field detector.&nbsp;At the start of each treatment, the NeuroStar Advanced Therapy System performs a self-test that includes verifying the magnetic field is operating within the specified limits. Each
SenStar also includes a sensory guard to reduce topical irritation and improve patient comfort at the skin-coil interface. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">SenStars also contain a patented contact sensor that allows the NeuroStar Advanced Therapy System to monitor and provide real-time visual
feedback to the operator that the NeuroStar Treatment Coil is in proper contact with the patient&#146;s head. The system tracks any pulses lost during treatment and will highlight lost pulses on the graphical user interface.&nbsp;At the end of
treatment, the system allows the operator to administer any missed pulses to complete the full prescribed dose. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:1px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g20j15.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We sell two versions of the SenStar: the SenStar Treatment Link and the SenStar Connect. <I>SenStar
Connect</I> is a <FONT STYLE="white-space:nowrap">multi-use</FONT> device for the U.S. market.&nbsp;To activate a treatment session, a provider needs to purchase an encrypted activation code to enable the SenStar Connect to deliver one treatment
session. NeuroStar Treatment Sessions are purchasable online 24&nbsp;hours a day, any day of the year. The treatment inventory is electronically managed between the NeuroStar Advanced Therapy System and TrakStar systems using digital encryption
technology. <I>SenStar Treatment Link</I> is a single use consumable.&nbsp;SenStar treatment links are used outside the United States and enable one treatment session.&nbsp;Each is programmed for the country of use.</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">102 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>TrakStar Practice Management System </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The TrakStar patient data management system component is a cloud or local application that interfaces with the NeuroStar Advanced Therapy
Systems. TrakStar maintains patient information, prescription, treatment and medication history, positioning coordinates, depression scores and psychiatrist notes. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">TrakStar automatically synchronizes patient data on all NeuroStar Advanced Therapy Systems on the network. Thus the information to treat a patient is available on every system in every
office within a practice. After each treatment is completed, the data is automatically uploaded to TrakStar. This seamless data integration simplifies record management and office workflow. TrakStar supports multiple reports including patient
treatment history, patient depression score trending, practice outcomes and system utilization. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">TrakStar cloud allows the
psychiatrist to see status of other NeuroStar Advanced Therapy Systems in real-time, and access patient data anywhere and anytime using an internet browser. TrakStar cloud is hosted in Microsoft Azure and employs multiple levels of security. Patient
data is encrypted both in transit and at rest. Third-party experts successfully completed penetration testing and an overall business security assessment and certified us as compliant with National Institute of Standards and Technology, or NIST, and
Health Information Technology for Economic and Clinical Health, or HITECH, standards. We also monitor traffic for cybersecurity threats on an ongoing basis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>The NeuroStar Advanced Therapy Process </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>The Treatment
Procedure </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">NeuroStar Advanced Therapy is an <FONT STYLE="white-space:nowrap">in-office</FONT> treatment that has been
cleared to be performed in as little as 19 minutes per session (but may take up to 39 minutes due to patient sensitivity or at the discretion of the treating psychiatrist) and is performed while the patient is awake, alert and seated and reclined
comfortably in the treatment chair. A course of treatment consists of sessions administered five days a week for up to six weeks. During the first treatment session, two essential steps are performed. First, the patient&#146;s cortex is mapped with
the NeuroStar Treatment Coil to identify the area of the brain controlling the thumb. Once the specific location on the motor cortex is found, the second step involves the use of a proprietary software algorithm, which assists the psychiatrist in
estimating the physiologically appropriate magnetic field intensity for each treatment session based on the intensity needed to stimulate movement in the thumb. After these two steps are performed, the location of the motor cortex then also serves
as a reference point to enable the psychiatrist to properly position the NeuroStar Treatment Coil over the left prefrontal cortical surface, resting the coil lightly in contact with the patient&#146;s scalp. Accuracy of positioning of the treatment
coil for pulse delivery is assured by use of the NeuroStar Advanced Therapy System&#146;s three-dimensional positioning device. Once the coil is properly positioned, the device delivers NeuroStar Advanced Therapy using a highly targeted pulsed
magnetic field to stimulate cortical neurons. Our therapy provides targeted stimulation of the prefrontal cortex and engages the neuronal circuitry connected to this region and known to be involved in the regulation of mood. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">During treatment, accurate positioning of our NeuroStar Treatment Coil is maintained by use of a proprietary contact sensing and
navigation system, which helps to ensure precise targeting of the treatment and assurance of accurate therapeutic dosing for each session. The patient typically hears a clicking sound during coil operation and feels a tapping sensation on the head
for the duration of the session. Over the course of each treatment, the patient receives 3,000 pulses. Real-time feedback ensures the patient receives a full dose with safe and effective care. When the session is completed, the psychiatrist removes
the coil and the patient is able to immediately resume normal activities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>The Patient Experience </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our clinical studies indicate that most patients find the NeuroStar Advanced Therapy easy to tolerate when contrasted with alternative MDD
treatments. After completion of a treatment session, a patient </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">103 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
may immediately resume his or her normal activities, including work and exercise. NeuroStar Advanced Therapy patients generally do not experience the systemic side effects associated with drug
therapy. The most typical side effect after treatment with NeuroStar Advanced Therapy, as shown in the figure below, is pain or discomfort near the treatment area, which is generally temporary and typically self-resolves within one week. In our
sham-controlled clinical trials, approximately 5% of patients discontinued treatment due to adverse events. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="font-size:1px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g67h10.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Potential Indications for Use and Research and Development </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We selectively invest in research and development for the use of the NeuroStar Advanced Therapy System in psychiatric disorders.
Throughout our history, we have provided material support to 50&nbsp;investigator-initiated trials of such prospective additional indications. We are currently considering a number of potential future indications for the use of the NeuroStar
Advanced Therapy System, including, but not limited to, those described below. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Bipolar Depression </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Bipolar depression is a psychiatric disorder characterized by a recurrent episodes of mania and depression. The depressed phase of bipolar
disorder is considered to be a form of treatment resistant depression and is the most difficult to treat phase of bipolar disorder. The depressive episode diagnostic criteria in bipolar depression are identical to our current MDD indication.
Although bipolar depression represents a smaller market than MDD, this disease state has few treatment options available and many patients experience suboptimal outcomes. Current treatment options for patients with bipolar depression include the use
of mood stabilizers, including lithium carbonate, anticonvulsant, and second-generation antipsychotics. While these treatments are effective in managing the recurrent mania, there are few effective treatments for the depressed phase of the illness.
For example, antidepressant medications may lead to instability in resolution of the manic episodes if administered alone, and the use of second-generation antipsychotic medications can be associated with undesirable long-term medical side effects,
including weight gain or the development of metabolic syndrome. Based on early research, we are evaluating whether treatment with our NeuroStar Advanced Therapy System could be beneficial to these
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">104 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
patients. If we were to pursue an additional indication in bipolar depression, we would need to conduct additional clinical trials, file an investigational device exemption and clinical trial
protocols with the FDA, submit a 510(k) pre-market notification and receive clearance prior to commercialization. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Post-Traumatic Stress Disorder </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Post-traumatic stress disorder, or PTSD, is a psychiatric disorder that develops in some people who have experienced an overwhelming traumatic event, such as witnessing death in a military
or civilian setting, or as a result of severe physical abuse such as assault or rape. This exposure to a traumatic stressor can lead to a later unwanted <FONT STYLE="white-space:nowrap">re-experiencing</FONT> of symptoms, avoidance behavior,
alteration in cognition and mood and states of increased physiological arousal. Treatment options for PTSD include psychotherapy and SSRI antidepressant medications. We believe NeuroStar Advanced Therapy may represent a potential new treatment
option for PTSD patients. If we were to pursue an additional indication in PTSD, we would need to conduct additional clinical trials, file an investigational device exemption and clinical trial protocols with the FDA, submit a 510(k) pre-market
notification and receive clearance prior to commercialization. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Adolescent MDD </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We completed patient enrollment with 112 adolescent MDD patients in a prospective, <FONT STYLE="white-space:nowrap">13-center,</FONT>
randomized, sham-controlled, double-blind pivotal clinical trial with three phases that mirrors the design of our original adult, randomized, controlled trial. The purpose of this study is to evaluate the acute and long-term safety and efficacy of
NeuroStar Advanced Therapy in treating adolescents with MDD. The trial utilizes a double-blind control design to minimize variability and allow for blinded assessment of the safety and efficacy of NeuroStar Advanced Therapy, using an active
NeuroStar Treatment Coil compared to a system utilizing a sham NeuroStar Treatment Coil. Patients were randomly allocated in a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-to-one</FONT></FONT> ratio to either active
NeuroStar Treatment Coil or sham NeuroStar Treatment Coil. At the time of enrollment, patients were antidepressant-free for at least one week and up to four weeks, depending on medication washout period. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The first phase is designed to evaluate the antidepressant effects of active NeuroStar Advanced Therapy compared with sham treatment when
administered five times per week for a six week acute course of therapy. The primary endpoint of this phase is the difference between active and sham arms using the <FONT STYLE="white-space:nowrap">24-Item</FONT> Hamilton Depression Rating Scale, or
HAMD24, total score change from baseline score over the six week acute phase. Safety will be assessed at every treatment visit by recording adverse events. We expect all analyses for the first phase to be available by the fourth quarter of 2018.
Based on a preliminary analysis conducted in the second quarter of 2018, the primary endpoint in the first phase of the trial was not met. Although we cannot directly attribute clinical trial outcomes from other studies to our own trials, we believe
several clinical trials for antidepressant medications failed to meet the primary efficacy endpoint in their studies for MDD in adolescents and children. These include duloxetine, venlafaxine and, most recently, desvenlafaxine. To date, the data
safety monitoring board has not identified any serious safety issues in the study population, including suicidality and seizure. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Consistent with our clinical trial protocols, we will continue to allow eligible patients who have completed the first phase to participate in the second phase of our clinical trial, which
is a separate, open-label extension study. The second phase trial is designed to evaluate the benefit of active treatment administered five times per week for a <FONT STYLE="white-space:nowrap">six-week</FONT> acute course of NeuroStar Advanced
Therapy in patients who received active or sham treatment and did not receive protocol-defined clinical benefit in the first phase. Patients will remain antidepressant medication free during the second phase. This trial will provide descriptive data
on patients who are switched from sham to active treatments or receive a longer course of active treatment up to 12&nbsp;weeks. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Patients who meet the criteria for at least partial response in either the first or second phases of the trial will be eligible to be
followed in a third phase that will be a separate <FONT STYLE="white-space:nowrap">six-month</FONT> follow up phase. Patients </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">105 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
entering the third phase will first undergo a three-week transition during which they will be gradually tapered off NeuroStar Advanced Therapy. Patients who experience symptom worsening during
this phase of the study may receive reintroduction of NeuroStar Advanced Therapy. Patients will remain antidepressant medication free during the third phase of the trial. The purpose of this phase is to provide descriptive data on the <FONT
STYLE="white-space:nowrap">six-month</FONT> <FONT STYLE="white-space:nowrap">follow-up</FONT> period and any retreatments received by patients. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Although we believe we are unlikely to seek a label expansion for the NeuroStar Advanced Therapy System for the treatment of adolescent MDD, we plan to evaluate next steps with respect to
our clinical development efforts for this indication following the completion of our clinical trials. The Data Safety Monitoring Board for the Adolescent Study reviewed the safety data by treatment group in the first phase of the clinical trial and
provided the guidance that we should continue the study through Phases 2 and 3 of the trial. However, despite this recommendation, we do not expect that the results from the clinical trial will be sufficient to obtain approval of our system for this
indication. Nevertheless, we do not believe these clinical trial results or the failure to obtain approval of our NeuroStar Advanced Therapy System for the treatment of adolescents with MDD will have a material impact on our current or future
business. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Research and Development and Clinical Operations </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Continued innovation through research and development is critical to our future success as a leader in improving the quality of life for
patients who suffer from psychiatric disorders. Our research and development activity is performed with a mix of internal and third party contract resources. As of March&nbsp;31, 2018, our research and development and clinical operations team
consisted of 20 employees with expertise in electronic, mechanical or electrical design, software, biomedical engineering and clinical trial design and management. Our research and development expenses, including spending on our clinical trials and
development efforts, totaled $8.2&nbsp;million and $7.9&nbsp;million for the years ended December&nbsp;31, 2016 and 2017, respectively. For the three months ending March 31, 2017 and 2018, our research and development expenses were $2.0 million and
$1.6 million, respectively. Our current research and development efforts are focused primarily on platform extensions for our NeuroStar Advanced Therapy System and a series of enhancements to our TrakStar cloud-based software application. Our
clinical development efforts are focused on further expanding the use of our products in additional indications. We coordinate our development efforts with our intellectual property strategies in order to enhance our ability to obtain patent and
other intellectual property protection. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Clinical Results and Studies </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Overview of Clinical Trial Evidence for the Safety and Efficacy of NeuroStar Advanced Therapy </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Clinical evidence supporting the safety and efficacy of NeuroStar Advanced Therapy has been published in 23 peer reviewed medical
journals, involving an aggregate of over 900 adult patients and more than 60 investigators. We have sponsored the largest prospective, multisite, randomized, sham-controlled trial ever conducted of a TMS device, enrolling 325 patients with treatment
resistant MDD at 23 U.S. and international study sites. Results from this trial served as the basis of our initial FDA 510(k) clearance of the NeuroStar Advanced Therapy System in 2008. The clinical data from this trial were reported in
<I>Biological Psychiatry</I> in 2007. A second, industry-independent prospective, multisite, randomized, sham-controlled trial, funded by the NIMH using the NeuroStar Advanced Therapy System, enrolled 199 patients with treatment resistant MDD across
four major academic medical centers in the United States. The clinical data from this trial were submitted to the FDA in 2014, leading to an expanded labeling for our NeuroStar Advanced Therapy System for an indication of use in adult patients who
have failed to benefit from one or more prior antidepressant medications in the current episode of MDD. This data was published in 2010 in <I>Archives of General Psychiatry</I>, now published as <I>JAMA Psychiatry</I>. We sponsored the largest,
post-market naturalistic outcomes study of the use of the NeuroStar Advanced Therapy System in routine clinical practice. This study enrolled 307 patients with treatment resistant MDD </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">106 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
seeking care at 42 U.S. study sites. Patients in this study were assessed at the beginning and end of their prescribed acute treatment course, and 257 of these patients agreed to be followed for
a period of 12 months to characterize the durability of the long-term outcome in clinical practice. Results of this study were published in the <I>Journal of Clinical Psychiatry</I> in 2012 and in <I>CNS Spectrums</I> in 2014. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Efficacy endpoints reported in these clinical trials used validated and well-accepted measures of symptomatic benefit to characterize
antidepressant medication treatment in clinical trials and included those measures listed in Figure&nbsp;1. An accepted goal of treatment with an antidepressant is the definitive resolution of the symptoms, which is defined as remission. Remission
is defined using a validated, clinician-administered rating scale such as the 17 or <FONT STYLE="white-space:nowrap">24-item</FONT> versions of HAMD or the Montgomery-Asberg Depression Rating Scale, or MADRS. Patients who achieve an endpoint score
below 8 points on the <FONT STYLE="white-space:nowrap">17-item</FONT> HAMD, below 11 points on the <FONT STYLE="white-space:nowrap">24-item</FONT> HAMD or below 10 points on the MADRS, are considered to have reached remission of illness. A
clinically global, psychiatrist rated scale, such as the Clinical Global Impressions-Severity of Illness, or <FONT STYLE="white-space:nowrap">CGI-S,</FONT> scale can also grade remission if a patient reaches an end of treatment score of one or two
on that scale. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="53%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD WIDTH="20%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:124pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Depression Assessment Scale</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Response&nbsp;Criteria</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Remission&nbsp;Criteria</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">MADRS</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">50%&nbsp;change&nbsp;from baseline</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&lt;10</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">HAMD17</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">50% change from baseline</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&lt;8</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">HAMD24</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">50% change from baseline</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&lt;11</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><FONT STYLE="white-space:nowrap">CGI-S</FONT></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><FONT STYLE="FONT-FAMILY:SYMBOL">&#163;</FONT>3 score</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><FONT STYLE="FONT-FAMILY:SYMBOL"></FONT>&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><FONT STYLE="FONT-FAMILY:SYMBOL">&#163;</FONT>2&nbsp;score</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><FONT STYLE="FONT-FAMILY:SYMBOL"></FONT>&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><FONT STYLE="white-space:nowrap">PHQ-9</FONT></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&lt;10</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&lt;5</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #465361">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #465361">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #465361">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #465361">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #465361">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #465361">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #465361">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Figure 1.</B> Validated measures of symptomatic benefit to characterize antidepressant treatment
effect. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Patient-rated outcomes are also used to verify symptom improvement. In the NeuroStar Advanced Therapy clinical trial
data, the <FONT STYLE="white-space:nowrap">PHQ-9</FONT> scale was used, with a score below five indicating remission of illness. Significant clinical improvement that does not constitute remission is termed response, and is graded by a 50% or
greater reduction of score from baseline on the HAMD and MADRS scales, and a score of one, two or three on the <FONT STYLE="white-space:nowrap">CGI-S</FONT> or a score below 10 on the <FONT STYLE="white-space:nowrap">PHQ-9.</FONT> Outcomes are also
reported for each of these rating scales as a mean change in total score from baseline, called continuous outcome measures. <B><I></I></B>Standardized effect size measures are used to assess the statistical magnitude of treatment benefit (active
versus control) in a clinical trial, and because they are normalized measures, allow the comparison of treatment benefit across different clinical studies. Standardized effect sizes of greater than 0.50 are considered large, between 0.30 and 0.50
are considered medium and below 0.30 are considered small. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Randomized Controlled Trial </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our U.S. registration trial was a prospective, multisite, randomized, sham-controlled trial at 23 U.S. and international study sites that
enrolled 325 patients from January 2004 through August 2005 to evaluate the safety and efficacy of NeuroStar Advanced Therapy in patients who met <FONT STYLE="white-space:nowrap">DSM-IV</FONT> criteria for MDD, with a moderate level of treatment
resistance based on rigorous evidence of failure of benefit from prior treatment with a research-grade exposure to at least one and up to four complete antidepressant medication trials. Patients were randomized to either active NeuroStar Advanced
Therapy or sham-controlled TMS. The primary efficacy endpoint of this trial was a statistically significant, or P&lt;0.05, average baseline to endpoint change in MADRS score for patients in the active NeuroStar Advanced Therapy treatment group when
compared to the change in MADRS score for the sham-controlled TMS patient treatment group using the last visit MADRS score through week four of the acute phase. The trial design consisted of three phases: a
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">107 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
one week, <FONT STYLE="white-space:nowrap">no-treatment</FONT> <FONT STYLE="white-space:nowrap">lead-in</FONT> phase; a six week acute treatment phase of daily TMS sessions scheduled in a <FONT
STYLE="white-space:nowrap">5-day</FONT> sequence, for a maximum of 30 sessions during which NeuroStar Advanced Therapy was given in the active treatment arm as a monotherapy in medication-free patients, and a three week taper phase during which time
all patients were begun on an open-label, single antidepressant medication and followed for six months to examine the durability of the acute effect of TMS. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Results for the overall trial population demonstrated clinically meaningful improvement on the primary efficacy outcome measure, baseline to endpoint change on the MADRS at four weeks, as
shown in Figure 2 (MADRS, P&#061;0.057, standardized effect size &#061; 0.38), although the primary efficacy endpoint of the trial was not achieved. Additionally, several secondary outcome measures demonstrated statistically and clinically
significant benefit for active NeuroStar Advanced Therapy compared with sham-controlled TMS. Among these secondary outcome measures were a superior outcome on the HAMD, with both the 17 and <FONT STYLE="white-space:nowrap">24-item</FONT> versions
showing baseline to endpoint change for active NeuroStar Advanced Therapy at four weeks, as shown in Figure 3 <FONT STYLE="white-space:nowrap">(17-Item</FONT> change: P&#061;0.006, standardized effect size &#061; 0.55) and as shown in Figure 4 <FONT
STYLE="white-space:nowrap">(24-Item</FONT> change: P&#061;0.012, standardized effect size &#061; 0.48). These outcomes were sustained at the secondary efficacy time point at week six, with a significant advantage in favor of active NeuroStar
Advanced Therapy. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.75em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Efficacy Outcome Measure&#151;MADRS</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px">


<IMG SRC="g542432g54c76.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.75em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Efficacy Outcome Measure&#151;HAMD17</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px">


<IMG SRC="g542432g34o10.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">P &#061; 0.057 for week 4 contrast</FONT></P>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px" align="left"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Figure 2.</B> MADRS total
score change from baseline during the acute treatment phase.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>P &#061; 0.006 for week 4 contrast</B></FONT></P>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px" align="left"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Figure 3.</B> HAMD17 total
score change from baseline during the acute treatment phase.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.75em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Efficacy Outcome Measure&#151;HAMD24</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px">


<IMG SRC="g542432g99i17.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>P &#061; 0.012 for week 4 contrast</B></FONT></P>
<P STYLE="font-size:10px;margin-top:0px;margin-bottom:0px" align="left"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Figure 4.</B> HAMD24 total
score change from baseline during the acute treatment phase.</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We also observed a statistically significant benefit in categorical outcomes of response and remission
rates on the MADRS, as shown in Figure 5, the HAMD17, as shown in Figure 6, and the HAMD24, as shown in Figure 7. In this trial, NeuroStar Advanced Therapy was well tolerated and safe. The dropout rate for any reason was low and similar in the
active therapy (7.7%) and sham-controlled TMS (8.2%) treatment groups at four weeks, and discontinuation specifically because of side effects was similar in the active therapy (4.5%) and sham-controlled TMS (3.4%) treatment groups. The trial
demonstrated that NeuroStar Advanced Therapy administered over a period of six weeks was effective in treating MDD and with a favorable tolerability profile. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">108 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.88em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>MADRS Response Rates</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px">


<IMG SRC="g542432g17d33.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.88em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>MADRS Remission Rates</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px">


<IMG SRC="g542432g79m05.jpg" ALT="LOGO">
</P></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="13" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Figure 5.</B> MADRS categorical outcome assessments during the acute treatment phase.</FONT></TD></TR>
</TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.88em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>HAMD17 Response Rates</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px">


<IMG SRC="g542432g54a57.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.88em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>HAMD17 Remission Rates</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px">


<IMG SRC="g542432g36p86.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Figure 6.</B> HAMD17 categorical outcome assessments during the acute treatment phase.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.88em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>HAMD24 Response Rates</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px">


<IMG SRC="g542432g15v79.jpg" ALT="LOGO">
</P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:1.88em"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>HAMD24 Remission Rates</B></FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px">


<IMG SRC="g542432g59s20.jpg" ALT="LOGO">
</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Figure 7.</B> HAMD24 categorical outcome assessments during the acute treatment phase.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our NeuroStar Advanced Therapy System received marketing authorization from the FDA in 2008 based on the
results of this initial registration trial. The FDA review determined that statistical significance for the primary outcome measure was obtained for the patients in that portion of the study population (N&#061;164) who had failed to benefit from one
prior research grade antidepressant medication treatment trial (MADRS, P&#061;0.0006). The original <FONT STYLE="white-space:nowrap">FDA-authorized</FONT> indication for use in MDD based on this trial was for adult patients who failed to benefit
from one prior antidepressant medication in the current episode. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>NIMH-Sponsored Randomized Controlled Trial&#151;the
Optimization of TMS, or <FONT STYLE="white-space:nowrap">OPT-TMS</FONT> Study </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The U.S. NIMH sponsored a prospective,
multisite, randomized, sham-controlled trial at four U.S. study sites that enrolled 199 patients from October 2004 through March 2009 to evaluate the safety and efficacy of NeuroStar Advanced Therapy in patients who met <FONT
STYLE="white-space:nowrap">DSM-IV</FONT> criteria for MDD, with at least a moderate level of treatment resistance to at least one and up to four complete antidepressant medication trials. Patients were randomly allocated 1:1 to either active
NeuroStar Advanced Therapy or sham-controlled TMS. The primary efficacy endpoint of this trial was remission, measured using the <FONT STYLE="white-space:nowrap">24-item</FONT> HAMD scale. The trial design consisted of three phases: a two week no
treatment <FONT STYLE="white-space:nowrap">lead-in</FONT> phase, a three-week fixed-treatment phase of daily TMS sessions scheduled in a <FONT STYLE="white-space:nowrap">5-day</FONT> sequence, for a maximum of 15&nbsp;sessions during which NeuroStar
Advanced Therapy was given in the active treatment arm as a monotherapy in antidepressant medication-free patients and a variable, three-week treatment continuation for clinical improvers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Results from the trial demonstrated that for the entire treatment resistant patient population, for the primary analysis of remission, there was a statistically significant effect of daily
NeuroStar Advanced </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">109 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
Therapy as monotherapy (odds ratio, 4.2; 95% confidence interval, 1.32&#150;13.24; P&#061;0.02). There were 18&nbsp;remitters (N&#061;13 or 14.1% in the active therapy and N&#061;5 or 5.1% in the
sham-controlled TMS treatment groups). NeuroStar Advanced Therapy was well tolerated, with no difference in adverse events between the active therapy and sham-controlled TMS treatment groups. Discontinuation specifically because of side effects was
5.4% in the active therapy treatment group. These results indicate that the likelihood of achieving remission using the NeuroStar Advanced Therapy System increased by more than four times when compared to sham-control TMS, which is clinically
meaningful. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The results of this clinical trial became available after we received our original marketing authorization in
2008. We submitted the clinical data from this trial to the FDA and received a new FDA 510(k) clearance in 2014 that expanded our original indication to adult patients who have failed to benefit from one or more prior antidepressant medications in
the current episode of MDD. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Acute Efficacy and Long-Term Durability in Real-World Clinical Settings Study </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The acute efficacy of treatment with the NeuroStar Advanced Therapy System was evaluated in a prospective, multisite, naturalistic,
observational trial at 42 U.S. study sites that enrolled 307 patients from 2010 through 2012 to evaluate the effectiveness of NeuroStar Advanced Therapy in real-world clinical practice settings in patients who met
<FONT STYLE="white-space:nowrap">DSM-IV</FONT> criteria for MDD. The mean patient age was 48.6 years and the mean number of medication trials in the current episode that were of adequate dose and duration was 2.5, indicating a treatment resistant
population of patients with MDD. Outcome assessments were obtained at baseline, week two, at the point of maximal acute treatment benefit and at week six in cases where the acute course of TMS therapy extended beyond six weeks. This naturalistic
study design permitted patients to continue concurrent antidepressant medications during treatment with NeuroStar Advanced Therapy if they were directed to do so by the prescribing psychiatrist. The primary efficacy endpoint of this trial was the
change from baseline to endpoint on the <FONT STYLE="white-space:nowrap">CGI-S.</FONT> Secondary outcome measures included baseline to endpoint change on the <FONT STYLE="white-space:nowrap">PHQ-9.</FONT> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The average number of NeuroStar Advanced Therapy treatment sessions across the acute phase was 28.3&nbsp;(standard deviation: 10.1).
Results from the trial demonstrated that there was a statistically significant mean change in depression severity from baseline to end of treatment on the <FONT STYLE="white-space:nowrap">CGI-S</FONT> <FONT STYLE="white-space:nowrap">(-1.9</FONT>
&plusmn; 1.4, P&lt;0.0001) and for the <FONT STYLE="white-space:nowrap">PHQ-9</FONT> <FONT STYLE="white-space:nowrap">(-8.7</FONT> &plusmn; 7.2, P&lt;0.0001). Clinician-assessed response rate for <FONT STYLE="white-space:nowrap">CGI-S</FONT> was
58.0% and the remission rate was 37.1%, as shown in Figure 8. Patient-reported outcomes measured using the <FONT STYLE="white-space:nowrap">PHQ-9</FONT> was 56.4% for response, and 28.7% for remission, as shown in Figure 9. Notably, the outcomes
were consistent across patients with both low and high grades of treatment resistance. Patients with low treatment resistance had been treated without success with one antidepressant medication in their current illness episode and patients with high
grades of treatment resistance had been treated with two or more antidepressants without benefit. These results further support NeuroStar Advanced Therapy as an effective therapy for those who have failed to benefit from antidepressant medication.
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>CGI-S Outcomes</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>PHQ-9 Outcomes</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="49%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g55p93.jpg" ALT="LOGO">
</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px" align="left"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Figure 8.</B> Categorical CGI-S response and remission outcomes&#151;stratified by baseline level of treatment resistance (low versus
high).</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g43l56.jpg" ALT="LOGO">
</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px" align="left"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Figure 9.</B> Categorical PHQ-9 response and remission outcomes&#151;stratified by baseline level of treatment resistance (low vs.
high).</FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">110 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The long-term durability of the clinical effect resulting from treatment with NeuroStar
Advanced Therapy was also studied as part of this report over 12 months of <FONT STYLE="white-space:nowrap">follow-up.</FONT> In the long-term phase, 257 patients who had participated in the acute treatment outcomes entered into long-term <FONT
STYLE="white-space:nowrap">follow-up</FONT> where their treatment outcomes were monitored over the next twelve months. This trial was conducted between March 2010 and August 2012. Clinical assessments using the
<FONT STYLE="white-space:nowrap">CGI-S</FONT> and the <FONT STYLE="white-space:nowrap">PHQ-9</FONT> were obtained at three, six, nine, and 12 months. A total of 205 patients provided data across the entire
<FONT STYLE="white-space:nowrap">12-month</FONT> trial period. Concurrent medication use and NeuroStar Advanced Therapy reintroduction were allowed for recurrent symptoms and were recorded during the long-term
<FONT STYLE="white-space:nowrap">follow-up</FONT> period. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Compared with baseline scores obtained prior to acute TMS
treatment, the statistically significant reduction in mean standard deviation <FONT STYLE="white-space:nowrap">CGI-S</FONT> and <FONT STYLE="white-space:nowrap">PHQ-9</FONT> total scores at the end of acute TMS treatment were sustained throughout
the <FONT STYLE="white-space:nowrap">12-month</FONT> <FONT STYLE="white-space:nowrap">follow-up</FONT> period (end of 12 months <FONT STYLE="white-space:nowrap">follow-up:</FONT> <FONT STYLE="white-space:nowrap">CGI-S</FONT> 2.8 and <FONT
STYLE="white-space:nowrap">PHQ-9</FONT> 8.6, both P&lt;0.0001). The proportion of patients who achieved remission at the conclusion of acute TMS treatment remained similar to that observed following the conclusion of the long-term <FONT
STYLE="white-space:nowrap">follow-up</FONT> phase: <FONT STYLE="white-space:nowrap">CGI-S</FONT> (total score 1 or 2), 41.2% (end of acute) and 45.1% (end of long-term), as shown in Figure 10; <FONT STYLE="white-space:nowrap">PHQ-9</FONT> (total
score &lt; 5), 31.1% (end of acute) and 37.0% (end of long-term). These results demonstrate that NeuroStar Advanced Therapy provides a sustained durability of effect over 12 months of <FONT STYLE="white-space:nowrap">follow-up</FONT> in a patient
population receiving minimal to no benefit with antidepressant medications. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>CGI-S Outcomes </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:1px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g27n66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Figure 10.</B> Categorical CGI-S response and remission outcomes during long-term follow-up phase.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Our Outcome Registry </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In 2016, we launched our voluntary outcome registry to measure and record the outcomes of MDD patients treated with our NeuroStar Advanced Therapy System. Since inception, we have recorded
results for almost 1,500 patients at approximately 50 treatment facilities. For the patients treated with our products who completed self-evaluations, such as <FONT STYLE="white-space:nowrap">PHQ-9,</FONT> and have had their results submitted to the
registry, our data indicates remission and response rates of 31% and 61%, respectively. For the more than 550 patients treated with our products who have been evaluated using an observer-dependent interview, such as CGI-S, and have had their results
submitted to the registry, our data indicates remission and response rates of 53% and 74%, respectively. Although we believe that these results demonstrate the potential of our products to treat patients with MDD, our registry is voluntary and only
a portion of psychiatrists using our products have reported their outcomes. Therefore, these results may not be representative of response and remission rates for all MDD patients treated with our products. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Sales and Customer Support Team and Psychiatrist Training </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of March&nbsp;31, 2018, our sales and customer support team consisted of 126 employees working collaboratively across the following departments: 83 sales, 7 marketing, 21 field service
and customer support, 6 clinical and 9 reimbursement. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Sales and Marketing&#151;United States </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our commercialization team selectively markets and sells the NeuroStar Advanced Therapy System and recurring treatment sessions in the
United States. Our primary focus is on selling to psychiatrists, with </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">111 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
primary care physicians and pain management specialists representing a small percentage of our customer base. We target approximately 3,600 high-decile psychiatric practices, who we estimate,
based on data from Symphony Health and our own internal estimates, treat approximately 33% of MDD patients who meet our labeled indication and are insured. We target these practices by the number of psychiatrists within their practices, the number
of patients they treat and their acceptance of commercial insurance and Medicare. We believe that our psychiatrist targeting strategy makes for a well-defined customer base that is accessible by our direct sales organization. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have structured our sales and customer support team with specialized roles to sell our NeuroStar Advanced Therapy Systems and
recurring treatment sessions, while delivering customer service at each stage of the implementation process. Our business development managers are responsible for identifying key customer prospects, educating them on the value of NeuroStar Advanced
Therapy System, gaining their commitment for capital placement and introducing our clinical practice consultants. Our clinical practice consultants enhance the operational experience for providers and drive implementation of the NeuroStar Advanced
Therapy System into our customers&#146; practices. We created the role of clinical training consultant to partner with our psychiatrist providers to conduct initial and ongoing <FONT STYLE="white-space:nowrap">on-site</FONT> clinical training to
ensure clinical and practice success. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Practice Management Support and Psychiatrist Training&#151;United States
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our clinical practice consultants play a pivotal role in ensuring the success of our customers as they implement a new
service line into their practice. In the early stages of implementation, they help the practice set goals, educate on the types of patients that can benefit from our therapy and assist in preparing the office work flow and staffing needs. As the
office prepares to begin scheduling consults, the clinical practice consultants will train the office staff on how to talk with patients about TMS and how to use patient educational tools such as presentations, videos and starter kits. Once the
practice begins treating patients, they will educate the psychiatrist on how to track clinical outcomes, interpret data and how to effectively convey results to existing and potential patients and referring physicians. Our clinical practice
consultants also work with our customers to increase awareness with referring physicians and develop external marketing tactics. Our dedicated reimbursement managers help each practice navigate all issues regarding the reimbursement process
including investigation of benefits, prior authorizations and claims documentation. This group has assisted our customers to conduct over 20,000 benefit investigations, and have helped approximately 50,000 patients gain access to our therapy.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Psychiatrists and staff training on the NeuroStar Advanced Therapy System is a key to success within each practice. Our
clinical training consultants take the burden of clinical training off our clinical practice consultants and provide a dedicated training resource to each customer. Clinical training consultants conduct at least a
<FONT STYLE="white-space:nowrap">three-day,</FONT> hands on training course that is scheduled after system installation at each practice and also provide ongoing advanced <FONT STYLE="white-space:nowrap">on-site</FONT> clinical training. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Field Support&#151;United States </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our field service engineers are responsible for maintenance, repairs and installation of upgrades. We provide a 24/7 support hotline to respond to medical information inquiries and
technical questions that arise in all time zones. We pledge to have a field service engineer <FONT STYLE="white-space:nowrap">on-site</FONT> within 24 hours of a service call. Because of the size and geographical coverage of our field service
engineers and our standard <FONT STYLE="white-space:nowrap">24-hour</FONT> response time, NeuroStar Advanced Therapy Systems experience over 99% uptime, helping to ensure uninterrupted patient treatments. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>International </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We market our products in a few select markets outside the United States through independent distributors. In Japan, we have an exclusive distribution agreement with Teijin, for the
commercialization of our products. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">112 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Distribution Agreement with Teijin Pharma Limited </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In October 2017, we entered into a seven and a half year distribution agreement with Teijin Pharma Limited, or Teijin, for the exclusive
distribution of our NeuroStar Advanced Therapy System to customers who will treat patients with MDD in Japan. Under the distribution agreement, Teijin is generally restricted from selling competing products in Japan. Our distribution agreement
provides that we will have primary responsibility for obtaining reimbursement approval for use of NeuroStar Advanced Therapy System for the treatment of MDD in Japan, and Teijin will promote the sales of NeuroStar Advanced Therapy System for
treatment of MDD in Japan. We have agreed to provide sales and technical support training to Teijin for our NeuroStar Advanced Therapy Systems. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Teijin is required to purchase minimum dollar values of NeuroStar Advanced Therapy Systems and treatment sessions from us following reimbursement approval by the JMHLW, TMS treatment for
MDD (or, if such approval requires certified training on the NeuroStar Advanced Therapy System by a third party, then upon the first psychiatrist being issued his or her training certification). In April 2018, we were approved to submit
reimbursement dossiers to the JMHLW. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In 2017, under our distribution agreement with Teijin, we received an upfront
payment of $0.75&nbsp;million and a milestone payment of $2.0&nbsp;million following JMHLW&#146;s approval of marketing the NeuroStar Advanced Therapy System for the treatment of MDD in Japan. These upfront and milestone payments have been deferred
and are being recognized as revenue over the seven and one half year term of the agreement. Teijin is required to pay us a milestone payment tied to JMHLW issuing reimbursement for use of our products for the treatment of MDD in Japan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The distribution agreement is scheduled to expire on March&nbsp;31, 2025, subject to earlier termination if we or Teijin breach the
agreement, Teijin fails to maintain distributor-level permits and approvals, Teijin fails to purchase from us specified dollar values of its sales forecasts, reimbursement for treatment of MDD using the NeuroStar Advanced Therapy System is not
obtained from JMHLW by specified dates or such reimbursement is below specified minimums, Teijin reasonably believes that it is not commercially reasonable to continue distributing the NeuroStar Advanced Therapy System in Japan or bankruptcy related
events occur. The term of the distribution agreement will be automatically extended for two years unless either party gives the other party at least two years&#146; prior written of notice of <FONT STYLE="white-space:nowrap">non-renewal,</FONT>
except that we cannot decline to renew the agreement if Teijin has purchased 100% of its sales forecasts over the term of the agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Competition </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our currently marketed products are, and any
future products we develop and commercialize will be, subject to intense competition. The industry in which we operate is subject to rapid change and is highly sensitive to the introduction of new products or other market activities of current or
new industry participants. If we are not successful in convincing others of the merits of our products or educating them on the use of our products, they may not use our products or use them effectively and we may be unable to increase our sales.
Key competitive factors affecting the commercial success of the NeuroStar Advanced Therapy System and any other product candidates we may develop are likely to be efficacy, safety and tolerability profile, reliability, convenience of administration,
price and reimbursement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have competitors that sell other forms of TMS therapy, including Brainsway, Magstim, Nextstim,
CloudTMS and Magventure, that compete directly with the NeuroStar Advanced Therapy System and have TMS therapy treatment times as short as 20, 37, 37, 19 and 19 minutes, respectively. Competing TMS therapy companies may develop treatments that can
be administered for shorter time periods, that have improved efficacy when compared to our products, or that require a less significant investment of resources from psychiatrists. We also face competition from pharmaceutical and other companies that
develop products, such as antidepressant medications, for the treatment of psychiatric disorders. Our </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">113 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
commercial opportunity could be reduced or eliminated if these competitors develop and commercialize antidepressant medications or other treatments that are safer or more effective than the
NeuroStar Advanced Therapy System. At any time, these and other potential market entrants may develop treatment alternatives that may render our products uncompetitive. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, our competitors may have greater financial resources or more established distribution networks than we do, or may be acquired by enterprises that have more established
distribution networks than we do. Our competitors may also develop and patent processes or products earlier than we can or obtain domestic or international regulatory clearances or approvals for competing products more rapidly than we can, which
could impair our ability to develop and commercialize similar products. We also compete with our competitors in acquiring technologies and technology licenses complementary to our products or advantageous to our business. In addition, we compete
with our competitors to engage the services of independent distributors outside the United States, both those presently working with us and those with whom we hope to work as we expand. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Intellectual Property </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our commercial success depends in
part on our ability to obtain and maintain proprietary protection for our products and services, to operate without infringing the proprietary rights of others, and to prevent others from infringing our proprietary rights. We rely on a combination
of patents, trade secrets, copyrights and trademarks, as well as contractual protections, to establish and protect our intellectual property rights. We seek to protect our proprietary position by, among other things, filing patent applications in
the United States and internationally. Our patent estate includes patents and applications with claims directed to our NeuroStar Advanced Therapy Systems and broader claims for potential future products and developments. On a worldwide basis, as of
March&nbsp;31, 2018, our patent estate included 100&nbsp;issued or allowed patents and pending patent applications for our products and novel design methods, manufacturing process, novel TMS devices and systems and future combination products that
are mainly designed to treat psychiatric conditions or perform diagnostic procedures. In the United States, as of March&nbsp;31, 2018, we owned or licensed 30 issued or allowed patents and seven patent applications filed that are directed to our TMS
technology. Outside the United States, as of March&nbsp;31, 2018, we owned or licensed 49 issued or allowed patents and 14 pending patent applications. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">These U.S. issued patents are expected to remain in effect until between 2018 and 2030. Our core patents in the United States will not expire before 2024. Our <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> patents are expected to remain in effect until between 2024 and 2035. Our worldwide intellectual property portfolio includes multiple pending patent applications relating to methods and apparatuses for the
treatment of psychiatric health conditions in Australia, Canada, the European Union, Japan and the United States. Our patents and patent applications mainly relate to iron core technology, including materials, manufacturing methods, geometries,
applications, and open core technologies, TMS design patents, including coil position, motor threshold level determination, contact sensing, and articulation arm designs, patient comfort, TMS support technologies<I> </I>and pulse monitoring, and
potential next generation technologies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In some instances, we submit patent applications directly with the USPTO as
provisional patent applications. Provisional applications for patents were designed to provide a lower-cost first patent filing in the United States. Corresponding <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent applications must be
filed not later than 12&nbsp;months after the provisional application filing date. The corresponding <FONT STYLE="white-space:nowrap">non-provisional</FONT> application benefits in that the priority date(s) of the patent application is/are the
earlier provisional application filing date(s), and the patent term of the finally issued patent is calculated from the later <FONT STYLE="white-space:nowrap">non-provisional</FONT> application filing date. This system allows us to obtain an early
priority date, add material to the patent application(s) during the priority year, obtain a later start to the patent term and to delay prosecution costs, which may be useful in the event that we decide not to pursue examination in an application.
We file U.S. <FONT STYLE="white-space:nowrap">non-provisional</FONT> applications and Patent Cooperation Treaty, or PCT, applications that claim the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">114 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
benefit of the priority date of earlier filed provisional applications, when applicable. The PCT system allows a single application to be filed within 12 months of the original priority date of
the patent application, and to designate all of the 152 PCT member states in which national patent applications can later be pursued based on the international patent application filed under the PCT. The PCT searching authority performs a
patentability search and issues a <FONT STYLE="white-space:nowrap">non-binding</FONT> patentability opinion which can be used to evaluate the chances of success for the national applications in foreign countries prior to having to incur the filing
fees. Although a PCT application does not issue as a patent, it allows the applicant to seek protection in any of the member states through national-phase applications. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">At the end of the period of two and a half years from the first priority date of the patent application, separate patent applications can be pursued in any of the PCT member states either
by direct national filing or, in some cases by filing through a regional patent organization, such as the European Patent Organization. The PCT system delays expenses, allows a limited evaluation of the chances of success for national/regional
patent applications and enables substantial savings where applications are abandoned within the first two and a half years of filing. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For all patent applications, we determine claiming strategy on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis. Advice of counsel and
our business model and needs are always considered. We file patents containing claims for protection of all useful applications of our proprietary technologies and any products, as well as all new applications and/or uses we discover for existing
technologies and products, assuming these are strategically valuable. We continuously reassess the number and type of patent applications, as well as the pending and issued patent claims to ensure that maximum coverage and value are obtained for our
processes, and compositions, given existing patent office rules and regulations. Further, claims may be modified during patent prosecution to meet our intellectual property and business needs. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We recognize that the ability to obtain patent protection and the degree of such protection depends on a number of factors, including the
extent of the prior art, the novelty and <FONT STYLE="white-space:nowrap">non-obviousness</FONT> of the invention, and the ability to satisfy the enablement requirement of the patent laws. The patent positions of medical device companies like ours
are generally uncertain and involve complex legal, scientific and factual questions. In addition, the coverage claimed in a patent application can be significantly reduced before the patent is issued, and its scope can be reinterpreted or further
altered even after patent issuance. Consequently, we may not obtain or maintain adequate patent protection for any of our product candidates or for our technology platform. We cannot predict whether the patent applications we are currently pursuing
will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient proprietary protection from competitors. Any patents that we hold may be challenged, circumvented or invalidated by third
parties. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our commercial success will also depend in part on not infringing the proprietary rights of third parties. In
addition, we have licensed rights under proprietary technologies of third parties to develop, manufacture and commercialize specific aspects of our products and services. It is uncertain whether the issuance of any third party patent would require
us to alter our development or commercial strategies, alter our processes, obtain licenses or cease certain activities. The expiration of patents or patent applications licensed from third parties or our breach of any license agreements or failure
to obtain a license to proprietary rights that we may require to develop or commercialize our future technology may have a material adverse impact on us. If third parties prepare and file patent applications in the United States that also claim
technology to which we have rights, we may have to participate in interference proceedings in the USPTO to determine priority of invention. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We further own trade secrets relating to our technology, and we maintain the confidentiality of proprietary information to protect aspects of our business that are not amenable to, or that
we do not consider appropriate for, patent protection. We seek to protect our trade secrets and <FONT STYLE="white-space:nowrap">know-how</FONT> by entering into confidentiality agreements with third-parties, consultants and employees who have
access to </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">115 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
such trade secrets and <FONT STYLE="white-space:nowrap">know-how.</FONT> These agreements provide that all confidential information concerning our business or financial affairs developed or made
known to the individual during the course of the individual&#146;s relationship with us are to be kept confidential and not disclosed to third parties except in specific circumstances. In addition, we enter into employment agreements that require
employees to assign to us any inventions, trade secrets or <FONT STYLE="white-space:nowrap">know-how</FONT> that they develop while employed by us. Although we take steps to protect our proprietary information and trade secrets, including through
agreements with our employees and consultants, these agreements may be breached, or third parties may independently develop substantially equivalent proprietary information and techniques or otherwise gain access to our trade secrets or disclose our
technology. Thus, we may not be able to meaningfully protect our trade secrets. To the extent that our employees, consultants, scientific advisors or other contractors use intellectual property owned by others in their work for us, disputes may
arise as to the rights in related or resulting know how and inventions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For a more comprehensive discussion of the risks
related to our intellectual property, please see &#147;Risk Factors&#151;Risks Related to Intellectual Property.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Manufacturing and Supply </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We manage all aspects of product supply through our operations team based in Malvern, Pennsylvania. We outsource the manufacture of components and high level assemblies, which are produced
and tested to our specifications. We rely on third party providers to provide components used in existing products and we expect to continue to do so for future products. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We manage our arrangements with our third-party manufacturers and suppliers to adjust delivery schedules and quantities of components to match our changing manufacturing requirements. We
forecast our component needs based on historical trends, current utilization patterns and sales forecasts of future demand. We establish our relationships with our third-party manufacturers and suppliers through supplier contracts and purchase
orders. In most cases, these supplier relationships may be terminated by either party upon short notice. Currently, we are engaged with Sparton Medical Systems to supply our console; Molex Incorporated to supply our SenStar Treatment Link; Paragon
Micro to supply our computer systems as well as other companies to supply components of our chairs and treatment packs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In
order to mitigate against the risks related to a single-source of supply, we qualify alternative suppliers when possible, maximize the use of commercial, off the shelf components and materials, minimize specialized or proprietary manufacturing
processes, and develop contingency plans for responding to disruptions, including maintaining adequate inventory of any critical components. To date, we have not experienced material delays in obtaining any of our components, nor has the ready
supply of finished products to our customers or clinicians been adversely affected by component supply issues. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Reimbursement, Payor Relations and Customer Support </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Coverage and Reimbursement in the United States </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales of a
medical device, which is utilized for <FONT STYLE="white-space:nowrap">in-office</FONT> medical treatments, depend, in part, on the extent to which such treatments using that medical device will be covered by third-party payors, such as government
health care programs, private insurance and managed healthcare organizations. Even if a third-party payor covers a particular treatment, the resulting reimbursement payment rates may not be adequate to cover a provider&#146;s cost to purchase such
medical device or ensure that purchase will be profitable for the provider. Additionally, patients who are treated <FONT STYLE="white-space:nowrap">in-office</FONT> for a medical condition generally rely on third-party payors to reimburse all or
part of the costs associated with the treatment and may be unwilling to undergo such treatment in the absence of coverage and adequate reimbursement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Reimbursement by a third-party payor may depend upon a number of factors, including the third-party payor&#146;s determination that a treatment is neither experimental nor investigational;
safe, effective, and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">116 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
medically necessary; appropriate for the specific patient; cost-effective; supported by peer reviewed medical journals; and included in clinical practice guidelines. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the United States, there is no uniform policy of coverage and reimbursement among third-party payors. Third-party payors often rely
upon Medicare coverage policy and payment limitations in setting their own reimbursement policies, but also have their own methods and approval process apart from Medicare coverage and reimbursement determinations. Physician reimbursement under
Medicare generally is based on a defined fee schedule, the Physician Fee Schedule, through which payment amounts are determined by the relative values of the professional service rendered. Reimbursement rates from commercial payors vary depending on
the procedure performed, the commercial payor, contract terms, and other factors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Coverage and reimbursement for treatments
can differ significantly from payor to payor. Decisions regarding the extent of coverage and amount of reimbursement to be provided for an <FONT STYLE="white-space:nowrap">in-office</FONT> treatment are made on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">plan-by-plan</FONT></FONT> basis. One payor&#146;s determination to provide coverage for a specific treatment does not assure that other payors will also provide coverage, and adequate reimbursement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, the federal government and state legislatures have continued to implement cost containment programs, including price
controls and restrictions on coverage and reimbursement. Third-party payors are increasingly challenging the price, examining the medical necessity and reviewing the cost-efficacy of medical services. Adoption of price controls and cost containment
measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit our net sales and results of operations. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Based on our estimates, over 65 major private insurers in the United States, including the top 25 largest private insurers, have coverage policies for reimbursement of NeuroStar Advanced
Therapy, representing approximately 205&nbsp;million covered lives or about 95% of the total payor covered lives in the United States. Treatments using NeuroStar Advanced Therapy are also eligible for reimbursement from Medicare, representing an
additional 58.5&nbsp;million covered lives in the United States as of January 2018. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Government Regulation
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our products and our operations are subject to extensive regulation by the FDA and other federal and state authorities in
the United States, as well as comparable authorities in foreign jurisdictions. Our products are subject to regulation as medical devices under the FDCA, as implemented and enforced by the FDA. The FDA regulates the development, design, <FONT
STYLE="white-space:nowrap">non-clinical</FONT> and clinical research, manufacturing, safety, efficacy, labeling, packaging, storage, installation, servicing, recordkeeping, premarket clearance or approval, import, export, adverse event reporting,
advertising, promotion, marketing and distribution, and import and export of medical devices to ensure that medical devices distributed domestically are safe and effective for their intended uses and otherwise meet the requirements of the FDCA.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition to U.S. regulations, we are subject to a variety of regulations in other jurisdictions governing clinical trials
and commercial sales and distribution of our products. Whether or not we obtain FDA clearance or approval for a product, we must obtain authorization before commencing clinical trials or obtain marketing authorization or approval of our products
under the comparable regulatory authorities of countries outside of the United States. The marketing authorization process varies from country to country and the time may be longer or shorter than that required for FDA clearance or approval.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>FDA Premarket Clearance and Approval Requirements </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Unless an exemption applies, each medical device commercially distributed in the United States requires either FDA clearance of a 510(k) premarket notification or PMA approval. Under the
FDCA, medical devices are classified into one of three classes&#151;Class&nbsp;I, Class&nbsp;II or Class&nbsp;III&#151;depending on the degree of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">117 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
risk associated with each medical device and the extent of manufacturer and regulatory control needed to ensure its safety and efficacy. Class&nbsp;I includes devices with the lowest risk to the
patient and are those for which safety and efficacy can be assured by adherence to the FDA&#146;s General Controls for medical devices, which include compliance with the applicable portions of the quality systems regulation, or QSR, facility
registration and product listing, reporting of adverse medical events, and truthful and <FONT STYLE="white-space:nowrap">non-misleading</FONT> labeling, advertising, and promotional materials. Class&nbsp;II devices are subject to the FDA&#146;s
General Controls, and special controls as deemed necessary by the FDA to ensure the safety and efficacy of the device. These special controls can include performance standards, post-market surveillance, patient registries and FDA guidance documents.
While most Class&nbsp;I devices are exempt from the 510(k) premarket notification requirement, manufacturers of most Class&nbsp;II devices are required to submit to the FDA a premarket notification under Section&nbsp;510(k) of the FDCA requesting
permission to commercially distribute the device. The FDA&#146;s permission to commercially distribute a device subject to a 510(k) premarket notification is generally known as 510(k) clearance. Devices deemed by the FDA to pose the greatest risks,
such as life-sustaining, life-supporting or some implantable devices, or devices that have a new intended use, or use advanced technology that is not substantially equivalent to that of a legally marketed device, are placed in Class&nbsp;III,
requiring approval of a PMA. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our NeuroStar Advanced Therapy System is classified as a Class&nbsp;II medical device. We
initially received marketing authorization of this device through the <I>de novo </I>classification process. Subsequently, we have cleared any changes made to our system through the 510(k) clearance process. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>510(k) Marketing Clearance Pathway </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">To obtain 510(k) clearance, we must submit to the FDA a premarket notification submission demonstrating that the proposed device is &#147;substantially equivalent&#148; to a predicate
device already on the market. A predicate device is a legally marketed device that is not subject to premarket approval, i.e., a device that was legally marketed prior to May&nbsp;28, 1976 <FONT STYLE="white-space:nowrap">(pre-amendments</FONT>
device) and for which a PMA is not required, a device that has been reclassified from Class&nbsp;III to Class&nbsp;II or I, or a device that was found substantially equivalent through the 510(k) process. The FDA&#146;s 510(k) clearance process
usually takes from nine to twelve months, but may take significantly longer. The FDA may require additional information, including clinical data, to make a determination regarding substantial equivalence. If the FDA agrees that the device is
substantially equivalent to a predicate device currently on the market, it will grant 510(k) clearance to commercially market the device. If the FDA determines that the device is &#147;not substantially equivalent&#148; to a previously cleared
device, the device is automatically designated as a Class&nbsp;III device. The device sponsor must then fulfill more rigorous PMA requirements, or can request a risk-based classification determination for the device in accordance with the &#147;de
novo&#148; process, which is a route to market for novel medical devices that are low to moderate risk and are not substantially equivalent to a predicate device. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I><FONT STYLE="white-space:nowrap">Pre-Market</FONT> Approval Process </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">A PMA application must be submitted if the medical device is in Class&nbsp;III (although the FDA has the discretion to continue to allow certain
<FONT STYLE="white-space:nowrap">pre-amendment</FONT> Class&nbsp;III devices to use the 510(k) process) or cannot be cleared through the 510(k) process. A PMA application must be supported by, among other things, extensive technical, preclinical,
clinical trials, manufacturing and labeling data to demonstrate to the FDA&#146;s satisfaction the safety and effectiveness of the device. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After a PMA application is submitted and filed, the FDA begins an <FONT STYLE="white-space:nowrap">in-depth</FONT> review of the submitted information, which typically takes between one
and three years, but may take significantly longer. During this review period, the FDA may request additional information or clarification of information already provided. Also during the review period, an advisory panel of experts from outside the
FDA will usually be convened to review and evaluate the application and provide recommendations to the FDA as to the approvability of the device. In addition, the FDA will conduct a <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspection of
the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">118 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
manufacturing facility to ensure compliance with the QSR, which imposes elaborate design development, testing, control, documentation and other quality assurance procedures in the design and
manufacturing process. The FDA may approve a PMA application with post-approval conditions intended to ensure the safety and effectiveness of the device including, among other things, restrictions on labeling, promotion, sale and distribution and
collection of long-term <FONT STYLE="white-space:nowrap">follow-up</FONT> data from patients in the clinical study that supported approval. Failure to comply with the conditions of approval can result in materially adverse enforcement action,
including the loss or withdrawal of the approval. New PMA applications or supplements are required for significant modifications to the manufacturing process, labeling of the product and design of a device that is approved through the PMA process.
PMA supplements often require submission of the same type of information as an original PMA application, except that the supplement is limited to information needed to support any changes from the device covered by the original PMA application, and
may not require as extensive clinical data or the convening of an advisory panel. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>De novo Classification Process
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Medical device types that the FDA has not previously classified as Class&nbsp;I, II, or III are automatically classified
as Class&nbsp;III regardless of the level of risk they pose. The Food and Drug Administration Modernization Act of 1997 established a new route to market for low to moderate risk medical devices that are automatically placed into Class&nbsp;III due
to the absence of a predicate device, called the &#147;Request for Evaluation of Automatic Class&nbsp;III Designation,&#148; or the <I>de novo</I> classification procedure. This procedure allows a manufacturer whose novel device is automatically
classified as Class&nbsp;III to request down-classification of its medical device into Class&nbsp;I or Class&nbsp;II on the basis that the device presents low or moderate risk, rather than requiring the submission and approval of a PMA application.
Prior to the enactment of the Food and Drug Administration Safety and Innovation Act, or FDASIA, in July 2012, a medical device could only be eligible for <I>de novo</I> classification if the manufacturer first submitted a 510(k) premarket
notification and received a determination from the FDA that the device was not substantially equivalent. FDASIA streamlined the <I>de novo</I> classification pathway by permitting manufacturers to request <I>de novo</I> classification directly
without first submitting a 510(k) premarket notification to the FDA and receiving a not substantially equivalent determination. We originally obtained marketing authorization for our system using the <I>de novo </I>classification process after
receiving a not substantially equivalent determination following the submission of a 510(k) premarket notification. We have subsequently used the 510(k) clearance process to obtain authorization from the FDA for changes to our marketed system.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Clinical Trials </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">A clinical trial is typically required to support a PMA application or <I>de novo </I>classification, and is sometimes required for a 510(k)
<FONT STYLE="white-space:nowrap">pre-market</FONT> notification. Clinical trials generally require submission of an application for an Investigational Device Exemption, or IDE, to the FDA. The IDE application must be supported by appropriate data,
such as animal and laboratory testing results, showing that it is safe to test the device in humans and that the investigational protocol is scientifically sound. The IDE application must be approved in advance by the FDA for a specified number of
patients, unless the product is deemed a <FONT STYLE="white-space:nowrap">non-significant</FONT> risk device and eligible for more abbreviated IDE requirements. Clinical trials for a significant risk device may begin once the IDE application is
approved by the FDA as well as the appropriate institutional review boards, or IRBs, at the clinical trial sites, and the informed consent of the patients participating in the clinical trial is obtained. After a trial begins, the FDA may place it on
hold or terminate it if, among other reasons, it concludes that the clinical subjects are exposed to an unacceptable health risk. Any trials we conduct must be conducted in accordance with FDA regulations as well as other federal regulations and
state laws concerning human subject protection and privacy. Moreover, the results of a clinical trial may not be sufficient to obtain clearance or approval of the product. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">119 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Changes to Marketed Devices </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After a device receives 510(k) marketing clearance, or <I>de novo</I> classification, any modification that could significantly affect its
safety or efficacy, or that would constitute a major change or modification in its intended use, will require a new 510(k) marketing clearance or, depending on the modification, a de novo classification or PMA approval. The FDA requires each
manufacturer to determine whether the proposed change requires submission of a 510(k) or a PMA in the first instance, but the FDA can review any such decision and disagree with a manufacturer&#146;s determination. Many minor modifications today are
accomplished by a manufacturer documenting the change in an internal <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">letter-to-file.</FONT></FONT> The
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">letter-to-file</FONT></FONT> is in lieu of submitting a new 510(k) to obtain clearance for every change. The FDA can always review these letters to file in an inspection. If the FDA
disagrees with a manufacturer&#146;s determination, the FDA can require the manufacturer to cease marketing and/or request the recall of the modified device until 510(k) marketing clearance or PMA approval is obtained. Also, in these circumstances,
we may be subject to significant regulatory fines or penalties. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Post-Market Regulation </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After a device is cleared or approved for marketing, numerous and pervasive regulatory requirements continue to apply. These include:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">establishment registration and device listing with the FDA; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">QSR requirements, which require manufacturers, including third-party manufacturers, to follow stringent design, testing, control,
documentation and other quality assurance procedures during all aspects of the design and manufacturing process; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">labeling and marketing regulations, which require that promotion is truthful, not misleading, fairly balanced and provide adequate
directions for use and that all claims are substantiated, and also prohibit the promotion of products for unapproved or <FONT STYLE="white-space:nowrap">&#147;off-label&#148;</FONT> uses and impose other restrictions on labeling; FDA guidance on <FONT
STYLE="white-space:nowrap">off-label</FONT> dissemination of information and responding to unsolicited requests for information; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">clearance or approval of product modifications to 510(k)-cleared devices that could significantly affect safety or efficacy or that
would constitute a major change in intended use of one of our cleared devices; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">medical device reporting regulations, which require that a manufacturer report to the FDA if a device it markets may have caused or
contributed to a death or serious injury, or has malfunctioned and the device or a similar device that it markets would be likely to cause or contribute to a death or serious injury or serious adverse events, if the malfunction were to recur;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">correction, removal and recall reporting regulations, which require that manufacturers report to the FDA field corrections and product
recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to health; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">complying with regulations requiring Unique Device Identifiers (UDI) on devices and also requiring the submission of certain
information about each device to the FDA&#146;s Global Unique Device Identification Database (GUDID); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the FDA&#146;s recall authority, whereby the agency can order device manufacturers to recall from the market a product that is in
violation of governing laws and regulations; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">post-market surveillance activities and regulations, which apply when deemed by the FDA to be necessary to protect the public health or
to provide additional safety and efficacy data for the device. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">120 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We may be subject to similar foreign laws that may include applicable post-marketing
requirements such as safety surveillance and risk-benefit analysis. Our manufacturing processes are required to comply with the applicable portions of the QSR, which cover the methods and the facilities and controls for the design, manufacture,
testing, production, processes, controls, quality assurance, labeling, packaging, distribution, installation and servicing of finished devices intended for human use. The QSR also requires, among other things, maintenance of a device master file,
device history file, and complaint files. As a manufacturer, we are subject to periodic scheduled or unscheduled inspections by the FDA. Our failure to maintain compliance with the QSR requirements could result in the shut-down of, or restrictions
on, our manufacturing operations and the recall or seizure of our products. The discovery of previously unknown problems with any of our products, including unanticipated adverse events or adverse events of increasing severity or frequency, whether
resulting from the use of the device within the scope of its clearance or <FONT STYLE="white-space:nowrap">off-label</FONT> by a physician in the practice of medicine, could result in restrictions on the device, including the removal of the product
from the market or voluntary or mandatory device recalls. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The FDA has broad regulatory compliance and enforcement powers. If
the FDA determines that we failed to comply with applicable regulatory requirements, it can take a variety of compliance or enforcement actions, which may result in any of the following sanctions: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">warning letters, untitled letters, fines, injunctions, consent decrees and civil penalties; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">recalls, withdrawals, or administrative detention or seizure of our products; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">operating restrictions or partial suspension or total shutdown of production; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">refusing or delaying requests for 510(k) marketing clearance or PMA approvals of new products or modified products;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">withdrawing 510(k) clearances or PMA approvals that have already been granted; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">refusal to grant export or import approvals for our products; or </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">criminal prosecution. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>U.S. and Foreign Healthcare Laws and Compliance Requirements </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Healthcare providers, physicians and third-party payors play a primary role in the recommendation, prescription and payment for medical
treatments. A medical device manufacturer&#146;s arrangements with third-party payors, providers and patients may expose it to broadly applicable fraud and abuse and other healthcare laws and regulations that may affect its business or the financial
arrangements and relationships through which it markets, sells and distributes its products. Even if a medical device manufacturer does not control referrals of healthcare services or bill directly to Medicare, Medicaid or other third-party payors,
federal and state healthcare laws and regulations are applicable to its business. In addition, a portion of our business is subject to the Health Insurance Portability and Accountability Act of 1996, or HIPAA, as a business associate of our covered
entity customers. To provide our covered entity customers with services that involve the use or disclosure of PHI, we are required to enter into business associate agreements. As a business associate, we are also directly liable for compliance with
HIPAA. The laws that may affect a medical device manufacturer&#146;s ability to operate include, but are not limited to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the federal Anti-Kickback Statute, which prohibits any person or entity from, among other things, knowingly and willfully soliciting,
receiving, offering or paying any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, order or recommendation of an item or service
reimbursable, in whole or in part, under a federal healthcare program, such as the Medicare and Medicaid programs. The term &#147;remuneration&#148; has been broadly interpreted to include anything of value. The intent standard under the federal
Anti-Kickback Statute was amended </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">121 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
by the Patient Protection and Affordable Care Act, or PPACA, to a stricter standard such that a person or entity no longer needs to have actual knowledge of the statute or specific intent to
violate it in order to have committed a violation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the federal civil and criminal false claims laws and civil monetary penalty laws, such as the False Claims Act, or FCA, which imposes
significant penalties and can be enforced by private citizens through civil qui tam actions, prohibits individuals or entities from, among other things, knowingly presenting, or causing to be presented, false, fictitious or fraudulent claims for
payment of federal funds, and knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim to avoid, decrease or conceal an obligation to pay money to the federal government. For example,
companies have been prosecuted under the FCA in connection with alleged <FONT STYLE="white-space:nowrap">off-label</FONT> promotion of devices and allegedly providing free products to customers with the expectation that the customers would bill
federal health care programs for the product. In addition, a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the FCA. As a result of a
modification made by the Fraud Enforcement and Recovery Act of 2009, a claim includes &#147;any request or demand&#148; for money or property presented to the U.S. government. In addition, manufacturers can be held liable under the FCA even when
they do not submit claims directly to government payors if they are deemed to &#147;cause&#148; the submission of false or fraudulent claims; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">HIPAA, among other things, imposes criminal liability for executing or attempting to execute a scheme to defraud any healthcare benefit
program, including private third-party payors, knowingly and willfully embezzling or stealing from a healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, and creates federal criminal laws that prohibit
knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement or representation, or making or using any false writing or document knowing the same to contain any
materially false, fictitious or fraudulent statement or entry in connection with the delivery of or payment for healthcare benefits, items or services; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their implementing
regulations, which imposes privacy, security, transmission and breach reporting obligations with respect to individually identifiable health information upon entities subject to the law, including health plans, healthcare clearinghouses and certain
healthcare providers and their respective business associates that perform services on their behalf that involve individually identifiable health information. HITECH also created new tiers of civil monetary penalties, amended HIPAA to make civil and
criminal penalties directly applicable to business associates, and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the HIPAA laws and seek attorneys&#146; fees and costs
associated with pursuing federal civil actions; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the federal physician payment transparency requirements, sometimes referred to as the &#147;Physician Payments Sunshine Act,&#148;
created under the PPACA, which requires, among other things, certain manufacturers of drugs, devices, biologics and medical supplies reimbursed under Medicare, Medicaid, or the Children&#146;s Health Insurance Program (with certain exceptions) to
report annually to the United States Department of Health and Human Services information related to payments or other transfers of value made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors) and
teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">foreign and state law equivalents of each of the above federal laws, such as anti-kickback and false claims laws, that may impose
similar or more prohibitive restrictions, and may apply to </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">122 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
items or services reimbursed by any <FONT STYLE="white-space:nowrap">non-governmental</FONT> third-party payors, including private insurers; state laws that require device manufacturers to comply
with the industry&#146;s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state
laws that require device manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures and pricing information; and other federal and state laws that
govern the privacy and security of health information or personally identifiable information in certain circumstances, including state health information privacy and data breach notification laws which govern the collection, use, disclosure, and
protection of health-related and other personal information, many of which differ from each other in significant ways and often are not <FONT STYLE="white-space:nowrap">pre-empted</FONT> by HIPAA, thus requiring additional compliance efforts and
data privacy and security laws and regulations in foreign jurisdictions that may be more stringent than those in the United States (such as the European Union, which adopted the General Data Protection Regulation, which will become effective in May
2018). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Because of the breadth of these laws and the narrowness of their statutory exceptions and regulatory
safe harbors, it is possible that some of a medical device manufacturer&#146;s business activities could be subject to challenge under one or more of these laws. The scope and enforcement of each of these laws is uncertain and subject to rapid
change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have recently increased their scrutiny of interactions between healthcare companies
and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Ensuring that business arrangements with third parties comply with applicable healthcare laws and regulations is costly and time consuming. If a medical device manufacturer&#146;s
operations are found to be in violation of any of the laws described above or any other governmental regulations that apply to it, it may be subject to penalties, including civil, criminal and administrative penalties, damages, fines, disgorgement,
individual imprisonment, exclusion from governmental funded healthcare programs, such as Medicare and Medicaid, additional reporting obligations and oversight if it becomes subject to a corporate integrity agreement or other agreement to resolve
allegations of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these laws, reputational harm, diminished profits and future earnings, and the curtailment or restructuring of operations, any of which could adversely affect the ability of
a medical device manufacturer to operate its business and the results of its operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>United States Healthcare Reform
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the United States, a number of legislative and regulatory proposals have been considered or enacted to change the
healthcare system in ways that could affect a medical device manufacturer&#146;s business. Among policy makers and payors in the United States, there is significant interest in promoting changes in healthcare systems with the stated goals of
containing healthcare costs, improving quality or expanding access. For example, in 2010, the PPACA was enacted, which includes measures to significantly change the way health care is financed by both governmental and private insurers, and
significantly impacts the medical device industry. Among other ways in which it may impact a medical device manufacturer&#146;s business, the PPACA: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">imposes an annual excise tax of 2.3% on any entity that manufactures or imports medical devices offered for sale in the United States,
with limited exceptions, although the effective rate paid may be lower. Under the Consolidated Appropriations Act of 2016, the excise tax was suspended through December&nbsp;31, 2017, and under the continuing resolution on appropriations for fiscal
year 2018, or 2018 Appropriations Resolution, signed by President Trump on January&nbsp;22, 2018, was further suspended through December&nbsp;31, 2019; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">123 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">establishes a new Patient-Centered Outcomes Research Institute to oversee and identify priorities in comparative clinical efficacy
research in an effort to coordinate and develop such research; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">implements payment system reforms including a national pilot program on payment bundling to encourage hospitals, physicians and other
providers to improve the coordination, quality and efficiency of certain healthcare services through bundled payment models; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">expands the eligibility criteria for Medicaid programs. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Some of the provisions of the PPACA have yet to be implemented, and there have been judicial and Congressional challenges to certain aspects of the PPACA, as well as recent efforts by the
Trump administration to repeal or replace certain aspects of the PPACA. President Trump has signed two Executive Orders and other directives designed to delay the implementation of any certain provisions of the PPACA or otherwise circumvent some of
the requirements for health insurance mandated by the PPACA. Concurrently, Congress has considered legislation that would repeal or repeal and replace all or part of the PPACA. While Congress has not passed comprehensive repeal legislation, two
bills affecting the implementation of certain taxes under the PPACA have been signed into law. The Tax Cuts and Jobs Act of 2017 includes a provision repealing, effective January&nbsp;1, 2019, the <FONT STYLE="white-space:nowrap">tax-based</FONT>
shared responsibility payment imposed by the PPACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the &#147;individual mandate&#148;. Additionally, the 2018
Appropriations Resolution delayed the implementation of certain PPACA-mandated fees, including, without limitation, the medical device excise tax. As a result, there is significant uncertainty regarding future healthcare reform and its impact on a
medical device manufacturer&#146;s operations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, other legislative changes have been proposed and adopted since
the PPACA was enacted. On August&nbsp;2, 2011, President Obama signed into law the Budget Control Act of 2011, which, among other things, created the Joint Select Committee on Deficit Reduction to recommend to Congress proposals in spending
reductions. The Joint Select Committee did not achieve a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, triggering the legislation&#146;s automatic reduction to several government programs. This includes
reductions to Medicare payments to providers of 2% per fiscal year, which went into effect on April&nbsp;1, 2013, and due to subsequent legislative amendments to the statute, including the Bipartisan Budget Act of 2018, will stay in effect through
2027 unless additional Congressional action is taken. On January&nbsp;2, 2013, President Obama signed into law the American Taxpayer Relief Act of 2012, or the ATRA, which, among other things, further reduced Medicare payments to several types of
providers and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. In addition, the Medicare Access and CHIP Reauthorization Act of 2015, enacted on April 16, 2015, or MACRA,
repealed the formula by which Medicare made annual payment adjustments to physicians and replaced the former formula with fixed annual updates and a new system of incentive payments scheduled to begin in 2019 that are based on various performance
measures and physicians&#146; participation in alternative payment models such as accountable care organizations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Recently
there has been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several U.S. Congressional inquiries and proposed federal legislation designed to, among other
things, bring more transparency to product pricing, reduce the cost of certain products under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies. At the
state level, individual states in the United States are also increasingly passing legislation and implementing regulations designed to control product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain
product access and marketing cost disclosure and transparency measures. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">124 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">It is likely that additional state and federal healthcare reform measures will be
adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for a medical device manufacturer&#146;s products or additional
pricing pressure. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Japanese Regulation </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In Japan, medical devices must be approved prior to importation and commercial sale by the MHLW. The approval process identifies a Marketing Authorization Holder, or MAH, who is designated
as the only authorized seller of products. Manufacturers of medical devices outside of Japan who do not operate through a Japanese entity are able to designate a MAH who will apply for product approval and take responsibility for the medical device
as designated. The MHLW evaluates each device for safety and efficacy. As part of its approval process, the MHLW may require that the product be tested in Japanese laboratories. The approval process ranges in length and certain medical devices may
require a longer review period for approval. Once a device is approved, the MHLW issues a Shonin to the MAH or designated MAH, thereby permitting such entity to import the device into Japan for sale. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After a device is approved for importation and commercial sale in Japan, the MHLW continues to monitor sales of approved products for
compliance with labeling regulations, which prohibit promotion of devices for unapproved uses, and reporting regulations, which require reporting of product malfunctions, including serious injury or death caused by any approved device. Failure to
comply with applicable regulatory requirements can result in enforcement action by the MHLW, which may include fines, injunctions, and civil penalties; recall or seizure of our products; operating restrictions; partial suspension or total shutdown
of sales in Japan; or criminal prosecution. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Employees </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of March&nbsp;31, 2018, we had 167 employees, with 126 employees on our sales and customer support team, 20 in research and development, including clinical, regulatory and certain
quality functions, two employees in operations and 19 employees in general and administrative. We have never had a work stoppage and none of our employees are covered by collective bargaining agreements or represented by a labor union. We believe
our employee relations are good. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Facilities </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We occupy an approximately 32,000 square foot facility in Malvern, Pennsylvania, under a lease that ends in February of 2021. We have an option to extend the lease for an additional five
year term followed by a three year additional term. We believe that our existing facilities are adequate to meet our needs for the foreseeable future. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Legal Proceedings </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are subject from time to time to
various claims and legal actions during the ordinary course of our business. We believe that there are currently no claims or legal actions that would reasonably be expected to have a material adverse effect on our results of operations, financial
condition, or cash flows. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">125 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_12"></A>MANAGEMENT </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Executive Officers and Directors </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table provides information regarding our current executive officers and directors, including their ages as of June 15, 2018: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="80%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="52%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #465361;width:25pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>NAME</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>AGE</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>POSITION(S)</B></FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Executive Officers</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Chris Thatcher</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">53</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">President and Chief Executive Officer and Director</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Peter Donato</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">48</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Vice President and Chief Financial Officer</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Daniel Guthrie</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">41</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Chief Commercial Officer</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gregory Harper</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">57</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Vice President of Research and Development, Operations and Product Development</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Yelena Tropsha</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">57</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Vice President, Commercial Access</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Brian Farley</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">61</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Chairman of the Board</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Stephen Campe</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">52</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Director</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Paulina Hill</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">36</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Director</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Ron Hunt</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">53</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Director</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Wilfred Jaeger, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">62</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Director</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Glenn Muir</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">59</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Director</FONT></TD></TR>
</TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Executive Officers </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Chris Thatcher </I></B>has served as our President and Chief Executive Officer since 2014 and as a member of our board of directors since 2014. Prior to joining our company,
Mr.&nbsp;Thatcher led the Reichert Technology Global Business Unit of Ametek, Inc. as its Divisional Vice President and Business Unit Manager from February 2013 to November 2014, where he was responsible for revitalizing the brand and expanding its
business globally. From 2009 to 2013, Mr.&nbsp;Thatcher served as the President of the Neurosurgery Division at Integra LifeSciences Holdings Corporation. Prior to joining Integra, Mr.&nbsp;Thatcher was at Bausch and Lomb in various roles from 2002
to 2009, including Vice President of the Americas and General Manager of its Canadian Division. Before joining Bausch and Lomb, from 1997 to 2002, Mr.&nbsp;Thatcher worked in Allergan&#146;s Surgical Products division. Mr.&nbsp;Thatcher also serves
as a Director of Micro Interventional Devices, Inc. He earned his bachelor&#146;s degree from Lafayette College. We believe Mr.&nbsp;Thatcher&#146;s leadership of both large organizations and growing businesses qualifies him to serve on our board of
directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Peter Donato</I></B> has served as our Chief Financial Officer and Vice President since March 2017. Prior to
joining our company, and beginning in 2015, Mr.&nbsp;Donato served as the Chief Financial Officer and Senior Vice President of Assurex Health, Inc., now a division of Myriad. From 2014 to 2015, he served as the Chief Financial Officer, Executive
Vice President, Secretary and Treasurer of Bovie Medical Corporation. From 2011 to 2013, Mr.&nbsp;Donato was the Corporate Controller of Cyberonics, Inc., now LivaNova. From 2010 to 2011, he served as the Chief Financial Officer and Principal
Accounting Officer of Catasys, Inc. From 2007 to 2010, Mr.&nbsp;Donato served as the Chief Financial Officer and Corporate Vice President of IRIS International, Inc. and also served as its Secretary and Principal Accounting Officer. From 2003 to
2006, Mr.&nbsp;Donato was the Chief Financial Officer and Vice President of Finance for the cardiology division of Accellent, Inc. Mr.&nbsp;Donato earned his bachelor&#146;s degree in business administration and accounting from The Ohio State
University. He received his MBA from the College of Business Administration at the University of Akron. Mr.&nbsp;Donato is a licensed CPA. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Daniel Guthrie</I></B> has served as our Chief Commercial Officer since May 2018. Prior to joining our company, Mr. Guthrie was Vice President of Commercialization at JADAK, a
business unit of Novanta Inc., from January 2017 to April 2018. Prior to JADAK, Mr. Guthrie was a General Manager at Zimmer </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">126 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
Biomet Holdings Inc. from August 2011 to December 2016, where, among other roles, he lead the Asia Pacific business for the company&#146;s dental implant division and regenerative therapies
group. Mr. Guthrie was a Director of Franchise Marketing for BioSurgery from May 2008 to August 2011 and a Director of Global Product Marketing from May 2005 to July 2008 at Medtronic PLC (formerly Covidien Ltd.), where he worked in the surgical
solutions and patient care and safety business units. Prior to Medtronic, Mr. Guthrie was Regional Marketing Manager, Asia at Fleet Laboratories from May 2000 to December 2004. Mr. Guthrie earned his bachelor&#146;s degree in finance and marketing
from American University and his MBA from Southern Illinois University at Carbondale. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Gregory Harper</I></B> has served
as our Vice President of Product Development and Operations since September 2016.&nbsp;Prior to joining our company, Mr.&nbsp;Harper was the Vice President, CT Global Research and Development for the Philips Healthcare Computed Tomography from March
2015 to September 2016, where he was responsible for leading the product innovation pipeline and development activities.&nbsp;From January of 2011 to March 2015, Mr.&nbsp;Harper held roles as Director, Computed Tomography Performance and Senior
Director, Computed Tomography and Nuclear Medicine within Philips Healthcare.&nbsp;Prior to Philips, Mr.&nbsp;Harper worked in General Electric in the Healthcare, Lighting and Appliance, and Aerospace businesses.&nbsp;Mr.&nbsp;Harper earned his BSEE
from Valparaiso University and his MBA from the University of Wisconsin, Milwaukee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Yelena Tropsha</I></B> has served
as our Vice President of Commercial Access since January 2018. Prior to joining our company, Dr. Tropsha was a Vice President of Research and Development, Clinical Research and Office of Medical Affairs at Coloplast from July 2017 to December 2017.
From July 2015 to July 2017, Dr. Tropsha was a Vice President of Research and Development, Clinical Research and Regulatory Affairs at Coloplast. From September 2008 to July 2015, she was a Vice President of Research and Development and Clinical
Research at Coloplast. Dr. Tropsha earned her M.S. in Chemistry and her Ph.D. in Polymer Science from Moscow State University in Russia. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Non-Employee Directors </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Brian Farley</I></B> has
served as a member of our board of directors since 2009 and as chairman beginning in 2011. From 2010 to 2015, Mr.&nbsp;Farley was the Chief Executive Officer of Entellus Medical Inc., and he served as a member of the company&#146;s board of
directors from 2008 to 2018. From 1996 to 2009, Mr.&nbsp;Farley was President and Chief Executive Officer of VNUS Medical Technologies. Prior to joining VNUS, Mr.&nbsp;Farley served in various management and executive positions in research and
development, clinical research, and business development at the Vascular Intervention Division of Guidant Corporation and in the Medical Device Division of Eli Lilly and Company. In addition to serving on our board, Mr.&nbsp;Farley serves on the
board of Neurolutions, Inc. He earned his bachelor&#146;s degree in engineering with an emphasis in biomedical engineering and his Master&#146;s Degree in electrical engineering from Purdue University. We believe Mr.&nbsp;Farley&#146;s leadership
and management in medical device companies qualifies him to serve on our board of directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Stephen M. Campe</I></B>
has served as a member of our board of directors since 2013. Mr.&nbsp;Campe is Managing Director and Senior Advisor to Patricia Industries, Inc., or Patricia, a wholly-owned private equity and venture capital subsidiary of Investor AB.
Mr.&nbsp;Campe joined Investor AB in 1998 as Managing Director and head of the healthcare investing team, and served as President of a predecessor entity to Patricia from 2008 to 2015 with responsibility for Investor AB&#146;s global venture capital
activities. Mr.&nbsp;Campe has been an active healthcare investor for over 20&nbsp;years, focusing his investing activities primarily on medical technology including therapeutic, surgical, and diagnostic devices. Mr.&nbsp;Campe currently serves on
the boards of Intuity Medical and HireVue Inc. and has previously served on the boards of numerous medical technology companies. Previously, Mr.&nbsp;Campe was a consultant at McKinsey&nbsp;&amp; Company where he managed corporate finance and
strategy engagements for several diversified healthcare companies, and was an investment banker specializing in mergers and acquisitions. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">127 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
Mr.&nbsp;Campe earned Bachelor&#146;s Degrees in Economics and Systems Science Engineering from the University of Pennsylvania and his MBA from Yale University. We believe Mr.&nbsp;Campe&#146;s
healthcare investment and management experience qualifies him to serve on our board of directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Paulina Hill,
Ph.D</I></B> has served as a member of our board of directors since June 2017. She has been a Principal at Polaris Partners since 2015, after joining Polaris in 2011 as an associate on its healthcare team. Dr.&nbsp;Hill served as the founding Chief
Executive Officer of Camp4 Therapeutics. She serves on the board of Kala Pharmaceuticals, a public pharmaceutical company, and the private company boards of Arsenal Medical, Faraday Pharmaceuticals, KinDex Pharmaceuticals, and Camp4 Therapeutics.
Dr.&nbsp;Hill completed her postdoctoral fellowship in the chemical engineering department at the Massachusetts Institute of Technology, where she worked on developing novel biomaterial scaffolds and drug delivery systems for neural applications.
She earned her bachelor&#146;s degree from East Carolina University and her Ph.D. in Molecular Medicine with a tissue engineering focus from the Wake Forest University School of Medicine. We believe Dr.&nbsp;Hill&#146;s investor experience and
specialized knowledge in neuroscience and medicine qualifies her to serve on our board of directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Ron Hunt</I></B>
has served as a member of our board of directors since 2015. Since 2005, Mr.&nbsp;Hunt has served as a Managing Director and member of New Leaf Venture Partners, L.L.C., a venture capital firm. Previously, Mr.&nbsp;Hunt served at the Sprout Group, a
venture capital firm, and was a consultant with consulting firms Coopers&nbsp;&amp; Lybrand Consulting and The Health Care Group. Mr.&nbsp;Hunt also previously served in various sales and marketing positions at Johnson&nbsp;&amp; Johnson and
SmithKline Beecham Pharmaceuticals. Mr.&nbsp;Hunt previously served on the board of directors of Durata Therapeutics, Inc., Relypsa Inc., Aspreva Pharmaceuticals Corp. and Corixa Corporation. Mr.&nbsp;Hunt holds a B.S. from Cornell University and an
M.B.A. from the Wharton School of the University of Pennsylvania. We believe Mr.&nbsp;Hunt&#146;s experience advising private and public healthcare companies qualifies him to serve on our board of directors. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Wilfred E. Jaeger, M.D.</I></B>,<I> </I>has served as a member of our board of directors since May 2005. Dr.&nbsp;Jaeger <FONT
STYLE="white-space:nowrap">co-founded</FONT> Three Arch Partners, a venture capital firm, in 1993 and has served as a Partner since that time. Prior to <FONT STYLE="white-space:nowrap">co-founding</FONT> Three Arch Partners, Dr.&nbsp;Jaeger was a
general partner at Schroder Ventures. He is a member of the board of directors of Nevro Corporation, a public medical device company, Concert Pharmaceuticals, Inc., a public pharmaceutical company, and numerous private companies. Dr.&nbsp;Jaeger
received a B.S. in Biology from the University of British Columbia, his M.D. from the University of British Columbia School of Medicine, and an M.B.A. from Stanford University. We believe that Dr.&nbsp;Jaeger&#146;s financial and medical knowledge
and experience qualifies him to serve on our board of directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Glenn Muir</I></B> has served as a member of our board
of directors since July 2017. From 1992 until 2014 when he retired, Mr.&nbsp;Muir was the Chief Financial Officer at Hologic, Inc., a publicly-traded manufacturer and supplier of medical products. He served as Hologic&#146;s Executive Vice President
of Finance&nbsp;&amp; Administration from 2000 to 2014, as Vice President of Finance&nbsp;&amp; Administration from 1992 to 2000, and as Controller from 1988 to 1992. Mr.&nbsp;Muir served as a Director of Hologic from 2001 to 2013. Mr.&nbsp;Muir
served as Chief Financial Officer and Vice President of Finance&nbsp;&amp; Administration at Metallon Engineered Materials Corp. from 1986 to 1988. He served as a Senior Auditor with Arthur Andersen&nbsp;&amp; Co. from 1981 to 1984. Mr.&nbsp;Muir
has been a Director of two publicly traded life science and biotechnology companies, Repligen Corporation and G1&nbsp;Therapeutics, Inc., since 2015. He served as an Independent Director at ReWalk Robotics Ltd. and RainDance Technologies, Inc., both
from 2014 to 2017. Mr.&nbsp;Muir earned his bachelor&#146;s degree in accounting from the University of Massachusetts in Amherst, his M.B.A. from the Harvard Business School, and his M. Sc. in taxation from Bentley College Graduate School of
Business. He is a certified public accountant. We believe Mr.&nbsp;Muir&#146;s leadership and management experience with medical product companies and financial expertise qualifies him to serve on our board of directors. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">128 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Board Composition and Election of Directors </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Board Composition </I></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our business and affairs are managed under the direction of our board of directors, which currently consists of seven members. Our amended and restated certificate of incorporation and
amended and restated bylaws, to be effective upon the closing of this offering, provide that our board of directors will consist of a number of directors to be fixed exclusively by resolution of our board of directors. Other than vacancies to be
filled through selection by the remaining members of our board of directors, our amended and restated certificate of incorporation and amended and restated bylaws, to be effective upon the closing of this offering, will provide that directors are
elected annually at the annual meeting of our stockholders by a vote of the holders of a majority of the voting power represented present and voting in person, by proxy or by other voting instrument at that meeting. We have only one class of
directors. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The primary responsibilities of our board of directors are to provide oversight, strategic guidance,
counseling and direction to our management. Our board of directors meets on a regular basis and additionally as required. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our
amended and restated certificate of incorporation and amended and restated bylaws, to be effective upon the closing of this offering, will provide that the authorized number of directors may be changed only by resolution approved by a majority of
our board of directors. Further, our amended and restated certificate of incorporation and amended and restated bylaws will provide that our directors may be removed only for cause by the affirmative vote of the holders of at least 75% of the votes
that all our stockholders would be entitled to cast in an annual election of directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Director Independence
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Applicable Nasdaq rules require a majority of a listed company&#146;s board of directors to be comprised of independent
directors within one year of listing. In addition, Nasdaq rules require that, subject to specified exceptions, each member of a listed company&#146;s audit, compensation and nominating and corporate governance committees be independent and that
audit committee members also satisfy independence criteria set forth in Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act of 1934, as amended, or the Exchange Act. The Nasdaq independence definition includes a series of
objective tests, such as that the director is not, and has not been for at least three years, one of our employees, that neither the director nor any of his family members has engaged in various types of business dealings with us and that the
director is not associated with the holders of more than 5% of our common stock. In addition, under applicable Nasdaq rules, a director will only qualify as an &#147;independent director&#148; if, in the opinion of the listed company&#146;s board of
directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our board of directors has determined that all of our directors, except Mr.&nbsp;Thatcher, are independent directors, as defined under applicable Nasdaq rules. In making such
determination, our board of directors considered the relationships that each such <FONT STYLE="white-space:nowrap">non-employee</FONT> director has with our company and all other facts and circumstances that our board of directors deemed relevant in
determining his or her independence, including the beneficial ownership of our capital stock by each <FONT STYLE="white-space:nowrap">non-employee</FONT> director. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">There are no family relationships among any of our directors or executive officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Role of the Board in Risk Oversight </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">One of the key
functions of our board of directors is informed oversight of our risk management process. Our board of directors does not have a standing risk management committee, but rather administers this oversight function directly through the board of
directors as a whole, as well as through various standing </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">129 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
committees of our board of directors that address risks inherent in their respective areas of oversight. In particular, our board of directors is responsible for monitoring and assessing
strategic risk exposure and our audit committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to
govern the process by which risk assessment and management is undertaken. The audit committee also monitors compliance with legal and regulatory requirements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Board Committees </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our board of directors has established an
audit committee, a compensation committee and a nominating and corporate governance committee, each of which operate pursuant to a committee charter. Our board of directors may establish other committees to facilitate the management of our business.
The composition and functions of each committee are described below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Audit Committee </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Upon completion of this offering, our audit committee will consist of Glenn Muir, Stephen M. Campe and Paulina Hill, with Mr.&nbsp;Muir
serving as chair of the audit committee. Our board of directors has determined that each of these individuals meets the independence requirements of the Sarbanes-Oxley Act of 2002, as amended, or the Sarbanes-Oxley Act, Rule <FONT
STYLE="white-space:nowrap">10A-3</FONT> under the Securities Exchange Act of 1934, or the Exchange Act, and the applicable listing standards of Nasdaq. Each member of our audit committee can read and understand fundamental financial statements in
accordance with Nasdaq audit committee requirements. In arriving at this determination, the board has examined each audit committee member&#146;s scope of experience and the nature of their prior and/or current employment. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our board of directors has determined that Glenn Muir qualifies as an audit committee financial expert within the meaning of SEC
regulations and meets the financial sophistication requirements of Nasdaq. In making this determination, our board has considered Mr.&nbsp;Muir&#146;s formal education and previous and current experience in financial and accounting roles. Both our
independent registered public accounting firm and management periodically meet privately with our audit committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The
functions of this committee include, among other things: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">evaluating the performance, independence and qualifications of our independent auditors and determining whether to retain our existing
independent auditors or engage new independent auditors; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing and approving the engagement of our independent auditors to perform audit services and any permissible <FONT
STYLE="white-space:nowrap">non-audit</FONT> services; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">monitoring the rotation of partners of our independent auditors on our engagement team as required by law;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">prior to engagement of any independent auditor, and at least annually thereafter, reviewing relationships that may reasonably be
thought to bear on their independence, and assessing and otherwise taking the appropriate action to oversee the independence of our independent auditor; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing our annual and quarterly financial statements and reports, including the disclosures contained under the caption
&#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148; and discussing the statements and reports with our independent auditors and management; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing with our independent auditors and management significant issues that arise regarding accounting principles and financial
statement presentation and matters concerning the scope, adequacy and effectiveness of our financial controls; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">130 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing with management and our auditors any earnings announcements and other public announcements regarding material developments;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">establishing procedures for the receipt, retention and treatment of complaints received by us regarding financial controls, accounting
or auditing matters and other matters; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">preparing the report that the SEC requires in our annual proxy statement; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing and providing oversight of any related-person transactions in accordance with our related person transaction policy and
reviewing and monitoring compliance with legal and regulatory responsibilities, including our code of business conduct and ethics; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing our major financial risk exposures, including the guidelines and policies to govern the process by which risk assessment and
risk management is implemented; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing on a periodic basis our investment policy; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing and evaluating on an annual basis the performance of the audit committee and the audit committee charter.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We believe that the composition and functioning of our audit committee complies with all applicable
requirements of the Sarbanes-Oxley Act, and all applicable SEC and Nasdaq rules and regulations. We intend to comply with future requirements to the extent they become applicable to us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Compensation Committee </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Upon completion of this
offering, our compensation committee will consist of Wilfred E. Jaeger, Brian Farley and Ronald Hunt, with Mr.&nbsp;Jaeger serving as chair of the compensation committee. Each of these individuals is a
<FONT STYLE="white-space:nowrap">non-employee</FONT> director, as defined in Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act. Our board of directors has determined that each of these individuals is
&#145;&#145;independent&#146;&#146; as defined under the applicable listing standards of Nasdaq, including the standards specific to members of a compensation committee. The functions of this committee include, among other things: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing, modifying and approving (or if it deems appropriate, making recommendations to the full board of directors regarding) our
overall executive compensation strategy and policies; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">making recommendations to the full board of directors regarding the compensation and other terms of employment of our executive
officers; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing and making recommendations to the full board of directors regarding performance goals and objectives relevant to the
compensation of our executive officers and assessing their performance against these goals and objectives; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing and approving (or if it deems it appropriate, making recommendations to the full board of directors regarding) the equity
incentive plans, compensation plans and similar programs advisable for us, as well as modifying, amending or terminating existing plans and programs; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">evaluating risks associated with our compensation policies and practices and assessing whether risks arising from our compensation
policies and practices for our employees are reasonably likely to have a material adverse effect on us; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing and making recommendations to the full board of directors regarding the type and amount of compensation to be paid or awarded
to our <FONT STYLE="white-space:nowrap">non-employee</FONT> board members; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">establishing policies with respect to votes by our stockholders to approve executive and director compensation to the extent required
by Section&nbsp;14A of the Exchange Act and, if applicable, determining our recommendations regarding the frequency of advisory votes on executive and director compensation; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">131 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing and assessing the independence of compensation consultants, legal counsel and other advisors as required by Section&nbsp;10C
of the Exchange Act; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">administering our equity incentive plans; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">establishing policies with respect to equity compensation arrangements; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing the competitiveness of our executive and director compensation programs and evaluating the effectiveness of our compensation
policy and strategy in achieving expected benefits to us; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing and approving on making recommendations to the full board of directors regarding the terms of any employment agreements,
severance arrangements, change in control protections and any other compensatory arrangements for our executive officers; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing with management and approving our disclosures under the caption &#147;Compensation Discussion and Analysis&#148; in our
periodic reports or proxy statements to be filed with the SEC, to the extent such caption is included in any such report or proxy statement; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">preparing the report that the SEC requires in our annual proxy statement; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing and evaluating on an annual basis the performance of the compensation committee and the compensation committee charter.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We believe that the composition and functioning of our compensation committee complies with all SEC and
Nasdaq rules and regulations. We intend to comply with future requirements to the extent they become applicable to us. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Nominating and Corporate Governance Committee </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Upon completion of this offering, our nominating and corporate governance committee will consist of Brian Farley and Stephen M. Campe, with Brian Farley serving as chair of the nominating
and corporate governance committee. Our board of directors has determined that each of these individuals is &#145;&#145;independent&#146;&#146; as defined under the applicable listing standards of Nasdaq and SEC rules and regulations. The functions
of this committee include, among other things: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">identifying, reviewing and evaluating candidates to serve on our board of directors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">determining the minimum qualifications for service on our board of directors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">evaluating director performance on the board and applicable committees of the board and determining whether continued service on our
board is appropriate; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">evaluating, nominating and recommending individuals for membership on our board of directors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">evaluating nominations by stockholders of candidates for election to our board of directors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">considering and assessing the independence of members of our board of directors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">developing a set of corporate governance policies and principles and recommending to our board of directors any changes to such
policies and principles; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing and making recommendations to the board of directors with respect to management succession planning;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">considering questions of possible conflicts of interest of directors as such questions arise; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">reviewing and evaluating on an annual basis the performance of the nominating and corporate governance committee and the nominating and
corporate governance committee charter. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">132 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We believe that the composition and functioning of our nominating and corporate
governance committee complies with all SEC and Nasdaq rules and regulations. We intend to comply with future requirements to the extent they become applicable to us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our board of directors may from time to time establish other committees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Compensation Committee Interlocks and Insider Participation </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">None of our directors who serve as a member of our compensation committee is, or has at any time during the past year been, one of our
officers or employees. None of our executive officers currently serves, or in the past year has served, as a member of the board of directors or compensation committee of any other entity that has one or more executive officers serving on our board
of directors or compensation committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Code of Business Conduct and Ethics </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Effective upon the closing of this offering, we will adopt a Code of Business Conduct and Ethics, or the Code of Conduct, applicable to
all of our employees, executive officers and directors. Following the closing of this offering, the Code of Conduct will be available on our website at <I>www.neurostar.com</I>. The nominating and corporate governance committee of our board of
directors will be responsible for overseeing the Code of Conduct and must approve any waivers of the Code of Conduct for employees, executive officers and directors. In addition, we intend to post on our website all disclosures that are required by
law or the listing standards of the applicable stock exchange concerning any amendments to, or waivers from, any provision of the Code of Conduct. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the year ended December 31, 2017, the chairman of our board was paid $50,000 and also received a restricted stock award. Our audit committee chairman received an option to purchase
shares in 2017 in connection with joining the board. Our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors also received reimbursement of their actual
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> costs and expenses incurred in connection with attending board meetings. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Non-employee director compensation policy </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In anticipation
of this offering and the increased responsibilities of our directors as directors of a public company, our board of directors has adopted a non-employee director compensation policy, which will go into effect upon the pricing of this offering,
pursuant to which each of our directors who is not an employee of our company, which as of the pricing of this offering will be all directors other than Mr. Thatcher, will be eligible to receive compensation for service on our board of directors and
committees of our board of directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each eligible director will receive an annual cash retainer of $40,000 for serving on
our board of directors. In addition, the non-chair members of each of the audit, compensation and nominating and corporate governance committees of our board of directors will be entitled to an additional annual cash retainer of $10,000, $7,500 and
$5,000, respectively, and the Chairperson of each of the audit, compensation and nominating and corporate governance committees of our board of directors will be entitled to an additional annual cash retainer of $20,000, $15,000 and $10,000,
respectively. The non-executive Chairperson of our board of directors also will be entitled to $65,000 annually, with $40,000 paid in cash and $25,000 paid in restricted share units. All annual cash compensation amounts will be payable in equal
quarterly installments in advance within the first 30 days of each quarter in which the service will occur. Cash retainers will be pro-rated for any partial year service. Eligible directors may elect to receive cash retainers in the form of vested
common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">On the date of each annual meeting of our stockholders, each eligible director who continues to serve as a
director of our company following the meeting will be granted a non-statutory stock option and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">133 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
restricted stock unit each valued at $50,000, vesting in full one year from the grant date and in any event will be fully vested on the date of the next annual meeting of our stockholders or upon
a change in control, subject to continued service as a director though the applicable vesting date. Eligible directors who are appointed outside of an annual meeting also will receive these grants, except their values will be pro-rated to reflect a
partial year of service between annual meeting dates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The exercise price per share of each stock option granted under the
non-employee director compensation policy will be equal to 100% of the fair market value of the underlying common stock on the date of grant. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">134 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_13"></A>EXECUTIVE AND DIRECTOR COMPENSATION
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>As an &#147;emerging growth company&#148; as defined in the JOBS Act, we are not required to include a Compensation
Discussion and Analysis section and have elected to comply with the scaled disclosure requirements applicable to emerging growth companies and smaller reporting companies. </I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Executive Compensation Process </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The compensation committee
of our board of directors has historically been responsible for the executive compensation program for our executive officers, including our Named Executive Officers, and reports to our board of directors on its discussions, decisions and other
actions. The compensation committee has reviewed and approved corporate goals and objectives relating to the compensation of our Chief Executive Officer, evaluated the performance of our Chief Executive Officer in light of those goals and objectives
and recommended to our board of directors the compensation of our Chief Executive Officer based on such evaluation. In addition, the compensation committee, in consultation with our Chief Executive Officer, has reviewed and approved all compensation
for our other executive officers. Our Chief Executive Officer has historically made compensation recommendations for our other executive officers and has initially proposed the corporate performance goals under our annual cash bonus plan to the
compensation committee. The compensation committee has been authorized to retain and terminate the services of one or more executive compensation consultants as it sees fit, in connection with its oversight of our executive compensation program and
related policies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Summary Compensation Table </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table provides information regarding the total compensation for services rendered in all capacities that was earned by each individual who served as our principal executive
officer and our two other most highly-compensated executive officers who were serving as executive officers as of December&nbsp;31, 2017. We refer to these individuals as our &#147;Named Executive Officers.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>2017 S<SMALL>UMMARY</SMALL> C<SMALL>OMPENSATION</SMALL> T<SMALL>ABLE</SMALL> </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="33%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:98pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Name and Principal Position</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Salary<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Bonus<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Option<BR>Awards<BR>($)(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive
Plan<BR>Compensation<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>All Other<BR>Compensation<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Total<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Christopher A. Thatcher,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">400,155</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$<B></B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">118,716<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B></B>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">240,093</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$<B></B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B></B>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">758,964</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>President and Chief</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Executive Officer</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Peter L. Donato,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">221,907</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$<B></B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">165,253<B></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B></B>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">127,643</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">26,050</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">540,853</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Vice President and Chief</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Financial Officer<FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gregory A. Harper,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">287,700</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">75,512</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">97,473</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$<B></B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>&#151;&nbsp;&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B></B>&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">460,685</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Vice President of Research</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>and Development,</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Operations and Product</I></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px; margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Development</I></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">The amounts reported represent the aggregate grant date fair value of the options to purchase shares of our common stock granted to the
Named Executive Officer in 2017, calculated in accordance with the Financial Accounting Standard Board&#146;s ASC Topic 718. Such grant date fair value does not take into account any estimated forfeitures related to service-vesting conditions. See
Note 12 to our financial statements as included in this prospectus for the assumptions used in calculating the grant date fair value of the stock options reported in this column. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>footnotes continued on following page </I></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">135 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Reflects amounts paid pursuant to our fiscal 2017 bonus program described in &#147;Narrative Disclosure to Summary Compensation
Table&#148; below. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Mr.&nbsp;Donato joined us as our Vice President and Chief Financial officer in <B></B>April&nbsp;10, 2017.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">The amount reported includes $26,050 representing payments to Mr.&nbsp;Donato for living expenses. If he terminates his employment with
us voluntarily or for cause within 24 months of the effective date of his employment, Mr.&nbsp;Donato will reimburse us all amounts paid to him for this relocation assistance. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Narrative Disclosure to Summary Compensation Table </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The compensation of our Named Executive Officers generally consists of base salary, an annual cash bonus opportunity and long-term incentive compensation in the form of equity awards.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Base Salary </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The compensation committee reviews the base salaries of our executive officers, including our Named Executive Officers, from time to time and makes adjustments <B></B>(or, in the case of
our Chief Executive Officer, may recommend adjustments for approval by our board of directors)<B></B> as it determines to be reasonable and necessary to reflect the scope of his or her performance, contributions, responsibilities, experience, prior
salary level, position (in the case of a promotion) and market conditions, including base salary amounts relative to similarly-situated executive officers at peer group companies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Annual Cash Bonuses </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each of our Named Executive Officers
was a participant in our 2017 annual cash bonus plan, pursuant to which each was eligible to earn a cash bonus based on our achievement of <FONT STYLE="white-space:nowrap">pre-established</FONT> revenue and earnings objectives, as well as on the
achievement of individual performance goals. For 2017, the target annual cash bonus opportunity for Mr.&nbsp;Thatcher was equal to 40% of his annual base salary and the target annual cash bonus opportunities for Messrs. Donato and Harper were equal
to 30% and 25%, respectively, of their annual base salaries. No bonuses were to be paid under our 2017 annual cash bonus plan unless and until the compensation committee made a determination with respect to the attainment of the performance
objectives. In early 2018, the compensation committee determined that, based on our achievement levels with respect to the <FONT STYLE="white-space:nowrap">pre-established</FONT> revenue and earnings objectives for 2017, as well as an evaluation of
each individual&#146;s performance during 2017, to pay each of our Named Executive Officers the cash bonus amounts for 2017 performance as set forth in the column entitled <FONT STYLE="white-space:nowrap">&#147;Non-Equity</FONT> Incentive Plan
Compensation&#148; in the 2017 Summary Compensation Table above. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Long-Term Incentive Compensation </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Historically, and prior to our initial public offering, we have generally granted options to purchase shares of our common stock to our
employees, including our Named Executive Officers. For a description of the options to purchase shares of our common stock granted to our Named Executive Officers in 2017, please see the &#147;2017 Outstanding Equity Awards at Fiscal <FONT
STYLE="white-space:nowrap">Year-End</FONT> Table&#148; below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Section&nbsp;401(k) Savings Plan and Other Benefits
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We maintain a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> Section&nbsp;401(k) savings plan that provides
eligible employees with an opportunity to save for retirement on a tax advantaged basis. Eligible employees are able to defer eligible compensation subject to applicable annual limits under the Internal Revenue Code, or the Code. Employees&#146; <FONT
STYLE="white-space:nowrap">pre-tax</FONT> contributions are allocated to each participant&#146;s individual account and are then invested in selected investment alternatives according to each participant&#146;s direction. Employees are immediately
and fully vested in their contributions. The Section&nbsp;401(k) plan is intended to be qualified under Section&nbsp;401(a) of the Code with the plan&#146;s related trust intended to be tax exempt under Section&nbsp;501(a) of the Code. As a <FONT
STYLE="white-space:nowrap">tax-qualified</FONT> retirement plan, contributions to the Section&nbsp;401(k) plan and earnings on those contributions are not taxable to the employees until distributed from the plan. We also pay, on behalf of our
employees, including our Named Executive Officers, a portion of the premiums for health, life and disability insurance. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">136 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Pension and Nonqualified Deferred Compensation Plans </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We do not provide a pension plan for our employees, and none of our Named Executive Officers participated in a nonqualified deferred
compensation plan in 2017. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Employment Agreements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have entered into employment agreements or offer letters with Messrs. Thatcher, Donato and Harper. The key terms and conditions of these agreements are described below. For a discussion
of the post-employment compensation arrangements with each of our Named Executive Officers, please see &#147;Post-Employment Compensation Arrangements&#148; below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Mr.&nbsp;Thatcher </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We entered into an employment agreement
with Mr. Thatcher dated November 1, 2014, pursuant to which we employ Mr. Thatcher as our President and Chief Executive Officer. Under the agreement, we will use our best efforts to ensure that he is elected to be a voting member of our board of
directors for as long as Mr. Thatcher is employed as our President and Chief Executive Officer. Mr. Thatcher&#146;s agreement does not specify a term of employment. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The agreement entitles Mr. Thatcher to an annual target bonus opportunity of 40% of his annual base salary, with the actual amount of such annual bonus payable to be determined by our
board of directors, based on the achievement of corporate or individual performance objectives determined and agreed to by our board of directors and Mr. Thatcher. Mr. Thatcher&#146;s current base salary is listed in the table above. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Messrs. Donato, Guthrie and Harper and Dr. Tropsha </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We entered into an employment offer letter agreement with each of Mr.&nbsp;Donato, effective April&nbsp;10, 2017, Mr.&nbsp;Guthrie, effective May&nbsp;4, 2018, Mr.&nbsp;Harper, effective
September&nbsp;12, 2016, and Dr.&nbsp;Tropsha, effective November&nbsp;15, 2017. The employment of each is &#147;at will&#148; and each agreement endures until terminated by either party. Under the terms of his agreement, Mr.&nbsp;Donato is eligible
to receive a target annual bonus of 30% of his annual base salary. Mr.&nbsp;Guthrie&#146;s agreement provides for a target annual bonus of 45% of his annual base salary, with the actual amount of such bonus based on the achievement of corporate,
departmental and individual performance goals defined by Mr.&nbsp;Guthrie and Mr.&nbsp;Thatcher. Mr.&nbsp;Harper&#146;s agreement provides for a target annual bonus of 25% of his annual base salary, with the actual amount of such bonus based on the
achievement of corporate, departmental and individual performance goals defined by Mr.&nbsp;Harper and Mr.&nbsp;Thatcher. Dr.&nbsp;Tropsha&#146;s agreement provides for a target annual bonus of 25% of her annual base salary, with the actual amount
of such bonus based on the achievement of corporate, departmental and individual performance goals defined by Dr.&nbsp;Tropsha and Mr.&nbsp;Thatcher. Each of Mr.&nbsp;Donato&#146;s and Mr.&nbsp;Harper&#146;s current base salaries are listed in the
table above. Mr.&nbsp;Guthrie&#146;s annual base salary is $296,000 annually. Dr.&nbsp;Tropsha&#146;s annual base salary is $289,000. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Mr.&nbsp;Donato, Mr.&nbsp;Guthrie, Mr.&nbsp;Harper and Dr.&nbsp;Tropsha&#146;s offer letters each provide for the grant of a <FONT STYLE="white-space:nowrap">non-qualified</FONT> stock
option under our Amended and Restated 2003 Stock Incentive Plan, as amended, or 2003 Plan, to purchase shares equal to 0.85%, 0.7%, 0.65% and 0.6% respectively, of our fully-diluted common stock. Twenty-five percent of each such option vests on the
first anniversary of the executive&#146;s applicable start date, with the remainder vesting in 36 equal monthly installments thereafter. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, Mr. Guthrie has been granted an award of restricted stock units representing 40,233 shares of our common stock, with an effective grant date as of the day following the
effective date of the registration statement on Form&nbsp;S-8 with respect to the 2018 Plan. The restricted stock units will vest in four substantially equal installments beginning on May&nbsp;21, 2019 and each of the three anniversaries of such
date, provided that Mr. Guthrie remains continuously employed by us through the applicable vesting dates. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">137 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Messrs. Donato, Guthrie and Harper are each entitled to relocation assistance under
their respective agreements, provided that they complete such relocation within 24 months, 6 months and 180 days, respectively. Dr.&nbsp;Tropsha is entitled to relocation assistance under her agreement, provided that she does not voluntarily
terminate her employment or is not terminated for &#147;cause&#148; within 24&nbsp;months. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Mr.&nbsp;Donato is eligible to
receive reimbursement for weekly round-trip coach class airfare to Malvern; reimbursement of certain related travel expenses; a temporary housing allowance in Malvern of up to $2,000 per month, as well as an allowance of up to $50 per day for food
and living expenses; the option, during the <FONT STYLE="white-space:nowrap">24-month</FONT> period following his hire date, to convert the balance of the assistance listed above to an allowance to pay for reasonable expenses, up to $100,000,
associated with moving his household goods to the Malvern area; a separate allowance for moving expenses up to $100,000; and a tax <FONT STYLE="white-space:nowrap">gross-up</FONT> payment to offset any tax liability Mr.&nbsp;Donato incurs as a
result of any reimbursed moving expenses. If Mr.&nbsp;Donato resigns his position or is terminated for cause within 24 months of his start date, he must reimburse any relocation reimbursement paid under his offer letter. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Mr.&nbsp;Guthrie is eligible to receive a temporary housing allowance in Malvern for a period of three months, not to exceed $2,000 per
month; a daily meal allowance while in Malvern not to exceed $50 per day; reimbursement of moving expenses up to $35,000; and home purchase assistance not to exceed $10,000. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Mr.&nbsp;Harper is eligible to receive up to $30,000 for expenses directly relating to the sale of his home in Ohio; up to $15,000 for temporary lodging expenses; up to $10,000
reimbursement of expenses associated with moving Mr.&nbsp;Harper&#146;s household goods to Malvern; and a tax <FONT STYLE="white-space:nowrap">gross-up</FONT> payment to offset any tax liability Mr.&nbsp;Harper incurs as a result of any reimbursed
moving expenses. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Dr.&nbsp;Tropsha is eligible to receive reimbursement for weekly round-trip coach class airfare to Malvern;
reimbursement of certain related travel expenses; a temporary housing allowance in Malvern of up to $2,000 per month; relocation assistance for expenses associated with moving household goods and automobile to the Malvern area; and a tax <FONT
STYLE="white-space:nowrap">gross-up</FONT> payment to offset any tax liability Dr.&nbsp;Tropsha incurs as a result of any reimbursed moving expenses. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Outstanding Equity Awards at Fiscal <FONT STYLE="white-space:nowrap">Year-End</FONT> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table sets forth information regarding the outstanding and unexercised stock options held by each of our Named Executive Officers as of December&nbsp;31, 2017. All of these
awards were made pursuant to the 2003 Plan.<B> </B>The vesting schedule applicable to each outstanding equity award is described in the footnotes to the table below. For information regarding the vesting acceleration provisions applicable to the
equity awards of our Named Executive Officers, see &#147;Post-Employment Compensation Arrangements&#148; below. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">138 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>2017 O<SMALL>UTSTANDING</SMALL> E<SMALL>QUITY</SMALL>
A<SMALL>WARDS</SMALL> <SMALL>AT</SMALL> F<SMALL>ISCAL</SMALL> Y<SMALL>EAR</SMALL><FONT STYLE="white-space:nowrap">-E</FONT><SMALL>ND</SMALL> T<SMALL>ABLE</SMALL> </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:24pt ; display:inline;" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>N<SMALL>AME</SMALL> </B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Option&nbsp;Grant<BR>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Number
of<BR>securities<BR>underlying<BR>unexercised<BR>options<BR>(#)&nbsp;exercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Number
of<BR>securities<BR>underlying<BR>unexercised<BR>options<BR>(#)&nbsp;unexercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Option<BR>exercise<BR>price<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Option<BR>expiration&nbsp;date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Mr.&nbsp;Thatcher</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">02/19/15</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">300,846</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">89,441</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.87</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">02/18/25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">07/15/15</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">165,786</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">49,288</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.87</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">07/14/25</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">07/20/17</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">115,726</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">07/19/27</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Mr.&nbsp;Donato</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">04/12/17</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">104,951</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">04/11/27</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">07/20/17</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16,572</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">07/19/27</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Mr.&nbsp;Harper</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10/12/16</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">23,918</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">52,619</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10/11/26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">07/20/17</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12,085</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">07/19/27</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12/07/17</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">
</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT><BR></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT><BR></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT><BR></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">25,203</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12/06/27</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE>  <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Option to purchase shares of our common stock vested as to 25% of the shares subject to the option on November&nbsp;1, 2015 and the
remaining shares vest as to 1/36th of such shares each month thereafter. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Option to purchase shares of our common stock vests as to 25% of the shares subject to the option on the first anniversary of the Named
Executive Officer&#146;s relevant vesting commencement date and the remaining shares vest as to 1/36<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP> of such shares each month thereafter. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Executive Officer Post-Employment Compensation Arrangements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Mr.&nbsp;Thatcher </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the event the employment of
Mr.&nbsp;Thatcher is terminated by us without &#147;cause,&#148; or he resigns for &#147;good reason,&#148; he is entitled to receive all accrued and unpaid base salary and vacation, and subject to his timely execution of a release of claims in our
favor, the annual cash bonus with respect to the calendar year ended immediately prior for the cessation of his employment, a <FONT STYLE="white-space:nowrap">pro-rated</FONT> target bonus for the calendar year in which such termination of
employment occurs, monthly severance payments equal to <FONT STYLE="white-space:nowrap">one-twelfth</FONT> of his current base salary for a period of 18 months, reimbursement of premiums for COBRA continuation coverage for 18 months and extension of
the exercise period for any outstanding and vested stock options until the earlier to occur of (i)&nbsp;the first anniversary of the employment termination date or (ii)&nbsp;the expiration of the option term. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the event the employment of Mr.&nbsp;Thatcher is terminated for any other reason, he is entitled to receive all accrued and unpaid
base salary and vacation, and, if such termination of employment is the result of death or disability, the annual cash bonus with respect to the calendar year ended immediately prior for the cessation of his employment and a <FONT
STYLE="white-space:nowrap">pro-rated</FONT> target bonus for the calendar year in which such termination of employment occurs. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For purposes of his employment agreement: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#147;Cause&#148; generally means Mr.&nbsp;Thatcher&#146;s indictment, conviction or plea of guilty or no contest to a felony or to a
misdemeanor involving moral turpitude or that causes material damage to the our public image or reputation, or to our operations or financial performance; gross negligence or willful misconduct with respect to his duties and responsibilities to us;
alcohol or illegal substance abuse in the event we have reasonable grounds for suspecting he is under the influence while at work and his ability to perform his duties and responsibilities has been impaired; willful refusal or failure to perform any
specific material lawful direction from our board of directors not cured within 30 days after delivery of written notice; willful and material breach of any written agreement with or duty owed to us; or if we determine that he has intentionally
omitted any requested information </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">139 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
or falsified any disclosed information either in his resume or during the interview process with us; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#147;Good reason&#148; generally means, subject to certain cure rights and without Mr. Thatcher&#146;s prior consent, due to a
material adverse change in his position with us that reduces his title, level of authority or duties/responsibilities; a reduction in base salary or target annual cash bonus; our failure to provide that he is eligible to participate in benefit
plans; relocation of Mr. Thatcher&#146;s principal worksite more than 35 miles, unless it reduces his commute; or any material breach of the agreement by us. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If however, the employment of Mr. Thatcher is terminated by us without cause or he resigns for good reason, within 90 days prior to or within 12 months following a change of control, he is
instead entitled to receive all accrued and unpaid base salary and vacation, and subject to his timely execution of a release of claims in our favor, the annual cash bonus with respect to the calendar year ended immediately prior for the cessation
of his employment, an amount equal to one and one half times his current target bonus payable in substantially equal installments over 18 months, monthly severance payments equal to one-twelfth of his current base salary for a period of 18 months,
reimbursement of premiums for COBRA continuation coverage for 18 months, acceleration of all outstanding unvested restricted stock, stock options and other equity incentives and extension of the exercise period for any outstanding and vested stock
options until the earlier to occur of (i) the first anniversary of the employment termination date or (ii) the expiration of the option term. In addition, regardless of whether Mr. Thatcher is terminated by us without cause or he resigns for good
reason, upon a change of control, Mr. Thatcher is entitled to acceleration of all unvested restricted stock, stock options and other equity incentives granted through March 2018. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Notwithstanding any other provision of his employment agreement, if any payment or benefit due under the employment agreement, together with all other payments and benefits that
Mr.&nbsp;Thatcher receives or is entitled to receive from us will constitute an &#147;excess parachute payment&#148; (as that term is defined in Section&nbsp;280G(b)(1) of the Code), such payments and benefits will be limited to the minimum extent
necessary to ensure that no portion thereof will fail to be tax deductible to us by reason of Section&nbsp;280G. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Messrs.
Donato, Guthrie and Harper and Dr. Tropsha </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have entered into severance agreements with Messrs. Donato, Guthrie and
Harper and Dr.&nbsp;Tropsha. Under the terms of their severance agreements, Messrs. Donato, Guthrie and Harper and Dr.&nbsp;Tropsha are entitled to receive nine months, nine months, six months and six months of their then-current base salary,
respectively, in the event they are terminated by us without &#147;cause&#148; or resign for &#147;good reason,&#148; subject to timely execution of a release of claims in our favor. However, in the event Messrs. Donato, Guthrie or Harper or
Dr.&nbsp;Tropsha are terminated by us without cause or resign for good reason, and such termination or resignation occurs within three months before or within 12 months following a &#147;change of control,&#148; Messrs. Donato, Guthrie and Harper
and Dr.&nbsp;Tropsha are then entitled to receive 18&nbsp;months, 18 months, 12 months and 12 months of their then-current base salary, respectively. Additionally, in the event such termination without cause or resignation for good reason occurs
within three months before or within 12 months following a change of control, all unvested restricted stock, stock options and other equity incentives held by Messrs. Donato, Guthrie or Harper or Dr.&nbsp;Tropsha shall fully vest. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For purposes of these agreements, &#147;cause&#148; generally means Mr.&nbsp;Donato, Mr.&nbsp;Guthrie, Mr.&nbsp;Harper or
Dr.&nbsp;Tropsha&#146;s indictment, conviction or plea of guilty or no contest to a felony or to a misdemeanor involving moral turpitude or that causes material damage to our public image or reputation, or to our operations or financial performance;
gross negligence or willful misconduct with respect to their duties and responsibilities to us; alcohol or illegal substance abuse in the event we have reasonable grounds for suspecting they are under the influence while at work and their ability to
perform their duties and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">140 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
responsibilities has been impaired; their failure to timely execute a restrictive covenant agreement; willful refusal or failure to perform any specific material lawful direction from our board
of directors not cured within 30 days after delivery of written notice; the failure to timely execute a restrictive covenant agreement; willful and material breach of any written agreement with or duty owed to us; or if we determine that they have
intentionally omitted any requested information or falsified any disclosed information either in their resume or during the interview process with us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For purposes of these agreements, &#147;good reason&#148; generally means a material adverse change in Mr.&nbsp;Donato, Mr.&nbsp;Guthrie, Mr.&nbsp;Harper or Dr.&nbsp;Tropsha&#146;s
position with us that reduces their title, level of authority, duties or responsibilities; a reduction in their base salary or target bonus; our failure to provide that they are eligible to participate in benefit plans on a basis at least as
favorable as that of our other similarly situated senior corporate officers; or relocation of their principal worksite by more than 35 miles, unless it reduces their commute. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For purposes of these agreements, &#147;change in control&#148; generally means the occurrence of, in one transaction or a series of related transactions, any person becoming a beneficial
owner, directly or indirectly, of our securities representing more than 50% of the voting power of our then-outstanding securities; a consolidation, share exchange, reorganization or merger in which our equity holders immediately prior to such event
own less than 50% of the voting power of the resulting entity&#146;s securities outstanding immediately following such event; or the sale or other disposition of all or substantially all of our assets; or any similar event deemed by our board to
constitute a &#147;change in control&#148;. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In consideration for the benefits extended under the severance agreements,
Messrs. Donato, Guthrie and Harper entered into restrictive covenant and invention assignments agreements with us, which agreements contain non-compete, non-solicitation and intellectual property protections in our favor. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Equity Award Acceleration </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B></B>Under the terms of our 2003 Plan, if, in connection with a change of control, the equity awards are not assumed in full or substituted with equivalent awards, the compensation
committee may fully vest all outstanding equity awards or cancel all equity awards and pay the participant the difference between the fair market value of the stock underlying the equity award and the exercise price or base price, if any, for such
equity award. For purposes of the 2003 Plan, the term &#147;change of control&#148; means a sale of all or substantially all our assets, consummation of a merger of us with or into another entity if our capital stock represents less than 50% of the
voting power of the surviving entity or its parent, the acquisition by a person of 50% or more of our voting stock or subject to various exceptions, the individuals on our board of directors as of January&nbsp;1, 2009 constitute less than a majority
of our board of directors.<B></B> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If, upon a change of control, awards are assumed by the successor corporation, and a
participant is terminated without &#147;cause&#148; or for &#147;good reason&#148; at any time in the period 90 days prior to a change of control or before the first anniversary of the effective date of such change of control, then such
participant&#146;s awards will fully vest and/or become exercisable as of the later of the consummation of the change of control or the date of such participant&#146;s termination. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>2017 D<SMALL>IRECTOR</SMALL> C<SMALL>OMPENSATION</SMALL> T<SMALL>ABLE</SMALL> </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="17%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="13%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="9%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #465361;width:20pt ; display:inline;" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Fees Earned or<BR>Paid in
Cash<BR>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Restricted<BR>Stock
Awards<BR>($)(1)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #465361">
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Option<BR>Awards<BR>($)(1)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #465361">
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B><FONT STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive<BR>Plan<BR>Compensation<BR>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>All
Other<BR>Compensation<BR>($)</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Total<BR>($)</B></FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">B. Farley</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$50,000</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$44,384(2)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$94,384</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">G. Muir</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$21,235(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$21,235</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">141 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">The amounts reported represent the aggregate grant date fair value of the options to purchase shares of our common stock or restricted
stock awards granted to the director in 2017, calculated in accordance with the Financial Accounting Standard Board&#146;s ASC Topic 718. Such grant date fair value does not take into account any estimated forfeitures related to service-vesting
conditions. See Note <B>12</B> to our financial statements as included in this prospectus for the assumptions used in calculating the grant date fair value of the stock options reported in this column. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">As of December&nbsp;31, 2017, Mr.&nbsp;Farley held 15,783 shares of unvested restricted common stock and options to purchase 12,575
shares of common stock. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">As of December&nbsp;31, 2017, Mr. Muir held options to purchase 20,700&nbsp;shares of common stock. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Equity Benefit Plans </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>2003 Stock Incentive Plan </I></B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The 2003 Plan was
adopted by our board of directors and approved by our stockholders in April 2003 and amended and restated effective January&nbsp;1, 2009. The 2003 Plan provides for the grant of stock options, stock appreciation rights, restricted stock and dividend
equivalents to our employees, directors and consultants. As of March&nbsp;31, 2018, options to purchase 2,669,144 shares of our common stock remained outstanding under the 2003 Plan. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The 2003 Plan will be terminated on, and we will not make any further awards under the 2003 Plan following, the date on which grants may first be made under the 2018 Equity Incentive Plan,
or the 2018 Plan. However, any outstanding awards granted under the 2003 Plan will remain outstanding, subject to the terms of the 2003 Plan and award agreements, until such outstanding awards vest and are exercised (as applicable) or until they
terminate or expire by their terms. The material terms of the 2003 Plan are summarized below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Authorized Shares
</I></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">A maximum of 3,131,790 shares of our common stock may be issued under the 2003 Plan. If an award under the 2003 Plan
expires, terminates or is forfeited, any shares subject to such award may, to the extent of such expiration, termination or forfeiture, be used again for new grants under the 2003 Plan. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Plan Administration </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The compensation committee currently
administers the 2003 Plan and the awards granted thereunder. The plan administrator may select participants, grant awards, determine the terms and conditions of such awards, interpret the terms of the 2003 Plan and any award agreements and adopt
rules and procedures for the administration, interpretation and operation of the 2003 Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Awards </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The 2003 Plan provides for the discretionary grant of stock options, stock appreciation rights, restricted stock and dividend equivalents
to our employees, directors, advisors and consultants. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Stock Options. Stock options provide for the purchase of shares of our
common stock in the future at an exercise price set on the grant date. The exercise price of a stock option may not be less than 100% of the fair market value of the underlying share on the date of grant, except with respect to certain substitute
options granted in connection with a corporate transaction. The term of a stock option may not be longer than ten years. Vesting conditions are determined by the plan administrator. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Stock Appreciation Rights. Stock appreciation rights provide for a payment, or payments, in cash or shares of our common stock, to the holder based upon the difference between the fair
market value of our common stock on the date of exercise and the stated exercise price at grant up to a maximum amount of cash or number of shares. Stock appreciation rights may vest based on time or achievement of performance conditions.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">142 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Restricted Stock. Restricted stock is an award of nontransferable shares of our common
stock that remain forfeitable unless and until specified conditions are met. Conditions applicable to restricted stock may be based on continuing service, the attainment of performance goals and/or such other conditions as the plan administrator may
determine. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Dividend Equivalents. Dividend equivalents are a right extended to certain stock option holders that allow the
option holder to receive a payment, in shares or in cash, that is equivalent to the value of dividends paid on the shares subject to the option between the record date of the option and its exercise date. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Assignment and Transfers </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Except as provided in the 2003 Plan, any award agreement or as expressly authorized by the plan administrator, a participant may not transfer stock options issued under the 2003 Plan.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Change in Control </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Upon a change of control of the company (as defined in the 2003 Plan), if awards are not assumed or substituted with equivalent awards, the compensation committee may fully vest all
outstanding equity awards or cancel all equity awards and pay the participant the difference between the fair market value of the stock underlying the equity award and the exercise price or base price, if any, for such equity award. </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If, upon a change of control, awards are assumed by the successor corporation, and a participant is terminated without &#147;cause&#148;
or for &#147;good reason&#148; at any time in the period 90 days prior to a change of control or before the first anniversary of the effective date of such change of control, then such participant&#146;s awards will fully vest and/or become
exercisable as of the later of the consummation of the change of control or the date of such participant&#146;s termination. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Plan Amendment and Termination </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The 2003 Plan shall continue in effect for a term of ten years from its effective date. Notwithstanding the foregoing, our board of directors may at any time terminate, amend or modify the
2003 Plan subject to stockholder approval in certain circumstances. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>2017 Bonus Plan </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each of our Named Executive Officers and directors participated in our 2017 bonus plan, pursuant to which each was eligible to receive a
bonus based on our achievement of specified revenue and earnings objectives, as well as on the achievement of individual performance goals. For 2017, target bonuses were equal to 25% of each executive&#146;s annual base salary, except for our Chief
Executive Officer, whose target bonus was equal to 40% of his base salary, and our Chief Financial Officer, whose target bonus was equal to 30% of his base salary. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The actual annual cash bonuses paid to our executive officers and directors for performance in 2017 are set forth in the Summary Compensation Table above in the column titled <FONT
STYLE="white-space:nowrap">&#147;Non-Equity</FONT> Incentive Plan Compensation&#148;. We expect target bonus levels to remain the same under our 2018 bonus plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>2018 Equity Incentive Plan </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our board of directors
has adopted and our stockholders have approved prior to the completion of this offering the 2018 Plan. We do not expect to utilize our 2018 Plan until after the completion of this offering, at which point no further grants will be made under our
Amended and Restated 2003 Stock Incentive Plan, as amended, or 2003 Plan, as described above under &#147;2003 Stock Incentive Plan.&#148; No awards have been granted and no shares of our common stock have been issued under our 2018 Plan. </FONT></P>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">143 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Stock Awards.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The 2018 Plan provides for the grant
of incentive stock options within the meaning of Section&nbsp;422 of the Code, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance-based stock or cash awards, and other forms of
equity compensation, which are collectively referred to as other stock awards. Additionally, the 2018 Plan provides for the grant of performance cash awards. Incentive stock options may be granted only to employees of the Company or a &#147;parent
corporation&#148; or &#147;subsidiary corporation&#148; thereof (as such terms are defined in Sections 424(e) and 424(f) of the Code.). All other awards may be granted to employees, including officers, and
<FONT STYLE="white-space:nowrap">to&nbsp;non-employee&nbsp;directors</FONT> and consultants. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Share
Reserve.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Initially, the aggregate number of shares of our common stock that may be issued pursuant to stock awards under the 2018 Plan after the 2018 Plan becomes effective is the sum of (i)&nbsp;1,334,315 shares plus
(ii)&nbsp;the number of shares reserved, and remaining available for issuance, under our 2003 Plan at the time our 2018 Plan becomes effective and (iii)&nbsp;the number of shares subject to stock options or other stock awards granted under our 2003
Plan that would have otherwise returned to our 2003 Plan (such as upon the expiration or termination of a stock award prior to vesting). The number of shares of our common stock reserved for issuance under our 2018 Plan will automatically increase
on January&nbsp;1 of each year, beginning on January&nbsp;1, 2019 and continuing through and including January&nbsp;1, 2028, by 4% of the total number of shares of our capital stock outstanding on December&nbsp;31 of the preceding calendar year, or
a lesser number of shares determined by our board of directors. The maximum number of shares that may be issued upon the exercise of incentive stock options under our 2018 Plan is 4,200,000 shares. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If a stock award granted under the 2018 Plan expires or otherwise terminates without being exercised in full, or is settled in cash, the
shares of our common stock not acquired pursuant to the stock award again will become available for subsequent issuance under the 2018 Plan. In addition, the following types of shares under the 2018 Plan may become available for the grant of new
stock awards under the 2018 Plan: (1)&nbsp;shares that are forfeited to or repurchased by us prior to becoming fully vested; (2)&nbsp;shares withheld to satisfy income or employment withholding taxes; or (3)&nbsp;shares used to pay the exercise or
purchase price of a stock award. Shares issued under the 2018 Plan may be previously unissued shares or reacquired shares bought by us on the open market. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The maximum number of shares of common stock subject to stock awards granted under the 2018 Plan or otherwise during any one calendar year to any
<FONT STYLE="white-space:nowrap">non-employee</FONT> director, taken together with any cash fees paid by us to such <FONT STYLE="white-space:nowrap">non-employee</FONT> director during such calendar year for service on the board of directors, will
not exceed $400,000 in total value (calculating the value of any such stock awards based on the grant date fair value of such stock awards for financial reporting purposes), or, with respect to the calendar year in which a <FONT
STYLE="white-space:nowrap">non-employee</FONT> director is first appointed or elected to our board of directors, $600,000 . </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Administration.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors, or a duly authorized committee thereof, has the authority to administer the 2018 Plan. Our board of directors
may also delegate to one or more of our officers the authority to (1)&nbsp;designate employees (other than other officers) to be recipients of certain stock awards, (2)&nbsp;determine the number of shares of common stock to be subject to such stock
awards and (3)&nbsp;specify the other terms and conditions, including the strike price or purchase price and vesting schedule, applicable to such awards. Subject to the terms of the 2018 Plan, our board of directors or the authorized committee,
referred to as the plan administrator, determines recipients, dates of grant, the numbers and types of stock awards to be granted and the terms and conditions of the stock awards, including the period of their exercisability and vesting schedule
applicable to a stock award. Subject to the limitations set forth below, the plan administrator will also determine the exercise price, strike price or purchase price of awards granted and the types of consideration to be paid for the award.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The plan administrator has the authority to modify outstanding awards under our 2018 Plan. Subject to the terms of our 2018
Plan, the plan administrator has the authority, without stockholder approval, to </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">144 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
reduce the exercise, purchase or strike price of any outstanding stock award, cancel any outstanding stock award in exchange for new stock awards, cash or other consideration, or take any other
action that is treated as a repricing under generally accepted accounting principles, with the consent of any adversely affected participant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Stock Options.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Incentive and nonstatutory stock options are evidenced by stock option agreements adopted by the plan administrator. The plan
administrator determines the exercise price for a stock option, within the terms and conditions of the 2018 Plan, provided that the exercise price of a stock option generally cannot be less than 100% of the fair market value of our common stock on
the date of grant. Options granted under the 2018 Plan vest at the rate specified by the plan administrator. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The plan
administrator determines the term of stock options granted under the 2018 Plan, up to a maximum of ten years. Unless the terms of an option holder&#146;s stock option agreement provide otherwise, if an option holder&#146;s service relationship with
us, or any of our affiliates, ceases for any reason other than disability, death or cause, the option holder may generally exercise any vested options for a period of three months following the cessation of service. The option term will
automatically be extended in the event that exercise of the option following such a termination of service is prohibited by applicable securities laws or our insider trading policy. If an option holder&#146;s service relationship with us or any of
our affiliates ceases due to disability or death, or an option holder dies within a certain period following cessation of service, the option holder or a beneficiary may generally exercise any vested options for a period of 12 months in the event of
disability and 18 months in the event of death. In the event of a termination for cause, options generally terminate immediately. In no event may an option be exercised beyond the expiration of its term. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined by the plan
administrator and may include (1)&nbsp;cash, check, bank draft or money order, (2)&nbsp;a broker-assisted cashless exercise, (3)&nbsp;the tender of shares of our common stock previously owned by the option holder, (4)&nbsp;a net exercise of the
option if it is an nonqualified stock option and (5)&nbsp;other legal consideration approved by the plan administrator. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Unless the plan administrator provides otherwise, options generally are not transferable except by will, the laws of descent and
distribution, or pursuant to a domestic relations order. An option holder may designate a beneficiary, however, who may exercise the option following the option holder&#146;s death. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Tax Limitations on Incentive Stock Options.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The aggregate fair market value, determined at the time of grant, of our common stock with respect to
incentive stock options that are exercisable for the first time by an option holder during any calendar year under all of our stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will be treated as nonqualified
stock options. No incentive stock option may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our affiliates unless (1)&nbsp;the
option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant and (2)&nbsp;the term of the incentive stock option does not exceed five years from the date of grant. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Restricted Stock Awards.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Restricted stock awards are evidenced by restricted stock award agreements
adopted by the plan administrator. Restricted stock awards may be granted in consideration for (1)&nbsp;cash, check, bank draft or money order, (2)&nbsp;services rendered to us or our affiliates or (3)&nbsp;any other form of legal consideration.
Common stock acquired under a restricted stock award may, but need not, be subject to a share repurchase option in our favor in accordance with a vesting schedule as determined by the plan administrator. Rights to acquire shares under a restricted
stock award may be transferred only upon such terms and conditions as set by the plan administrator. Except as otherwise provided in the applicable award agreement, restricted stock unit awards that have not vested will be forfeited upon the
participant&#146;s cessation of continuous service for any reason. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">145 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Restricted Stock Unit Awards.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Restricted stock
unit awards evidenced by restricted stock unit award agreements adopted by the plan administrator. Restricted stock unit awards may be granted in consideration for any form of legal consideration or for no consideration. A restricted stock unit
award may be settled by cash, delivery of stock, a combination of cash and stock as deemed appropriate by the plan administrator, or in any other form of consideration set forth in the restricted stock unit award agreement. Additionally, dividend
equivalents may be credited in respect of shares covered by a restricted stock unit award. Rights under a restricted stock units award may be transferred only upon such terms and conditions as set by the plan administrator. Restricted stock unit
awards may be subject to vesting as determined by the plan administrator. Except as otherwise provided in the applicable award agreement, restricted stock units that have not vested will be forfeited upon the participant&#146;s cessation of
continuous service for any reason. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Stock Appreciation Rights.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Stock appreciation rights
are evidenced by stock appreciation grant agreements adopted by the plan administrator. The plan administrator determines the strike price for a stock appreciation right, which generally cannot be less than 100% of the fair market value of our
common stock on the date of grant. Upon the exercise of a stock appreciation right, we will pay the participant an amount in cash or stock equal to (1)&nbsp;the excess of the per share fair market value of our common stock on the date of exercise
over the strike price, multiplied by (2)&nbsp;the number of shares of common stock with respect to which the stock appreciation right is exercised. A stock appreciation right granted under the 2018 Plan vests at the rate specified in the stock
appreciation right agreement as determined by the plan administrator. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The plan administrator determines the term of stock
appreciation rights granted under the 2018 Plan, up to a maximum of ten years. Unless the terms of a participant&#146;s stock appreciation right agreement provides otherwise, if a participant&#146;s service relationship with us or any of our
affiliates ceases for any reason other than cause, disability or death, the participant may generally exercise any vested stock appreciation right for a period of three months following the cessation of service. The stock appreciation right term
will be further extended in the event that exercise of the stock appreciation right following such a termination of service is prohibited by applicable securities laws. If a participant&#146;s service relationship with us, or any of our affiliates,
ceases due to disability or death, or a participant dies within a certain period following cessation of service, the participant or a beneficiary may generally exercise any vested stock appreciation right for a period of 12 months in the event of
disability and 18 months in the event of death. In the event of a termination for cause, stock appreciation rights generally terminate immediately upon the occurrence of the event giving rise to the termination of the individual for cause. In no
event may a stock appreciation right be exercised beyond the expiration of its term. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Unless the plan administrator provides
otherwise, stock appreciation rights generally are not transferable except by will, the laws of descent and distribution, or pursuant to a domestic relations order. A stock appreciation right holder may designate a beneficiary, however, who may
exercise the stock appreciation right following the holder&#146;s death. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Performance
Awards.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The 2018 Plan permits the grant of performance-based stock and cash awards. The performance goals that may be selected include one or more of the following criteria: (1)&nbsp;earnings (including earnings per
share and net earnings); (2) earnings before interest, taxes and depreciation; (3)&nbsp;earnings before interest, taxes, depreciation and amortization; (4)&nbsp;total stockholder return; (5)&nbsp;return on equity or average stockholder&#146;s
stockholders&#146; equity; (6)&nbsp;return on assets, investment, or capital employed; (7)&nbsp;stock price; (8)&nbsp;margin (including gross margin); (9) income (before or after taxes); (10) operating income; (11)&nbsp;operating income after taxes;
<FONT STYLE="white-space:nowrap">(12)&nbsp;pre-tax</FONT> profit; (13)&nbsp;operating cash flow; (14)&nbsp;sales or revenue targets; (15)&nbsp;increases in revenue or product revenue; (16)&nbsp;expenses and cost reduction goals;
(17)&nbsp;improvement in or attainment of working capital levels; (18)&nbsp;economic value added (or an equivalent metric); (19) market share; (20)&nbsp;cash flow; (21)&nbsp;cash flow per share; (22)&nbsp;share price performance; (23)&nbsp;debt
reduction; (24)&nbsp;customer satisfaction; (25)&nbsp;stockholders&#146; equity; (26)&nbsp;capital expenditures; (27)&nbsp;debt levels; (28)&nbsp;operating profit or net operating profit; (29)&nbsp;workforce diversity;
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">146 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
(30)&nbsp;growth of net income or operating income; (31)&nbsp;billings; (32) <FONT STYLE="white-space:nowrap">pre-clinical</FONT> development related compound goals; (33)&nbsp;financing; (34)
regulatory milestones, including approval of a compound; (35)&nbsp;stockholder liquidity; (36)&nbsp;corporate governance and compliance; (37)&nbsp;product commercialization; (38)&nbsp;intellectual property; (39)&nbsp;personnel matters;
(40)&nbsp;progress of internal research or clinical programs; (41)&nbsp;progress of partnered programs; (42)&nbsp;partner satisfaction; (43)&nbsp;budget management; (44)&nbsp;clinical achievements; (45)&nbsp;completing phases of a clinical study
(including the treatment phase); (46) announcing or presenting preliminary or final data from clinical studies; in each case, whether on particular timelines or generally; (47)&nbsp;timely completion of clinical trials; (48)&nbsp;submission of INDs
and NDAs and other regulatory achievements; (49)&nbsp;partner or collaborator achievements; (50)&nbsp;internal controls, including those related to the Sarbanes-Oxley Act of 2002; (51) research progress, including the development of programs;
(52)&nbsp;investor relations, analysts and communication; (53)&nbsp;manufacturing achievements (including obtaining particular yields from manufacturing runs and other measurable objectives related to process development activities); (54) strategic
partnerships or transactions (including <FONT STYLE="white-space:nowrap">in-licensing</FONT> and <FONT STYLE="white-space:nowrap">out-licensing</FONT> of intellectual property); (55) establishing relationships with commercial entities with respect
to the marketing, distribution and sale of the Company&#146;s products (including with group purchasing organizations, distributors and other vendors); (56) supply chain achievements (including establishing relationships with manufacturers or
suppliers of active pharmaceutical ingredients and other component materials and manufacturers of the Company&#146;s products); (57) <FONT STYLE="white-space:nowrap">co-development,</FONT> <FONT STYLE="white-space:nowrap">co-marketing,</FONT> profit
sharing, joint venture or other similar arrangements; (58)&nbsp;individual performance goals; (59)&nbsp;corporate development and planning goals; and (60)&nbsp;other measures of performance selected by our board of directors or a committee thereof.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The performance goals may be based on company-wide performance or performance of one or more business units, divisions,
affiliates, or business segments, and may be either absolute or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise in the award agreement at the time the
award is granted or in such other document setting forth the performance goals at the time the goals are established, we will appropriately make adjustments in the method of calculating the attainment of performance goals as follows: (1)&nbsp;to
exclude restructuring and/or other nonrecurring charges; (2)&nbsp;to exclude exchange rate effects; (3)&nbsp;to exclude the effects of changes to generally accepted accounting principles; (4)&nbsp;to exclude the effects of any statutory adjustments
to corporate tax rates; (5)&nbsp;to exclude the effects of any items that are unusual in nature or occur infrequently as determined under generally accepted accounting principles; (6)&nbsp;to exclude the dilutive effects of acquisitions or joint
ventures; (7)&nbsp;to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture; (8)&nbsp;to exclude the effect of any change in the
outstanding shares of common stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination or exchange of
shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (9)&nbsp;to exclude the effects of stock based compensation and the award of bonuses under the Company&#146;s bonus plans;
(10)&nbsp;to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; (11)&nbsp;to exclude the goodwill and intangible asset impairment charges
that are required to be recorded under generally accepted accounting principles; and (12)&nbsp;to exclude the effect of any other unusual, nonrecurring gain or loss or other extraordinary item. In addition, we retain the discretion to adjust or
eliminate the compensation or economic benefit due upon attainment of the goals. The performance goals may differ from participant to participant and from award to award. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Other Stock Awards.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The plan administrator may grant other awards based in whole or in part by reference to or otherwise based on our common stock. The
plan administrator will set the number of shares under the stock award and all other terms and conditions of such awards. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">147 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Changes to Capital Structure.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;In the event that
there is a specified type of change in our capital structure, such as a stock split or recapitalization, appropriate adjustments will be made to (1)&nbsp;the class and maximum number of shares reserved for issuance under the 2018 Plan, (2)&nbsp;the
class and maximum number of shares by which the share reserve may increase automatically each year, (3)&nbsp;the class and number of shares that may be issued upon the exercise of incentive stock options and (4)&nbsp;the class and number of shares
and exercise price, strike price, or purchase price, if applicable, of all outstanding stock awards. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Corporate
Transactions.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;In the event of certain specified significant corporate transactions, the plan administrator has the discretion to take any of the following actions with respect to stock awards: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">arrange for the assumption, continuation or substitution of a stock award by a surviving or acquiring entity or parent company;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">arrange for the assignment of any reacquisition or repurchase rights held by us to the surviving or acquiring entity or parent company;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">accelerate the vesting of the stock award and provide for its termination prior to the effective time of the corporate transaction;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">arrange for the lapse of any reacquisition or repurchase right held by us; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">cancel or arrange for the cancellation of the stock award in exchange for such cash consideration, if any, as our board of directors
may deem appropriate or for no consideration; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">make a payment equal to the excess of (1)&nbsp;the value of the property the participant would have received upon exercise of the stock
award over (2)&nbsp;the exercise price or strike price otherwise payable in connection with the stock award. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our plan administrator is not obligated to treat all stock awards, even those that are of the same type, in the same manner. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Under the 2018 Plan, a significant corporate transaction is generally the consummation of (1)&nbsp;a sale or other disposition of all or
substantially all of our consolidated assets, (2)&nbsp;a sale or other disposition of at least 50% of our outstanding securities, (3)&nbsp;a merger, consolidation or similar transaction following which we are not the surviving corporation or
(4)&nbsp;a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of
the transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Change in Control.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;The plan administrator may provide, in an individual
award agreement or in any other written agreement between a participant and us that the stock award will be subject to additional acceleration of vesting and exercisability or settlement in the event of a change in control. Under the 2018 Plan, a
change in control is generally (1)&nbsp;the acquisition by a person or entity of more than 50% of our combined voting power other than by merger, consolidation or similar transaction, (2)&nbsp;a consummated merger, consolidation or similar
transaction immediately after which our stockholders cease to own more than 50% of the combined voting power of the surviving entity, (3)&nbsp;a consummated sale, lease or exclusive license or other disposition of all or substantially all of our
consolidated assets and (4)&nbsp;certain dissolutions, liquidations and changes in the board of directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Amendment
and Termination.</I></B>&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors has the authority to amend, suspend, or terminate our 2018 Plan, provided that such action does not materially impair the existing rights of any participant without such
participant&#146;s written consent and provided further that certain types of amendments will require the approval of our stockholders. No incentive stock options may be granted after the tenth anniversary of the date our board of directors adopts
our 2018 Plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">148 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>2018 Employee Stock Purchase Plan </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our board has adopted and our stockholders have approved our 2018 Employee Stock Purchase Plan, or 2018 ESPP. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Share Reserve</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;The maximum number of shares of our common stock that may be issued under our 2018
ESPP is 243,699 shares. Additionally, the number of shares of our common stock reserved for issuance under our 2018 ESPP will automatically increase on January&nbsp;1 of each year, beginning on January&nbsp;1, 2019 and continuing through and
including January&nbsp;1, 2028, by the lesser of (1) 1% of the total number of shares of our common stock outstanding on December&nbsp;31 of the preceding calendar year, (2) 487,399 shares of our common stock or (3)&nbsp;such lesser number of shares
of common stock as determined by our board of directors. Shares subject to purchase rights granted under our 2018 ESPP that terminate without having been exercised in full will not reduce the number of shares available for issuance under our 2018
ESPP. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Administration</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors, or a duly authorized committee
thereof, will administer our 2018 ESPP. Our board of directors has delegated its authority to administer our 2018 ESPP to our compensation committee under the terms of the compensation committee&#146;s charter. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Limitations</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;Our employees, including executive officers, and the employees of any of our designated
affiliates will be eligible to participate in our 2018 ESPP, provided they may have to satisfy one or more of the following service requirements before participating in our 2018 ESPP, as determined by the administrator: (1)&nbsp;customary employment
with us or one of our affiliates for more than 20 hours per week and five or more months per calendar year or (2)&nbsp;continuous employment with us or one of our affiliates for a minimum period of time, not to exceed two years, prior to the first
date of an offering. An employee may not be granted rights to purchase stock under our 2018 ESPP (a)&nbsp;if such employee immediately after the grant would own stock possessing 5% or more of the total combined voting power or value of all classes
of our common stock or (b)&nbsp;to the extent that such rights, when aggregated with other employee stock purchase plan rights would accrue at a rate that exceeds $25,000 worth of our stock for each calendar year that the rights remain outstanding.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our 2018 ESPP is intended to qualify as an employee stock purchase plan under Section&nbsp;423 of the Code. The administrator
may specify offerings with a duration of not more than 27 months, and may specify one or more shorter purchase periods within each offering. Each offering will have one or more purchase dates on which shares of our common stock will be purchased for
the employees who are participating in the offering. The administrator, in its discretion, will determine the terms of offerings under our 2018 ESPP. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">A participant may not transfer purchase rights under our 2018 ESPP other than by will, the laws of descent and distribution or as otherwise provided under our 2018 ESPP. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Payroll Deductions</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;Our 2018 ESPP permits participants to purchase shares of our common stock
through payroll deductions up to 15% of their earnings. Unless otherwise determined by the administrator, the purchase price of the shares will be 85% of the lower of the fair market value of our common stock on the first day of an offering or on
the date of purchase. Participants may end their participation within a time period established by the administrator and will be paid their accrued contributions that have not yet been used to purchase shares. Participation ends automatically upon
termination of employment with us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Corporate Transactions</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;In the event of certain
specified significant corporate transactions, such as a merger or change in control, a successor corporation may assume, continue or substitute each outstanding purchase right. If the successor corporation does not assume, continue or substitute for
the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">149 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
outstanding purchase rights, the offering in progress will be shortened and a new exercise date will be set within ten business days prior to such corporate transaction. The participants&#146;
purchase rights will be exercised on the new exercise date and such purchase rights will terminate immediately thereafter. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Amendment and Termination</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;Our board of directors has the authority to amend, suspend or terminate
our 2018 ESPP, at any time and for any reason, provided certain types of amendments will require the approval of our stockholders. Our 2018 ESPP will remain in effect until terminated by our board of directors in accordance with the terms of our
2018 ESPP. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Limitation on Liability and Indemnification of Directors and Officers </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our amended and restated certificate of incorporation, which will be effective upon completion of this offering, limits our
directors&#146; liability to the fullest extent permitted under Delaware corporate law. Delaware corporate law provides that directors of a corporation will not be personally liable for monetary damages for breach of their fiduciary duties as
directors, except for liability: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">for any transaction from which the director derives an improper personal benefit; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">for any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">under Section&nbsp;174 of the Delaware General Corporation Law (unlawful payment of dividends or redemption of shares); or
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">for any breach of a director&#146;s duty of loyalty to the corporation or its stockholders. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If the Delaware General Corporation Law is amended to authorize corporate action further eliminating or limiting the personal liability
of directors, then the liability of our directors shall be eliminated or limited to the fullest extent permitted by the Delaware General Corporation Law, as so amended. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Delaware law and our amended and restated bylaws, which will be effective upon completion of this offering, provide that we will, in certain situations, indemnify our directors and
officers and may indemnify other employees and other agents, to the fullest extent permitted by law. Any indemnified </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">person is
also entitled, subject to certain limitations, to payment or reimbursement of reasonable expenses (including attorneys&#146; fees and disbursements) in advance of the final disposition of the proceeding. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We maintain a directors&#146; and officers&#146; insurance policy pursuant to which our directors and officers are insured against
liability for certain actions taken in their capacities as directors and officers. We believe that these provisions in our amended and restated certificate of incorporation and amended and restated bylaws and this insurance policy are necessary to
attract and retain qualified persons as directors and officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Insofar as indemnification for liabilities arising under the
Securities Act, may be permitted to directors, officers or control persons, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">150 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_14"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY
TRANSACTIONS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>The following includes a summary of transactions since January&nbsp;1, 2015 to which we have been a
party, in which the amount involved in the transaction exceeded $120,000, and in which any of our directors, executive officers or, to our knowledge, beneficial owners of more than 5% of our voting securities or any member of the immediate family of
any of the foregoing persons had or will have a direct or indirect material interest, other than described below and the equity and other compensation agreements that are described under &#147;Executive and Director Compensation.&#148;
</I></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Convertible Preferred Stock Financings </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Series F Preferred Stock Financing</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;In April 2015, we issued and sold to investors in private placements an aggregate of 102,334,194 shares of our
Series F convertible preferred stock at a purchase price of $0.3356 per share, for aggregate consideration of $34.3&nbsp;million, including approximately $18.6&nbsp;million in principal and accrued interest under our convertible notes that were
issued in 2014 and converted into shares of Series F convertible preferred stock, which we refer to as our 2014 notes. Our 2014 notes accrued interest at a rate of 10%, compounding monthly. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Series G Preferred Stock Financing</I></B>.&nbsp;&nbsp;&nbsp;&nbsp;In June 2017, we issued and sold to investors in private placements an aggregate of 40,584,416 shares of our Series
G convertible preferred stock at a purchase price of $0.3696 per share, for aggregate consideration of $15.0&nbsp;million. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The table below sets forth the number of shares of our Series F and Series G convertible preferred stock purchased by our executive
officers, directors, holders of more than 5% of our capital stock and their affiliated entities or immediate family members. Each share of our convertible preferred stock in the table below will automatically convert into shares of our common stock
immediately prior to the closing of this offering in accordance with our Certificate of Incorporation, including adjustments in connection with the reverse stock split of our common stock effected in June 2018. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="89%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:40pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Participants</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Shares of<BR>Series F<BR>Convertible<BR>Preferred<BR>Stock</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Series F<BR>Convertible<BR>Preferred&nbsp;Stock<BR>Aggregate<BR>Purchase
Price</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Shares of<BR>Series G<BR>Convertible<BR>Preferred<BR>Stock</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Series G<BR>Convertible<BR>Preferred&nbsp;Stock<BR>Aggregate<BR>Purchase
Price</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>5% or Greater Stockholders</B></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Entities affiliated with Investor Growth Capital, LLC</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14,955,168</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,018,954</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,247,768</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">830,775</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Onset IV, L.P.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,108,153</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,056,696</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,251,033</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">462,382</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Entities affiliated with InterWest Partners</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,163,940</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,739,818</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,291,234</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">477,240</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Entities affiliated with Three Arch Partners</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,079,014</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,711,317</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,248,185</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">461,329</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">New Leaf Ventures II, L.P.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12,222,657</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,101,924</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,933,174</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">714,501</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Entities affiliated with Polaris Venture Partners</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,567,206</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12)</SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,203,954</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,033,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">381,889</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">GE Ventures Limited</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,797,378</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT>
<FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,000,001</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,116,883</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">CHV IV, L.P.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">21,645,022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Additional details regarding these stockholders and their equity holdings are provided in this prospectus under the caption
&#147;Principal Stockholders.&#148; </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Represents securities acquired by IGC Fund VI, L.P. Mr. Campe, a member of our board of directors, is affiliated with Investor Growth
Capital, LLC </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Represents securities acquired by InterWest Partners VIII, L.P., InterWest Investors VIII, L.P. and InterWest Investors Q VIII, L.P.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Represents securities acquired by Three Arch Partner IV, L.P., Three Arch Associates IV, L.P., Three Arch Capital, L.P. and TAC
Associates, L.P. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Mr.&nbsp;Hunt, a member of our board of directors, is affiliated with New Leaf Ventures II, L.P. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>footnotes continued on following page </I></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">151 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Represents securities acquired by Polaris Venture Partners V, L.P., Polaris Venture Partners Entrepreneurs&#146; Fund V, L.P., Polaris
Venture Partners Special Founders&#146; Fund V, L.P. and Polaris Venture Partners Founders&#146; Fund V, L.P. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Includes 11,081,508 shares of Series F convertible preferred stock issued upon conversion of an aggregate amount of $3,718,954.41 in
principal and accrued interest of the 2014 notes. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Includes 6,117,269 shares of Series F convertible preferred stock issued upon conversion of an aggregate amount of $2,052,955.73 in
principal and accrued interest of the 2014 notes. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Includes 6,432,955 shares of Series F convertible preferred stock issued upon conversion of an aggregate amount of $2,158,899.72 in
principal and accrued interest of the 2014 notes. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Includes 6,421,612 shares of Series F convertible preferred stock issued upon conversion of an aggregate amount of $2,155,093.10 in
principal and accrued interest of the 2014 notes. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Includes 9,631,109 shares of Series F convertible preferred stock issued upon conversion of an aggregate amount of $3,232,200.37 in
principal and accrued interest of the 2014 notes. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Includes 5,184,981 shares of Series F convertible preferred stock issued upon conversion of an aggregate amount of $1,740,079.91 in
principal and accrued interest of the 2014 notes. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Investors&#146; Rights Agreement </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We entered into an amended and restated investors&#146; rights agreement, or the IRA, in June 2017 with the holders of our preferred
stock, including certain of our directors and entities to which certain of our directors are related. The agreement provides these holders the right, subject to the terms of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements entered into
in connection with this offering, to demand that we file a registration statement or request that their shares be covered by a registration statement that we are otherwise filing. See &#147;Description of Capital Stock&#151;Registration Rights&#148;
for additional information. The agreement also provides these holders pro rata participation rights, information rights and, in some cases, board observer rights, which will terminate upon completion of this offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Stockholders&#146; Agreement </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We entered into an amended and restated stockholders&#146; agreement, or the Stockholders&#146; Agreement, in June 2017 with the holders of our preferred stock, including certain of our
directors and entities in which certain of our directors are related. The agreement provides that each stockholder party to the Stockholders&#146; Agreement shall vote their shares to maintain the size and membership of our board of directors as set
forth therein. The agreement also provides the stockholders party to the Stockholders&#146; Agreement with rights of first refusal and co-sale in connection with certain sales by specified stockholders of the company.&nbsp;The shares of common stock
and preferred stock held by stockholders party to the Stockholder Agreement are also subject to certain drag-along rights set forth therein. The Stockholders&#146; Agreement will terminate upon the completion of this offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Employment Agreements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have entered into an employment agreement or offer letters with our named executive officers, which are filed as exhibits to the registration statement of which this prospectus forms a
part. For more information regarding these agreements, see &#147;Executive and Director Compensation&#151;Employment Agreements&#148; and &#147;Executive and Director Compensation&#151;Executive Officer Post-Employment Compensation
Arrangements.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Indemnification Agreements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have entered or will enter into indemnification agreements with each of our directors and executive officers, the form of which is filed as an exhibit to the registration statement of
which this prospectus forms a part. These agreements, among other things, will require us to indemnify each director (and in certain cases their related venture capital funds) and executive officer to the fullest extent permitted by Delaware law,
including indemnification of expenses such as attorneys&#146; fees, judgments, fines and settlement amounts incurred by the director or executive officer in any action or proceeding, including any action or proceeding by or in right of us, arising
out of the person&#146;s services as a director or executive officer, as the case may be. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">152 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Stock Option Grants to Executive Officers and Directors </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have granted stock options to our named executive officers as more fully described in the section titled &#147;Executive and Director
Compensation.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Policies and Procedures for Transactions with Related Persons </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Prior to this offering, we have not had a formal policy regarding approval of transactions with related parties. Prior to the pricing of
this offering, we expect to adopt a related person transaction policy that sets forth our procedures for the identification, review, consideration and approval or ratification of related person transactions. The policy will become effective
immediately upon the effectiveness of the registration statement of which this prospectus is a part. For purposes of our policy only, a &#147;related person transaction&#148; is a transaction, arrangement or relationship, or any series of similar
transactions, arrangements or relationships, in which we and any related person are, were or will be participants in which the amount involved exceeds $120,000. Transactions involving compensation for services provided to us as an employee or
director are not covered by this policy. A &#147;related person&#148; is any executive officer, director or beneficial owner of more than 5% of any class of our voting securities, including any of their immediate family members and any entity owned
or controlled by such persons. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Under the policy, if a transaction has been identified as a related person transaction,
including any transaction that was not a related person transaction when originally consummated or any transaction that was not initially identified as a related person transaction prior to consummation, our management must present information
regarding the related person transaction to our audit committee or, if audit committee approval would be inappropriate, to another independent body of our board of directors, for review, consideration and approval or ratification. The presentation
must include a description of, among other things, the material facts, interests, direct and indirect, of the related persons, benefits to us of the transaction and whether the transaction is on terms that are comparable to the terms available to or
from, as the case may be, an unrelated third party or to or from employees generally. Under the policy, we will collect information that we deem reasonably necessary from each director, executive officer and, to the extent feasible, significant
stockholder to enable us to identify any existing or potential related-person transactions and to effectuate the terms of the policy. In addition, under our Code of Conduct that we expect to adopt prior to the completion of this offering, our
employees and directors will have an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest. In considering related person transactions, our audit committee, or
other independent body of our board of directors, will take into account the relevant available facts and circumstances including, but not limited to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the risks, costs and benefits to us; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the impact on a director&#146;s independence in the event that the related person is a director, immediate family member of a director
or an entity with which a director is affiliated; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the availability of other sources for comparable services or products; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the terms available to or from, as the case may be, unrelated third parties or to or from employees generally.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The policy requires that, in determining whether to approve, ratify or reject a related person transaction,
our audit committee, or other independent body of our board of directors, must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, our best interests and those of our stockholders, as our audit
committee, or other independent body of our board of directors, determines in the good faith exercise of its discretion.</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">153 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_15"></A>PRINCIPAL STOCKHOLDERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table sets forth information regarding beneficial ownership of our common stock as of May&nbsp;31, 2018 by: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our common stock;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">each of our named directors and executive officers, individually; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">all of our directors and executive officers as a group. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The beneficial ownership of our common stock is determined in accordance with the rules of the SEC and generally includes any shares of common stock over which a person exercises sole or
shared voting or investment power, or the right to receive the economic benefit of ownership. For purposes of the table below, we deem common stock issuable pursuant to options and warrants that are currently exercisable or exercisable within 60
days of May&nbsp;31, 2018 to be outstanding and to be beneficially owned by the person holding the options for the purposes of computing the percentage ownership of that person, but we do not treat them as outstanding for the purpose of computing
the percentage ownership of any other person. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The percentage of common stock beneficially owned has been computed on the
basis of 11,252,047 shares of common stock outstanding as of May&nbsp;31, 2018. The table below does not reflect any shares of our common stock that our directors, officers or other stockholders named below may purchase in this offering, including
through the directed share program or otherwise, as described in the &#147;Underwriting&#148; section of this prospectus. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">154 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Unless otherwise noted below, the address of each stockholder, director and executive
officer is c/o Neuronetics, Inc., 3222 Phoenixville Pike, Malvern, Pennsylvania 19355. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="61%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Number&nbsp;and&nbsp;Percentage&nbsp;of<BR>Common&nbsp;Stock&nbsp;Beneficially<BR>Owned
Prior to Offering</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Percentage&nbsp;of&nbsp;Common<BR>Stock&nbsp;Beneficially&nbsp;Owned<BR>After the
Offering</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:89pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Name of beneficial owner</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Assuming&nbsp;no<BR>Exercise of<BR>Option<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(20) </SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Assuming<BR>Full<BR>Exercise&nbsp;of<BR>Option<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(20) </SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Number</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Percent</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>5% or greater stockholders:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:1px; margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Entities affiliated with Investor Growth Capital,&nbsp;LLC</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,794,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Onset IV, L.P.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">998,609</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Entities affiliated with InterWest Partners</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,030,689</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">New Leaf Ventures II, L.P.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,543,115</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">13.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9.5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Entities affiliated with Polaris Venture Partners</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">824,765</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">GE Ventures Limited</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,308,041</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">CHV IV, L.P.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">746,753</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">QPIV, LLC</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">628,769</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Directors and executive officers:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Christopher Thatcher</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">583,846</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Peter Donato</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">36,940</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Daniel Guthrie</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gregory Harper</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">38,100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Yelena Tropsha</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(13)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Stephen Campe</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(14)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Brian Farley</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(15) </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">110,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Paulina Hill</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(16)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Ronald Hunt</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(17)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,543,115</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">13.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9.5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Wilfred Jaeger, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(18)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Glenn Muir</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(19)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,175</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">All executive officers and directors as a group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,317,614</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">19.4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">13.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">13.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
</TABLE>  <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Indicates beneficial ownership of less than 1% of the shares of common stock outstanding </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of (i) 840,511 shares of common stock issuable upon conversion of convertible preferred stock held by Investor Growth Capital
Limited (&#147;Investor Limited&#148;), (ii) 360,217 shares of common stock issuable upon conversion of convertible preferred stock held by Investor Group, L.P. (&#147;Investor Group&#148;), and (iii) 593,500 shares of common stock issuable upon
conversion of convertible preferred stock held by IGC Fund VI, L.P. (&#147;IGC Fund&#148;). Investor Limited is a wholly-owned subsidiary of Investor Group; Investor Growth Capital, LLC (&#147;Investor Growth&#148;) is the general partner of each of
Investor Group and IGC Fund. Investor Growth is controlled by a Board of Directors consisting of Michael V. Oporto, Noah Walley and Lennart Johansson. Investor Growth is deemed to share voting and investment power over the shares held by Investor
Limited, Investor Group, and IGC Fund. The address of the foregoing entities is c/o Patricia Industries, 1177 Avenue of the Americas, 47th Floor, New York, New York 10036. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of 998,609 shares of common stock issuable upon conversion of preferred stock. Onset IV Management, LLC is the general partner
of Onset IV, L.P. Robert F. Kuhling, Jr. and Terry L. Opdendyk are managing directors of Onset IV Management, LLC, the general partner of Onset IV, L.P., and have shared voting and investment power over the shares owned by Onset IV, L.P. The address
of Onset IV, L.P. is 2400 Sand Hill Road, Suite 150, Menlo Park, California 94025. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of (i) 994,315 shares of common stock issuable upon conversion of convertible preferred stock held by InterWest Partners VIII,
L.P., (ii) 7,932 shares of common stock issuable upon conversion of convertible preferred stock held by InterWest Investors VIII, L.P. and (iii) 28,442 shares of common stock issuable upon conversion of convertible preferred stock held by InterWest
Investors Q VIII, L.P. InterWest Management Partners VIII, LLC is the general partner of the entities in this footnote. Philip T. Gianos, W. Stephen Holmes, Gilbert H. Kliman and Arnold L. Oronsky are the managing directors of InterWest Management
Partners VIII, LLC and share voting and investment power with respect to the shares held by the InterWest entities. The address of the InterWest entities is c/o InterWest Partners, 2710 Sand Hill Road, Suite 200, Menlo Park, California 94025.
</FONT></P></TD></TR></TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>footnotes continued on following page </I></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">155 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of 1,543,115 shares of common stock issuable upon conversion of convertible preferred stock. New Leaf Venture Management II
L.L.C. is the general partner of New Leaf Venture Associates II L.P., which in turn is the general partner of New Leaf Ventures II, L.P. Ronald M. Hunt, Vijay Lathi and Liam Ratclifte are the individual managers of New Leaf Venture Management
L.L.C., and they may be deemed to have shared power to vote and dispose of the shares held by New Leaf Ventures&nbsp;II, L.P. Ronald Hunt is a member of our Board of Directors. The address of this fund is 7 Times Square, Suite 3502, New York, NY
10036. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of (i) 795,849 shares of common stock issuable upon conversion of convertible preferred stock held by Polaris Venture Partners
V, L.P. (&#147;PVP V&#148;), (ii)&nbsp;15,509 shares of common stock issuable upon conversion of convertible preferred stock held by Polaris Venture Partners Entrepreneurs&#146; Fund V, L.P. (&#147;PVPEF V&#148;), (iii) 7,957 shares of common stock
issuable upon conversion of convertible preferred stock held by Polaris Venture Partners Special Founders&#146; Fund V, L.P. (&#147;PVPSF&nbsp;V&#148;), and (iv)&nbsp;5,450 shares of common stock issuable upon conversion of convertible preferred
stock held by Polaris Venture Partners Founders&#146; Fund V, L.P. (&#147;PVPFF&nbsp;V,&#148; and together with PVP&nbsp;V, PVPEF&nbsp;V and PVPSF&nbsp;V, the &#147;Polaris Funds&#148;). Polaris Venture Management Co. III, LLC
(&#147;PVM&nbsp;V&#148;), the general partner of the entities in this footnote, may be deemed to have sole power to vote and dispose of the shares held by the Polaris Funds. Each of Jonathan Flint and Terrance McGuire are the managing members of
PVM&nbsp;V and may be deemed to have shared power to vote and dispose of the shares held by the Polaris Funds. The address of the Polaris Funds is One Marina Park Drive, 10th Floor, Boston, Massachusetts 02210. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of 1,308,041 shares of common stock issuable upon conversion of convertible preferred stock. GE Ventures Limited exercises
voting and investment power over shares held by it. GE Ventures Limited is an indirect, wholly-owned subsidiary of General Electric Company, a public company. The address of GE Ventures Limited is 2882 Sand Hill Road, Suite 240, Menlo Park, CA
94025. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of 746,753 shares of common stock issuable upon conversion of convertible preferred stock. Ascension Ventures&nbsp;IV, LLC is
the general partner of CHV&nbsp;IV, L.P. Ascension Ventures&nbsp;IV, LLC is governed by a Board of Managers, which has authority to invest and vote the shares held by CHV&nbsp;IV, L.P. Signatory, and voting authority has been delegated to
Matthew&nbsp;I. Hermann, Senior Managing Director of Ascension Ventures&nbsp;IV, LLC. Decisions regarding liquidation of investment positions have been delegated by the Board to Anthony&nbsp;J. Speranzo, Executive Vice President and Chief Financial
Officer, Ascension, and Matthew&nbsp;I. Hermann, Senior Managing Director, Ascension Ventures&nbsp;IV, LLC, acting jointly. The address for each of the individuals and entities listed above is Ascension Ventures, 101&nbsp;South Hanley Road,
Suite&nbsp;200, Clayton, MO 63105. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of 628,769 shares of common stock issuable upon conversion of convertible preferred stock. QPIV, LLC is managed by Quaker
BioVentures Management, LLC, the Executive Managers of which are Richard Kollender, Sherrill Neff and Adele Oliva, who have shared voting and investment power over the shares held by QPIV, LLC. The address of QPIV, LLC is c/o Quaker Partners
Management, Cira Centre, 2929 Arch Street, Philadelphia, Pennsylvania 19104. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of 583,846 shares of common stock issuable upon exercise of outstanding options. Does not include 232,894 shares of common
stock issuable upon exercise of outstanding options which have not yet vested. Pursuant to a Stock Option Transfer Agreement, Mr. Thatcher has agreed to transfer options to purchase 374,255 shares of our common stock to his wife in connection with
their divorce. In addition, Mrs. Thatcher has agreed to sign a lock-up agreement with respect to such transferred options. The transfer of such options is conditioned upon entering of the divorce decree with the applicable court and is anticipated
to occur after the completion of this offering. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of 36,940 shares of common stock issuable upon exercise of outstanding options. Does not include 115,269 shares of common
stock issuable upon exercise of outstanding options which have not yet vested. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Does not include 99,819 shares of common stock issuable upon exercise of outstanding options which have not yet vested or an award of
restricted stock units representing 40,233 shares of our common stock which have not yet vested. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of 38,100 shares of common stock issuable upon exercise of outstanding options. Does not include 75,724 shares of common stock
issuable upon exercise of outstanding options which have not yet vested. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(13)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Does not include 84,010 shares of common stock issuable upon exercise of outstanding options which have not yet vested.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(14)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Does not include 8,767 shares of common stock issuable upon exercise of outstanding options which have not yet vested.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(15)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of (i)&nbsp;65,921 shares of common stock, (ii) 34,856 shares of common stock issuable upon conversion of convertible
preferred stock and (iii)&nbsp;9,661 shares of restricted common stock. Does not include 10,959 shares of common stock issuable upon exercise of outstanding options which have not yet vested. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(16)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Dr. Hill is affiliated with the investment manager of the Polaris Funds but does not have any voting or dispositive power with respect
to the shares owned by the Polaris Funds referenced in footnote (5) above. Does not include 8,767 shares of common stock issuable upon exercise of outstanding options which have not yet vested. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(17)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of beneficial ownership of shares held by New Leaf Ventures II, L.P. described in footnote (4) above. Does not include 8,767
shares of common stock issuable upon exercise of outstanding options which have not yet vested. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(18)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Does not include 8,767 shares of common stock issuable upon exercise of outstanding options which have not yet vested.
</FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(19)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Consists of 5,175 shares of common stock issuable upon exercise of outstanding options. Does not include 24,292 shares of common stock
issuable upon exercise of outstanding options which have not yet vested. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(20)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Underwriters&#146; option to purchase an additional 750,000 shares of common stock, as set out on the cover page of this prospectus.
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">156 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_16"></A>DESCRIPTION OF CAPITAL STOCK
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>The following description summarizes some of the terms of our amended and restated certificate of incorporation and
amended and restated bylaws to be effective following the completion of this offering, our outstanding warrants, our amended and restated investors&#146; rights agreement, and the General Corporation Law of the State of Delaware. Because it is only
a summary, it does not contain all of the information that may be important to you. For a complete description, you should also refer to our amended and restated certificate of incorporation, amended and restated bylaws, warrants, and amended and
restated investors&#146; rights agreement, which are filed as exhibits to the registration statement of which this prospectus is part, as well as the relevant provisions of the General Corporation Law of the State of Delaware. </I></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>General </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Upon the completion of this offering, our amended and restated certificate of incorporation will authorize us to issue up to 200,000,000 shares of common stock, $0.01 par value per share,
and 10,000,000 shares of preferred stock, $0.01 par value per share, all of which shares of preferred stock will be undesignated. Our board of directors may establish the rights and preferences of the preferred stock from time to time. As of
March&nbsp;31, 2018, we had outstanding 251,278 shares of common stock, including 12,823 </FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">shares of unvested restricted common stock subject to repurchase by us, held by 99&nbsp;stockholders of record. As of March&nbsp;31, 2018, after giving effect to the conversion of all of
the outstanding shares of our preferred stock into 10,994,280 shares of common stock, there would have been 11,245,558 shares of common stock issued and outstanding, held by 135 stockholders of record. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Common Stock </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Voting Rights </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each holder of our common stock is entitled
to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors. Under our amended and restated certificate of incorporation and amended and restated bylaws, which will become effective upon
consummation of this offering, our stockholders will not have cumulative voting rights. Because of this, the holders of a majority of the shares of common stock entitled to vote in any election of directors can elect all of the directors standing
for election, if they should so choose. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Dividends </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Subject to preferences that may be applicable to any then-outstanding preferred stock, holders of common stock are entitled to receive ratably those dividends, if any, as may be declared
from time to time by the board of directors out of legally available funds. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Liquidation </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the event of our liquidation, dissolution or winding up, holders of common stock will be entitled to share ratably in the net assets
legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then-outstanding shares of preferred stock. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Rights and Preferences </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Holders of common stock have no preemptive, conversion or subscription rights and there are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences
and privileges of the holders of common stock are subject to, and may be adversely affected by, the right of the holders of shares of any series of preferred stock that we may designate in the future. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">157 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Preferred Stock </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of March&nbsp;31, 2018, there were 304,958,337 shares of convertible preferred stock outstanding, consisting of 4,800,000 shares of Series <FONT STYLE="white-space:nowrap">A-1</FONT>
convertible preferred stock, 25,384,615 shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, 17,000,000 shares of Series B convertible preferred stock, 20,958,084 shares of Series C convertible preferred stock,
49,426,229 shares of Series D convertible preferred stock, 44,470,799 shares of Series E convertible preferred stock, 102,334,194 shares of Series F convertible preferred stock and 40,584,416 shares of Series G convertible preferred stock. All
currently outstanding shares of preferred stock will convert automatically into 10,994,280 shares of common stock upon completion of this offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Following the closing of this offering, our board of directors will have the authority under our amended and restated certificate of incorporation, without further action by our
stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the rights, preferences and privileges of the shares of each
wholly unissued series and any qualifications, limitations or restrictions thereon, and to increase or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the
voting power or other rights of the holders of our common stock. The purpose of authorizing our board of directors to issue preferred stock and determine its rights and preferences is to eliminate delays associated with a stockholder vote on
specific issuances. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in
control of us and may adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock. It is not possible to state the actual effect of the issuance of any shares of preferred stock on the
rights of holders of common stock until the board of directors determines the specific rights attached to that preferred stock. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have no present plans to issue any shares of preferred stock following completion of this offering. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Warrants </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In December 2012, we issued a preferred stock warrant to Comerica Bank, which was immediately exercisable for an aggregate 402,461 shares
of our Series E convertible preferred stock at an exercise price of $0.6746 per share. This warrant remains outstanding. The holder of this warrant may exercise it, at its election, by check, by wire transfer of
<FONT STYLE="white-space:nowrap">same-day</FONT> funds, or other form of payment acceptable to the Company. The shares underlying the warrant are considered registrable securities for purposes of our amended and restated investors&#146; rights
agreement, or the IRA, and accordingly are entitled to registration rights as described below under &#147;&#151;Registration Rights.&#148; The warrant expires on December&nbsp;20, 2022 if not earlier exercised. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In February 2014, we issued a preferred stock warrant to purchase an aggregate of 878,298 Series E convertible preferred shares at an
exercise price of $0.6746 per share to Oxford Finance LLC, which was later exchanged for warrants that are immediately exercisable for an aggregate of 878,298&nbsp;shares of our Series F convertible preferred stock at an exercise price of $0.3356
per share. This warrant remains outstanding. The holder of this warrant may exercise it, at its election, by cashless exercise, by check, by wire transfer of <FONT STYLE="white-space:nowrap">same-day</FONT> funds, or other form of payment acceptable
to us. The warrants includes a provision requiring the holder to sign a joinder to the IRA at the time the warrant is exercised, such that the shares underlying the warrant would be considered registrable securities for the purposes of the IRA. The
warrant expires on February&nbsp;18, 2021 if not earlier exercised. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">158 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In August 2016, March 2017 and December 2017, we issued preferred stock warrants to
Oxford Finance LLC, each of which was immediately exercisable for 588,498 shares of our Series F convertible preferred stock at an exercise price of $0.3356 per share. Each of these warrants remains outstanding. The holder of these warrants may
exercise either warrant, at its election, by cashless exercise, by check, by wire transfer of same-day funds, or other form of payment acceptable to us. The warrants include a provision requiring the holder to sign a joinder to the IRA at the time
such warrant is exercised, such that the shares underlying the warrants would be considered registrable securities for the purposes of the IRA. The August 2016, March 2017 and December 2017 warrants expire on August 31, 2023, March 28, 2024 and
December 27, 2024, respectively, if not earlier exercised. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The outstanding warrants which are currently exercisable to
purchase shares of our Series E or Series F preferred stock, upon the completion of this offering will become warrants to purchase shares of our common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Options </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of March&nbsp;31, 2018, there were
outstanding options under our equity compensation plans to purchase an aggregate of 2,669,144 shares of our common stock, with a weighted-average exercise price of $2.63 per share. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Registration Rights </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We and the beneficial owners of our
preferred stock have entered into the IRA. The registration rights provisions of this agreement provide those holders with demand and piggyback registration rights with respect to their shares of our common stock, including common stock issuable
upon conversion of our preferred stock in connection with this offering, which we refer to herein as registrable shares. After registration pursuant to these rights, such shares of common stock will become freely tradable without restriction under
the Securities Act. The IRA restricts us from granting additional registration rights to any other party without the consent of 60% of the holders of registrable securities unless such additional registration rights are no more favorable than those
in the IRA. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Demand Registration Rights </I></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">At any time beginning 180 days following the effective date of the registration statement of which this prospectus is a part, the holders of at least 20% of the registrable shares who are
party to the IRA, voting as a single class, have the right to demand that we file a registration statement for the registration of their shares of common stock. These registration rights are subject to specified conditions and limitations, including
the right of a managing underwriter to limit the number of shares included in any such registration under specified circumstances. Upon such a request, we are required to effect the registration as expeditiously as possible. An aggregate of
10,994,280 shares of common stock will be entitled to these demand registration rights upon the consummation of this offering. We are not obligated to file a registration statement pursuant to this provision on more than two occasions (unless such
registration statement was not declared effective by the SEC). </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Piggyback Registration Rights </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If we propose to register any of our common stock under the Securities Act, either for our own account or for the account of other
stockholders, other than pursuant to certain specified registrations (including relating to company stock option plans), the holders of registrable shares will each be entitled to notice of the registration and will be entitled to include their
registrable shares in the related registration statement. These piggyback registration rights are subject to specified conditions and limitations, including the right of a managing underwriter to limit the number of shares included in any such
registration under specified circumstances. An aggregate of 10,994,280 shares of common stock will be entitled to these piggyback registration rights upon the consummation of this offering. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">159 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Registration on Form <FONT STYLE="white-space:nowrap">S-3</FONT> </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">At any time after the 90</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"> day following the date our registration statement becomes effective, and subject to the lock-up
agreements entered into in connection with this offering, holders of our registrable shares who are parties to the IRA have the right to demand that we file a registration statement on Form <FONT STYLE="white-space:nowrap">S-3,</FONT> and holders of
such shares will be entitled, upon their written request, to have such shares registered by us on a Form <FONT STYLE="white-space:nowrap">S-3</FONT> registration statement at our expense, provided that such requested registration has an anticipated
aggregate offering size to the public of at least $2.0&nbsp;million, and subject to other specified conditions and limitations. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the event that any registration in which the holders of registrable shares participate pursuant to our IRA is an underwritten public
offering, we agree to enter into an underwriting agreement containing customary terms for such offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Expenses of
Registration </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are required to pay all expenses, including fees and expenses of one counsel to represent the selling
stockholders, relating to any demand, piggyback or Form <FONT STYLE="white-space:nowrap">S-3</FONT> registration, other than underwriting discounts and commissions and stock transfer taxes, subject to specified conditions and limitations.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The IRA contains customary cross-indemnification provisions, pursuant to which we are obligated to indemnify the selling
stockholders in the event of material misstatements or omissions in the applicable registration statement attributable to us, and the selling stockholders are obligated to indemnify us for material misstatements or omissions in the registration
statement attributable to them, subject to certain limitations. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Termination of Registration Rights </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We may not terminate the registration rights granted under the IRA without the consent of holders of at least 60% of the registrable
shares who are party to the IRA. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Anti-takeover Provisions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Section&nbsp;203 of the Delaware General Corporation Law </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are subject to Section&nbsp;203 of the Delaware General Corporation Law, which prohibits a Delaware corporation from engaging in any
business combination with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">before such date, the board of directors of the corporation approved either the business combination or the transaction that resulted
in the stockholder becoming an interested stockholder; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder
owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder,
those shares owned (i)&nbsp;by persons who are directors and also officers and (ii)&nbsp;employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered
in a tender or exchange offer; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of
the stockholders, and not by written consent, by the affirmative vote of at least 66<FONT SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&nbsp;2</SUP></FONT><FONT SIZE="2">/</FONT><FONT SIZE="1"><SUB
STYLE="vertical-align:baseline; position:relative; top:.1ex">3</SUB></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">% of the outstanding voting stock that is not owned by the interested stockholder.
</FONT></FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">160 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In general, Section&nbsp;203 defines a &#147;business combination&#148; to include the
following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">any merger or consolidation involving the corporation or any direct or indirect majority-owned subsidiary of the corporation and the
interested stockholder; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder
(in one transaction or a series of transactions); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation or by any direct or indirect
majority-owned subsidiary of the corporation of any stock of the corporation or of such subsidiary to the interested stockholder; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">any transaction involving the corporation or any direct or indirect majority-owned subsidiary of the corporation that has the effect of
increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits by or
through the corporation. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In general, Section&nbsp;203 defines an &#147;interested stockholder&#148; as an
entity or person who, together with the person&#146;s affiliates and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the
corporation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Provisions in our amended and restated certificate of incorporation and our amended and restated bylaws that will become effective upon
the completion of this offering may discourage, delay or prevent a merger, acquisition or other change in control that stockholders may consider favorable, including transactions in which stockholders might otherwise receive a premium for their
shares. In addition, these provisions may frustrate or prevent any attempt by our stockholders to replace or remove our current management by making it more difficult to replace or remove our board of directors. These provisions include: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">a prohibition on stockholder action through written consent; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">no cumulative voting in the election of directors; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of the board of directors
or the resignation, death or removal of a director; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">a requirement that special meetings of stockholders be called only by the board of directors, the chairman of the board of directors,
the chief executive officer or, in the absence of a chief executive officer, the president; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">an advance notice requirement for stockholder proposals and nominations; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the authority of our board of directors to issue preferred stock with such terms as our board of directors may determine; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">a requirement of approval of not less than 66 2/3% of all outstanding shares of our capital stock entitled to vote to amend any bylaws
by stockholder action, or to amend specific provisions of our amended and restated certificate of incorporation. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Choice of Forum </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our restated certificate will provide that
the Court of Chancery of the State of Delaware will be the exclusive forum for: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">any derivative action or proceeding brought on our behalf; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">161 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">any action asserting a breach of fiduciary duty; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">any action asserting a claim against us arising pursuant to the Delaware General Corporation Law, our restated certificate, or our
amended and restated bylaws; or </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">any action asserting a claim against us that is governed by the internal affairs doctrine. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Our amended and restated certificate of incorporation further provides that the federal district courts of the United States of America
will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The enforceability of similar choice of forum provisions in other companies&#146; certificates of incorporation has been challenged in
legal proceedings, and it is possible that, in connection with any action, a court could find the choice of forum provisions contained in our restated certificate to be inapplicable or unenforceable in such action. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Transfer Agent and Registrar </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The transfer agent and registrar for our common stock is American Stock Transfer &amp; Trust Company, LLC. The transfer agent&#146;s address is 6201 15th Avenue, Brooklyn, New York 11219
and its telephone number is (800) 937-5449. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Stock Exchange Listing </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have applied to list our common stock on the Nasdaq Global Market under the trading symbol &#147;STIM.&#148; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">162 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_17"></A>SHARES ELIGIBLE FOR FUTURE SALE
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Prior to this offering, no public market existed for our common stock. Future sales of our common stock in the public
market, or the availability of such shares for sale in the public market, could adversely affect market prices prevailing from time to time. As described below, only a limited number of shares will be available for sale shortly after this offering
due to contractual and legal restrictions on resale. Nevertheless, sales of our common stock in the public market after such restrictions lapse, or the perception that those sales may occur, could adversely affect the prevailing market price at such
time and our ability to raise equity capital in the future. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Based on the number of shares outstanding as of
March&nbsp;31, 2018, upon the closing of this offering and assuming no exercise of the underwriters&#146; option to purchase additional shares, 16,245,558 shares of common stock will be outstanding, after giving effect to the automatic conversion of
all outstanding shares of our convertible preferred stock into 10,994,280 shares of common stock upon the closing of this offering. All of the shares of common stock sold in this offering will be freely tradable without restrictions or further
registration under the Securities Act, except for any shares sold to our &#147;affiliates,&#148; as that term is defined under Rule 144 under the Securities Act. The remaining 11,245,558 shares of common stock held by existing stockholders are
&#147;restricted securities,&#148; as that term is defined in Rule 144 under the Securities Act. Restricted securities may be sold in the public market only if registered or if their resale qualifies for exemption from registration described below
under Rule 144 promulgated under the Securities Act or another available exemption. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As a result of the <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements described below and the provisions of Rules 144 and 701 under the Securities Act, the shares of common stock that will be deemed restricted securities after this offering will be available for
sale in the public market as follows: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">none of the existing restricted shares will be eligible for immediate sale upon the completion of this offering; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">substantially all of the 11,245,558 restricted shares will be eligible for sale in the public market upon expiration of <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements 180 days after the date of this prospectus, subject in certain circumstances to the volume, manner of sale and other limitations under Rule 144 and Rule&nbsp;701 under the Securities Act, which
are summarized below. </FONT></P></TD></TR></TABLE>  <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><FONT STYLE="white-space:nowrap">Lock-up</FONT> agreements </B></FONT></P>
 <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For the period ending 180 days after the date of this prospectus, we have agreed not to, without the consent of the representatives,
and our executive officers and directors and substantially all of our security holders have agreed not to, without the consent of Piper Jaffray &amp; Co., subject to limited exceptions: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">offer, pledge, announce the intention to sell, sell or contract to sell any shares of our common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">sell any option or contract to purchase any shares of our common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">purchase any option or contract to sell any shares of our common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">grant any option, right or warrant to purchase any shares of our common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">make any short sale or otherwise transfer or dispose of any shares of our common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">enter into any swap or other agreement that transfers, in whole or in part, the economic consequences of ownership of any shares of our
common stock whether any such swap or transaction is to be settled by delivery of shares or other securities, in cash or otherwise </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">make demand for or exercise any right with respect to the registration statement of our common stock; or </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">publicly announce the intention to do any of the foregoing. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">163 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Piper Jaffray&nbsp;&amp; Co. and William Blair &amp; Company, L.L.C. may, as
applicable in its or their sole discretion and at any time or from time to time before the termination of the <FONT STYLE="white-space:nowrap">180-day</FONT> period, without public notice, release all or any portion of the securities subject to <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements. There are no existing agreements between the underwriters and any of our stockholders who will execute a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement providing consent to the sale of
shares prior to the expiration of the restricted period. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Upon the expiration of the
<FONT STYLE="white-space:nowrap">lock-up</FONT> period, all of the shares subject to such <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions will become eligible for sale, subject to the limitations discussed above. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, at our request, the underwriters have reserved up to 250,000 shares of common stock, or approximately 5% of the shares
offered by this prospectus, for sale, at the initial public offering price, to our directors, officers and current investors. Shares purchased by our directors and officers will be subject to the 180-day lock-up restriction described above and in
the &#145;&#145;Underwriting&#146;&#146; section of this prospectus. Accordingly, the number of shares freely transferable upon completion of this offering will be reduced by the number of reserved shares purchased by our directors or officers, and
there will be a corresponding increase in the number of shares that become eligible for sale after 180 days from the date of this prospectus. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Rule 144 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In general,
<FONT STYLE="white-space:nowrap">non-affiliate</FONT> persons who have beneficially owned restricted shares of our common stock for at least six months, and any of our affiliates who owns either restricted or unrestricted shares of our common stock,
are entitled to sell their securities without registration with the SEC under an exemption from registration provided by Rule 144 under the Securities Act. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I><FONT STYLE="white-space:nowrap">Non-affiliates</FONT> </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Any
person who is not deemed to have been one of our affiliates at the time of, or at any time during the three months preceding, a sale may sell an unlimited number of restricted securities under Rule&nbsp;144 if: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the restricted securities have been held for at least six months, including the holding period of any prior owner other than one of our
affiliates (subject to certain exceptions); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">we have been subject to the Exchange Act periodic reporting requirements for at least 90&nbsp;days before the sale; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">we are current in our Exchange Act reporting at the time of sale. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Any person who is not deemed to have been an affiliate of ours at the time of, or at any time during the three months preceding, a sale
and has held the restricted securities for at least one year, including the holding period of any prior owner other than one of our affiliates, will be entitled to sell an unlimited number of restricted securities without regard to the length of
time we have been subject to Exchange Act periodic reporting or whether we are current in our Exchange Act reporting. <FONT STYLE="white-space:nowrap">Non-affiliate</FONT> resales are not subject to the manner of sale, volume limitation or notice
filing provisions of Rule 144. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Affiliates </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Persons seeking to sell restricted securities who are our affiliates at the time of, or any time during the three months preceding, a sale, would be subject to the restrictions described
above. They are also subject to additional restrictions, by which such person would be required to comply with the manner of sale and notice provisions of Rule 144 and would be entitled to sell within any three-month period only that number of
securities that does not exceed the greater of either of the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1% of the number of shares of our common stock then outstanding, which will equal approximately 162,456&nbsp;shares immediately after
the completion of this offering based on the number of shares outstanding as of March&nbsp;31, 2018; or </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">164 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the average weekly trading volume of our common stock on the stock exchange on which our shares are listed during the four calendar
weeks preceding the filing of a notice on Form&nbsp;144 with respect to the sale. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Additionally, persons who
are our affiliates at the time of, or any time during the three months preceding, a sale may sell unrestricted securities under the requirements of Rule 144 described above, without regard to the six month holding period of Rule 144, which does not
apply to sales of unrestricted securities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Rule 701 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Rule 701 under the Securities Act, as in effect on the date of this prospectus, permits resales of shares in reliance upon Rule 144 but without compliance with certain restrictions of Rule
144, including the holding period requirement. Most of our employees, executive officers or directors who purchased shares under a written compensatory plan or contract may be entitled to rely on the resale provisions of Rule 701, but all holders of
Rule 701 shares are required to wait until 90 days after the date of this prospectus before selling their shares. However, all such shares are subject to <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements as described below and in the
section titled &#147;Underwriting&#148; and will become eligible for sale upon the expiration of the restrictions set forth in those agreements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Equity Plans </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We intend to file one or more registration
statements on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities Act to register all shares of common stock subject to outstanding stock options issued or issuable and common stock issuable under our stock plans. We expect to file
the registration statement covering shares offered pursuant to our stock plans shortly after the date of this prospectus, permitting the resale of such shares by nonaffiliates in the public market without restriction under the Securities Act and the
sale by affiliates in the public market, subject to compliance with the resale provisions of Rule 144. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Registration Rights
</B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Upon the closing of this offering, the holders of 11,099,375 shares of our common stock, including common stock
issuable upon the conversion of our preferred stock, or their transferees, and common stock issuable upon the exercise of outstanding warrants, will be entitled to specified rights with respect to the registration of their registrable shares under
the Securities Act, subject to certain limitations and the expiration, waiver or termination of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements. Registration of these shares under the Securities Act would result in the shares becoming
freely tradable without restriction under the Securities Act immediately upon effectiveness of the registration. See &#147;Description of Capital Stock&#151;Registration Rights&#148; for additional information. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">165 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_18"></A>MATERIAL U.S. FEDERAL INCOME TAX
CONSEQUENCES TO <FONT STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following summary describes the material
U.S. federal income tax consequences of the acquisition, ownership and disposition of our common stock acquired in this offering by <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders (as defined below).&nbsp;This discussion is not a complete
analysis of all potential U.S. federal income tax consequences relating thereto, and does not deal with foreign, state and local consequences that may be relevant to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders in light of their
particular circumstances, nor does it address U.S. federal tax consequences (such as gift and estate taxes) other than income taxes.&nbsp;Special rules different from those described below may apply to certain
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders that are subject to special treatment under the Internal Revenue Code of 1986, as amended (or the Code), such as financial institutions, insurance companies,
<FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations, broker-dealers and traders in securities, U.S. expatriates, &#147;controlled foreign corporations,&#148; &#147;passive foreign investment companies,&#148; corporations that accumulate
earnings to avoid U.S. federal income tax, corporations organized outside of the United States, any state thereof or the District of Columbia that are nonetheless treated as United States income taxpayers for United States federal tax purposes,
persons that hold our common stock as part of a &#147;straddle,&#148; &#147;hedge,&#148; &#147;conversion transaction,&#148; &#147;synthetic security&#148; or integrated investment or other risk reduction strategy, persons who acquire our common
stock through the exercise of an option or otherwise as compensation, persons subject to the alternative minimum tax or federal Medicare contribution tax on net investment income, persons subject to special tax accounting rules as a result of any
item of gross income with respect to our common stock being taken into account in an &#147;applicable financial statement&#148; (as defined in the Code), partnerships and other pass-through entities or arrangements, and investors in such
pass-through entities or arrangements. Such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders are urged to consult their own tax advisors to determine the U.S. federal, state, local and other tax consequences that may be relevant to
them.&nbsp;Furthermore, the discussion below is based upon the provisions of the Code, and Treasury regulations, rulings and judicial decisions thereunder as of the date hereof, and such authorities may be repealed, revoked or modified, perhaps
retroactively, so as to result in U.S. federal income tax consequences different from those discussed below.&nbsp;We have not requested a ruling from the U.S. Internal Revenue Service, or IRS, with respect to the statements made and the conclusions
reached in the following summary, and there can be no assurance that the IRS will agree with such statements and conclusions.&nbsp;This discussion assumes that the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder holds our common stock as a
&#147;capital asset&#148; within the meaning of Section&nbsp;1221 of the Code (generally, property held for investment). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Persons considering the purchase of our common stock pursuant to this offering should consult their own tax advisors concerning the U.S.
federal income, estate and other tax consequences of acquiring, owning and disposing of our common stock in light of their particular situations as well as any consequences arising under the laws of any other taxing jurisdiction, including any
state, local or foreign tax consequences. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For the purposes of this discussion, a
<FONT STYLE="white-space:nowrap">&#147;Non-U.S.</FONT> Holder&#148; is, for U.S. federal income tax purposes, a beneficial owner of common stock that is neither a U.S. Holder, nor a partnership (or other entity treated as a partnership for U.S.
federal income tax purposes regardless of its place of organization or formation).&nbsp;A &#147;U.S. Holder&#148; means a beneficial owner of our common stock that is for U.S. federal income tax purposes any of the following: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">an individual who is a citizen or resident of the United States; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">a corporation or other entity treated as a corporation for U.S. federal income tax purposes created or organized in or under the laws
of the U.S., any state thereof or the District of Columbia; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">an estate the income of which is subject to U.S. federal income taxation regardless of its source; or </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">166 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">a trust if it (1)&nbsp;is subject to the primary supervision of a court within the U.S. and one or more U.S. persons have the authority
to control all substantial decisions of the trust or (2)&nbsp;has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Distributions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Distributions, if any, made on our common
stock to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder to the extent made out of our current or accumulated earnings and profits (as determined under U.S. federal income tax principles) generally will constitute dividends for U.S. tax
purposes and will be subject to withholding tax at a 30% rate or such lower rate as may be specified by an applicable income tax treaty, subject to the discussion below regarding effectively connected income and foreign accounts.&nbsp;To obtain a
reduced rate of withholding under a treaty, a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder generally will be required to provide us with a properly executed IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> (in the case of
individuals) or IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (in the case of entities), or other appropriate form, including a U.S. taxpayer identification number, or in certain circumstances, a
foreign tax identifying number, and certifying the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s entitlement to benefits under that treaty. This certification must be provided to us or our paying agent prior to the payment of
dividends and must be updated periodically. In the case of a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that is an entity, Treasury Regulations and the relevant tax treaty provide rules to determine whether, for purposes of determining
the applicability of a tax treaty, dividends will be treated as paid to the entity or to those holding an interest in that entity.&nbsp;If a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder holds stock through a financial institution or other
agent acting on the holder&#146;s behalf, the holder will be required to provide appropriate documentation to such agent.&nbsp;The holder&#146;s agent will then be required to provide certification to us or our paying agent, either directly or
through other intermediaries.&nbsp;If you are eligible for a reduced rate of U.S. federal withholding tax under an income tax treaty and you do not timely file the required certification, you may be able to obtain a refund or credit of any excess
amounts withheld by timely filing an appropriate claim for a refund with the IRS. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We generally are not required to withhold
tax on dividends paid to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that are effectively connected with the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s conduct of a trade or business within the United States. (and,
if required by an applicable income tax treaty, are attributable to a permanent establishment that such holder maintains in the United States) if a properly executed IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8ECI,</FONT> stating that the
dividends are so connected, is furnished to us (or, if stock is held through a financial institution or other agent, to such agent).&nbsp;In general, such effectively connected dividends will be subject to U.S. federal income tax, on a net income
basis at the regular graduated rates applicable to U.S. residents.&nbsp;A corporate <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder receiving effectively connected dividends may also be subject to an additional &#147;branch profits
tax,&#148; which is imposed, under certain circumstances, at a rate of 30% (or such lower rate as may be specified by an applicable treaty) on the corporate <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s effectively connected
earnings and profits, subject to certain adjustments. <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders should consult their tax advisors regarding any applicable income tax treaties that may provide for different rules. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">To the extent distributions on our common stock, if any, exceed our current and accumulated earnings and profits, they will first reduce
the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s adjusted basis in our common stock, but not below zero, and then will be treated as gain to the extent of any excess, and taxed in the same manner as gain realized from a sale or
other disposition of common stock as described in the next section. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Gain on Disposition of Our Common Stock
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Subject to the discussion below regarding backup withholding and foreign accounts, a
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder generally will not be subject to U.S. federal income tax with respect to gain realized on a sale or other disposition of our common stock unless (a)&nbsp;the gain is effectively connected with
a trade or business of such holder in the United States (and, if required by an applicable income tax treaty, is attributable to a permanent establishment that such holder maintains in the United States), (b)&nbsp;the
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder is a </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">167 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
nonresident alien individual and is present in the United States for 183 or more days in the taxable year of the disposition and certain other conditions are met or (c)&nbsp;we are or have been a
&#147;United States real property holding corporation&#148; within the meaning of Code Section&nbsp;897(c)(2) at any time within the shorter of the five-year period preceding such disposition or such holder&#146;s holding period.&nbsp;In general, we
would be a U.S. real property holding corporation if interests in U.S. real estate comprise (by fair market value) at least half of our business assets.&nbsp;We believe that we have not been and we are not, and do not anticipate becoming, a U.S.
real property holding corporation.&nbsp;Even if we are treated as a U.S. real property holding corporation, gain realized by a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder on a disposition of our common stock will not be subject to U.S.
federal income tax so long as (1)&nbsp;the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder owned, directly, indirectly and constructively, no more than five percent of our common stock at all times within the shorter of (i)&nbsp;the
five-year period preceding the disposition or (ii)&nbsp;the holder&#146;s holding period and (2)&nbsp;our common stock is regularly traded on an established securities market. There can be no assurance that our common stock will continue to qualify
as regularly traded on an established securities market. If any gain on your disposition is taxable because we are a United States real property holding corporation and your ownership of our common stock exceeds 5%, you will be taxed on such
disposition generally in the manner applicable to U.S. persons. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">If you are a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT>
Holder described in (a)&nbsp;above, you will be required to pay tax on the net gain derived from the sale at regular graduated U.S. federal income tax rates, and corporate <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders described in
(a)&nbsp;above may be subject to the additional branch profits tax at a 30% rate or such lower rate as may be specified by an applicable income tax treaty.&nbsp;Gain described in (b)&nbsp;above will be subject to U.S. federal income tax at a flat
30% rate or such lower rate as may be specified by an applicable income tax treaty, which gain may be offset by certain U.S.-source capital losses (even though you are not considered a resident of the U.S.), provided that the <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder has timely filed U.S. federal income tax returns with respect to such losses. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Information Reporting Requirements and Backup Withholding </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Generally, we must report information to the IRS with respect to any dividends we pay on our common stock (even if the payments are exempt from withholding), including the amount of any
such dividends, the name and address of the recipient, and the amount, if any, of tax withheld.&nbsp;A similar report is sent to the holder to whom any such dividends are paid.&nbsp;Pursuant to tax treaties or certain other agreements, the IRS may
make its reports available to tax authorities in the recipient&#146;s country of residence. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Dividends paid by us (or our
paying agents) to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder may also be subject to U.S. backup withholding.&nbsp;U.S. backup withholding generally will not apply to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder who
provides a properly executed IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN,</FONT> IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E,</FONT></FONT> or IRS Form <FONT STYLE="white-space:nowrap">W-ECI,</FONT>
or otherwise establishes an exemption. Notwithstanding the foregoing, backup withholding may apply if the payor has actual knowledge, or reason to know, that the holder is a U.S. person who is not an exempt recipient. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">U.S. information reporting and backup withholding requirements generally will apply to the proceeds of a disposition of our common stock
effected by or through a U.S. office of any broker, U.S. or foreign, except that such information reporting and backup withholding requirements may be avoided if the holder provides a properly executed IRS
<FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or otherwise meets documentary evidence requirements for establishing <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> person status or otherwise establishes an exemption.&nbsp;Generally, U.S. information reporting and backup withholding requirements will not apply to a payment of disposition proceeds to a <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder where the transaction is effected outside the U.S. through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> broker.&nbsp;Information
reporting and backup withholding requirements may, however, apply to a payment of disposition proceeds if the broker has actual knowledge, or reason to know, that the holder is, in fact, a U.S. person.&nbsp;For information reporting and backup
withholding purposes, certain brokers with substantial U.S. ownership or operations will generally be treated in a manner similar to U.S. brokers. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">168 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Backup withholding is not an additional tax. Any amounts withheld under the backup
withholding rules may be credited against the tax liability of persons subject to backup withholding, provided that the required information is timely furnished to the IRS. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Foreign Accounts </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sections 1471 through 1474 of the Code
(commonly referred to as FATCA) impose a U.S. federal withholding tax of 30% on certain payments, including dividends paid on and the gross proceeds of a disposition of our common stock paid to a foreign financial institution (as specifically
defined by applicable rules) unless such institution enters into an agreement with the U.S. government to withhold on certain payments and to collect and provide to the U.S. tax authorities substantial information regarding U.S. account holders of
such institution (which includes certain equity holders of such institution, as well as certain account holders that are foreign entities with U.S. owners).&nbsp;FATCA also generally imposes a federal withholding tax of 30% on certain payments,
including dividends paid on and the gross proceeds of a disposition of our common stock to a <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity unless such entity provides the withholding agent with either a certification that it
does not have any substantial direct or indirect U.S. owners or provides information regarding substantial direct and indirect U.S. owners of the entity.&nbsp;An intergovernmental agreement between the United States and an applicable foreign country
may modify those requirements. The withholding tax described above will not apply if the foreign financial institution or <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity otherwise qualifies for an exemption from the
rules.&nbsp;Holders are encouraged to consult with their own tax advisors regarding the possible implications of FATCA on their investment in our common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The withholding provisions described above currently apply to payments of dividends, and will apply to payments of gross proceeds from a sale or other disposition of common stock on or
after January&nbsp;1, 2019. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>EACH PROSPECTIVE INVESTOR SHOULD CONSULT ITS OWN TAX ADVISOR REGARDING THE TAX CONSEQUENCES OF
PURCHASING, HOLDING AND DISPOSING OF OUR COMMON STOCK, INCLUDING THE CONSEQUENCES OF ANY PROPOSED CHANGE IN APPLICABLE LAW. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">169 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_19"></A>UNDERWRITING </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Piper Jaffray&nbsp;&amp; Co. and William Blair &amp; Company, L.L.C. are acting as representatives of each of the underwriters named
below. Subject to the terms and conditions set forth in an underwriting agreement among us and the underwriters, we have agreed to sell to the underwriters, and each of the underwriters has agreed, severally and not jointly, to purchase from us, the
number of shares of our common stock set forth opposite its name below. </FONT></P>  <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="84%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:45pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Underwriters</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Number<BR>of&nbsp;Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Piper Jaffray&nbsp;&amp; Co.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">William Blair&nbsp;&amp; Company, L.L.C.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Canaccord Genuity LLC</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">BTIG, LLC</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">JMP Securities LLC</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Subject to the terms and conditions set forth in the underwriting agreement, the underwriters have
agreed, severally and not jointly, to purchase all of the shares sold under the underwriting agreement if any of these shares are purchased. If an underwriter defaults, the underwriting agreement provides that the purchase commitments of the
nondefaulting underwriters may be increased or the underwriting agreement may be terminated. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The underwriters have
reserved up to 250,000 shares of common stock, or approximately 5% of the shares offered by this prospectus, for sale, at the initial offering price, to our directors, officers and current investors in a directed share program. The number of shares
available for sale to the general public in the offering will be reduced to the extent these persons purchase the reserved shares. Any reserved shares that are not purchased under this program will be offered by the underwriters to the general
public on the same terms as the other shares offered by this prospectus. Shares purchased by our directors and officers will be subject to the 180-day lock-up restriction described below in &#147;&#151;No Sales of Similar Securities.&#148;
</FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have agreed to indemnify the several underwriters against certain liabilities, including liabilities under the
Securities Act relating to losses or claims resulting from material misstatements in or omissions from this prospectus, the registration statement of which this prospectus is a part, certain free writing prospectuses that may be used in the offering
and in any marketing materials used in connection with this offering and to contribute to payments the underwriters may be required to make in respect of those liabilities. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Discounts and Commissions </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The representatives have
advised us that the underwriters propose initially to offer the shares to the public at the public offering price set forth on the cover page of this prospectus and to dealers at that price less a concession not in excess of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. After a bona fide offering of the shares of our common stock at the initial public offering price, the public offering price, concession or
any other term of this offering may be changed. The underwriters reserve the right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">170 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table shows the public offering price, underwriting discount and
proceeds, before expenses, to us. The information assumes either no exercise or full exercise by the underwriters of their option to purchase additional shares. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="63%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Per&nbsp;Share</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Without<BR>Option</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>With<BR>Option</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Public Offering Price</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Underwriting Discount</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Proceeds, before expenses, to us</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE>   <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The estimated offering expenses payable by us, exclusive of the underwriting discount and
commissions, are approximately $3.0 million. We have also agreed to reimburse the underwriters for certain of their expenses in an amount not to exceed $40,000 as set forth in the underwriting agreement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The underwriting agreement provides that the obligations of the several underwriters to pay for and accept delivery of the shares of
common stock offered by this prospectus are subject to the approval of certain legal matters by their counsel and to certain other conditions. The underwriters are obligated to take and pay for all of the shares of common stock offered by this
prospectus if any such shares are taken. However, the underwriters are not required to take or pay for the shares covered by the underwriters&#146; option to purchase additional shares, described below. If an underwriter defaults, the underwriting
agreement provides that the purchase commitments of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> underwriters may be increased. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Option to Purchase Additional Shares </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have granted
to the underwriters an option, exercisable for 30&nbsp;days from the date of this prospectus, to purchase up to 750,000 additional shares of common stock at the public offering price listed on the cover page of this prospectus, less the underwriting
discount and commissions. The underwriters may exercise this option solely for the purpose of covering overallotments, if any, made in connection with the offering of the shares of common stock offered by this prospectus. To the extent the option is
exercised, each underwriter will become obligated, subject to certain conditions, to purchase about the same percentage of the additional shares of common stock as the number listed next to the underwriter&#146;s name in the table above bears to the
total number of shares of common stock listed next to the names of all underwriters in the preceding table. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>No Sales
of Similar Securities </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have agreed not to sell or transfer, without the consent of the
representatives, and our executive officers and directors and substantially all of our other stockholders have agreed not to sell or transfer, without the consent of Piper Jaffray&nbsp;&amp; Co., any shares of our common stock or securities
convertible into, exchangeable or exercisable for, or that represent the right to receive shares of our common stock, for 180&nbsp;days after the date of the prospectus used to sell our common stock. Specifically, we and these other persons have
agreed, with certain limited exceptions, not to directly or indirectly: </FONT></P>  <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">offer, pledge, announce the intention to sell, sell or contract to sell any shares of our common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">sell any option or contract to purchase any shares of our common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">purchase any option or contract to sell any shares of our common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">grant any option, right or warrant to purchase any shares of our common stock; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">make any short sale or otherwise transfer or dispose of any shares of our common stock; </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">171 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">enter into any swap or other agreement that transfers, in whole or in part, the economic consequences of ownership of any shares of our
common stock whether any such swap or transaction is to be settled by delivery of shares or other securities, in cash or otherwise </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">make demand for or exercise any right with respect to the registration statement of our common stock; or </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">publicly announce the intention to do any of the foregoing. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Listing </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have applied to list our common stock on the
Nasdaq Global Market under the symbol &#147;STIM.&#148; In order to meet the requirements for listing on that exchange, the underwriters have undertaken to sell a minimum number of shares to a minimum number of beneficial owners as required by
Nasdaq. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Before this offering, there has been no public market for our common stock. The initial public offering price
will be determined through negotiations among us and the representatives. In addition to prevailing market conditions, the factors to be considered in determining the initial public offering price are: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the valuation multiples of publicly traded companies that the representatives believe to be comparable to us;
</FONT></P></TD></TR></TABLE>  <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">our financial information; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the history of, and the prospects for, our company and the industry in which we compete; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">an assessment of our management, its past and present operations and the prospects for, and timing of, our future net sales;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the present state of our development; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">the above factors in relation to market values and various valuation measures of other companies engaged in activities similar to ours.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">An active trading market for the shares may not develop. It is also possible that after this offering the
shares will not trade in the public market at or above the initial public offering price. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The underwriters do not expect to
sell more than 5% of the shares in the aggregate to accounts over which they exercise discretionary authority. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Price
Stabilization, Short Positions and Penalty Bids </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Until the distribution of the shares is completed, SEC rules may limit
underwriters and selling group members from bidding for and purchasing shares of our common stock. However, the underwriters may engage in transactions that stabilize the price of our common stock, such as bids or purchases to peg, fix or maintain
that price. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In connection with this offering, the underwriters may purchase and sell shares of our common stock in the open
market. These transactions may include short sales, purchases on the open market to cover positions created by short sales and stabilizing transactions. Short sales involve the sale by the underwriters of a greater number of shares than they are
required to purchase in this offering. &#147;Covered&#148; short sales are sales made in an amount not greater than the underwriters&#146; option to purchase additional shares described above. The underwriters may close out any covered short
position by either exercising their option or purchasing shares in the open market. In determining the source of shares to close out the covered short position, the underwriters will consider, among other things, the price of shares available for
purchase in the open market as compared to the price at which they may purchase shares through the overallotment option. &#147;Naked&#148; short sales are sales in excess of the overallotment option. The
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">172 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
underwriters must close out any naked short position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may
be downward pressure on the price of our common stock in the open market after pricing that could adversely affect investors who purchase in this offering. Stabilizing transactions consist of various bids for or purchases of shares of our common
stock made by the underwriters in the open market prior to the closing of this offering. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The underwriters may also impose
a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter in
stabilizing or short covering transactions. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Similar to other purchase transactions, the underwriters&#146; purchases to
cover the syndicate short sales may have the effect of raising or maintaining the market price of our common stock or preventing or retarding a decline in the market price of our common stock. As a result, the price of our common stock may be higher
than the price that might otherwise exist in the open market. The underwriters may conduct these transactions on the Nasdaq Global Market, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market
or otherwise. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Neither we nor any of the underwriters make any representation or prediction as to the direction or
magnitude of any effect that the transactions described above may have on the price of our common stock. In addition, neither we nor any of the underwriters make any representation that the representatives will engage in these transactions or that
these transactions, once commenced, will not be discontinued without notice. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Electronic Offer, Sale and Distribution
of Shares </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In connection with this offering, certain of the underwriters or securities dealers may distribute prospectuses
by electronic means, such as <FONT STYLE="white-space:nowrap">e-mail.</FONT> In addition, one or more of the underwriters may facilitate internet distribution for this offering to certain of their Internet subscription customers. Any such
underwriter may allocate a limited number of shares for sale to its online brokerage customers. An electronic prospectus is available on the internet websites maintained by any such underwriter. Other than the prospectus in electronic format, the
information on the websites of any such underwriter is not part of this prospectus. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Other Relationships </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which may include
securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing and brokerage activities. Certain of the underwriters or their affiliates may in the
future engage in investment banking and other commercial dealings with us or our affiliates in the ordinary course of business, for which they may receive customary fees and commissions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the ordinary course of their various business activities, the underwriters and their respective affiliates may make or hold a broad array of investments and actively trade debt and
equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their customers, and such investment and securities activities may involve securities and/or
instruments of the issuer. The underwriters and their respective affiliates may also make investment recommendations and/or publish or express independent research views in respect of such securities or instruments and may at any time hold, or
recommend to clients that they acquire, long and/or short positions in such securities and instruments. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">173 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Selling Restrictions </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>European Economic Area </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In relation to each Member State of
the European Economic Area which has implemented the Prospectus Directive, each being referred to as a Relevant Member State, an offer to the public of any shares of our common stock may not be made in that Relevant Member State, except that an
offer to the public in that Relevant Member State of any shares of our common stock may be made at any time under the following exemptions under the Prospectus Directive, if they have been implemented in that Relevant Member State: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(a) to any legal entity which is a qualified investor as defined in the Prospectus Directive; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(b) to fewer than 150, natural or legal persons (other than qualified investors as defined in the Prospectus Directive),
as permitted under the Prospectus Directive, subject to obtaining the prior consent of the representative for any such offer; or </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(c) in any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of shares of our common stock shall result in a requirement for the
publication by us or any underwriter of a prospectus pursuant to Article 3 of the Prospectus Directive. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For the purposes of
this provision, the expression an &#147;offer to the public&#148; in relation to any shares of our common stock in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and
any shares of our common stock to be offered so as to enable an investor to decide to purchase any shares of our common stock, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State,
the expression &#147;Prospectus Directive&#148; means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in the Relevant Member State), and includes any relevant implementing measure in
the Relevant Member State, and the expression &#147;2010 PD Amending Directive&#148; means Directive 2010/73/EU. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>United
Kingdom </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each underwriter has represented and agreed that: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(a) it has only communicated or caused to be communicated and will only communicate or cause to be communicated an
invitation or inducement to engage in investment activity (within the meaning of Section&nbsp;21 of the Financial Services and Markets Act 2000, or the FSMA) received by it in connection with the issue or sale of the shares of our common stock in
circumstances in which Section&nbsp;21(1) of the FSMA does not apply to us; and </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(b) it has complied and will
comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the shares of our common stock in, from or otherwise involving the United Kingdom. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Canada </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The common stock may be sold only to purchasers
purchasing as principal that are both &#147;accredited investors&#148; as defined in National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> Prospectus and Registration Exemptions and &#147;permitted clients&#148; as defined in National
Instrument <FONT STYLE="white-space:nowrap">31-103</FONT> Registration Requirements, Exemptions and Ongoing Registrant Obligations. Any resale of the shares of common stock must be made in accordance with an exemption from the prospectus
requirements and in compliance with the registration requirements of applicable securities laws. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Hong Kong </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The common stock may not be offered or sold in Hong Kong by means of any document other than (i)&nbsp;in circumstances which do not
constitute an offer to the public within the meaning of the Companies </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">174 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
Ordinance (Cap. 32, Laws of Hong Kong), or (ii)&nbsp;to &#147;professional investors&#148; within the meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules
made thereunder, or (iii)&nbsp;in other circumstances which do not result in the document being a &#147;prospectus&#148; within the meaning of the Companies Ordinance (Cap. 32, Laws of Hong Kong) and no advertisement, invitation or document relating
to the shares may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be accessed or read by, the public in Hong
Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to shares of common stock which are or are intended to be disposed of only to persons outside Hong Kong or only to &#147;professional investors&#148; within the
meaning of the Securities and Futures Ordinance (Cap. 571, Laws of Hong Kong) and any rules made thereunder. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Singapore
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this
prospectus and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of the common stock may not be circulated or distributed, nor may the shares of common stock be offered or sold, or be
made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor under Section&nbsp;274 of the Securities and Futures Act, Chapter 289 of
Singapore, or the SFA, (ii)&nbsp;to a relevant person pursuant to Section&nbsp;275(1), or any person pursuant to Section&nbsp;275(1A), and in accordance with the conditions specified in Section&nbsp;275 of the SFA or (iii)&nbsp;otherwise pursuant
to, and in accordance with the conditions of, any other applicable provision of the SFA, in each case subject to compliance with conditions set forth in the SFA. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Where the common stock are subscribed or purchased under Section&nbsp;275 of the SFA by a relevant person which is: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(a) a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole business of which is to hold investments and the entire share capital of which
is owned by one or more individuals, each of whom is an accredited investor; or </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(b) a trust (where the trustee
is not an accredited investor) whose sole purpose is to hold investments and each beneficiary of the trust is an individual who is an accredited investor, shares, debentures and units of shares and debentures of that corporation or the
beneficiaries&#146; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the shares of common stock pursuant to an offer made under Section&nbsp;275 of
the SFA except: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(i) to an institutional investor (for corporations, under Section&nbsp;274 of the SFA) or to a
relevant person defined in Section&nbsp;275(2) of the SFA, or to any person pursuant to an offer that is made on terms that such shares, debentures and units of shares and debentures of that corporation or such rights and interest in that trust are
acquired at a consideration of not less than $200,000 (or its equivalent in a foreign currency) for each transaction, whether such amount is to be paid for in cash or by exchange of securities or other assets, and further for corporations, in
accordance with the conditions specified in Section&nbsp;275 of the SFA; </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(ii) where no consideration is or
will be given for the transfer; or </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(iii) where the transfer is by operation of law. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Switzerland </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The common stock may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange, or the SIX, or on any other stock exchange or regulated trading facility in
Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">175 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock
exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating to the shares of common stock or the offering may be publicly distributed or otherwise made publicly available in
Switzerland. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Neither this document nor any other offering or marketing material relating to the offering, or the common stock
have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and the offer of common stock will not be supervised by, the Swiss Financial Market Supervisory Authority, and the
offer of shares of common stock has not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes, or the CISA. Accordingly, no public distribution, offering or advertising, as defined in CISA, its implementing
ordinances and notices, and no distribution to any non-qualified investor, as defined in CISA, its implementing ordinances and notices, shall be undertaken in or from Switzerland, and the investor protection afforded to acquirers of interests in
collective investment schemes under CISA does not extend to acquirers of common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>United Arab Emirates
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">This offering has not been approved or licensed by the Central Bank of the United Arab Emirates, or the UAE, Securities
and Commodities Authority of the UAE and/or any other relevant licensing authority in the UAE including any licensing authority incorporated under the laws and regulations of any of the free zones established and operating in the territory of the
UAE, in particular the Dubai Financial Services Authority, or the DFSA, a regulatory authority of the Dubai International Financial Centre, or the DIFC. The offering does not constitute a public offer of securities in the UAE, DIFC and/or any other
free zone in accordance with the Commercial Companies Law, Federal Law No 8 of 1984 (as amended), DFSA Offered Securities Rules and NASDAQ Dubai Listing Rules, accordingly, or otherwise. The shares of common stock may not be offered to the public in
the UAE and/or any of the free zones. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The shares of common stock may be offered and issued only to a limited number of
investors in the UAE or any of its free zones who qualify as sophisticated investors under the relevant laws and regulations of the UAE or the free zone concerned. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>France </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">This prospectus (including any amendment,
supplement or replacement thereto) is not being distributed in the context of a public offering in France within the meaning of Article L. <FONT STYLE="white-space:nowrap">411-1</FONT> of the French Monetary and Financial Code (Code mon&eacute;taire
et financier). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">This prospectus has not been and will not be submitted to the French Autorit&eacute; des march&eacute;s
financiers, or the AMF, for approval in France and accordingly may not and will not be distributed to the public in France. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pursuant to Article <FONT STYLE="white-space:nowrap">211-3</FONT> of the AMF General Regulation, French residents are hereby informed
that: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1. the transaction does not require a prospectus to be submitted for approval to the AMF; </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2. persons or entities referred to in Point 2&deg;, Section II of Article L. <FONT STYLE="white-space:nowrap">411-2</FONT>
of the Monetary and Financial Code may take part in the transaction solely for their own account, as provided in Articles&nbsp;D. <FONT STYLE="white-space:nowrap">411-1,</FONT> D. <FONT STYLE="white-space:nowrap">734-1,</FONT> D. <FONT
STYLE="white-space:nowrap">744-1,</FONT> D. <FONT STYLE="white-space:nowrap">754-1</FONT> and D. <FONT STYLE="white-space:nowrap">764-1</FONT> of the Monetary and Financial Code; and </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3. the financial instruments thus acquired cannot be distributed directly or indirectly to the public otherwise than in
accordance with Articles L. <FONT STYLE="white-space:nowrap">411-1,</FONT> L. <FONT STYLE="white-space:nowrap">411-2,</FONT> L. <FONT STYLE="white-space:nowrap">412-1</FONT> and L. <FONT STYLE="white-space:nowrap">621-8</FONT> to L. <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">621-8-3</FONT></FONT> of the Monetary and Financial Code. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">176 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">This prospectus is not to be further distributed or reproduced (in whole or in part) in
France by the recipients of this prospectus. This prospectus has been distributed on the understanding that such recipients will only participate in the issue or sale of our common stock for their own account and undertake not to transfer, directly
or indirectly, our common stock to the public in France, other than in compliance with all applicable laws and regulations and in particular with Articles L. <FONT STYLE="white-space:nowrap">411-1</FONT> and L.
<FONT STYLE="white-space:nowrap">411-2</FONT> of the French Monetary and Financial Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_20">
</A>LEGAL MATTERS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The validity of the shares of common stock offered hereby will be passed upon for us by Cooley LLP, New
York, New York. Certain legal matters will be passed upon for the underwriters by Latham&nbsp;&amp; Watkins, LLP. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_21"></A>EXPERTS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The audited financial
statements of Neuronetics, Inc. as of December&nbsp;31, 2016 and 2017, and for the years then ended, have been included herein and in the registration statement in reliance upon the report of KPMG LLP, an independent registered public accounting
firm, appearing elsewhere herein, and upon the authority of said firm as experts in accounting and auditing. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_21a"></A>WHERE YOU CAN FIND MORE INFORMATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> under the Securities Act, with
respect to the shares of common stock being offered by this prospectus. This prospectus, which constitutes part of the registration statement, does not contain all of the information in the registration statement and its exhibits. For further
information with respect to our company and the common stock offered by this prospectus, we refer you to the registration statement and its exhibits. Statements contained in this prospectus as to the contents of any contract or any other document
referred to are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is qualified in all respects by this reference.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">You can read our SEC filings, including the registration statement, over the internet at the SEC&#146;s website at
<I>www.sec.gov</I>. You may also read and copy any document we file with the SEC at its public reference room at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. You may also obtain copies of these documents at prescribed rates by writing to
the Public Reference Section of the SEC at 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-SEC-0330</FONT></FONT></FONT> for
further information on the operation of the public reference facilities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Upon completion of this offering, we will be subject
to the information reporting requirements of the Exchange Act, and we will file reports, proxy statements and other information with the SEC. These reports, proxy statements and other information will be available for inspection and copying at the
public reference room and website of the SEC referred to above. We also maintain a website at <I>www.neurostar.com</I>, at which you may access these materials free of charge as soon as reasonably practicable after they are electronically filed
with, or furnished to, the SEC. The information contained in, or that can be accessed through, our website is not part of, and is not incorporated into, this prospectus. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">177 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="toc542432_22"></A>INDEX TO FINANCIAL STATEMENTS </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="80%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="91%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Page</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Audited Financial Statements as of and for the Years ended December&nbsp;31, 2016 and 2017:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="#fin542432_1">Report of Independent Registered Public Accounting Firm</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="#fin542432_3">Balance Sheets</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="#fin542432_4">Statements of Operations</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="#fin542432_5">Statements of Changes in Convertible Preferred Stock and Stockholders&#146;
Deficit</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="#fin542432_6">Statements of Cash Flows</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="#fin542432_7">Notes to Financial Statements</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Unaudited Interim Financial Statements as of March&nbsp;31, 2018 and for the Three Months ended March&nbsp;31,
2017 and 2018:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="#fin542432_8">Balance Sheets</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="#fin542432_9">Statements of Operations</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="#fin542432_10">Statements of Changes in Convertible Preferred Stock and Stockholders&#146;
Deficit</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="#fin542432_11">Statements of Cash Flows</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="#fin542432_12">Notes to Interim Financial Statements</A></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-36</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-1 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="fin542432_1"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">To the Stockholders and Board of Directors </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Neuronetics, Inc.: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Opinion on the Financial Statements
</I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have audited the accompanying balance sheets of Neuronetics, Inc. (the Company) as of December&nbsp;31, 2016 and 2017,
the related statements of operations, changes in convertible preferred stock and stockholders&#146; deficit, and cash flows for the years then ended, and the related notes (collectively, the financial statements). In our opinion, the financial
statements present fairly, in all material respects, the financial position of the Company as of December&nbsp;31, 2016 and 2017, and the results of its operations and its cash flows for the years then ended, in conformity with U.S. generally
accepted accounting principles. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Basis for Opinion </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">These financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion on these financial statements based on our audits. We are a
public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules
and regulations of the Securities and Exchange Commission and the PCAOB. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We conducted our audits in accordance with the
standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing
procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the
amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We
believe that our audits provide a reasonable basis for our opinion. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">/s/ KPMG LLP </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We have served as the Company&#146;s auditor since 2003. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Philadelphia, Pennsylvania </FONT></P>  <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">March 16, 2018, except for the
recapitalization described in Note 2, as to which the date is June&nbsp;14, 2018 </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-2 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="fin542432_3"></A>Balance Sheets </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(In thousands, except per share data) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Assets</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Current assets:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash and cash equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">17,040</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,147</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accounts receivable, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,267</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Inventory</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,696</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,468</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Prepaid expenses and other current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">607</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,123</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">22,920</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">37,005</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Property and equipment, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,628</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,359</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">574</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total Assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">24,798</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">38,938</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Liabilities, Convertible Preferred Stock and Stockholders&#146;
Deficit</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Current liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accounts payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,483</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,513</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accrued expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,034</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,511</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,330</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,970</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Current portion of long-term debt, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,491</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">13,338</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,994</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Long-term debt, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15,647</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,556</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,275</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">459</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">478</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred rent</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">151</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total Liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,611</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">44,454</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Commitments (Note 15)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock, $0.01 par value: 308,593 shares authorized, issuable in series; 264,374 and 304,958
shares issued and outstanding at December&nbsp;31, 2016 and 2017, respectively; aggregate liquidation value of $&nbsp;108,324 at December 31, 2017 </FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">172,311</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Stockholders&#146; deficit:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Preferred stock, $0.01 par value: no shares authorized, issued or outstanding at December&nbsp;31, 2016 and 2017
</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Common stock, $0.01 par value: 407,024 shares authorized; 187 and 231 shares issued and outstanding at December
31, 2016 and 2017, respectively</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Additional paid-in capital</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,761</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,292</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accumulated deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(180,887</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(196,946</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total Stockholder&#146;s Deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(177,124</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(192,652</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total Liabilities, Convertible Preferred Stock and Stockholders&#146; Deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">24,798</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">38,938</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The accompanying notes are an integral part of these financial statements. </FONT></P>

 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-3 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="fin542432_4"></A>Statements of Operations </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(In thousands, except per share data) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Years&nbsp;ended&nbsp;December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">40,433</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,632</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gross Profit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">27,606</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30,801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Operating expenses:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">21,794</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">27,900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,926</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,572</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,937</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">36,943</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">44,409</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Loss from Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(9,337</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(13,608</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other (income) expense:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Interest expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,835</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,808</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other (income) expense, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">62</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(357</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(11,234</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(16,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net loss per share of common stock outstanding, basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(76.95</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(86.34</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Weighted-average common shares outstanding, basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">146</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">186</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma net loss per share of common stock outstanding, basic and diluted (unaudited)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma weighted-average common shares outstanding, basic and diluted (unaudited)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,601</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The accompanying notes are an integral part of these financial statements.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-4 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="fin542432_5"></A>Statements of Changes in Convertible Preferred Stock and Stockholders&#146; Deficit
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(In thousands) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Convertible</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">
<B>Preferred Stock</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Common&nbsp;Stock</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Additional<BR>Paid-in</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Capital</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Accumulated</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Deficit</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Total<BR>Stockholders&#146;</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Deficit</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance at December&nbsp;31, 2015</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">264,374</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">172,311</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">126</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,534</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(169,653</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(166,118</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Issuance of restricted stock awards</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">42</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;(1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Exercises of stock options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Share-based compensation expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">161</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">161</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(11,234</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(11,234</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance at December&nbsp;31, 2016</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">264,374</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">172,311</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,761</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(180,887</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(177,124</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Issuance of Series G convertible preferred stock, net of issuance costs of $175</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">40,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14,825</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Issuance of restricted stock awards</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Exercises of stock options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Share-based compensation expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">496</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">496</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(16,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(16,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance at December&nbsp;31, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">304,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187,136</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">231</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,292</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(196,946</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(192,652</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The accompanying notes are an integral part of these financial statements.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-5 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="fin542432_6"></A>Statements of Cash Flows </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(In thousands) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Years&nbsp;ended&nbsp;December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash Flows from Operating Activities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(11,234</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(16,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Adjustments to reconcile net loss to net cash used in operating activities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Depreciation and amortization</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">673</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">596</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Share-based compensation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">161</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">496</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Non-cash interest expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">391</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">722</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Change in fair value of convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">108</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(271</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of rental units purchased by customers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">216</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Changes in certain assets and liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accounts receivable, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(123</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(690</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Inventory</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(646</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1,068</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Prepaid expenses and other assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(156</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(175</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accounts payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">734</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">788</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accrued expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,201</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,391</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">363</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,915</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred rent</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(28</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:9.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Cash Used in Operating Activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(8,541</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(11,144</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash Flows from Investing Activities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Purchases of property and equipment and capitalized software</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(324</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(594</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:9.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Cash Used in Investing Activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(324</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(594</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash Flows from Financing Activities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Proceeds from issuance of Series G convertible preferred stock, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14,825</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Borrowings under credit facilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Payments of debt issuance costs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(171</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1,015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Proceeds from exercises of stock options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">67</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:9.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Cash Provided by Financing Activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,896</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">23,845</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:9.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net (Decrease) Increase in Cash and Cash Equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(3,969</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12,107</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:9.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash and Cash Equivalents, Beginning of Year</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">21,009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">17,040</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:9.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash and Cash Equivalents, End of Year</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">17,040</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,147</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Supplemental disclosure of cash flow information:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash paid for interest</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,406</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,043</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Transfer of inventory to property and equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(531</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(296</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Supplemental disclosure of non-cash financing activities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Allocation of proceeds from debt financing to convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">135</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">290</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred initial public offering costs included in accounts payable and accrued expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The accompanying notes are an integral part of these financial statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-6 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="fin542432_7"></A>Notes to Financial Statements </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>1.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>DESCRIPTION OF BUSINESS </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Neuronetics, Inc., or the Company, is a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients
who suffer from psychiatric disorders. The Company&#146;s first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a
pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system was cleared in 2008 by the United States Food and Drug Administration (FDA) to treat adult
patients with major depressive disorder, or MDD, that have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. The Company intends to continue to pursue development of its NeuroStar Advanced
Therapy for additional indications. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Liquidity </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of December&nbsp;31, 2017, the Company had cash and cash equivalents of $29.1 million and an accumulated deficit of $196.9 million. The Company has incurred negative cash flows from
operating activities of $8.5 million and $11.1 million for the years ended December&nbsp;31, 2016 and 2017, respectively. The Company has incurred operating losses since its inception, and management anticipates that its operating losses will
continue in the near term as the Company seeks to expand its sales and marketing initiatives to support its growth into existing and new markets and invest in additional research and development activities. The Company&#146;s primary sources of
capital to date have been from private placements of its convertible preferred securities, borrowings under its credit facilities and sales of its products. As of December&nbsp;31, 2017, the Company had $30.0 million of borrowings outstanding under
its credit facility, which matures March 2022 and has $5.0 million of additional availability, subject to the achievement of $45.0 million of trailing twelve month revenues in 2018. Management believes that the Company&#146;s cash and cash
equivalents as of December&nbsp;31, 2017, sales of its products and availability of borrowing under its credit facility are sufficient to fund the Company&#146;s operations at least into the second half of calendar year 2019. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Risks and Uncertainties </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s ability to implement its business strategy is subject to numerous risks and uncertainties, including, but not limited to: uncertainty in the Company&#146;s ability to
generate sufficient revenues from the commercialization of its products to achieve or sustain profitability; the need to raise additional capital to fund the Company&#146;s existing commercial operations, development and commercialization of new
products and expansion of its operations; uncertainty with regard to competitors&#146; development of competing products and technologies; uncertainty with regard to adoption and use of TMS therapy by physicians and patients; comprehensive
government regulation and oversight both in the United States and abroad; reliance on coverage and reimbursement from third-party payers for treatments using the Company&#146;s products; the Company has limited experience in marketing and selling
its products; and the Company relies significantly on technology to deliver treatments with its products. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>2.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>BASIS OF PRESENTATION </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP). Any reference in these notes to applicable
guidance is meant to refer to GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Updates (ASU) promulgated by the Financial Accounting Standards Board (FASB). </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-7 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Use of Estimates </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The preparation of financial statements in accordance with GAAP and the rules and regulations of the United States Securities and Exchange Commission (SEC) requires the use of estimates
and assumptions, based on judgments considered reasonable, which affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues
and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various other factors that management believes to be reasonable under the circumstances, the results of
which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Although management believes its estimates and assumptions are reasonable when made, they are based upon
information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes adjustments. Due to the risks and uncertainties involved in the Company&#146;s business and evolving
market conditions, and given the subjective element of the estimates and assumptions made, actual results may differ from estimated results. The most significant estimates and judgments impact share-based compensation, convertible preferred stock
warrants, product warranty accruals and the net realizable value of inventory. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Recapitalization </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company effected a 0.0345-for-1 reverse split of its common stock on June 14, 2018. The reverse split combined each approximately 29
shares of the Company&#146;s issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion price of its convertible preferred stock. No fractional shares were issued in connection with the reverse
split. Any fractional share resulting from the reverse split was rounded down to the nearest whole share, and in lieu of any fractional shares, the Company will pay in cash to the holders of such fractional shares an amount equal to the fair market
value, as determined by the board of directors, of such fractional shares. All share, per share and related information presented in the financial statements and accompanying notes have been retroactively adjusted, where applicable, to reflect the
reverse stock split. </FONT></P>  <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>3.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Cash and Cash Equivalents </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company considers all highly
liquid investments purchased with an original maturity of three months or less to be cash equivalents. As of December&nbsp;31, 2016 and 2017, cash equivalents consisted of money market funds. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Concentrations of Credit Risk </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s cash is
held on deposit in demand accounts at a large financial institution in amounts in excess of the Federal Deposit Insurance Corporation, or FDIC, insurance coverage limit of $250,000 per depositor, per FDIC-insured bank, per ownership category.
Management has reviewed the financial statements of this institution and believes it has sufficient assets and liquidity to conduct its operations in the ordinary course of business with little or no credit risk to the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Financial instruments that potentially subject the Company to concentrations of credit risk principally consist of cash equivalents and
accounts receivable. The Company limits its credit risk associated with cash equivalents by placing investments in highly-rated money market funds. The Company limits its credit risk with respect to accounts receivable by performing credit
evaluations when deemed necessary, but it does not require collateral to secure amounts owed by its customers. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-8 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Allowance for Doubtful Accounts </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company maintains allowances for doubtful accounts for estimated losses resulting from amounts deemed to be uncollectible from its
customers. These allowances are for specific amounts on certain customer accounts based on facts and circumstances determined on a case-by-case basis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Inventory </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Inventory is stated at the lower of cost and net
realizable value, with cost being determined on a first in, first out basis. The Company&#146;s inventory is primarily comprised of finished goods. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Property and Equipment </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Property and equipment are recorded
at cost. Maintenance and repairs are charged to expense as incurred and costs of improvements and renewals are capitalized. Depreciation and amortization are recognized using the straight-line method based on the estimated useful lives of the
related assets. The Company uses an estimated useful life of three years for computers and software, five years for laboratory and office equipment, six years for devices in the rental agreement program and the lesser of five years or the remaining
life of the underlying facility lease for leasehold improvements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Software development costs relating to assets to be sold in
the normal course of business are included in research and development and are expensed as incurred until technological feasibility is established. After technological feasibility is established, material software development costs are capitalized.
As of December&nbsp;31, 2017, the Company had capitalized software costs of $0.4 million which are included in &#147;Other assets&#148; on the balance sheet. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Impairment of Long-Lived Assets </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Long-lived assets, such as
property and equipment, are tested for impairment when events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. Impairment testing requires management to estimate the future net undiscounted cash flows
of an asset using assumptions believed to be reasonable. Actual cash flows may differ from the estimates used in the impairment testing. If such assets are considered to be impaired, the Company recognizes an impairment loss when and to the extent
that the estimated fair value of an asset is less than its carrying value. The Company has not recorded any impairment of its long-lived assets. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Warrant Liability </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s current and previous
credit facilities require the issuance of warrants to purchase the Company&#146;s convertible preferred stock at the date of borrowing. Because the convertible preferred stock warrants are a form of a contingently redeemable instrument, they are
classified as liabilities on the Company&#146;s balance sheet. At the date of borrowing, the Company bifurcates the estimated fair value of the convertible preferred stock warrants from the proceeds from borrowing, resulting in the recognition of a
debt discount, and records a warrant liability on its balance sheet. This warrant liability is revalued at each reporting period, with changes in fair value recorded in the Company&#146;s statement of operations as a component of other income or
expense. The warrants will continue to be revalued at each reporting period until such time as they are exercised, expire, are reclassified to permanent equity or are otherwise settled. The valuation of the warrant liability is based upon estimates
of the fair value of the underlying convertible preferred stock and the related volatility and expected term for an illiquid instrument, which could vary significantly from period to period. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-9 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Immediately prior to the closing of an initial public offering in which all of the
Company&#146;s outstanding convertible preferred stock converts to common stock, all of the Company&#146;s outstanding convertible preferred stock warrants will automatically convert into common stock warrants. At such time, the warrant liability
will be remeasured at its estimated fair value and reclassified to additional paid-in capital on the Company&#146;s balance sheet. Upon reclassification into equity, the Company will cease mark-to-market accounting activities. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Deferred Debt Issuance Costs </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company capitalizes direct costs incurred to obtain debt financing and amortizes these costs to interest expense over the term of the debt using the effective interest method. These
costs are recorded as a debt discount and the unamortized costs are netted against the related debt on the Company&#146;s balance sheet. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Revenue Recognition </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Revenue is recognized when title and
risk of ownership has been transferred, provided that persuasive evidence of an arrangement exists, the price is fixed and determinable and collectability is reasonably assured. Transfer of title and risk of ownership occurs when the product is
shipped or transferred to the customer. The Company sells to end users in the United States and to third-party distributors outside the United States and does not provide return rights. Sales to distributors outside the United States are in U.S.
dollars. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company generates revenue from sales of NeuroStar Advanced Therapy Systems and treatment sessions. NeuroStar
Advanced Therapy System revenue consists primarily of a capital component, including updates to the equipment, attributable to the initial sale of the NeuroStar system unit. NeuroStar Advanced Therapy Systems can be purchased outright or on a
rent-to-own basis by certain customers. Treatment session revenue primarily includes sales of NeuroStar treatment sessions and SenStar treatment links. The NeuroStar treatment sessions are access codes delivered electronically in the United States.
The SenStar treatment links are disposable units containing single-use access codes that are sold and used outside the United States. Access codes are purchased separately by customers, primarily on an as-needed basis, and are required by the
NeuroStar Advanced Therapy System in order to deliver the treatment sessions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s NeuroStar Advanced Therapy
System sales in the United States typically have post-sale obligations of installation and training. These obligations are fulfilled after product shipment, and the Company defers recognizing revenue until installation occurs. In accordance with the
accounting guidance related to multiple element arrangements, the Company defers the fair value attributable to the post-shipment training and recognizes such revenue when the obligation is fulfilled. The Company bases the fair value of the training
using stand-alone service rates. The Company&#146;s sales to its third-party distributors outside the United States do not have these post-sale obligations. The Company&#146;s treatment sessions have no post-sale obligations and no return rights.
Revenues on the sales of treatment sessions are recognized upon delivery. Revenue related to operating leases for the Company&#146;s NeuroStar Advanced Therapy System is recognized over the term of the lease. Revenue attributable to the NeuroStar
Advanced Therapy Systems purchased on a rent-to-own basis are accounted for as operating leases and revenue is recognized on a straight-line basis over the term of the lease. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company provides a one to two-year warranty for systems sold in the United States. Terms of product warranty differ amongst its third-party distributors outside the United States, but
are generally </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-10 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
three years or less. The Company provides for the estimated cost to repair or replace products under any warranty at the time of sale. The Company also offers its customers in the United States
annual service contracts. Revenue from the sale of annual service contracts is recognized on a straight-line basis over the period of the applicable contract. The Company also earns revenue from customers from services outside of their warranty term
or annual service contracts. Such service revenue is recognized as the services are provided. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Research and Development
Expenses </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development activities are expensed as incurred. Costs incurred in obtaining technology licenses are
charged immediately to research and development expense if the technology licensed has not reached technological feasibility and has no alternative future uses. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Share-based Compensation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company recognizes the
grant-date fair value of share-based awards issued as compensation as expense on a straight-line basis over the requisite service period, which is generally the vesting period of the award. To date, the Company has not issued awards where vesting is
subject to performance or market conditions. The fair value of restricted stock awards is based on a determination by the board of directors of the estimated fair value of the common stock at the date of grant. The fair value of stock options is
estimated at the time of grant using the Black-Scholes option pricing model, which requires the use of inputs and assumptions such as the estimated fair value of the underlying common stock, exercise price of the option, expected term, risk-free
interest rate, expected volatility and dividend yield, the most critical of which is the estimated fair value of the Company&#146;s common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The estimated fair value of each grant of stock options awarded during the years ended December&nbsp;31, 2016 and 2017 was determined using the following methods and assumptions:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Estimated Fair Value of Common Stock.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>As the Company&#146;s common stock has not historically been
publicly traded, its board of directors periodically estimated the fair value of the Company&#146;s common stock considering, among other things, contemporaneous valuations of its preferred and common stock prepared by an unrelated third-party
valuation firm in accordance with the guidance provided by the American Institute of Certified Public Accountants 2013 Practice Aid, <I>Valuation of Privately-Held-Company Equity Securities Issued as Compensation</I>. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Expected Term.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>Due to the lack of a public market for the trading of the Company&#146;s common
stock and the lack of sufficient company-specific historical data, the expected term of employee stock options is determined using the &#147;simplified&#148; method, as prescribed in SEC Staff Accounting Bulletin (SAB) No.&nbsp;107 (SAB 107),
whereby the expected life equals the arithmetic average of the vesting term and the original contractual term of the option. The expected term of nonemployee stock options is equal to the contractual term. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Risk-free Interest Rate.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>The risk-free interest rate is based on the interest rate payable on
United States Treasury securities in effect at the time of grant for a period that is commensurate with the assumed expected term. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Expected Volatility.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>The expected volatility is based on historical volatilities of peer companies
within the Company&#146;s industry which were commensurate with the expected term assumption, as described in SAB 107. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="7%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Dividend Yield.&nbsp;&nbsp;&nbsp;&nbsp;</I></B>The dividend yield is 0% because the Company has never paid, and for the
foreseeable future does not expect to pay, a dividend on its common stock. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-11 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The inputs and assumptions used to estimate the fair value of share-based payment awards
represent management&#146;s best estimates and involve inherent uncertainties and the application of management&#146;s judgment. As a result, if factors change and management uses different inputs and assumptions, the Company&#146;s share-based
compensation expense could be materially different for future awards. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Income Taxes </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax
consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in operations in the period that includes the enactment date. A valuation allowance is recorded to the extent it is more likely than not that some portion or all of the deferred tax assets will not be realized. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Unrecognized income tax benefits represent income tax positions taken on income tax returns that have not been recognized in the
Company&#146;s financial statements. The Company recognizes the benefit of an income tax position only if it is more likely than not that the tax position will be sustained upon tax examination, based solely on the technical merits of the tax
position. Otherwise, no benefit is recognized. The tax benefits recognized are measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. Accrued interest and related penalties are
classified as income tax expense in the Company&#146;s statements of operations, if applicable. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of December&nbsp;31, 2016
and 2017, the Company had deferred tax assets of $63.4 million and $47.3&nbsp;million, respectively; these deferred tax assets are primarily attributable to federal and state net operating loss carryforwards. Although the loss carryforwards are
available to offset future taxable income, they will begin to expire in 2020 for state and 2023 for federal. In addition, prior ownership changes may create a limitation in the Company&#146;s ability to use the net operating loss carryforwards for
federal and state income tax purposes. These loss carryforwards have been fully offset by a valuation allowance because management does not consider realization of these deferred tax assets to be more likely than not. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Corporate tax reform was enacted on December&nbsp;22, 2017 and is effective for the Company for year ended December&nbsp;31, 2017. The
provisions of the corporate tax reform did not have any impact to the Company due to the full valuation allowance position. As a result of the reduced corporate rate, the Company&#146;s deferred tax assets were revalued from 34% to 21%, which was
fully offset by a reduction in the valuation allowance. In connection with the corporate tax reform, the Medical Device Tax was suspended for another two years. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>4.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>RECENT ACCOUNTING PRONOUNCEMENTS </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>JOBS Act Accounting Election </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company is an
emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the
JOBS Act until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-12 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
private companies until the earlier of the date that it (i)&nbsp;is no longer an emerging growth company or (ii)&nbsp;affirmatively and irrevocably opts out of the extended transition period
provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In May 2014, the FASB issued ASU 2014-09, &#147;<I>Revenue from Contracts with Customers</I>&#148; (Topic 606), regarding the accounting
for and disclosures of revenue recognition, with an effective date for public companies of annual and interim periods beginning after December&nbsp;15, 2016. In July 2015, the FASB issued ASU 2015-14, &#147;<I>Revenue from Contracts with Customers
(Topic 606): Deferral of the Effective Date</I>,&#148; which deferred the effective date of the previously issued revenue recognition guidance by one year. This guidance will be effective for public companies for annual and interim periods beginning
after December&nbsp;15, 2017. For all other entities, including emerging growth companies, this standard is effective for annual reporting periods beginning after December&nbsp;15, 2018, and interim periods with annual periods beginning after
December&nbsp;15, 2019. Early adoption is permitted. This update provides a single comprehensive model for accounting for revenue from contracts with customers. The model requires that revenue recognized reflect the actual consideration to which the
entity expects to be entitled in exchange for the goods or services defined in the contract, including in situations with multiple performance obligations. In April 2016 and May 2016, the FASB issued ASU 2016-10, &#147;<I>Revenue from Contracts with
Customers (Topic 606): Identifying Performance Obligations and Licensing</I>&#148; and ASU 2016-12, &#147;<I>Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients</I>,&#148; respectively. Both of these
updates provide improvements and clarification to the previously issued revenue recognition guidance. The new standard can be adopted using one of two methods: the full retrospective method, which requires the standard to be applied to each prior
period presented, or the modified retrospective method, which requires the cumulative effect of adoption to be recognized as an adjustment to opening retained earnings in the period of adoption. The new standard will result in additional
revenue-related disclosures in the notes to the Company&#146;s financial statements. The majority of the Company&#146;s revenue relates to the sales of NeuroStar Advanced Therapy Systems and treatment sessions to various customers. The Company is
still analyzing the impact of ASU 2014-09 on its financial statements and disclosures. The Company is also continuing to evaluate the impact on certain less significant revenue streams. In addition, the new standard will require changes to the
Company&#146;s processes and controls to support additional disclosures, and the Company is in the process of identifying and designing such changes to processes and controls to ensure readiness. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), with guidance regarding the accounting for and disclosure of leases.
The update requires lessees to recognize all leases, including operating leases, with a term greater than 12 months on the balance sheet. This update also requires lessees and lessors to disclose key information about their leasing transactions.
This guidance will be effective for public companies for annual and interim periods beginning after December&nbsp;15, 2018. For all other entities, including emerging growth companies, this standard is effective for annual reporting periods
beginning after December 15, 2019, and interim periods within annual periods beginning after December 15, 2020. Early adoption is permitted. The Company is currently evaluating the effect that this guidance will have on its financial statements and
related disclosures. The Company expects the implementation of this standard to have an impact on its financial statements and related disclosures as its aggregate future minimum lease payments were $1.7&nbsp;million as of December&nbsp;31, 2017
under its current non-cancelable office lease with an expiration date in 2021. The Company anticipates recognition on its balance sheet of an additional asset and corresponding liability related to this lease. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-13 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In March 2016, the FASB issued ASU 2016-09, Compensation&#151;Stock Compensation (Topic
718): &#147;<I>Improvements to Employee Share-Based Payment Accounting</I>,&#148; with guidance regarding the simplification of accounting for share-based payment award transactions. The update changes the accounting for such areas as the accounting
and cash flow classification for excess tax benefits and deficiencies; forfeitures; and tax withholding requirements and cash flow classification. This guidance was effective for public companies for annual and interim periods beginning after
December&nbsp;15, 2016. The Company adopted the new guidance effective January&nbsp;1, 2017, and it did not have a material effect on its financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In May 2017, the FASB issued ASU 2017-09, Compensation&#151;Stock Compensation (Topic 718): &#147;<I>Scope of Modification Accounting</I>,&#148; which provides guidance about which changes
to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. This guidance will be effective for all entities for annual periods, and interim periods within those annual periods,
beginning after December&nbsp;15, 2017, with early adoption permitted. The amendments in this ASU should be applied prospectively to an award modified on or after the adoption date. The Company will adopt the new guidance effective January&nbsp;1,
2018, and it is not expected to have a material effect on its financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In August 2016, the FASB issued ASU
2016-15, Statement of Cash Flows (Topic 230): &#147;<I>Classification of Certain Cash Receipts and Cash Payments</I>,&#148; with guidance intended to reduce the diversity in practice regarding how certain cash receipts and cash payments are
presented and classified within the statement of cash flows. The update addresses eight specific cash flow issues including: debt prepayment or debt extinguishment costs; the settlement of zero-coupon debt instruments or other debt instruments with
coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the
settlement of corporate-owned life insurance policies or bank-owned life insurance policies; distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and
application of the predominance principle. This guidance will be effective for public companies for fiscal years beginning after December&nbsp;15, 2017, and interim periods within those fiscal years. The Company will adopt the new guidance effective
January&nbsp;1, 2018, and it is not expected to have a material effect on its financial statements. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>5.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>FAIR VALUE MEASUREMENT AND FINANCIAL INSTRUMENTS </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The carrying values of cash equivalents, accounts receivable, prepaids and other current assets, and accounts payable on the Company&#146;s balance sheets approximated their fair values as
of December&nbsp;31, 2016 and 2017 due to their short-term nature. The carrying values of the Company&#146;s current and previous credit facilities approximated their fair values as of December&nbsp;31, 2016 and 2017 due to their variable interest
rates. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-14 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Certain of the Company&#146;s financial instruments are measured at fair value using a
three-level hierarchy that prioritizes the inputs used to measure fair value. This hierarchy maximizes the use of observable inputs and minimizes the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Level&nbsp;1</U>:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Inputs are quoted prices for identical instruments in active markets.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Level&nbsp;2</U>:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Inputs are quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; or
model-derived valuations whose inputs are observable or whose significant value drivers are observable.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Level&nbsp;3</U>:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Inputs are unobservable and reflect the Company&#146;s own assumptions, based on the best information available, including the Company&#146;s own
data.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following tables set forth the carrying amounts and fair values of the Company&#146;s financial
instruments as of December&nbsp;31, 2016 and 2017 (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31, 2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Fair Value Measurement Based on</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Carrying<BR>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Fair Value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Quoted<BR>Prices<BR>In Active<BR>Markets<BR>(Level 1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Significant<BR>other<BR>Observable<BR>Inputs<BR>(Level 2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Significant<BR>Unobservable<BR>Inputs<BR>(Level 3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Assets</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Money market funds (cash equivalents)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Liabilities</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">459</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">459</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">459</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31, 2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Fair Value Measurement Based on</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Carrying<BR>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Fair Value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Quoted<BR>Prices In<BR>Active<BR>Markets<BR>(Level 1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Significant<BR>other<BR>Observable<BR>Inputs<BR>(Level 2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Significant<BR>Unobservable<BR>Inputs<BR>(Level&nbsp;3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Assets</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Money market funds (cash equivalents)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,149</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,149</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,149</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Liabilities</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">478</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">478</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">478</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-15 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Significant changes in the estimated fair value of the Company&#146;s convertible
preferred stock will significantly impact the valuation of the convertible preferred stock warrant liability. The fair value of the convertible preferred stock warrant liability was estimated using the Black-Scholes option pricing model and the
following inputs and assumptions as of December&nbsp;31, 2016 and 2017: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="7" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Series E</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Series F</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Series E</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Series F</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Estimated fair value of convertible preferred stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.52</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.51</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.33</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.38</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Exercise price</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.6746</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.3356</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.6746</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.3356</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Remaining term (in years)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6.0</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.1-6.7</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5.0</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.1-7.0</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Risk-free interest rate</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.1%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><FONT STYLE="white-space:nowrap">1.7%-2.2%</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.2%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><FONT STYLE="white-space:nowrap">2.0%-2.3%</FONT></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Expected volatility</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">39%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">38%-40%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">43%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">43%-44%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Dividend yield</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0%</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table presents the changes in Level 3 instruments measured on a recurring basis for the
years ended December&nbsp;31, 2016 and 2017 (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="90%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance at December&nbsp;31, 2015</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">216</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Issuance of warrants</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">135</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Change in fair value</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">108</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance at December&nbsp;31, 2016</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">459</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Issuance of warrants</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">290</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Change in fair value</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(271</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance at December 31, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">478</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>6.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>ACCOUNTS RECEIVABLE </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table presents the composition of accounts receivable, net as of December&nbsp;31, 2016 and 2017 (in thousands): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gross accounts receivable&#151;trade</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,920</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,684</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Less: Allowances for doubtful accounts</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(343</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(417</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accounts receivable, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,267</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Bad debt expense was $0.1 million for each of the years ended December&nbsp;31, 2016 and 2017. The
following table presents a rollforward of the allowance for doubtful accounts (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Balance&nbsp;at<BR>Beginning<BR>of Period</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Bad Debt<BR>Expense<BR>Recognized</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B><FONT STYLE="white-space:nowrap">Write-offs&nbsp;
of</FONT><BR>Uncollectible<BR>Balances</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Balance<BR>at&nbsp;End&nbsp;of<BR>Period</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Year ended December 31, 2016</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(274</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(343</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Year ended December 31, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(343</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(116</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">42</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(417</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-16 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>7.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>PROPERTY AND EQUIPMENT </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table presents the composition of property and equipment, net as of December&nbsp;31, 2016 and 2017 (in thousands): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Laboratory equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Office equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">542</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">487</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Computer equipment and software</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">431</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">680</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Manufacturing equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">273</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">273</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Leasehold improvements</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">153</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">153</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Rental equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,743</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,447</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Property and equipment, gross</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,292</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,190</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Less: Accumulated depreciation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1,664</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1,831</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Property and equipment, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,628</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,359</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Depreciation expense was $0.7 million and $0.6 million for the years ended December&nbsp;31, 2016 and
2017, respectively. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>8.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>ACCRUED EXPENSES </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table presents the composition of accrued expenses as of December&nbsp;31, 2016 and 2017 (in thousands): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Compensation and related benefits</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,361</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,465</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Consulting and professional fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">453</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">461</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">751</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">455</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">620</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Warranty</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">184</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">570</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales tax payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">308</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">322</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Interest payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">146</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">188</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">376</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">388</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accrued expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,034</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,511</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-17 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>9.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>DEBT </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The
following table presents the composition of debt as of December&nbsp;31, 2016 and 2017 (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="75%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Outstanding principal</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accrued final payment fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">682</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">940</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Less debt discounts</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(544</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1,384</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total long-term debt, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,138</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,556</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Less current portion of long-term debt, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(4,491</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Long-term debt, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15,647</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,556</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Current $35.0 Million Credit Facility </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In March 2017, the Company entered into a new loan and security agreement with Oxford Finance LLC, or Oxford, for a credit facility that replaced its previous $25.0 million credit facility
with Oxford and which allows it to borrow up to $35.0 million in three tranches of term loans: a Term A Loan in the amount of $25.0 million, which was drawn down immediately upon closing in March 2017, a Term B Loan in the amount of $5.0 million,
which was drawn down in December 2017, and a Term C Loan in the amount of $5.0 million, which will become available to the Company upon the achievement of $45.0 million of trailing twelve month revenues in 2018. Each term loan accrues interest from
the date of borrowing through the date of repayment at a floating per annum rate of interest, which resets monthly and is equal to the greater of 8.15% or the 30 day U.S. LIBOR rate on the last business day of the month plus 7.38%. The Company is
also required to issue to Oxford at the date of each borrowing warrants to purchase its Series F or later series of convertible preferred stock or, if it is a public company at the date of borrowing, warrants to purchase its common stock, with a
seven year term and in an amount equal to 3.95% of the first $5.0 million of each tranche borrowed. The credit facility matures and all amounts borrowed thereunder are due on March&nbsp;1, 2022. As of December&nbsp;31, 2017, the Company had borrowed
and had outstanding an aggregate of $30.0 million of principal under the credit facility. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Term A Loan features an
interest-only period through March 2019, during which time the Company is required to make monthly interest payments, after which time the Company is required to make monthly payments of principal and interest based on a 36-month amortization
schedule. However, if $45.0 million of trailing twelve month revenues is achieved in 2018, the interest-only period can be extended for an additional 12&nbsp;months through March 2020 and the amortization period then becomes 24 months. In connection
with the drawdown of the Term A Loan, the Company issued to the lender warrants to purchase 588,498 shares of its Series F convertible preferred stock, which have an exercise price of $0.3356 per share and which expire in March 2024. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Term B Loan features an interest-only period through March 2019, during which time the Company is required to make monthly interest
payments, after which time the Company is required to make monthly payments of principal and interest based on a 36-month amortization schedule. However, if $45.0 million of trailing twelve month revenues is achieved in 2018, then the interest-only
period can be extended for an additional 12 months through March 2020 and the amortization period then becomes 24 months. In connection with the drawdown of the Term B Loan, the Company issued to the lender warrants to purchase 588,498 shares of its
Series F convertible preferred stock, which have an exercise price of $0.3356 per share and which expire in December 2024. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-18 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition to principal and interest payments due under the credit facility, the
Company is required to make final payment fees to the lender due upon the earlier of prepayment or maturity of each tranche, which are equal to 8%, 7% and 6.5% of the principal amounts of the Term A, Term B and Term C Loans, respectively, except
that if the interest-only periods on the Term A and Term B Loans are extended then the final payment fees increase to 8.5%, 7.5% and 7% of the principal amounts of the Term A, Term B and Term C Loans, respectively. The Company accrues the estimated
final payment fees using the effective interest rate, with a charge to non-cash interest expense, over the term of borrowing for each tranche. As of December 31, 2017, the effective interest rates for the Term A and Term B Loans were 10.7% and
11.6%, respectively. If the Company prepays its term loans prior to their respective scheduled maturities, it will also be required to make prepayment fees to the lender equal to 3% if prepaid on or before the first anniversary of funding, 2% if
prepaid after the first and on or before the second anniversary of funding or 1% if prepaid after the second anniversary of funding of the principal amounts borrowed. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s obligations under the credit facility are secured by a first priority security interest in substantially all of its assets, other than its intellectual property. The
Company has agreed not to pledge or otherwise encumber any of its intellectual property. The loan and security agreement related to the credit facility includes a financial maintenance covenant that requires the Company to achieve at least 75% of
its trailing 12-month forecasted revenues, as measured each month in accordance with a forecast that the Company provided to Oxford upon signing the agreement and future forecasts that the Company is required to deliver to the lenders each year for
the life of the credit facility, as well as customary affirmative and negative covenants. The Company was in compliance with all of the covenants under its credit facility as of December&nbsp;31, 2017. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The loan and security agreement related to the credit facility contains events of default, including, without limitation, events of
default upon: (i)&nbsp;failure to make payment pursuant to the terms of the agreement; (ii)&nbsp;violation of covenants; (iii)&nbsp;material adverse changes to the Company&#146;s business; (iv)&nbsp;attachment or levy on the Company&#146;s assets or
judicial restraint on its business; (v)&nbsp;insolvency; (vi)&nbsp;significant judgments, orders or decrees for payments by the Company not covered by insurance; (vii)&nbsp;incorrectness of representations and warranties; (viii)&nbsp;incurrence of
subordinated debt; (ix)&nbsp;revocation of governmental approvals necessary for the Company to conduct its business; and (x)&nbsp;failure by the Company to maintain a valid and perfected lien on the collateral securing the borrowing. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Based on a 36-month amortization of the outstanding principal amounts of the Term A and Term B Loans beginning on April&nbsp;1, 2019 as
discussed above, the following table sets forth by year the Company&#146;s required future principal payments (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:18pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Year:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Principal<BR>Payments</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2019</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2020</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2021</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2022</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total principal payments</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-19 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Previous $25.0 Million Credit Facility </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Prior to March 2017, the Company had a $25.0 million credit facility in place with Oxford, which it entered into in February 2014 and
which allowed it to borrow up to $25.0 million in three tranches of term loans: a Term A Loan in the amount of $15.0 million, a Term B Loan in the amount of $5.0&nbsp;million and a Term C Loan in the amount of $5.0 million, which was never drawn
down. Each term loan accrued interest at per annum rates ranging from 8.5% to 8.9%. This facility featured an interest-only period on all tranches through March 2017, and the Company was also required to issue convertible preferred stock warrants to
the lender at the time of borrowing of each tranche. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition to principal and interest payments due under the previous
$25.0 million credit facility, the Company was required to make final payment fees to the lender upon the earlier of prepayment or maturity and equal to 8.5% and 4.7% of the principal amounts of the Term A and Term B Loans, respectively. The Company
accrued final payment fees using the effective interest rate, with a charge to non-cash interest expense, over the term of borrowing and until its entry into the current credit facility in March 2017, at which time the Company paid the lender $1.0
million in satisfaction of all final payment fee liabilities due under the prior credit facility. As of December 31, 2016, the effective interest rates for the previous Term A and Term B Loans were 10.4% and 11.6%, respectively. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Management evaluated whether the current credit facility entered into in March 2017 represented a debt modification or extinguishment in
accordance with ASC 470-50, Debt&#151;Modifications and Extinguishments. Upon determining that the change in cash flows between the previous and current credit facilities was not greater than 10%, management accounted for the transaction as a debt
modification. As of March 2017, the unamortized balance of deferred debt issuance costs incurred in connection with the $25.0 million credit facility, and certain additional deferred debt issuance costs incurred in connection with entry into the
current credit facility, are being amortized to interest expense through March 2022 utilizing the effective interest method. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For the year ended December&nbsp;31, 2016, the Company recognized interest expense of $1.8 million, of which $1.4 million was cash and
$0.4 million was non-cash interest expense related to the amortization of deferred debt issuance costs and accrual of final payment fees. For the year ended December&nbsp;31, 2017, the Company recognized interest expense of $2.8 million, of which
$2.1 million was cash and $0.7 million was non-cash interest expense related to the amortization of deferred debt issuance costs and accrual of final payment fees. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>10.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#146; DEFICIT </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Common Stock </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s amended certificate of
incorporation authorizes the issuance of 407.0 million shares of common stock, $0.01 par value per share, of which 0.2 million were issued and outstanding as of December 31, 2017. In addition, the Company is required to reserve and keep available
out of its authorized but unissued shares of common stock a number of shares sufficient to effect the conversion into common stock of all outstanding shares of convertible preferred stock and convertible preferred stock warrants, convertible
preferred stock warrants issuable upon borrowing the Term C Loan under the current $35.0 million credit facility and stock options granted and shares available for grant under its stock incentive plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-20 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes the total number of shares of the Company&#146;s common
stock issued and reserved for issuance as of December&nbsp;31, 2017 (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,&nbsp;2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Shares of common stock issued</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">231</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Shares of common stock reserved for issuance for:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock outstanding:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series A-1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">166</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series A-2</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">898</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series B</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">697</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series C</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,063</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,705</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series E</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,534</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,531</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series G</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrants outstanding:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series E</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">91</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F convertible preferred stock warrants issuable upon Term C Loan borrowing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Stock options outstanding</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,444</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Shares available for grant under stock incentive plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">246</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total shares of common stock issued and reserved for issuance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14,040</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Shares of Series A-2 convertible preferred stock convert to common stock at a ratio of 0.03539 shares of common stock per share of
Series A-2 convertible preferred stock. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Shares of Series B convertible preferred stock convert to common stock at a ratio of 0.04103 shares of common stock per share of Series
B convertible preferred stock. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Shares of Series C convertible preferred stock convert to common stock at a ratio of 0.05071 shares of common stock per share of Series
C convertible preferred stock. </FONT></P></TD></TR></TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each share of common stock entitles the holder to one vote on all
matters submitted to a vote of the Company&#146;s stockholders. Subject to preferences that may apply to any outstanding preferred stock, holders of common stock are entitled to receive proportionally any dividends that the Company&#146;s board of
directors may declare out of funds legally available for that purpose on a non-cumulative basis. The Company has never paid, and for the foreseeable future does not expect to pay, a dividend on its common stock. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Convertible Preferred Stock </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In June 2017, the Company amended its certificate of incorporation to increase the number of shares of convertible preferred stock, $0.01 par value per share, authorized for issuance from
266.8&nbsp;million to 308.6&nbsp;million shares, of which the Company has designated and issued Series A-1, Series A-2, Series B, Series C, Series D, Series E, Series F and Series G shares. Series A-1 through Series E shares of convertible preferred
stock are referred to collectively as Junior Securities and are subordinate to shares of Series G and Series F shares of convertible preferred stock. In June 2017, the Company sold an aggregate of 40.6&nbsp;million shares of its Series G convertible
preferred stock in a private placement to certain of its existing investors, each taking their pro rata or super pro rata share of the placement, as well as a new investor, at a purchase price of $0.3696 per share and received aggregate net proceeds
of $14.8 million. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-21 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
All of the Company&#146;s convertible preferred stock is classified outside of stockholders&#146; deficit because the shares contain deemed liquidation rights that are a contingent redemption
feature not solely within the control of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes the Company&#146;s outstanding
convertible preferred stock as of December&nbsp;31, 2016 and 2017: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Shares<BR>Authorized<BR>and<BR>Designated<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Shares<BR>Issued&nbsp;and<BR>Outstanding<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Carrying<BR>Value<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Liquidation<BR>Value<BR>per&nbsp;Share</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Liquidation<BR>Value<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series A-1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.0617</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">296</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series A-2</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">25,385</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">25,385</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16,428</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.2052</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,209</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series B</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">17,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">17,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16,859</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3168</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,386</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series C</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.5253</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">49,426</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">49,426</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,970</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.2874</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14,205</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series E</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">44,873</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">44,471</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.5144</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">22,876</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">105,567</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">102,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">43,513</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34,343</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance&nbsp;at&nbsp;December&nbsp;31, 2016</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">268,009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">264,374</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">172,311</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">93,324</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series G</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">40,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">40,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14,825</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3696</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance&nbsp;at&nbsp;December&nbsp;31, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">308,593</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">304,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">108,324</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Conversion</U> </FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each share and series of convertible preferred stock is convertible into common stock at any time at the option of the holder thereof at the conversion price then in effect (each subject
to adjustments upon the occurrence of certain dilutive events). At December&nbsp;31, 2017, the conversion price for Series A-1, Series&nbsp;D, Series E, Series F and Series G shares was equal to the original issue price, resulting in a common stock
conversion ratio of 1:0.0345. At December&nbsp;31, 2017, as a result of past anti-dilution adjustments, the conversion price for Series A-2, Series B and Series C shares was below the original issue price, resulting in common stock conversion ratios
of 1:0.03539, 1:0.04103 and 1:0.05071, respectively. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">All shares of each series of convertible preferred stock are
convertible into common stock at the affirmative election of the holders of at least (i)&nbsp;60% of the outstanding shares of convertible preferred stock, (ii)&nbsp;60% of the outstanding Series E convertible preferred stock, (iii)&nbsp;75% of the
outstanding Series&nbsp;F convertible preferred stock and (iv)&nbsp;55% of the outstanding Series G convertible preferred stock. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company may at any time require the conversion of all outstanding convertible preferred stock upon a qualified initial public offering of its common stock, as defined in the
Company&#146;s certificate of incorporation. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Liquidation Preferences</U> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the event of a liquidation, dissolution or winding up of the Company, either voluntary or involuntary, or in the event of a deemed
liquidation event, which includes a sale of the Company as defined in the Company&#146;s certificate of incorporation, holders of Series G convertible preferred stock are entitled to receive, in preference to all other stockholders, an amount equal
to their original investment amount plus any declared and unpaid dividends. If upon the occurrence of such event the assets and funds available for </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-22 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
distribution are insufficient to pay such holders the full amount to which they are entitled, then the entire assets and funds legally available for distribution shall be distributed ratably
among the holders of the Series G convertible preferred stock in proportion to the full amounts to which they would otherwise be entitled. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After payment in full of the liquidation preference of the Series G convertible preferred stock, holders of Series F convertible preferred stock are entitled to receive, in preference to
all holders of Junior Securities and common stock, an amount equal to their original investment amount plus any declared and unpaid dividends. If upon the occurrence of such event the assets and funds available for distribution are insufficient to
pay such holders the full amount to which they are entitled, then the entire remaining assets and funds legally available for distribution shall be distributed ratably among the holders of the Series F convertible preferred stock in proportion to
the full amounts to which they would otherwise be entitled. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After payment in full of the liquidation preferences of the
Series G and Series F convertible preferred stock, holders of Junior Securities are entitled to receive an amount equal to $59.2 million in the aggregate. If upon the occurrence of such event the assets and funds available for distribution are
insufficient to pay such holders the full amount to which they are entitled, then the entire assets and funds legally available for distribution shall be distributed ratably among the holders of the Junior Securities in proportion to the full
amounts to which they would otherwise be entitled. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After payment in full of the liquidation preferences of the Series G,
Series F and Junior Securities convertible preferred stock, holders of Series F convertible preferred stock are entitled to receive an additional liquidation preference at an amount equal to $0.1678 per share. If upon the occurrence of such event
the assets and funds available for distribution are insufficient to pay such holders the full amount to which they are entitled, then the entire assets and funds legally available for distribution shall be distributed ratably among the holders of
the Series F convertible preferred stock in proportion to the full amounts to which they would otherwise be entitled. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After
payment in full of the liquidation preferences of the Series G, Series F and Junior Securities convertible preferred stock and the additional liquidation preference for holders of Series F convertible preferred stock, holders of common stock and
holders of Junior Securities, Series F and Series G convertible preferred stock are entitled to receive a liquidation preference until the amount distributed to holders of the Series F convertible preferred stock equals $1.0068 plus declared but
unpaid dividends on each share and then to the holders of common stock and holders of Junior Securities and Series G convertible preferred stock until the aggregate amount distributed to such holders equals the amount distributed to holders of
Series F convertible preferred stock divided by the Series F ownership percentage. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After payments of the above liquidation
preferences have been made, any remaining assets shall be distributed ratably to holders of common stock and holders of Series G, Series F and Junior Securities convertible preferred stock on an &#147;as-converted&#148; basis. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Dividends</U> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each class of convertible preferred stock is entitled to receive non-cumulative annual dividends at a rate of 9.0%, if and when declared
by the Company&#146;s board of directors. The holders of Series G convertible preferred stock are entitled to dividends in preference to holders of any other class or series of the Company&#146;s stock. The holders of Series F convertible preferred
stock are entitled to dividends in preference to all holders of Junior Securities and holders of common stock. The holders of Junior Securities are entitled to dividends in preference to holders of common stock. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-23 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the event a dividend is declared to common stockholders, holders of each class of
convertible preferred stock will also receive an equivalent dividend on an &#147;as-converted&#148; basis. The Company has never paid, and for the foreseeable future does not expect to pay, a dividend on its common stock. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Voting</U> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The holders of each class of convertible preferred stock are entitled to one vote for each share of common stock into which their shares
of convertible preferred stock may be converted and, subject to certain convertible preferred stock class votes specified in the Company&#146;s certificate of incorporation or as required by law, the holders of convertible preferred stock and common
stock vote together on an &#147;as-converted&#148; basis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Convertible Preferred Stock Warrants </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes the Company&#146;s outstanding convertible preferred stock warrants as of December&nbsp;31, 2017:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="60%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Warrants<BR>Outstanding<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Exercise<BR>Price</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Expiration<BR>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series E</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">402</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.6746</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Dec-2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">878</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Feb-2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">589</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Aug-2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">589</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Mar-2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">588</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Dec-2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,046</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>11.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>LOSS PER SHARE </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s basic loss per common share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period. The
Company&#146;s restricted stock awards (non-vested shares) are issued and outstanding at the time of grant but are excluded from the Company&#146;s computation of weighted-average shares outstanding in the determination of basic loss per share until
vesting occurs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">A net loss cannot be diluted, so when the Company is in a net loss position, basic and diluted loss per
common share are the same. If in the future the Company achieves profitability, the denominator of a diluted earnings per common share calculation will include both the weighted-average number of shares outstanding and the number of common stock
equivalents, if the inclusion of such common stock equivalents would be dilutive. Dilutive common stock equivalents potentially include warrants, stock options and non-vested restricted stock awards using the treasury stock method, along with the
effect, if any, from the potential conversion of outstanding securities, such as convertible preferred stock. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-24 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following potentially dilutive securities outstanding as of December&nbsp;31, 2016
and 2017 have been excluded from the denominator of the diluted loss per share of common stock outstanding calculation (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Stock options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,826</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,444</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Non-vested restricted stock awards</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrants</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">105</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Shares of convertible preferred stock &#147;as-converted&#148;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,594</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,994</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The unaudited pro forma net loss per share is computed using the weighted-average number of shares
of common stock outstanding after giving effect to the conversion of all issued and outstanding shares of convertible preferred stock into shares of common stock immediately prior to the closing of the Company&#146;s proposed initial public offering
as if the conversion had occurred at the later of the beginning of the reporting period or the issuance date of the convertible preferred stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes the calculation of unaudited pro forma basic and diluted net loss per share of common stock for the year ended December&nbsp;31, 2017 (in thousands, except
per share data): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="85%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Numerator:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(16,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Denominator:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Weighted-average common shares outstanding, basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">186</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Effect of pro forma adjustments:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Conversion of convertible preferred stock into common stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,415</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma weighted-average common shares outstanding, basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,601</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma net loss per share of common stock outstanding, basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1.51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>12.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>SHARE-BASED COMPENSATION </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>2003 Incentive Stock Plan </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In April 2003 (and as
subsequently amended), the Company adopted the 2003 Stock Incentive Plan (2003 Plan), which authorizes the issuance of up to 2.9&nbsp;million shares in the form of restricted stock, stock appreciation rights and stock options to the Company&#146;s
directors, employees and consultants. The amount and terms of grants are determined by the Company&#146;s board of directors. To date, the Company has granted restricted stock awards only to an independent member of its board of directors and only
as compensation for board service. All stock options granted to date have had exercise prices equal to the estimated fair value, as determined by the board of directors, of the underlying common stock on the date of the grant. The contractual term
of stock options may be up to 10 years, and stock options are exercisable in cash or as otherwise determined by the board of directors. Generally, stock options vest 25% upon the first anniversary of the date of grant and the remainder ratably
monthly thereafter for 36 months. As of December&nbsp;31, 2017, there were 0.2 million shares available for future issuance under the 2003 Plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-25 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The amount of share-based compensation expense recognized by the Company by location in
its statements of operations for the years ended December&nbsp;31, 2016 and 2017 is as follows (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="75%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Year&nbsp;ended<BR>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2016&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">141</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">226</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">37</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">111</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">161</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">496</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Stock Options </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes the Company&#146;s stock option activity for the years ended December&nbsp;31, 2016 and 2017: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Number of<BR>Shares under<BR>Option<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Weighted-<BR>average<BR>Exercise&nbsp;Price<BR>per Option</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Weighted-<BR>average<BR>Remaining<BR>Contractual<BR>Life&nbsp;(in&nbsp;
years)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Aggregate<BR>Intrinsic<BR>Value<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Outstanding at December 31, 2015</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,767</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Granted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">255</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Exercised</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Forfeited</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(161</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5.68</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Expired</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">19.63</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Outstanding at December 31, 2016</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,826</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.07</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Granted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">967</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.03</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Exercised</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1.05</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Forfeited</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(316</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Outstanding at December&nbsp;31, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,444</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.39</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">515</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Exercisable at December&nbsp;31, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,190</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">389</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Vested and expected to vest at December 31, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,444</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.39</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">515</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>   <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company recognized $0.2 million and $0.4 million of share-based compensation expense related
to stock options during the years ended December&nbsp;31, 2016 and 2017, respectively. As of December&nbsp;31, 2017, there was $1.4 million of total unrecognized compensation cost related to non-vested stock options which the Company expects to
recognize over a weighted-average period of 3.2 years. The weighted-average grant-date fair value of stock options granted during the years ended December&nbsp;31, 2016 and 2017 was estimated at $1.16 and $1.45 per option, respectively. The total
intrinsic value of stock options exercised during the years ended December&nbsp;31, 2016 and 2017 was de minimis and $0.1 million, respectively. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-26 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For the years ended December&nbsp;31, 2016 and 2017, the grant-date fair value of stock
options was estimated at the time of grant using the following weighted-average inputs and assumptions in the Black-Scholes option pricing model: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="81%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Estimated fair value of common stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Exercise price</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Expected term (in years)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Risk-free interest rate</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1.4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Expected volatility</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">44.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">48.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Dividend yield</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
</TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Restricted Stock Awards </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes the Company&#146;s restricted stock award activity for the years ended December&nbsp;31, 2016 and 2017: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B><FONT STYLE="white-space:nowrap">Non-vested</FONT><BR>Restricted<BR>Stock&nbsp;
Awards<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Weighted-<BR>average<BR><FONT STYLE="white-space:nowrap">Grant-date</FONT><BR>Fair&nbsp;
Value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Non-vested at December 31, 2015</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">n/a</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Granted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">42</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.03</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Vested</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.03</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Non-vested at December 31, 2016</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">22</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.03</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Granted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Vested</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.90</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Non-vested at December 31, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>   <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company recognized $0.1 million of share-based compensation expense related to restricted
stock awards during the year ended December&nbsp;31, 2017. As of December&nbsp;31, 2017, there was minimal unrecognized compensation cost related to non-vested restricted stock awards which the Company expects to recognize over a weighted-average
period of 1.3 years. The grant-date fair value per share of restricted stock awards granted during the years ended December&nbsp;31, 2016 and 2017 was estimated at $2.03 and $4.06 per share, respectively. The total fair value at the vesting date of
restricted stock awards vested during the years ended December&nbsp;31, 2016 and 2017 was minimal and $0.1 million, respectively. </FONT></P>  <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>13.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>EMPLOYEE BENEFIT PLANS </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>401(k) Defined Contribution Plan </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company maintains a
401(k) defined contribution retirement plan which covers all of its employees. Employees are eligible to participate on the first of the month following their date of hire. Under the 401(k) plan, participating employees may defer up to 100% of their
pre-tax salary but not more than statutory limits. There is currently no employer matching of employee contributions and employee contributions vest immediately. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-27 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>14.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>INCOME TAXES </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s loss before income taxes was $11.2 million and $16.1 million for the years ended December&nbsp;31, 2016 and 2017, respectively, and was generated entirely in the United
States. The Company did not record current or deferred income tax expense or benefit during the years ended December&nbsp;31, 2016 and 2017. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">A reconciliation of the statutory United States federal income tax rate to the Company&#146;s effective tax rate is as follows: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="78%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Tax&nbsp;Year&nbsp;ended<BR>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">U.S. federal statutory income tax rate</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">State and local taxes, net of federal benefit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Nondeductible expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(0.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development credits</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Tax rate change and true-up</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(138.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Change in valuation allowance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(36.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Effective income tax rate</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The tax effects of temporary differences that gave rise to significant portions of the deferred tax
assets were as follows (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="75%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred tax assets:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net operating loss carryforwards</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">56,441</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">41,430</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development credits</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,854</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Share-based compensation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">295</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">316</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accruals</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">778</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">753</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Capitalized start-up costs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,729</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,530</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other temporary differences</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">352</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">253</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gross deferred tax assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">63,449</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">47,341</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Less: Valuation allowance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(63,449</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(47,341</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net deferred taxes</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In assessing the realizability of the net deferred tax asset, the Company considers all relevant positive
and negative evidence in determining whether it is more likely than not that some portion or all of the deferred income tax assets will not be realized. The realization of the gross deferred tax assets is dependent on several factors, including the
generation of sufficient taxable income prior to the expiration of the net operating loss carryforwards. Management believes that it is more likely than not that the Company&#146;s deferred income tax assets will not be realized. As such, there is a
full valuation allowance against the net deferred tax assets as of December&nbsp;31, 2016 and 2017. The valuation allowance increased by $4.1 million during the year ended December&nbsp;31, 2016 due primarily to the generation of net operating
losses during the year and decreased by $16.1 million during the year ended December&nbsp;31, 2017 due primarily to the decrease in the federal income tax rate from 34% to 21%. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-28 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes carryforwards of federal net operating losses and tax
credits as of December&nbsp;31, 2017 (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Expiration<BR>Beginning&nbsp;in</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Federal net operating losses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">167,396</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">State net operating losses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">96,392</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development credits</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Under the Tax Reform Act of 1986 (1986 Act), the net operating loss and tax credit carryforwards are
subject to review and possible adjustment by the Internal Revenue Service and state tax authorities. Net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the
ownership interest of significant shareholders over a three-year period in excess of 50 percent, as defined under Sections 382 and 383 of the Internal Revenue Code, respectively, as well as similar state provisions. This could limit the amount of
tax attributes that can be utilized annually to offset future taxable income or tax liabilities. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership
changes may further affect the limitation in future years. The Company has not done an analysis to determine whether or not ownership changes, as defined by the 1986 Act, have occurred since inception. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company will recognize interest and penalties related to uncertain tax positions in income tax expense. As of December&nbsp;31, 2017,
the Company had no accrued interest or penalties related to uncertain tax positions and no amounts have been recognized in the Company&#146;s statements of operations. Due to net operating loss and tax credit carry forwards that remain unutilized,
income tax returns for tax years from inception through 2016 remain subject to examination by the taxing jurisdictions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In
December 2017, the Tax Cuts and Jobs Act (2017 Tax Act) was enacted. The 2017 Tax Act includes a number of changes to existing United States tax laws that impact the company, most notably a reduction of the United States corporate income tax rate
from 35% (34% for the Company) to 21% for tax years beginning after December&nbsp;31, 2017. The 2017 Tax Act also provides for a one-time transition tax on certain foreign earnings and the acceleration of depreciation for certain assets placed into
service after September&nbsp;27, 2017, as well as prospective changes beginning in 2018, including repeal of the domestic manufacturing deduction, acceleration of tax revenue recognition, capitalization of research and development expenditures,
additional limitations on executive compensation and limitations on the deductibility of interest. Due to the enactment of the 2017 Tax Act, the Company reduced both its gross deferred tax assets and the related valuation allowance by $22.2 million
as of December&nbsp;31, 2017, resulting in no net effect on the Company&#146;s statement of operations for the year ended December&nbsp;31, 2017. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>15.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>COMMITMENTS </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Leases </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In January 2013, the Company entered into a
93-month lease for its new headquarters office and warehouse. The Company also rents certain office equipment. The Company recognizes rent expense on a straight-line basis over the lease period and has accrued for rent expense incurred but not yet
paid. Landlord allowances for tenant improvements are deferred and recognized as a reduction to rent expense on a straight-line basis and over the remaining lease term. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-29 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Rent expense under operating leases was $0.6 million and $0.5 million for the years
ended December&nbsp;31, 2016 and 2017, respectively. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following is a schedule of future minimum annual payments at
December&nbsp;31, 2017 under non-cancelable operating lease agreements (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="88%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For the years ending December&nbsp;31,</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">490</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2019</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">547</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2020</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">560</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2021</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">88</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total future minimum lease payments</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,685</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Executive Employment Agreements </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company has entered into an employment agreement and offer letters with certain key executives, providing for compensation and severance in certain circumstances, as defined in the
agreements. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>16.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>DISTRIBUTION AGREEMENT WITH TEIJIN PHARMA LIMITED </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In October 2017, the Company entered into a seven and a half year distribution agreement with Teijin Pharma Limited, or Teijin, for the exclusive distribution of its NeuroStar Advanced
Therapy System to customers who will treat patients with MDD in Japan. Under the distribution agreement, Teijin is generally restricted from selling competing products in Japan. The distribution agreement provides that the Company will have primary
responsibility for obtaining reimbursement approval for use of NeuroStar Advanced Therapy System for the treatment of MDD in Japan, and Teijin will promote the sales of NeuroStar Advanced Therapy System for treatment of MDD in Japan. The Company has
agreed to provide sales and technical support training to Teijin for its NeuroStar Advanced Therapy Systems. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Teijin is
required to purchase minimum dollar values of NeuroStar Advanced Therapy Systems and treatment sessions from the Company following reimbursement approval by the Japanese Ministry of Health, Labour and Welfare, or JMHLW, for TMS treatment for MDD
(or, if such approval requires certified training on the NeuroStar Advanced Therapy System by a third party, then upon the first psychiatrist being issued his or her training certification). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In 2017, under the distribution agreement with Teijin, the Company received an upfront payment of $0.75 million and a milestone payment of $2.0 million following JMHLW&#146;s approval of
marketing the NeuroStar Advanced Therapy System for the treatment of MDD in Japan. These upfront and milestone payments have been deferred and are being recognized as revenue over the seven and one half year term of the agreement. Teijin is required
to pay the Company a milestone payment tied to JMHLW issuing reimbursement for use of its products for the treatment of MDD in Japan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The distribution agreement is scheduled to expire on March&nbsp;31, 2025, subject to earlier termination if we or Teijin breach the agreement, Teijin fails to maintain distributor-level
permits and approvals, Teijin fails to purchase from us specified dollar values of its sales forecasts, reimbursement for treatment of MDD using the NeuroStar Advanced Therapy System is not obtained from JMHLW by specified dates or such
reimbursement is below specified minimums, Teijin reasonably believes that it is not commercially reasonable to continue distributing the NeuroStar Advanced Therapy System in Japan or bankruptcy
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-30 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
related events occur. The term of the distribution agreement will be automatically extended for two years unless either party gives the other party at least two years&#146; prior written of
notice of non-renewal, except that the Company cannot decline to renew the agreement if Teijin has purchased 100% of its sales forecasts over the term of the agreement. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>17.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>GEOGRAPHICAL SEGMENT INFORMATION </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision
making group, in deciding how to allocate resources and in assessing performance. The Company currently operates in one business segment as it is managed and operated as one business. A single management team that reports to the chief operating
decision maker comprehensively manages the entire business. The Company does not operate any material separate lines of business or separate business entities with respect to its products or product development. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following geographic data includes revenue generated from the Company&#146;s third-party distributors. The Company&#146;s revenue was
generated in the following geographic regions for the years indicated (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="45%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Year ended December&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2016</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>%&nbsp;of&nbsp;Revenues</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>%&nbsp;of&nbsp;Revenues</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">United States</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">31,577</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">92</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">39,853</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">99</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">International</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,651</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">580</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">40,433</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>18.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>SUBSEQUENT EVENTS </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company has evaluated subsequent events from the balance sheet date through March 16, 2018, the date at which the financial statements were available to be issued, and determined there
are no other items requiring disclosure. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-31 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="fin542432_8"></A>Balance Sheets </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited; In thousands, except per share data) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="66%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,<BR>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31,<BR>2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31,<BR>2018<BR>Pro&nbsp;forma</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Assets</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Current assets:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash and cash equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,147</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accounts receivable, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,267</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,282</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,282</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Inventory</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,468</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,597</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,597</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Prepaid expenses and other current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,123</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,542</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,542</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total current assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">37,005</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,775</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,775</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Property and equipment, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,359</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,440</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,440</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">574</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total Assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">38,938</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">32,016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">32,016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Liabilities, Convertible Preferred Stock and Stockholders&#146; Deficit</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Current liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accounts payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,513</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,968</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,968</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accrued expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,511</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,670</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,670</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,970</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,615</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,615</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total current liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,994</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,253</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,253</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Long-term debt, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,556</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,275</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,177</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,177</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">478</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">485</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred rent</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">151</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total Liabilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">44,454</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">42,854</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">42,369</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Commitments (Note 14)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock, $0.01 par value: actual: 308,593 shares authorized, issuable in series; 304,958
shares issued and outstanding at December&nbsp;31, 2017 and March&nbsp;31, 2018; aggregate liquidation value of $108,324 at March&nbsp;31, 2018; pro forma: no shares authorized, issued or outstanding and no liquidation value at March&nbsp;31,
2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Stockholders&#146; deficit:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Preferred stock, $0.01 par value: actual: no shares authorized, issued or outstanding at December&nbsp;31, 2017
and March&nbsp;31, 2018; pro forma: 10,000 shares authorized; no shares issued and outstanding at March&nbsp;31, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Common stock, $0.01 par value: actual: 413,918 shares authorized; 231 and 251 shares issued and outstanding at
December&nbsp;31, 2017 and March&nbsp;31, 2018, respectively; pro forma: 200,000 shares authorized; 11,246 shares issued and outstanding at March&nbsp;31, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">112</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Additional paid-in capital</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,292</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,466</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">191,978</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accumulated deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(196,946</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(202,443</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(202,443</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total Stockholder&#146;s Deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(192,652</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(197,974</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(10,353</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total Liabilities, Convertible Preferred Stock and Stockholders&#146; Deficit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">38,938</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">32,016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">32,016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The accompanying notes are an integral part of these unaudited interim financial
statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-32 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="fin542432_9"></A>Statements of Operations </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited; In thousands, except per share data) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Three&nbsp;Months&nbsp;ended&nbsp;March&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="border-bottom:1px solid #000000"> <P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,526</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,152</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,538</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,457</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gross Profit</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,695</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Operating expenses:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,306</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">8,109</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,642</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,636</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,555</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total operating expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,976</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">12,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Loss from Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(3,988</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(4,605</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other (income) expense:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Interest expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">921</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other income, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(24</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(29</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(4,514</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(5,497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net loss per share of common stock outstanding, basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(27.03</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(24.43</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Weighted-average common shares outstanding, basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">226</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma net loss per share of common stock outstanding, basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(0.49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma weighted-average common shares outstanding, basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,220</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The accompanying notes are an integral part of these unaudited interim financial
statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-33 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="fin542432_10"></A>Statement of Changes in Convertible Preferred Stock and Stockholders&#146; Deficit
</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited; In thousands) </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Convertible<BR>Preferred&nbsp;Stock</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Common Stock</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Additional<BR>Paid-in</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Capital</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Accumulated</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Deficit</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Total<BR>Stockholders&#146;</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Deficit</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance at December&nbsp;31, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">304,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187,136</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">231</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,292</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(196,946</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(192,652</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Exercises of stock options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Share-based compensation expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">144</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">144</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(5,497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(5,497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance at March&nbsp;31, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">304,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187,136</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">251</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,466</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(202,443</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(197,974</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #465361">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The accompanying notes are an integral part of these unaudited interim financial
statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-34 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="fin542432_11"></A>Statements of Cash Flows </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited; In thousands) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Three&nbsp;Months&nbsp;ended&nbsp;March&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" STYLE="border-bottom:1px solid #000000"> <P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash Flows from Operating Activities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(4,514</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(5,497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Adjustments to reconcile net loss to net cash used in operating activities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Depreciation and amortization</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">165</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">139</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Share-based compensation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">42</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">144</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Non-cash interest expense</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">104</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">247</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Change in fair value of convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(11</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of rental units purchased by customers</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Changes in certain assets and liabilities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accounts receivable, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">836</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Inventory</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(298</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Prepaid expenses and other assets</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">26</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">219</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accounts payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(847</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">263</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accrued expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1,926</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(3,106</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred revenue</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(52</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(453</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred rent</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:9.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Cash Used in Operating Activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(6,685</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(8,297</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash Flows from Investing Activities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Purchases of property and equipment and capitalized software</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(84</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(297</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:9.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Cash Used in Investing Activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(84</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(297</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash Flows from Financing Activities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Payments of initial public offering costs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(230</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Borrowings under credit facilities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Payments of debt issuance costs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1,015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Proceeds from exercises of stock options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:9.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Cash Provided by (Used in) Financing Activities</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,985</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:9.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net Decrease in Cash and Cash Equivalents</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(2,784</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(8,793</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:9.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash and Cash Equivalents, Beginning of Period</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">17,040</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,147</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:9.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash and Cash Equivalents, End of Period</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14,256</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Supplemental disclosure of cash flow information:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cash paid for interest</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">592</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">628</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Transfer of inventory to property and equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">139</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">169</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Supplemental disclosure of non-cash financing activities:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Allocation of proceeds from debt financing to convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">171</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"> &#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Deferred initial public offering costs included in accounts payable and accrued expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"> &#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,339</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The accompanying notes are an integral part of these unaudited interim financial
statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-35 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="fin542432_12"></A>Notes to Interim Financial Statements </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>1.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>DESCRIPTION OF BUSINESS </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Neuronetics, Inc., or the Company, is a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients
who suffer from psychiatric disorders. The Company&#146;s first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a
pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The system was cleared in 2008 by the United States Food and Drug Administration (FDA) to treat adult
patients with major depressive disorder, or MDD, that have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode. The Company intends to continue to pursue development of its NeuroStar Advanced
Therapy for additional indications. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Liquidity </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As of March&nbsp;31, 2018, the Company had cash and cash equivalents of $20.4 million and an accumulated deficit of $202.4 million. The Company has incurred negative cash flows from
operating activities of $11.1 million for the year ended December&nbsp;31, 2017 and $8.3 million for the three months ended March&nbsp;31, 2018. The Company has incurred operating losses since its inception, and management anticipates that its
operating losses will continue in the near term as the Company seeks to expand its sales and marketing initiatives to support its growth into existing and new markets and invest in additional research and development activities. The Company&#146;s
primary sources of capital to date have been from private placements of its convertible preferred securities, borrowings under its credit facilities and sales of its products. As of March&nbsp;31, 2018, the Company had $30.0 million of borrowings
outstanding under its credit facility, which matures March 2022 and has $5.0 million of additional availability, subject to the achievement of $45.0 million of trailing twelve month revenues in 2018. Management believes that the Company&#146;s cash
and cash equivalents as of March&nbsp;31, 2018, sales of its products and availability of borrowing under its credit facility are sufficient to fund the Company&#146;s operations at least into the second half of calendar year 2019. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Risks and Uncertainties </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s ability to implement its business strategy is subject to numerous risks and uncertainties, including, but not limited to: uncertainty in the Company&#146;s ability to
generate sufficient revenues from the commercialization of its products to achieve or sustain profitability; the need to raise additional capital to fund the Company&#146;s existing commercial operations, development and commercialization of new
products and expansion of its operations; uncertainty with regard to competitors&#146; development of competing products and technologies; uncertainty with regard to adoption and use of TMS therapy by physicians and patients; comprehensive
government regulation and oversight both in the United States and abroad; reliance on coverage and reimbursement from third-party payers for treatments using the Company&#146;s products; the Company has limited experience in marketing and selling
its products; and the Company relies significantly on technology to deliver treatments with its products. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>2.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>BASIS OF PRESENTATION </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States (GAAP). Any reference in these notes to applicable
guidance is meant to refer to GAAP as found in the Accounting Standards Codification (ASC) and Accounting Standards Updates (ASU) promulgated by the Financial Accounting Standards Board (FASB). </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-36 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Interim Financial Statements </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The accompanying unaudited interim financial statements have been prepared from the books and records of the Company in accordance with
GAAP for interim financial information and Rule 10-01 of Regulation S-X promulgated by the United States Securities and Exchange Commission (SEC), which permit reduced disclosures for interim periods. All adjustments, consisting only of normal
recurring adjustments, necessary for a fair presentation of the accompanying balance sheets and statements of operations, changes in convertible preferred stock and stockholders&#146; deficit and cash flows have been made. Although these interim
financial statements do not include all of the information and footnotes required for complete annual financial statements, management believes the disclosures are adequate to make the information presented not misleading. Unaudited interim results
of operations and cash flows are not necessarily indicative of the results that may be expected for the full year. Unaudited interim financial statements and footnotes should be read in conjunction with the audited financial statements and footnotes
included elsewhere in this prospectus, wherein a more complete discussion of significant accounting policies and certain other information can be found. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Use of Estimates </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The preparation of financial statements
in accordance with GAAP and the rules and regulations of the SEC requires the use of estimates and assumptions, based on judgments considered reasonable, which affect the reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on historical experience, known trends and events and various
other factors that management believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Although
management believes its estimates and assumptions are reasonable when made, they are based upon information available at the time they are made. Management evaluates the estimates and assumptions on an ongoing basis and, if necessary, makes
adjustments. Due to the risks and uncertainties involved in the Company&#146;s business and evolving market conditions, and given the subjective element of the estimates and assumptions made, actual results may differ from estimated results. The
most significant estimates and judgments impact share-based compensation, convertible preferred stock warrants, product warranty accruals and the net realizable value of inventory. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Recapitalization </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company effected a 0.0345-for-1
reverse split of its common stock on June 14, 2018. The reverse split combined each approximately 29 shares of the Company&#146;s issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion price of
its convertible preferred stock. No fractional shares were issued in connection with the reverse split. Any fractional share resulting from the reverse split was rounded down to the nearest whole share, and in lieu of any fractional shares, the
Company will pay in cash to the holders of such fractional shares an amount equal to the fair market value, as determined by the board of directors, of such fractional shares. All share, per share and related information presented in the financial
statements and accompanying notes have been retroactively adjusted, where applicable, to reflect the reverse stock split. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Unaudited Pro Forma Financial Information </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Immediately prior to the closing of an initial public offering, all of the Company&#146;s outstanding convertible preferred stock will automatically convert into common stock. The
unaudited pro forma </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-37 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
  <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
balance sheet as of March&nbsp;31, 2018 assumes (i)&nbsp;the conversion of all outstanding convertible preferred stock as of March&nbsp;31, 2018, into an aggregate of 11.0&nbsp;million shares of
common stock and (ii)&nbsp;the reclassification of the $0.5 million convertible preferred stock warrant liability to additional paid-in capital upon the automatic conversion convertible preferred stock warrants into common stock warrants. In the
statements of operations, unaudited pro forma basic and diluted net loss per share of common stock outstanding has been prepared to give effect to the automatic conversion of all outstanding shares of convertible preferred stock as if this proposed
initial public offering had occurred on the later of the beginning of the reporting period or the issuance date of the convertible preferred stock. </FONT></P>  <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>3.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s complete summary of significant accounting policies can be found in &#147;Note 3. Summary of Significant Accounting Policies&#148; in the audited financial statements
included elsewhere in this prospectus. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>4.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>RECENT ACCOUNTING PRONOUNCEMENTS </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>JOBS Act Accounting Election </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company is an emerging
growth company, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act
until such time as those standards apply to private companies. The Company has elected to use this extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies
until the earlier of the date that it (i)&nbsp;is no longer an emerging growth company or (ii)&nbsp;affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, these interim financial statements
may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In May 2014, the FASB issued ASU 2014-09, &#147;<I>Revenue from Contracts with Customers</I>&#148; (Topic 606), regarding the accounting for and disclosures of revenue recognition, with an
effective date for public companies of annual and interim periods beginning after December&nbsp;15, 2016. In July 2015, the FASB issued ASU 2015-14, &#147;<I>Revenue from Contracts with Customers (Topic&nbsp;606): Deferral of the Effective
Date</I>,&#148; which deferred the effective date of the previously issued revenue recognition guidance by one year. This guidance will be effective for public companies for annual and interim periods beginning after December&nbsp;15, 2017. For all
other entities, including emerging growth companies, this standard is effective for annual reporting periods beginning after December&nbsp;15, 2018, and interim periods with annual periods beginning after December&nbsp;15, 2019. Early adoption is
permitted. This update provides a single comprehensive model for accounting for revenue from contracts with customers. The model requires that revenue recognized reflect the actual consideration to which the entity expects to be entitled in exchange
for the goods or services defined in the contract, including in situations with multiple performance obligations. In April 2016 and May 2016, the FASB issued ASU 2016-10, &#147;<I>Revenue from Contracts with Customers (Topic 606): Identifying
Performance Obligations and Licensing</I>&#148; and ASU 2016-12, &#147;<I>Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedients</I>,&#148; respectively. Both of these updates provide improvements and
clarification to the previously issued revenue recognition guidance. The new standard can be adopted using one of two methods: the full retrospective method, which requires the standard to be applied to each prior period presented, or the modified
retrospective method, which requires the cumulative effect of adoption to be </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-38 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
recognized as an adjustment to opening retained earnings in the period of adoption. The new standard will result in additional revenue-related disclosures in the notes to the Company&#146;s
financial statements. The majority of the Company&#146;s revenue relates to the sales of NeuroStar Advanced Therapy Systems and treatment sessions to various customers. While the Company is still analyzing the impact of ASU 2014-09 on its financial
statements and disclosures, it currently anticipates no significant changes to its revenue recognition practices as a result of the adoption of Topic 606. However, the Company currently expects the adoption of Topic 606 to change the accounting
treatment for sales commissions and is analyzing the impact such change will have on its financial statements and disclosures. The Company historically expensed sales commissions as incurred. In addition, the new standard will require changes to the
Company&#146;s processes and controls to support additional disclosures, and the Company is in the process of identifying and designing such changes to processes and controls to ensure readiness. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), with guidance regarding the accounting for and disclosure of leases.
The update requires lessees to recognize all leases, including operating leases, with a term greater than 12 months on the balance sheet. This update also requires lessees and lessors to disclose key information about their leasing transactions.
This guidance will be effective for public companies for annual and interim periods beginning after December&nbsp;15, 2018. For all other entities, including emerging growth companies, this standard is effective for annual reporting periods
beginning after December&nbsp;15, 2019, and interim periods within annual periods beginning after December&nbsp;15, 2020. Early adoption is permitted. The Company is currently evaluating the effect that this guidance will have on its financial
statements and related disclosures. The Company expects the implementation of this standard to have an impact on its financial statements and related disclosures as its aggregate future minimum lease payments were $1.6&nbsp;million as of
March&nbsp;31, 2018 under its current non-cancelable office lease with an expiration date in 2021. The Company anticipates recognition on its balance sheet of an additional asset and corresponding liability related to this lease. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In May 2017, the FASB issued ASU 2017-09, Compensation&#151;Stock Compensation (Topic&nbsp;718): &#147;<I>Scope of Modification
Accounting</I>,&#148; which provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic&nbsp;718. The amendments in this ASU should be applied
prospectively to an award modified on or after the adoption date. This guidance was effective for all entities for annual periods, and interim periods within those annual periods, beginning after December&nbsp;15, 2017. The Company adopted the new
guidance effective January&nbsp;1, 2018, and it did not have an effect on its financial statements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In August 2016, the FASB
issued ASU 2016-15, Statement of Cash Flows (Topic&nbsp;230): &#147;<I>Classification of Certain Cash Receipts and Cash Payments</I>,&#148; with guidance intended to reduce the diversity in practice regarding how certain cash receipts and cash
payments are presented and classified within the statement of cash flows. The update addresses eight specific cash flow issues including: debt prepayment or debt extinguishment costs; the settlement of zero-coupon debt instruments or other debt
instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims;
proceeds from the settlement of corporate-owned life insurance policies or bank-owned life insurance policies; distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash
flows and application of the predominance principle. This guidance was effective for public companies for fiscal years beginning after December&nbsp;15, 2017, and interim periods within those fiscal years. The Company adopted the new guidance
effective January&nbsp;1, 2018, and it did not have an effect on its financial statements. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-39 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>5.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>FAIR VALUE MEASUREMENT AND FINANCIAL INSTRUMENTS </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The carrying values of cash equivalents, accounts receivable, prepaids and other current assets, and accounts payable on the Company&#146;s balance sheets approximated their fair values as
of December&nbsp;31, 2017 and March&nbsp;31, 2018 due to their short-term nature. The carrying values of the Company&#146;s current credit facility approximated its fair value as of December&nbsp;31, 2017 and March&nbsp;31, 2018 due to its variable
interest rate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Certain of the Company&#146;s financial instruments are measured at fair value using a
three-level hierarchy that prioritizes the inputs used to measure fair value. This hierarchy maximizes the use of observable inputs and minimizes the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:
</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="90%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Level&nbsp;1</U>:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Inputs are quoted prices for identical instruments in active markets.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Level&nbsp;2</U>:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Inputs are quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; or
model-derived valuations whose inputs are observable or whose significant value drivers are observable.</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Level&nbsp;3</U>:</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Inputs are unobservable and reflect the Company&#146;s own assumptions, based on the best information available, including the Company&#146;s own
data.</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following tables set forth the carrying amounts and fair values of the Company&#146;s
financial instruments as of December&nbsp;31, 2017 and March&nbsp;31, 2018 (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31, 2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Fair Value Measurement Based on</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Carrying<BR>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Fair Value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Quoted<BR>Prices In<BR>Active<BR>Markets<BR>(Level 1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Significant<BR>other<BR>Observable<BR>Inputs<BR>(Level 2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Significant<BR>Unobservable<BR>Inputs<BR>(Level&nbsp;3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Assets</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Money market funds (cash equivalents)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,149</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,149</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,149</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Liabilities</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">478</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">478</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"> &#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">478</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-40 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31, 2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Fair Value Measurement Based on</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Carrying<BR>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Fair Value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Quoted<BR>Prices In<BR>Active<BR>Markets<BR>(Level 1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Significant<BR>other<BR>Observable<BR>Inputs<BR>(Level 2)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Significant<BR>Unobservable<BR>Inputs<BR>(Level&nbsp;3)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Assets</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Money market funds (cash equivalents)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,184</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,184</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,184</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><U>Liabilities</U></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrant liability</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">485</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">485</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"> &#151;&nbsp;&nbsp; </FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">485</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Significant changes in the estimated fair value of the Company&#146;s convertible
preferred stock will significantly impact the valuation of the convertible preferred stock warrant liability. The fair value of the convertible preferred stock warrant liability was estimated using the Black-Scholes option pricing model and the
following inputs and assumptions as of December&nbsp;31, 2017 and March&nbsp;31, 2018: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31, 2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31, 2018</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Series E</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Series F</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Series E</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Series F</B></FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Estimated fair value of convertible preferred stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.33</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.38</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.34</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.39</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Exercise price</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.6746</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.3356</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.6746</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$0.3356</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Remaining term (in years)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5.0</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3.1-7.0</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.7</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><FONT STYLE="white-space:nowrap">2.9-6.7</FONT></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Risk-free interest rate</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.2%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><FONT STYLE="white-space:nowrap">2.0%-2.3%</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.5%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><FONT STYLE="white-space:nowrap">2.4%-2.7%</FONT></FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Expected volatility</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">43%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">43%-44%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">42%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">43%-45%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Dividend yield</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0%</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0%</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table presents the changes in Level 3 instruments measured on a recurring
basis for the three months ended March&nbsp;31, 2018 (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="90%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance at December&nbsp;31,&nbsp;2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">478</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Change in fair value</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance at March 31, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">485</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>6.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>ACCOUNTS RECEIVABLE </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table presents the composition of accounts receivable, net as of December&nbsp;31, 2017 and March&nbsp;31, 2018 (in thousands): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,<BR>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31,<BR>2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Gross accounts receivable - trade</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,684</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,733</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Less: Allowances for doubtful accounts</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(417</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(451</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accounts receivable, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,267</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,282</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-41 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>7.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>PROPERTY AND EQUIPMENT </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table presents the composition of property and equipment, net as of December&nbsp;31, 2017 and March&nbsp;31, 2018 (in thousands): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,<BR>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31,<BR>2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Laboratory equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">150</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Office equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">487</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">487</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Computer equipment and software</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">680</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">779</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Manufacturing equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">273</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">273</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Leasehold improvements</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">153</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">172</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Rental equipment</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,447</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,409</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Property and equipment, gross</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,190</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,270</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Less: Accumulated depreciation</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1,831</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1,830</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Property and equipment, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,359</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,440</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Depreciation expense was $0.2 million and $0.1 million for the three months ended March&nbsp;31, 2017 and
2018, respectively. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>8.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>ACCRUED EXPENSES </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table presents the composition of accrued expenses as of December&nbsp;31, 2017 and March&nbsp;31, 2018 (in thousands): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,<BR>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31,<BR>2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Compensation and related benefits</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,465</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Consulting and professional fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">461</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,665</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">233</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">620</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">186</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Warranty</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">570</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">563</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales tax payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">322</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">231</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Interest payable</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">188</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">234</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Other</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">388</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">545</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accrued expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,511</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,670</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>9.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>DEBT </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The
following table presents the composition of debt as of December&nbsp;31, 2017 and March&nbsp;31, 2018 (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>December&nbsp;31,<BR>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31,<BR>2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Outstanding principal</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accrued final payment fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">940</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,198</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Less debt discounts</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1,384</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1,395</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Long-term debt, net</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,556</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,803</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-42 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Current $35.0 Million Credit Facility </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In March 2017, the Company entered into a new loan and security agreement with Oxford Finance LLC, or Oxford, for a credit facility that
replaced its previous $25.0 million credit facility with Oxford and which allows it to borrow up to $35.0 million in three tranches of term loans: a Term A Loan in the amount of $25.0 million, which was drawn down immediately upon closing in March
2017, a Term B Loan in the amount of $5.0 million, which was drawn down in December 2017, and a Term C Loan in the amount of $5.0 million, which will become available to the Company upon the achievement of $45.0 million of trailing twelve month
revenues in 2018. Each term loan accrues interest from the date of borrowing through the date of repayment at a floating per annum rate of interest, which resets monthly and is equal to the greater of 8.15% or the 30 day U.S. LIBOR rate on the last
business day of the month plus 7.38%. The Company is also required to issue to Oxford at the date of each borrowing warrants to purchase its Series F or later series of convertible preferred stock or, if it is a public company at the date of
borrowing, warrants to purchase its common stock, with a seven year term and in an amount equal to 3.95% of the first $5.0 million of each tranche borrowed. The credit facility matures and all amounts borrowed thereunder are due on March&nbsp;1,
2022. As of March&nbsp;31, 2018, the Company had borrowed and had outstanding an aggregate of $30.0 million of principal under the credit facility. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Term A Loan features an interest-only period through March 2019, during which time the Company is required to make monthly interest payments, after which time the Company is required
to make monthly payments of principal and interest based on a 36-month amortization schedule. However, if $45.0 million of trailing twelve month revenues is achieved in 2018, the interest-only period can be extended for an additional 12&nbsp;months
through March 2020 and the amortization period then becomes 24 months. In connection with the drawdown of the Term A Loan, the Company issued to the lender warrants to purchase 588,498 shares of its Series F convertible preferred stock, which have
an exercise price of $0.3356 per share and which expire in March 2024. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Term B Loan features an interest-only period
through March 2019, during which time the Company is required to make monthly interest payments, after which time the Company is required to make monthly payments of principal and interest based on a 36-month amortization schedule. However, if $45.0
million of trailing twelve month revenues is achieved in 2018, then the interest-only period can be extended for an additional 12 months through March 2020 and the amortization period then becomes 24 months. In connection with the drawdown of the
Term B Loan, the Company issued to the lender warrants to purchase 588,498 shares of its Series F convertible preferred stock, which have an exercise price of $0.3356 per share and which expire in December 2024. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition to principal and interest payments due under the credit facility, the Company is required to make final payment fees to the
lender due upon the earlier of prepayment or maturity of each tranche, which are equal to 8%, 7% and 6.5% of the principal amounts of the Term A, Term B and Term C Loans, respectively, except that if the interest-only periods on the Term A and Term
B Loans are extended then the final payment fees increase to 8.5%, 7.5% and 7% of the principal amounts of the Term A, Term B and Term C Loans, respectively. The Company accrues the estimated final payment fees using the effective interest rate,
with a charge to non-cash interest expense, over the term of borrowing for each tranche. As of both December&nbsp;31, 2017 and March&nbsp;31, 2018, the effective interest rates for the Term A and Term B Loans were 10.7% and 11.6%, respectively. If
the Company prepays its term loans prior to their respective scheduled maturities, it will also be required to make prepayment fees to the lender equal to 3% if prepaid on or before the first anniversary of funding, 2% if prepaid after the first and
on or before the second anniversary of funding or 1% if prepaid after the second anniversary of funding of the principal amounts borrowed. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-43 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s obligations under the Credit Facility are secured by a first priority
security interest in substantially all of its assets, other than its intellectual property. The Company has agreed not to pledge or otherwise encumber any of its intellectual property. The loan and security agreement related to the credit facility
includes a financial maintenance covenant that requires the Company to achieve at least 75% of its trailing 12-month forecasted revenues, as measured each month in accordance with a forecast that the Company provided to Oxford upon signing the
agreement and future forecasts that the Company is required to deliver to the lenders each year for the life of the credit facility, as well as customary affirmative and negative covenants. The Company was in compliance with all of the covenants
under its credit facility as of March&nbsp;31, 2018. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The loan and security agreement related to the credit facility contains
events of default, including, without limitation, events of default upon: (i)&nbsp;failure to make payment pursuant to the terms of the agreement; (ii)&nbsp;violation of covenants; (iii)&nbsp;material adverse changes to the Company&#146;s business;
(iv)&nbsp;attachment or levy on the Company&#146;s assets or judicial restraint on its business; (v)&nbsp;insolvency; (vi)&nbsp;significant judgments, orders or decrees for payments by the Company not covered by insurance; (vii)&nbsp;incorrectness
of representations and warranties; (viii)&nbsp;incurrence of subordinated debt; (ix)&nbsp;revocation of governmental approvals necessary for the Company to conduct its business; and (x)&nbsp;failure by the Company to maintain a valid and perfected
lien on the collateral securing the borrowing. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Based on a 36-month amortization of the outstanding principal amounts of the
Term A and Term B Loans beginning on April&nbsp;1, 2019 as discussed above, the following table sets forth by year the Company&#146;s required future principal payments (in thousands): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:18pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Year:</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Principal<BR>Payments</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2019</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2020</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2021</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2022</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total principal payments</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Previous $25.0 Million Credit Facility </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Prior to March 2017, the Company had a $25.0 million credit facility in place with Oxford, which it entered into in February 2014 and which allowed it to borrow up to $25.0 million in
three tranches of term loans: a Term A Loan in the amount of $15.0 million, a Term B Loan in the amount of $5.0&nbsp;million and a Term C Loan in the amount of $5.0 million, which was never drawn down. Each term loan accrued interest at per annum
rates ranging from 8.5% to 8.9%. This facility featured an interest-only period on all tranches through March 2017, and the Company was also required to issue convertible preferred stock warrants to the lender at the time of borrowing of each
tranche. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition to principal and interest payments due under the previous $25.0 million credit facility, the Company was
required to make final payment fees to the lender upon the earlier of prepayment or maturity and equal to 8.5% and 4.7% of the principal amounts of the Term A and Term B Loans, respectively. The Company accrued final payment fees using the effective
interest rate, with a charge to non-cash interest </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-44 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
expense, over the term of borrowing and until its entry into the current credit facility in March 2017, at which time the Company paid the lender $1.0 million in satisfaction of all final payment
fee liabilities due under the prior credit facility. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Management evaluated whether the current credit facility entered into in
March 2017 represented a debt modification or extinguishment in accordance with ASC 470-50, Debt&#151;Modifications and Extinguishments. Upon determining that the change in cash flows between the previous and current credit facilities was not
greater than 10%, management accounted for the transaction as a debt modification. As of March 2017, the unamortized balance of deferred debt issuance costs incurred in connection with the $25.0 million credit facility, and certain additional
deferred debt issuance costs incurred in connection with entry into the current credit facility, are being amortized to interest expense through March 2022 utilizing the effective interest method. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For the three months ended March&nbsp;31, 2017, the Company recognized interest expense of $0.6 million, of which $0.5 million was cash
and $0.1 million was non-cash interest expense related to the amortization of deferred debt issuance costs and accrual of final payment fees. For the three months ended March&nbsp;31, 2018, the Company recognized interest expense of $0.9 million, of
which $0.7 million was cash and $0.2 million was non-cash interest expense related to the amortization of deferred debt issuance costs and accrual of final payment fees. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>10.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#146; DEFICIT </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Common Stock </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s amended certificate of
incorporation authorizes the issuance of 413.9&nbsp;million shares </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">of common stock, $0.01 par value per share, of which 0.3
million were issued and outstanding as of March 31, 2018. In addition, the Company is required to reserve and keep available out of its authorized but unissued shares of common stock a number of shares sufficient to effect the conversion into common
stock of all outstanding shares of convertible preferred stock and convertible preferred stock warrants, convertible preferred stock warrants issuable upon borrowing the Term C Loan under the current $35.0 million credit facility and stock options
granted and shares available for grant under its stock incentive plan. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-45 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes the total number of shares of the Company&#146;s common
stock issued and reserved for issuance as of March&nbsp;31, 2018 (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="81%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31,&nbsp;2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Shares of common stock issued</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">251</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Shares of common stock reserved for issuance for:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock outstanding:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series A-1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">166</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series A-2</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">898</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series B</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">697</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series C</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,063</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,705</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series E</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,534</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,531</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series G</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,400</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrants outstanding:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series E</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">91</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F convertible preferred stock warrants issuable upon Term&nbsp;C Loan borrowing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Stock options outstanding</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,669</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Shares available for grant under stock incentive plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">240</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total shares of common stock issued and reserved for issuance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14,279</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Shares of Series A-2 convertible preferred stock convert to common stock at a ratio of 0.03539 shares of common stock per share of
Series A-2 convertible preferred stock. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Shares of Series B convertible preferred stock convert to common stock at a ratio of 0.04103 shares of common stock per share of Series
B convertible preferred stock. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Shares of Series C convertible preferred stock convert to common stock at a ratio of 0.05071 shares of common stock per share of Series
C convertible preferred stock. </FONT></P></TD></TR></TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each share of common stock entitles the holder to one vote on all
matters submitted to a vote of the Company&#146;s stockholders. Subject to preferences that may apply to any outstanding preferred stock, holders of common stock are entitled to receive proportionally any dividends that the Company&#146;s board of
directors may declare out of funds legally available for that purpose on a non-cumulative basis. The Company has never paid, and for the foreseeable future does not expect to pay, a dividend on its common stock. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Convertible Preferred Stock </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In June 2017, the Company amended its certificate of incorporation to increase the number of shares of convertible preferred stock, $0.01 par value per share, authorized for issuance from
266.8&nbsp;million to 308.6&nbsp;million shares, of which the Company has designated and issued Series A-1, Series A-2, Series B, Series C, Series D, Series E, Series F and Series G shares. Series A-1 through Series E shares of convertible preferred
stock are referred to collectively as Junior Securities and are subordinate to shares of Series G and Series F shares of convertible preferred stock. All of the Company&#146;s convertible preferred stock is classified outside of stockholders&#146;
deficit because the shares contain deemed liquidation rights that are a contingent redemption feature not solely within the control of the Company. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-46 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes the Company&#146;s outstanding convertible preferred
stock as of December&nbsp;31, 2017 and March&nbsp;31, 2018: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="41%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Shares<BR>Authorized<BR>and<BR>Designated<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Shares<BR>Issued&nbsp;and<BR>Outstanding<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Carrying<BR>Value<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Liquidation<BR>Value<BR>per&nbsp;Share</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Liquidation<BR>Value<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series A-1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">900</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.0617</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">296</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series A-2</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">25,385</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">25,385</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16,428</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.2052</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,209</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series B</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">17,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">17,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16,859</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3168</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">5,386</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series C</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34,841</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.5253</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,009</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">49,426</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">49,426</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,970</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.2874</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14,205</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series E</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">44,873</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">44,471</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">29,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.5144</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">22,876</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">105,567</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">102,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">43,513</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">34,343</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series G</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">40,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">40,584</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14,825</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3696</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Balance&nbsp;at&nbsp;December&nbsp;31,&nbsp;2017 and March 31, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">308,593</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">304,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">187,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">108,324</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Conversion</U> </FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each share and series of convertible preferred stock is convertible into common stock at any time at the option of the holder thereof at the conversion price then in effect (each subject
to adjustments upon the occurrence of certain dilutive events). At March&nbsp;31, 2018, the conversion price for Series A-1, Series&nbsp;D, Series E, Series F and Series G shares was equal to the original issue price, resulting in a common stock
conversion ratio of 1:0.0345. At March&nbsp;31, 2018, as a result of past anti-dilution adjustments, the conversion price for Series A-2, Series B and Series C shares was below the original issue price, resulting in common stock conversion ratios of
1:0.03539, 1:0.04103 and 1:0.05071, respectively. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">All shares of each series of convertible preferred stock are
convertible into common stock at the affirmative election of the holders of at least (i)&nbsp;60% of the outstanding shares of convertible preferred stock, (ii)&nbsp;60% of the outstanding Series E convertible preferred stock, (iii)&nbsp;75% of the
outstanding Series&nbsp;F convertible preferred stock and (iv)&nbsp;55% of the outstanding Series G convertible preferred stock. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company may at any time require the conversion of all outstanding convertible preferred stock upon a qualified initial public offering of its common stock, as defined in the
Company&#146;s certificate of incorporation. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Liquidation Preferences</U> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the event of a liquidation, dissolution or winding up of the Company, either voluntary or involuntary, or in the event of a deemed
liquidation event, which includes a sale of the Company as defined in the Company&#146;s certificate of incorporation, holders of Series G convertible preferred stock are entitled to receive, in preference to all other stockholders, an amount equal
to their original investment amount plus any declared and unpaid dividends. If upon the occurrence of such event the assets and funds available for distribution are insufficient to pay such holders the full amount to which they are entitled, then
the entire assets and funds legally available for distribution shall be distributed ratably among the holders of the Series G convertible preferred stock in proportion to the full amounts to which they would otherwise be entitled. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-47 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After payment in full of the liquidation preference of the Series G convertible
preferred stock, holders of Series F convertible preferred stock are entitled to receive, in preference to all holders of Junior Securities and common stock, an amount equal to their original investment amount plus any declared and unpaid dividends.
If upon the occurrence of such event the assets and funds available for distribution are insufficient to pay such holders the full amount to which they are entitled, then the entire remaining assets and funds legally available for distribution shall
be distributed ratably among the holders of the Series F convertible preferred stock in proportion to the full amounts to which they would otherwise be entitled. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After payment in full of the liquidation preferences of the Series G and Series F convertible preferred stock, holders of Junior Securities are entitled to receive an amount equal to $59.2
million in the aggregate. If upon the occurrence of such event the assets and funds available for distribution are insufficient to pay such holders the full amount to which they are entitled, then the entire assets and funds legally available for
distribution shall be distributed ratably among the holders of the Junior Securities in proportion to the full amounts to which they would otherwise be entitled. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After payment in full of the liquidation preferences of the Series G, Series F and Junior Securities convertible preferred stock, holders of Series F convertible preferred stock are
entitled to receive an additional liquidation preference at an amount equal to $0.1678 per share. If upon the occurrence of such event the assets and funds available for distribution are insufficient to pay such holders the full amount to which they
are entitled, then the entire assets and funds legally available for distribution shall be distributed ratably among the holders of the Series F convertible preferred stock in proportion to the full amounts to which they would otherwise be entitled.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After payment in full of the liquidation preferences of the Series G, Series F and Junior Securities convertible preferred
stock and the additional liquidation preference for holders of Series F convertible preferred stock, holders of common stock and holders of Junior Securities, Series F and Series G convertible preferred stock are entitled to receive a liquidation
preference until the amount distributed to holders of the Series F convertible preferred stock equals $1.0068 plus declared but unpaid dividends on each share and then to the holders of common stock and holders of Junior Securities and Series G
convertible preferred stock until the aggregate amount distributed to such holders equals the amount distributed to holders of Series F convertible preferred stock divided by the Series F ownership percentage. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">After payments of the above liquidation preferences have been made, any remaining assets shall be distributed ratably to holders of
common stock and holders of Series G, Series F and Junior Securities convertible preferred stock on an &#147;as-converted&#148; basis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Dividends</U> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Each class of convertible preferred stock is
entitled to receive non-cumulative annual dividends at a rate of 9.0%, if and when declared by the Company&#146;s board of directors. The holders of Series G convertible preferred stock are entitled to dividends in preference to holders of any other
class or series of the Company&#146;s stock. The holders of Series F convertible preferred stock are entitled to dividends in preference to all holders of Junior Securities and holders of common stock. The holders of Junior Securities are entitled
to dividends in preference to holders of common stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In the event a dividend is declared to common stockholders, holders of
each class of convertible preferred stock will also receive an equivalent dividend on an &#147;as-converted&#148; basis. The Company has never paid, and for the foreseeable future does not expect to pay, a dividend on its common stock. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-48 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><U>Voting</U> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The holders of each class of convertible preferred stock are entitled to one vote for each share of common stock into which their shares of convertible preferred stock may be converted
and, subject to certain convertible preferred stock class votes specified in the Company&#146;s certificate of incorporation or as required by law, the holders of convertible preferred stock and common stock vote together on an
&#147;as-converted&#148; basis. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Convertible Preferred Stock Warrants </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes the Company&#146;s outstanding convertible preferred stock warrants as of March&nbsp;31, 2018: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="57%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Warrants<BR>Outstanding<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Exercise<BR>Price</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Expiration<BR>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series E</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">402</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.6746</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Dec-2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">878</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Feb-2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">589</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Aug-2023</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">589</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Mar-2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Series F</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">588</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0.3356</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Dec-2024</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,046</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>11.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>LOSS PER SHARE </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company&#146;s basic loss per common share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period. The
Company&#146;s restricted stock awards (non-vested shares) are issued and outstanding at the time of grant but are excluded from the Company&#146;s computation of weighted-average shares outstanding in the determination of basic loss per share until
vesting occurs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">A net loss cannot be diluted, so when the Company is in a net loss position, basic and diluted loss per
common share are the same. If in the future the Company achieves profitability, the denominator of a diluted earnings per common share calculation will include both the weighted-average number of shares outstanding and the number of common stock
equivalents, if the inclusion of such common stock equivalents would be dilutive. Dilutive common stock equivalents potentially include warrants, stock options and non-vested restricted stock awards using the treasury stock method, along with the
effect, if any, from the potential conversion of outstanding securities, such as convertible preferred stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following
potentially dilutive securities outstanding as of March&nbsp;31, 2017 and 2018 have been excluded from the denominator of the diluted loss per share of common stock outstanding calculation (in thousands): </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="79%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>March&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Stock options</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,117</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,669</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Non-vested restricted stock awards</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Convertible preferred stock warrants</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">105</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Shares of convertible preferred stock &#147;as-converted&#148;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,594</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,994</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-49 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The unaudited pro forma net loss per share is computed using the weighted-average number
of shares of common stock outstanding after giving effect to the conversion of all issued and outstanding shares of convertible preferred stock into shares of common stock immediately prior to the closing of the Company&#146;s proposed initial
public offering as if the conversion had occurred at the later of the beginning of the reporting period or the issuance date of the convertible preferred stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes the calculation of unaudited pro forma basic and diluted net loss per share of common stock for the three months ended March&nbsp;31, 2018 (in thousands,
except per share data): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="87%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Numerator:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Net loss</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(5,497</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Denominator:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Weighted-average common shares outstanding, basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">226</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Effect of pro forma adjustments:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:5.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Conversion of convertible preferred stock into common stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,994</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:7.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma weighted-average common shares outstanding, basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,220</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pro forma net loss per share of common stock outstanding, basic and diluted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(0.49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>12.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>SHARE-BASED COMPENSATION </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>2003 Incentive Stock Plan </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In April 2003 (and as
subsequently amended), the Company adopted the 2003 Stock Incentive Plan (2003 Plan), which authorizes the issuance of up to 3.1 million shares in the form of restricted stock, stock appreciation rights and stock options to the Company&#146;s
directors, employees and consultants. The amount and terms of grants are determined by the Company&#146;s board of directors. To date, the Company has granted restricted stock awards only to an independent member of its board of directors and only
as compensation for board service. All stock options granted to date have had exercise prices equal to the estimated fair value, as determined by the board of directors, of the underlying common stock on the date of the grant. The contractual term
of stock options may be up to 10 years, and stock options are exercisable in cash or as otherwise determined by the board of directors. Generally, stock options vest 25% upon the first anniversary of the date of grant and the remainder ratably
monthly thereafter for 36 months. As of March&nbsp;31, 2018, there were 0.2 million shares available for future issuance under the 2003 Plan. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The amount of share-based compensation expense recognized by the Company by location in its statements of operations for the three months ended March&nbsp;31, 2017 and 2018 is as follows
(in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="77%"></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Three&nbsp;Months&nbsp;ended<BR>March&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2017&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Cost of revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Sales and marketing</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">54</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">General and administrative</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Research and development</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">42</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">144</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-50 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Stock Options </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes the Company&#146;s stock option activity for the three months ended March&nbsp;31, 2018: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Number&nbsp;of<BR>Shares&nbsp;under<BR>Option<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Weighted-<BR>average<BR>Exercise&nbsp;Price<BR>per Option</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Weighted-<BR>average<BR>Remaining<BR>Contractual<BR>Life&nbsp;(in&nbsp;
years)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Aggregate<BR>Intrinsic<BR>Value<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Outstanding at December&nbsp;31, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,444</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.39</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Granted</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">277</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Exercised</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(20</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1.58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Forfeited</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Outstanding at March&nbsp;31, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,669</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.63</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">504</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Exercisable at March&nbsp;31, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,320</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">408</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Vested and expected to vest at March&nbsp;31, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2,669</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.63</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">504</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>   <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company recognized de minimis and $0.1 million of share-based compensation expense related
to stock options during the three months ended March&nbsp;31, 2017 and 2018, respectively. As of March&nbsp;31, 2018, there was $2.0 million of total unrecognized compensation cost related to non-vested stock options which the Company expects to
recognize over a weighted-average period of 3.3 years. The weighted-average grant-date fair value of stock options granted during the three months ended March&nbsp;31, 2018 was estimated at $2.90 per option. The total intrinsic value of stock
options exercised during the three months ended March&nbsp;31, 2018 was $0.1 million. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">For the three months ended
March&nbsp;31, 2018, the grant-date fair value of stock options was estimated at the time of grant using the following weighted-average inputs and assumptions in the Black-Scholes option pricing model: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="89%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Estimated fair value of common stock</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Exercise price</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">4.64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Expected term (in years)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Risk-free interest rate</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Expected volatility</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">66.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Dividend yield</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
</TABLE>   <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In April 2018, the Company&#146;s board of directors granted options to purchase 54,794 shares
of common stock to the members of the board. These options have an exercise price of $5.22 and vest in 12 equal monthly installments beginning in March 2018; however, the entire grant is subject to forfeiture if an initial public offering of the
Company&#146;s common stock has not occurred by December&nbsp;31, 2018. The estimated grant-date fair value of the options awards was $0.2 million. Upon completion of an initial public offering, the Company will immediately recognize the fair value
of the vested portion of the awards as share-based compensation expense, with the unvested portion recognized as share-based compensation expense ratably over the remaining service period. The Company also granted options to purchase 169,909 shares
of common stock to certain employees at exercise prices ranging from $5.22 to $10.14 subsequent to March 31, 2018. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-51 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Restricted Stock Awards </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table summarizes the Company&#146;s restricted stock award activity for the three months ended March&nbsp;31, 2018: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="72%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Non-vested<BR>Restricted<BR>Stock&nbsp;Awards<BR>(in&nbsp;thousands)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Weighted-<BR>average<BR><FONT STYLE="white-space:nowrap">Grant-date</FONT><BR>Fair&nbsp;
Value</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Non-vested at December 31, 2017</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Vested</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">)&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Non-vested at March 31, 2018</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">13</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2.32</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company recognized minimal share-based compensation expense related to restricted stock awards
during the three months ended March&nbsp;31, 2017 and 2018. As of March&nbsp;31, 2018, there was minimal unrecognized compensation cost related to non-vested restricted stock awards which the Company expects to recognize over a weighted-average
period of 1 year. The total fair value at the vesting date of restricted stock awards vested during the three months ended March&nbsp;31, 2017 was minimal. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>13.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>EMPLOYEE BENEFIT PLANS </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>401(k) Defined Contribution Plan </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company maintains a
401(k) defined contribution retirement plan which covers all of its employees. Employees are eligible to participate on the first of the month following their date of hire. Under the 401(k) plan, participating employees may defer up to 100% of their
pre-tax salary but not more than statutory limits. There is currently no employer matching of employee contributions and employee contributions vest immediately. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>14.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>COMMITMENTS </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Executive Employment Agreements </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company has entered
into an employment agreement and offer letters with certain key executives, providing for compensation and severance in certain circumstances, as defined in the agreements. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Leases </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In January 2013, the Company entered into a
93-month lease for its headquarters office and warehouse. The Company also rents certain office equipment. The Company recognizes rent expense on a straight-line basis over the lease period and has accrued for rent expense incurred but not yet paid.
Landlord allowances for tenant improvements are deferred and recognized as a reduction to rent expense on a straight-line basis and over the remaining lease term. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>15.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>GEOGRAPHICAL SEGMENT INFORMATION </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Operating segments are defined as components of an enterprise about which separate discrete information is available for evaluation by the chief operating decision maker, or decision
making group, in deciding how to allocate resources and in assessing performance. The Company currently operates in one business segment as it is managed and operated as one business. A single management team that
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-52 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>NEURONETICS, INC. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Notes to Interim Financial Statements&#151;(Continued) </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>(Unaudited) </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
reports to the chief operating decision maker comprehensively manages the entire business. The Company does not operate any material separate lines of business or separate business entities with
respect to its products or product development. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following geographic data includes revenue generated from the
Company&#146;s third-party distributors. The Company&#146;s revenue was generated in the following geographic regions for the years indicated (in thousands): </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Revenues by Geography</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Three Months ended March&nbsp;31,</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2017</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>2018</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>%&nbsp;of&nbsp;Revenues</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>%&nbsp;of&nbsp;Revenues</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">United States</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,394</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">9,972</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">International</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">132</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total revenues</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">7,526</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10,152</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>16.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>SUBSEQUENT EVENTS </B></FONT></TD></TR></TABLE>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The Company has evaluated subsequent events from the balance sheet date through June&nbsp;15, 2018, the date at which the financial statements were available to be issued, and determined
there are no other items requiring disclosure. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">F-53 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g15j05.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g542432g57t54.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>PART II </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Item&nbsp;13.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Other expenses of issuance and distribution. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The following table indicates the expenses to be incurred in connection with the offering described in this registration statement, other than underwriting discounts and commissions, all
of which will be paid by us. All amounts are estimated except the SEC registration fee, the Financial Industry Regulatory Authority, Inc., or FINRA, filing fee and the Nasdaq initial listing fee. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="86%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Amount</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">SEC Registration fee</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">11,454</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">FINRA filing fee</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">14,450</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Nasdaq initial listing fee</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">125,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Accountants&#146; fees and expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Legal fees and expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">1,540,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Blue Sky fees and expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Transfer Agent&#146;s fees and expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">6,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Printing and engraving expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">212,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Miscellaneous</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">75,096</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Total expenses</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">3,000,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">*</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">To be provided by amendment </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Item&nbsp;14.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Indemnification of directors and officers. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We are incorporated under the laws of the State of Delaware. Section&nbsp;102 of the Delaware General Corporation Law permits a corporation to eliminate the personal liability of directors
of a corporation to the corporation or its stockholders for monetary damages for a breach of fiduciary duty as a director, except where the director breached his duty of loyalty, failed to act in good faith, engaged in intentional misconduct or
knowingly violated a law, authorized the payment of a dividend or approved a stock repurchase in violation of Delaware corporate law or obtained an improper personal benefit. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Section&nbsp;145 of the Delaware General Corporation Law provides that a corporation has the power to indemnify a director, officer, employee or agent of the corporation and certain other
persons serving at the request of the corporation in related capacities against expenses (including attorneys&#146; fees), judgments, fines and amounts paid in settlements actually and reasonably incurred by the person in connection with an action,
suit or proceeding to which he is or is threatened to be made a party by reason of such position, if such person acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of the corporation, and, in any
criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful, except that, in the case of actions brought by or in the right of the corporation, no indemnification shall be made with respect to any claim, issue or
matter as to which such person shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of
the circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which the Court of Chancery or such other court shall deem proper. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">As permitted by the Delaware General Corporation Law, our amended and restated certificate of incorporation and amended and restated bylaws to be in effect upon the closing of this
offering will provide that: (i)&nbsp;we are required to indemnify our directors to the fullest extent permitted by the Delaware General Corporation Law; (ii)&nbsp;we may, in our discretion, indemnify our officers, employees
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">II-1 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
and agents as set forth in the Delaware General Corporation Law; (iii)&nbsp;we are required, upon satisfaction of certain conditions, to advance all expenses incurred by our directors in
connection with certain legal proceedings; (iv)&nbsp;the rights conferred in the bylaws are not exclusive; and (v)&nbsp;we are authorized to enter into indemnification agreements with our directors, officers, employees and agents. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In connection with this offering, we have entered into, or expect to enter into indemnification agreements with each of our directors and
executive officers that require us to indemnify them against expenses, judgments, fines, settlements and other amounts that any such person becomes legally obligated to pay (including with respect to a derivative action) in connection with any
proceeding, whether actual or threatened, to which such person may be made a party by reason of the fact that such person is or was a director or officer of us or any of our affiliates, provided such person acted in good faith and in a manner such
person reasonably believed to be in, or not opposed to, our best interests. The indemnification agreements will also set forth certain procedures that will apply in the event of a claim for indemnification thereunder. We intend to enter into similar
indemnification agreements with our executive officers prior to the completion of this offering. At present, no litigation or proceeding is pending that involves any of our directors or officers regarding which indemnification is sought, nor are we
aware of any threatened litigation that may result in claims for indemnification. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">We maintain a directors&#146; and
officers&#146; liability insurance policy. The policy insures directors and officers against unindemnified losses arising from certain wrongful acts in their capacities as directors and officers and reimburses us for those losses for which we have
lawfully indemnified the directors and officers. The policy contains various exclusions. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In addition, the underwriting
agreement filed as Exhibit 1.1 to this registration statement provides for indemnification by the underwriters of us and our officers and directors for certain liabilities arising under the Securities Act, or otherwise. Our investor rights agreement
with certain investors also provides for cross-indemnification in connection with the registration of our common stock on behalf of such investors. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Item&nbsp;15.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Recent sales of unregistered securities. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Issuances of capital stock </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Set forth below is information
regarding securities issued by us since March 31, 2015 through the date of the prospectus that is part of this registration statement. Also included is the consideration received by us for such shares and information relating to the section of the
Securities Act, or rule of the Securities and Exchange Commission, under which exemption from registration was claimed. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Preferred Stock Issuances.</I></B><B><I>&nbsp;&nbsp;&nbsp;&nbsp;</I></B>In April 2015, we issued 102,334,194 shares of our Series F
convertible preferred stock at a purchase price of $0.3356 per share for aggregate consideration of $34,343,356.<B><I> </I></B><B><I></I></B>In June 2017, we issued 40,584,416 shares of our Series G convertible preferred stock at a purchase price of
$0.3696 per share for aggregate consideration of $15,000,000. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>2003 Plan-Related
Issuances.</I></B><B><I>&nbsp;&nbsp;&nbsp;&nbsp;</I></B>Under our 2003 Plan since March 31, 2015, we have granted to our directors, officers, employees and consultants options to purchase an aggregate of 2,408,296&nbsp;shares of our common stock
with exercise prices ranging from $0.87 to $10.15 per share. In addition, we granted to an independent member of our board of directors, as compensation for board service, restricted stock awards for an aggregate of 53,253 shares of our common stock
with estimated grant date fair values ranging from $2.03 to $4.06 per share. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Stock Option Grants </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Since March&nbsp;31, 2015, we have granted to our directors, officers, employees and consultants options to purchase an aggregate of
2,408,296&nbsp;shares of our common stock at a weighted-average exercise price of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">II-2 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
$2.96 per share. Of these, through March 31, 2018, 280,027 options have been cancelled or forfeited without being exercised and 41,985 shares of common stock have been issued upon the exercise of
stock options for aggregate consideration of $40,287. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><I>Restricted Stock Awards</I>
</FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Since March 31, 2015, we have granted to an independent member of our board of directors, as compensation for board
service, restricted stock awards for 42,316 shares of our common stock at an estimated grant-date fair value of $2.03 per share on July&nbsp;20, 2016 and 10,937 shares of our common stock at an estimated grant-date fair value of $4.06 per share on
October&nbsp;19, 2017. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Warrants </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">In August 2016, March 2017 and December 2017, we issued preferred stock warrants to Oxford Finance LLC, each of which was immediately exercisable for 588,498 shares of our Series F
convertible preferred stock at an exercise price of $0.3356 per share. The August 2016, March 2017 and December 2017 warrants expire on August 31, 2023, March 28, 2024 and December 27, 2024, respectively, if not earlier exercised. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The outstanding warrants which are currently exercisable to purchase shares of our Series E or Series F convertible preferred stock will
become warrants to purchase shares of our common stock upon the completion of the offering to which this registration statement relates. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">None of the foregoing transactions involved any underwriters, underwriting discounts or commissions, or any public offering. The sales of the above securities were deemed to be exempt from
registration under the Securities Act in reliance upon Section&nbsp;4(2) of the Securities Act (or Regulation D or Regulation S promulgated thereunder), or Rule 701 promulgated under Section&nbsp;3(b) of the Securities Act as transactions by an
issuer not involving any public offering or pursuant to benefit plans and contracts relating to compensation as provided under Rule 701. The recipients of the securities in each of these transactions represented their intentions to acquire the
securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock certificates issued in these transactions. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Item&nbsp;16.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Exhibits and financial statement schedules. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The exhibits to the registration statement are listed in the Exhibit Index attached hereto and are incorporated by reference herein. Financial statement schedules have been omitted because
the information required to be set forth therein is not applicable or is shown in the financial statements or notes thereto. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Item&nbsp;17.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Undertakings. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement, certificates in such denominations and registered in
such names as required by the underwriters to permit prompt delivery to each purchaser. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Insofar as indemnification for
liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such
indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or
paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the
registrant will, unless in the opinion of its counsel the matter has been </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">II-3 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">
settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and
will be governed by the final adjudication of such issue. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">The undersigned registrant hereby undertakes that: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(1) For purposes of determining any liability under the Securities Act, the information omitted from the form of
prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be deemed to be part of
this registration statement as of the time it was declared effective. </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">(2) For the purpose of determining any
liability under the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">II-4 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>EXHIBIT INDEX </B></FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="91%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Exhibit</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #465361;width:28pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Number</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #465361;width:76pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Description of Exhibit</B></FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;1.1*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex11.htm">Form of Underwriting Agreement </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;3.1*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex31.htm">Eighth Amended and Restated Certificate of Incorporation of the Registrant,
 as amended (currently in effect) </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;3.2*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex32.htm">Amended and Restated Bylaws of the Registrant (currently in
effect)</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;3.3*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex33.htm">Form of Ninth Amended and Restated Certificate of Incorporation of the Registrant
 (to be effective upon the closing of this offering)</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;3.4*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex34.htm">Form of Second Amended and Restated Bylaws of the Registrant (to be effective
 upon the closing of this offering) </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;4.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="d542432dex41.htm">Specimen Stock Certificate evidencing shares of common stock of the Registrant</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;4.2*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex42.htm">Form of Warrant to Purchase Stock, by and between the Registrant and Oxford
 Finance LLC </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;4.3*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex43.htm">Warrant to Purchase Stock, by and between the Registrant and Comerica Bank,
dated December&nbsp;20, 2012 </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;&nbsp;5.1</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="d542432dex51.htm">Opinion of Cooley LLP </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.1<FONT STYLE="FONT-FAMILY:SYMBOL">&#224;</FONT>*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex101.htm">Distribution Agreement, by and between the Registrant and Teijin Pharma
 Limited, dated October&nbsp;12, 2017</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.2*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex102.htm">Sixth Amended and Restated Investors&#146; Rights Agreement by and among
 the Registrant and certain of its stockholders, dated June&nbsp;1, 2017 </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.3*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex103.htm">Sixth Amended and Restated Stockholders&#146; Agreement by and among the
Registrant and certain of its stockholders, dated June&nbsp;1, 2017</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.4&#043;*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex104.htm">Employment Agreement by and between the Registrant and Christopher Thatcher,
 dated as of November&nbsp;1, 2014, as amended on May 25, 2018 </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.5&#043;*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex105.htm">Offer Letter, dated August&nbsp;
11, 2016, by and between the Registrant and Greg Harper</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.6&#043;*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex106.htm">Offer Letter, dated February&nbsp;
27, 2017, by and between the Registrant and Peter Donato</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.7*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex107.htm">Form of Indemnification Agreement between the Registrant and its <FONT
STYLE="white-space:nowrap">non-employee</FONT> directors and officers </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.8*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex108.htm">Loan and Security Agreement by and between Oxford Finance LLC and the Registrant,
 dated March&nbsp;28, 2017</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.9&#043;*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex109.htm">Amended and Restated 2003 Stock Incentive Plan of the Registrant, as amended
</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.10&#043;*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex1010.htm">Form of 2018 Equity Incentive Plan (to be effective upon the closing of
 this offering)</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.11&#043;*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex1011.htm">Form of 2018 Employee Stock Purchase Plan (to be effective upon the closing
of this offering)</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.12*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex1012.htm">Lease Agreement by and between Exeter 3222 Phoenixville, L.P. and the
 Registrant, dated January&nbsp;3, 2013</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.13&#043;*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex1013.htm">Form of Non-Qualified Stock Option Agreement for the Amended and Restated
 2003 Stock Incentive Plan, as amended, of the Registrant </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.14&#043;*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex1014.htm">Form of Incentive Stock Option Agreement for the Amended and Restated
 2003 Stock Incentive Plan, as amended, of the Registrant</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.15&#043;*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex1015.htm">Forms of grant notice, stock option agreement and notice of exercise under
 the 2018 Equity Incentive Plan (to be effective upon the closing of this offering)</A></FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">II-5 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="89%"></TD></TR>

<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" COLSPAN="2" NOWRAP> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Exhibit</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #465361;width:28pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Number</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #465361;width:76pt ; display:inline;"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Description of Exhibit</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.16&#043;*</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex1016.htm">Forms of restricted stock unit grant notice and award agreement under
 the 2018 Equity Incentive Plan (to be effective upon the closing of this offering) </A></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.17&#043;*</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex1017.htm">Form of Severance Agreement </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.18&#043;*</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex1018.htm">Form of Restrictive Covenant and Invention Assignment
Agreement</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.19&#043;*</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex1019.htm">Offer Letter, dated February 27, 2018, by and between the Registrant and
 Daniel Guthrie</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.20&#043;</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="http://www.sec.gov/Archives/edgar/data/1227636/000119312518179910/d542432dex1020.htm">Offer Letter, dated November 10, 2017, by and between the Registrant and
 Yelena Tropsha</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">10.21</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="d542432dex1021.htm">Non-Employee Director Compensation Policy </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">23.1</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="d542432dex231.htm">Consent of KPMG LLP, independent registered public accounting firm</A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">23.2</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="d542432dex51.htm">Consent of Cooley LLP (included in Exhibit 5.1) </A></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" COLSPAN="3"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">24.1*</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><A HREF="#ii542432_ex241">Powers of Attorney (included on signature page)</A></FONT></TD></TR>
</TABLE>  <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.8pt solid #465361;width:39%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">&#043;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Indicates management contract or compensatory plan. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><FONT STYLE="FONT-FAMILY:SYMBOL">&#224;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Portions of this exhibit (indicated by asterisks) have been omitted pursuant to a request for confidential treatment and have been separately filed with
the Securities and Exchange Commission. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361">Previously filed. </FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">II-6 </FONT></P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><A NAME="ii542432_ex241"></A>SIGNATURES </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pursuant to the requirements of the Securities Act, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in the City of Malvern, Commonwealth of Pennsylvania, on this 15</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"> day of June, 2018. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">NEURONETICS, INC.</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">By:</FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">/s/ Christopher Thatcher</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Christopher Thatcher</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Chief Executive Officer</B></FONT></TD></TR>
</TABLE></DIV>   <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Pursuant to the requirements of the Securities Act of 1933, this registration statement on
Form <FONT STYLE="white-space:nowrap">S-1</FONT> has been signed by the following persons in the capacities held on the dates indicated. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="42%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="35%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #465361;width:32pt ; display:inline;" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Signature</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #465361;width:16pt ; display:inline;" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Title</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1px solid #465361;width:16pt ; display:inline;" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Date</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">/s/ Chris Thatcher</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Chief&nbsp;Executive&nbsp;Officer&nbsp;and&nbsp;Director (Principal Executive
Officer)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">June 15,&nbsp;2018</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Chris Thatcher</B></FONT></P>
<P STYLE="font-size:2px;margin-top:0px;margin-bottom:0px" align="left">&nbsp;</P> <P STYLE="font-size:2px;margin-top:0px;margin-bottom:1px"><FONT SIZE="1">&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">/s/ Peter Donato</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Chief&nbsp;Financial&nbsp;Officer&nbsp;(Principal Financial and Accounting Officer)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">June 15, 2018</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Peter Donato</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">June 15, 2018</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Stephen Campe</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">June 15, 2018</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Brian Farley</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">June 15, 2018</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Paulina Hill</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">June 15, 2018</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Ronald Hunt</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #465361"> <P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">June 15, 2018</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Wilfred Jaeger, M.D.</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">June 15, 2018</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#465361"><B>Glenn Muir</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD></TR>
</TABLE>  <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">*&#8201;&#8201;Pursuant to Power of Attorney</FONT></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">By:</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #465361"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #465361"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">/s/ Christopher Thatcher</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B>Christopher Thatcher</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361"><B><I>Attorney-in-Fact</I></B></FONT></P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2" COLOR="#465361">II-7 </FONT></P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>d542432dex41.htm
<DESCRIPTION>EX-4.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>COMMON STOCK</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>COMMON STOCK</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NEURONETICS, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CUSIP 64131A 105 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS CERTIFIES THAT </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Is the owner of </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:19%; font-size:10pt; font-family:Times New Roman">FULLY-PAID AND <FONT
STYLE="white-space:nowrap">NON-ASSIGNABLE</FONT> SHARES OF COMMON STOCK OF </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Neuronetics, Inc. (hereafter called the &#147;Company&#148;)</B>,
transferable on the books of the Company in person or by duly authorized attorney, upon surrender of the Certificate properly endorsed. This Certificate and the shares represented hereby, are issued and shall be held subject to all of the provisions
of the Certificate of Incorporation, as amended, and the <FONT STYLE="white-space:nowrap">By-Laws,</FONT> as amended, of the Company (copies of which are on file with the Company and with the Transfer Agent), to all of which each holder, by
acceptance hereof, assents. This Certificate is not valid unless countersigned and registered by the Transfer Agent and Registrar. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Witness </B>the
facsimile seal of the Company and facsimile signatures of its duly authorized officers. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">DATED DD-MM-YYYY&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">***SEAL OF THE COMPANY*** </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="18%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">COUNTERSIGNED AND <B></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>REGISTERED
AMERICAN</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>STOCK TRANSFER AND</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TRUST COMPANY,
N.A.</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRANSFER AGENT AND</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">REGISTRAR</P></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="21%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="21%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Secretary</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">By:&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Authorized&nbsp;Signatory</P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NEURONETICS, INC. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THE COMPANY WILL FURNISH WITHOUT CHARGE TO EACH SHAREHOLDER WHO SO REQUESTS, A SUMMARY OF THE POWERS, DESIGNATIONS, PREFERENCES AND RELATIVE, PARTICIPATING,
OPTIONAL OR OTHER SPECIAL RIGHTS OF EACH CLASS OF STOCK OF THE COMPANY AND THE QUALIFICATIONS, LIMITATIONS OR RESTRICTIONS OF SUCH PREFERENCES AND RIGHTS, AND THE VARIATIONS IN RIGHTS, PREFERENCES AND LIMITATIONS DETERMINED FOR EACH SERIES, WHICH
ARE FIXED BY THE CERTIFICATE OF INCORPORATION OF THE COMPANY, AS AMENDED, AND THE RESOLUTIONS OF THE BOARD OF DIRECTORS OF THE COMPANY, AND THE AUTHORITY OF THE BOARD OF DIRECTORS TO DETERMINE VARIATIONS FOR FUTURE SERIES. SUCH REQUEST MAY BE MADE
TO THE OFFICE OF THE SECRETARY OF THE COMPANY OR TO THE TRANSFER AGENT. THE BOARD OF DIRECTORS MAY REQUIRE THE OWNER OF A LOST OR DESTROYED STOCK CERTIFICATE, OR HIS LEGAL REPRESENTATIVES, TO GIVE THE COMPANY A BOND TO INDEMNIFY IT AND ITS TRANSFER
AGENTS AND REGISTRARS AGAINST ANY CLAIM THAT MAY BE MADE AGAINST THEM ON ACCOUNT OF THE ALLEGED LOSS OR DESTRUCTION OF ANY SUCH CERTIFICATE. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="40%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="58%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt; padding-right:2pt"> <P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written
out in full according to applicable laws or regulations:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">TEN COM&nbsp;-&nbsp;as tenants in common</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">UNIF GIFT
MIN ACT -&nbsp;Custodian</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;(Cust) (Minor)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">TEN ENT&nbsp;-&nbsp;as tenants by the entireties</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">under Uniform Gifts to Minors Act</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;(State)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">JT TEN&nbsp;-&nbsp;as joint tenants with right of</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;survivorship and not as tenants in</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;common</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UNIF TRF MIN ACT -&nbsp;Custodian (until age&nbsp;)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;(Cust)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;under Uniform Transfers to Minors Act</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; padding-right:2pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;(Minor) (State)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Additional abbreviations may also be used though not in the above list.</P>
<P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="46%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="53%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" NOWRAP>For value received,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;hereby sell, assign and transfer unto&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING POSTAL ZIP CODE, OF ASSIGNEE) </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Shares of the common stock represented by the within Certificate, and do hereby irrevocably constitute and
appoint </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Attorney to transfer the said stock on the books of the within-named Company with full power of substitution in the premises. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dated:&nbsp;20</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Signature:</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Signature:</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:10.00em; text-indent:-4.00em; font-size:10pt; font-family:Times New Roman">Notice:&nbsp;&nbsp;&nbsp;&nbsp;The&nbsp;signature to this assignment must correspond with the name as written upon
the face of the certificate, in every particular, without alteration or enlargement, or any change whatever.</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Signature(s) Guaranteed: Medallion Guarantee Stamp&nbsp;&nbsp;&nbsp;&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" align="left">THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (Banks, Stockbrokers, Savings and Loan Associations and Credit Unions)
WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. <FONT STYLE="white-space:nowrap">RULE&nbsp;17Ad-15.</FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The IRS requires that the named transfer agent (&#147;we&#148;) report the cost basis of certain shares or units acquired after
January&nbsp;1, 2011. If your shares or units are covered by the legislation, and you requested to sell or transfer the shares or units using a specific cost basis calculation method, then we have processed as you requested. If you did not specify a
cost basis calculation method, then we have defaulted to the first in, first out (FIFO) method. Please consult your tax advisor if you need additional information about cost basis.</P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><B>If you do not keep in contact with the issuer or do not have any activity in your
account for the time period specified by state law, your property may become subject to state unclaimed property laws and transferred to the appropriate state.</B></P></TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>d542432dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g542432g51r14.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Divakar Gupta </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 212 479
6474 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">dgupta@cooley.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;15, 2018 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neuronetics, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3222 Phoenixville Pike </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Malvern, Pennsylvania 19355 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You have requested our opinion, as counsel to Neuronetics, Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), in connection with the filing
by the Company of a Registration Statement <FONT STYLE="white-space:nowrap">(No.&nbsp;333-225307)</FONT> on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (the &#147;<B><I>Registration Statement</I></B>&#148;) with the Securities and Exchange
Commission, including a related prospectus filed with the Registration Statement (the &#147;<B><I>Prospectus</I></B>&#148;), covering an underwritten public offering of up to 5,000,000 shares (the &#147;<B><I>Shares</I></B>&#148;) of the
Company&#146;s common stock, par value $0.01, including up to 750,000 Shares that may be sold pursuant to the exercise of an option to purchase additional shares. All of the Shares are to be sold by the Company as described in the Registration
Statement and the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with this opinion, we have (i)&nbsp;examined and relied upon (a)&nbsp;the Registration Statement and the
Prospectus, (b)&nbsp;the Company&#146;s Eighth Amended and Restated Certificate of Incorporation, as amended, and Bylaws, each as currently in effect, (c)&nbsp;the Company&#146;s Ninth Amended and Restated Certificate of Incorporation, filed as
Exhibit&nbsp;3.3 to the Registration Statement, and the Company&#146;s Second Amended and Restated Bylaws, filed as Exhibit&nbsp;3.4 to the Registration Statement, each of which is to be in effect immediately following the closing of the offering
contemplated by the Registration Statement and (d)&nbsp;originals or copies certified to our satisfaction of such records, documents, certificates, memoranda and other instruments as in our judgment are necessary or appropriate to enable us to
render the opinion expressed below and (ii)&nbsp;assumed that the Shares will be sold at a price established by the Board of Directors of the Company, or a pricing committee thereof, in accordance with Section&nbsp;153 of the General Corporation Law
of the State of Delaware (the &#147;<B><I>DGCL</I></B>&#148; ). We have undertaken no independent verification with respect to such matters. We have assumed the genuineness and authenticity of all documents submitted to us as originals, and the
conformity to originals of all documents submitted to us as copies and the due execution and delivery of all documents (other than by the Company) where due execution and delivery are a prerequisite to the effectiveness thereof.&nbsp;As to certain
factual matters, we have relied upon a certificate of an officer of the Company and have not sought independently to verify such matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our opinion is
expressed only with respect to the DGCL. We express no opinion to the extent that any other laws are applicable to the subject matter hereof and express no opinion and provide no assurance as to compliance with any federal or state securities law,
rule or regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when sold and issued against payment
therefor as described in the Registration Statement and the Prospectus, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the reference to our firm under the caption &#147;Legal Matters&#148; in the Prospectus included in the Registration Statement and to the filing
of this opinion as an exhibit to the Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cooley LLP </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 1114 Avenue of the Americas New York, NY 10036 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">t: (212) 479-6000 f: (212) 479-6275 cooley.com </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June 15, 2018 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page
Two </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Divakar Gupta</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Divakar Gupta</TD></TR>
</TABLE> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">Cooley LLP 1114 Avenue of the Americas New
York, NY 10036 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center">t: (212) 479-6000 f: (212) 479-6275 cooley.com </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21
<SEQUENCE>4
<FILENAME>d542432dex1021.htm
<DESCRIPTION>EX-10.21
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.21</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.21 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N<SMALL>EURONETICS</SMALL>, I<SMALL>NC</SMALL>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>N<SMALL>ON</SMALL><FONT STYLE="white-space:nowrap">-E</FONT><SMALL>MPLOYEE</SMALL> D<SMALL>IRECTOR</SMALL> C<SMALL>OMPENSATION</SMALL>
P<SMALL>OLICY</SMALL> </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each member of the Board of Directors (the &#147;<B><I>Board</I></B>&#148;) who is not also serving as an employee of
Neuronetics, Inc. (the &#147;<B><I>Company</I></B>&#148;) (each such member, an &#147;<B><I>Eligible Director</I></B>&#148;) will receive the compensation described in this Eligible Director Compensation Policy for his or her Board service upon and
following the date of the underwriting agreement between the Company and the underwriters managing the initial public offering of the Company&#146;s common stock (the &#147;<B><I>Common Stock</I></B>&#148;), pursuant to which the Common Stock is
priced in such initial public offering (the &#147;<B><I>Effective Date</I></B>&#148;). A Eligible Director may decline all or any portion of his or her compensation by giving notice to the Company prior to the date cash may be paid or equity awards
are to be granted, as the case may be. This policy is effective as of the Effective Date and may be amended at any time in the sole discretion of the Board or the Compensation Committee of the Board. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Annual Cash Compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The annual cash compensation
amount set forth below is payable in equal quarterly installments, payable in advance during the first 30 days of each quarter in which the service will occur. If an Eligible Director joins the Board or a committee of the Board at a time other than
effective as of the first day of a fiscal quarter, each annual retainer set forth below will be <FONT STYLE="white-space:nowrap">pro-rated</FONT> based on days served in the applicable fiscal year, with the
<FONT STYLE="white-space:nowrap">pro-rated</FONT> amount paid for the first fiscal quarter in which the Eligible Director provides the service (payable not later than 30 days after the Eligible Director commences such service), and regular full
quarterly payments thereafter. All annual cash fees are vested upon payment. An Eligible Director may elect to receive his or her cash payment in the form of vested common stock based on the prevailing market price at the date of grant. These grants
must comply with the Company&#146;s Insider Trading and Window Policy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Stock in Lieu of Cash Compensation</U>: No later than the first business day of
each calendar quarter, an Eligible Director may instruct the Company to pay some or all of the cash compensation payable to the Eligible Director for such calendar quarter (the &#147;<B><I>Stock in</I></B> <B><I>Lieu of Cash Amount</I></B>&#148;) in
common stock of the Company instead of cash. If so instructed by an Eligible Director, the Company will issue to the Eligible Director a number of shares of common stock of the Company from the Plan (as defined below) equal in value as the Stock in
Lieu of Cash Amount, and the cash compensation payable to such Eligible Director for such calendar quarter will be reduced in an amount equal to the Stock in Lieu of Cash Amount. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"><U>Annual Board Service Retainer</U>: </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top">All Eligible Directors: $40,000 </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Non-Executive</FONT> Chairman: $65,000 ($40,000 in cash and $25,000 in RSUs), which is in addition to the compensation received as an Eligible Director </TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1. </P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"><U>Annual Committee Member Service Retainer:</U> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top">Audit Committee: $10,000 </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top">Compensation Committee: $7,500 </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top">Nominating and Corporate Governance Committee: $5,000 </TD></TR></TABLE> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"><U>Annual Committee Chair Service Retainer:</U> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top">Chairman of the Audit Committee: $20,000 </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top">Chairman of the Compensation Committee: $15,000 </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top">Chairman of the Nominating and Corporate Governance Committee: $10,000 </TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The equity compensation set forth below will be granted under the Company&#146;s 2018 Equity Incentive Plan (the &#147;<B><I>Plan</I></B>&#148;), subject to
the approval of the Plan by the Company&#146;s stockholders. All stock options granted under this policy will be nonstatutory stock options, with an exercise price per share equal to 100% of the Fair Market Value (as defined in the Plan) of the
underlying Common Stock on the date of grant, and a term of ten years from the date of grant (subject to earlier termination in connection with a termination of service as provided in the Plan, provided that upon a termination of service other than
for death, disability or cause, the post-termination exercise period will be 12 months from the date of termination). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Annual Grant</U>:
On the date of each annual stockholders meeting of the Company held after the Effective Date, each Eligible Director who continues to serve as a <FONT STYLE="white-space:nowrap">non-employee</FONT> member of the Board following such stockholders
meeting will be automatically, and without further action by the Board or Compensation Committee of the Board, granted a stock option and restricted stock unit, each valued at approximately $50,000 (using the Black Scholes pricing methodology at the
time the award is granted) (the &#147;<B><I>Annual Grant</I></B>&#148;). The shares and restricted stock units subject to each Annual Grant will vest in full on the first anniversary of the date of the grant, provided that the Annual Grant will in
any case be fully vested on the date of the Company&#146;s next annual stockholder meeting, subject to the Eligible Director&#146;s Continuous Service (as defined in the Plan) through such vesting date and will vest in full upon a Change in Control
(as defined in the Plan). If an Eligible Director is appointed in a period in between the annual stockholder meeting, such Eligible Director will receive a <FONT STYLE="white-space:nowrap">pro-rated</FONT> Annual Grant, subject to the restrictions
noted above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2. </P>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>d542432dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consent of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Neuronetics, Inc.: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the use of our report dated March&nbsp;16, 2018, except for the recapitalization described in Note&nbsp;2, as to which the date is June&nbsp;14,
2018, with respect to the balance sheets of Neuronetics, Inc. as of December&nbsp;31, 2016 and 2017 and the related statements of operations, changes in convertible preferred stock and stockholders&#146; deficit, and cash flows for the years then
ended, and the related notes (collectively, the &#147;financial statements&#148;) included herein and to the reference to our firm under the heading &#147;Experts&#148; in the prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ KPMG LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Philadelphia, Pennsylvania </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">June&nbsp;15, 2018 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g542432g00o02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g00o02.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( 5<"10,!$0 "$0$#$0'_Q  ?  $  00# 0$!            " 4&!PD#
M! H""P'_Q !A$   !@(  P(%#0L(!P4&!04! @,$!08 !P@1$@D3%!46(=88
M&1HB,5-66)25EI?4%S4V-U%5='6TTM,C05=VL[6VU20R.7&8M]<*-$)A=S,X
M0U1R<R4F4I+1)X&1H:/_Q  < 0$  P$! 0$!             0(#! 4'!@C_
MQ !8$0 "  ,$!0@$!@T'"P4!     0(#$1(A,5$$06%QH043@9&QP='P%"(R
MX0860E)4DQ4U4V5R<X*2I-+3Y/$',V)TE+*S%R,T-E5FHJ6UU.4D8[3BXR7_
MV@ , P$  A$#$0 _ /?Q@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M'R"IA_[_ .X1JZ./^G>9%8?#>@[P:0Q5N>.I^?+WXRIP:# & , 8 P!@# &
M, 8 P"$O%%^$];_4*O\ >#C)U+>^Q&4>/1WLC#D%!@# & , 8 P!@# & , 8
M P!@# & , 8 P!@# & 7^RUE;Y!6LHM6*)S6YF[?0IA>-RIJMV*)%W(N%#'
MK4Y$U4N2:PE.<RJ9" )CE 9IY\^>B\FC=-O<<8ZYLWB\D@0D8J*L>ZE4HY.8
MC?'"T:Q5=(NWB$29P5\X10,R="<4$5!Z$%3 40(;E-EUIXTKEAMUBC\M=F)Q
MK:^L:,467Z8U9(89O83LF\O'*RZ,(X(10DDK$@X\/!J0BA3+*%0,")1$ZG20
MIS%K3SF*/OU'!!4F5L,>[DV+V 1;,"B=Z$A/1D>NT1[Y%N5RY0=.$U46RCA=
M%%)=0I4U%5"ID,)A ,4\]?A7<$F_XI%N>+7XF(5-FY6[Q0R2)D4%5B.#E*)Q
M!N=,ABK@) %0HIB;FG[</:^?)H]^[J(.(K1V=-98C5P9%N8"N%2HJ&30,(\@
M*L<"B5(PCY@ XE$1\V*/)]0*B_KTY%NC,WT6\1<D;MG9TNY,H)&[MFF_04,9
M(#E+S:JE5.43 9'D<BP$434*51[]U_GSJ&!T 8/A5[D&;H5@1\(%(&ZPJ]QT
M@?ON[Z.KN>D0-WG+HZ1 W5R'GD4>0/DK1V9$7!6K@R  417*BH*( 90R11%0
M"]  94IDRCU>=0IB![8!#)H\F"M!4[",\A61C%B3;GN!38J&2(8".&I7I5%%
M3* @DD1J85W"JJI$VQ"*BX,F*2@%4\ZO/E5)HZTUGU,U26A%(\JP,GZ4J54T
M:ZA7[68:/#(*]RX2168*K@*Z"H@FJB8"J )BF HD,4PFFO+[Z$%%(Q>J'.DF
MS=**)'%-1,C=4QTU"E.<2'(4@F(<"IJ&$I@ P%3.(AR*804>3Z@59.L3)V"4
MH9J5NQ<LGS]HNY710*\1CETFSHK0JAP.LN598I$D"E[U?I5,B4Y4SB"R_=K]
MW2"DG8O4S$*=FZ(90%13*=NJ4R@(=0+B0!( F!$2'!42\^[Z#=?+I'DH\F#C
M\&<=/5X.MT]*9^KNE.GH6,)4C\^GETJF 2IF]PY@$"B(XH\G_' '*#!\(',#
M-V)4C&*H(-UA!,Q#E2,4X]'(ABJ'(F8#<A YBD'D8P *CR8.!5)5!0Z*R:B*
MJ9A*HDJ0R:A#![I3D. &*8/YP, #D X\ 8 P!@# & , 8 P!@# & , 8 P!@
M# & , 8  1 0$!Y"'G 0\P@(>X(#@$T=*[J"4!I4+>Z ), (WAIEP?D$B <B
MI,'ZAAY!( '(C9R<?].\R2H^&]!GDX]Z[UWKI5V&D,6I]?B2GR#08 P!@# &
M , 8 P!@# (2\47X3UO]0J_W@XR=2WOL1E'CT=[(PY!08 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@$A*_N*(AXV$9JQDBJO#(5%!!R0K410+'2R#JT
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M*QCG;DYRJ*]X#A=J=4BAS]Z<ABBH!3\RA#>'G6WWD-U?5V%JY! P!@# & ,
M8 P!@# & , 8 P!@# & , 8 P!@$@=-Z=<7%PC89]-5M5VRO4BGS.DO.+I'\
MZ*!@Z3IL$SEZ73L@@90P&;-3 H"RS:<+]>KQ\%TX8WAAK>\.TGL4H%*!2AR*
M4 *4 ]P  .0 '^X/-D&I_< 8 P!@# & , 8 P!@$;=VZLM-^FH=_ ^+NX8Q9
MVB_AKPS8_?&=JK!T%!!7J+T'#VW,//S#EDZJ;7W>!G'"V[EJ,*^IOV/^2!^=
M#_9,@K8BRXKQ'J;]C_D@?G0_V3 L19<5XCU-^Q_R0/SH?[)@6(LN*\1ZF_8_
MY('YT/\ 9,"Q%EQ7B/4W['_) _.A_LF!8BRXKQ'J;]C_ )('YT/]DP+$67%>
M(]3?L?\ ) _.A_LF!8BRXKQ'J;]C_D@?G0_V3 L19<5XCU-^Q_R0/SH?[)@6
M(LN*\1ZF_8_Y('YT/]DP+$67%>(]3?L?\D#\Z'^R8%B++BO$>IOV/^2!^=#_
M &3 L19<5XCU-^Q_R0/SH?[)@6(LN*\1ZF_8_P"2!^=#_9,"Q%EQ7B/4W['_
M "0/SH?[)@6(LN*\1ZF_8_Y('YT/]DP+$67%>(]3?L?\D#\Z'^R8%B++BO$>
MIOV/^2!^=#_9,"Q%EQ7B/4W['_) _.A_LF!8BRXKQ'J;]C_D@?G0_P!DP+$6
M7%>(]3?L?\D#\Z'^R8%B++BO$>IOV/\ D@?G0_V3 L19<5XCU-^Q_P D#\Z'
M^R8%B++BO$>IOV/^2!^=#_9,"Q%EQ7B/4W['_) _.A_LF!8BRXKQ'J;]C_D@
M?G0_V3 L19<5XCU-^Q_R0/SH?[)@6(LN*\1ZF_8_Y('YT/\ 9,"Q%EQ7B/4W
M['_) _.A_LF!8BRXKQ'J;]C_ )('YT/]DP+$67%>(]3?L?\ ) _.A_LF!8BR
MXKQ'J;]C_D@?G0_V3 L19<5XCU-^Q_R0/SH?[)@6(LN*\1ZF_8_Y('YT/]DP
M+$67%>(]3?L?\D#\Z'^R8%B++BO$>IOV/^2!^=#_ &3 L19<5XCU-^Q_R0/S
MH?[)@6(LN*\1ZF_8_P"2!^=#_9,"Q%EQ7B/4W['_ "0/SH?[)@6(LN*\1ZF_
M8_Y('YT/]DP+$67%>(]3?L?\D#\Z'^R8%B++BO$>IOV/^2!^=#_9,"Q%EQ7B
M/4W['_) _.A_LF!8BRXKQ'J;]C_D@?G0_P!DP+$67%>(]3?L?\D#\Z'^R8%B
M++BO$>IOV/\ D@?G0_V3 L19<5XCU-^Q_P D#\Z'^R8%B++BO$>IOV/^2!^=
M#_9,"Q%EQ7B/4W['_) _.A_LF!8BRXKQ'J;]C_D@?G0_V3 L19<5XCU-^Q_R
M0/SH?[)@6(LN*\1ZF_8_Y('YT/\ 9,"Q%EQ7B/4W['_) _.A_LF!8BRXKQ'J
M;]C_ )('YT/]DP+$67%>(]3?L?\ ) _.A_LF!8BRXKQ'J;]C_D@?G0_V3 L1
M9<5XCU-^Q_R0/SH?[)@6(LN*\3A<<.VPVK==RJ$'W;=%5=3IDSB;H2(90_2'
M@@<S=)1Y!S#F/FYX%F++BC!."I(#3FG%[FNE8+ DJWJK97FDD/4DM.K)&Y&0
M0,'(Y(],Y1([=E$#*& S5J;O066:SAW+O?<NEW8WAAK>\.TGDW;H-$$6K5%)
MNV;I$1001(5)%%%(H$3223( $(F0@ 4A"@!2E     ,@U.; & , 8 P!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M<H#TF 2CRY" AYLE8K>B'@]S." =+OH.(>.3]XX=1S-PN<"E(!U54"'4-T$
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M;-FR2:#=N@F5)%!%(H$3223( $(F0@ 4A"@!2E   .6 <V , 8 P!@# & ,
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M & , 8 P!@# & , 8 P!@%F4#\%V7Z3*?WH\R7CT+L16#V5T]K+SR"PP!@#
M& , 8 P!@# & 4J=^\DS^JI#]D6R5BMZ[2'@]S[#JU7\&H#]41_[,GAXO>^T
M+!;EV%?R"1@# & , 8 P!@# & , H-I_!J?_ %/(_LBN2L5O7:0\'N?8=F"^
M\D-^JH_]D1P\7O86"W(JN02, 8 P!@# & , 8 P!@%EW41!O <AY<[9!@/\
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ML[>;@^:C"KS?6RF>JLXF_C [D^L>V?YKCFX/FH5>;ZV/56<3?Q@=R?6/;/\
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M4.U5*0H"80* F,(  B( '/SB 9DL5O-7@]S*+1)%I*TZMOF*Q%VZT0S*!R&
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M"+EJN0!'H605(8I@YB4Y>A5,3)*)G,5T2WKM(K6%M9,\;^=YB, 8 P!@# &
M, 8 P#=OV-/WQXAOT+5W]O?\YY_R/RNXTEZ^CO-TUH:N7*U8%N@JN#:S,'+@
M4B&."+=-)R!UE1* ]"9!,4#'-R .8<QS&'7^"RT2=8=C\"Z\J6/$;/\ W]FO
MUM(_MBV>@<Y2< 8 P!@# & , 8 P!@'N(SSSH& , 8 P#A4<-T1Y*KHI"/N
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MQC;97:H[(:V'2LOI[4DE98?>-1X+K7 :WM\?78&58T_B>XE]DZJ96\MU7O\
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M/G35PF/--9NNZ5515(/FYE43,4Q?, \A\X!FRP6Y$/%[V4[)(& , 8 P!@#
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M[NO*ND/&*\(*R;%>239=YX61LW>+H))R*:8$;/C(=VL1P"?(FTTUBBII#O\
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M@%J7GPP*E/#'@V,_!@?P$KPRI&9GG63P8'9T"G6*V%;H!<R)#JE2ZA3*8X
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M.4?YC% ?YL%H?:7G4;'\&PP!@'$@@@V3[INBD@GUJJ=VB0J9.\75.LLH)2
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M.*%)-I=N9,*JTF9DE] Z[1BI):/A'YWR3%THS(24DUCF<D1.9 I4N_-WAA4
MH 3D/4/FY#SS-8JN&LT<"HZ*_5>0SFZTN6YNJM#,5S.C2*,<S8")S+@X4(D
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M"XRL?LOH[46@]I=/8R1<TJHWAY9=$>2R,:_52'D!N2B;54Y!Z1 0-R,4!Y"
M@/N"'+,5BC5X/<^PQ;I.AM*=4VKPY2*S5A0;R$DYY!S2243[QI')#_,DU34$
M51 1!5T=8_49,$0)+RR[=9$"HMK\HQ=;_P *)[]9NO[0<V6"W+L,GB][[2W,
MD@8 P!@# & , 8 P"]->?AC#?_4]_NUYE8_9?1VHM![2Z>QDD)MXK'P\H_0
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MVD=ZYVT]:@^DEETM4J711[;Y.+#2\.C9WEN<A;O5,;Z;(K\:5OHJ0K>91E^
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M$2^W H&]J(AY_,/+#O;>9"P6XBU;_P *)[]9NO[0<W6"W+L,7B][[2W,D@8
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M!\ZCIZJ,JKG6/'A3?EN-:2W=6FVNV'N;ZKKZEEJ;*XTK5$14/8V^P(2.7O\
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M.$5EX]PNYCWJ*#U%,YE&BRS)RV=I)+E3.HU<(."%%)5,YH"Q6]=IMAP;C &
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M14#S\VT7U*)'Y?\ ZWIW8\P Z941\P*Y7=O7X4-% EC?V&<RE*0I2$*4I"E
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M:*ZDU@YAR$#/5&9#%$#IBJ'F$64#>S?X$N*7J2ET@$EX^.!]*D !&9E.AT^
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M_B9Q?,[9+D8 ,0[D7CA,P=2:Y/<!7^.OW=%#50);?.1FL     #D >8 #S
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MK2#E9,1$AC%]LF<A@\_, 'D/(>89+[EV(K#<DGM[3\Y+MD/]IIQ<?U_A_P#
ME2S^ROY.O]2O@_\ U29_\K2#ZKR)]JM"_%/^_&:S,_:GJC & , 8 P!@# &
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M3OZI)_NGT/D[_0-$_$2^PPEGJG:, 8 P!@# & , 8 P!@# & , 8 P!@# &
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MMQ'UJ'M$N,'1.O8/6&L]LIPU3J2T^O1 E*#K2W6'7*UJ457L9];7*X4^>MU
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MW[=6.D,4,*OJZUM*FK!)U3WW;-:,_EXP.'-GJ)+4KC>FEK-4V? F7AX<(GT
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M:\A95U_S:]--EV^KZR$6[-$.]-L:1)>5,5;XZXLY GC&$!HK',+!",J\_GH
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M.6G2"B<-JW2%_P!L_!+L"J.T(ZVS%/UL6O0D\&Q;7?K4!J=$6Z*XB-O\/K*
MC7-5@YV4.M*V75$TW:)%82:!&T+/V^2E8NI(G<Q\2/A-HD^&*/1Y>D:;SLV5
MZ'(T21_ZB9H\SD?D_E>*=&I\V5+I+DZ?*<3MP.U-E:/!+F:0Z1Q!I\N.KEPQ
MS;3@YJ"7!Z\4$6C2=)<3MQ0JB@G0MNL+K%#+4,4;5J',M&KPLK)P[I9@X<Q,
M@]C7*\5)Q\U%KKL7*C59:-F8ER]BI9@HHD8[.3C'CN/?MS)NF3E=LJFJ?]'+
MC4V7!,A4:AF00QPJ9!'*C2CA424<N9##,EQI/UH(X88X'6&*%1)H[H6HH5$J
MTB2:JG"Z-5586DT\TTFG<U4W!]@7_M1-#?U>W-_R=O&?//Y5_P#4?E3\=R;_
M -1T8\3X1_:C2?PI'^/+/T))=%1Q$RB")!467CGJ*1 Y<SJ*-E2$(',0#F8Q
M@ .8@',?..?R,L5O1\R>#W,Z]>;K-(&':N4Q2<-XUDBLD;D)DU4VY"G(/2(A
MS*8! >0B',/=P\7O86"W(\\O$E^/O;G]>Y_]M4S[5R']I^3OZI)_NGT3D[_0
M-$_$2^PPEGJG:, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8!5X"4\23<5,
M"AX2$8_;/?!^\[GOO!U2J=UWO=J]WU]/3U]V?IY\^DWN9RZ;HWIFB:3HMOF_
M2),R3;LVK'.0N&U9K#:I6M*JN%48:5)](T>=(45AS9<4NU2MFTJ5I55IE5;R
M;NC+>&Z=CQ.ORQXUL91I+.O&PN_&P(>*XYP_[OP$&T;WG?\ <=UU>%D[OJZ^
MD_+H'YORM\%OL7H4S3'IO/V(I</-^C\W7G(U!6WST=*5K[+KA=B?C=-Y"BT/
M1XM(>DJ8H7"K*E.&MJ)0X\X\*UP)MR?#([8$:&;VE60%S(-6:I$*XIS;(.#&
M*H]4Z)=8>Y;@ &4Z@(7D(=2I/=S\FK.WK7@>&X-NO(BS,%;Q?C8'9^MI%ED3
M/%>Y.H M&!5C.EC()@J<Q 0144.F4J@] "  ;^>*7T6=%UE#2?N[:\AMNZ.I
MHXK(03#O&%9C5!Y>!QA5.?A"R8") ?R)R@Z?& 3B4PI-"J'0:(<NR"%0K;K>
MT&'LN!@# & , 8 P!@# -V_8T_?'B&_0M7?V]_SGG_(_*[C27KZ.\W2VELX<
M+5<6Z"RX-[/'N' HI'4!! B3H#KK"0IN[1()B@90_(A1,',0YAF,.O\ !9:)
M.L.Q^!=F5+'B-G_O[-?K:1_;%L] YRDX P!@# & , 8 P!@# - ^=!SEQ/*C
M;(ZMPERD*Q8F-0LKZ6C*Y:WD+)-:W/R4#X)X]CX2<7;$BY5]"^'L/&S1BZ77
MCO#6GAB:/A*/7%55JJJL56]5S0,C</E/V)>-KUZ#U3:7E*O2;.RSD19XQY;V
M<M%(UNL3$]+JQ :^BIZ]/I-6&CG[9I&5.$EIF146\%19'147.G$323;55===
MK=-=%UDJM;L?.1)N+U%Q9O5]@3=.WY(3Y+1LV@:GV9.0&T]E-']I<W^/@H^(
MLE\CI2-A[9(U"!=7>"I-P\K(?RBIUDL+>J3=::/79FQJN*"Y.'!.))I74KAJ
MK<VJ.C5Z=":/4\73'&O\;ZYG/#<)'$@VE8!Y7-OQ;2TV.)X<V"BK.:W7 +QM
M=VH]U634+%Y=G^NXFH336I/IK6RAJQ4;;9Y>M!7DY&"@W3.BR#N%..'6L+7S
M<8:UHJUSO:6.T4=U^-,]E+Z;L.XBGM1CNUDC4$MQ.KVY01A@9TQ&Z3DG,IQ$
M2U08=Y!QB,@_?!7SQS5:)%Y6^E@]C&[B+%Y'-DG#(5+JS?2F-],\]N\AUUUR
MO,0Y)!L^[&3_ &F?"O\ UBO?_*6_YE/_ )J/=WHO+]N'>?HA9YAVD#;G"3FS
M-DP4<D(&>/H9/PUV5$"HL8]G,2Z*SQ8A.DH%00(0I2\RBNX,DB4>\6+SFG51
M<57SWT,;XFL\#PF]KU'IP_:.<4,*W6<K,X6VUR*8B[<*.54V;/7]1313ZU##
MTE#SF!-,")$$P@DF0G(H?V1_)Q##!\"N0+,,,-K1IL45E)5BBTO2'%$Z4K%$
M[VW>W>SZQR%"H>2="4*27-Q-TUMS(VV]K=[9!#7-^G]6WFL;"JQF9;#4I1&7
MB#2#;PQD#Q IRD%RU[Q+ODN1S<R=X3GYO/GZ[3-$DZ=HL_0Y]KF=(EN7,L16
M8K+QLQ4='=C1GI39<,V7'+CK9CA<,5'1T>3U&>JCQF;DJ^J:[HYZ:KW74M=\
MN&1*5<X9=\SE*QL!S!RT[2I&6BI*%LB-7;6FOL+O7F\+-Q$G6KF=Y8(.58NG
MBW5Y6D?!SDZ?I\[E2'G]&Y0G>BQ/2=&FJ&*"?HD,V7*TF"7,@FR7.BD3HM%G
M.9*F03]&4,J;!%#"CGF:#(CG1:0K<N=%S;YR7$DU'*44,,:344+CL1N7$XH6
MHX*0Q)I(X)3C$W%+3-4F5CU9LI1IFYRM08,( K2,K[.Y:>UKH8:XP;)N^H*]
M6-7ZDHU=JK9959\Q\5J/W\C*/G;A<Z#X.<G02](EKGVM*EZ-!I$44VU'.BT;
ME'3>5N>CB</\]/T[E#2IT]I*"+G%!!!!#"DD.@R(5&O7?.*!3&XKXW!/FZ3;
M=WM1S9TR*.E$ZT222.K2.+;;5&@;9&-5H>?GK9"W&NK;#LX3\GL&/@+]4#46
MUP/CU&P,D+17WM;47;Q5=V''72!J$D\DK%2HVN6.5E)5Y;2?@_R?I,W1XVID
MF5H\S1IRT.1S,&AQ3M$TCTJ1.YIR8G(G0SJ.9.T./1IND00P2=)CG29<N7#,
MS0Y,R*!M10PP101\W#94MQ2X^<@BLN%V(E$DW%*<N*-)0S'' E"LOV3CHL#"
MZ:XE*)!1MB@M0:CUMJZC2.S(A2-N*3W7I4';2]DEM;V2O3=?L'A::%>!K&V]
M['SM"K]5K-Y);&T2D5/SY/P7E1Z-IL&ES8Y,WE'E#3=.TJ#0IEO1W#I=88M$
MYO39,Z5.DV6YUJ/1X(Y6ESI\_1?1XIC;PAY/A<N8ID3@BG3ITV8I,58*3;G+
MI-@BABAIZU\"<,R*..78<3+4C^.W<"<*SKUA@=<7:(0,LY?,[' 331*=E$ME
M;'VQ79B7+4;-5BG=U"W[AVH:$:,2L(9[!7R=K-JBK) >+H]AO'\%>3G-CG29
MNF:-,BHH8I,V5$Y4MZ%H7)\Z7+>D2)[4.DZ/R=H'.Q16YD,W1)4^1,DS;<<=
MWR=(M.*&*;+=R3ABA=E<U*DQ0PVX([HX)$FU6K44N&.!P15;Q5/<26R[)"3<
M!**5T6-AU:;4$D#&OLHH!J!^( .)4Y636,\$C8U]]TP.M(T>P;,6U?Y0;2/0
M0(FJ3OE<C:%)FRIT'/6I.G+E&"U.BF?^H7)/V%5J*9:F1P^A8VXXHXIW^=BC
M;;3VAT65#%#%#:K!.Y]5B<7KK1O1%5Q5B:YK-MN+UFV9*L/&]M>ZST[+W^NZ
MUOD59BSJD[3+'6Y,*F_DIK>6RN(9";,VA;##S"$I!;%VU=C1!VLT@T4K,JM5
M)MG,P;J1:/N*3\&- T:5*EZ).TW19DGFE*TB3.@Y^&"5R7H7([E5F29DMRYN
MA\GZ+SBBEN)3Y:TB5%*FPP10Y0<GR9<,*E1S9;@L*&.&-6U#!H\K1K-8H8H7
M#%*DR[586[<*CA<,23439V9?6.;F;#)^">,IZ5D)F0\ CV$2Q\.E':SYWX%%
M1;9G&1C3OUU/!H^.:-6#)'H;,VR#=--(OORI<,F5+DP6K$J7!+@MQQ3(K,$*
MAAM3(W%''%1*L<<4443JXFVVSMAA4,,,*K2%*%5;B=$J*KB;;=-;;;Q;;-OW
M8%_[430W]7MS?\G;QGSW^5?_ %'Y4_'<F_\ 4=&/$^$?VHTG\*1_CRS]":57
M4:QDBZ1$"K-F#Q=(P@!@!1%NHH01*/F, &* B ^8?<'/Y&6*WH^9/![F<$"[
M6?PL2]<F SAW'M'"QBE A3*JH$.<0*7D!0$PB( 'F#W \V'<VMH5Z3V'GBXD
MOQ][<_KW/_MJF?:N0_M/R=_5)/\ =/HG)W^@:)^(E]AA+/5.T8 P!@# & ,
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M# & , 8 P!@# & , 8 P!@# )?\  M_[Q]3_ %1;/\.R&?FOA;]I)_XW1_\
M&A/(Y<^UTW\.5_B0F\6=B#S"4<F1<J'@,PPDS"8@G[PK(YC&1  ,7I,IU<@,
M/,"\O. Y\D5W'BJ'X9W\.#J69NL #3&VP    UA?0  \P  525Y  ?S &2L5
MO7:0\'N?8>,;.\P& , 8 P!@# & , 8!NW[&G[X\0WZ%J[^WO^<\_P"1^5W&
MDO7T=YNUF8@\JI#'(L5'Q7,-90P&()^^*W(L042\C%Z#&[T! X\P#E[@\\P3
MI7:FNLLU5IY%<R"QXC9_[^S7ZVD?VQ;/0.<I. , 8 P!@# & , 8 P#.WL9C
M=?QH-6_0JV?;<KZ5!\V+AXD<P_G+J8]C,;K^-!JWZ%6S[;CTJ#YL7#Q',/YR
MZF/8S&Z_C0:M^A5L^VX]*@^;%P\1S#^<NICV,QNOXT&K?H5;/MN/2H/FQ</$
M<P_G+J8]C,;K^-!JWZ%6S[;CTJ#YL7#Q',/YRZF/8S&Z_C0:M^A5L^VX]*@^
M;%P\1S#^<NICV,QNOXT&K?H5;/MN/2H/FQ</$<P_G+J9++@:["/:?"7Q5ZAX
MAI_?FO[?$:VD["_>UR'JUBCY*3)-4VQUA--J\>NE&J)D%YQ)T<52& R2"A"\
MCF*(4F:1#'!%"H8DWG3,M#)<,2=5=L/3!G(;EF4#\%V7Z3*?WH\R7CT+L16#
MV5T]K/SUNU]UALJ;[27BOE877EYEXMY?(A1G)1=2GW[!TF6CU1,RC9XTCU6Z
MY 4(<@F24,4#D,41ZBB ?V!_)[IVA2O@;R#+FZ9HLN9#HLQ103-(DP1POTJ>
MZ10Q1IJYIWK!GU'D6=*AY+T-139<+4IU3CA37KQXINIK;^XWM[^BK9'T&L_^
M5Y^R^R7)WT_0O[5(_:'J<_(^[2OK(/$?<;V]_15LCZ#6?_*\?9+D[Z?H7]JD
M?M!S\C[M*^L@\1]QO;W]%6R/H-9_\KQ]DN3OI^A?VJ1^T'/R/NTKZR#Q'W&]
MO?T5;(^@UG_RO'V2Y.^GZ%_:I'[0<_(^[2OK(/$?<;V]_15LCZ#6?_*\?9+D
M[Z?H7]JD?M!S\C[M*^L@\1]QO;W]%6R/H-9_\KQ]DN3OI^A?VJ1^T'/R/NTK
MZR#Q'W&]O?T5;(^@UG_RO'V2Y.^GZ%_:I'[0<_(^[2OK(/$?<;V]_15LCZ#6
M?_*\?9+D[Z?H7]JD?M!S\C[M*^L@\1]QO;W]%6R/H-9_\KQ]DN3OI^A?VJ1^
MT'/R/NTKZR#Q-O\ V$>M]B5WM--&2U@H5T@HMO ;A*O)3%6G(R/0,OJ&ZHHE
M6>/6*#=,RRRA$D@.H45%3D3)S,8 'Y[_ "I:;H<[X%<J2Y.EZ--F.=R<U!+G
MRID;IRAHS=(88W$Z)-NBN5YXGPAFRHN2=(AAF2XHG%(HH8X6W2?+=R3KA>>^
MR=^\DS^JI#]D6S^3UBMZ[3YL\'N?8=6J_@U ?JB/_9D\/%[WVA8+<NPT#<1=
M9LCK>NUW+6OSCENM>)Y1%=")?K(JIF>'$ITU4VYB*$,'G Q3" _S#GV3D72-
M'AY)Y.ABGR88EHLI.&*; FG95S3BJND^@\G39:T'14YD":D0)IQPIJ[6JF&/
M)&U_!BP_,LE]FSU/2M&^D2/K9?ZQV<]*^ZR_SX?$>2-K^#%A^99+[-CTK1OI
M$CZV7^L.>E?=9?Y\/B/)&U_!BP_,LE]FQZ5HWTB1];+_ %ASTK[K+_/A\1Y(
MVOX,6'YEDOLV/2M&^D2/K9?ZPYZ5]UE_GP^(\D;7\&+#\RR7V;'I6C?2)'UL
MO]8<]*^ZR_SX?$>2-K^#%A^99+[-CTK1OI$CZV7^L.>E?=9?Y\/B/)&U_!BP
M_,LE]FQZ5HWTB1];+_6'/2ONLO\ /A\1Y(VOX,6'YEDOLV/2M&^D2/K9?ZPY
MZ5]UE_GP^(\D;7\&+#\RR7V;'I6C?2)'ULO]8<]*^ZR_SX?$>2-K^#%A^99+
M[-CTK1OI$CZV7^L.>E?=9?Y\/B?)JG:2%,<]:GR$* F,8T-(E*4 \XB8PM@
M  /=$1Y!CTG1OI$CZV7^L.>E?=9?Y\/B?T*G:C !BUFP&*8 $I@AI$0$!#F
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MALQC:0!)$VOG*DHM I*-S)GFU>E3&G4U7R@:XLL!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8!WXN4DX.3CIJ%D7T1,Q#YI*1,M%N
MW#"2BY)@X3=,9"/?-5$G3)\R=)).6CMLJFNW733614(H0I@ ]V_9&]K]>^)+
M1<U7][:DW1L+9FG'%=KDML_46KIZ^15]CI=G)'B).SMZVU,C7;L@C#K$GT@(
MG'S?>M9J.3;'=/H]EC%#1[&#P<YL!@# & , 8 P!@# & , 8 P!@# & , 8
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MNWTNOOZ.&ZZAFRR1'&4FOPL5R,L$N_L;6AV21W+9V)ZC"TA6V0NQ^'E5B&P
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M$G8JXY:,WCE@O-1(7.O#N79NH89AM6]I(O4;&O,[?493C-]7%:O%@6CN7TG
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M]V!TU=_>O.S F?@@8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
)8 P!@# & ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g542432g07s21.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g07s21.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1[V4&AO=&]S:&]P(#,N,  X0DE-!"4
M     !                      .$))300Z      #E    $     $
M  MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M
M $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN
M=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P
M4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $
M0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L
M     BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<
M0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O
M;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP
M $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !
M4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M         $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M        0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M           *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',
M    4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B-2
M;'0               !38VP@56YT1B-0<F- 60           !!C<F]P5VAE
M;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG          QC
M<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M   +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #P     $  @/
M     0 ".$))300F       .             #^    X0DE-! T       0
M   >.$))3009       $    'CA"24T#\P      "0           0 X0DE-
M)Q        H  0         ".$))30/T       2 #4    ! "T    &
M   !.$))30/W       <  #_____________________________ ^@  #A"
M24T$"       $     $   )    "0      X0DE-!!X       0     .$))
M300:      ,U    !@             "VP   _(          0
M               !              /R   "VP                     !
M                         !     !        ;G5L;     (    &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   "VP    !29VAT;&]N9P   _(
M   &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S
M;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N
M=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N
M=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M  !"=&]M;&]N9P   ML     4F=H=&QO;F<   /R     W5R;%1%6%0    !
M        ;G5L;%1%6%0    !        37-G951%6%0    !       &86QT
M5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q4
M97AT5$585     $       EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!
M;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R
M=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC
M94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P         *
M;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M"W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M.$))3001       ! 0 X0DE-!!0       0    !.$))300,     !5V
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MTW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H
M# ,!  (1 Q$ /P#U*FFJBIE-+&U55-#*ZV -:UK1M8QC&^UK&M4TDDE*2222
M4I),2&B28'B4Z2E))+-ZQFY%?H8&"0,_/<64O(#A56P;LG-L8?I,QV.:VO\
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MV3A"24T$(0      50    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\
M<P!H &\ <    !, 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !#
M %, -@    $ .$))300B      $N34T *@    @ !P$2  ,    !  $   $:
M  4    !    8@$;  4    !    :@$H  ,    !  (   $Q  (    >
M<@$R  (    4    D(=I  0    !    I    -  +<;    G$  MQL   "<0
M061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C Q.#HP,SHQ-" Q,3HR
M-CHU.0   Z !  ,    !__\  * "  0    !   #\J #  0    !   "VP
M       & 0,  P    $ !@   1H !0    $   $> 1L !0    $   $F 2@
M P    $  @   @$ !     $   $N @( !     $              $@    !
M    2     $X0DE- _T       @          /_A 3!-30 J    "  ' 1(
M P    $      1H !0    $   !B 1L !0    $   !J 2@  P    $  @
M 3$  @   !X   !R 3(  @   !0   "0AVD !     $   "D    T    \
M   !   #P     %!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$X
M.C S.C$T(#$Q.C(V.C4Y   #H $  P    '__P  H ( !     $   /RH ,
M!     $   +;          8! P #     0 &   !&@ %     0   1X!&P %
M     0   28!*  #     0 "   " 0 $     0   2X" @ $     0
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ Z@%# P$1  (1 0,1 ?_$ !X
M 0 # 0 # 0$!           '" D&! 4* P$"_\0 .A   00" @$# P,# @0$
M!P  ! (#!08!!P ($1(3% D5(18B,1<C0211)3)A<3-3@9$80D.AL<'A_\0
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M71UYSCVWUX_/ DY6Z?JL#)P2[TIT'(MXQE2H^/['L"G9QC\^VDDZ(R%AS/\
M&%?N1ZLX\_C@>GS]0/LQKO#CO8?Z:O8JJQ@^?)4]HZ>JG8D!D?&/+AY(]93!
M.@!,I\K?621E3+:5K7C]N,9"Q'7[ZA/4;LN:/ :UV_!LWE]YP3.MKH@BC;!Q
M(,>OY4<)6K*V 1.%AX0K)>*TY-,#XQG+CZ<8SX"Z7 <!P' <!P' <!P' <!P
M' <!P' <!P' <!P' <!P' <!P' <!P' <!P' HKW0[[ZJZ=1$;$R AVR-UW
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M/ XXSK^?;X%E]/;<L>WX9FSBZ].JU7,0AZ*E[ 3+ N30KJ<+;,BXB7K4%,/
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MV\VV\RXAYEY"'6G6EI<;=;<3A:'&UHSE*T+3G"D+3G*5)SC.,YQG&>!_O@.
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M_K= [*&F44#;&^&=7EU:,IT)(4ZOG;'I]= W7JZ2O-M(=I)L6%8C<U^L6DN
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M5(R)1!IC^7""7G'G%KR'1<!P' <!P' <!P' <!P' <!P' <#)CZM<V[==?\
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MQ%D'"O+%!U%:-(V&<T55*#J^<EH-^!'D4PPM+D*W)@$H$DJE)2+ 3<Q4SAR
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M?PSKI^T.EB)R8:XXK#[N ^DBG1D)"U*L1%;B?L->C:_$!0D+D=T143%#@#M
M1[@Q&,$,.B#);8=;(_U"7$+P_G+OKSP.DX%';9O-$!N>6EJ/(VJVQ4-$+B]B
M:\= DGX^PP]5EI"-L=XT6\\C+%@N&K)=UV)VE4X52DRD6MOVVE6*'%P6%W6'
MFR&62&LJRT^TV\WE;;C2\MNHPM&5M.I0ZTKTJQZFW4(<1GRE:4JQG& _7@.
MX#@. X#@. X#@. X#@. X#@17NG541NC7%@H$J4[%N2*!3H*?&89(.K%HARF
MI2MV,%E_&67WHB6%&)=#>_TTF%@J*-PL$XEI85%Z3;AD8EH_JAM8-%8VKI_!
M$+7P'C'"A+#2HU+:XP6%/);86?FNQ3P?VC&4J*E]?NUFQN?\25:(Z!#W^_\
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MZE5@.4J]?;]J#KTDQ#!MGPT2UEXC+<?&E8=$%3D@G*66DXR0_G^\L._X#@.
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M6UY6=+[#EVF53K0B\85D*K!&-FXPIMN7&SE#F0R9UMJO=7U3.S-9+V'MV];
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7@. X#@. X#@. X#@. X#@. X#@.!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g542432g15j05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g15j05.jpg
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MHK.VN-5(56-D<X.%AI:7H]2G*6>$AZ2FJ+7$Q]+3UO_$ !T! 0 !!0$! 0
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M@T,J&<GJ 'Q)44)2 I1*DI4H MU29/)&,?Y?H*5LXV@V[:;;BN>S!I20@\(
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MY.>A)R+%D!)SCSQ.?S/2??5/KZ\_KQK$"\JX*@XXV%I &$I6D]0Y&<)*C[H
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M.$-I&7'7%$(:;2MU9"4$ZB7M[;:=:75]>O)M[6U8<N+AY9 2AIM)*U%1@X&
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M;#[>UW<>]JDW'@4Z.I%,IGG-&I5>LO-O?5M)I3"\^=.GOLNHC(Z%--H8E39
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M>*+CSA$))E#2!A#;8! #: 0 .2?:)*B:]*3M2@-,2B.2 )4>JU$B95X8 _E
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M.28'Y2EI4HN.NO/K<==<4I)!Y!='22G^\IQ:2G *AGD=NE:0EL;0 (G)GYC
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MN()Q\^_W:%,QCTQ(/[U<%= ?/P/7W]:AR ..K/PSQ^6#\3^N02OP$>D'X>M
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MPE &#U2W4K!92E1QY+1#Q'^T<8&%&.7C*FF!*C(W\I3GH?$&1^L\Y^[&2I4
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M  <FLEKKN)^XZN_Y;B%4N I:6O?"4K6E0;\]"5A2.$92@$DE'*4YY&UM+=2
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MIZ3.3N*L1-?6-18E%M>WHK44M1*="C)!6OH'4 @9>5@#K<<(R G@DA* $]N
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M21( _$> , @9..28!R8/A6!QL3,'@$DR>D8,D)!Y@9).:E2T_P!W)(!RE/\
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M_GK)\S2/9!^/U_7PJ#/KG[\ZO2B><?G\(_:J8Z>_C!CK]>5=15GD$CY??QC
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MP$E)SPLGP,>"#9Q#,MG;>UJQ4(W3_P ;WY-?O":7$X/7[/77Y-+9<*@%?ZM
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M@VI=9;2>KH1&F/2:+,=2G@]%7BK=(_LXP)"=:_8K<<^&%#:H8)B1N2J?\1*
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M2(2"""#Q)@XQDBO&.T'VY:@4+3H5G;:6QD??-04W<W7/*6R$VK<ID'^_*5&
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M<Q%1EZ4QT0V,$\;3.3B!(CQ''-5'!O6='*2B8XKU_P!H<Y^&<\#GYD?;JWW
M8/0^[IGG^DBM9<=GK=X$%&_GE1,'UG]?=5?TO=BIQNA*Y*E)"L<K4GT^('8'
M]D\<\ZN2M2<I41'6)GQQQ$$R"#B>>G)ZG]GVFWR5(N+1#J"I0(*CN$C,$>T)
MGH1CSS5Y[4\0-0IKK"FYTF*X",+CR%I(PKGJ&<+''/6%#'PSQ<XM-PDMW3+5
MTV?Q(>;2H9'3=D$3RF.:\KU;[%K!*R_IP<TZX2I90]:.N-+3,G.W#LP-R7=X
MB,<DY:V5XJ''O(8JRHT]I8Z7'!B/( 40,\ M+*059RE*CGN2..;ONR.A7X4;
M="]/?()!00ZR3DY222D$P/Q8Z#)GB;KL_P!ONSCFY*F=<L@K;L<FWNDH. 0L
M(*%[4B50@+/,D5>VL.;)[ZT5VV;XH-NW539392ND7+3H<QL=0QUQ5OI*HSH_
M:1(BN-2$JPM*Q@'7!ZGV*U:R0IQI"+RW&-S9W+"09]I!0"('&(&$A52]([?+
MTR_2._U+L_J;4$*W.,-DS VOH6&E[EA4H41,RMN#%:L/$3]#G:5?3/N3PX7,
MNUIZTK?18UU2)%1MJ0LY5Y%*KP2_5*2%DA+;<Y%48!(3YK#8*D\>[;+:44J"
MFU D%*TJ$$3*0#"AY*RG$<FOI;LI]NU^TEICM*PC5;94 :C9=VU>I1P5NMB+
M>ZC$[>Y<5,[CDC1ON_L+NWL/7C;NZECUBTY:BOV*5+92]2JFVVOI+]*J\8O4
MZ>T<!1\A]3C8(\YMM7NB.H 86 %$ #JDJ\E=>N)!!D>9^B= [3Z#VFM_O&AZ
M@S=A !=8DMW;!,?W]LL)=;R8W;5()X6JK1 ?Y>G?]?KM&<;^HY]?K\JZ$*(B
M1S$8@^$^?[USJ,M'CSB/C'^7SQQD!GI]>_\ 2H3@]SC[\=^-8MI\#SX>'GZU
M< 3T)^-=:AWQV^T'[OU^>L*FSGT\(]<1\N/RJX$CG CK^GU')KI*<8QSCT]2
M/Y_#MK I&,?E]3'NQ64$<B#4&#G@'OQ\?CK&<#VL>,\?.E<:L4GDB9\*4UC@
M^!^%5B/Z']JXYR/AZ_AJW ,]3\^.G[5>@\^ZN=5K)35,<3Y_/]>/.E-5D>-*
MX(^>#_E_+2E ?QP"1I5/RCG\_P!*YTJM<@_,@>N-*5V$!659[ _ESJ]*B('0
MF9\N#^5*Z^1\1G\]99GBE<G!R1G@#O\ </3Y?9JO,R>F/=P/A5I'&.#/QR?G
M4.KDJC'0G\ZQD')CK$>' ]_ACK366K::4II2N1V/V?Q&KD\_#_K"E<:MI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*5D?X=;$^O+
MA>O"H1DO4>TUM/LM.)RB;6597%:"2DA;<5($EXXZ4++"5D!>3=G$"2J1'^R.
M2?+@> GTK1:]??=K<6[:H=?_ !$$>RV#GC/M&1 Y ,\P+K;@W8]49[D9F0XJ
M+!D/O+6K'_5CP<#2E'WA^R@H!*L$I. /=SM[-H[0OKG\1)CCV0<21[/KQQ7G
M%T\H'"MPW1 Q)R,@CC!@&3ZCFC(DI[I2MQ:%*"<%".GI\I0"UE1 *E!2>5)
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MD].#W R?@0..>,  #  &!\;T"04^GK'7\JL5X$$CD1D=('!E/7GWUWI=*E@
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MRH0[*A..-M2XRJG=$EI9;=B6VETQ1!9=20&)EPRP:8R0L.BFL5N0T N,VHY
MJ K;[1F!YQ@F>.>GD?0E*2F%QM)G:B#B>#'/&>.H'I5#+?E-H;:2VAIMI+;;
M;:>EMEM">E+3:$$AM#:0$(2G'2D!(QJX_A&XF%84<2=W\P,\CI[JN25[2D!.
M?:GVA$Y,S@^?2?6*Y'2$IZE'( #02HYZL9)&<Y[8&>.K@'5$F( X!&>L9'M$
M8^/E6)*P%C"U!6." ")R1$@=!^PKJ=Y&%<XP2 <!(X)&0?F!A/;)Q@@ZL/M*
M*LGG@@0!UDX]<GJ/2_V251M@P%&?Q 92" "0#/ ]>>>AT+4%!93C'NI R,9
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M2K'8OKQA.59*L9_O>KN20ZPE4IB&-T"(ZJDD'/\ +CF16 J[0N;O^X=DV1*
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MITYKU)$(2&P$I2D0 /9'@/EP8XJI5OA12D%2D]6,J))5@\K40?VED]1)[=N
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MTDC*@05$$''2 !C/.?GZVE(2,)GQ(/)(&<0!\/ YK O<I4-K5MY4K*B8X3/
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ME3;SFE4E0]E8 48VD?A42 <=9CE)SU$P:^S^R?;+1>V-F;G2WBFX;$7>GO*
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MUB>D?UI35:4^_P#7Y:52/RCX<5P#Q]W/!TJO]/Z_I4041V/Y?STI3))Y_=^
MX^>KDJC'0FE<:S4KGOG]?9Z?#]VJ\\G@8_05:4S$#^:3[^:X^W502GIS'/Z5
MCB8$ &2/R^)^A36:9XJVN1V/V?Q&KD\_#_K"E<:MI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E9&^&BR(MS7P:[5PA-"L]@5>6XZ$^
M2J6"?86UE8*,-J0N4L*Q[C'SU?$"<@JP",D'H1TY$@GR \:T^N7/W>S+8,+>
M.TQR$ 2H^(G"3Y&(.:K#=>]'+FK\B0V![%%/LT-"%A82TEQ7OD#U<2>OL .P
M. ,;"W4TRB9)6J 9$ !,DP>OXO$GKTKS\L+?6$R$I$K1G\6("5&)$Q/C^EKA
MUJ0VH.%25%7"2<_+(&<](_SXUD#J ?#KGP_PXDG/'GZQ5Q9(201)G/A,G(F(
MQR.M3:"\8ZO,3T/K"0$K6#AM:5A:58!P1D=."D^Z2!@G.I27D;8*=@(/L\8,
M^T1T &2>D>/.O6AP*PH*4< 9V@] #,$^ ]V*]MHVQ6-QKQI%NTMI4AZH5%E@
ME1'1YBU>8IR0M6&T---A;\E2L);92>I6,G6BO[M-RXJW"]K+,.7"P"/8&=H$
MY\^F/(@=)8,*L6/O"D W=R"TPC) *C!4(@@)'$'HK$YK[8OH]_#A2MDMHJ"]
M[)Y%<NBDQO97'&0V]$MMU+<TU&5D(<9G7-*/UU-_9+=/%'IZ@DQ5A7B?:/5U
M:I?**93;6RE-,I)D>RI0"O#($SQX<5Z/H.FIL[,;RK[PL$O8PHJ2DQN(DP3$
M#^:<]*V.J7T-(0,I'2A#:"?V&2D=.3C!6\K+[@)5@J"#_LSKGFT))WJ''4>T
M>1$\8)\N<<UOU81M2G/))R)@S[_/X<UTI6O /"2K/ '(.2!DG XP5*(^/ YU
M(D2H9X!!C&>GNSSQX\U:"("#P>2%#G&2.1)GKX]:]"%*6H @* [Y'5D? G]W
MP[:OE*B!D1&>N/(<GR!SCB:QJ0D%4'V<01GD29CP@^7%31K "3_>X^X'T_'&
M,D?;QJ0@#:<9'QXZ^<S/GS4=94#Y&,Q@D3GW^^NY2^.3@Y2$CJ"<YP3WXQR<
M8/H<C.-!&X',#J1$&/GSSQ[JQ$$9CD9/KF2?E]37(<2K 2"I("AZ\J!)[8R3
MGGCC QCG5!F)(B0!F?9'D.( )XQSFF/; .X\DF9$QP/UGB>*L+X@M^:7L):%
M+JZZ!4KVO*\KBA63MIM]0%-,UR][UJP68-*BO/A;,*%';;=FUBJO-K8IT%IQ
MYQ*UJ9;<Z'L]H+O:"[>9^\,V-G96SE[J6H/;U,V-BR4[GEI2D=XM9(0TPE>Y
MQ9P0 JLS%N7RH2$H2DJ<6K"6TI$E4]20" /$#QQCU5_$IXK=GX2+VW]\,%!7
MMDAL/W'<6QU]2+ZNK;VF*Y?F7%:\^FP)=<I],;*55*=;[Y88::=?0TM"!KHF
MNS79+6U_<NS_ &JN$ZF?^+6^M6(T^VU!XR FUNFG%I:<<) ;;N4[E':#[2B:
MD_=[5W%O<DN'"0XG8E1Q!2K;B<D;HQZ58O?7PG[F>/C=;;2\[BWSM.K^"!B'
M3;WM>U[$9J4&L7$ZZ$]4:K)D+?B3JG-:6_$=N:1*;^I8*I=/A4"#4U/I7OM!
M[6Z9]GVD:I96V@W3/;DN.V-W=7Y;4S;[<I+1;2%I902A0M@F'UE*UW"VX S,
MWB+!EQ 84;XJ6V5*4 $  9/5.W=*0,F <SN.<.ZUW/V';E+M?:^@T]VX(D=Z
MU]J+0:ACZJGU^W+=?K*X+,9,JG04TFS+3I4R8RU.J-,IS]712Z6[48>%O)\Y
MTNU1JNI/7>J7"_N32A=ZO>*<_B['[A# 63L<47+JY?2A9;:==2%ON);66P@P
M[=L/;U/E11E;RP)("B E(\E.*VE1&$YY@5:SP9[8U*!;S.[5U0JQ2[IN&CS*
M+3*9+-'CTUFV:I6DW;+D0HE/CN55<657YDM%*-RW%<LJ)3HZW:5*ATZJ^RZZ
M'MGJ;3EQ_95HIARWMWD/NO)[U;ANFK?[HEM2EJ#:5(MDMETVUO;I6XL)=;6X
MT5U(U%U&\--K2XVA6\G)45[=H0) "8 ]L(2E)4,R4BLX5*P>CW58YSPH*5GG
M*>2,C))&">V.#KA9R3T2(].@ B)^O6M<"![:@J03UC)Y$Q'EQY5Q_P G&!@'
M(/;JYSSC*E=SE7R]1JD(209R,@?B&[S.![O6*IM4H R"-W,_BC/3]1'B:[$]
M*2E2CU'D I( ^7)[$\>[U9R1G.,:KO/\QC.>D$@D 8_2L@VS"QS W$;BDS$D
MI, @>OPXMVZZFZKD)R';?M*4MEO/+51NU*5HD/C!*'(UKH5[(RL?M5^5.4,+
MI+)U1:"0$\IR<',#]0>/J;EE1;2$'O"/[SV /Q&8@G"8Y,RH1G!JLD(Z$E(
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M<;.2,^8]WPQ\Z],28B9XQX>,Y-%)!Y^ X U'RF/,Y^0F<9\9ZFLZ51 Q!/\
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M?#CI Q7OL[;O</<F>*?9EK7!=,S/]I]54^3,:CCG*YDSH]DB-)!ZE.R7F6T
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MEFD/W[J4@>T6I2FW;DB7[I;+')"R<5D[3]DMA[.;2FYJE7=P*JCA\LRTVS0
MZ$J"A'88$JJR6@2DH>>G4]QWI'7$:*B@=1I_V4(?(<U6ZN'2K\3%H.X:2DQ
M4Z4E]S))W)[O$PG(KAKWMWVGNTJ%DO3M 9,[);3J=[ /_*/OK18MKV@$MHM7
MT@RE+RXDST0O#6EL1W-J:3T=/2'4W!=8E]\=1?36R.K')/DD?+OK<*^QOLTL
M98O1 G_NA<R9',*5MYP)(K5#M7VK!*D]J;Q95! -CHZFT$]2D:<%8Y* % C
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MS6&X>#%N\Z?Y$*(]8('S(_RFKT[EW8BO7%.=CMJ8A-E,.GQLG$6GQ!Y$&,,
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M4B#&*;%D_B"9C@!6)!\(Z9\,SG@U0-;3*%&)A0,',3,#B8P 8CKDU6."2.@
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MI0)SU^JBHY^/KQGMG7F?:%]=RZZI#JB)(3GIT/E,#RSC->[:8VEEI V)& 2
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M*_NX;:6W*U!) ..M1MBR]A0W'NF@0;_W'80E<ZGU9UUVR;8E%.4P?8H3K/\
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MSK"OMM=)DN=T[B?XC85@YG\.[('3TJ\]D[%U*D?=X2J=P'X>)RDB",<$0<>
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MV285'F!G,F!,5YWGBX\5J45GDDJ)*^HDY.1GOG!' ]<ZU2[DETJVIF5$I<W
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MC*4\ YSD'6;\61ZP3TXX\3/GUJ.0LX]K.-R>4@F9!CVH(QY'BH4E> K!2<D
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MPE:2J9+<*F8*"D+</N^E:;:=G;0)4X2V%*>*3MWN+6I)V.?XDH !"9C=),Y
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M*E2<)Y,9K2:6[:VML&WEI-SN67E'$+WJ,<<!,=1Z@U+%1'TA)4RM*#[P7Y9
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MXDC*H5+C(=J<\]@RP6B?,>:"K@K:@[]NP#.?D>.1Z^G2L@4'@H*D==T9F3
MZR3\,^-=M#IL:E0X]-AEQQ+"5J?DN!2I$Z7*6I^=/EK)5URITIQR2ZYE2>IP
MH; 2E(%A]I.]2AMY& #!Z0.(/)ZS5I;A2DA);@?BD[EJXRDF,8VP..9JWV\6
M]UF[-6O-K]S5./%3'CNNM,N/H2XL(0H]71UY2T#CJ6OI2G!2.=9VFB\4AM"U
ME:@A"&TG<XL\(0 #O)G( P2)P:N;42K=<+0TA!]I;BO82D945$D0?F!)!Q7R
MO>.#QK[E[^,W U1ZG+MZQF%NL0HD-;C#]09_V7G2.E76W'6E"?)02'"CWW#D
M\>S]COLZ2X];ZAK[02V)<M](5"DC*5(7>+Y6X0,L@;0  H3@\-VA[9=TERUT
M5405)<U!/XC[6TBV'(1'_+$\&4F)4,)_ KL5?^_6Z+E$MEIQB@TI]N1>-UR$
M.&FV_"?=44AU64^V5:<0X*?3FU^=(4A;[A:BL/R&_7[BXM[*T4VH) 00AAE*
M0$X'LI2,)0 !,@ A. 0":\J[9=H++L\U;7=TK?=73*Q;VB5_QKET@?Q50DN(
MMT</7)*AN6@)"G#M/UJ;=V#9.RUG1;;M2$W#8::0]/FOE#E2JLXMA#T^IR4I
M!?DN=.$HPEB.V$L16VF4A YVQTNZU=Y3[_\ #82KE22E"1N&$R9RG&#*L[O&
MOG?M!VIN]1NN]>4JZO[E.QAA!)2PA60RVVD!*4(4HDXG=*B>IU[>+[<^9%D.
M0HDA338*"6VS@*\LA>7!V[I_8SR>3G&=>QZ%]WM[5%M;("$@J)4!!48V[CYS
M(Q@ S6/L[]G*[C47-:U<)=N%-MI;2N%(92#O4TA)]D$X*R3,@>$59GP[W;7;
MPK2X$ E]$9*'Y\^0X6:=2XQ41[74YJ\LQ6#TKZ,]3CRDEMAIUS"=:_7TI:;W
MKW*6O#;21+KBO!"1DD"940 (]HA()'N%L_I.AV[0<V,[U%%NTVC>]<N[8V6[
M(E3F8!4 4H!"B1(!V2T^KT>WH#\F@S&'%M-EFJWU,95Y+#JF\/4ZW896%NOD
M%2/=*'B%A<R3&;*6T^:W"_:4;GNU+;*E=SN'W>VB0%ON8"E=0)VPD!">5G8+
M:OM86TB[2M##I0Y;:$RO8XXA4P[JCH4K8E,$%M:?945!I+A*HTM>-NNWM?E3
M3M[MT*A":N:>EB8MB6&JI<3J#Y@=K]4PUTP8R&W92F0N/2J;&3(E);9P\\K5
MW';2[@6NC(4]=.D6[;K8W../.J4RVW;)2-K06H@%1._:-SDH28ZFU[):7I;2
MM:UYQ!;L&P["FPBUMK8.-*%O:L*"E*6M?=-H"0JXO'BVUO*E)36N3=G<6VMN
M:+2-LK(6U(3;],CP*]78RWE/7-<2&6_KNKE;Q\Q,614#(]C;7Y8:IR8K13YZ
M'U+]E&LCLUH]D-6<0[JJ;-KO&P=R6W2DJ65+.7%%:BK(3N!*R!N2FM#HND7W
M:&[O=1>+C3%[?7#[-N8 M;:4)MK)L"$S;L-I3<NG=ON-Q0I24@G"FJUZ;5W5
MK>64MJ*B$)*L')S[ZB<JP>,'C/W#7C/:3MZ_>.K#2H4HQNY,$",$CIX&?4\^
MO:9H#%HA"2D& !M P/.8DF>GGGBKP63LY#?I42]-RZRNU+3E-&32X,=#;UTW
M(P 2EVEP'?[*GTUTX2BLU'^Q=!ZX,6H * UG9_LGKW:L*OWW?[,T9)]O4;E.
M[[P L)6+)M1 =@I6"XH!H'\/>CC4:YVO8T^Y7H^@V[.J:NA1;N0I:DV&FN0E
M13=K;&]Y\!:5"U8,I/LW#UN2F:MJ&_E+LV#(M_9JW8EF4]]LQI=69495S55L
M!25*J=Q/I-0?2YW7$A+B4T*&68C0UWK5SV.[&(*=)LF[[44I4ES4[P=[<+(B
M2%*$-H*@"$-[$ P=HKG4=E=5[0OMWW:2_?O5!3;K=FO8FQM% 2/NEFV!;M+
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MC*<;;6G&K5;#34NM:/;*84XC8_>ON%^^N$[MRD*>)"&VE*VK[JW;:02@!S=
M-9VM-><<;N-2NU7S[:BMEH(2Q:6I(()M[9!5[022GOGEO/E)4D+"%;:I)0<)
M&.0?OP/CWQV_S/.M:=34XD]YN!$3)S('3IT_RK:!L X 'GT)\!Y^'%<!HJX*
MLY[ '/<\8'V_+UQC/:*N]/1,9B28$Q)SY3G,>8Q5VQ7A/U'Y_OQFKHVA:=!:
MI[EV7Y(EPK;CJ**?2X!#=:NF:C)$6GK<;<1#IS2NGZPJSC;B6N&(S;\E2@UT
M.@]FW];WW]\^NRT:W)#MRA)6]<N8"[:R2H;5+"/[Q\A;3&[(4N$#F=9UNXMW
MD:5HS+5UJKPW///DFRTIA0(0_=!"@IZX<5_<6*5-K6G<ZZXVT$]Y/&MX*A!F
MMQ[6MNT+7HB%E"(#%O4NJ276,8ZZC5*U%J%3J+N"2I4B4IL+4?*::3[NN^TE
M.A,K^ZZ?H&F_=&\./WUJU>W+P!*9>N+E*G"OK"0E(2<) @5S]WV?4\W]XU35
MM6O[QP%15_:-W;LMJ(R+:ULWV+6V;P/9;:'$J4H[E&JYOB(K]/AKCVS2[2I$
M]Q(#U;I5GVW3*CU@X*D3(E+9D)<Y/OMK2><$G&==-J?:;0]+8;M]-TFR;?2
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M\XXZ5;LC\( F9,G,\DCQ_?KTX4E6""#@Y)& ,D$#!XSG//8<*'H<&X'KN \
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MR#[C5SU266(SC[KK$9AEI<AQV4XEMJ.RRE2W''7"4I0RVT@N+<6I*4I25*(
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M %D,X/NG"N!S.H=G=?TS>J]T;4&&FT[E/A@W%NE/.]5Q;*?80F/_  CJ5=8
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M^AMR26VRE#:4(\2=>>O'U73X2'G3E+<!M"8*6T(2D)"4MH(0D)2!M$X,FMT
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M\*><2V#C@=2L9^[]^-=1H5JB[N$MJB%F.GB .<9D#S\N:UFH/J:;4L?R@Y\
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M:L)&=QC'L^8Z?I2N>,_$?K[-8MX@^,F/3I3ZS_2G;C]?EK'P<CZ]U*XU>E0
M(./B?/SC-*A*02,_KX?QU(2OQB(Q3\_\_P"E#U9&.W&>WQ_7;5^Y/B/R_.E1
M:W-1Z:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4I@GL,
MGCC[3C50 3!,#W?K]=:1/%?2]]![X2GZ2F[O%'?-)2T\ZW.LW;82 VLI8CK:
M_K97(^1TH<<DMM6^PZ%>8@L5=H D\^3=M]=:O56FEV+P=9:<^]7:D@A"G677
M&V&53A:0K<]N!@[40"G)WVFVQ1WKRTD.;>Y92<*0I:=RG3R4PDE"0?:23)S@
M;[Y,A4J6X4DK)SD9*"AH! ">I13@ =825)*NG&"""#Q25*2"3DI(">H..JB/
MSC \!4I2>[*2("T_A2$J4D$B).W$CB3YYFJZM)'5)2L@I\M#HSTX(RCI 4 2
M.KW@H8*@<9ZM6) 0J% %:H../"4F,SUX$U8 D)*E)E9,;H,[IF0/ C GP]U7
M%4H$\DGC/2?V0HXRK/&3\/Q!.,ZEX @!,>OKF#F?23QSBK%)ZDF<$X/AG/!S
M_G-=8)&!DY3R"?ESCC@G[NH=@<@G5X'^T)&# \L>?('EY<U3QGU$>..GY^F.
M*]*'@@8ZB"KW2.>R<J(]%  YQ@\$X'.-7"-H!'J3DCTXX\)BJ*'@3\P9\"/S
MYJ4U^YJ#;%,DUVYZY2K>HL+I7+J];J42E4Y@+(2CSILYUB.WE8*4A;J5K5[H
M2M7NZD6]M<WCJ+>UMWKJX7'=LL-J>=4.82VV-QQ/M &.L5C"8,>TI2@< $DY
M 4H"3UB0..HK$#Q*^![:3Q'5VE[FI=<M'>2A18*+=W"8I]-NNE2H\%*UTVGW
M78MRM3K5NJBI0ZM/DO0HLDLND>V.-X:/<=E>W^M=EK=[2P@7NB/ES[SISBUV
M;Z%/$=ZY:7[!:N;5Y4296L)6@?P\R)5M>.,@MX*%R"GVD$#,GV8@B>>IP?"K
M.VWNG.\,;[% \4WA\VYLNWVWFH4#Q*[(;>TA_:ZJ]>&H[]\4*ETA%R[=39 &
M)#CT:11"ZISV;V>*A+AW-UIJ.U:57'9'M+J5W<;2XOLQKVIOHU5F05*187#[
MZK;4VT"0E*5H<3 2Y*S5RT*>_P"+.J6 ?[AU9"R08);,@GWA0(R%*X&PBW[M
MMNXK>@W'9U<I%>MRI1D2*;4K9J$2H4BH-N=(:]AD4]:XCG65!L);(6A1+2PV
MH*"?+[NVNK>Z<M;YAYB[:5L=:NFUMOMJ!F%-O"43R(B1E)(,U$4G9*G4[%#D
M&"3/!) E1XR,=<54]-8+*%N/))D/$//E(!Z5X"6XZ%*& RP@!( Z0HA3A'6Y
MU&B6RG,I.,1DQY8@1Y<=35BU#<0E*LS&('6#B))S\8\A[R25J*NKW@3DXP#T
MY5A) Y ! .#Z@*YSHE028"3UR,)_K_EUS5A28]M0,B B0"D3,P.N/YIZ^,T:
M<'6%=^5*&.K.$@944CA('))/[6,D=CH5;4**82KC:"8D=2/'/],5>A4Q[ *4
MB0" 23UA/0=9GH.E ,\A'8=?25C)0>>DJS@9Z,D9Z@ "0!WIO!(5*M\0!DB1
MF"??F??D&<:D[PI.XP#G;B)../<,<P>>DMKE3<I\(*AM&3/D.B#3(9P@2)\C
M_9(>60I+<1H(=DSI'_883,AW]I !*)2E16J58( !('EB8!S/QF1%$=VLI21A
M&$DD^RH8( $@J$8!,GT(K#7=H5C<&[+9\+]G5.0)=TF1<F[-SP.IF;2K)0^T
M;GJ"'6^DPJU=,E3=MV_EW,7VM3S2@BB-@RK5&XC?NC:%*)4$P@Y2@9(A1B,=
M9)YFMRX;=.].Q3RT]VT ,H5P7%1_@09CQ!3$YJBOI'O%3:/@>\.$:T+0^K*=
M>5ST,VQ8MM07?)<IM @P_JM+S<9)2^W%0E+=.8?)ZDH8F.ATNM\]AV?TA6OZ
MHU9I+G=(A=PH)&UME*AO )&"8"$Y"I,@^, O(TNT+[R0MQ22E@!7LN/1E:P2
M00@2XO'XX3@*%?';MG:EQ;J7U+N.NKE52I5FJ.3ZE+<2IYZ5,FO^84MI"5J)
M<<4E+3* K \ME( "<?3-K;,:;:H0VA*&VF@VPV( 2A*0 !T X.8S)F3GRC5[
MU5Z^JU#IA14[=/9ZRI17P)&5*C 3T"<CZQ_"+X>X&PNWS5:K\-I%\7'3XSE0
M!0A;E$IA0%QJ$TO*NAQ&0_52 D.R^EE16B"T=<R0YKFH)MV@2PVN7%F8F2"J
M<=)VF!CC\4U\Y=O.UJ+E9;8<4=/M#W=BT,FYN% -NW3@,J&X_P )E!CNVC*H
M6MU(Q[\7>\9 ?HD*4D*)4A2DJ'8IY)0.,CL,8X/8Z]AT:Q:M+=## VM(0(&V
M)(R28 R01U]V:Y3LEV?=N[PZI?MA;[C@)48.P&2E( @ (,0$@#GC%8+;6Q)E
M?NN!&8;7)DRIC+2&T#J6\Z\ZA#:$)">7'5J2VA([K4  >VI&K/H:MEK4J$)"
MB2>@X)QQ&23[R1FO>M*LT6H*UE"-B5+6I1"&TI2E3A4LXA.U)GK@&#^$[>[K
MA-V/0Z38T9:#*AQ(\JXWT'*)-9D,)6XWU#!4S 0H1(XSTIZ5N@!UUTGR^W>#
MX=U%P0%K5W"3(4EE)AL=#N<_O#/!5MB$R)&EES4[EW4%3W3A#%BV=NUNU0HA
M3B4P0A;[B'%NQ(5#9W$(3'S_ /TCEYO29[%.5+<<\A2H\=HK4I#+:BI?2VDD
M^6E2^IPA'2G)4H %2LSUZJ&K"X*2&TJ1$ Y((VY!$ F<G!/7B:Z?3],!U"V*
M6VPHNE:U!*0I6 CVH )@(2!() 2D"!BM6MAQQ*N&G(P3_K;:LXR2HJ&2>Y.3
M]_I]GG#]XISO5;YW>?0'W#CW?IZ)>L!#;: !SG'EC_TN>1S7U%^#R&*5;%M3
M7>H)BRJ7)(*>>EMYMU83_P KH2K'?D <G@\8M]*;]EV8#;C2R>FUIQ*SX]$\
MYCG)JKUL7K!]C'\9IQH"=LK=;4A(@G.520.@&((FI_%?8M)I-K2JO?8*XD4/
M/Q;;8=4B355(!4T:G(:(<IM-4D(6MIIT520CJ:2( 6B6G?:/H*;Z_6]JEQ]W
MT\NJ40VM/WB[2%$'NL*+#1_"IX^V-W\()6 [7/ZIK+[EFW;:(D)>6A"7=1<:
M4MFU)V2&&E(*;BX2D'8M?^JH5M+B;F%6Y^6[>J]:E>MYU&;,4AN/'>,*G0F&
MTL0H-/A],>+%A1D -QHL9AMMB.RV.E#38/)42>F[7:\R6&-+TUI-KIUG;_=[
M:W9@(;0/Y0! D_B*@ 5*,'DS-['Z0FQM%NN K??>6^ZZXKO'G75F5.O.J_B/
M/+/M./.[G'%E2E*).XVIC2##DL20RR\&'$+\F0@.L. $%3;K9(ZT+3E*L$'I
M/NJ"L$><Z;>KL[YFZ2VVZH+WK:>0'&GDGV5-.I5(*%I*D$_B&Z4D$ UV;[0?
M8<:*UMA25)#C:MCB2?PK0H<%)@B00>% B9FE%H51N:J&'2(/6M279*RIY#,.
MGPVR2[)ES)*@U%BQDD>9(D.!/["<K=6A*^ELE"^O2W::<M3KRU*9M$J*TH2/
M:5N<60E++:3[3KRTI;3!6L')@7EPUI]H'+R[@ I:[P(*GGW580AIIH%3KKI!
M(0TG@*4=J$DIJWV/;^@$IGS*E=]0;X>9I3B:314NX)*$39$>34)K(.$*4U&I
MA405-N%/2L^B,V^E:>@#45VSSI&;>R0DM)5S!NW4E3D9&YME$&=A4 %5RI>U
MN_)5:)_LUHF4.71%S=1YLH4BW8<,SM*KH"((\(V]QOJK']5[7MBW7 GW9K=-
M35:LVKD LU6N*JE1B.8.>N#(BCN$I1GFU7:32[, V6FV;*T*!2XXV'W)3D+2
MM]3H!20/: 2J8B1!%A[,.WO_ '3U'4=023[3#]PIJT7,;@Y96OW>S=!R(6RK
MQR:HZL7+7*Z^N36:O.J4AW]MV7)>?6K@ !2W7%*4 D)2GDX2 .W!YW4>UM[>
M$I+JSE42HP 1X'V1Y8P!BN@LM#L[)M+3%NRPVD"&VFT-)$  80!TQD'&.E2,
MJSZ #^/Q].PURCUTMXRM2B9G)GKQ/$>@/QXV[;81@" ,=<]/?C\ZZDDDGI]>
M^<<9'/?';]PXU!^[_>' #)DP$@X)D $Y^,X\8YK,3M!)Q GY<XSZ>/G5X;&V
M]_K%;%Z7"X'%O6W3HE0C,( =2]%6^J+-D*#9*T>Q/O4\'S.E*?:DDIR<Z]>[
M&=F&&K.^?O+>'3;NN6#B5M*$M@!Y!2DJ.Y)*%#_$%0,C'G?:CM0+35=$TAO<
M4ZF\^R\X4K"&UM(2ZALJ4 F76N^4@@G+*TD9D6YKL41*@^A'^Q=2U)8PGI26
MI#:7$8 'JE61CCX9USO:]D6UPDH$(>;;<0<04K0DI(Y_E(]X\ZW_ &:NA>6#
M;O*D%;2Q(W)6RM33B5 G\2'4*!G,@CI4NA-AZ4PRH\.O,MJ[# 6XA"B..V"?
M3M]N3SFA-IN-3M&U?A5<-I/O6 #Z\$3B:W=\LHM'U#E+3AQSA*C]>59';\U6
M/*J+E"I*@FW[/J[5H0([7^R+E#MV"U(EJ )25SJK(J[_ %!1*D$ 9 3CTSMM
MJ:KU-Q8,E2+>TU9G3=DR MFQDY&/[UU;0ZGN1*B37DGV:MNO6MIK]YM-WK6A
MG6 H3BUOM9NWVT01(*+%-AN&)6H\$5C/TY)'/ R.V2/O[X^WU]/7Q9P[%''\
MV?A'SC]X->RSU/U%.D@<=^XX^6.,G'/ZS@:)< .,B#/2E>N([Y;S+A[LNI=Q
MD ?V:@2"?3(SKJ.SMV6;U@XC>CGU!XCIY\_&=?J+/>V[@'5)''4C]>/\ZSWM
M>K1JSLG=D)G'M+%<M"<H)2GF,W!NXOK4H]PA++?2D]B2>"3GZCLWV[QUBX*X
M;7IFU<9 6-[:L0(VE _Z8Z&OF'6 _IO:MFW2V5*N=-ONYD).TV^K:3O )5)[
MU&I$F 0?NZ,[@!6"53<2N;,6C]E<APCUR 2.._W?;\<:^;^TU^E5^^A"B4H4
MI/)YDY'G^_E7TMI=N1;M*4(44I)QUCGGKT\,^^5G)[>@/IR3SC]$?#7&.+E4
M^/CX=?Z16WC@#CZ/^?K7OIJ Y*C(//4^Q^'6"<X';CM_CKI.S".\U-@3@*).
M,",YGIUGX5KM45MM'#Y$#U\_?@S5^KHK+C>TU(H[3G2BH5JOW#(0GLI2Y<2@
M1E$ G/\ JM#0 3CW5^N!GV2]? [-WCJ3+E_=7#BB)_NK5Y5DCR,MV[*0/Y0!
MG$UYU968_P!)2\L#_5[.TM4@D$RM"KM03G'\2ZN/(Y,Q%8]+/)YSG!].3C@
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M\Y* AM)*1[SF$H4#D*/[!1D<DK&>W',=J]-&I:2IQ(!N;*'4$B5%L3WC:3F
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M@V;JTG*5! 5;K'1=N222JL_83MUV>[9-7[&AWINO['=:8>6MI;/>I>2M;3[
M=2A;C!"%H"]B=ZDR  03(?HTO$A_P>O$I;Z*U43$L'<\,6#>@=<"84-=0F-J
MMJX'@HI;0:)7"QY\A1'DTF?5@%!+JLR/M6[,_P"DO9:X6P@*U#1]^HV2MH*U
M=TA1N;9)_'%PP%0E/XG0VG@5UNI6X=MUK"=RFR%)2)DB3N('4[23' /M&OL
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MJ80_LW;A(3]*5,1*7#8]K6I;RFT+<X"$A93@)0VG"$-M\-MH2A+;;:4H2E"
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M3:(9<),D@[VS,\GC%2NS3JC9WC!VA5KK&L6X"5<--:G==T,P1[!3'3XYI3G
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M6_H78%3C1XTBI5*V*0W*;2XRB;<U)=E>6O 2IVG4QVHU.,3RKRY$-ISI&2A
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M<&#70H4AQ"7&U)<;6D+0M"@M"DGA25))2I)\1((R#&:Z5(">4G';L<G\/O\
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M2<)2".2EII*&(_)/E@$DJ4HZLRX ?Q[3(.0,^ &<>7C/C6-M!2XJ508!V@D
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M0A9+,IP/.1U'S8X;?0VZB=_9_9-M3CMA=)L+TIV,7Z 7'K<JPIQD.MJ9#D2
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MB$NL(D/LAQZ(V\I#9?,9:_*+@;3UE).!VUY_VSTC3=)U -V+FYM;*%N-E27
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M0("B!MR:N32?%#28<!NE2:-N-(IS20ANGQ-RF(<%E _N,17;3E,M-CLE*$#
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M0PI02O\ :9>#;[?2ZVVL=/I%\TV5V]TGO+2Z;5;W+1)A;3B8)G<-JD':IMQ
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MILN#9SDY:GICL5M9JKXD4JF24MIE3HG:/.:-=:>TZ.]+.GQ;J=A25N)2E)#
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MHJBN65]D+.NWHO.Q7;3L[V@)0E0T^X6[I>K*2![6VR=WO;1[(4X^W;(!P85
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M.D=)4D@)5PG "5'@'WD](/96-7I*0J0%&1"4GVA'!D GCI/Y&KEH41L*MB
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MES'92">3SZIX/R&<ZO[-W=UI=VE"I2GA7,3D \?+@]<YJ1JK+-ZQ.#.0<<'
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M *1"L21UKB+K1>TO9=??,*?N+5*MQ=M=[C&V"(=MPDNV\!.]2PIQI,A/?*)
MKR4NR)=BIJUQU)4KZN@198A4M:DYF2U%+"GT)=2K"HYD"/'<(#[$U]N6PM0I
M\I"?GK[8-":7K>F?9WV3>W:EVF0K4-70RM18T[0;10<^^7C"#M2IYQE88D N
M)MGK<K0;ULJ^COL=N+5O2]0^U/M/:M*T[LDXFTT$NI'>:IVD?;BWMK5T[5J;
MM4$.O[5#:IUIX)=%J\D61JE0@W+.>FU!2J=4WR IU'G/TQ70GRVF_)452Z>A
MMM(0E+:I; 2$I;8:2GIUICV<M=):9L6VE:<FW1W8<6%OV;BQM*G'=H=NV5NN
M'>^XE5RE3A5M;9021H[_ %[5=6OKS5[MX:L[?/JN74GN[>[0'%J/=M&6[-UM
MM&QIAI:;,MLH""ZM0!J0RZ=4J7TO$$,+.6YL1WSHJR#P$265%(<P<J:<*'T
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MK'QB.G)K>*&)'](,D?G59VA5F685S6])E-P6KII;$%,I[/D,S(%1B5.&F0H
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M:UNDR ];LKGQ4R-BC'7V0GKF8KY;[(W+MF[J5NB0YI>N/NM%,)4G<\+A@HG
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M$7F] ;F 1WWM%*?:E*5$PFL$=O'E(FD9Y)0K'/;D<?+.,GT[G7H:R5V;!/\
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MR"204DG*0!A(P"2<Y'21G59)22I,A0XG:4A)D#GJ3@]:O#FXN@)R3MW)'/@
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MT#[.;9CM%?(6$7FMK43V<TL*"@75WB(3J#HVJVM6JEVZB$D/O+"[6OJWL_\
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M+"A;=I]G:"U*OP&]MK*RT?6+5L\(5]WM-*O4(DK=4_?NI&UE9%#K2'$^<WC
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M[,E7<-\! KTY=C:75W9:BXVE=Q9-7"+=:A_=FX0A*U)'X=VQ*FTJ_$E+C@!
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MW=I)C("[U69@Q7K]NO[*.U*0HKU/L-J+J05*:/\ :&D*6>JDPHI@F 0+="0
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MCRYZ?6*;5&<&??\ D#^7KUKD'M@J!&<X.3SQW^'W?=ZZR)N.2J,\>'SG/O\
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M_9[N2!'7KB,]/<8S',U=U<;V&C29RT]#,=MM3B\<)4XXAML*/8%;BTA(YR<
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M-+V7%\%/@J8-U!+5DEY,EI-RM#UP$S:L7"QL5P'83[.^T/:UA5S9V[=CI-N
MJ\UW5%_<M)M$")*KIZ$.+2$J_AL!;DQ@"35SW:YL3LXXABWZ<-R[NC ^;5Y_
MLDNEQ)(&4J9<Z95#C>6M*2ENF1KCD$?LW%'<!Z?$SIWVF]OBI[5KO_0C0G5'
M9IMF'#K#[!&S:^ZI3%T@J2967E:>E*MR7-,6"9]&-Y]F78;^'IML?M U]M("
M]0O0JV[-6SX$_P"JVB9<OPE1*2IZ6G-H6AQ(,596_=Y[YW#4XS6*L8U*4H*3
M1:=YD> 0WD-&65N.2:BXV,!#D^1)4V,^2&D81KM>SG8'L_V62%6%EWEYLA>H
MWBDW%^Y,A8#D;64N25+1;I:2M65!1,GB^T_;SM%VL6E.IWFVR;,6VE63:;/2
M[5( "0Q9L@(!2D!(<6E;D""LR:M25)/<@X^6?P]!KL-JO"N/W ="#SZ]*ZLG
MD_'OJ]* $@>_GK[JM*@3Q(C \_'^GSIU]!3@J3CU1PK..^?D>WY:S,N.LN!Q
MI12X#*5!124P>4E)!28Z@UC4E*DE*DI4E0@I4 01X$'!]#BJHH-S" M3<N+'
MD-O.(2[-0PT:DRUYB2XIDKPP\XI&0!)0K)P?,3C!]4[,=M;BR"F[NWM5%Q"4
MIOA;,&[9(QOE4(>@9A<$D$DR2:Y?5NSHN]J[:Y?9[OBU+SHM' 9.U6P]ZR-T
M&6C$>SM@FJWJ%?I1*W;>M=NN--)#JYM:ER*K(92D)2IQZEMICPX72OO_ *HM
MD$^X\L84>NOM8T_NQ>-6MQV@22 7WW'+M*%J!(2[I]NE#5J.@*FNZQM"R8 Y
MVWT^\40U>ZA_9*I*>YMT-6:%#B6KY7>.7 ZB7DND$%38((JF*M=MTUB$S!]D
MCLTYAQ;[$6GTB(S';6X A:PEI@@%20$J*L9P,YP-:*^[1=I+UE+5CH?<6S>4
M)18(.U./PH"%$3'0), !7%;FTT;1K-XO.WZGGUC:IQV]<)<Y(W.%8"@"20,I
M!)*0"3-&A\.KZ);26CRCS6FPTXC_ )2T( 2H)/*T]/41P%# UQ5W??VFM5CJ
MELBW=W#:ZVT6%-+R$EYO"5(4K!"DX$D9&-\;=VV;%QISH>@A18=<[QMY RI#
M3H]IM:LAM<J1OPI.TR/*ZR67G&U\%!.#R0H'!2I/Q"DJ!!^!URUZ'V%JMUIA
M;:N[6!XI,$^$1[23P4E)R.=C;OMW#35PW[3;K86F><R"%)(]E0(*5).4J!!X
MBN@<DD^AP/E\?U]O&I3"-K8')(S/UB/K&*O]*C_/[/\ +4I *?61C]/KYU8N
M<1X*_+-5':]Q5.TZ_2;@I$E<6=2)T>;'D-.*0XV['<0XA0*>04K1D8.<\8QK
MM^SFHJL;EMP9!A*TD$I4DX4#F<ID'!'7FM!K-@UJ-H]:O)"VWFG&UI(D*2L$
M$9Q^$Y]X,R:NEOG3Z=/KE-W(MZ.VQ0=R(KU<=BQATQ:5=C3@1=M':2!TLMIJ
M#R*Q!CIPEFF5>$TG_9J&K.U&GILM3*F2#9ZD@WEF0!@%00Z@D8)0Z#N4<[G,
MQ@UINQ=ZZ;2ZT*\65W_9YQ%LIQ9E5SIKH6K3+J3DPRVY9NJ.2]9N*(&X5:NV
M8CT^N4V,RA2W'GPA*$C)6HD#"0 594I0 P"<\#GO/[&M+?ODLP3[:9Y&/YCT
M\"?=)Q6TUYQ+-HZZH@!#;A)ST2"/C\Y]:R<W^;I-CT:U]K(*FW;KD)AW!?*D
M85]5.RFD+HEO+4#_ -6-QWUU*I-C_J<NP(ZTID-OMHW7;#M0=6U_3NRVFJ4;
M2QN$.:@ZF AUUE(+=N"DPH-J(<>)X<"$_P IKB>Q5B\\G5NT=PG;9+0[9Z25
M;M]R2K;>7I!&&0M/W2U"1M6$/.R4*;5647@LKB:'?=LODI AU6GNJ!X!2A3?
M5\0.,D<\_'.O8%L)=TBS97^!=OW#D<[5#8H_#'Q,5Y9V[:>N=-[0M,07U6]P
MZP%04J=; +0(S'MA,F./'@W5\0^V/^E39>XJ7264N7EMS<M:O>U&D EZH4Q;
M;K5VT&*@<J<J%.CQ*LPA 4X].H$>&T@N3AGANV%H\FR3J%HE2G;)/\1"4RXN
MV4"EP",[F1+J?$)6/*L?976DZ)VJTV\OE)%AKFFVNDZJO<4,6KY0@Z=?+22!
MM3>+5;K<4/X+-T\L^R"4X[;=WU4O^ EN?08[Y"9^Z.V] JJ2%+6:>CZ_KJ4I
M((Z"N?1*>"LE66U.-].5)(II]U_:]CV<N"L0@7+97G;WC0;[H8ZJ0 $@GDA7
M2*ZC7-&MFOM0T=UW:'&M+UBZM48@N[+9E<B!*DMW;K@B,\@()%68LA&:@U\?
M*!S\"#GY_9\^/ECU-D_Z@ 5;H) B)((Z]9R?$S)XYRWS@7J!$SM"C/\ SCD_
M#P'ZUF+;8PW$/IV(^/ZP,_9K4J5"R/\ :^ C/Z^/6H=Y_<SXI(.#@YZ>A$UN
M \(+A72J?SE(BN#/KA"W4@?'CMWUSW:@#^P-0 R-[)(_]V"?FH5\E=O!';O1
MRGK]_G,X[IF/G@CXS6DOZ71'5XPZF<8SMO8><GU":PCT^2$X^7VC7F=BDKM&
M53G:9Y_\,[UZ_MY U]8?8@J.RNII.0.TU[C!_P#E1H1]V5'X^=:MWFP?ECD?
M9_GG]8UD4D9Q!&?<!\/ 5[&)!)B9Q@]3GYC/'AQFI>I.1\QV_CK"H2".M9:[
M&E<<9!]!^_N/0?B/36NN&P1GISZ\8CT_K4AI7 ]QYXZ<^?G/A7J/[(SP21S^
M[)^S^?QUJU1)CH<_ #\Y^HJ7((B8]K'D(@?M\Z#I R?VN?B>1^6L+LE./4\<
MSY^7S]U9&S'/(.?CGUQ]37)SQZC^]QZ>I_R^W4%0 W3R<?J.//UJ4G;!GW?.
M(CZXXJ!8Y/?!_CWQJ(M/)Z?OCZ]:N2K.>OY_4UYB.,^N2#^OQU#,R4\&/7KG
MRK+^>9^OC7&L"QNW".9Q0>5=@(PGDGGG)_7&<']^M6\E0W0(Z>N3]>OGQE3^
M+KD<'F9/]?US40(.,9_6?Y>GPU <3&3SQ^OY'ZS69!,QTR3\JY(Y!^8^X>O\
MOEW]-1'1C<!X9]XB:S#Z^OJ.<\5T:[ZM=32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI62'A)V*J7B.\0.W.U4)IQ4*M5R-*N.2VG(@6O37$3*[+6K!
M2WB"VXPR5<*DOLMCE8UJ=<U)&D:5>7ZR);;*&0HP%W#GLLH\Y602!/LI-9[=
ME3[J&A_.?:/4( )4K'^%()]0FOOEH]#I=KT*CV_2([<"F46EP:53HC '0Q"@
MQDQXS;0 "0AEEL(3[N E.,'L/ VPLEU:U%2GG"XXKJIQ9W*,J!Y)/EQFNB"F
MU$("PE*40-I4I02E/L@)A(F!R),@GB37DD+ ZAR.G(6,\='4<*3TE75D$G^[
MC'J!G4I2$J,*.T"#[2L3$@8YGX>F:Q@)6V"$K!R5$S)SCTQ\_?4G>RC&,E1(
MSV Z>0593QTJ(X!Z2$]SCDU*5%*2" "< $DST)DY$?UG%7)V)V@$K!Y)(A(!
MY\H.#/A4J=2H!1Z@.G )_O!7) R,@X/5S@=QW[ZO[LDID)!7( 4?Q!/D,1X=
M3QGBKW2D*"@?;4,+2)(&! QUZ$B!5/5ZHMT6E29BLI?Z2&BI)*A(="0CI1@
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MCL!@]SWXQ\CS\O7YC7-W2P!S!),^Y0(/^7!P:V30Y/0?/!!_/ZBLRO _>?\
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M+:E@#.-=[V:4&RIIZ0TXD!?BF(*%@#DH42#UVJ4!X5H-80YL;N&$=X_;[E!
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MNP5+1*N)Y3B,@"'0)BPK'8I7.DT['QY3G'.",:SGL%IML?\ 6M0O'# D,V>
M<2D=Z\@E.8DA)^=94]I]6>3N8T1" ?PFZU&W1((E*E"V3=A(/.%J( X)KQ%Z
MTV 2%5VI$X"4AF%24DY )*S(JQP>Z>E&3SV]9*>SN@6ZI[J_N$I'_*.VUJ#U
M@A+=X3YY!'!\:H;_ +1/Q']DV9,;BE=]?P#' +>FI*H,Y,*/4#GK=K+H:6Q2
MH;%+;6%MN.,]<B<ZV< I7-?45H0M*<+;C-16G 3UH5J1]ZL+)I:+9#.GLK3M
M66UGOG&R"2AVX<EP@R04MJ;24QN0JJ)T]Y]:'+VX>U%U"@M#;B4-6K;N %HM
M6AL!205(5<.7"T+/LK! 54J8A3)*^EIIQY:L#I0A2U'L!PE.!R4C/5P2,D<#
M6G<U>R&X6R7;HID_ZJTMT)/7<I,A.9F<>)BMMW+B8+[C;() EY:43Z%>V<<
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M^AK4_P QQ/3QQ'I$<3_6J:BI(MU 'VCD>D$]<=>:W ^#Z,4T".H<'RI"DGU
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M[4:X[V5T+5]8;R\QIU[:V:-R@'K_ %%A>GV+ *2(4Y=W3 ]D;HG(!)':]F=
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M";J:]U+BN5B0T'X:(.W=YVW2W&RE*TK<K%;H+C*DJ)( C!UL@'IDCNGI&/\
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M$[0 DQ5%%(SU Y/]XJ'KZ9.0,D>OK]N=1G=>;<DJ6"3)(GD'.!^WF:DHLTH
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MU+E41?4,9ZQ CTX%2N59SDIQJGVF618[4NO!/L7ME:7*59(W("K=4&(F$-F
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M<85C)R4])]Q/4K)4,9"N_1TD!7;/) .7=($$D),0(Z]?$_']:L G=@ F3/\
M* .I\, "//UJ7N)(3PLI24D9()6KL4\]0X2<=0)R,)"02.#8<)6% 2(V@<D$
M1F,2/C.(K'M2IO)(1R5)( P2.L*)D=.F8B#4NEN)884OJ6@H'6% 84.GE?\
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M=/UJ0-[O[J-+ZD[CWV5XQU.7=<#JAQ@ >94%#^1]?4U7V0[)N!/_ ,:798)
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M?#K!$.U"H=DQ8S)&.D##:<GG'?R@3SW'SQKANW3FVRTQGJJXN'.I]E, 2)Z
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MR<*?;0^-W.Z.X;60/-[(Q(S-7-0UM.XNZV\6B(V--N-*(Y(*W+MY&1@D,SU
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MTDN/%:MV[[@PH'N25&$W#@6\K!1!)K?6VGO/-,_?@W8Z<TVE+&CV@0U;MM(
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MNN/N+==6IQQQ:EK6LE2E*422I1).5$DE1[E1)]=>[VEHU9V[-K;B&V6TH
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M(2E*<!*4]/3CDD#J.5'JR,#O@$Y[\ZTDMI3M24CDID3P9R//H0?VRN+'M$D
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M)!'& !F:][L A#6\P$I3N*B0, 9,D@8 )/QB!4Q+ZX4%VGR0F2I>#[,XHK3
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MKXUD3^0 ^O6!']:@9Z@2/3G//Z_1U!N$\^,SCYY].D=.:SM$@D]/U@QCWU[
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M#S]/HUOTX3D@^&(QX_Y^->7JQA6"<_/MW!X^ S\^^I'W=QX;4X Q^'Y3\_\
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MZ88[Y())2^TRAI7/0E$QR3/K6#1K<:=9IT_?(ME.(:\2RI:EMI@=$I(3
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MD@;2I'\ 029"DR*MU&T?:U+LVVFZ<<4K5+E:2LJ="4MZ3J)44]\M:DSN /\
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M"5"1/C^9^0-1ER >,Q$<3!'YGK52QD9/8<8S_'6W:2# ZCX?0(-:YQ4B/&2
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M?.?K]?.NS.(C&!^0]_[>^O:R07 KOY?NH!/J<\_=\SG.., ZS6X[L%7\RE
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MA2XF 8J[58VTV>V\;,2YKR-W7 A/1(IMJ-^V1&7^?,9545J1%64'A18\U!/
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MCWE8SGC!3D\_CSI-7N?N=E ,+=DG_=R!//4DGQCUK[&T*T#C@.TA+9 DCE0
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M\JF)/!\#\,\?#%29P8/XC\.^HI.0/.3\#^HK*<A0B)(Y$<P/S!J5OC!Y^/\
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MPCWF/TZ^-=G&1\B!GX8)[_=CY<?+7/.\DD_S&)]PQ[^E;%'X<=/K\HK@GO\
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M&>OP]]3R.ZE"<YQ@8/;('RR>58[#[^W.MI;J($#\2HZB1C) Z\]/A43[N5D
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MJ4I2B23E1)),FMVSL0TEIM*6VVT(;0A"0E"$(0EM"$I  2D)2( C;&!P*Z,
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MRE4;20">1U,&!R.#R(. 14B>)9"E(5[ZDX2DX 3CA6 2?VL9/Q/?/(UKGB5
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M:Q8>D14(6Y[0WA()4"Z.KI]X9"$DG*@!TIP>>>.^K'@7%!*$J<<. $S!,8(
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M\R8_2L85D@>UG$"!$1E7E!XD^L5!@*)P@G/&5=A]PQC[?3\=9, 0)/F3^0$
M522.HZ&$Y]<]?>:Z_?X&<C([\@'X\\_N^7)U< 8 )('H3G/A&?\ +TNE)F,8
M/B/3C!G']:8">#ZGN1Z8^1SSG_#5L)// XQYUCGYT/0<X[_8K5P2C_% \DG_
M "I0! _:*C\0$CM]Y[_GK( T>"3CJ/RE7Y0:5UZM!(.WSZ\Y]\4IK,D@&32F
MLU*:S)(/ CY?E5JN(.2>/=QZ1]8IW!'QU*28"3Y#\JCJGD1 S\*@ ())^'IZ
MG[]3F5CK.2/A!Q^ONJ.X H&..<^'48J-GW7A\_PQWQ^6/\-;>V5)P3QGW?K)
M&:AJ20#!Y'["?B?=59T@E2T_#Y=SZC]VNBLQ*A,\9V]<GXUKWH""8SS[A%7P
MLJ'[3483>,@N(ZA\0#DG&.WZ.O4M"1W=DZX<$M@ ^JI_H/'TS7!ZXX2MA!RD
MK42/) )^(P?=TQ&W7PH6J*K=E*#C?4VRZSU@@_[-*NMQ0/IA"%\#N2!GDZQ7
M=T+*RU"^./N]L\Z@D3+FTH:&>3O4F!,PD]8GY?\ MWU5?]E6FB-+_BZOJ%O8
M%(7'^KNNA=RH$$&$,(5N@<E(.,U9WZ0"]573XA:O1FG.N#8U%HUKQD!64MR3
M'%9J:@.P5[75#'7_ 'L1$!62G4/L/9FUT)EU8AR]==NUJ/*@LA#9'@%-(21Y
M*SU)[/[-[ 6O9A#NQ*5:A=//2!DLL*^[MI7(SM6AXI3)3"]P(W*%8..D*.,<
M@=_F><_+'Z UVR>/KZ^IQ,5V3IDE$_AD>6:E[@*DK2#C]W*<#M\]9$F"#Z^O
M']:PK![L_#KSC/SJ2G@D'N./PXU((A,]"HGW$R/E\)J*Q/>GJ0F!/IU]]=2L
M*3Q\>?N!_AK$Y^!7I6T8/\1'E^]=0[#[!J H2D^E;=,X,XVCX^-=2Q@_;SK6
MO  '))S(Z8\//W"MDP=R3($8CT'CYYFO&[Z_\X_QUJW!D^H],D?7QJ4UT_W1
M^E>)T9P!W[G]VH#PP3X\?+FI[1&/,$>_K^1KR*['[L?+G6L<$;AX0?B?VJ8@
MX(\/UJ7R>V/7&?P/.M>[S_SC4A'2>('_ %E5+%]P?E^OWZB*.[;'B1GW5(;X
M/EGXP*ETD<$^@42=1'?YO=^E34 E(SR('K /S BI.X.3CLK./EJ*K@^G^57
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M2\3@1_EG]:U=0Z4))YII2FE*:4II2FE*:4KE/<?:-53R/4?G2A[G[3K/2NP
M>[Q_=S]_&J@9'G^\53D'SF/+I^8J+^ZHCCO]N>?Y:SI'X1Z3^M8S(.3($2))
MF-L\^M."/D?N_=J<T.(\?R'%1S_-.3[(],9BN,=_GV_#^?.IJ.?<?TK O /K
M/N@_L:Z'!_:) X 'YCG\QC^.MJP,$Q$8^H]]07OQ >6?KGCXU-(:.>?P],9Y
M^'VZV#21(/E/B/+''OJ,LX]\?*?R^L54L1!][MCW?B3QC/XZV2/Q#ZZ5&7T]
M_P!?E4Y8Q@_'//\ AK8-8QUX^4_M4)_D?+^M3B/PDCU!'[M3F.OO_2HBSTZX
M/YU[&\YY!(Z3QS@_K_+6R;Y2/*/E417)Z?7-3! XS\?Y_P"&MD@#F!C'R'G'
MRJ(L],R1/YS\A7K1V2?F!^OPU.;R"1X&)YDU"6849\S[L?O7J3_(#Y$^OW<Z
MV+"9]0 ?(@S@_*H[RMN>D>/'/'N'UT[">0!W'(^SL1^'/PXU( 42>I)"??(&
M?*,>_P ZC @"9@03/A@GSZ_#F<5GY7:>3;^W4F4$F3_HLL1*E*X46S08XCA9
M^(B>S@=O=2GTUH[4D=[&XI-U<%)]7%$P,\+W DC)R)%<GV;=EO5VB94.TG:)
M1)&2!J]V$R>(V;2V#G81@9 L3693492@E0!)5W^T@\?:<#GC/VZV[*=V?R\^
M#GR/AQ(ZUU1.T 8GSG@>,=8QCUJWM:KQCMH+2AUJ+B#A6.P3SCT_:QS\_34Q
M#:$A1<,)$',9QQF)^.#[ZM1O=6$H$G(,3CSC]ORXN'9E>]LI@*ECS$#H<!4.
MH'&!G)((^!]1Z:BW#6QSV<I5E,>'/&?,XGUZ5'N6N]VR/:284%8SG\_C^56R
MW)DY<2C.<MJ7C/()R!GCU^/Q_#5ETK987!ZD0>.@)^!QQX5LM+:(N&@!A*9Z
MS.!Z<3U)XK%>Y7,J/H?>'R][&,_#[C^6O']46"H]/7(Z\_Y>%>F68]GTCX1C
M_+\ZHM&0#GMD ?'G'Z_7/'7?X?/:<^_Z^=;A@YCP$GTYZ<F,=.LUZ0 0"?3.
M?F?4G\-<\YE:I\8\<5MD\#_=_(?MQ[IKJU%5U CRQ&#[O#QJO,#'P'7Z]W2N
MQ? 2/M_AK <3/NZ\&/TJ]&2H^GZUUZMJ\B1$QYUWIY P,?+2L)$')D_TKG..
M^JSB/V_:?G5*XR/B/Q&J4KG2E<$X_7RSI2N=*5U*.21\/WYU:I)/Z>OG[N*?
MG3NH#X8'X:L_F2/"/EG\JN&)\TG]OTK@\8'R(_\ @CJJXG/A^M528CS)'_5J
M$=C]_P#Y]^AJP_H/R%9::I3S^NO[5&025??W],$'5IR#ZQZR(_4?"GAY_P"5
M0:QJD>S,Q^PC]:O2F9/J!ZTUC.8/A)^!$_E0C) \4CY&G^/Y<:N'SZ^M9 ($
M>OYTU8L8GS_I6)8@@#P_4UZFO3_F_P M59&?+(CW<UC,21'29'KFJG@W9(IT
M0T:?#C5RAO*4\JEU$N=+#ZP J739;2D2:=,*1@K97Y+V$B2Q("4!.WL-7O-+
M4M+!;?LWLW.GW2"Y9OD>R%[4J2MAX0 FX96AR(2OO$ (K1W^ALW[B+QA]_3-
M3:3L;U&S".\6V)AB[9<!9O;8$X:>&]H@FV>MU+65=;R[(?\ [1IJYH)/[48&
MF3VT=L],E1@N* /">IA)Z>ZB>^S&I=FW/;>T74F'#^)-K?L/,2>B2_;L.)!$
MY5O(G^:*C]UVP;A"7] O4C:GO7?[0T]PXA:_N[;6HI!G(0E^#U6#D>4SK?BJ
MS3Z3)F. D(=K,M*FDD\!8AP$1P5#A02[*>;S^TA0.-8U:U8M3_9^B,-D20[J
M%PN^(Q@_=VFK1E*L'*UOI/!01!K.-.UFXC[]JZ+=$$EK2K,-.Y)]DW=ZNZ"D
M$0#LLFE]4K2:ELZISIW0B0ZD,M9\F,PVW&B,=1R2S&80VRE1_O+Z.M1)*E$\
MG47%Y=7R@NZ?6]L)[M"MJ6FYP>Z9;2AEH;3$-MH&!TK:VMC:604;=HAQ8VN/
MNK6_<NB9ARY>4MY:9R$%6Q$ )2)Q+M8JE5SW[D??_@,_C_/0?7T:?7C7(44_
ML\?,9S\^>/U^.LB8!F8/']9R./GCC%6G(@B1[XGS3SSTSXTSG&1D_:<GO]OQ
M&JD&0H0??U/)_KS5.A!GCPXQ$9]#[LSUJ/*LD#@>OV<>HP?LY&K_ )?#^M4&
MT $Y.>OF>E<@'XDG(_+Y#X\_EJ_:KQ!SGGZ/ACK5FX=!@ @]<^O6/SD5RI!R
M#DC'PY'^'P.A0?7WP?KWU2?3'I\ZA*5>AX^T_?V^>J!)S(,_4^OE%*AZ#\1^
MONT ,C!/J(_7]:5SY?S_ "_QU=D?RY\=O[$_72JSZ? ?M7!0?0Y_+1)/\T^O
M _8?7%4J#4A"IQSUGRQ2FL[9SY1,?"J&2(!ST^-<#/K^OR&I:3(^7$?J:P5P
MKL<:EL*$@&?/XSXU'.8CC./$9Y^(^%<#/F)YP?B/3)/V=M;BVP<>,?\ 5J&L
M\>\?D?U^-5S0T%2T$>F 0>W/K]P/PUT]@DE: /?\2/?S/Z5J[E4(5('B.,#J
M,^A^0K*#:RG^=4FED?[%*3P,X*SCX_D?CV^'K5HCN=-:2.5@2?$)B/ \GCYQ
M7F^KO3<.DG^X2#CB7,2.@G^;C CK6\#P>T1F$U4ZY("4-P8*W2Z?<" X@A9)
M/ Z&FG5DD@ 9[<ZY3MF\IG0F;9O^\U"\2WMC*VV!*]HQN)<6V(X,9CFOBC[3
M;]6K_:'I]@A?>(TJS>O"E!P+B^4AFW$",AM"_23MS6G3<6ZG;WW O6\'E*6J
MXKKKM705DDI8FU!YZ,V,D\,QU-LA.?="  3DG7<6%J+*RM+1, 6]JRT8)();
M;"29/,J'LGP(ZXKZBT6W%CI.G683M^[6MNTI.T !WNTE_P )/?EWO"1E948/
MXE4*LX)/Z^&M@G@>@K.LC<I7F?7%>!7[2OF /PP?YZO$0!XJ_(?UJU7]V?\
M>_2I.O\ :7_SE?O.LTF!G^5/_5%0V/[P^_\ (5U8..<<'/'K\1Z#M_CJU?X3
M[OSK8L_C$>%=7;CX:A'DB.I^%;E)E*3Y"NI??[OXG6K?X5ZGX9GY5L&,)/\
MND_)/[XKPN=OO_GK6+_$?=^0J:WS[OVKRN?GC^>H+P!QYG\ZEMF!/@?EUKPN
M9"L'MT_=SG'?Y_NUJW!&^>O^0^!^&:G(\/7](_6O!(]/^:=:QWGWJ_.I*./<
M/S54M7W&H@'!Z;@*D-\'Z^N*ETCD* ]?PXSG\=1G2,XXB?/(J:DP1X>'3B*E
M+W[>/3 U"7T]_P"E4Z#U/Z5*7P KU^'RX]?PU%</MF.2)SQ./EGUJ2![ ,#.
M?/P_.I0O^]_WVHI'3G ^>:S#@5&W^R!]_P"0'V_D1]^M:_\ A/US)^0-263!
M!^L#/Q(/Q]17I&"D^N >_P!_;OC6L7TF.O'N_K4L04JQQ)\A/AX43PH? @<?
M8/Y@_P">HK_"?4UE;QP.@^,@']O&NP#WA\,CC[^=:Y?\WF"?B)'RJ0,\^!_(
MU+]1ZSTTI32E-*4TI7U"?T?WPD,,,WSXUKVI:2*>:CMKLPB:TL?Z^\PA-]WA
M#2XUTN>SPY+%ITV6TLA+\JXVU)#L=*AYYVZU7:EC26%"5S<7121@1##2XZ!P
M*>4"!A+4'VCMV=DR?:>/ .Q!(@SC>1)Q"3L2H\$F.,[T=S;G4ZX^@.))ZE]1
M'^]QU>I[ X'KC@]M>9>/AT\8CR_2MGR.,1QX\^$_ER,35H[=@KE/+F.@E;Q'
M3G)"6P04#D#]O]L\<DC/; O0 A,GZST_/TJPG@CCIC/$'Z!\.HJK;^W!M?9'
M;"]-VKQD)A6]8]OU"M2U+]U4A45I1C0&1@]<JI3?9X<9('4I;H2,9)&6U8=U
M"\8L[="EN7#@;2$SC<4^T8!]EM.Y:B<  CR-5+#;16J$I2G<H]8"3@#Q4=H'
M4$XP*^"_?#=RYM]MV+YW9N]\O5R]:],JSS84LLPHJU^73J9%"UK*(E-@-QX,
M9'4>EEA R3SKWZQM&;"SM[)@0W;MI0G$;B![:SQ[3BY6J1,DDF9GGEKWG<9D
MDD]<F.,G@"/=Q5J=2JLII2FE*:4II2FE*:4II2HT=_N_B-7HY]WZBE< 9)'K
M_B-9:5QW(^X?PUF2F!F"?2E=R00G[/XYU=6)9S^?U\/A4>."1VZL#Y=_\-3F
ML%/O_P#2) ^ '[5%49)/0Q^5=*N !G)]3\OUC\/LUL6OY<>/UX^'P]*C.&4\
M] .<])^/!^%=(RI8(/;'?XJ]?YZVC49C'RX,5!49)\XY\Q4\B). >.Q^W]<Z
MV#*8Y/6/RK XH"!')'[54L883]HS\_3]VMDT).?&/KUG]ZCJ,F/#^L_']*FK
M0P@?/G]>NIPP4^>9]1 _K4!TRL\XQFILS^S^OG_+4YG]#^=1E\_/^GQ!^->Y
MKG'IC^&/X:V3?XO".OA417)ZY,^F?K.*]R/V?L_SULF_P^.>?=^M15CVB>/9
M5CX_O7J;_9'_ #A^]6IC8XC'L_F/WS4%9]L^223\OVKU#D?/*?XZVEMU]/S,
MU'?X ^NM3VW:#4;HN*B6Y2&%2:G7JI!I$!A.<N2JA);B,@G^ZD+>"EJ/NI0E
M15P#H^\FW8==7PT%*5R>$G@ $DR,#$F,BH-S<,V=M<7=PH(8M6';ATF([ME!
M<4G./:"=H'\Q(3UK/#>2M4RGU)ZG4Y]+E/H4"EVS3G ?<<@6[38U%BOI&!GS
MF8+;RB0"EQ:^/?(&MLFE[&DD>V0%. 1A:_;4.> 5'@F>3! KE^R%L\SH[3UV
M%"XNW;B^>*BOV7+U]5TX %"9WN[<Y0$[ HB36$]P5]4F0L-.>[U*[<#!_EWP
M,_?KI6FD-)!7"2 .8GCD?UCF3TCIE)<=(VR4G@@D=>OY8SS5"3YRE!(*B2"5
M? 9XSGU/IC(S^[6GU:];0$(2<=?01C!SSQXXY%;W2[(I"BJ 3GKU$SCI,]?#
MWUW855#2G6UJX=2%#D_M)ZN.3QZ'5]HX;FS0Y,E*B.9@$8CT@\]> *CWS26;
MDIF$JS[^D&/SR3G,U3M[S_:9CY"LAOW ?AVS\?7@>I'';6+6%=U8)1_,XDGW
M8B?$D<X/.36?1VR7W'(D80 1'K!R!YYZ=*QUN-94\O P 0/\/PX],:\=U14K
M/G/AT'R]U>B6@]@$B<3^N?A/6J83D 'XJ/S[#\O\/AQKEKM4R!_A)]WE\?(5
MLVAC=XS$8_3IX]>/.O1_<^W^)_7V?=KGW9W*QG,>?,&MHB"G)S_7S^NM0XP0
M#WZN?L.,:AN9R,8!(XXD_J/A50>OUQ@U$O\ :2/L_/6$F3-7@P@^),?K^]1*
M3D< #5*H%$'))'K7*1@ :?UJA,DFA_/!QI5*8^9_+^6E*YTI4!4/MQQ\OO\
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MJ0G[0.P\9[7]F_P[?^[%@/\ ]?Y_1J&YV3[2R2G0M4(*]W_%'2?^J?Z5YU^
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MV3+E[*[C1X[+21RXZ\Y;@0A ]5*(2/4C4)7:CLTXL):U_1EJ42$I1J5FHD]
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MBSJ<^.AAYI2"I2F'@4D'/=.?VLYX[Y XUR%[V3N$PY8G[PV 5E((E.<0.O6
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M) #BNGLP=@5U)6)$$G<=N3<BG7'\+R/?'5P 5DDDG&?V3Q^//P\Y!GR\ .(
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MZX;=2E!+A2@K@E*TB=H,3(F <P1K/>\1/B&9H<&YI.Z&^ H52=#,"KFGV,W
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M&*<<*"N?,!]<<=/IR-!IP_\ &;B8@?Q"/&>4YY@X^'6O]L+ZVMGY#N01B(D
MG\^G7 KL]EOD!('B7WJZ4IP/]>A'D#'=3A[#CD*SR"K'8-.Z_>;HDQ_RH/'_
M #8S&/ ^F']L*!C[I9#G_O>,F(,;IP)GB?2N<;@-^\GQ-;SY'J9, YX((P71
MG@XX(^/<#3^SCG_6[KQ/\6)Z_P"#;[ZK_;''^HV/H& <\=5'X1SP:M15]W;E
MH=Q56V'=_O$;+GTEMF3*>@1J6_"=A/08\HS8LE56;:<2Q+G0:3)AN>546YDJ
M.Z(*J;(B3I5J+$K.'[N$N!I:U.MA*3WUNTE2CO'L[K@'=L,);65)]F3>=3V@
M$VVGRI"G4I[E04H!NY<4V(1MD)MRD01*W$)2N2=M*7%XD[CMJH2Z:=[/%-6&
MX%.F55,ZWZ!1ZK!?IT6FUVLPW6GG*W$6'JM2:&9U/9<:2Z6:C3A*]F=<?0Q1
MJQ+A3_KEVG>D*3O<2$C<TT\ 2!"8#P2?_*2@3!-7+U-2 2;&Q5"MAVMC<"'%
MM'!DX+:E A)!1"L2)V ^#B_+TK%]U>!6MS;^OJWYM-NZ-'C7S!@-*%4M6Y*5
M2$5NC.L2GI0I<L(KC+)D-0_K!CV2:S'>A.PY;M]NRME;#O?O.-OI<!:?5[2"
MGO"A<8"=Z$2 ?:VK25;5!2$X[F[:NF76ONENP[;K;<2ZP"E+B5!"7&B/YBA2
MQG$+2H)W A1V6%X=)'4GMQS@=N!PDCX9R,X'"3C!V9]8CP^B/3KX<UJ(S.>L
M?#U'T<D'CX]/Z242J^?#J.^*?N/Z\G,^VCG'H/0#[>XY/O\ ]B4FW[1#D_>+
M #CCN%'/'UTZUQO:[\.G20(%QCP)<,CXR1'I7R_N\9^9_?SKW!9R3Y'_ -(_
MI%<<C\7I_E^M2^1^SGY']Q_GJ$^)@X''R$?.14IOK[OUJ2NC! ^'^&HIZ>H^
M1G]*E B3GK^@%2N1W^_^*M17OQ^X5D'X3[_S14J=_P!HK[O_ #T:AJ'XO,J'
MU\:R(_"/?^9J%G'21CL>?X?AJ!<84O/\I]TC'P_6I+9F,<$#\J]8&">/[OIZ
M_+T'H<<#.M23N3Z$D_ODD]1UJ8CDGG!GZ\ZY'!/KSG[C_+'[M1'N)\OU_K6=
ML9,YE4_(_E7)[I^'/[O\-:YP]?\ =/Y5FKP:CU(II2K]>&'8*[/$_OQMIL99
MC*U5>_KEATR1-#2W6:)06>J;<EQ3 @>["H%"CU"KR5$IRW#* >M:08E_>LZ=
M97%Z^8;8;W1B5KG^&V!.2XYM;ZY4!UD9&D%:@A(!4HP)Z3RH\X2 2H\ 3)K]
M!M5OVMLYMO9VU-B16Z9:.WEL4>T+?AM(2CRH-%@MPV7GNGI"Y<I3;DZ<Z>I4
MB=)D2'%%U:U'P"ZN7;M]VX?5+MPZIY?@E1)5"<F1D)S/LH2.*W[2$H0$I! "
M0!Q, =/&25*)ZE7D*QEK$A=9J?LX)4CS%J= /_8PKJ4.^ I9 2#\U8YU@ E:
M??Z<>[SX_P KXY5UCSZ>/!.?'I5Q;?IW66&TIP $D_!(!_+N !Z\ #55&3/$
MX'P_IZ8JB1$R9Z3_ %]WITR:^?7Z<WQ4L2I-J^$JT9R7&:.]!OO=%3.0455Q
MATVI;;C@Z4D18DERN3&0E39,FC*"@ZPX->D]@])*$NZP^@A2TKM[0G(*=R>^
M> /&[:AD ]$N*_Y0BM=?O^T&P3 45K2(C=G8F>H (5XR1X"OG)UZ/6KII2FE
M*:4II2FE*:4II2FE*:4II2HT=_N_B-7HY]WZBE<)&3QZ<ZRTH/>..V<_=K*C
MCW_H*5Z$]DG' /X9 Q^&L@Y'J/SK"Y /NG\ZX/I\Q^[C^&MDS@>/!^ORJ+U^
M'ZUU.<@C_D_O('Y<_B=;%CD#R!^ J(\,+/2#CSGFN8A]XGM[WZ'Z^&MLV>/,
M?/%03C,3]=*J&-W2?3C\@<ZV+1D$_76HY,$CK_6*J&.K*0/M_$>OWZV#7'ES
M\>GNXJ.XD2KT^7,5,&S@#D_/[CJ8<1ZCYX_6H2_Q'W?E4T9/';USC[SQ^OCV
MU+9.1[/CCW_KQ_3%8%^$G,'Z_/PSP*]K1!(P,>GY:VK//R_,_K4-?"O7]:]X
M[?;S^)SK8-& 2/&,^8GQ\JB.'(]/K\J]3'[)^W4EHY2?]J?GQ]>-07<+!\@?
MF?VKT X(.MLSE1'& ?\ HD?G6![GWC\J[]2V3))DC)C]JAKY]WZFM@7@1VMH
M=4K=W;XWM!;FVIL_&C.T>)):2Y&JE^5!IYZD(6TM*D26Z)&9-4<;(/3+>I;J
MATIZ5<SVGNG[AVTT2U6I"K\K<NG4*(6S8LD%Y:5<(4M2D,HD0"L&9$#S/[2=
M=N+"PM-"TXD:IVB>1:)4 26[9Z6B-B<E#VUXO+!"NXM;E! 2YN-!>)??^OW#
M7I\J14'#+DN.+*?,641&.LAEIIOD)"4< >@&<ZE-IM=-LD+*4MVS" U;LI&T
M**$QT\\J5@J)W&<D=5V%[%V>B6;-G;L 7+W\:_NE'>^\\L@E3[A W+(!"?Y4
M!,) $5KLK^X55>>442WW'5*5[RG'">%9(P58 ^0[9UPVI]J[P&&'>Y0"2D(2
M (!X/N$3R>N.?:;'0;1  4T%D@3N)62?$3X'@<5XZ?NE=D)Q/LU6GLJ2>K*)
M#X'' QAP<]O3CU^.M<CM9J*4()=S/+B4*GB!*DF/#&*S/]G].>0I+UJVXDX4
MA200?'<"""(P9]*S#VEW(J=_6;=MG7?49E88F1V*E2%SI"WS"JL!92EY@N*(
M0AZ*M^,XE(&?,;6?]DE.N[T*Z_M%A%XX0AYG>A>U*0EU#@G:M*4@94F1QD&?
MQ;J\7[9]DF=([0]F]>[/:?:6BD7:K'6Q;LH85>Z/>MJ:<#RF@@.*M+G[I<LJ
M=2I: VXE"DI4H'%R[Z<J+.D((STNNH5D]RA73]F<Y[?=QKG^TEJ&+Q2PF$+
M6F,87!&.(_*O6-%N0[;(&[*/85B""E6TICC"@?(\\59V0UY<AP'N25#[S_#C
M]=O.]124 @#,J))\SX?0KK[4@E/$@$>?3Z'NXZ^U"3Y?2.RTJ'I_NGM^>/\
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M2=JNZ?NG74;DG\)V.#<.AP3BO<=,8<M-,TZU>V]];Z?9V[P2J4AUBW;:7M5
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M>LY^?I5^=N*L[0W&I#:RE0)0H$<*0L84/G_>Q_R@!KUSL>\VVRMEPB'-H,Q
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M!A"5)]% J">:I_"LG_#.1'\R?'Z\SR<#W+,_^$Q'^XKGK\L^\QKVO"M;32+
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MR+^N'=*_KPW&NN8Y.N*];BJMQU>2XHJZYE5F.RW$(R3TLL^8&F&T^XVTVA"
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MBMNR9LZ;+>:C1(L=MQZ0^ZVTTA2UI2:[TM@K60E"4DJ4H@)2D9*E$X  $DG
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MMD,(1;6Z0TTR E,  DP)4HP)6HB5DR5$F>:BK.2I62KGPQQ@GSP/+I7Z!_T
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M:S6W]\WZG\C]?MS7Z=:NQ'?XY)[XSV&23G.>HA0[D\G7C)($=#]8F#Y3\:W
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MC>&W=2N?2%P-RJ?N>UNI4X=DL;H[:4?:RO';]%C6F\RN/;U(M2T/.IYN1ZX
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MVV4I+CA.W<<Q[0B8.0(R*K0?1:[3_P#FQMP^/7IMK"OLQ1CW^W\M5/VOZO\
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M<U]GG\("<<]L<\8U;_V6.T>?X>FY_P#G9SY?Q<?"153]G.BG'?W\?^>;Z?\
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M6L>RP7*E)7'>GN(5%AH*UOK0I3*7-#VB =TU^U0XE-R\@NL-&=SPM%MOO);
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MY[6[2WL>SM[;VK26FD-M )3R2;AF5*494M9ZJ423U-2&5J<N&U+.XR?=[)X
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MW^@6\Y[-S6AO-(MJ5,KE(JFW5$O%4U%O;ATBGN0ET.5MU/H%19K34B/,AO\
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MHF5EEIHK5*E;EJ4JNQT'M)JC5LVTMY-PVF$([])6M* ("0X%)6H# &]2HX!
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MMT--A72F!==E-,N'GKAS[SWUPXX\O:\ G>XM2E0"@P))($^4U<BY6D!'LX@
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MFL,Z13DQ4!:AR>^3C/&3P?\ '@\ZZ>UL%CD$F,^IQC&/\JUKM\D82H9^7O\
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MQ'-3"YATW5XG$=RBPO$.1Z\NTOZ5Y1[CM_;*[=\ZH"($]=L^N/AT\/WOF9'
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M_/$U2ELTU72'W$'S7E>8O/?*L*2@?'I3A)^>3K(/82!_,?D!Y9\?=Q%8RJ3
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MD%099OG'%W%P $;T(3N("E"U\AJV>8M1WA6'77G)&UNW,E.Y6/:4T(2DY,R
M" *T$03[@^/QS\@?X?GKW)C'E "O6!D>^>DCFN6=$QY"?6)Q53QU$8/?/?\
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M9@R!6I5'[/Z^.NF3_+[J@J_$KRC]!^M<D=>/3)!^S/\ GJ<T8]WZB*CDY/\
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MHW3FT*[JX=8@KMVIWOC>$[W3O64!.U4>Z646KC%JV5) _P!8?QL'$H"Y&]6
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M[X5Z_P#!+W+'X;D[,?/]<:G_ &B '0F#_P#=*WS/_P [W?'E]=:P:9BX4/\
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M>,<;O/RS_2N=T*A3VK9M=**A#)56?$%UA,EE60[ ^D^6C@+]2EKI^/FMG/\
M:(R''PQX8^OZ\U4\*\TB/7'''@?AZU'N?5*<G>7<-P3X1Z&MPE%7M;'2IM5)
M^D/'ND.8XPWVSDOM_P#;49&9_3^O2/#]B*H.,>,X\ 23\>9Z=*GC57I3-Z;P
M.*J<#I4Y5%-J]LC=*B9GB85TH5YN"2L8 'JM'JI(-,9^HX^4"BP3CTG_ *)'
MZU25T5JBBS=R0FK4U2G:_4W&PF=%*E?\=;O$% #I*DE3 ((SGJ3C.1E'AQCT
MZ?# ,>=7').>)(CPG/Y_"H+PK]!;IVVH56:3EJMJ#B?K&("TH7[8K^5CSLI
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MAZX*.^<0D!;O=@A&\B-Q2%$ G,8JU2U0 22E(44@].)CUQ\*MZE. 3G.,_\
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MAG\5&]M*WBWXN_9:Y-D+/?E3Y,RO7]=-VUV<JEBVX=<5_6"I6QLQ;=7IS/\
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MTLNMJ]J;5(J-1::J-0;2N6[#)2$@SDDSC$2H)B)W2D),G:9)D"*E&.!,;1F
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M.T+:]J]M^I:*TX75*E3 U'3-JU2DJ7,J<Q+#*5N*:C,MHBQ(Z$]MV:T5C0K
M6S2N]=>67KE_;M+KIZ!,JVMH3[+:9, $G*C6"^?5<N;S[*4#:E,S F)]3R3Z
M#@"L=HY!(/;!!/'Q[#]?<-=>T1(/C'[S/QQDUJO#Z]_Z>ZJHB'(2?CC_ -)U
ML$Y,]"K]#^]0G\$CR)^-5#%';T]?PQ^_&MHQU]_Z5!=C.>L_O\)^53Z/W2?@
M!]_ZX_/6XMC)!\3Z\$5KKA1CRCCU _>I\W@$>F<JR/CSQ\^W&?76_M@(\H_8
MG\ZYU\D[O]D@#CS(_;K.)XJ8H[??G]?AK=V@S/CP?C'/KSY5SU^X ><\'RZ3
M0X*@#V')_7Q_G\]=-;CV)\OS_P JY.Z7*SXC'CG^@GTJ8QFLK3QQG/)^?';Y
M?9K(H_J#CZ^L^%:[,\=1U(Q!S&/(<>7B:K"&R./=]?7!S\!S]GP!X^W459,^
M,=/#\ZV; &T8Z8X/Z?#CBJCB-'& G *@D$>H]< <#L?G\?G%5S,QXSQ)^'7P
MJ0ER/Y>H /QD\>7B?=TRY\'VXL;;3>FWU55[HMJ\&7[)N4*)# AUQ;;<.6^,
MXZ8=31!<<<5D-,>>L <G7,]I[)=YICJK?-W9.-WUF1,][:^WM $SO1WB D#V
MM^V3B=!VITO^U-&?;"#OMTN/I2D2I:-J@^!D*"NY)<DG"F&RD)A4U1XO=G7[
M9NJOP#'_ -5<<<EP7 A70J.\%*04+QA7H<=P3JW2-0:N6;6]8PU<-[@# *<
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MQ=X>A*>A(,&.<'UZ5=]?B_\ %\LY/BO\2P^S?;='U_\ LI&L!TW3R9^Y6O\
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M3XC)\\'/E/ATJ<DR/A[NG]??7 2,\<9(SZ^N=:][J/&(/@<&?7\_*LR"21Y
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MBTTKLIVB[47EX7+!]8M-*7=,H[-AMJW2\X\XG3-/LFWD,MJ^[N>R 0F1)/\
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MM2ZE*%J;E7?-(]HC*@$K5 XW$9$9YOM)J-SIUJT[;*2E2GPVHJ0')1W:UXF
MDDI G//!Q&,UI[W[NUQU^95:O<B;?CL2D+J-M6?!G^74(YB/F(MWZJE1FEJ@
MNR'3YRF@A:H:GEM1W5NIZ^][.Z';!*&6[8W*RDI:N[]3,M+WI[P#>E9'>I"9
M2%2 YM2I:0D\YI^MZK=KWO&[39I*DN/6E@'REU*4+#95W:D)):*UPLB#L)*4
MJ*A<3_29=:VGG4W/NJE2Y$9F#&.WU**Y2!6'HM0<?>3;?EQ7&J73JR]&CQDU
M1;E4B*B/KCIA3@WJ?['M 0#;:.80M:U?VH["26$J:"4FZ2I0-P\PE2W TD,+
MW)"U.LUM/[1=(!%QJZ?:0#NTMN00^>^*E?=BE!1:M/.!L=ZLOC8L)2VN+:7M
MO3O';M6DIA5ZY(UN2)4IF@5"Y+4@TJ=4682FT2>M#]%@M+E15O-MS$1F0B.I
M;045^8A:MOIW9_0[QA&]FV7=H;;7<M6E\MUMHN[BV1M?=*4K"24;S[<*(@A0
M&EO]<UBT=)2JX3:+]FW=NK1+2WBV '0-S2$J4VI0"]@  (&9"JRS\.]YW!?5
M@.5>YYB*C4V*_4:<)8CLQRY&9BTV4T'$,(0T7$+G.HZTH1EM+8()25*XKM/8
MVVFZD6+1LMM%AI825%12I6])VJ.=OL3MYR9,8KL- NKF]L$OW+B5N]ZXA12@
M(20F"GV1B=J@"<R1..*OM@? ?AKFY/B?B:WM,#X#\!I)\?CGY&E,#X#\!I)\
M?ACXQS[Z?7-,#X#\!IN5XG\_SH1-<'I&!COQV&J@DGI,^ _:J0!G./,]/?5K
M;,"O^$/7<#(1:_4?7"?JVW^3GX%7?/Q&4_M#EM:/^NM1('=B/@[(/,SGJ/E7
M8Z"2+)P8DDS[EHD_M63:U8*1@@G &>D'/?W?>]Y0R"ELY&>KJZ> -9'3CC(X
MZ<"<'D^O)K;8,Y$9GY#]/3X2<2O'AL^YO[X,?$5M9!B"HU^H[?U"Y[3B^4AU
M]RZK&6S=M'C048<5[74E4E=,;4E39")I2RI740KJNQ&JC1NU>AWZUE+";Q%O
M<J)VI#%T#;.*4?\ "D.]X9P=@.8%:O6[4WNDWULE,K6PM32>274?Q&X'BI20
M/$37YYK[2VUK2M"D+2I25(4"%)4DD*"@>01C!!P01@CG7VPXD'VIQDR,X(&9
MX@_,<&O!FG(60.9(,CC$1TZG]ZE<A(.>/UC_ #_'6N>Y,<3[^/AXUM&EPE)\
M3!^/UD5*7D9X_7IS^(_0UK5CJ/?\"/#P/Y1FI*53CU/S/Y8_:I&^G!5G[OD?
M3]XU <$%4Y)(_+!/S\JE(5P>/GCK4H=&4G/H,C^(Q^'/SU%69D'D<><Q^E3D
MJW5*L@$<=E#M]G^/Y:@7 E1'^S'YY\H^1SFI3,%)SSF>./K/%>K6J5"3.,F)
MQQGK[O'X5,;,I^L3TJ())!X^!^[G]?/&M:\94!X#]:GM&1$9'/ECCY#$_E7.
M.4Y'Q_( ']V?GG4!_(CGY<R?UBLZ#SZ'''!^HK]+OQE_0E['>-:GV51+_P![
M]]K3MRR)4^I0Z!9<NP&(%3K,YA,1-8JOUU9%7??F087G1( :=99CLRI>&BI]
M1UX9HNJN:(7U6]O;O.7"&VU./APK2A&2E/=N( [Q02IPD$J*$2?9%=6\VE[;
MND;2I0VP/:49)R">)2,P 5=5$U@3_P!"?>"G_P Z'\4G_B1VF_\ %8ZW_P#I
MOJ/_ (K9?]%__P!G5&^Y-?XG/BG_ -@I_P!"?>"G_P Z'\4G_B1VF_\ %8Z?
MZ;:C_P"*V7_1?_\ 9U/N37^)SXI_]@I_T)]X*?\ SH?Q2?\ B1VF_P#%8Z?Z
M;:C_ .*V7_1?_P#9U/N37^)SXI_]@I_T)]X*?_.A_%)_XD=IO_%8Z?Z;:C_X
MK9?]%_\ ]G4^Y-?XG/BG_P!@I_T)]X*?_.A_%)_XD=IO_%8Z?Z;:C_XK9?\
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M(/:%*ZPAU6#HW>TNC6ZG"PAQ];J][IMF A+BP  7%N]VI> !,*,>45[EI_\
MP>OM:[0LZ<C6[NRTFVTVW%MI[&LZP[=NV%H7%.EFSM=/3J"+=!=67>Z#C WD
MD[35R/\ @:;36W:-2O:ZMZ[AN^C49ZF-U1W;.Q8ZH;":K/D4UF>W6[HKT*(]
M2F92(3LJJB.(:(-<H-3;6Y3JK&DJUCW;(E1%O81/5Y\S'@4-MB./\>1/6*]
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MYA3'_LBO:G^BX^#=.,;^>)G@Y_\ (CM9\<_^:UU*;^V_M$WD:5HICQ1?>?\
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MH\_$Z3,_45-V?H3O"TSC-T;H.=/^]-M$?CTVF ?CSG51_P (+M0#/]C=G_\
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M**G$C5-N#M7!F+@O/1T(DIBS8KY:*@T^TO"QB?[87]PRZPNVLPAY"FU%*7I
M6()$O1(!Q.)JY-HTA04%+)!F"1'OA(/SK<9UY2,<A/\ NG& !@I[8!YQC"<^
MG.1KEXP9R2.#Q.3 ^L1SQ4J?KQ](K'#Q/@.[62$J''U]0E#E)QB>V H>_P"]
M@**<#J("L'@'INP J>J8^?OZ3Y_*L3G+<?XS/3^6<GB.,^XUX+=6I="HA/!-
M$I"NP/[4%H_WAZ$>@!].V==T#[*2#D@DCSGC&8(@\_.O.BG^(H1A)@3GQY_*
M,>729V"1Z@_:E!_])TGQSY$F/=]&FT9Z>F/Z?*K5[H;NT#:IBCNUV%5J@JN/
M36H;-)CT]U:1 ;CKD.OF;*A-H0DRXZ4A*UK65DA.$*(W.DZ)<ZTMY%JMA'<I
M0I:GU.B0X5@0$-N$Y09P,#F2*U.J:M;:0AI3Z'E]\I24):VDRE*5&=RT   C
MSJT)\8%@\9MR\^> /8Z!@\A/'_'?;)QVUO1V%U/,W&G\?^$N?E_JQ]WYUI/]
M,-/!!^[7TDX]FW/7_P!R9^.>N*X_X7U@\=-MWF22  (=OYYX]*WD>OIS@C5/
M]!]4&#<Z?MG)[RYS !_\7\(//ABKO],K _\ >NH8P1W=OSTD=_\ I[Q7'_#
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MQE1@8+:1Z^T.M8G]$6VTZM-PE1;0M1"FBD$)25$;@XJ# ,&")@&)D>^SR?\
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M<X_K!M#_ .*@UB/VJZZ3/W#2?_>5Y_\ #M91V7T\1_&O,1_RC/3_ .EZ\_\
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MI0M/]<5%Q]4AM3[U27FJ2E.N,R9[T4^SZM7J_99Q/=+MM24-V\9$[H(!'^M
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M4BLU%$XL)GRF4QVJR_49\)-2D9)A22$@;5.E.,^V@)3^'V4]VH),)2$DH"@
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M3XZ076*94:+,@LHF#J;;G4]Q"T^^5CYX[4-MV^K7#B00U=*^\MF!M2'R5E)
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MJ=4:U9;MCK)M+JYO+4(^Y.OWC5@W=NMV2D%^P9<7W=J\ZZ\VA+JRH?H_<?\
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MZ7J('F39O#]>?=UK2K](QC_1MX/<>EF;D)/.?_+Y;6/XZV?:/_N_JOG<S_\
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M(\L@*^(* $@APJ( \Q<CW?7/YUB)@QGW'IQ&1]2/ 5:C?,AS;>H@@>Y4J(M
M*L#I]M1[R4J5E62>D]+21TJ\PJ*LC5ID$\\'TGT\O3XU0_R1B5#]>I&3''7G
M@&LHMA?^LM'QZ:7]W_%,;/X\>GIK::W_ ,89'_D3_P"L7CXS[P>M:G0<VSYX
M/WB/=W:<>[%7NUI:WE:Q_&M"J"JQ<M1<ZBW&L^GL4U.24I@J147'U#T"USUR
MTGISD(1G..(BY4\@3T, _P"(XX/(3G@R/?681W:B#_,/6!'@1R()ZR#6+=@[
M3;K;@V+1:CM_;=>J$6-$ID*15*72!5(R)#5*AOOPEH6XTVEX-2HKQ/45(0ML
MC]L]/P6SV7[0:SJ.L7FF:!J.KV:-6U"W<<LTN!M+Z7BLH+J!^-*'$**,X4@D
M]!]RO]I="T>RTNTU+7=/TJZ<TRQN&V[LH4M5NIGNPM+:E"$*<0L!4X4A0\S4
MO_!D\3G_ +#-WC_[#6/X3-3_ /0/M='_ +0VN>O>7!/R3^E0/]..RO\ \VFB
MG_W4S^BZI29X;_$BW?5N05V_=29LFS[YE1V3:#(==C0ZYMRU,6VCVOWD-.38
M27%' 276T\^9Q+1V'[5#3[IH]B-:[Q=[ISB6RI_<M+3&II6X"42$MEY"51U=
M341?;7LP;^V<';+1RVFSOD+<#;6U"G7M/4A!&^-S@:<*9Z-JCK56?\&/Q.?^
MPU=W_P!IK/\ ^%ZB?Z"=KO\ YA=<_P"G<?F$3\ZE_P"G'97_ .;71?\ WDQ_
M['734=D-ZK,H53K=[6O<C5'A^0J359U"%+B0$/O-1&DOJ0\Z@^?*?9:0M6#Y
MCB$ 85G6IUGL?VGTZS=U"\[,:II=C;)1]XN+E+JV4=ZZVTV5N+C9N=6AL S*
MEIX/.VTCM;V;U&[;L+3M'I>I7MPI7W>WMRAMU7=M..N!*4E6XAM"UDR(2E53
MG8.I/2-QME78O4E3,FU8N4]U,KIK+,OG/[!C*>"L<=/5Z:^_+/-E:?\ N-;^
M'5I /EQ-?"]YF]O.O^LW!GJ"'E$<>?AT!]:W0J_95_S5'\$DZECD?GX3P?<:
MAJ_"?=^=4!MC_P!:<?\ ]KZC_P"A!/\ '6PU7_CJ_P#<:_\ 5IK6:-_Q%$<=
MX]_ZQ57" R<?H_(:UU;6M"7B)JDNX-Q-X:M)5U*1N%3Z<V#D=,&C7A1*%3T
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M2U'=(68;1PD(==6M2<Y5:]INI66HV]G=+?<3I]VXH+MW6H;[HIF5,MH,*4G
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M^#C+B665MI;?6Y;*2\7$%:^Z;;?7<H0V3L6JX982M?\ =%U(W#5O](=O+?\
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MGN7]4HRT!*5O!4:5;,AI6$ $KZ#[A("NE1!V#G:2\<3M5::5'^SIS"3Q$$I
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MDQ&.3\"!656Q"2FSAD ?^0T<?#ZKCX^?IK::W_?LCP8C_P"N+K4Z""+=^?\
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M34Z[Q:71\+=[_P!6JM95'7C?2[P!RJA1QGN2$T2RN$C_ 'CQP.^?7MK8ZO\
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M,FFU6"^Q-@KDQGDK3N6'4B"KVF5@MN(202I(.9!S*5 $9!Q((2<Z=,V[RFW
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M B!UENR&6PC 5.Y<=5')!GPP!Q^'C-7FN+_K>KW_ '%JO_H!(U2U_P",V_\
MY]G_ -8FJ7?_ !2Z_P#<=[_U:JUDTGW=\[S43A0M]DYY&<TBR,\A2<9'&"<'
MM@\:V.KYU#_FMSTG^ G!\)Z>ZH&B0-/Y'XW,^8N#^@CBKF..D]65Y(2?VP"2
M?VAG(P4I (22%!!X!2L.),/'$P(Q^OK\QR0<5LNDD9/)B!X'(.">OY5<CP\1
MRO>)R6>DC^K#C1)0?,*OKVB$J*G$I<0DCI'0>H*/()QU*@OB7VC,^RYX^* /
MR! ,SUYFI;1/<O"(_NY^#G@(//S/I6RK5U8::4K5QO?'1&OVXBD! =K524KW
MDI6KS' \"AI2DB1AQWKZ2H(3CJ4M)Z>B0V=R!C@E(\?#@\P<\X\NEJB 8YP#
MX<B<GD0!&.1TJ\?@NJ*I"=T8)*B(M8MY]/4DMX#],D,=*6RM90$B($'WB%*0
MI8/O8$0@"Y> ! +;*H/$[G@?3@#W>6,T@VS694'KA).> FW*?S/ZUG)J^L=-
M*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI
M32E-*4TI32E-*4TI32E-*4TI5'UW<*Q+8EF!<=XVS0IR642%1*M6Z=3Y*6',
M]#RF94AMQ+:^E12LI"5 $@D G69NWN'1N:8?=3F5-M.+2(B05)21(D$B9C/%
M6*<;1^-QM!\%N(2?6%*!CG,1@YP:DUW[N;?V3MM=6[-:N*$;'LVR:UN%6:K!
M<1,(M6@TR35IU2B,-J\R6A42([[*&@1*=+;32E*<3F.M8;W;L%(42G^?V>0$
MF#,XCQQ65""LI"8.X@ S[.>/:&(C/I7QW;/;N4#Z6;QM7UXBM\ZA18FQ>WE>
M%F[![17I7J/3FJLF#UR:0R[09,_R:_+A1GG;AN>+&34(LFY*Q&1YCD"EL,'B
M->O[A2VF&0MM#I*KA[=L2S;B$H:#AA*7'UDS!"@E)'\TUZAV1TNT#;MT^6W5
MVY"+:W*0LW-X1O4ZIJ"I;5LW&U*@4E:DD_@(-\_'WN'L_MK$_J55MP-NK67/
MAR:5%M5^4Q+DX#)CN15T2EQ9,AIIMEU(;;1"6VDJ"4Y(P/)=4TF_?U,N:8TI
MX,%)>7;/HW6[@(PXM2D!LB)_%/Y5[5:Z[IMMI7=:L^VR;E!#3=S;KBX;."66
MT(<*DP8!V@3!@ @UK@^AOW<J&R'CRK6R<:M-.;<>(BVZW-H[3,AURFNWG9#4
MFNQ5--RDM2H<]=!DU9MZ#*8CRC'2QU-J0AE0]K[+ZD]>V7=725-W=NA >2L@
ME7LQWB2"4K2H @J02#M@D%-?./:[36+2]*[4I<M'UK+*D2 F23W9"PE:%)D>
MPM(4 9_"J:W">/\ \0,6^:;/VXLF1)EVY3U/0*K6:5&$]JH5Y#S+ZGV76U>[
M1Z,]"0RF>QYAERER'&$.1VF'GLE_J <7W;)"DHZ]%+!!E)X@1 /4SF(G46ED
MI"0IX$$D$8SM.,SX@F0>,""9J_4G;>B^*SPVV!7J36&8=XT:E0*E;=SI]H2]
M2:Y"91!K-*JGLRVY28<EQEZGU5C"_)6B/4?(D"&AE[IM+U VVQP2XP\V$O-R
M/: \.1O0J2.ARDQ)C1:K8BZ2I(.QYI1+3@!,'J.,I6#DCCD9 %;;/#OO&]>5
M+9L6\I<-.YEL4*AOUE,=Q9C5R/*@->95Z4I]J.])CM3VYD!]Q4=ISSXCJG&F
MUAQ*8Z7D*=<;3(A2B@*G<6R93/(W 8,$B01)B:S)2KNFU*@DI3O(XWP-T8&"
M9B0*L;XG$A4FK?.>?R6 ?W?HC6)^-JR>D_G]?Y5D'//\H'QB.GG^YBKY>$_
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M4MMHJ4A+,]5+3*9EDM(:G5=Y+S26(;LB3TVE.K"+9TC<;:YMW-O!4FWN&W2
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M))YV&<9C<(CQR<=)CPK8MI5E-*5J_P#$$OIOBLK2.@+J50*E*\I#>&W$LK!
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M=OS\:A:&(T[GJY/&/]84?ASCP]TUJZ5\DI21RI0 )3G(4E74D*0,(R<>8 Z
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M2RMRY5,,NIW))LV!'CU<7XU2)KTRZ8<VA,-0YKZEU*#.8R%0I7E6_P!N$_\
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MQUIT^T&&XXG>H@$S&4J4"3!CQ@D @2*#0;?$W#\D2$_PP8$3A3:5")A6/9)
M5!(!JFI;B;T4>E2:W5KSV?@TR!#5-FR5[37N\&&&T=2NAF/O.])DNJX0Q&CL
MO2I+RD,1F7I#K;2J*UMQ.2PG*@  IPDJ40E*0E(4I14HA*1$DD#*E9)T%A6
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MT1H--]HGF#3XD8,08+,F;49*8[#;L^?/F+D27]5</*N;@.K"0I<B ?9]E 2
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MW$K1N;" 0%*69)*I,$_A)!)DJW>T3)FV<*TZ#3)GUE!\.6Y,*I/,U..JHQ[
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MJWJG(I#SADQA0I-,,<1U./L(G(M&'4?Q&TX4J-LI(X!DIB<B<BL2WEMK&Q1
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M"6[>O ,XZ'H>,9!Y'4<^E22",G$&,XR#XX_+)B#SVFJ+/21U%:B%]76X,]6
MI02X&\ I.%.(+?0I)!/'E&H Y R#QM^>13<KDG&0,SG,#!Z=/\C7(J3B.$N*
M9&#GRWDJSV""I2PZE0' 2E;?5_:HZT+ZVPI@S[*><G ]P_:![\4S$3/QGTQ!
MGGKT(Z$B/ZS>5CJ"E^\%)25I.$Y2DD?VR^OJRG!/FMMD]3?6%--%,],?A \@
M,GGH<1QZB*<$>G)\3/)B?&2,D<Q!-/K-\)&5X4#@D)5[I43GHZG5M)7G)SU'
MI'274 )(+:/ 1Z"?ABJR>>>8)XCX \9XZ&*)J;^2.LE.5 ^^@H*.0G*FS&6<
M8"4%:E*44H0" I3@$2< 1G!_J?+CQ^(I.(,B?=F.  #XCIUG! %/K%[(*RZK
M*E!/7A(*58RDI0ZEQ"L!7]HA*AU=;@RCJU=B9 CW 'WD0?GYXXJH'@J(YCR'
MCT]<><FNSZPD=>0XLD''N)/4EPI&?*><1U%Q0Z%(2A;3"NE(_N.I9M$2?:YZ
M'W<8_7Q\ZJ< $D^DGW$_EU.>O)&HN$86KJ)Z0H$K= 0L]/E+\SK7T8*D)\QM
M64EQ2"C!&KL2#/I$QQ/CGR\LU0$SR1B0> ?,>?7Y$8KL^L9((0EP 8))2M24
M\YZ$CR\%'3D +"@@MHZGF/-_MM" ?EX >A$1Y_UJLQ/)R1&2>G$G],9S%0IF
MO=6 DE2NH=327"#@@E)<04OI2$D#J2IU260M72@A2BV[1)CI/2!R/0>8\#FJ
M;CU*L2/:.1Z8^((P8 J!51<4LI*L$])PM?4><I!23UM *! *@M_J26U*:;*D
MI73!\_#U/$9'Q$QCQJA) ZX//E/7\NF9$\S")[B<Y7UC^ZDJ9R0#D ]11T)!
MZ@58+G6DH1TMJ=.@]?/I'IF,4!/GGD@J'KQ/RQQ(Z5V_6#A ]]9'24A06X4J
M45$%11E2B3_?6I'2#A8R2$A0DB1)Y!]>,8@>/'ICKUF><'W\)Z4IQ_9H(2D$
M=*_[+R/+SE3?0E0;4587Y92L  !$ >@ _+H.G--Q^/4E1^<\\SZ>ZHDRUN93
MDN>J4!74K@CWE-GJ6>HX3E2^IL%70$=2D 1$$\=)CZZU3<?=CQ_/IU,CF/YN
M:B0XE!*B2K/?K!45D )4%*2 2!U%.6DH*1GJ6>$ZJ02<S)\R?A\,$?O23B"0
M!Z#GQ]8F3,D\9SV%]I>58Z>GL&RHA*N>K(&0%GD*(Z',**>E*D]:J01C]Y]_
M]<^/G7D9)!/4F ?+TCW?(5P7F%I2E:,H5C)+25>F$E12. D^\@E*E*.#@I/E
M:1Y#X?7QI[4\D<XDB>O/'J)P!SUKJ)BE1)0/>!&>1C@Y1E13U<]>4DJ6V>/+
M0D*\E&>(XZ ?6/&DJ\9XZS^9QX#H1P9BO*\TA2AT%:P"#GK4HG/(*>M1Z"!U
M Y4E:4_'W\U \!Z^?KGCQ..>M))&?=/'GB.OXL=0.<"NA#+;1]U+:<#J_9*1
M@YZAPD\%0.0,E/3@@$*Z0Y_?K]?4U0F8.1Z9R#X3X14+KF4E*01E*025'I 2
M% I*5N%:E)(*2.H!)4"5*1^S7KS \?K/J)\^*>><GISTZ@8YG@R,"),TI,?:
M;42>I)ZR$^\H$).,H*.C'<#WW. ""%C(Q8H3N X'7B/ 9Z<=2?G%08/N, #'
MJ,]<^'ACBK1[B7I3K#M.OW3)62BGQ75L-^65%^8[U)AQPM2FTEQ;ZP&T(6EA
M&5907% BI4$I*U'V$)4HX !QU,>GG) 'C5P"E$("25+*4I'))\ !R>N>8R>A
MV'_1W;,2]L=E6;CN.-T7MN3-?O.Y77F^F4U*K0:D-T]Q2\NI%-@H@4]QDJ*$
M38LYQ'^W45:RUW.=Y<K_ !OJW#_9;']VG_H0HCHHE)XK87FUKNK1!E-LC8HX
M]MTF7%F.NXD _P"$ CFL_P#4NH--*4TI32E-*4TI32E-*4TI32E-*4TI32E-
M*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E>:9+CP(LB9+=0
MS&C-+?>=60E*&VTE2E$GX :M6M+:%+60E*$E2B>  ))^%7MH4ZM#: 5+6H)2
M!R23 K6?N%XCXTNXUPQ/"Y=QM5JH6S36U$OL6S;T^GT-Z6AE!RI$RIR9BU.G
ME7LP4G*<HUP-SJYN'%*2N2\I:F41E%NVKN@0/]MQ#I)',)/6*]-LM#3:MH;*
M8[A#?WE<8<N7DET@D_\ @VU-) /&XCD36/>]>]DS:G9G<'=6MNJ#-N6[+F4Z
M*MQ+"Y=5J"TTR@04!2E$NR:K,B-A)2<!961TH4=:+5]45IVFW=XXK^[1M;3,
M$NO*#3(3)R2M8,1@9P :W%E8-W%VPP@96HE9B0$-I[Q9/@ E)F#B0.373:N[
M%_W#;-NU*VMEIDBASJ+39%(E56](S:W*:["95$<>2E]Y[S"P6RX%H"RKJ*O>
MSJ(UJ-VZVVIG324;$[2Y<P"D!(2<*)!C_9^=8';"V;=6'=0"5[U%03;Y"I)/
M3QQZ=>)J&7?USI8CQJU1:;;=0\Q3LFG1:F[5 Q&PVJ.Y(DE 2A:D><L!(Z4M
MJ"E>]A(FVUP\I,N-):<]HE"'"N  -LJ,'VA)@$0#XBKT6;*4E:'%/))$+4@(
MG)F (D2!DQ) Y$D6AO'=5--I=>N.7,>=HEJPG9U5<CJ1EQ#3;J6FFU*6D#VF
M0IMH+5U^S-^8Z4N= 3HM\ %:I 0#,S)W$I2!D#,$<'B:D%H(1P),%(]V<9!@
M'(G/! -8Q6?XIW;BA0Y"IKS3E84'DKC/+8D(=<42$,+\U>76!TH;0VYE*0G*
M0D9U;][7&V5"1/A!Q$*F9_,=*@%EN22$SX$2"#T.(R/'KSBN;X\7][;,3Z'+
MO_R]Q=G;FE*ISM9,-J+>]E3UH_L5&0WY,6KPRDDM"4TA\^SNM./)7T%RQ>I/
M-;0__'95*=Y2.];)ZA6-T>!DP.A%7(L&W"I37\%X>UM!/=N#G:I.0F3@$1!(
M-4YXJ?$+7*CLO"J-NWM]=4FO;G;9?U2J]%BHIE+F42HU^E0XU!0PB3(\F0S(
M<E0:E'<=]K3-:0Y)9]E>;"XNH7%P^PVAMU3J%7#"TJ0G:GN@00-H)2$ISN$E
M1(S S4^S9MT$K4TEIP(<0XA4E06J1OW$ DDP0< 3 '2L@-[/%Y;>R=K4:#8=
M/AW+O)>,NEVU0Z5-@ORZ?2Y4OV=3[U2:B.M/R5MQE)=;IZ)33[OF,.R2RPL%
M6Q7?HMDI1;A+ETYM&1N2TDX.Z#^(X 1,DY5 YU@L5NJ5WRE)805'V2-[G.T#
MH!R28D#\,\C(;9N\MW=O94"\;PN=RMW+6&8]1D4YUJF0*7#C>S,MR*; IU,8
M2EB"\KK6XE]Z0LN$K2Z7FD.C:V=W>6CH><=WJ4-VU1&W;@0$(  29S'43RD&
MM5>VEM=-%GN]H!B1N)!),'>KE0SGW1M,'I\;E[4+<W:^O5BCH>9K45BCWO3*
M5-:<9DM3:2Y%JZ$1WBCR)J6EL.,+7$=6HI2L+2T<@=TA+K]BWJ3;:C;.)W%:
M2%;%2 6W-I);*2H@[@ >1((K@U%IB]>TUU83<#<@)(*2X "4+;W !8//LDF9
M! C&PKP6U>+<&R=*KL(YB5B6:G''JEJ= @2DMK'/2ML.^6M.24K20>1I:C:E
M:?!9^OV\JP+Z>/EQ]3-9)S[OM6E2UP*E<=%@36DH4Y$EU*)'DH2XGJ0I;+CJ
M7$I6DA224@$$$:D%:08*DR.DB?AS5L'P/PJ0SMU-NJ:VIV7=]%2A.22S)]J5
MP,G"(B7ED_ !))[#)TWI&-P_SJH2H]*L_<_B[V=MM*PW-K5==3G#=)I#J4J4
M.R?.JCE-;P?]Y)6/7G6%5RTF1DGP Y]Y@>Z9\JO2TI4< 'J3Q\)K&J[/'[4'
M%.,6794*$@92F;<<QV:\<C 4(-/,1IM0/.%3)"?CD9U&7?'.Q$>&Z2?@"/=S
M65-OXJYX @?,^_W^HK6]XRO%)O)<&VD6AS-PJI0(NYE^69MA4JM1G_J2):5O
M7O6$4NO5V.B!Y"43(M)5)ATR9+6\(=3FPI*EY;SK"+A:R5+4=J4*5M& 2D'H
M(..8SQ'C61+83^%.1B<SGQ/ \.GOJ@)7ANG;@6/&HE.A6MX?/!985M%F_-Y*
M]7)5O"50G75BNTJR*<S$;=N2L56*%,NW"Y4)$2K52IEEI=6EO/$Q4-N72PXD
M%M"%%7>K'LCQ.?Q$#A('^\4GV:SE2&O95_$=5$(2<YC_ *(ZS,X$8K>1X"[.
M?M7P\4V>];LZT6-Q;\W2W8HUK56*Y!JM M?<B_Z_=%H4ZJP'@'J?5$VK.H[]
M2I[O]K!G/R(KN'&E@;UH0@1P9(]"<'@<C/OK7O&5^.U*4D^)2 #P3.>O7FLS
M=9*Q4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*
M4TI32E-*5 XVEUMQI8RAQ"FUCXI6DI4/P)TI6H#>'83>S:BX*I6+,JK5W6/-
MFR)-*IM=B//?5Z93JY"J6W4Z<IR53%(*EAM<N"N"XD>X_P!94VFQ3JFR"J=L
M  @2.<[B3(G$'(]8BLH2A:4[@"4R#!VJ@ [3D$*ZCF02..:L*C==RE*2S?%I
M7!:G0LMJJ<9MZX*$M75Y;@%1I+3SC3;?EH40_&C!L^[C*>K65+Z5@YQG\)*I
MX]_@.@\(Q6,M2"4K3,R4K 00(D<F#SR%*!\Q@W$HETT.Y8XDT&K4NL,$)<<7
M!FQY1;6?1YIAYUQ#H"5#I?ZRE06E044.%O)N!C(\2"<X/AGIQSF/=:I"D?B"
M@)@R/$3S@ >,0?/BIX)"D\I (ZE*PE!]Y1(]Y74XVTX\!GK4EQ20I/0GA2$K
MN!!2?4F!&3TQC,<GCXS5F!@]8YGCG!S"<>N<Q%=PDI!2,].<]1;\X>^.I1ST
M])*4X6I(4$8PM:5I<'2BLD0/',>DR)P<>'J: >GOY@X@<B8CRR)%1^<E1 4E
M/."HH;).1G"LH4XX4A"R"/)475.)<QY7(ISX01X?/GPYQXFAP9DF/',3TZ#X
M''%<A[J4,=)[C*%>7@I)4G]MP++>#@GI6W^RXGW,-Z<QY3X].3SQ\NM5'69(
MP<Q!''7'@>AZ=*A\W/0KI03A/]]"ECJPCK)2.A:5Y+80EK/[16IM66]5CW=<
M^$QT_IUG(BG 5.>8GCJ?7S)Z\^9[ ZK*>%%W&<A:@KI2 O\ M'"D>\2 ?>*%
M.A2RE:F@Z#0^7P'./J<?TJ@C,&!S.(SX"1Q,>$]) J/"P.6U* 22K^ZV,J*>
MGJ&%*;2I!;5[Y0KIZ$'S/9V5(',1,SP3UY\O?T\P"/\ O=>GITG P?/IGDU#
MYBE%72KJZP 6QYOO^[RIP%QOK4M/[*5O.J!2HD% 2E->#C/7$"?*0>O'/K50
M)Z$'H3D_#Z\CS5JMVK__ *F4,PX*VS7*TR]&I^%K#L2,/=D5%2$HZ&/(#@:A
M]74IR1_:M>T--/(1L]+L3=/;W "RTK<OKO422EN,8Q*HF$"#!4F?-?M*[:-]
ME=(^[6C@&M:HAUFQ _%:L[0A_4%1^$M]XE%ON*2M]06E*TV[R1\_?CYW:\6%
M]7EMAX/+!I&X='HM^3:7*I%0#%9H_P#I+EU1+9C4V'<&6?;;(M5EQ50KC;TA
M<&%+0].JC4>)2(KVO<.Q&F]F;.UU+M7>O6#SMDEP.H*FG3IR6I)<7;J42B\N
M5#:P0G>XB$H)4ZH5M/LBM-8MNRR+WM!?/7 N%=[IEI>$+N+2Q@[%*><_C."X
M*DN,M+*NY8+>R ]M3M=B[.WML3X>_#ALI;&[=T*O.F;EVO3)]^U&IU&L(JE9
M?HUY7+-IU0@39[BIFWJZW&8IK=H!^*E^U8R(B2S55.U!/F*]7M-:UW7]6N-+
MMONCNGW3C=@VVVWL;#MK;H=;6A,)O@RI2_O6TJ-PI2RDMDMUWA4%N.N%."DJ
M"1@C( S',&28P? 17C>\1=\+O2[Z=18$^%<TNL;+;;URUWXT2XF-M;NET7?:
MX;G<@T*MW38U'J/]9!9U"CVY5)-QT5BX*57[0N-IBMI=@T*H9$:#:"TM7'EM
MKMDMZOJ+-PE2F%ZA9H<T9FV"WFK:\=;^[F[>7<-AAU5NNWNK<EHA;[=FP0%<
M_C((($PI*9)Z3N/H>@%7)9WZO^FVKN/)O.F4&@7/9NR-SW]269R:?'36ZS;=
MU[I4)%4D0Z5>%S0XU-J$&V+)G5.VF;FJLFWJE7WJ/*KSK[\)8@G1K)=SIZ;1
MUY^VO-8M[%Q39<46F;BVTZX+:5NVMNI:T./WK:+A5NVBX;82ZEE("Q5 @$I&
M0"I.X$S$P"/+&0?#RF/<[N?NC)@WC<K5<LRWJ31-P+)VHA4FN6A69OU15;IF
M;;4N?>]>JZKQI*WX]+GWK45Q+7BT^FM/)@P(4ZNQG7Y,MC&G3M/2NTMULWC[
MCEE>:HX\S=-I+C5JG45M6;#/W5T(6XFU:FY+CI!4XM-OM0E"JJ2E,>:20<>>
M#XB!SX'$]<;_ !&RZQ?SM*M6]]U-E7E;3[G5YB99%^;@U[82Q/$%3I6V5I5]
M5-EUVA734ZA2+PVODWE&D>Q(=KM"?>DPZK5X, .F%&W^@ANR#ES9Z9J__;33
MF%)O;*QM]<O-#<1J%TR'$,O6[3;EIJ2+12=Y2R\A*5-M+<(W&]KV9A*L@ *2
MF2DDJZ*QG;ZX]#5N=E=Z&1NU8]\P-QJGMOM QX-J_=,+:>ZZB-Q'*FBQ=Q;N
MI=>HMM7-.K9K%_RX[U&E7'0+KH<.9<%8LJ-3Z5':;I$CS&]AJVD_]JKRR7I[
M5_JBNUC-LO4[9O[@&S>V%HNW=N;=#0:L4*#B6'[5]:&6;M2UJ)<20JJQ[&W;
MN4'?Q#! V @D &() C\,[NN:G&UOC:\0&X1DV4Y3]M:?=MQ7OLI0[%OZ1;T2
M70:?;&[]&W'K[E2N.Q[%WTW$0_6*7 V[=-'I$S<>VZRM%;C/5^CTY$9)J.'4
MNR&A6!3>!R_7;,6>LNWEDEY:;A=QI;M@P$,7E]HU@>Z6Y?#O7D6%RR"RH,/.
M;O8J66TYR?945)ZRCI.W@^(DR!$Y)V@6]%59%GE=06*I5(\676[CD4.#5A%K
M5QS"[4:_/H]%J%8N"HTB%/J:Y<J!1C6:D(##PC-R9+;#K^O,]1O$3<W>UU-O
M;LNK::&UZX3:VK2BRS_ 9:%S<)90EL*0RA;[G"4E1 B7+R6VG7W$K4AAEQU2
M4(*G.[:;*U)0A,;U[4F D2I4) *E"9E;%TQ[LHD*O18E3IT><"I,>JL+A3$)
M"NA"'&NE*27,$MJ;.72D.H/2 \O4:+J[&O:39:O:M73-M?-*=::O63;W* EY
MQHAY@J5L45-J4F%*"FRA:24J!J#I6H,ZO86VHL,OLM725K2S<M]T^V4+4V0X
MB5")02"A:T+04K2HA0%3Q:U%/[)]_&3CS$9R.K +BRG&0M'6M!0L8)5A*E;+
MKQ\8(^'S&,>=;&(G.1QT_89."1Z5 7"%82D94?\ 9]"PO*1CK!/0D%.$I4>E
M11A(40.A0N\/&)\\$^_R\.)Z5:.HF(ZR".F#T(R?GCD5XY<OI03GI3P.O*<
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M8CD>/D& ,#X<GISXCF#G!]:A4\C.4I;'3PE. "E/2>Q RX!D<]*' 5..G!4
MJV1.-L\XG Z< 8$SQ/7KFGN//C^(XYG\IYQR,="WD #)ZR<%7O*PL)R$X!<5
MU% P$]0#@PDI*5A6J>8@]<8ZX(DXB.N9'CBJP>N!\QX].#F>GNJGZE*0>HE0
MP"!E?E*"BK!*2"E9Z<#J*,*'NI*>.%U@^<<_OF#[IP*H,8@9.#&(''O/K-8Z
M[QW]4K;AT^UK0BJJFY=]2/J:TJ1#<6)<=<H(2_4GEI0V^Q&BME;IEK]E:"6U
MOR%(0V5HM=>##16KVI_"CJM<^R !X'G  G.*D-L+?6EI!QRM2>$I$R500
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MX[=A5.L4Z*ARH.T"%)5/=CALH0?.1G2ZC?WS2S:Z?I]Q<7"FPL7"@VBT;25
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MUL6K2'!UQ:5$9>2I$>:^UY;M84G$AMI9@.]"YM0#VN2I5TYWRTE+:<-H(C:
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M (XU_P"Q#LL^'%:1KVKZ2XY$HNT6VH-I"25;4]W_ &>Z,D05.K5"1/)KL_\
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MFE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*A4I*$E2U)2E()4I1"4I [DDX
M ]2>-*5B3NWX]/!KL5,>IFZOB3VCM*L1RM+]#E7C29E=9<;Z<M/4:FOS*DRZ
MH*RAMZ,A2PE92"$+(P&Y8!("PLIPH-A3A!Q@AL*@C<)!X!!/-24VEPO/=%((
M!!<(;!"I@CO"F08,$3Q/%6,H_P!,%]&]6I8A1_%5MU$<4H .51ZI4R-A2N@+
M5)F0&F4-]1&5K6E(!!40#G5$W+2HCO,F)[IR)SR=N!@Y./.JKLWT"2$$;=WL
MN-JQ,084<^7,9B*^;+Z="N[9;Y[XIW!V+W"H&YM$KVR]I/7)4;"E,7A3:=.M
MVM7&Q%IU8>H[4H4.94Z3(;DM>UO19[D> 74MN18[P3?9K0';UPK_ (*_NZ@K
M(3W@0M#GM>*4I:5@IV2)P14MP$VMBQM N J[94B4EQ3*UM.)/=3O@K<=0D@$
M$R "08T">'K:'=?=+<.A2=K=M[@W#-DW';MQ7.W1XAD4JB4>+6(SZI5Q51;L
M>%1X$GV5;++\Z2PE]U)905JRDS9;9AYWVVD05D0!&8 )!$GD!,D@3'-:"Z4D
MH<MDE:;AY"PR@)4MS\0 6&P/P F"LJ2!@$CFOH4N:(S4*I*=<<JL,N.>:Y'9
MJ2'"VZYA;C:GC&P\&U$M]2>E*@D%.1C7(*:2HJ*5JV]XHI.XD[=QB1$C<,G
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MUMZ]X;?M:SFK];EQ8T^LU!%<@?5]+;IL./T2/,D)JDJ.\ZI3[1:C-!U;A1U
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M'PGB?HR*SO\ "ON0_1;B;M.HR5_5];"33RZHE,:JM#S&L$@X$EI*FE?%:&R
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M'4Y/0>L5D2E*9)X&3/UXQCK6Q:+&:AQF(C"0AF,RVPTD=DH:0$)'X ??K:I
M2 D<  #W5@))))Y.:[]5JE-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI3
M2E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*5:[>K>*Q-@-K+WWAW*J[5$LN
MPJ%,KM9FN$%UQN.C$>!":_;E5*I2E,P*=$:"G94R0RRVDJ6!K$\\EALN*DQ
M2E.5+6HPA"1U4M1"1ZYQ6:W87<O(904I*I*EJ,(;0D%2W%J_E0A(*E'P'C7Q
M5T*W/$A]/!XUJG6JM)JME;&66\AB9.CI,J@[2;?%XO4ZA4QI\M0ZEN)=B6UO
M.R>AQ:I2ESY+(I,"'&.&W8*MS[X/>JA*U DA.21;M8$)0 -ZIE2I43*DI$R[
MN PVBTMRG9[2FA$[S^$W3XP=QX:;.-HVB4A:E?9=X<_#9L]X5-L*)M+LK:4.
MUK5H[84\M #U6KU36A"9M>N&J+3[35JS47$!Z7,D*)*B&VD-,H;:1+^0' '
MK61DDDJ4HRI2C)4?,_D. ,"K[Z56FE*EE:BQ9M'JD2:PQ)B2:?,9DQY33;T=
MYER.XEQMYIU*FW&U))"T+24J3D$$:M4 4J!$B#(B9QX=:N1(6F.=P\NM?$SX
M%/#GN+N-](]OK.VQJEN46X;*M:^7DKO"W7ZI9E:I%8IUK4;^I[T>!)@2Z27V
MI90W6H;ID04^2[$2I27$#*I2C:J;!0I2TM[YY6D)2F 9.S:I,@P23*>F;K]E
MLOZ<M7>IVEU;)3!2V4)6"',0N$/I"1(/7,16RO<GPZ7Q0:FPW>M@3=M;BK50
M;IM*0U4F+EL.YJN\DB/2[;NEI3"X=9J*T+^K+;N"+$G5 _V%+J%9G?V!TQ06
M\;% G@*B5J,D[2DY/@"-Q ) ,$5>K<HR"A2 "2I). , N)(E&XGD$HD@&"0#
MC[.LVL4:0_$J-/?B/LN%IQ*VBVIIU!Z5-.H6$K9<2<]:'D(6DYR.-4VF>#/S
MY\#[OW%4)VB"(,=!CW=,8ZQX5WPJ&XM8ZDJ2CLI03\CR1P>_&0/EGX44F()Q
MQ@^?6(Z_H/4V;B<#'ID^/UY575-I'0A/4" .D' )/H#SQC@9'R.5$GC5H'/L
MP#(/NXX]_P"\5:29&9C/$Y\B?VYJOJ?3%#I]S.![N!QC/ )X SV&1D?:-$A(
M!,XY_I_G5228$21CXQG]9JMXE,44=('N\\<9'RR<']K*>!P,<$<:L))@B8_4
M?'/ D\GRI(@X$B<\YSD#&.O@!GFJJI5,"%A11S\",A/."<9YZDGOC !/Q)U>
ME,YZF>>A\B1SZ_$S-4DC)\0<'F!!3Z9\AXC%7+I$)0*"$I5SD D@XS@J&<@!
M..<]SQ\]2$)VB#()D\S[Q\C/G0J.V#$@SC &,#'UY=*N/!6]'*%LN.,NHY2M
MEQ2%I^&%H(4"/M'?5\'$<]/KZX-6'B0?/$B8/D?G^PBX5)OZ\Z7@0KCJS3:0
M,-N2E26R1@\HDEP'!SZG(R,#665#,D8S$P<'RQQF/F35$DD<CX#Q,=?T'OJX
M=/WWOF+TB2Y3*@G">),+RU$#&27(SK')^)2>_;52XXF#((\QGTQ%79GH0?='
M[_U^%70O$A*04HJ=JM+Q@+>@U$IZOFAE^.H#_OG\?$Z!]74#X_Y>X4D#G']/
MKCFJS@>(.S9!"9D2L4\G&2J,B4D$X'*HKCG&<_/ R0,\7]\GJ",QX\<^77W]
M* @\>1^,_L:K"%NWM_.">BX&&5*[(EL28QS\"IQD-\>OOG&KN]1XQZ@_M]8J
MM53%NNV9O3[+7Z0_U#*0W/C%1'_-\P*!'J" 1ZC5P4D]12/VJ<MR8[HRU(9<
M'Q;=;6/Q2HZK(\1\:5W:K2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4I
MI2FE*IVY+LMZT8)J%PU2/3H^%% <*EOOE(RI,>.V%OOJ QD-MJZ<CJ('.LS+
M#MPK8T@K/6.!YJ4< >IK&XZAH;EJ"1\SZ#D^ZL>;F\66W="I$FL>T)CP4^8S
M%FU5U#"7I*<A(3"CE^2ML* RE2F72..E!SC:-Z)<J6$*(W<E* 50.LJ("1'D
M%#UJ"O4F4I*AQP"H@2?028!Y&#Z5\:?](RMU?B,MO;3Q,4)BF3I6W,NI6/>U
M8H;*8TJ39UQR(,BT/;VG(\60J#;]?8JD1N0\:BXTY="$&5T*0VG'KFD?<&K:
M[::4D'<Q<DG>2H@*86H@E(R'4$@()*FT0?9B3I&HBZ<=MUN;N'6! 3 $AU*0
M1N,@MKY(A#A'4GYF]I=QF*'0*MM_64!ZDR'GJW;D[I4\]1:_Y;2%*2ZXM!3
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MVD\9<2F%U@'*P@=Y;6D;U!#[K@<(!PV6FTR!@NO"21(D!L^M1'-36 5,M-E
M,274N.*CG:TV<>14X,# Z#'6\+1>HM6KU.?]HILNFSJG'E0E%Z+Y4FFR7?-C
MK8?92 IMUA390E;921@,H(Z!QR'"2 8.8D09)Q,XP1Y>&?'IU-C;()'LS!D>
M?7RC$GW]<_/ A1ZSNB_#L*B,^TW!5YK=+I74XVRRVZ5I:0Y+DN8;BP(K+:9,
MN4Z?+B1H[LAPI;05#2W-@[<ZDBWMT!2[AQ(2(@2H;E%1$^RGVE$Q@2>!6\L[
MQMG3UO/J*46Z%%2L2$HD!(\21M2!.50!S68.XOT6&SRI%TWMO7X^=MJO7+=I
M(0G;'9V/1:W7IDJ P6VZ#2;BN^[:%$_;2DNU0V[(=>>*E-TM0:995Z19=F7&
M&T)6^VV#*G%)25'(_P )VG=R$@Q!R8Z<%?=HD7#JG VM<>PA)6D  $<P5<@
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MY]8!\]_?AVN:%$LA-0=4E"&H^?VN24H! &>"2><'U(^8'J>G*2M#>.0/".A
M\.O/ZXKSC5-R7%B<Y'ESR?B/ >X5BKNA/DWUN%/F8+C,4K0P#DI""OH!(Y 4
ME273QQTN#MJ'K:PMX)!E+22D9ZJC'RYYXR*:4A2&23&Y9W$CKMG.8QG \JSA
M\-?AHI-UV1;TZMR44B54[Z;JDV6JGB8[*M&&PJES*3'4N1%,-Z4IV7,C3U>T
MLQGVV''H,QL%H^2]I+A3EZW;MD@-) 5!GVG<J$9R $@#Q^7HNB6J?NCCKHDN
M$D=(",#/F2KPFKHQFZ52:?>-?A4^M0MM;3N5%"@W#.:1-9#<Z6VS284AR+AY
M<X1YE-=EEJ$B,V)\<H4E/6VU*U+2TZ7]W;-RAQ:[=EQQM:P7DK6(5"4B"WN!
MV]0D>U/XE1-/O5WX>4&"EM%P\VVXD2VI"#[)*E&=Q2?:Q$\') R@HFTM]QET
MFKTEN 'F7(=2AN)J,8*24+0\T7 %DH*D@=2%>\ <* .1K4*5M_W@9]XZ<CK@
MY\16Q /H(@].>.GEY>/IDK4_#IM!?>X=1W7O:SVKIN^LQ:&U(:KTQZHT2 JC
MT:GTE#,&C-^SP'6E"%YZ_K)JHEQYUQ8Z$*#:=TUVGU>ULD6%G<?=6&RX992E
M+RRXM2R5.F5 C= VE. )DB:U=QH>GW%VN]N6?O#J@VF'%%320A"4!*6\)_ED
M[@K)G&(R0HM.I]&A,TRC4^!2*;'"1'IU+AQJ=!92D  ,PXC;,9L #&$-)X U
MI7GW[A2G'WG'5J,J4XXI:B3G)42?\C6P;::92$--H;2,!*$A(CT$54;1[9)_
M7\<>ORU1)QTZYGGW>G4P>*O-3)I6%#G@C]=OEG5_0_OQT_:JU*+DK"Z2Y;CQ
M/EQI-P1H,EU1Z4M^U0YS<7*NR2JH>R-I)/*UI ]XC5"K:4G_ &@#Z9^O6*J?
M: ',"3[B3GTZ>L55L*5(DO-,-!;KCBTMH;;27'''%D)"$)3DJ4HG"4@$DD#'
M;1:HR!R8^H^O?DWM@*,'GG/$#X_7D2*V-[&[;/6A1_KFM,^77JLP@".L N4V
M"K"TL+R,IDO82N0G_L82AHX6'!J=:LE [Q?XU" #T3S\_#' K"ZL$[4F4@R3
MXGR\OKPJ_>I=8::4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2F
ME*:4II2FE*:4II2FE*:4II2FE*:4II2ODY^GV\0M];P;S[0?1\;/>VU:7,F6
MU=%[T2DJ*G*]>=SSTTZPK:FI;<2M<>F1)!K\B.YAHO3Z9(4"J,DHBI2;F\B-
MR+:$A,$_QU(WJ=,=&&2(/12U=16S#[>FZ8[<.)W+NTD<@*^[I<[M+:<_BN+D
M!/0D(3$A1K?KX!?!_:/@E\-ED;-V^RQ)N%$45_<>Y@TTF;==^UA"9-=J4I]#
M;:W8T5Y0I='96.F'2(4.,VE(0<S7"G="!#:?90/+JH_[2C[1/B?*M,REP!3C
MRM[[Q[QY70*@!+:?!MI(#:!_A3)R36:.K*S4TI32E4;N+<$&U;!O2Y*E*9@P
M*':]<J<J6^H)9CM1*;(>4ZXH\!*>D$G5JHVJGB#,9^0S61I*ENMI2)4I:0!X
MF16A'Z$6UEW?N+XL/$0XDF-7ZS0;-I<AMM2&7TJ=GW$4*"O=0XW;+]F34MMG
M/15NMW/4WC(3[,$0H'V@4[3N(W0(_E"%H2)R((@=<EZ@H?;3N04-L[&TH5N
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MMI/2% 9XFI)3;<;\U]AQ'1(BK\N3'>0IE^*ZDX4S(CN!$B,\/V2V\VE0&04
M@XL/A$$8/]#Q^<8GPK#!'A[LGSGP^L]*K2)04-A/2D=>1]H[^[A0P4\X^/'I
MSJ[9,2,^?S)GGG]IS%!.9C/A]?TXJH&:6$C& ,$G QCT.0/7\_7C5>[4/('F
M(S^^?R^-9-5%3Z45*_85PL!1&<IXYX/J0,#TSG&LH3 '7!CY^7Q])Q5//WU7
M4.(AM/2$@ =NH <>H^T'X\$Y[DYU6,#,X^A[A']*L))..#/'C'D,8&(R,$^%
M3]EH#  ]..,=C\OC\\>F-7"> ?/SR//'[]3P*MW2/D8SX^/[GK.8KW#'&0,#
M[<?$#\OA]VJ_AB3UQGKGIC'4F?+QJY/'GS&/,3GQ&3G\\B<=N/F,_P 3]WY_
M94^"@>D<<GC/CX]/S-TQCD_G^73)\)KJ4<_(8.0>.?A\SZXT CUY!P8'T3X2
M 8K%)!!)_7Z]U$$YY(YQGXY^7Z[<:1 RGB>N(YSU^N*J%B((Q]?7K7<%GOW_
M !_R'X?+5PS_ %^O?66:[/.6.QQZ<'''J,C'\M6^R2!U/Z?XA]'SI/GQ\OVK
MUM56HQCF/.E,D>K4AU'PQCI6,GYD?XT !!\9D &.!CQCF/+W4DC@QZ?4^GOJ
M;L7U=T3"6+DK"0.P,Z0Y@C '#BUC _W2"/EQJZ"/PJ5/C)@^7^7O.15.)SXG
MQ\<?7ZU.X^[FX,;'3<<M>/1YJ.\%#G (=94?7/!!^>="5]%$<=?+]_\ **M"
M^F,]3B./C_G@"INUOIN UWJ$1\C_ += 8QG@_P!T)//KVU7>YX\<#'ID]8S'
MC$FF_' \>29S$8QT/RJ9->(2]F\>:U27?C_JA0!QQREW/./EZG&J=XYF8$>7
MY4WF"8$>I].O/Z5[4>(VZ@1UTNDK!'8)?3S]OF>F,?GSJO>K()A(''4Q\\\^
MF*N!GZ^I^I@U6]B;W5RZ;JH]ORZ136&*B[)0[(9<D><T&84B2DMI4>@]2V0D
M]79))Y.-50ZHJ ,$'G$'\_W_ %JFX$Q!Z^%9,:D5=32E-*4TI32E-*4TI32E
M-*4TI32E?+/]*9X^=[/##XQ[GM:D4V#5K0_JG9<BC1YSCK1:A3*''D3%,!Q,
MB$ZE=4<JO6'(G6IW 4^$M(0.PT4VQL-CC1*@ZX5K2J">(D<R$!($%(B8.ZN?
MU$OINPI"T[2VD)0H8Y5,01^(]2%1Z8.&-(^DCV#ORFMHW$JEWV0MVHIG5:CT
M^U'*RJ<H,NH=9I%59F5&)1D2'5M*>DO4R<L!H^SPXI<\Q&_3=6Z GNU#<E.T
M;PL%(_EWPA05&8]OCDQ .M+#K@/>(@&"0@I,GJ4DJ]DP?\,?G5:7!XZ/ !>.
MW-X[0UFT*Q*LV^[?J%M7)*J,.J3JO/@U%@LK>:J,JBOS8TJ.YY4R"\TZP(4Q
MAB1';;<90!%O66]08<8N+MLM.C;M2%(V&=R5@ @;D* 4DP3N2#! K-:N&T>0
MZQ;N!;9D*("Y_%*2>H4#M4,>R8KY*O$#X=F]MMP)T/:FX9.[%C5!V5*M.N4N
MF2Z=4V8"W#[- NB!-1%%.JL1*T)DKBKEP9);5(AN *5'9X"ZTFZM'>Z]A])R
MVZTH%*A, J2)*%<%222 .IB1V#&I6]PV5D+94("FG,;3R0DXW)\#U\!BIWM#
M3]U;.A,PZE07'X;DMV8ZU*EMM>2Y+4DR%MH2YU./%"$H2ZYGR\$M(0I:BK)9
MVUS:OJ>;;*2YL2ZJ0"I"9@#.(DY&>HC!JVYN;>Y92PM84ELJ4VD2=JE<JCW#
M!$1XR9W5>%WQ5;%[*PX#M=V1F56OM!)D5F76&:DX%D#K6RV]0)(1E0)&5NK'
M&'#WUW+-^P&4M"683G^&5J) Y*P=W,G]:Y1ZS/>J<,NDG'M; @8_EP)Y]"8$
M5M"MWZ7_ &-BMLQ7+>O2DL]*$%,5;KC#(&"<,,T&("D?[J5DX3QWXLW6R\E]
MOG$L.2?4\#P\9Z4VK1PVO'0+1 ]/HB#SDU\W_P!(3MWM3=NZ]Q[T^&NM5JXH
M.Z]:N&Y;IL"925TN79MSUIQ<RINQ954=:9FT&LU"5*F,,1T>T4I2W(:4.QT1
MW$\9J.A%A[O+-Q#UNZ5+"!^-@E6XH)QN0"3W9@%*80H&-RNGL=7#C7=W*5MN
MMI"-Y'LN@)@*@S"@  L D*_$",I&%VS3&Z^U3$Q#=OO*<GN*\U(F(B);96DH
M6QYK:U..(=!_M$Y;2KI0%# P<#%J[:W";L,J4\E)0F2  ""%''M$D2)Q[,C,
MUF>NT/VRK7O/X*U!:@GDP04S/&0#&>,^%7_@W->4IDNNVO1Z>M;R5N2'*F9#
MGD#)6E+ &2XLX 6I_H0G/]FI2@4[Q-[?*C<PVD[A[165$#D0B<DQR3$=#6F5
M9V:5"''-L04A,23Q[4 @<^R!)CF.<E8/C5\05#LF-MQ;=RTJS[9C,^5[/0J1
M!CS%@\+*I\5EB65N8RMU<E;BR2HJ)YU*-_=K4D[D(C_"G/C S[H$2>OCB^ZV
MX01L4H$]"!/J8GQQG.*D]E[T[HRICB9]Y5:<J4\V\MV8[YSY<0%)2XE;@4IM
M6'5@%"NLY.5$C4ZVN'W#M<45R>3X9QX^O3UK4WMJP 5);"(S[/$G)YQZF/Z7
M?C2I-4DIG5*4]*?6X'%O/N%QQ1*P>ZNHY)'8>F/LUL/P]8! /'G^7/NY$XK1
M96< G/J1,=/K'QJS='I]37NW?L8,+<\^O5>>E*!GKB.56<I#O2@8(4%M9 '.
M1\1J&EU+:W%K/LC=N*C&"M9!R0.N=V(/G6V=;+MNRA$[E=V (),[ D@\]9X\
MNE9043:&_J^VJ5!MNI>PLMJ>=G2([D6(TRE!6MY;KZ49;;0%*4I((Z!GGC6O
MN.T-DTH)#J5JF E'\3)P!*?8$F?Q*$5E8T&[<3N4VH)Y)5[  $R8/MF/))]U
M9?V-X"[NJ7D2KOKE-M^,OIZV8Z3+EE)Y("EEIM*\'&.A>M!==J5&>Z;*1QO>
M7M''&Q/ZK!CW5O;;LX@ =XO<J9"6A/3 WJ Z8_#'6LN;3\)>R-CI:E5*GR+H
MGMCJ#E9>ZHZE#'+4! 2T>1QEE:?]Y6-<U=Z]<.R"\H@_RM2V#(B)_$?B?#Q-
M=#;:*RW&UE ('*_;5.<Y]GTX\A6(>[GA&EWA?]UW;!I%N0:-7YR'XU&IJN@Q
M8L6+&AQNL.,LH$I3<9+[BF<);?><#"NG&8C&MW#20WWKZ "HC:9C)5$C/7,^
M!\:E.Z0RM6_NVEJ@ RGP$<<&>>,&O#2/ _=%P071;M4CMU&'&<6W3I+B5J4I
MELE#825A[!(">L%8]<*]=S:=H;ELI.Y-PG!4D^RL P"0H1)\B"(,3%:FYT2W
M5,I+*B#$9029,$'XX(/AFL;[HLN_=JZBY2+RHDVF*\Q242'6W%PGPE1&6)00
M$Y..H-K"7,$DH3CCM-+URWN@$A0#@&6E^RL'F8S(D\C<GI7'ZEHS]LK<$2V3
M_>(RDYZD> @08/S%<P:DS+;">M+9 2H((]XCG]DCCD'TXQZZZ)#B5I]D] 8&
M!\.#Y1C%<\MLMKE0)'&Z,$\#$3CXGRFJC]C$AI)=2A;3V6G$+2EQ#B""%(<0
MH*0XV02%)4DA2>K5\3@@$*E)! ((.#S@_4XK'NVR4F"/:!$C:1G$>T.)$'F
M*QRW(\)5I72'*Y8PCVC="GE.F $E-MU-]!ZE-NLMI6NDN/*S_;Q$JCH4<KC.
M%16-)=:.PI1=82&7-TE G8N.?9&4$^*<<^Q,FM_8Z_<M0Q<G[RU&%DPZA/$[
MCAT#P5"O]N*H2WKON*QFGMO[CILF@5:'Y;+\60M*D.LN<-2X;Z%%B9#?Z5>5
M)CN+;4 I/5U)4D;K3EE"0VL%*D#;!Y\/0XX(P9\:CZB4/#O62'$+)(6)/D9F
M((/(.4GIFLDMM-N5W&T:DAI2U5.1':C=(ZO-4]@#WNG/4OJ0?CD\COB+J 2
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M/D41+K8_M6;6IB:9:\92G'\,4="6WE,AL"XS)*E%:B2I2U&5+4<J43US@>0
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MT%DR)0'G5#@)1 SXE9!]3!-6*T.[>,*+2$GDJ,GG_"D>_D>IFLKJ9X>;8I,
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MW5C)23G)[JSU*WO$)6TZE0(!D&,QD$0"#Q@@'QS7$7NF/6RE)<0I"Y(..?\
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M-6Z3;U%IL=V74*M6JA%IE.A1F$*<>?E3)CK,=EIMM*EK6XXE*4I))P-6J4E
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M?@2FXGM^ M !"A)25;5^(!C:1Y\B"H$D@@^R:N4Z"""J%!,IZ@\R,=?PF>
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MYTI32E-*4TI32E-*4TI32E=+\>/*:4S*89DLK&%M/M(>:6/@IMQ*D*'R(.A
M/(GUI5H;MV#VLO%*C4K8B1I1)4B?3"J!,:*E=:BRZR0&NI7)+:4D8&",:PKM
MVEC\(2>04X(_3Y5>%J3QZ9 JQ]8\*E:@%;MD;@20T!_9TBZHQJL/ YZ$S@L5
M-'8)23+4VC.?+5C!QEA8REPD#A*O'U^AY13^&3)1M_W20)Z&.,>0JU-:VUWA
MMGS%5.QOK^.GGVVSIS50(0.ZE4^=[#+ZN.KH;6_P< G.-8MKJ8"T'$RI!D?
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M!X^[P\)$5YI*AX$=<@>/I&,CX=:R=I%8@UAA+T5Q)7TCK961YC9([*!QQDD
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MG76[ED;%*4ANY Q*#"4NP9!*!A6)*=IGV:W=G=[$+:<D@!2FNIW1)0( P3!
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M.L^7( &5)93<*0I:3QTE*G$Y(_N]0]>?$;\QK=W@?\:7)\9Z>/&)D> KTRT
M.F6PZ?=D'_T1[QSX8'A6U2*L+CL.(.4K9:4@CL4J;!!!YSD'@_>!JR1)GB2>
MIS/U^1-8JFK2R!V^S/X_E\,_NU;Y$R)G^N<&??[JKD?,>ZI@VX3QG\N_V_=^
M7;5M7@Y)//C,9$8QB/#T/N]C:S^\DYSZ?9\ 1]OV:5<,C/GY<'R\(QS$<U,&
M7.W.?T?W^N/RU0]?E'U[_/PQ5U39A?;!_ESG_$8[C[=#$>7Q]]4  ^NA,_+Z
MYK)KPPL+D[L6^M&<18U9D.8!(\OZIEL@J/8 K>0G)]2!W/.:S!^\(ZX),]"
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MQPEA"D)MN][FW;#JQW=HI2M[[3J@0%%O8A2@F.35=+<U6Z6%J2SIS!;0GO%
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ML2^7:OO!0:LP"22S%=JUK"/'3GLAF,VTVA(P$I1C &!K:,.%3>H F8O$D?\
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M/XF\FX2ZM80[N"(ZG6+[2+W67;JTT^VM=/<L]H8;3W03>*LE%:RE#I2DHOU
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MG)I]33#?JC+=6>,2GOTMN/ D))4R9'I-T&6]4T6W>;4;2T9[TG[M<$)3;H*
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MFE*:4II2FE*:4II2FE*:4II2H''6V6U.O.(::0.I;CBTH;0/BI:B$I'S) T
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M,G 'E(YF:5K-\[E7\QFW*6BU*"O'GU-QYF54W65?M*9;*DOI0E/(]GC(4I6
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M\>*H.I?26>$BF%283-QUM2<XZ(=Q85S\12Z<@C[%@?,:RITF_4/[@IB/QO,
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M!V^;<,B\H50[SL>ZPT%K'?%Q)OC>MV;7?Z@XP;1H:;]W8'MOLMW7WM5PVF&
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M"\?=4RHQWK2]9:9?0%?RK4RXX&UD$(7M44J *3U]A<&UT47 3N[M:B4G$@W
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MF7+4B5&!07PT_P"5Q?:?[,.U'9BW<O7V6-0T]H;G;S3EN.IMT?X[EAQMI]I
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MQRM*T^:VD=20H>\,HZDYZACV!<-K)"3U$2!/.? \8."8\1D!Q( )_P ),"?
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M,* ^]!:?E_4I2U*4I14I1*E*425*43DJ43DDDG))Y)Y.OI4",# & !TK[S
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MF$_R^W4H29@GR.X*$^@K'%>>IW-*K,=MJ6\I0CNI>2E8*@H=;96D'^Z>E/4
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MA,2(EQSK?EOL18S<B6_'C/96$L+N+=NYNF;)AY]EER[N"0RPEUQ*"ZYM!.U
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M_P#D$:G_ .<N/_LW;UT[7_M.N^JO_?E-?7)KYWKF*^/OZ1#8O<?Z'WQNV?\
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ME)!2KK[).Y"NJ3!\OL_^A\_\EG>#W_W%3?\ \45>U\R_:-_[6_:3_P"B*_\
MU3=<IJO_ '0NO_.?_ IK1-])Y9VZWT9/THFW_P!*)MQ9LV[ME=S*A C[E08
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MOO-\Q]BNJ6^G]KG+:Y6EO^U=->LK=2B #=I>M[EILDX!=;8>0@3*W2VA,J4
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MVJ4N-.@;2HK0#O:<2GH],>:N]/0T2"4,_=WD3"@ DM@^BT $'QD<@UNIV_\
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M5CWCPQ'P %3AF&A& E.3\ ,Y_C^.<?'MA5:FC44\%?NIX.!W/V_#Y^NE*]H
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MZOVINK47Z*T%**BRRJ\:;=M:0R,X2DUE2DIP$K&!KTNW^V?MNPT&W+C3KI0
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MI5:\#NTZ/2,G\!\_4_NTI,#]I_3ZP*ESNTS?/^K??TC@?9U#^?Y:57=C_/\
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MU9V#H.YM-V]1=SE8WMK&[%,M:K7+4KU@.0+GN^UMM+@G?U4HU02W1Z- J"3
M5G[/Z7ICK5C<:OH_9:TL->U%]5F-3U37FM7>L5WGW<-Z6WI[C[;"+586Q;W%
M\RG[PXC^(XM'MU=;-,D-J>8LT-W+J]G>NW >+97LAD-E24A!E*%.)]HC*HS4
M^L?>?Q(^-S>O8"QZ-XBKZ\,EG7K]&;L-XQ;C@;+VOM=.JM1W5W1O>X[?K$%R
MO;G6/?L]BTJ;%@14T^CPE1%/AHKG/O.NE2,5UIFB=EM,U>Z=T:UUVYM>W&K]
MFV5ZF_?H;186%JPZVL,V-U:(-PXI:M[B]P3,(2 *HMEBT9?66$7"T:@]:)+R
MG  TVA*@=K:V_;,Y)F.E45MUXK_%;O\ 6_X+?#@-ZO\ 1MN)O)NUXWK#W9\1
MUI6)9:[RK=J>"^X95"B_U1M.X:36+!MF\=SV:C1)-=GLT*;$H::56ZE;],C-
M.-T]J3>]G] TA[M/K7]F??;+3=/[+7>GZ+<75T+5JX[3LI>5]YN&7&KQ^VL"
MAU+2.]0IWO&D/.$@K-[EM;,*NWRUWB&F[1;3"G%[ J[3)W*3"U):(.T;@52
MHU67B^W:W^\,-R^%+PLJ\2OB:O")O/4M][VO7?+;GP^63NUXF$61MC1;(-O[
M<VG:5@;65"UG?::[>#E0N2_WMMGZK2J' CL..CVA;KD;LYIVD:ZQK^O?V)H5
MLK3&])M;;2KW6+K3M#-W?.W7>WMQ<7FH(N!#5ML9LQ?!MQU:B.(%MJTS<IN;
MG[O;H[D,H0RX\MJWWN%>YQ:EN!7X4PE < *CQ5L+9\8?C1E;9T?9J;7MV+0N
M'<KQY[9>&':3Q7[Y^&YW:7<>?L?N)8%R[C3;L=VLO.T[=LVL[H6J]95;VYCU
MG^JK5LUB7/IU:?H?U@V79DZX[.=F4WSNI(:T^Y9LNR5[KNH]G])UL:C9(U6S
MO&+)-N+^VN7KEJP?%TU?*;^\%]I*%M!W80$WJM;0.%W:TI+=DY<.VS-QWK??
M(6&PD.(4I8;5N2Y&[< "F8XR+\*&VMX;5?2@^)VU[TWKW"WZJ2O![X>:G$O7
M<V!8L&Z(M-E[G;O-M6^X=O;3LNARX4&7&FS(DIZBBI8J+D61*?8BQ0WI^T%[
M;7_830G[;2[/24?Z2:PA5K8KNUL*6FQTXEX??+FZ=2M:2E*DAW9[ 4$@J5."
MY<0YIUNI#*&1]Z?!0V5E)(;:]K^(I:I((!$QCCFJH^DVVUVY4]X(*NJP+)55
M;C^DM\*$&X:FJU:$:A7H53K-T?64.LS3 ]IJD6H="/;H\YQ]F7T)]H0YTC&#
ML-?7L=J6_OEUW;'8CM ME'WAW8RI#=OL4TG?M;4B3L* "F3!%66#CG^MC>N!
M87$#<8$!,0)Q'2.*HGQO;.2:QXV/HSMO-F;XF^&B75FO&U.-Y;36?M^:S3D-
M;5[:NU=-,I-SVU6[4:G5RGPQ29%6ET&;-B15AZ&IN4Q&>:D]E]22WV8[;WFI
MVJ=<2V>RZ/NVH7-YW:YU"]#>]QA]JX*&EJ[P-I=2E2A"I25 WVCH%I?K=0+@
M#[J-CBUP?XCD24J2J 3,!0D\XFL=-SO&QXH_#[MMXA-AJMNU<VXNXVW?CI\/
M_A9M#Q%T[9^A7=NQ"VRW\V_H>Z#E9:VCL^A"V]P=U+4HXKEJ6Q'AVREBZZU4
M*$J517IR5^T[JQ[+Z#K%[H^K-Z>Q965YV4UC7[C1EZD[;:<J^TB\=L T=1N7
M>_L[!]WNKBX4M^;=I#NUT(_#G;M+9]QAX-);0Y9OW*F"Z4M%QEQ30'>J.YMM
M1 6J5>R 8,<5+MWXS_$UM'1O&G,?/B>WFVCVD\'EX>(7:3=7Q?>&&N[!7)1-
MW[,%1A5/:.LU&-MYMC0+_H%61)H=YTQ^)3(E?ATZ-<%'2^['@(F(P7G9G0]1
M=[,)3_8.FZCJ/:2VT?4=/[.:\UJ[#NFW/=J1J+:%7E^]9O-E+ULL*<4RI99<
M@*64T<M+=U5H/]7:==NDL.MVMP'DEI4$.@%;BD*'M((G;.TP.*O?=<K=_P /
MOAWMF]=[/'CXH[]W%\2+^U5GV30-H]DO#_5;X5NE<\9V\*A:FP]H?Z,E4:F)
MK= IU>@2)E^S:G2K?M^G/58U>G5=$>4O56XT[5]8>MM+[):#:6>BIO[FZ=U'
M5-81:_<&%"V1<:K<_?@XONGELJ";1"''GEAL-K;)2,"0T\^I#5G;(1;AU2RX
M\^$=VGV-SR^\DD**2-@!4HQM(Q6))\=GB]VDVK\?]BU>L[N,WGLE#\(4_9"\
MO%'M]LG WKM.G>*/=>%M%7'KRHNS%5JVU5[-6I(=?NNQ)\AF/)EO*<I=V4V3
M#8:BIZ'_ $4[.ZC?]D;MMK3C;:HKM&C5+70;S5%Z9<+T'3U:DT+5W4VT:A:F
MX2!;W:$E24 !=NM*B55)^YVSKEDL):VNFZ#R+=QTM*-LUWHV%T!Q&[\*@) Y
M2>M9@UU'BPV;\0$/PDTWQ:W[NTOQ.>%K?^[MK=Q=R+0VFCW[L=OGM.JSF:1<
M<:79=@VU;E9V[N!5[10_;%RVQ5G8,ZCI;@59+$J:R_SK7^C^I:.KM$YV>M-/
M_L+7M(MK^SLKC439ZKI6H?>2XPI-U>/O-7K(M50^S<-A2'96W(01%'W9U@W1
MMD-?=[AA+C;:G>[>9=WDI.]:E!P;#[25)P>)B)/X;?&INUXN-S? S85I7!)M
M&?;VR.X&]'CPI+%*HAF-W;956F; 4G:J49E.FKMMRN;ZT:_;H?A012ZN_:UF
M1U0Y*8$Q;IR:WV8T_L]8]JKNX9%PA[5+/3.R;BG'MIM[EM&KN:@G:M(?#6DN
MVEN%K+C8N+I6Y.],5<_:-6S=XM0W!3R&K(R8*%@/EP9&Z&%(3)W#<O.:W3:\
MRK4TTI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4
MTI32E-*4TI74MEM?)3@GU'!_EI2NA40'LK[E)!_/C]VE*ZE0B?\ </XC^&-*
M5U&"?^UI^XC^.E*ZS3\]VOS'\#I2NLTY![L'Y\9_@<Z4KK--;_[4H?\ U/'\
M-*5UFF,>J#^'^&E*ZC2XY[#\2=*I \!\*ZS2&3\!]@TJM=:J,QVP#]P_CG]V
ME4CU^)'Y5U*H3)S[B>?CTY_\]QI5:Z56^S_N(/P'2#^X ?NTI72JW&3_ -C2
M?3]@?O)TI4(MQG/^R'_@@_EG2E>A%OLCLA _[T#C[\_OTI7L11V4@< 8]..W
MW ?CC.E(^?OKVMTUD8Z6RK[!GGX@D'\?AI2*]J(&.S0 _P"41^[O^L:4KTIA
MXX)2!\AG]^-*5W"*V.Y4?O _AI2NP,M#^X#]O/[\Z4KL  [ #[!C2E<Z4II2
MFE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2FE*:
M4II2FE*:4II2FE*:4II2FE*:4II2FE*:4II2K,;I;";>;RW1LS=5_1:I59&Q
M&X7^E6PZ2W5'HMOIOV/0JI;]&N*MTIM/EUB9;46M5*5;OGK2BFU*09J4N.)2
M!L[#5KS36-3M[13;:=6L_N%VX6PI[[H7FWG&6G#EM+ZFD)>@2XV-A@$UE;><
M:2ZE! #R.[68!5LD**03QN@!4<C%-VMA-O=Z*SM!<=Y1:HBX-C-SZ5NUMU6Z
M%5'J/4Z5<]-IE4HDB')DQTJ5/MNOT:LU"E7);\@&#6(;C29"?,C1W6FGZM>:
M8UJ+-LI'<ZK8N:?>M.H#B'&%K;=2H).$OLNM(<8>'M-*!VX4H$V\MH.I01M>
M;+2P1(*20J1X*! *3R#6+T/Z,KPR0;V@W)&<W?19%+W,;WDI?A[.\U_'PVTW
M<]JX57>U=L+9SZV_JVRZS>"UW2S0@DVHS6EK?:H"&5&.=ZKMSKBK53!&G&Z<
ML3ICFL?V;:?VTNP+/W8VZM2+??D&V_U<N_\ &"U@NE7M5).H7!04GNMY;[HO
M]TC[P6]NS:78W91[)5^(IQNJ^.XOA&V+W4\0.ROB<O2U7:ENYL%#N&#M]645
M"0Q3VF;@B2XP-;I""8=;=H#E1JE0M=R6DJH55J<VHQ,27$+;U=GVBU6PT?4]
M"MGPC3M74PN\;V K)84E7\)S\30>"$(?"?[UM"4*]D$'"W=/-L/6Z%0T^4E8
MC/LD'V3R-T *CD "K2[Q_1U["[S7[?NX-0N'?3;ZH;OT^ETK>R@[.[X[@;8V
M=O33Z-146S"9W)MBVJM&IU9=%KMIMJ3-A(IE0FT/J@3);[:UE6PTWMEJVF6E
MI:(9TJ\1IRW'-+>U+2K.^N=,6XZ7U&QN'VU.-#OR7TH45H2[[:4@@5D:OGVD
M(0 RL-$EE3K*'%M$G<>[4H2/:]H R <Q5\++\,.SVW>Z%'W9LJW7K=N&W?#_
M &?X8[?IE/GOHMBB[/V'<52N:UK>IU$7UM,OTN?5)##=0+JY"Z>B/$65)9"C
MJ[G7=2O+!S3[IX/,O:Q<ZZ\XM []W4KME#%P\MT02'$-I)1$;R5#FL2KAU;1
M:6K<E3ZKA1(&XNK2$J45<Y XXG-67K/T=GANJ^W%#VY8B;@6TJS]VK_WOL'<
M*R]Q;EL_=;;S<?<ZMURNWI6;,OZWY4"L4J)6GKBJL&71'3+HLJF/,19D"28,
M%V/LF^V6M-WKMZ56;_WG3[/2[NSN;)BYT^\LK%IIFU;N;1Y*VG%-)9;4ET;7
M4K!4E:=Z@<HOK@.*<)0K>VAI:%MI4VXVV$A 6@C:8VC/(.01-<USZ/G9BYK%
MLBU+BO;Q"UR[MM+RKU_;?;\5/?K<*7X@[/N:Z*8Q0[A=H>Z;E4-7C46LT&,Q
M1*A:*F7;0DTYEEMR@EUAAYHUVPU-B[NKAFUT=JVOK9JTO-)1I-FG1[EAA9=9
M#MAW?=J=:>)=1<R+E*R2'8400O74K6I*&4I<2$+9#* PI*25)EN(D$DA7XI_
MFR:G\SP-;.7!LG5]C+^N+>G=*C5:^J?N<S?6Y.\]_71NY;FX=#11TVU=UD;D
M/U=BOV-4K570J>_;T:TG:/2*>\:B137$5JM(J&%/:G4F=4;U6T9TRP=;M5V)
MM++3+1C3G[-TN]_;W5D&RU=HN \M+RK@..K&S^("TT46_?'0\'D)9;(06]C;
M2$M%"IW(4W&U85N,[]Q.,X$5/X>_"/MAX<:Q?%VVW6MS]P=QMR&;?@WKNGO5
MN5<^ZFXE;HMI(J";7MPW!<LM\4VWJ":M5'8-)H\2GQ5/SGI$M,IY#"V<&L=H
MK[6F[6W?:L;.RLB\NUL-,LF+"S:=N2@OO=RPD;WG>[;"G'%+5" E)2)!M?N7
M'PA*@VA#>XH;:;2V@%4;E;4C*E0 223 %7"W?V-L'?%&V;=_1:E*3M)O!8N^
M5G?5M2>IICW]MU(FR;9E3BR#[?3679\@RZ:[AF6"D.$=(U$T[5;O2OOQM%(3
M_:.FW>E7.] 7-I>! ?2B?P+(0G:L93F*L:=6UWFR/XC2VE2)]A<!4>!Q@]*Y
MO'8^PKZW:V:WKK\6I.WUL.QN1'V^DQJD]&IT5K=6@TRW+N%3IR$EFIE^F4B&
MB"7BDP7DN/-94X1JEMJEW::?J6F,J0+35C9&\2I 4M1T]U;UOL6<MPXXHJC\
M8@'BB7EH;=:$;'N[WR,_PU%28/3),^-6<O7P*>'/<1G?]B\+8K55_P"$A>EA
M;C7[*:NFMTFJ4J_-L+?H5NV'=M@UFBRJ=6+(KUMQ;;I,N#4*'/8>,YEY;ZGH
MTR7%?V5KVKUJR.D&V?;;_L6VN[*T26&G$.6E\\Z_=VUVTZE;=TR^I]Q*T.H(
MV$ 0I*5#*B\?;+)0H#N$+;1[*2"AQ2E+2L*!"TJ*E2".#'A4OH_@9VXC;<[R
M;87CNCXDMX+>WRL.;MM>+V\F^UY[@3X%HU&#4Z?-@VBFJR!2K6F2F*M),RL4
MNE-U>H.-0E5&;+3"C);O<[57IO=-O[:QT73GM*NT7UL--TJULT*N$+;6E5QW
M:>\N$I+:=K;CA;0"K8E.Y4U-XYWC3B&V&E,K[Q'=,I0"J0051E0$8!,"3 S5
MQ]Z/"SM+OSMC:>U=]1+ECTK;ZL6M<^W5S6A=U?LO<#;Z\+*@OTRV;QLZ];<F
MT^M46Y*7 ES8B)S+RFY$:=-CRX[[$AQLPM,U[4-)OKB_M%,%R\;N&+QBYMF;
MJSO+:Z4%OVUS:OI6TZRM:4JVD2E2$J2H%(-8VKAUEQ3J"DE84EQ*DI6A:5F5
M)6A0*2DF#$8(!$$5@%XHOHTZ:[X0?$9MIL*O<K<G?'Q!7?X;ZA>^Y&[F\=9N
M;<^[*)M'OEMW=#<9[<6\JO'11H=CV33+JDVO3J4JEMQY2U-P&7JE)CA77:#V
MW6.T>C7VK"QLM+T>VUM%K9:=IK3%A;NZCI5ZP5"RMFSWJKNZ<MTW"W.\*DY6
M0A)B;;Z@1=,./;&V6$W 0VTTE+:%.LN)D-I&2M93N)F1S@5E9MOX/;#\-U1O
MO>ZRQO/XBM_$[:UFUK9KF^N^-P[@WO/M^#U7'3=IK4NO<"HN4"Q:)<]SP*<9
MU0]EBM.U%<>J7%/ELP^I&@O>T=WK2+32[G^S-&TG[ZU</M:5I3-G:H>5_ 7J
M%Q;V: ]=.L,+7M1N40B6V4)*HJ,Y=+?"&5]TPSW@4I++*4("C[)<4E E:DIF
M!)Q(3$U;GZ/OPL7%LS6/%)X@MS=N;;VJWB\8&]U3W/N3;RV[@AW:S8%HP$2(
M]IVK5+IIR?JFNW/,JM4N^^;LJ5!6:(]7;SD1H"0U!23-[7Z\QJ;>@Z18WC]_
MIW9S2T6#-X^RJW-Y<+VFXN&V%_Q&F$MMVUI;H=_BAFU25Y5%9+VY2Z+9AM:G
M&K5D-I<4DIWJ,;E!)RE( 2A(/M;4":V1:XJH%-*4TI32E-*4TI32E-*4TI32
ME-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4
MTI32E, ]QG2E0]*3W2D_<-*5QY;?^XC_ ,$?RTI7'DM'^XG]W[M*5QY#7^X/
MS_GI2N/9VO\ <_\ @E?STI7'L[7^Z?\ PC_/2E1>0U_N#\3_ #TI40;0GLA(
M^X:4J/2E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
M-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4T
MI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E-*4TI32E
#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g542432g15v79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g15v79.jpg
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M 0$! 0$!_\  $0@ 6P$; P$1  (1 0,1 ?_$ !X  0 !!0$! 0$
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MT\( [;I@$43,$:1^;F60D#0W1[@PO2%4WK!FE-L(3&[1XA%2R5>>G+<'M?\
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MW.@' .CCR0_^FJY_[W67_@VM^#EKZ_'VR5#@@< F>Z.ZDXTKK[&5)QGU*O\
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M?>4)Z'&Z[Z%U9J?HZ;$C6&YZNJ]9EWFGD2Y!<&F5 \V>%60C6]<O!9A7-KF
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MRN2G+R74<C0IJ0("TO43TB1D8S' VFT+N%&V Y]4YB>-LP,Z:07!3Q61CH.
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MW*"R+I2*H;F.$$0$@8=XM NG0SR^TC2$2HP\V<$Y(,+<A(9&NS2"IB$P<LO
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M R5(0I4YB4!72NC-1'=<,:C.T"OF]<PPDVMCJL9C.%(8@'.@21;@T)(GNR"
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M2F9T-^/,8;D,O1)T92H\R*ZVXE;$IA2F9#2D/-*RA:<\ ]O ' ' ' ' ' '
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MJ,,1*E#AR!!*&8@Q(<PI$!8+#!8T,')RJS&G-5PA/ C@XUBNRR J4_7E1&I
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G%BQVFV(\=E"&F66T-MI2A.,8 ]G ' ' ' ' ' ' ' ' ' ' /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g542432g17d33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g17d33.jpg
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M(CAW&2<Q,D%2DI.7MD91U</_Q  7 0$! 0$                  @$#_\0
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M/Y\5<N[%%"LA]F]$\*A_A4_GQ5R[L44*R(9;8ZEMN4#8M/!,F^F6"+V-?SM
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M6<Y[,8Q_PYRU-]3W?IZ^#KI2Z5LO7T\FY_9\#]R"/PV'_!Y-7+NRJ*%9#V?
M_<@C\-A_P>*N7=BBA60]GP/W((_#8?\ !XJY=V**%9')+^DYP(,&S]&^(4*)
M#PZ!WEES$6,S'PYE!#57=RO#*$=_N]Y7=[W;V=[/9V=N>7H=:U\?)M$NRH<L
M'.@' .C3R0G^&V\?YX63_P!"UKP<M??V^66J<$#@%Q?3T&#R=,4%^0*&OO."
M7\N//08KKJ\^LYV.U;BVE+5GLQC':K.<]F,8_P"'.6IOJ>[]/7P==*72MEZ^
MGDW-[/@?N01^&P_X/)JY=V510K(>SX'[D$?AL/\ @\5<N[%%"LB+X;H>Z>*[
MM:1ND *V>&OTNV&KK*>%]0W4)!JTDW9+B0V!8&7]>1MH-Z]=KIJYE2=B*4]=
M754IQ$A,=DA'$R7D+5^UE_/<TEOS . 0-*]+-F.S]L12L4"Y3+2QM8N*JR]M
M;;)BK??KQ<9-@JUF-"I#([.HXP $2LM2MHG69LE"OHVY$LS6![ ('!X^ ;UT
M)0]FZZ&VBN7RRBK*$9L9632)D9,51I\80/'BDDM97XE;KB%G#C,\80L&).;!
M.DW)=K-9L4@<9&"@X'M0*V7>OMURW?;;$QD;5'<)CQ:0K"4/.6-3<?&95-DJ
MRS%QC*&,J4J0I"L^DOR%]U::KLMEW<PO)--WN^RCSX,M]E#?O)NWP>OOH/F5
M4+G)M'+XP<UGZ2H&GC-$]-CDRTG[ EW;5G0ADNQ6FFHZL4Y2LNLY!UT*]EQ6
M/[F</NO-]W_=;2K^]R]'?LEMY\2Q[MV^$<?'.AHX!T5^2!5G'3UL#LSG'^N8
MQ_LSG'_PBA\'+7W]OEEK_?7_ ,RO^K/Y\$#OK_YE?]6?SX!;=T_UXM-T]1I3
M%ZM8QIX;*4B!!C4Q<2-C!4@G*&5DJ@0G*2K*<KSF1-?7WU*[%81W4)Y:G^I[
M+TF/N==*_2MWZQ/V-Q>RAOWDW;X/7WT'R:J%SDJCE\8'LH;]Y-V^#U]]!\54
M+G(HY?&![*&_>3=O@]??0?%5"YR*.7Q@Y/?TF<5-&'.C;$RQFK#YX5OGS>3#
M-?:S$\W,U#WL1_40()A6'^^GSOI6).<>:;\SEKM=\Y>CUVIVGS+9OO6WPD<L
M_.@' .BWR07^':^_YTF__1M?\'+7W]OEEK?! X!;CH&NE9FGJ+)8O-K%LNBY
M"D0($:EKB1L8)SDY0PHE4"$[*<YQE>?2)CZ^\I6,*PCNH3RU/]3V7I,?<ZZ5
M^E;OUB?L;A]E#?O)NWP>OOH/DU4+G)5'+XP/90W[R;M\'K[Z#XJH7.11R^,#
MV4-^\F[?!Z^^@^*J%SD4<OC!R:_I,HJ:,LW1YB98S5AR\"W?EM1AFOM9B>;(
M:L[V(_J($$PK#W?3EWTG$G./--^9RUC+F'+T>NU.T^9;-]ZV^$CEOYT X!T:
M>2$_PVWC_/"Q_P#H6M>#EK[^WRRU3@@< MRT%72LS3]%DL7JUBV713RD0($:
MEKB1L8)34]QA1*H$)V4YSC*\^D3'U]Y2L87A'=2GEJ?ZGLO28^YUTK]*W?K$
M_8W![*&_>3=O@]??0?)JH7.2J.7Q@>RAOWDW;X/7WT'Q50N<BCE\8,VYAHX
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MMR!Z_ ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' '
?' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' ' /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g542432g20j15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g20j15.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1O04&AO=&]S:&]P(#,N,  X0DE-! 0
M     !D< 5H  QLE1QP"   "   < E  !61E;'1A #A"24T$)0      $*G5
M7=->M'KZ3)V]^HUM;5\X0DE-!#H      /<    0     0      "W!R:6YT
M3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90
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M=6T     4&=0<P    !09U!#     $QE9G15;G1&(U)L=
M %1O<"!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9
M    $&-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO
M;F<         #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG
M:'1L;VYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0
M$ /      0 ! \     !  $X0DE-!"8       X             /X   #A"
M24T$#0      !    '@X0DE-!!D       0    >.$))30/S       )
M       ! #A"24TG$       "@ !          $X0DE- _0      !( -0
M  $ +0    8       $X0DE- _<      !P  /______________________
M______\#Z   .$))300(       0     0   D    )      #A"24T$'@
M    !      X0DE-!!H      S4    &              (U   ##
M   !                          $              PP   (U
M              $                         $     $       !N=6QL
M     @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L
M;VYG          !,969T;&]N9P          0G1O;6QO;F<   (U     %)G
M:'1L;VYG   ##     9S;&EC97-6;$QS     4]B:F,    !       %<VQI
M8V4    2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P
M   &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E
M9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S
M3V)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F
M=&QO;F<          $)T;VUL;VYG   "-0    !29VAT;&]N9P   PP    #
M=7)L5$585     $       !N=6QL5$585     $       !-<V=E5$585
M  $       9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O
M; $    (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /
M15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0
M  ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N
M=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L
M;VYG          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T
M;&]N9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P
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M7.Y?USQ\7)MQ;<+(;?0XM<UWI@$?F6-=ZKOT=K/?6[_OZZ)8OUEZ WJN.+J
M&Y] _1/.@>WEV-:?W'_X-_\ @;?^NUVI3CY'UUS;@6XM#,<'\]Y-CODV*V-_
M\$68_+OR;3;DV.NL(C<\SH?S6M^@QO\ )8LV7-):YI8]A+7L<(<UP.U['M_>
M8Y%98DIW>F]6MPP*7@WXG^B_/K\\=SOS?^ ?_P!;6V^O$SZ&Y%3P]IT9D,Y!
M'^#N8?W?]&_WKD*[%>PLJ_&<<JAXK:=+"X379'^#=7_AK/W?3_25_P#%I*=)
M]5M#MMWM;$^H-6D#]S^5_P &EBN:;_M%QVL=H&?2! ^A46C=O<K]?4NGYV$Y
MS_H..TU&"\/[ -_[\L7U75W/8P.K=K^B?J2R?:_3VV_UV?0_/24V.KYK"?3J
M!!( UY'Y5FX>%=FY+<:@:NU>[LUHY>4:O'ORKA52"^Q_)[#^4X_NKINE8N%@
M,]!CPZ]\>I8=-SOW6G^3^XDIN8N+5B8[,>D0Q@@>)\7._E.1DQ( DF D'-=]
M$@_!)2Z2222G_]+U2!X)@QH)<  3 ) U,<*222E))))*4DDDDIIYW4681;OK
M>\/T:6#=)U]OM^"K7=8=LAE987"6OYT/YVPM_P"B]:&3CLR:'TOD!PB1H0>S
MFD+%:QK7.HN(%C7!I$N^F?HQN'T+_P"M_.)*>,ZG9U+]IOLZH6O+P!]IKJ#&
MN:T?H[?38[<]^W]'9ZC_ %*_^M*F.I=+W;676WO'^#IJ!/\ G.N]O]I=CUGI
M6#U+!?AWL9SN:ZP2P.&OOW'Z'[ZY+[/]G>[&=5]G-1VNJ  @_+:S:YON8[\]
MB2DU&7N,58^W^5>[U#X?S58KH;_USUU>K]6T[K7ESHB3V'[K?S6-_D-5*MS*
M@)+*V^+W#^'_ ))7Z:LFP!S9:S_2%OI,^5EV]]G_ %BJQ)2>FAM;O4!=/?B#
M\=%:>\YN,:0UKW#6JXF-A'TK*GM]UC_ZO_7%5=]GJ'N_6'C]^=G^8X[[/[>Q
MG_ (K'5YA-V(XC)K$OH)]P _.I_X/_H)*7R<K-P\9M5=C*B\0\M$6OC_  AY
MVL_JK%&=EXMIMHM<U[M7R=P=_P :Q^[U%9R'N<YSG$EY/N+N9_E2J+PS9=8\
M2VMH:P>-MA].GCZ6W]+=_P!924[O3OKO6"*NH#TB--YEU7^?[K,?_KGJ5?RU
MUF!F8F3#J; 7.;(9(U'[S2/;:W^76O.<'ZL]2S[!O:['K/8B;2/Y-7^"_KW_
M /;:[/I'U3Q,&IK7#:UKM_IM<22[_266_O\ _%[&)*>@22224__3]522224I
M))))2DDDDE(,W).+C69 K=<*AN<QD;H'TG-W%OT&^]<]E]3Q\ZJS*JQK;@*W
M LI/N<WZ?M<YOI>W;ZC/_,UU"QNK]2ZCB93*<8,<RQF[Z#G/:9V^_P![6;'_
M )B2GB^I_6.KJ#*WX^,ZNYH ^TV6->7L/:REE;:W[_I[MZJMZA=8RMM[*[S4
M-M;WAS7!G/I$X]E'JUL_P7J?S2-UKICJ;AD8]+@S(>0^JMLAMI]_Z-E>_:RW
MW.V*M5@=0<0!BWZ\36YO_5AJ2FY1GOJ!>UE=1'+JF-:8_KQZO_@BE;U!QJ%^
M[>'.+'&22UT;FLLG_2,_25_O_I/]$EC],SR0#4&\?3>P<^6]SD?&^K537V&]
MY=5<-EF.PN(+9W@,]M6VRI[?5Q[/4_1)*<K(ZF "2X ?%5Z;.HY-K;.GU6OL
M899=6(#3_P <_;5_TEU^+]7>G8[IKQFO<W46/$R/WM=[_P#P5;%(-0!974P]
MB6EQ$#]Y[W)*<7&Z1U/JF.Q^?0W'S)BRR@AS'M'#G[V[&6?U/6V?]!;73?JU
MB8K=1+MVYSIEQ=&W^</T=ON_FO31WYUS-OJ6BL'02!KI.@]WT4.KJ0OTJR),
M$[8 (']5PW)*=6JFJENVIH:/)366W)O89]0GQ#M1!5VG,KM(:[V//#2>?ZKO
MSDE)TDDDE/\ _]3U5))))2DDDDE*22224I5.H89R:@ZN!=7)K)X/[U;_ /@[
M/SO^W/S%;224\^&UVMG5K@8VN'N:6GW5N_EL3#$JY($GN? ?FME:.;@V>M]H
MQH#GB+F'@P/T=@_X1OT/^*_XNM!&'F'\UH/<R2DIS\G MLCTK-H'+. 3^]-?
M];8BX>-;2'&VT6$Q#1K']5[O<KPP,L\N:/ Q^65(=.O[V"/ -"2D+".#$2=I
M,<IS TX1_P!FN(AUKC\('Y I'I[ 1O<X]MT]_P"4DII6TUVM(L;NY#=8(W#W
M;8_DH=6)C4.W5LAW[SCN,'L-5IMP*"-02),3^53&%CC\V4E.>7#F?AQ.JB7-
M&DS',1^1:HQ:!PP*0JK'#0DISZ,VRLAI#K&>$$G_ #O_ "2T6.W-#H(D3!Y'
MQ2V-\ I)*?_5]522224I))))2DDDDE*22224I5>I9CL+$=D-:'$.8TEQAC0]
M[:G76N_-JIW^K;_(5I!RB15 >&%SF@2[9ND_S;7_ )KGI*<QOUB9N%1H-EQ9
M4YOI.!8\W.IKK=6ZWTG_ &=[LEOIY#Z]EGI9-?\ .4J#/K30XLW8]D6EYJ:P
MM?86-QV=0;8ZD?1=8Q_H^G_I?3_TBO3EQN]>MK"):2001[6SNV_1]W_;O_!_
MHE%HZC(W7U@2=YD&#H UGZ,?G-V^Y)36/7W.Q\FVJJN**J+:WFYAK>+RYI<V
MQOZ/TZ_3=LL]3T;O]+3[WL@WZSTNJ>?LUKRRMCW1#0XNK=D.V>L:W^GZ;'^E
M;L_3;/T:OU?;&->;+6.:02RPD1O)VL;H&^QL?N_]N)IS /Z0P@ DNTD CVNC
M9_F?^C$E-4?63&%@J]"P$7G'TVGZ.S:YNUQ:][VV>KZ#?T_V>N^VS^9V(W3.
MMU]0N-/HOHL%-=X:\M=[; 'C^9=8UNW>SZ3O^+_1_I$1OVTN<6WUNX$2" 1N
M'[F[W?UO_4CNOLKQKG/OK+I(H?N:/S=S6ND;-Z2FZDJ-C\QK21:PG726CL-O
MTF_2_/W?^!_X.N=/VLVGU+JW,!( ;S,?1=_:24VTE3#.I:38T::\'4 _R&_G
M_P#@7_"?I'P]'JNPL]5OT8:\$;]T1O<?2V?2_P"#24__UO54E\JI)*?JI)?*
MJ22GZJ27RJDDI^JDE\JI)*?JI!RO0]$^O_-R)B?'^2OEM))3],_Y+]5FZ?5V
MF-TS]-WTOY?J^LFK_96YNS=&[3Z6W=/M_D_O[?\ KB^9TDE/TY7^SOL->W^C
M2=DSS[O_ #)#/[*]4SNW0(^E'#XV_P!GU5\SI)*?ID_LR!MGD?1W?]*/S?WE
M(?LW9[?H[F_1GGW[?_1FY?,B22GZ6_R1^FB9C])&Z8]F[CW?N*>)]C]:KT]V
M[;9LW>$CG^SN]#_K_P">OF9))3]5)+Y5224__]D .$))300A      !5
M 0$    / $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P    $P!! &0
M;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <  @ $, 4P V     0 X0DE-!"(
M     4)-30 J    "  ( 1(  P    $  0   1H !0    $   !N 1L !0
M  $   !V 2@  P    $  @   3$  @   !X   !^ 3(  @   !0   "< 3L
M @    8   "PAVD !     $   "X    Y  AAM   "<0 "&&T   )Q!!9&]B
M92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$X.C S.C$P(#$R.C$R.C0Q
M &1E;'1A      .@ 0 #     ?__  "@ @ $     0   PR@ P $     0
M C4         !@$#  ,    !  8   $:  4    !   !,@$;  4    !   !
M.@$H  ,    !  (   (!  0    !   !0@("  0    !              !(
M     0   $@    !.$))30/]       (          #_X0%$34T *@    @
M" $2  ,    !      $:  4    !    ;@$;  4    !    =@$H  ,    !
M  (   $Q  (    >    ?@$R  (    4    G $[  (    &    L(=I  0
M   !    N    .0   /      0   \     !061O8F4@4&AO=&]S:&]P($-3
M-B H5VEN9&]W<RD ,C Q.#HP,SHQ," Q,CHQ,CHT,0!D96QT80     #H $
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M%2)!40D6(S)A<22!D1>AL? E)C-"4E3!T>$8-O$9-'*2PO_$ !4! 0$
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MMOK*HP*5!R[)).Y<^R@4E;MG"J*J44G[^6%U:5M6/'9I(<R+)G ?8I"C^0[
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M$9W,%+&C)<57J2*<#T1Z![M;*=0,'=_&J*7E%6;;K.)T-TC]V[F5#\EB$;U
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M:,C0G5R*UHW(U7:"Y11RRBL!%$XYW\*U@^/M^/O<[EK1,3\D>YC4X1>].$5
MN#':TM55QXAGM>1%(1Z,_D&XI'$40_M;]@U<K47A.?E&M3A$#.:!H&@:!H&@
M:!H&@:!H&@:!H&@:!H&@T<ZK,3S\4*VR7!9K)5S8TH8-!$MFCDUL"_KU+(#
MCCE+Z. 7)HOGB1+.0P\2OM6-/81I<8K8KP\\<!ONIFT=475Q*M[;&3M=]:P[
M+<%C8O=GA26>"PKQ3HF+XZ@+:()Y7Q'*.5$), %J$( BD<%D7M'95+E) >DJ
M%+C-DUQICG=A*Q7D<HWL8YJ@F0RO+&FQO*+O1"H]KRB$Y K"T-DHE]3%LH<-
M&/Y>X;?)Z?MX\DE6,>][V*USGN:I%$C5>56N>)C=!XS]6?0ND[)).XFWMNZJ
MQ?(EE.R"@=%N*BMQ[+I!B^EKH$R#4R1>GRLSTCTXO51XL:[<.I9Z1+&KC*'F
M[2[WY/TUTMM H]SF[?5,B>V39Q)TZD?)D6;!-C<K]=#,EK(\;&C4 7(B*USE
M:J+RT('_ /JC;\LG/B8MU!;UVLDSW!AUV!WUCC\!>5540TJI=6%E/7V3FOC2
MHK6_8PBO7[@Q-KGW5/OPQ?W^R'-9E9*>[_[ZRR]NY;&O:SDGCR*9,F(5SQHY
M"1:B,5O=RUZ.[#Z"=8C@$2M,8UO/E34A# !DJ&B/;(DD3L?6QCF=(E'D#(O#
M6A&SYX5S55$T&T&W^&RQ0!.LXT=))"D>-K!JIAQGOY"*0A'F&Z0QO_:>+^&G
MLQ%5S%<X-F*&J8$8VHSLXX3V_E^/T1$3X]D_3CV_307%21F,:Q$]U:J?C\?'
MM_3Y5/TYY_306A5#1B,7GGGV7V1/?GCWX5>>.?A?;]-!*1N&QBO>YK&HG+G.
M5&M:G'RKEX1/\U3X]U_.@CLK.L=9*%719)+JQE$9&C5M'&-;RY4A[D&.*-L)
MA@I(*3A@A/,CWDX8UJO5$T%@4U1(6S!2[DVD;%"6'\6#B9K5EE;0 M$'T\++
M5A>6OQZ;.5ZK%JWSW3HOA>*U'#*L1D@+Y_<"M+">&MKXT89&J,""<Q_C$I$8
M^.H0I_!5CGJB*HG'4K2O<QCG/>\*-W3O]L\#IK;&;&JA9ADDJ.:,E4U[PCI)
M(U.L:PL[4+G&BR >=Q(];!<EDK6_X@\(!@D*'G'?D7A5<GNJ+SRJ+[_GW3G]
M?PO">W'"+H*3R4J<\<?I^>?GWY_'ROM^>?SQH*5OB(JD:O'LCE7W3V3E%3G]
M/?\ 7]/;050:ZML?L8]M164VIM()V'AV%;*+$EQ) E1PRAD@<PHR,<U%;VN1
M47\\)QH-^]COVH6X.%$AT6\U<NX./!_@?O)"0<7,X8V.?VO.USV5]_\ :YK5
M:=L"87L:\M@Y4T'O;TS_ +12CMZL-CM[EM9N+C+/ ^XQFU*6!D]"UHFL9'=Z
MIJ6]:\7:H@))C3J@W8K8*O&]LA ]?=H^HG;/>(+ 8W<-AW[0J:3BMPHX5[':
MB<O<('>\%D ?*=\JK/+"/E$.H7KV:"]45%]T7G0?N@:!H&@:!H&@:!H&@:!H
M&@:!H&@:#'VE;$MX,BOG 9)BR1J,H2(BHYJ_"IS_ "O:[M>PB<.&YJ/8K7(B
MH'CWO7L^7;+=]]VTK*W#\_G"'?6;R6;8]9ER17)4VTF-#24(4'*8D)*Y\AL-
M4#DD?TDHCG745P@R>(4U?4S)6%2LJI3PK9[+'&(Z!R!A*Z_E$:X\>/)F4 *L
M=9>L5CI(4L6*VY1I8\8TNW/P'Q+V^,(\IA+8<",A_&RO> SRC5.5.!A!UTQO
MB(]7N CI4=XFN6.S@81E:EAC)6UN.SZ^?66;BS*JRB+7V<4E4.5728I?9[9+
MUR"/(1S55'QRQZYTB.\82!>T[&E<'\PW[0C]G;M%$WM@9WD6'9"8MQ%D1W7$
M>]/$QK+O22".B2+B-75U3,#F,&$:)'M)0)HXMW'8"X<-YI<@80H'']M<)P.$
MV/CF/4F/Q6<,_P #"  KU547L(9B>JDD>Y.[@A2O([Y155-!(6PSS")$CQG*
MKW\>F9RV65'*G*2C=W96QG(GW*]RR7LY08VKH++QO#QQB@D2FC-(&WL @V>.
M/#&J>X88N>4:Y%7O,3_$F=RA>&<,T%QQ)=+4^+ZA8UT!%7[/6RX\9RL1$7X,
M]BN7Y]VIQQ_7CD)1 W PL?V@MEL7-<U.RHKK.X)W<\=K6UD*4O*K[)^%7CX_
MFT$YKLRN9[O'C.!9%-Y5$9.O_38I6<N5.7.^H/-=N8U%1RM!1$>ONUJ*[A-!
M)DGYA]B7N68_BK'.]JO%JQ]_=N1SE1@F6-XWTZJ]R>Y7XLP:>Z(]J(K]!<-=
ML]<3H$6ZS:6?!L;.(<D-WN+(DW68W045'*[%-O@*..YQN%?'F&@5%"KE#_TY
M&5R)H-B-OZ/;N1CEG7[5RIM!?D Z):9?:/!*W!,URN9VE.Q%BXW2S0*UOTW&
M? Y6J4$R\M>'L:&N>8X9?8;/]-=QE>,[G.C68D>2'/3V[GL._A4,J\J8+U0K
M'>[N45%T'*S=_/:C'28S6WCP0R#4+9R"&MM%B]G#HD.Q5//'&]OV(1G^($)5
M#'.$+G#<&N-R17N(YSE<5SB*Y7O>]SG/<J]SG.57.<O+E5555T%27YE^Y.>>
M>?;CV1?M14_I\+_P_304EDA%[W<\*C>45$YYX3]..5Y1R<?"^_XXT&'W,P .
M);=;:9;.LC+D&Y@LINQ4#HS1BKL.J;(%+173Y"D\A39#:Q<B: +6*(<2K$="
M/\_&@U+N2)VN7E.5>J\<>W'#N5_I^/S_ *\Z#&XI@N8[E7P,;P?'K/)KF6]R
MBA5D8AG,&UR->>25$\42,->/))DO" :>Y"MY1=![ =,70',VYN*/.MQ+JPGY
MR P#4V)X786 HD&6O:X8+*RKW195W*\C?":N@**O*X7:LBTBE>QH>ZNS/2!G
M67VL"]OB3<:APCH84>OF/@VXR1D1PUE6X1O93.1W#6 @-L+EB_P9<&L$=TH(
M>SE!7RJJIKZ^9-+8GA1!1GS3.,XLCQHC6O*^1(E22$[41KC29,B094\L@Y3D
M*]P9G0- T#0- T#0- T#0- T#0- T#0- T%3[O;=5&X>)V-390 3FFBE"4!!
M,*LF,[M*\3&D81GF"00Y<-SF.1DL D5JL>]%#S-AVT*+?Y7MYD&VX0V>&1PO
MHYRW8I4+)J(C&GKK6.8N#PU@FDHQX9$ "6(H%E$F0VRI:1GG>%@8_EXMP:VT
M]54"@9%CCVLNZLDGZBVSH2&<VNN %)%C/D$48VQ[%5C"<&:)"*U@),1Y A%I
MDTBGEN:*CKHR\JK#AM;@ CA5$['(%]NR.U5551S"#<UCPD$Y45%<@4CN[089
MNIB-MB^Z9\?A4EK$1@[IL2@@SJ.V%VEK+D%LV''*X\(CW=K32A^:/(EQSN<%
M\D$@/YW-Z]F\QV3W"LL(SH)V2 -2;26ZGCQ8N34$M4=!N*F2=S%CPY3'>,L>
M&!YHL@9HIY3W@<JA#ZHWB_APY./P$Y5W#IC9KN>?N>5C6Q$>3E/N52N5WRK^
M55=!,88(9G+]7S-BM<J?X2!.@4\7AR>S54!G6*M3X5GK.'(G\R?&@FE9*VUH
M&,D%/1#=V_?+-Q/.]6N5R]TLJ2CD5O'/N57)Q[>WR%L81D%CGDQU3M'M_G>Z
M-J->2Q\+QFQ-!KAN54&>VMC!CUM1#541%G32LC#3W<1J(N@V)QS9K.YS&S-U
M-PL8VUKNU7$Q#;<D7<C.B=H5,L2=>Q9U?A=.]Z?P#/9D19T,ZJPE:=PR@0+@
MJ++ MMHS&;=8E"J+8+7>3,\BDAS'.#F7SL4\6VGPXM70F<I4(.1C6/U%N!6#
M$Z[E(Q2$"H\NSD]A*E39\Z3-F2".-*F3I1I4V25R^Y329#R',5[OYR$>KWJO
M+G.7G04O_M'ML7M@WN/V1:ZSBN5PC ?]KVK_ -H&2%6O$>,9B=IP&&\1&K]P
MWKH-X]H.HC;[?>$7!<MCUU?EI1O0V/RR(L:[2,-2NG8W)(YI?5B8-\HL-C_J
ME:UCS")(BB=->%;;N;26N"+(N*U36V)O?RR:@^950A'=@P7#1IV('N[!CLFM
M9'>1[!F;'*0+"!JE:&555WRGS[?"I]R(OXX]D5?=$]OG05)?/<KG+W)\K[>W
MY5R_'^[]=!655C5IG>94&&4@O4W.57U;153/N[%E6LT<43G]OP(2E\QW>Z#$
MQY%Y:Q50.+J'G'W/WHGXOMI66&1T6+#KML=N:RFA&L)DK&<(B,QV!.CQ8:RC
M$2X?"DWTJ1R[N+9FDG5B.<J!<VT/[-7*LG6)>;V7#L/IWN&46(4KHT_*9@W=
MKO%83N#UE"JJ[A6B9>2W)W!?&A%5I=![B=/O0^"CKH^/;?X3!V\Q][1$ERO0
M./D5DQWWBE61)1F6$ISVD<HSY!91Q"$BM@,(HDB*'JGM3TO81M\P$TT,-A;=
MO$B695/*+RO+F%G.&(C JG#7PZX%9!D#5PI\>=PA7!LX"-'BC&&,$8 B:C!B
M"U!B&U/AK!LX8U$_"(B<<KQ\KH.?0- T#0- T#0- T#0- T#0- T#0- T#0?
MB\*B\IRG]=!YA]6VSDUUC$S/%X\/]\L;+*N\5DGB0Y1LDQTTR//S+;<QY@W*
M,TTH66F/J(\:0.8.'$%*C0C7#R!JA<S,LQ;-,.W'VOKH%@"4"%*LL1JJD<:3
M;TUG'%Z^M.%[TM1B.%%&\$D17UTL8),N&LB#P@61O]M%>[KX&T^'-R_';*3$
M6_QX(F6E18P+,D5WFQG)X<8C7>$S^^*YSW%C1I303XY21O*I@\!MR=W8.WEU
M:8)NQ7Y/69UB;00WXX?$/0V37SQALD/>SK!M<>6XT&2"172T/)0L60)X9"A<
MWO"?X-U.[';]X4'8O?63<84M2R<7:/=VY "?^Y$P@6L#C]Y)KW'L'8K-<G'C
M4*Q8H6()3A6/6RJH*<!M!25[@GR;J*Z9<;CR&^<;Z[(<MW.G/ JNX(L#;S#K
MKTY'-1KAQ+&1"-]S1D01$5J!*J#&NF]TT5=:;V;GYI(.1R-B;>[<TFV=/+4?
MNL<&69C:Y'?QR&1'MCE3$$([[6(%A7(S07721^G[&3 EXILCBTFR"1Z,R#=*
MWN-W;M_"*@I"P,A-7X(PBHJJ<1,$D,[E18I8[FM*H6!:;UWMK7LJ)=T;Z''5
M%B8Y":"HQ>%V<M:M=BU2.%CU>O")SZ"MC\K]SD>Y5>X('.W$<J?]LG">[>7-
MX;[]WM[IQ[HB^W_>]_GC00"VW"[N[_$<+^JD15_U[D7WY5?GW]_GWT%37^X0
M&M(BF[WJOX>B^W*IQQ]W"_G\^R?'ZA25]G:E5ZM-V(K53A'M^?RO\S?=/[)^
MF@I:RSF5#EBGP9\B'/@R!RX4V(<D>7$EQGH>/)C20$:8!P&8A!%$\9&%:U['
M(YO.@]1NE']I!190>'M9U V5=76\A&U='N#9)'C45^AD\+:S+D>-L*JLBM<T
M K=S655HB.9.;!F=I)@;#[X]/1H8I66;:QGS:Y['R[+$XSO/)ALY>0DO'41S
MEEQNSESZ5O=,!V-94^J&8=?&#0.+C^29G9NJ,/QVXR>R5_B+%J(I9'I'KWMY
MLY:*R#4"1S5:Z5;3(,5'-5JF1R=J!O7TL=%.5X]D$_<K<*PCQ)]91VU5CN*X
MQQ;Y!"R+*($FFA6#[9XBUT:THX\J9/C"JHMTH)8HDME@@A.0H>C6Q/1+"Q>*
ME;@V%5V&1"L8*QGABMLLHGH%[55+BXFF>=I6J5Q&P\@MQ%#R](E;V <) ]'=
MNNF3$,1\,R8%)=DUJ.60KW'E*_A$5RV+F")%5R*OV4\>J<WE4(>4WC0;+0:V
M#6QV18,0$4#.5:( F#;WN<KWD5&HG)"/57D>O+GO7N<JN]]!W= T#0- T#0-
M T#0- T#0- T#0- T#0- T'$9%<SA.>55/A.53CWY3V7]/\ GXT'A/U"]8?5
M)L7O!<[6[B;@X5A\52/L\&LXF)\MS_$IAWLKK:J2/59-8QY,!1OJLA@G9%?
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M3'LJJXDT\0%Y33(Y"/\ 3S6"9)]%-;'LX0SA9/B1R/8C@J]?PO'*I[I[)_\
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M@K[REAQOWZPQTB?BTPZ>.-9@+X#V6'7A$Y0V/Y"Z'%>1AV$9 MX-3<"8KH)
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M_,"L]UZW)+K!+2IQ21/KK2S&-K2O>*$.<&&8"S832O$4<%LP4F3$DF9/6.\
MGGG2Q\3WD#13<O%<JQROPS"G8]?L^A52V=P>/36DF')R+('LG6363AQCU\YE
M;71ZZL]9',9HUBF\97(UZJ$+H=N<\O',2JQFZD>%1#]9(B2JR%#>XK&A,2SG
M)$A@<Y',>B>53%:558CG-1-!Z<XC0WM7C>.X]E4XEQ;UM.&'9J(UH8TH37*,
MJ^J1!%.'L04-I2"4<UOHY"^1HFO6;^=;TK:@G<D"7 H(V%+)6 Z-+)($%TT
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M1R/Y(62LEY/32@-66C7,>DI!@$-I@QG%";X5NQ/QDX@UM[]5J2$<YT(C9EI
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M.A.R*4 O85Q8PGR/ H_ITBO='"9KY!XT=;*!&!)CIXV.?Y(X7%*8?@FQF/\
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M!H&@:!H&@:!H&@:!H&@:!H&@:#7'=63!F[E8'BN8WLN@V^N,7SB;(=&R>QQ
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MUNH,K*I9OW)M\57(DKK -+=RTF65-5BN;3'KB1'I,@ T\F=1V4@<"Q;'D/\
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M;"CS"/1]58Q)-%62HTQ@I8WB;+BEB*L@<@ =*KV6+)@;ABW RR3F]EN5B$/
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H,J\(PMLNL5\ P,3P^NIJIJ0C2(;)0I;H\B4TBRBAL!H&@:!H&@__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g542432g27n66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g27n66.jpg
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M)KUBG4,@/A6.J;/^J7SDYU*L]<:TBK4RYQ/6$U=-KMF079U>J\NG4SI7;)B
M5"SYX\DW L:U*40K(6&B1S$?;("4"J3O;!$O MI>_.[Z?-3>R-.-M T&:K:)
M)6RGF@?49F(D]:LC87_GKC8J8(B+F$L$W4/FINR^/22%Q( QM4L8UM0@V((<
M@=>U^L$*\E?#Q*:H^M3Z*'&L>F^VT SY9J([!')Q"? "P&B8BAGZDB0 2+P
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M*RSIUOBKFIMTHU2/%FKBUYH3%<[HBK4A^DILD<D$ZT5G//!#I\\4\VNF)O\
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M.(!IO*W7&SQSJ)LZE#C12:!%2:8C/@(ASM'G4,J9J=#WW.>)F*=$G*E;KU+
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M8JFM\,_5HC3W.2Y3WOEW>-3]P.F?GQ:?W*YG_M7Q.'AS9)1<62$9L$,X[YW
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MA>R$&+AQ-%+%F2'7XD>^GSZY.I\GT+#3%"G4XEU-"W_XZGRMG]>'K']SH_\
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M18A^$4WYK]A_>T'_ $'Q-W8+0;/FBQ*>[719*Q5UQ^UVOEDQ,^&$^HVEX,S
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MVL,-&M>L:L)RF8QQ$#ZF+F$&A L^1C(1S!M]HM]?BC%CCEC28W@)@AGCWCU
MSW@!X > '@!X > '@!X!@W]E158+[0?LH%HF<'9CWEQ)))/E:H9/SHQAX(Y2
M"IADR=HRDA'BEF^J $RZZ9Q%MX!AD'1J-:\5.2KV=78Q+W4<WVF-$4VS9)9Z
M;C"?;[R)'H&DZ=@JVTL"*30D<[?7>)RKET^E&<-O( 3]'H8MY7\S)MB."_-E
M1[M75)CHHW#!:KP+NRG#&WSCZS(#"<(64)%ML9""1$?O!@+;X_@%>D>SWK^*
M.C+GZQ3]!;*<0M0$?:&=X6QHIXRN6(*32+;2;'VB6.'#-C/P"2)<1CR2YQM]
M$"Z5K)>X7AM51@[!<>/&4$:+)K,.2/+KC:.6*33.<;:[8S__ 'KGY]=L8VQG
M& .=X > '@!X > '@!X > '@!X > '@!X > '@!X > '@!X > 1VRU5+;@@5
M[V(Z<1<^KUF%C!<N4NWVQ5G(5@1S$3)&"Z<T41NO",E5FR$*C\CZ0L0BQ_I0
M[ 47'ZA< A.LYX]2?"[78+I"RY@B=,ZF*EMROK-EM=RO"JS(![K&C>*C;7?+
MU84JQDO) IS>Z6TVFCH)[&XV,%F^F7]>N\XY'IUZ_EZ8P56+203C9W/AI-UG
MKLKS[0?M^7V$MUA]O>MG.K\*P\8YE8:\_P!3L.*H_J@CJLFJ&9;,HT)OOUU8
MR2X"!6 &M&D,E'!&A$AD8L6#<^2*"/6/3<QJV*-9L2=M=<9F,8%DED2?2E(G
MEDVVWR(<SP \ / #P \ / #P \ I+JE'LMFL%,;U_ 9D:Q)T^N&+V9>0UH)5
MRI^T"6V2R:1%$;$+&*?2KYP"$6;$JN[@J./: <F.4!?TOJ'9ZB4YUYYTD>@5
M:R4PK&>>BBW VN<^ZI8;;0[-T&T<X<TR\<HN*FJ="VJ1);^F@OD*R.XGL;B+
M#K][+DC<"SQ]*N4B9!\G[4'=J,P:$\JO-?YS2K*HKS2PM.F:6":UV9*= T>D
M++"9T$G79A/HHJ^C!K?+,T3TXFVY&R=/8LJQ!.^^["6<RX650J/0^=[NOC4V
MG7:V7,>O;'-7$*M9-<'5JY?S-(R;;889I/*]FJ@>OYFR+L-!0ZJJ6*U=:QE$
M +/OKC[EA<BJK2GTO*USC$;%I<NFW68/$L<^5$?1^EV[H(J"2>'>0:>:O"6>
M!'/,))(%+,ODD"DW$VAVR(6;X > '@!X > '@!X > '@!X > '@!X > '@!X
M > '@!X > '@!X > '@!X > '@!X!4/3.KZ<Y+5"[(MF_P!ICDD8WU98!^#]
M7DCC^A]'()GQ/I_$^?Z7TM/H_-\WS9^?Y\:4+BJW&8HMF5$YW_@B_L-U]YRC
M@;[K=:7K"6RN*D$CKG ;-N#F&SVRM(C(]Q$Q:QD9.,$[GE$T$FTDF+AAU^!+
MKMF#;+HH-0TRO4\I]LJ[F/N,ELM$I3VS5FT-+';YNJ,8%O+Z1:;;.%0Z#UUU
MS)#<[350HV=JH3*RC#H6%BYR[A.N/,K(;9*7<81V-'LI08LJ9<N_SZG'.^4!
MX*J7XLC/[V04(>G"WIYTE>'6[12JRA8Y[%$LW=&TZTV)GL2:?PCHZ:2%0H;:
M*'RP%)894[1L +,$NLI;YT:DK:>Y/,DES@Y^TK_0!+7%; J;8ENZA#)I3V[!
MWZ[)1<O38;/("6)MGVJX@RVEJY-CEC6VHO.\&#ZW9 %02?OUT9E*![<<KZ?8
MEM7I(ET?M22-('\:RLR-->>X)(= +MNFZ*BSR:"0<YK=@0S)K(.#8:\Y3G!V
M]/7?H:;R!)RGV^0E/RO7RK(?R4?+^2=),X83W33J=]:T?1.-T>+F^R/997IG
MV6>Q\M&O.&.LV(?JOU/ 8.8\[?&^L[_-\+(U!!MS2<I##<?]RC^Y_)V*O>6N
MT8.F,[/ZZVON"?GSIU-;0%)R*N/70B%D\!!J9#<66=/I"08* FFVBGVS%%%O
MIC.1&I1;-\I^LC]\@]S1K96S&%NKC9FW)ZK9.>U)7SBF6@RSO%5-J%,>7.SO
M^9GRGW"CCU.Q61J@P&VE+87"M 5/IE4!*K?2*V-J)+OOO ^I_OGS#Z@PS!7N
MAI"-ZFYLJ9NZK-?9J9!Q>=]NZ(I-E6J;]"S+@9K/7CK< R_:=.1(?4OJ+,U!
M!8ZPT:!*5>ZM;^Z;R?P^X/(,V<:ES',8;'+T)'RV4<[5"AU@N-B^/A"&? ]L
M@923[TX'V+HP+?09OT1;+"TYT!;U>=SM1"$!>^''!>;I[\XGL[-;-7TTC%TF
MI_V<&7<3?7)3[4DU0) 99FC56XWX@QVO\(I3!FA%%@(K&+FTM8V%Q0LG/NV6
MZ\:3FW0E'3ZMFU)@6RL>&S7RG'K'L0$+1;8N;7JR<YMB\G"MBV638"M%4<##
MEKV9P)PT4)@I,L$^FW@C4N[2>> '@!X > '@!X > '@!X > '@!X > '@!X
M> '@!X > '@!X > '@!X!A&U:KS[>&1VD5-I!]=](-V((QFT.F^<;;ZQ;3Q[
MYTUVVUQG;&N<8SG&,Y_[/$VJG(C2=9P[/2JA=:Y/3[?64=FJA7V?]9KCQ8(R
M2S_9)@K!7\9:7%*+)]GG@AFA?2BS]6*$&(A^A+#'MJ+5500Z7@_%)W>]DEY/
MSS=_*=:&<S?-11X/(87?15I<RRB<!8D*GMF42.>Q[D9DRZ,2ISF/U@Q8#/
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M+$"XIN\L!(2D.  6=Y9W!MALCB6 ?2./=D^?LF+MP;MKDADV8&L3))C"IYI
3,YX > '@!X > '@!X > '@'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g542432g30p52.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g30p52.jpg
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MM;C7&5F8V"0E,3,XQ$%1=__$ !@! 0$! 0$                ! @0#_\0
M-1$  @$!! @#!P4! 0$       $1(0(Q05%A<8&1H;'1\ ,2P1,R,U*RX?$B
M8G*2XJ)"@O_:  P# 0 "$0,1 #\ ^_C@#@#@#@#@#@#@#@#@#@#@#@#@#@#@
M#@#@#@#@#@#@#@&ICNSWG:T!W$ZH=:K N ?U8IR^H';<G?\ 88J/B6?>]D0P
MC#Q4-IX/*;)!2:LH/H0:R K))*=E<>)JOO81>.AG8%X9V>.1I66[+:4M-463
MFO#*/22K?#]Q(12UA6RCVK!I;5;UK*R%FUCE20 L+L*P8&.LJ5$I\96,"=E0
MS"< LU^Q4C$;>;"0ZX<PN*<[:D-'"@DK+GH^\<3 ?#GFO;?LGUSZ==K;%["B
MS RUH.G.K:JI"J(3'Q#IJ?ATI9BV42D0IBI(6&X:9J1@ONF[>YR^&LG[=9]C
M&?)OQ;4)VE%S:5^#BM<N)'9_O];L2\5ZH>ODE0CC3IO?0*ZJ,JB1(#=/>IGM
M51P>"3R:$2<H4]?* 9),U)*9"1I/RN'T[CAY3.7B[5OJD+Y5Y&YJHE:'3\WY
M4.7[&=D;ZBOB@41U)C=UL:WIFY^LELW&:+/897Y,S#I96CK46PT$G)**4:;1
M4GCV9,Z..HOR?F</L#)")8KM6HX1).S:>*:2T^:>44.0Z0]VNP-Y^'W=O8RT
MPD+;S^K9)V,C%;V'&Z\LLG6-Z1BI?.MH#=P*M84M,K'+P^8OFZK=^%KUS("9
MS8*67ANN//#V#8+22:2K*3P34X,SWK-V:O>^ZX[$NY<&>PHW%%#SR-V!#Q<+
M4A-<R@''1C.2T Z$S0RM:YJQZQF@<\K.2=H495K,H,D;%&*-WHI$)*2P.%&.
M:_%*X0W=4JCU9[2=[;K\*F!^(8$L: S&X%:RLVU9/14KK02-K";BZRE\Y'D(
M;#CT0= 9S!I0?C40]0#)#9N=A6DH<H[$XRX$*J)-A;22M.S6$XF]_>,E$FU/
MJGV=B/;GJW4?:6NQ!1".6W7K2:CXP[4;K&11/&CEH<B+AQI[)FZ) Y&/*1U1
MXC[-F\<L<ND?4;JZ>@9M+RMK)P:[?#0[QFN\%;0V^7?9^(IS0 ^LEYVPZ@YC
ML.$.:+$M,R]A&0@D7O&D;K'D(H3'Q3!"63&2FXY.D%)4Y&-@KO1A'AHMJSY7
MHP>>E:[]&;O+,51XI_2FW*A;7D)M)W&ZY(V>XJ4.<F<,FD?3-2MQ8DLK>(HB
M_;@5-'6L^+0]\^C#753WHDQ>#VLB'@CBC@.V!V6G$5A.%7">$U+(!NU/7@\;
MOB.L;:B2)7K @,=]@DC#IQ'FE2,S TV:&O9F4/MA@L6Q=!8Z8-:O-GN[5,,U
M3*JJICWC%PY$APG%'=I@UBQ?OOE_XJ%R0YU<DY_HD5MX;S#L,=B4QJ,_!6,
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MK9OEQ[ \1%)%,@<%&;I[HG[-+S>S;"6^N[]HS<*>7V(-T?+*;8UWQG7&^N.
M87,9Q(A[>)N:XB0NSD2=DQV'315M.P,;1@L6(.UF<EF6RS])ZG(7\55PS3S"
M&.6QPRN\U;-%D54ML; 9_J5%[DE VI)AL72:ZOE16KQODDFRW4]EH\48X4RZ
MT:[J_F]7&R6$ME/ZF-\[?DX!_=2@S9[H-U(L=B.Z3A?1AJ[;Y>[H-%4T'2VC
M7"GM]DFRZJ2+A3">=$55$TU,Z[[ZXR!',[M0;"YE4]?IL=S$LMZ0R,0!').M
M6J8T3$(8;F,DEIA7"#M=&/C,C0T;4<-VCG?XDF458;Z)ID-W"(9Z/P55H+O
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M% RZBST4[4R,DN\ < < < < < < < < < < < < < < < < < < < < < <
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M>$G$D9;X_J+IL9<9)5F^5].%4S=9EF*FOJ,D=]Q7<MNRO;I3;)=3@@X X X
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M?!$V>FSM@AJYT0U=-LJM5D5=QAIV7#HT3_P0< < < < < < < < < < < <
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M0^7]C=WC(DV<2289&0UBQ&2^Q2IN2!?"[GTP7.A:OKC:M=3V+K1.";2]%>N
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MKVN-6"B.AC:#62=<?$H?6+EQP/'+TP+H<$' ' ' ' ' ' ' ' ' ' ' ' '
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M6 &H[+#'G$<EL-BDY>V5%1Y1$2%-+- TY?0V!['G(+)SX3EV6D?P,$3Z.RT
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MX./Q?B6MGTHWJ\'F. . . . :3?'9\2"\O#&ZM5A=M!QBJY7*YI?P*JRK"W
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MX7V2V,!,/DM7*(PSJAZS= RT0432+-&ZKINR(ZN6B#U\BAH\7$(]OC^SK?\
M;BI?M9A'*K]CY,CNVKFB8N0HX X!TD$C_2$[^N2G^.7Y%<M2Y'>KEJ7(X;E*
M. . =I'\FQ^9OZK?K?L!_J-M?@X_%^):V?2C>KP>8X X X X!\IGRO'YOB@?
MWR8A]B5[<'MX'OO^+YHZ[K@ZAP!P"^WA7_.8>'_^^1UP^UN*<&/$]RUJ.X"X
M.(< < < < < ZISY07\\-W4_:FLOL*J[@[/"^'9V_4S35P>@X X!]T_R./\
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MA_\ 4X-^'[]G6=2%P=HX X X!W/'4W_XL=:/W?Z:^SJ.<' [WK?,L!P0< <
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M < < < ^4SY7C\WQ0/[Y,0^Q*]N#V\#WW_%\T==UP=0X X!?;PK_ )S#P_\
M]\CKA]K<4X,>)[EK4=P%P<0X X X X X!U3GR@OYX;NI^U-9?855W!V>%\.S
MM^IFFK@]!P!P#[I_D<?Z#]^OVKZZ?Y1<O!S>/?9U/F?:CP> X X X X!K$\:
M'YJKO;^[Y,/_ *G!OP_?LZSJ0N#M' ' ' .YXZF__%CK1^[_ $U]G4<X.!WO
M6^98#@@X X X X X X!JG[!=;K2F;_NQ6X, 0)BNY1SKF3C4[;N&&@:!C8V&
M@]:VJB=57>I/1CN"QFO=;%CJ.K7;67%9<W"1U1P59G/=HTG=HG;LX/0BP]XT
M&PE$E?OZ_K"..)0:&2Z=RZ1'%7;6.2F1-(L!BP""O6N'7D6[ZVL1N)1*T)6P
M%.";^D8:<KXZ[U9RL%L@).FGYY7WWF6=8"_84N,ERE[,73=NEM7WP>Z.C(X$
ME3DBXK**.;49OQ,3S@.E'P=HJR8-%GV^N7Q)LS?.$'IZ-8C4G. XP[J23:5?
MRRP6J H5.VD5":N8^1<LMX@B>=."L;D;*2L'6C]4X-]@WV=C!Z*[/#93UT4E
MO0OKLO\ FJFEA.V+Z&6F\8V3=4\/PG<_TPQ_ZJ6_WSXID]ZZ"N:W/J/A.Y_I
MAC_U4M_OGQ3)[UT%<UN?4?"=S_3#'_JI;_?/BF3WKH*YK<^I\V;SY)7T@>NW
M3U:Z+T]L[<+NE?46CVNGM7"NRJGJZY:YSKKZ^^?5QZ<^C'HQZ<\LV?E_Z9Z^
MU\3.S_7_ $>O^*1=&_IHO;^/'OY3B;/R\6/;>)G9_K_H?BD71OZ:+V_CQ[^4
MXFS\O%CVWB9V?Z_Z'XI%T;^FB]OX\>_E.)L_+Q8]MXF=G^O^C=OTZZ/$.C?7
MF#]9:2N-?:M:^<2MR VF4"8'Y%E28R\[-C'GBK>1BD7.N#4B(8:8T8H^P9^P
M0VRKLGE7>39R:V]4>=IVK3;;4O1HC,L[\)W/],,?^JEO]\^*9/>NA*YK<^H^
M$[G^F&/_ %4M_OGQ3)[UT%<UN?4?"=S_ $PQ_P"JEO\ ?/BF3WKH*YK<^H^$
M[G^F&/\ U4M_OGQ3)[UT%<UN?4?"=S_3#'_JI;_?/BF3WKH*YK<^I1COWX9
M;Q(ZGBM,]C+D-:0Z'6&/LX1F 0T;&"WQ*-C<HBK;#M\[-FDUQWNN7%LJ-=6R
M>^SG#5;"^NJ.R:EFSE.WHD:LVK=ERFKH]W5IT&I+\4BZ-_31>W\>/?RG$V?E
MXLW[;Q,[/]?]#\4BZ-_31>W\>/?RG$V?EXL>V\3.S_7_ $/Q2+HW]-%[?QX]
M_*<39^7BQ[;Q,[/]?]$I4?\ )@>I/7VYJJO6 W/<.9Q3EAP^S8A@XB!(A<R6
M$'F,C"8*CTM&:CT=[Q'-_.-4W;;==O[1+5=+.V-\)L_+Q9'XOB---V8?[?\
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MUACUD^:Z(,'*&SMJNWV=XPLDF*E,Z%)C])=U*>M."!)),))$*:EI.QK+J-6
M3N?Q5H0?6!4]VF.O4E:P<@\=B?CZ.EK1$I!(7(! Y!21['8ZR4$BY"2R ;A#
MX)[&O-RJ2J!O.!9@0&<3R?TW%&,A6D_NTF)MT#(X039QPL4:JN04W),HDU-J
M-A;%)[(D6XQ/2.D<D1*R[Q,;[S=":C*75N50RF0JN7MG5ZTL([EK@'!'4TC;
M>9&<OA!N0,L"HNJ2T-D<O ,:D9MKAHQ6\P( &R27KLQ3Y9 (QP)"X X X!1J
M9=EKWAU]5)1+BAZP<$+MSV#)P@\X[ R5DBWBM(/X^H/)R@:SZ^&O=9::1R6
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M!<([;),/,2A\38 G?JBBYW$A*];LCNT57VU&(G5PRL*UZZ32E0\6;(9#$0)
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MQ(P=##Q X_#X0HM(I/''SYN>!LQ<@3)#F[R,2-L*$CN\QJ2=Z*!C8!^?W7M
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M)C?AY]I++TC L9#'>@LU6>LKBL"F\.3G&[R6,#S#+XIL,=::,&8)4M:+*?\
MU97J28EXAE8*0X'-?P;6_H+D75;L/VU&(;,JY\ZK"^LDH@,4LJ&;IZV3LBC8
M7G;)C#P$V57UAQ,>LZVS,V[QHJSP(E.*O2QQFMUU->@]AYWN&#4A39_UX[$[
MRLE$5+-W@,8B .RIBUJ9S(6D=C$[W'55)9RVQM-U%2Q&+Q5T]9RA5C$I6W+#
M1!MH'#G0C2N6O=C^2^7!!P!P!P!P"&^Q)0R"H&[3\<,D([(8_4]A2 "=%;-L
M$!!H%%"I840:X>MGC)11J^9H*^Q>-'31?779%RW60443V%5ZUHIIU9O";O:.
MK6VYLU[$RXV<Z[42>D(V6"J_8P^5S.?Q9S(BTYCTA36#!X>)';!"Z\J?R60
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MM+%S)2#ZQA%O)8XQB\2((A @KE/"Y/!X3CCGI,$LJT9-U9(D:2=Q:T[-Z_\
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M_8N*19/@@X X X X X X X X X X X!%UUQ,3-JJG $SA?5#W*H<8/&:B:1
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,WT1T DW@#@#@'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g542432g30q00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g30q00.jpg
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M 0             " 0,$!08'" G_Q !D$0 ! @4" P4%!@,$! L# !L! A$
M P0A,1)!!5%A!A,B<8$RD:&Q\ <40L'1X2-2\14S8G(D0X*R%C0U-E-S='62
ML[1CHK4(%R5$5)/"TF1V@Y25T]0F-U56A):CQ$5EXL/_V@ , P$  A$#$0 _
M /?QI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0A
MI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0C$WJQXL[1Z5]0Z79,FFR*Y':9WWA4
M*:^V9%NNR@RY3V&(JP&ZC)1'*I51BE^*IF/(B>2Z[(\V,-I2\+FU-.J=J$LD
M_P )*@6F >T2<I239)93D%P 08\N[4_:EPGLQQZFX--IYE:A*-7%9],M.OAZ
MIN@TZ$2E,FHF!#S:B7WDHHEKE:%+F:I8R0M6[;;O>BQ+BM2L0JY1YJ<LS(3F
M]*5@)*X\AI00_$EL[@'X<IIF4PH[7FD*XUKYLJ9(69<U!0L9!W&Q!P4G90)!
MV,>@\,XIP_C-'*XAPNKDUM).'@G25. 0 52YB2RY4U#@+E3$HF()9:08D6K<
M;"&D(U>^.CXNGA!\!C[UJ]0;FJ-_]8/E6Y+/1SIFU!K=V0426DNPY%WSI<V#
M0+*B2$.1Y"&JY4FZ_*I[Z*C2+?JT;U'N^RGV=]H^UH$^CD(I.&ZBD\2KBJ53
MJ*2RDTZ4I5.JE"X)E(,E*TE$R=+5:-C1\,JJWQ2TA$K_ *68X26SI#%2VZ!G
M!!(,: [T_E375N5575=._";TYH=#2ZI+#5Z=0KFNJJO,)5A+CK]#H]FPXSKJ
M %*91&E(84KRQ(DA/F+]=IOL$X>F6/OG:&LFS6\1IJ*1(E@\@)LVI40.9*7R
MR<1NT=G)0'\2IF$_X$)2!_XBLF_EY1?SH%_*B[#K-8@T;Q*^&RMV/3)#K;,B
M^>DUUMWI&AETA'S$VQ[BIUNU%F!&)\V4_3KIK=0+&\1*1*?;0R_J>+_8/5RI
M:YO!.-RJM:02*7B%.:52VOI1525SD%:L)"Y$I#^U,2"2+$_L[, )IZA*SLB8
MG03Y+25!^3I YD9CTP]"_$!T:\3'3RD]5NA/4.W>I-AUG*(];M^4I:H<Q"&W
M)%)K=+E-QJO;M=AH>:,ZA5Z!3JO"#K1E0F@ZV5>'\5X/Q/@=9,X?Q:CG4-7*
MN94Y/M))($R5,252YTI3'3-E+7+4QTJ+&.?G2)M/,,N=+5+6-E#(YI.%).RD
MD@[&+PZUL6H:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:
M0AI"&D(:0AI"-?/CJ^)GX6_A^4. [UGN6H5>_K@@N3[2Z16-&B5KJ!7X27'8
MZ:L]#E3:?3+<MTRV78XKMQU*F19;L:='HR*O/A2(*.P[*=AN/=L)JQPR0B72
M25!%1Q&K4J51R5,%=V%I0M<Z=I(5W4E"U)"DJF]VA25'.H^'U-<3W*0$)+*F
MK.E"3R< E2FV2"19V!>/.O?G\J<ZC2:G(3TQ\)%DT>C(=4B*[?G4FNW)4Y+*
M20A^0Q;]O6I%@NNIPI41N144,$EL39('F'V6D^P2C$M/W[M%4S)I#J%)0RI,
MM):X2J=.GJ6 ?Q%*''X$NPWJ.SDMOXE4LG?1+"0#_M*43[AZ8BN=-_Y4[<3=
M0CL=7O")19E*=<2F55.F_4^=3:A":SZW8] N>UZK&JCF,A,=RY*0DDY,H8P;
M5;]@DDH)X=VCF)F#V9=;0)6A1Y&=(J$*E^8D3/\ +$9G9Q+'NJHOL)DL$'S4
ME0;STGRCT">!WXH/A-^( FITKH?<]?@]0K?H)N:YNEE]V^]0+TH=!1.I]+=K
M!7$?JUKUFEM5.J4^"]+MZY*M\H_-AHJ#4-4R,ESR'M3V$[0]D.[F<5D254<Z
M:)$BOI)PG4LV<4+F"5XA+GRYA1+6L)G2)>H)44%6E3:2LX=4T3&<E)0I6E,Q
M"M2%%B6NR@6!+*2,6>,Z+UNRD6#9MVWU7S(30;+MFO796U0V/F9::1;E*E5B
MI&+&W(^8D"'#>+#&]'FN[6]R=V1RE-3S*NIIZ63I[VIGRJ>5J.E/>3IB9:-2
MKLG4H.6+"\8:$E:DH3[2U!(?FH@#XF-.737X_OP^NJ_4:P.EMIU/K NZNI-Z
MVK8-LHJ'31R% 7<%XUV!;M&3.F&MN")#54:C&$F26W PR5N[%[-I](KOLB[8
M</HJROJ)7#A3T-+45D\HKDJ6)--*7.FE*>[&I6A"M*7#E@\;29P6NE2US%IE
MZ9:%+4TP$Z4 J+!KV&(W9Z\PC4PTA#2$-(0TA#2$-(0TA%O>J-]JZ<V;+N.-
M1G+BJ[]6MBUK9MY$U%,36[MO>YJ19MJ4V75%QYHI%*?N"NTXURM)@5%5$HB*
MC6!3:A\C\F]F4-)]\J4R3,$F6)<^?/G%.ONJ>ED3*FH6F6Z>\F"3*7W4K6@3
M9I1*UHUZA.6CO%:7TAE*4K+)0DK40+.=*3I#C4I@X=XP1Z">.2Y.H]YURD7)
M1:)+MNAW9:-GW)4:)1H- F654^H?4*]^D]A3 *9U:ZN"[Z#7^I=BU*SY1N*%
MT9Z@45%1MJ[I?3%RU*Y*GT+J^+=EI%%32IDB;,3.FT]34R$39BYJ:I%'1TO$
M*M![SAW#ONTZ50U<NI3W"^)T<THGTR:X5$I*)V9.I$H0"E1"BE2D@DD+$M")
MDS,N5I4F6L*&GO4%E)$S4D!6S#7$1@0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$
M-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0T
MA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA%BO
M$'UE@]&;$DU=*F7[GJWG4VTZ:[A0D5(M@N3Y#6=RJ?2&UIE2^R77#%@EQIR:
MVL9M!2&KG!-Q*0RIJALE[)'^)9L.0=3'21'$]O.UTCLAP295@H7Q*JUT_"Z=
M5^\J"GQ3UIR:>E21-FX"E&5)U)5.21HQJ-1G5>H3JK4Y3TZI5*7(G3YLE9<D
M2YDMU;\F0\X>5NO/+6XM1[J4==DE(2 E( 2D!*0,  , .@%H^*ZBHG5<^=55
M,U<ZHJ)JYT^=,453)LV:HKF3%J-RI2B23S,3SIGU9O?I+6TUJSZJN,'%-BI4
MF3OD4:L,MDX8J4#>A#N$J6EJ2TIF=%WK,24PI:B;%132:I&B:E_Y5"RT'FE6
MW47!:X,;SLYVIXSV6K!6<)JC+"BG[Q2S'F4=6A/X*B1J 4P)")J"B=*U*[J:
MAR^W?HCXE[(ZQL,T[>BV[U0UNE6Q/D(/S90G<[(H,Q0:15(X 4M; 0U4(R$N
M*?BF.A,IWEZSATZD)5_>27M,2/9Y"8/PGD;I.Q=TCZM[&_:+P;M<A%.%#A_&
M EYO#9ZP3-*0ZIE#.(2*F6 "HH9,^6 HKE: )BM='QI/B9M> KH9'M#II5(2
MO$UUFA3H'3QA28\URP+8;*HE=ZIU*GO)=94J X54FS(M0;,2J7.MR8J-5*9;
M->@+[[[,NPY[6\5-37(5_8?#%(76GQ)%9//BE4"%ACXQ_$J5(.J7( 2%2YD^
M4L>K\)X?]]G:I@/W>409F1K5M+!ZY41A-K%0,?SS*]7JY=-;J]RW-6*I<-Q5
M^I3:S7:]6Y\JJ5BLU:I2')=0J=4J4UU^9/J$Z4Z[)ES)3SLB0^XMUUQ:U*4?
ML:3)E4\J7(D2Y<F3)0F5*DRD)ERY4M"0E$N6A("4(0D!*4I     :.Y2E*4A
M*0$I2 $I 8 "P  L !@12=7(K#2$>J[^31^%?KA4>H][^*]=Y7E8G0.BPZA8
MK-JT^?(AT'KI>KD1;;B*S2GDN0JK;?39B<N>FJAAN6W=LVGP*14O+@77!/@'
MVW\?X4BCI.SXIJ6KXO,4FJ54+0%3N%4NH$=W,#*ESJXITF624_=T*7,0ZZ=<
M<WV@J9(0BFT(7.)"RHAU24?X3D*F<L:021=)CVA:^9HY.,%/B>+6W\/#QH+;
M4I"T>''JFI"T**5)4+6GD*2I)!20>0001KK.PH![9=F00X/&J!P;C^_1&9P_
M_CU)_P!HE?[XCQ$_!W^(_<'@+\0,(=0*C6)7AGZT5"':75-A_P"=F0K;J<)3
M":3U)HJ,.;JG99J['\Z(4$.R:C9]5E-JA2ZHQ;:H_P!1?:1V*D=K>$+^YHEI
MXYPQ"JB@*="53Y:]7>44W'\.J[M7<+4P14RTD*3+,\*Z_BE FMD'0 *B4"J6
MS J!S+5T6WA)PH6+%3_T5:=4:?6*? J])G0ZI2JI#BU&F5*GR69D"HT^<PB3
M"G09D=;D>7#EQG6Y$:2PXXR^RXAUI:D*2H_&:T+EK5+F)4B8A2D+0M)2M"TD
MI4E25 *2I*@0I) ((((>.%(()!!!!8@V((R"-B([FHQ2//M_*5'WH_P\: MA
MYUA?_L2/39.]EQ;:MIM+J42G<@I."0"1G!P/IKV#[$4A7;*<% $?V)6EB ?_
M )XH><;O@'_'C_U$S_>1&<OP@'''?AH^#YQU:W'%=*VRI;BBM:C_ #BKW*E*
M)43^9.N3^T4 =M^T@ 8#B*F L/[J7&)Q7_E"J_ZS_P"I3&R37%QKX:0AI"&D
M(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(BM]WA2.GED7E?\ <"UMT&Q[5N&\
M*VXT 7$4BV:1,K526V%%*2M,.$\4!1 *@,D#G6124TRLJJ:DDL9M542::4#@
MS)\Q,I#]-2A$D(*UH0G*U)0/-1 'Q,?RQ>L_5CJ]XV/$M<O4>Y?G[MZK==.H
M4:+1J''>7)*)MQ52/1;,L6WDR%H#-+HT9ZDVO;T12FT,PHL1#BM_F.*^]N&<
M/X=V7X'(HI.BGX?PJC4J;-4 ETR99FU-7.TB\R81,GSE7)4I3;"/1Y,J524Z
M9:63*DH<JQ9(=:U=274H\R8]370/^2Z]/C9])G^)OQ$WV]?$^%'E5>VNBM/M
MJC4"W)KK25/4EBZ+RHUURKG^562A553;MN-/*W):@%M"9#W@G%_MXK/O,Q'
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MLH6XXM*$J4/MOM0A4SLSVB0A*EK7P+BZ$(0"I2U*X?4!*4I )4I1(  !))
M>._K 3250 <FGG@ 7))E*8 1_3V_]B"Z"?\ S;^D/_QRK,_^K6OA7^Q^+?\
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ME/[#X?\ VA62VXIQ&6E2DJ'BI*4LN73WNF8OPS:@6901+(>42K[O^Q/[.?\
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M1*G"Q4.[G:4IG) U?$:)5#4&7<RENJ2L[H_E)_F1A7HI@%",%_Y2U_R=]O\
M_G)=-?\ T2ZEZZO[$/\ GE._[DKO_44,9G /^/G_ *B9\T1G/\'S_DSO![_Y
M*F__ $BKVN3^T;_GOVD_[Q7_ .5+C$XK_P H57_6?_4IC0%\<BNW%XP?B?>$
MCP TBL2X%HTF1T[H];$5?-.NSK;<D9VZ;E>CX4S)5;G3.%;D^G?,-/.1?,K*
M6$A%1>0]Z]]E<J3V;["]HNU\R6E53,363)6H>W3\+D$4\A*LI[^N7.0MB II
M6JZ 1NN#A-+PZJKB 5'64XNF4GPI?(U3"0>;)Y1Z[^G'3NR^D=A6CTQZ<V]3
M[4L6Q*!3;9M:WJ4R&(5+H]*CHC16&P,K==4E!>ERWU.2YTMQ^;,>?E/O/+^=
MJVLJN(U=175LY=15U<Y<^HG3"ZYDR8=2E'D-DI#)2D!*0$@ <Q,6N:M4R8HJ
M6M14I1R2;D_6,1*YL*%4X4NG5&)%J%/J$61"GP)L=J5"FPI32V)427%?0XQ)
MBR6'%LR([R%M/-+6VXA2%$''2I2%)6A2D+0H*0M)*5)4DNE25!BE22 00000
MXO$ 2"""Q%P18@C!!CQ4=&+98^&3_*#FNC=AJ<HW1CK;<<>RZ70&G%HAFQNO
ME"B5VSK<80M1_HEC]6/L:C4MQ\OR7*=;00IXNS7G-?3O$YZNW/V/'B56!-XG
MPN2JIF3B 5?>N$3E2JF>3_-5</[R;,TLD+G&S) CKIJO[1X(9J[SI*2LJ_QR
M20I5OYY3DX#JY"-X'\H$_P"2TZ\?^_+T7_\ 7#96O+?L@_Y^\)_ZCB?_ ,-J
MHT_!/^49/^6;_P"4N.[\ 7_DK?#K_ICK9_Z\NHNH?:[_ ,_^-?\ 5\+_ /A-
M%%.-?\I5'E)_\F7&Y37FL:J//9_*7O\ D\K9_P#.7Z;?^A?5'7L7V'_\\I__
M ''6_P#JJ"-WP#_CY_ZB9\T1GE\(/_DT?!W_ .22'_\ GNLZY+[1O^>_:3_O
M%?\ Y4N,/BG_ "A5?]:?D(\YOQC:2KQ2_&Q\+GAANB7)_F"VWX>NFE0I[,AU
ME+5(ZB7S*N2^JC$+:DJ9JU0H%;9@_,-J;6L4BEH*D^0E8]G^S:9_8/V7\>X[
M3I3]\)XQ6H60"\VCI4R*1"LO+1.E%>DNW>3"S*C>\*/W;A%34)'C_CK!ZH0$
MH!Z!0);J><>SZA4.C6Q1*1;=N4JGT*W[?I<"B4*B4F(Q I='H]+BM0:;3*;!
MC(;C0X$"&PS%B18[;;,>.TVTTA*$) ^9YLV;/FS)\Z8N;.G3%S9LV8HKF3)D
MQ14N8M:B5*6M1*E*)))))+QRA)42I1)4HDDDN227))W)-R8JNK<4CQE_%X-2
M\<7QF_#/X&)=3FL]/;&<Z:6E7Z=#D+0Y#7U'1"ZH=5;AA8.&:O)Z7_S;AQE$
M (708;A4E+CBM?2WV=:.ROV9\=[5)EI-95??:B2M0'B%%JH*"2OG+37F>I72
M:H-81U?"VH^%5%8 .\7WBDD[]V\N4D]!,U$^9CV*6G:=M6):]O659E#IELVE
M:=&IUO6U;M&B-0:31*)2(C4&F4RG0V4I:CQ(41AIAAI PE"!G)R3\WU%1/JY
M\ZJJ9LR?45$Q<Z?.FJ*YDV;,45+6M1N5*4223N8Y92E+4I:R5*42I2C<E1+D
MD\R8D&K,1CQM_P H=Z1?^PO>*CPK^/?HK'8M.^[FKSKET3:8U\HQ*ZE]'I]L
MW!9]T5!MCR_FJA<5!GNT.M94EN=3;2BHDMNN2I;K_P!*?8WQ'^WN <?[(\4)
MJ*21)'<)6=2DT/$D3Y-3(02^E$F:@395G1,J%%) 2D#JN!S?O--4T4[Q(2GP
M@W:7-"DK2.B5#4GD5&^(]>G3V\Z;U&L&Q^H5&2I-(ORS[9O.E)4H+4FFW118
M5;@I4M("5J$6<T"H !1Y  .OG.LIET5754<W^\I*B?33&L-<B:J4MO\ :08Y
M=:#+6M!RA2D'S22#\1&G+XD?P/\ H+X[:[4>KMGU]WH5XA9L=I%6O&E4=JLV
M=U 7#80Q#7?UJ(DTUY=90PRS :NZAU&%4T1-OVS!N9,.G1HOI78G[4N+=DY2
M.'5,D<5X,E1**:9,,NIHPHNK[G4$+ EN2LT\U"I94_=KD:EJ5M:#B\^C E*'
M?2!A!+*1_D5=AOI((Y:;QY6O$%\!_P"(]T&<GS(/2"+UQM>$75(N3H76FKS?
MD-(RIOR['F,T3J0[(6T-RVX=GS&4. LHE.DMJ<]\X/\ :SV*XL$)7Q%7"IZF
M>3Q64:9(.[U2#-H@E\%52@D7*1=NDD<9H)S S3)4?PSDZ?\ WQJEMYJ'E&O[
MIAUN\4?@SZB2Y?32^NJ_0#J%19K2*[0V'ZU:LIR1'VK13KRLJKLMTZM1D^E3
ME'NJB3X3@V^;#6 G785_"N ]IJ-*:ZDX?Q>CF))DS2)50 %6*Z6JEDKE*Y3*
M>:A7)49LR335:!WB)4]!'A5X56.Z%BX\TD'K'M@^#C\9A/CI>?Z ]>X-$MCQ
M+4"AR*S1:Q0V?LVV>L5OTEM)J\ZG4I;BT4*]J-'(J-=M^$ZY3:E3A-K] CTZ
M! J5)I'R_P#:3]FG_!0#B_"5S9_ YTT2IDN<=<_ATZ8?X:%S !WM+,5X)4U0
M"T+TRIJEK6B9,Y+BO"ON?\:22JG46(5=4I1P"?Q(.$J-P;%RQ.XWQ2?][+XB
M_P#R$]7?_5_<.O-N!?\ +?!O^]>'_P#JY,:JG_XQ(_ZZ5_OIC^97X&?^_9\'
MG_G3>'W_ -;5HZ^Y.U?_ #6[2?\ <'&/_AU3'H-9_P 3J_\ LT__ ,I4?U2M
M? T><0TA&D#KYTD^"5X&+YO3J]XE[4Z'IZL]6+ONSJE6(O5&#5NN=_5^O7G<
M52N&I5:WNE<YF]5T.D+K,^4Q3JA2+1H]%A*0A#]22\R[('J7".(?:AVJI:7A
MW ZCBIX?P^FIZ"4J@7+X5229--)1)ERYU>@THFS!*0%+1-J)DU5V000F-O)F
M\7K$(E4ZIW=RD)E#NB)*$A*0D!4P: 2P#@J)/)K1A)?7QHO@B5.GR[-J7A#K
M5_6N\TY#6W"\+'0X4-QA22V%Q8MRWA;]0BE*<+8=13XLJ.H(<:\IU"2GJ*3[
M,OM1EK352^T4JDJ 0H%7'N*=Z^?$J133D*=O$"M258+AXS$<)XN#K%2$*ZU,
M[5[TI4/.\>3_ ,7E1\,M;Z_WW7_"!3+WM_H'<$F%6K/M/J%!8A7'9STZ"PY7
M;8*H]?N43*/3*W\]_-Z4]6)DP4-Z!$GR)4V(_,D_079Q''97"*23VC72SN+R
M4JE5%11K*Y-2E"B)4^\J1IFKEZ>^2):4]Z%J0$I4$IZ6E%0F0A-44*G)LI2"
MZ5@85A/B(;58!W(L8_HO?"RZI5KK-\//PE7]<<MZH5V7TBHUN5:HR5J=E5*=
M8$N?T_?J<QY9*WIM17:YFS'U$J>E/NNJY6=?&/;V@E\,[8]H:.2D(E)XC-GR
MT)#)0BL2BL2A(V2@3]*1LD ;1PG$98E5U4A( 2)JB , +9;#RU-'\^GQRWM<
M_B/^('XCZ_*E*F5F^O$=>%HVZ9CJU)C46F7>]8=ATMQTA:A'I%M4NA4M*DIP
MEF("AM(P@?8'96ED<$['\%DA.F72<%IZF<$CVIJZ85=6L#^:9/F35^:LQV]&
MA-/0R$C"*=*U-NHI[Q9]5%1]8_H/>&7X:G@W\+O32V;!M#H1TPN&KTFCP8EQ
M=1;RL6V[HOR]:PW';34ZW7+BKM/J-20FHS?F)C%$ARF*%1D2#"H]/AQ&T-#X
M]XYVW[2\>KI]94\6KI,N9,6J314U5/D4E+**B9<J5)E+0CP)TI,U23-FE.N:
MM2B3'#U%?55,Q2USIB02=,M"U)0@/9(2"!;F0YR3%Z(GA \*=-ONVNJ%(\.'
M1&@]2+/GKJ=M7Y;O3&SK=NZD37(LB$X['N&B4B!5%)7%ER6%,/2G8Y0^YEK*
MB=:U7:/CZZ2?03.-<4FT52C1/I)U=4SJ:8D*"@%29LQ<NRDI((2%.!>+7WJI
M*%2S/G&6L,I!F+*2,W221MRC(S6EBQ#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0
MTA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2
M$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA&+OBEZ
MY(Z1V8JG462D7U=3+\2A)0H*=I$/'ESKA=1^R8H5Y%,"^'JDM#@0^Q"F(&RX
M;1?>INI8_@RB"O\ QJ_#+'GE?)-K%23'FOVF=M$]E.#F11S$CC7$TKE40!=5
M+)]F=7J&W=/HIM5EU!"@%HDS4C2HXXMU:W75K<<<6IQQQQ16MQ:R5+6M:B5*
M6I1*E*425$DDDG771\=*4I2BI1*E*)4I2B2I2B7))-R2;DFY-S'XTBD-(1B[
MX\K*\5BO"#>U\>'SIE<UUT%V:];W4.ZK7V2Z]9]E_(.2+CK%)H$=9KM3C%E3
M5,K-9H\.8W;5,ESZG*5$3&74*?U_80\ 7VEI97&ZV13JEI$ZAIZATR:JL"P)
M$N9.4TI&DO,ERYBD]_-2B6G4^A7O7V&=AJ;CO'$=H>-)3_97"9R302)R?X7$
M>+(94L*<:52*%TSUA3)G5)D2?XB4SY<>0'7U3'W-#2$-(1ZUOY.S\-'[;J,?
MQ^=:;?W4BC2I],\-EOU:-N;J5;BN/4VO]7'8SR=BXM"?1+MZR'' [OKB*Y7V
MVHTBAV[4)'SS]LO;CND*[(<,G?Q)B4+XW.EJNB6=,R3PX*!LJ:-,ZJ%FE=U)
M)(FSD#F..\08&BDFY8U"@< W3*]?:7TTC=0CV-:^;8Y:&D(:0C!+XG__ "=O
MC2_\W#JI_P"BT_76=A/^>?9C_OJ@_P#/1&9P_P#X]2?]HE?[XC5!_)?O^\>Z
MU_\ G673_P"J+HSKT#[=O^=7#/\ [7Z?_P"(\3C9]HO^.2?^S)_\V;'H_J=-
MIU:IU0H]8@0ZK2:M"ETVJ4NHQF9M/J5.G,.19L"?#DH<CRX<R,Z['E1GVW&7
MV'%M.H4A:DGQ5"UREHF2UJES):DKES$**5H6@A25H4D@I4E0!2H$$$ @O&A!
M((()!!<$6((P0=B(\1_7.QNI'P!?B.6]UQZ5TVM5WP==<9<]E=ML/.O1)MC3
M)\>7>722;(DN!IN\NF\EZ-</36JSWP[4*6BCIF5&:ER]H@^HN%5=%]KO8N=P
MKB"Y4KM+PI*2)Y "DU24%--Q! 2'--6@&172T#P3.\*4):E5'725R^-4"I,T
M@54D ZL'6 0B: /P+'AF !@7L/ 8V:_R@SJ59'6/X5O2[JITVN"#=5AW]UQZ
M171:M?IZRJ-4J15;)ZD28SA0L)>C26@I4>= E-LS:=.9D0)S#$N,^RCAOL>H
MJKAO;ZOH*V2NGJZ3A7$9%1)6/$B9+JJ)*@XLI)9T+22A:"E:"4J!.NX)+7*X
MDN7,24K1*FI4DY!"D?0."+BT;(?@^?\ )G>#W_R5-_\ I%7M<3]HW_/?M)_W
MBO\ \J7&#Q7_ )0JO^L_^I3'E&^*)9'6B\_CS7;9O1:^E=,>K5_77X>:'TDO
MUVXZY:#=O5FM="NFMOP)K5R6Y#J-<I#:ZNBI0#*I4*5*+SSJ$,J+JDZ^@>P=
M5PRE^R6GJ>*4GW_A])(XQ-XC2)DRJDSI4OBU;.6DR)RD2IA$LH7IF+2G2 2;
M1TG#ER4<%2N<CO)2$SU34:0K4!.F$^%1 -F-R,1G?_\ *MOY01_]T<8__*U\
M2O\ ^K;7)_\ #S['_P#]BE?_ ,/<$_\ RZ,+^T.!_P#T ?\ [VD?_C(?_*MO
MY01_]T<8_P#RM?$K_P#JVT_X>?8__P#L4K_^'N"?_ET/[0X'_P#0!_\ O:1_
M^,BA=,O@>_$]D^+[P\^)CQ%^(?I!U9F]*.L'1N\KAN.X.L/5V][\>LWIM?\
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MFM.FFD)'W45:ZR:O5+%,*<*$R6L%3!)5)%"5KFM44_<R4H5,J=2^Z'>>PFZ
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MD!1TE2B #TO'>NWXD?A_H_AWZ)^(FQX'4/K-3?$A7(5H]#.FW2VUD5GJE?\
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M1,F=VOONX5X""O602); ^%BS "S70@W9XC^EGB,Z7>/J[O"7UTZAT7KSX)K
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M&U'#ZN5Q*3V8X)PO@_$:FF3,^ZUH1-K/[3E4IFH0J;(72UBY")JI:0M3J"&
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MM<M<M$X?=ZI4D2>^1,#@%)52D7*D(JJ14VCF*69,R7,FI5,I5*0%:T%12""
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MNTS=YC;U&H-*J=4GIW99A0Y#IR$$:W]%QKA4O[6:WC*Z^G3PJ95<<6BN*_\
M1U(J.#UTF00MF:;-F(EIYJ4!&2B?)'&)D_O$B255+3'\)"I$Q*;]5$ =2(MO
MUR\-G57I)XV_%3U*K]*^)=4^D/B+JW3V_P#IY='P[^H42&EJX:+8].M*[K3Z
MPV,FITZJ0ZE3IM+8?M"Z%%VC/T*8(BY#,AN6W"S.%<;X?Q'LOP"AE3.Q".)<
M%EUE)62.V-$I15)FU<RIIZCAU7H7+4A:)A%13VF"<DJ (*2J<J?*FTE-+2:
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MJCTWMKJ?\8CPR=8.COA^N2N&\^NR^GEN2*+2[?H]=<KMY7&ZF_KPGT.?'IE
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MD(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(X7Y#$9&]]U#2?8K4 3^21W4?H
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M=[JN.XJCT]IE'J]S-URS+@M9N+"KLJ;#IRX[M:BQT3%N/T^2EQM@J6T$I4L
M+3GJ.T'8_CG9B733>+R),E%6N9+DF542IY4J4E*E@B6HE+!88G.T;&NX76</
M3+54H0D35*2C3,2MRD E].+$1V/%W\1OPC>!\TJ!U^ZG-4>[:]!-3H?3^VZ3
M4KLOFI4SSG8Z:HNB4=AY-&I3[\>2Q#JUQRJ-39\F),BP)<F3%D,MQX!V0X_V
MEUKX51&9(E*T3:N=,1(I4+8'0)LPCO)@!252Y*9BT!25+2E*@32BX76\0<TT
MG4A)94U:@B6#RU*(U*#@E* I0!!( +QBQT>^.]\./K#<U.M%GJE='3NMUF='
MIM&3U-L*NT*F5*?+>0Q&C?;]'1<-!IA><6E*'J[4J5'*B&_.\U2$*WG$/LO[
M8</D+J#0R:N5+25S/N55*FK0A()4KNIAE35L!<2D3%;LSD9D_L[Q20DK[I$Y
M*02KN9B5$ ;Z5:%J\DI4>D9F>+[QS^'CP-6[9UT^(:XJY;M'ONM5"@6Z]0[6
MK-TNR:E3(**C+:?8HT>0[$;1%<2M+SR4MK5E"25#&N=[/]F.+]IIU1(X3)E3
MIE++1-G";/ER $+44)(,P@*.H8%QF,&AX=4\05,13)2I4M(4K4L(8$L&?-XP
M,_\ 9@SX9G_S3NH'_P :&^O_ *F:ZG_Y4_;/_P"@J3_\(4W_ -?&Q_X-<5_Z
M*5_].1^L;6NAG6JP?$7TFLGK9TNJ$VJV!U"I;E9MBH5&F3*--E0&I\RFK<D4
MR>VU,AK$J#(0&WVTK*4I6!M4DZX7B?#:KA%?4\-KD)15TDP2YR$+3,2E92E;
M!:24J\*A<&--44\VEG3*>< )DH@+ (4 2 H,18V(C!;Q-_&*\!'A3NVI]/;^
MZN/W1U"H<AR)7[+Z76_4+YJ5OS&5;'Z?7:K"^7M2E5:,Z%,S*',N)JMP74E$
MVG1SC/3\%^SWM3QVG15TE )-)- 5*J:V:BE1.2;A<I"GGS):A=,U,DRE#V5F
M-C2<#XE6($V7)T2U %*YRA+"@;@I2764D7"@G21@F(=T$^.'\.[K_==-L>E=
M6:KTWNBMRF8-#@]7[7FV53JK-?6EMB(U=27:K9T&2^ZM#,5BL7#379LAQN/"
M1(?6ELY'%?LT[7<*D+JIE BLD2DE4U7#YZ:E<M(#E1D,BH4D!RI4N4L) *E$
M"\3J>S_$Z9!F&2F<A(=1D+[P@#)T,F80!<E*2PN6$;<M<#&EC3%7/CY_#:MV
MMUBWJIU+OUFIT*JU"C5%MOI-?#S;4ZF2WH,Q"'FJ8I#J$2&'$I<;*DN) 4C(
M(UZ+*^ROMC.E2YTNCI2B;+1,037TP)2M(4FQ78D$6.-XWR>S?%5)"A*E,H C
M^,C!#C>,G_#5\43P+^+6Y8]C]%>O-"JM^S$.K@V+<]'N:PKHJA8:7(>9H,"]
M*-0VKFDLQ6W9;T:VI-7?8BLOR'FVVF'E-Z7C/8CM/P&2:GB7"YJ*5+:JJ1,D
MU4B6Y !FJIIDTR05$)"IR98*B "21&'5\(XA1(,R?3J$L9F(4B8A.WB,M2M
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M4KG+162)BDI7,1*!"$J*E>-:; 8<[18J>!<1I)$RHG2Y8E2P"LB:A1 *@D,
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M_P#YJ(U,C^_D_P#6R_\ ?$>/#^2^_P#?"^)O_P C-M?^F\?7T']MG_)/!?\
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M_2_1;_UX=/->/_9;_P ^.#_Y.)?_  NLCENSO_*]+Y5'_IIL>;_JCT#=OSX
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M[T67%?0MF1'=<:=0I"U ZR7,F29DN=*6J7-E+3,ES$**5RYB%!2%H4&*5)4
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M0AT,/+6T'4)<"=Z01]!5'VP]GJM*4579VJJ4)5J2FH%#.2E3-J2F85 *8D.
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M8!QSGZZ8Y>[EYQ1SS]/JW]8IST@D922>#D=CVSWQ_ ^Q(/L=4A]>_P NAO\
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M714E4I%?(2A53329ZD)-.Y"3-0HI!-R P)O&3V5DR9M/5&;*ES")R "N6E9
M[O *@6C<7\2CQB=0?!M\-NG]7>G#Z!U3NFC]+>GEH7)4H[571;M=O&@IEU&[
M9$2>B1&J50IU%I-:D4M-1;DPEU]RFOU*-4(:),&5Y[V.[/4G:+MBOA]8/]!D
M3*ZKJ)*"9??2J>:4HIPI#%"%S%RPLH*5=T%A"D**5#2\*H95=Q54F:/X,M4Z
M:M .G6E"V" 0Q *E)U,QTNQ!N///X2_AB^/OXAW1*F>,&5XX:G1*G?-9NH6@
MU>E]]4KBN.8NUKCJEL5"96:O2ZBLVBT:]1JBS3*? BU-;5+9B3&XL6/(BQ]>
ML\>[:]E>R7$E]GT]F4344LN1]X--2T,F2GOY,N>A,N6M'^D'NIB"M:E(!65)
M*E*"C'2UG%^'<,GFA% "$!'>=W*DH0 M"5C2D@=X=*@Y.F[AR08]+OPN/#SX
MP?#ET1NRS_&;UMJO66_'>H$T6>[+O2J=0:;;W3^FTRGPZ6FF75<D"'=DLUJI
M&JSG(-;*12Z>S2(D:#3W4S4.^-=M^+=G^,<3D5'9WALOAU**1/W@)ID4BYM6
MM:U+[R1)6JG3W:.[3JE/K69BE+6-+<IQ>JH:JH0NAITR)?=#6TL2BJ822=2$
M$H&D:0Z?:)4256CSZ_!DZS=8+S^+/U@M.\.J_4JZ[5AT'Q#N1+9N2^KHKMOQ
M5TZ^Z2Q3UQJ-5*I*IS"X+"U,PU-1DF,TI3;!0@D'UC[1.'</I^P7#Y]/0T<B
M>J;P@*G2:61*FJUTJRMYB$)6=1NISXC<O'2\=D24<&DK1)E(654KK3+0E1=!
M=U  WWO>-DOQT/BD7[X,J'9?0#P^U.-0NM_5.WI5VU^^%QHD^;TZZ=?:$NAT
MZ1;\*<U(@_SGNZKTZMQ(-5F1Y**!3J#49$:)]JU"DU*E\;]F/8BE[1S:GBO%
MD&;PRAFID2J4*4A-76:4S5B:I)"NXIY:Y:E2TE/>KFH!5W:)B)FJ[/<(E5RI
ME34C53R5!"9;D";-8*.LACH0DI)2"-14 3I"DJUK]*_@D_$F\2/3ZB]<^L7C
M$JUB=0+VI,6ZZ+:U_P!Y=5+QO2)'JL=,ZF)O2M-5-(M:J2&G6GWZ73TW!*H[
M3J(TYJ+4V95+B]E7?:3V-X/5S.&</[/2ZJDIIBI$R?24U#3TRE2U%"_NTLH_
MCRP00)BNZ3,(*D%2"F8K;3N/\*I)JJ>11"9*0K0I<J7)ERR4ECW:6\:1=E'2
M%&Z24D*/3\%OQ ?&A\.?QM0O _XZ+UKU_P#3BH7?0+"JDR\[BG7I)L-5WF$B
MRNI-A7W6<UR?T\F(J5*DU*BU-Y42#;STU<6C4.Y*7,IKDNT?93LYVO[-J[3=
MF*:525B*>;5(3324TR:K[OJ-31U5++:4BK3H6$34 *7-"=4R9)6E85_#*'BE
M :_A\M,N:$*F)$M EB;H)[R5,EADB8"% *%RL %2D$&-OG\H3OF]NGW@'IU?
ML&\+IL>NJZ]=.X"JU:%P5:VJLJ#)H-\KD0C4:++A3#$?6PRMZ.7O)=4RTI:%
M%M!'G_V34U-5]JE2JJGD5,K^RZQ7=U$J7.EZA-I@%:)B5)U!RQ9PY;,:3LS+
MES>(J3,0B8G[M-.E:4K#ZY0=E A[F_4QHW^"]\1CJWT#\5U(Z*>)^_[]KG3'
MQ*TRT*=1ZGU-NBNU_P#F?=]>B-U3I9==,GW%/GF!;=Z1ZTFW:NJ(Y'AO+K-!
MK%3?:9MMY(]-^T;LA0<5X%,XEP2DI95;P9=0N8BBD2I7WBGE***Z0M,E"-<Z
MF5+[Z7J!4.[FRT F<(Z#CO"Y-31JJ*27+3.I"M1$I"4]Y+2=,Z60D!URRG6E
MW(TK2D.N-X?\H7OF]NGO@*I%>L&\;IL>NKZ_]/("JU9]PU:VJLJ!(MN_W)$)
M51HLN%,,1]QAA;T8O%EU;+2EH4IM!'F7V34U-5]JE2JJGD5,K^RZQ7=U$J7.
MEZA-I@%:)B5)U!RQ9PY;,:#LQ+ES>(K3,EHF)%+,(2M*5@'O)(=E AV)#Y8G
MG&7?PDKCN&[?AR^%:X[JKM9N:X:K8=3?JE=N"J3:S6:D^F]+H92]/JE2?DSI
MCJ66FFDN2'W%AIM#8.U"0-#V]DRI':_CDF1*ER92*I 1*E(3+EH'W:062A "
M4AR2P N28PN-H2CBM8E"4H2%H9*0$I#RI9+   .23;>+U^-_HGU+\1?A:ZL=
M&.CW4!/2WJ1>\&VHULWZNJU^B)MYZD7K;5PU!TU2UT.5Z)\[2*14*8%4]!6X
M9H9?Q%<?(UO9KB5'PCCE!Q'B%)]^HZ94Y4ZET2IG>B933I2!HG_PE:9DQ"_'
MC2X\0$8W#ZB52UDF?/E][*EE17+TI5JU2UI'A6R2RE WY<X\5GQ#?"7X^OAT
M6STUN?J5XV+RON+U-KM?H-*CV-U<ZT)D4^1;]/@5"2]4#7Y-+;++[=0;0Q\L
MMY>]"_,2E.TGZ/[)<?[+=KY]9(H^S=/2JHI4J:LU-!PXA8FK4@!'=)67!227
M8,0T=[PRMX=Q14U,FA1+,E*%*[R1(OK*@&TZL:;NT9T>#WX5GQ%^K%I^'#Q,
MM^.Z8FQ+TB]-.KJK/K753KI*K"[9G2*5<K] J+"6Y%'D37J=YD%]HR7:>ZXL
MH6ZIA2E:Y?M#VY[(T$_C'!3V73]ZIS6\/^\2Z'AB98G)3,DB:@VF!(6R@6"P
M [ QKZ[C'"Y*ZJD^X?Q)?>R=:9-.$ZP"G4#J"F!N"P/1XY_Y27UAZM]-_$5X
M>J=T[ZI=1K"I]0Z*U2;4(-EWO<UK0YTQ%\UAA,N9%H=3@L29*6$(92^\A;H:
M2EL+"$@!]CO#Z"LX1Q==70T=4M'$I:4*J::3/4E)II9TI5-0HI2]V! >\4[+
M2),VDJ3,DRIA%0 "N6A9 [M!8%0) ?:+*>(+P-?%G\"O0][Q;6_XY;NNVS[4
MA6U7KII]H]:NL#=>I%+N*=2X,*=.M:[&TVU=-&BU"K0&*Q">E3%M(=^:-(F0
M&)DB+LN$]I^P?:?B8X!-[,T\BHJ%3Y4A=1PWAYE3%R4+4I*9\@]](FJ1+692
M@E-QI[Q*RD*R*;B'!N(U'W)5 A"UE:4&93R-*BD$D!:"5(4P.DL'_F"B ?0U
M\&SQQ7SX[/"-_/KJLB"[U5Z<7W5NEM[UJFP8]+AW<_3*);UQ4B[TTJ$VW ID
MNJ4BY(T.KPZ>W'@*K=+J4V!!IM/F0Z?&\D^T3LS2]F./_=:'4*&LI9==32UJ
M*U4X7,FR9E/WBG4M*)DE2I:E$K$I:$K4M:5+5S''>'R^'UO=R7[F;+3.EI)<
MH=2DJ0YN0%)=)+G2H E1!)\JL>@^+GQA_%'\0OA?Z8^*?J5TYEU;Q ^)Y5 E
M5?JAU-C6I0Z38UWWS644MBG6_5'G8D5%-I(I]-BPH:8T8!AH(:81Z?<3.X!V
M>[#\'XW6\#HZQ*.$\$$U,NBHC/FS*FFID%97-0 I16O6M2E:E7-R8[$*HJ+@
M]-63J27-":6C*],F49BC,1*2[K !.I3J)+FYN8WL^!WX3/CP\-_BFZ4]:>L'
MC8/5?IQ9,FZWKEZ?_P _.L=8_G"W6[$NBV::C[-NC_B*3]G5FLTZKXG^EOY#
MSH_]*;8UYCVF[>=E^,<#KN&\/[-_<:RI3($FK^Z\.E]T955(G+.N1_%&N7+7
M+\&=;'PDQSW$>,\-JJ.=3R*%4F;,T:)AE2$Z=,U"SXD**@Z4D6&][/&Y+QJ^
M(2#X5?"GUUZ_2W8Z)73KI_6*A;;,K:8\^]ZFEN@6%2GDKX4U5;SJM"I[V$K*
M69+BPVO;M/GG9SA*N.\=X7PI(5IK*N6B<4^TBF0\VJF#K+ID35C%TBXC14%*
M:RLIZ:[39B0MLB6GQ32/*6E1'41X!.EO7?QE^'L^&?QPW#U4ZN7-T[K77RY8
MD"D5CJ%>%3I]W_\ !#*L"LWM2*Q"GU5ZEN4F[X-XU&W(:'T[GWZ/<9;2U\@A
MT?55=POL[Q;^VNS,F@X?)K)7"I*E3)=)3H53_P!H)JY=-,EJ0@+$RG53(G*(
M]D3)+DZVCTB;3T-3]ZX>F3(3,33(U%,I ,OOQ-3+4E@#JEF6%VPZ.<?T2JZ\
MSUBZ*5F1TYN-EICJGTMJ+UB7;'?E,1VV;XM-Y=L7&S)ACYUEE"*I!J;;\4?-
M-MA+C \T)&ODB4#P_B4L5DDDT-<@55.0DDFFG@3Y)"O"2Z%((/A)S:/,4O3U
M">]1>3.'>2RSO+7XT$&WX2+VCQ:>-?X<GQ%O!!X?[C\0M]^.ZNW?;EMUBV*-
M*H=I=6^N::W(?NFMQ:'$=8-9-/@>5&?EH>D>9*0OR4J\M*UX2?HWLWVP[(]I
MN*R>$TO9>53SITN?,3-GT'##+ D2U35 ]V%*<A) 8&^;1WE!Q3A?$*E--*X>
M$+4E:@J9(I]+(#GV2HWVM%/\#GP]/B(^.SH1"Z^6!XZKALVWIUT7':K=%O#J
MWUQ5642[;>CLRI*S155&#\O(5(26,22[A*O,0@XS+M-VM[)=E^**X55=F)-3
M-3(DSS-IZ#A@EE,X$I'\0(4X:]FY17B'$^&<.J#33: +4$)7JER*?2RW8>(I
M+AKVC9!\>FM]8_#QX(? _:E&ZKWG1KXMNM4.QKUO"R;QNFA2KNJEL=(V:;5:
MA+JD6;3ZO5(M2J\%^J(55E*D.N/"1);3**R./^RV7P_B_:7M+/F4%-,IITJ;
M4TU/4T\B:FG1/KRM"$H4E4M!1+4$'NV  8>%HU?9T2*GB'$%F3+,M85,ERUH
M0H2TKG$I2 Q2&20GPVLPM$$_D[/BDZJ3>KWB/\*_76^;SNRY)%MT#JI9)ORZ
M:Q<TV"JW)35 O"'2ZA6Y\]QV+6Z9=-F5NGL0GA'>@4N95&$O,O.O)ROM<X)0
MIX?P?CO"Z:FD21.FT-3]UD2Y*5B<DS:92TRTH8RER*F6LJ#A<Q*"Q#&YVGHY
M0D4M73RY:$I6J3,[M"4/K&I!4$@>RI"TE]U 1GY\?_Q3USP[>"=BT+%N>K6M
MU(Z\W]0[,HE6MVJS*+<E)M:VG6[RO.LTFI4]^/-B@_9=!M2:Y%=2\8UWJ0DI
M"U+3ROV4\#E<7[2&HJI,N?1\*I9M3,ESD)F29D^</N]/+F(6"E7MS9Z00VJG
M?H=;V;HTU->9DQ 7*II:EJ"DA2%+7_#EI4"X/M+6+9EQI_\ Y/WU*Z^U;XA?
M53IOUBZG=4KG<M'H)U2@5:U;XOVZ;G@4JZ;=ZG=+J+,4:?6:M/A-U*G/*J,%
M,IMKSFT/26FW0V\X%>@?:O1\*E]DZ"LX?14,D5'%:)4N?34LB2J9(G4-?,3X
MY<M*BA8T*TDL2$DAP(W7:653IX;)FR94I&NIE$+ERT)*D*DSE"Z0"0;%L6$5
MG^4@]9>K_3CQ;=%*3T\ZK=2;#I4WPYTNHS*99E\W/:]/EU!74SJ/&5/E0J'5
M(,9^8J-&CQU2G6UOEAAEHK\MI"4V_L>X=P^LX#Q*95T-'5+3Q=:$KJ::3/6E
M'W.D5I2J:A1"7).D%G)+.3%.RTB3-HIZIDF5,(JE %<M"R!W4HL"H$LY);K%
MS&?@7?$Z>::>3\1M0#K:' #U/\060%I"@#@XR ><:PS]IW8L$C_@A@D?\2X3
MM%O_ (0\(%O[-5_](I?_ *Z-BWQQZ]U!Z0_#&@KMJ^[FMV\Z!>O16W9]W6E<
M5;H-8FNQF9$&JNHK$"5"JJX]3?C*>?2\\%20I)DI4O.N0^S.525_;50G4LF;
M33:;B4Y-//DRYLM()"I8,M252W0"P86VC5=GTRYW%CKEI4A4N>H(6E*DAR"/
M"019_3:-#'P=OB.=7_#CXL+9Z<^)OJ'U KW1[Q*4FV:&W4NIEU5ZX8MIURLN
M..=,[_H\^XJA.;A6_4I\Z3;%S2(DB+ 1%JIJ=9<+UH)CL^H_:%V0X?QC@,^L
MX+24LKB'!IDZ8444B5)5/E2P!6TDQ$E"2J<A"4SY 4%**I?=RPU1J/1\<X7)
MJJ-<VEE2TSZ52E-*0E)6E(_BRB$@.H !: 02Z63:8\>@;X_MZWE8'P^*O<-B
M7;<UE5]'5[IG$17+2KU5MNKHB29%8$F*FI4>7#FICR A ?9#P;="4AQ*MHQY
M3]E5-3U7:R7*JI$FIE?V?6J[J?*1.EZDB6RM$Q*DN-BSC:.:[-2T3.)!,Q")
MB>XFG2M(4EQH8LH$.(LWX<^COB$\:_P..@UA].NN5:L?K/=C]3JZNK-SWA>Z
M*RJ);/7Z^7YL:?<]"<G74^N71X+=*9277&C'0S%=*8K82G8<7XCPGLW]IG%*
MJKX9+JN'2 B7]PDT]-W>J=PJF"5)DS0F0-,Q16; N2H>(Q?J9]-0=H*F9-IQ
M,D( 3W*)<LAUT\MB$*THLHN>M\QY[OB)>'/QX?#BF=)874SQGWU?B^KL6]I5
M&78O5SK&A%+18[MJM3TU/[?ETLE4PW9#,3Y4/C$:3YQ;/E;_ %GLCQCLOVP3
M7JH^SE+2_P!GFF$S[S0</.O[T*@HT=TE?L_=U:M3>TEGNW3<,J^'<4$XR:%$
MON.[U=[(D7[S6VG3JQH+NV0S[;9/!=\*'XAK=Z>%'Q,7+XY7;@Z:BY.AW7*O
M6%/ZG=<*C4*U9!J5L7[4K1F09[+E G3:A0B]1Y$68^ND27W5M2'E0UK6>#[1
M]N^R9IN.\&D]F1)K.YXGPR55(H^&H1+J=$^E14)4@B:E*)K3 I($P .!J#1I
MZ_C/# BMI$T&F=HJ:9,P2:<)3,TKE!8(.H!*O$"!JM9C'K#UX3'%PTA#2$-(
M0TA#2$-(0TA'PD#OI",7>L_BQZ9](TRZ6)R;JN]E*T)MRB/H=,5\<;*Q4$I<
MBTS:HC>PLNSL=HF#O&YX=P.MKR%Z>XIRQ[^:&U#_ -FAPI?0LE'^.\94FDFS
MKMH1_,K?R&3YXZQJOZC^)KJAU@KD"+5ZNJBVVNIPPS:]"6_$IJFQ*;*?M!?F
M&14W ,%1EN*9W^IIAH82.VI.#47#Y:E2Y?>3@A7\>:REOI/L6 EOR2'YDYC:
M2Z65)2X *V]M5R_3EZ1OSUYA&AAI"/A (((R",$'W![C2$8=WK332ZS4HN-J
M6Y#A;&, MN?>M'/ QY:T8]LCC\]?-&DD,['RV?#';]>HR$^)NL0QFMR:>H(W
MJ\G@E&<%!&["D'/I4.,XXP""-6 HIN#;D?3RQD[_ "B^78MGZ^A$KAW)'F)W
ML.M1*H/P%:O+AU,I( :D)R$QIBLE*)*0EMPX#OLK5_6E08V5=E,S\@I^> KX
M1;T$@@C)Z?EMS%FR.45VFUV/5$K2E1;D-.%J3'='ENQW4Y*FG$D\*R/3QM4,
M*0HI5NU1[M@BS.#ZCI%A2&W];WZX?J3YL+142K(R <9/;/&[//'T[$'CZ<ZK
M$6N0XM;;;Z_(QQJ6.XY^A/\ <0.<8_<.,]N$4V-^K8!_?TC@4OU>X[>Y[<\_
MN_VGC@80+;?)OKH.75X^9W$X)SCO@<#]X!_OTBD,*[YSWXX^OY@X! QW'?2$
M?OW_ %&1_$C_ !^G/&-(J.?)GC])P>#[\X  [?3VSSVQ]?W(I%'N&@1[B@"*
MM]Z#,C2&:A2:K%#:IM'JT7=\I4(GFI6WYC>]UB0RL%F=!D2Z?*2Y$EOMJ*2E
M22DX+7%E BZ5).RD&Z3SRX)$5!(+AGN+XOL>AW^8S'):M??JR)5,J[":?=%$
M+3-9@M$_+NAP*^6K%**B7'J+5T-.O07%%3K#C<JG2O+G093:8I*@=$RZD@%[
MM,0<+#X)N% /I5;J:J LI+Z39S9B!<;X)MS!>\3)!QC'.>0?J/I]3]1Q^G&-
M7.6&%SEL\L;LPZO$?K](YQSV/Y_[O[O[SSQJXEK,+^0NUMCN?/!BA>S?/Z]/
MF(_7<G'/'(QS] >/\9_0G4HK]?G^4<H).#V]_P#=_?\ Q'YZCIR7?]=]CY>5
MH1V$K_9P.??GGG\^<''8]Q^1&H%-[7YV8=6)M^GI%&N"YMMM$GH_E36IE*D@
M*C5&.Y'4GT\%:<9 ]E)R%!7!"@"#D :N25Z%#F2-M[,][C8=+[Q";*3.ES)2
MPZ%RUH4.B@S^8R#MEQ&.]1@O4R?+I\@8>AR'8Z_^EY:RD+&?V5@!:3[@@ZW
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M197WC1_"N+ZM/=-NVGI%SL__ ,B*[O\ O'JL9[R^GU;3\(]VFOF"/.X\+O\
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MC41Y8?Y47_[:3PE_^4;J7_Z,VWKW#[$O^4./?]CH_P#SIT=AV1_O:W_JY/\
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MWQ-O.*_SG'?$'T^6L\_52B=;;[2P!]GG9X# J>"@>0X161D=H+<$H1RF4O\
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MY0DSVZM2J-,6MEN)5/GX;D=+C,G:WA?E.;]>K*H.%]H^PO!^"U/%J>B$SA/
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MCK+UB<>B.N-J0W)9;E7P_&6ZPLAUM$AAYA2TA+S3C94@^5)^U3ML%))XK*4
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M-1D%!&L/^S:H33)5W$N8)8F*$RKI980%**0E:ESDI3,U!E2B>]3;4@/'4?\
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M0KBENRBLQ#&:^13&=8<><5)0I#:'<*0FG[PBL542Y8!'\"6A<S6" $E,V9*
M'M.=3@@#3<D=AQB=QW[A+F]F)'!:VL7-E*T\9KJRBH54:Y:U*FRZCA]!Q*:J
M;J[GND]P)2T*6HS4E*0K'_I?XAZS5.EM)ZT=9(U@]/>GMT-4)-NS:/7+GKE1
MCSJY65T5ABYF)%KPH5)CJE&.!/CU"="CH<<?J$B'&:6\-E6<,EHJUT% :FIJ
M9/>&:F8B3+04RT!9,DB:5++/X2E*C8("B6CS[LM]HM95]E:3MKVSE< [.]GN
M*(H!PV?1U_%*^HESZZM512Y?%)<SA-/(HY9FF6!/EU$^1+"E3*B9)E(*XN'/
M\1/2RFTJ@U:34;F*+EAUJJTJE1NGM_SKF-#MZ<JGUBXJA:D*V9%R4>WH;Z0H
MUJKTN#3WF76'H[[R'VBK%3PNL6N8@)D_PE2T+6:FF3)[R:G5+E)G*FB4N:H6
M[M"U*!!! :.BG_:-V5IJ2@JYM1Q1N)2:VKI*25V=[0S^*&@X=/-/6<2J.$R.
M&3.)T?#I,P FMK*613K0I"Y<Q8F(>I7/UTZ;VG1:+<E1J=;GV]7J$;H@UZV+
M,O.\:,W;*&&9+EP5*IVK0*Q"I%):C2&9#DJIOQ &5ET)*$.*1&3PZJG3%RD(
MEIFRYG<JES9\B1,,YR!*0B=,0I:R00 @*O;<1D\4[=]F^$45%Q*IJ:ZHX=Q"
MA/%)%?PO@O&N,T2>&)0B:KB%35<*X?62*.D1+F(F*FU4R2 @E;%*5%-)/B L
MI752D=*XL>XJC-K=H4J[H%?I-L7/5Z [%KTYF+1LU*F4.93V:9+CN+EO7+*G
M1[?@J0($J>W/\UAB?]F5'W-=83+2F7/7(5+7-E(F RTE4SPKF)45@C2)*4F:
MKVDI*6)Q3]H/!#VKH^RDJ7Q&IGUW!Z7C%/7TG"^*5G#UR:^>B51G[U2T,ZG1
M2SI:E35\3FSY?#I!3W$VH34:I:*&QXM>@TI=.$:[:J^S61+;H4UJP^H"X%?J
M,%6R70+?FIM?Y>N7,PYAE=N4IR76OF3\H(1EA3 N'@O$AJ>0@%#=XDU--JEI
M5B9,3WSRY1SWJV0WBU:;QKY?VN=@III^[XO5KEUHFIH)Z> ]H54_$:F06G</
MX?/'"^[KN)RU>!7#:54VM[W^")'? H$I:\0/2E^S6KZ9N":Y1G[F>LIB"BV;
MI5=;UZ,/.L/6@S9*:,;N=N1IQAY2Z0BBJEIC-.35($%"I(LGAE8)YI^[3K$D
M5!5WLH213EFG]^5B3W5P->O3J.GVK1MD?:#V47P5''D<0GJHYG$U\$1('#.*
M'BR^-2UKEKX.C@8HCQA7$TJEK*J--$9PE(5/*>X!F1QR/$/TBB6Y1+IDW1(9
MI=P7)4+-IK)MFZUUQ5X4N+4)<VU)ELMT-=Q4VXVT4R4RU1JC2XL^7,^5@PV'
MY=0@,R0X77*FS)(D@KERDSUGOI'=]PLI"9R9QF=TJ5XP2M*RE(U*40$J(C,^
MT7L?)X;1<5F\5F(I>(<3J."TR#PSBQKCQFEE5$V?PF=PQ-"KB5-Q)(I9J$45
M32RJB=.[J1)ES)U13HFQ>O\ BGZ8TFTJ3>%--RU^'4NI-'Z7RJ="L^\&:]0[
MDG5.GQ:K#K5ONV\:]3ZE2*?.^TF:,_3$5*O+$6FT1F7+GQ\WI?!ZM<Y<A?=2
MU(I5UB5JGR#+F2DH4I"I<SO1+4B8I.@S K1+NJ84I28U7$/M5[,4G"*3C%-_
M:?$)-3VFHNRTVFD\&XRCB%#Q*?54\JJDUW#E<.-?3U-'3S_O2**92IJN('NJ
M:A1.G5$I\A*54HU8IE.J\-,Q$2J08E1BHJ%/GTB>F/-8;DL)FTJJQH54IDL-
MN)$B!48<6=#>WQY<9A]MQM.L6DH6I"M.I"E).E25I=)(.E:"I"TN+*0I25"Z
M2008]#I:F564M/5R1.$FJD2JB4*BGJ*2H$N=+3,0)])5RI%52S@E0$VGJ9,J
MHDKU2YTJ7,2I(Q<KO4_Q"0>K43I;3++Z-2'JW;USWE0:G.OJ]X[1MFWJ[2:.
M$5=$>P)"XM=D"N0'C#A(G4])1,3]I?=L^?N)='PM5$JL7/KP)<R5(FI33TY/
M?3):EO+>H&J6-"@ZBE6/#<MY;7]J?M"D=KY/96FX)V,F+KN'\4XSP^JG\?XY
M+2>%\.KZ2C:L3+[/33)KY@KJ=?<R!44X(G#[UX4=Y=:!USZ9U6Z:U9E*KDZJ
M7!;;M>CW'$IULW3-8H,BW$/.5&/5JA'HSE/AR7$QW_LN.Y*\^N%M7V,W.RG.
M$KAU6B3+GKEI1*FB692E39*3,$T@(*$F9J(N-99I;^/3'64_;KLS5\5K>"TE
M=457$>&KKY?$I5-POBLZ703.&I6JIEU=3+HE4TF8H2U_=9:INNN*3]R3/L]/
M@>(7I7.I]XU)RL5RCM6%;HN^YXES61?%K5B':BTS%,W'$H5PV[3:S5J2_P#(
M2T,RJ3!G!3K)8*0^MMM<E<,K$JD)$N6LU,WN)*I513SD*G#2\HS)4U<M"QJ2
MX6I-B^ 3&/3_ &B=E)]/QFI565U&G@'#1QCBDGBG N.\*K)/"5">4<2E4'$>
M&TU;64B_N\Y*)M'3SW6CNR!,4E*OE%\1/2"NO7 S$NEZ*+:M27?=0D5NW+HM
MV')LB"K9+NZAS*]1J=&N.W&7"E!JU!=J,1PN,*:<<;DQEO5F<+KI0E%4D'O9
MPIDB7-DS2FH5[,B8)<Q1E32+Z)FE0N" 00*47VC=CZ]?$$2>*KE#AG"9O'ZB
M97<-XIPZ3-X'(+3N,4$ZOHJ:7Q+AJ%,G[Y0*J9*M4LH6I,V4I=ONIGBDH%N]
M(KLZA652[EJ%4I#MN4ZCQ+KZ:]3K?I\F;=DYN)1JF^W/MFES)E ^7^9GJEP7
M6V92V8E(;G1JI6:2S)R:3@\V;6R::H7*0A8FJF&354DQ83(3JF(&F:L)F.R&
M4#I=2]*D2UD<]VG^U/A_#NR'%^T/!*7BE154:^'4U'*XMV9[4</IID_BT],F
MBJIB:CA=+.G</[OO*@S9"THG%$FC3/EU=92(F5R/XB;-M&B4./U-NGYFZY%
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MJGU4F=)EQ"-XLNADUR$S!N6O37ZO2_M>VV(G3SJ*^_>$)!9$@V8RW:I<NQZ
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MWVAI:PSY%5PZ@^SKLOV-D5!*DULZJX%55ZZB>N24%$J1/E3J=:0FH6>\"D%
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ML]5<"XUVT[0=H#Q(<?K)?$:>AXSQ!=2A(X7_ &$N1,J),K1JE_VBA"EE2>]
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MJ3&43*ICB6W]8LBOE(D\-EIGSZ6;2*KE+GRY*)S?>3*T 2US$"8A00M,Q*F
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MSV<XH)DO[C/4\R6"9!4?;EN"9=\J074/\-L)$6^G)P#Z3SD#/(![C/Z?IQ_
M'5NY\GO^GN][OB_4Z2SYWW^/Q^>':(34>HX]_I[=L>K!Y& >!Q@J_/45 ^@
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MP)ZL !%6A,C[M]7M4HP!&<R&GD@$Y:9@798+CV9J6<;LM(]K.2QSM:+92"G
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MD%_+W<X,7:.M.@Q*G$?I]2B,3H4I!:DQ93:7F'FR,@+;6%)5M.TH/="TA:%
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M<!2B0<_IC@^_/MJT9H)9(ZN0P;I@_7*\-GBD.NN/8\S<K/?*OP]_H?S]OUU
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MMI+H+/D&[1=4 +B[[V-_/Z+AWS%=AU)I_P!"RIIY(.YI>,X3QD$'U#.0=N
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M5.?=5O>#BRO)<<<)6M2U<G))WYRLD[U;AMY2,I2*:0 0D-LPL/=@>[WQ-);
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MWES]+6NS/'.2."K@D$$?LJ]L<@]Q[']^""-5B/K'W.,$]@"3C)&!@GWX..4
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MW+D6+%P^1;I'@$-4NP#^$^7.]VA#4F*7(((^8?RA#5$L^X.U_P!H0U4J('M
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M)0HI=;4II^,Z"V]'?;.%LNM*4%(<2OTJ0I*=O!QSJ8.Q<* N#D?KYBUXQR@
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M;.;)H)TR]5,T)QW%.5)/43:CPS%"S%,M$D@X4H7BP9K @7ZD;@82]C;=S87
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MH DED@J/1F YDNP'QZ8B>P+V 9C@L_,9?Y13)<B<ILO5*8U;T+&?*:6R_4U
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M+3GR^&*6K563E3"S]Q)>53@W)U*_O9S?XE(00SR<QC*GBX0E@=U7)Z@/I2,
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MIAX]4PJ.IDRJ)-+3I7/J9HX;)4M6G6LA4R5H *9-.0J>>\F=XK2I:F0I,K0
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M\R71*44AE'5^,I9FYV\C=["+=U/J#+45^0%^HJ05..\'DC. %;OQ*Y2I.0.
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M70<9Q]<OKTB9VU=TZCRFW$/%'I+6Y24N-N,.#86)C*PMN1'6/2IMQ*@!@@<
MB[*G%!#G&#RYOS!Y%_6(+05ETL"6<%P+==O3WM%^;?KS*@)%&04IVI6_;_G;
MPD827)% <<6"XP#N)I+JB^VC_N)3J$H9&:%)4VDI0IB=( "5C8@G\1O;'+)B
MPI(5J.0"Q<9(PXV;8GIJ:+NT:JP:HPEV,Z'$D;%@9#C3B5$*;<0K:MIQ!)2I
M+B M*L)6!Z1J04#T(R#D?5_=&.4$%^IW]^QP[N[\KAXD3;9(X"2K]>_.-V#D
M\DCD=_UP-2B*KLWEY<@]AYC:.RE'JXXR/W\#ZXX_0<$_EQI%' Q?!OC%PQ^?
MNYGF2D< \<9'"1R!DCT@'\N1W]\G.D5(#D$LP#7>[?6![HI]3H5+K+32*C&#
MCD=?FQ)C;KT6? ?_ /<]/J$1;,Z"^I/I*XS[96V5-N;VG%)-2Q&D@%+OI-QR
M?H>2@Q&0T$G2Y!\^N18&Q]1;E'3:-UT1!\MQ-W4Y/*6Y"HM-N1D Y\M,C;'H
MU5P#ALR11W]@^^ERWB%*AH*0="K"^F:79R'9;!5KEEZO\SYN:@68:?\ 9+;G
M W\G%W#"T5BG771)SZ8ADKIM242G[(J[2Z;4BH?B#$>6EKYUM)RGYB N5&<(
MRT\XGU:H5Z?;24<BKV3R98=)]"6BK'H>H?XAK>OO,27&0<8P<?3'Y]L^_P#U
M'MJKAL_ECE]'W13Z_7Z+W@0!]<8*E?7C!SGZ_P!GTU7?W?,_KCW0Z_6_KOC:
M.NX\$\*)&.Q]^W&?X=\=_KG&GU]?5_E!0<AS;G^7[FT=%V?L]0/OVY!)[#Z^
MYQW_ +#JK$_36]?RORB@8-N;[A@S_P!?TB/7 U0;FI3]#NJD0:[1Y PY#FLI
M<+2^2'HKN _%DHR"S)C+:>;6D*2M)[30M2#X38MJ2?94.13<&W3]8C=WP3?W
M_6^T:D_$=X8;EZ=1)]]6%4ZE=EB(+BJJY)WS;RM>*XLK4FLR4I\^7;L?<$,2
MX"8T2!&"?M"%&;:5,>]$["I[)=^9<[A\F3Q29,UH74J[R1/43X4RQ,Q.>Z14
M&8=6D2%BTM/&=KD]H9DHS*"H6*((/?T],DIJ$M=<S6ZIDR7G7+DZ2A#ZTK2Z
MXQL:NJF,4Y4.V*>Y45+1$>J'E!5#LZ-(;<0ZXFK2Y3S]1K2FBER+4HSDJ.),
M<->52WVV$R'.SXIQ>AX;,4*ZJEJGHUIE4TDHJ^(Z2"@:=&BFH062J45ZIJ"5
M$*.HICD.&<)K:]'^B4JTR5HE][4S@JDH-85K4HE>NIKE"Z5Z6EED:DLE*HI\
MZGSJV^Q*NR<TXW\I/DTNEQXC]-@NPZ8B'\ZN@VY2HYN:[5Q(YI[<E^G4],&5
M%5&9G/+)9USLSB?'.(!:*))X)1S=14M2ES>(5"<DF8K^,"-14$R4R):2HZ"=
M1,;K[KP3AQ2:M9XW62]*4H1HE4%.IV2"D-(VTGOUSUJ8:D)*6B[]J]*Z_5/E
MC'IL:D0X51V^;78\*2A46!6*G$DII5!ILARA4^'5H$6G5>@563.K];@,5-QB
MHTJG3&'&!:D</HJ$]ZI)G5(4"J=//>SE*U%UA.HRY;LDIF%YER%^*+=3Q3B/
M$0J4DB13%(2F33@R9" 4I9*UD";-""5!4L-+< H8"+ZT'IS9]F[:E47552MN
M(8,JLU=[YRHRWVZ52J0[( &/+5-BT2FJFL0&(=/D28_S2H+;SCBE9/>39I:2
MDA[%3NO %UJ]EPD/I;8V,8IDT\A.JHFI4;D2PX0&*E )0DDK8DMJ"B'BIU.\
MPVRI,!MJ%&0,&3)\I*4#L-J"?)93^R/,4O'Y8QJ2I4F0DSJN<A"1=6I02GWD
ME2CY#4=@\0%3/J"F112%J4<!"-:C9K)3X4#F2^FY)!$8'770KV/5.Y:[;51M
MF)!OJGT2,Y,JR*O5[D^T:/.N%\2:%9]/BLFK,3(U<7MJ,FK1($1]EE502W'2
MOSN1'"JSC%953Z&04T9FJ4:R>3(I9:21<S9@"5$DG^&C5-&-#VCN$<0I^%45
M)(KIP56(DI2::21.J%+ +C0@V   ,Q93+-V4P)%1LGIY!K=8I\F$NO7G>NPK
M;E2*0+QO5E]JJ5.ER8=(HJ66K!Z?933GG7IGRS['RK]/EJJ3S\HC75TW9?AW
M"Y9J.)&56*201-JIPH^&("I4F:E81>IJP3."1+3H*U(F(53CNR3S]3VAKJ]8
MIZ+O*4*!!E4R%5%>HA<Z6I)6&E2"#*U:TZ@D*0H3B%1L Z?^$FO3UBJ7C*9L
MB)-9V3Z;1Y8KU_59A:&-\>NWQ/1)5365EG#D&WR WO=0F84E.,2O[64\E/<4
M2%5IED&2N9+^[\-IV"@E5-02U($S2%,%S[D >!Q&32=G:F<KO:HIHT+!$P(*
M9W$)S^UW]8I*^["L]W*) =0*F(;-*R>F]D].H'V?9]O0:.VL#YF2V@O5*>L
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M0$)# ?$[DW-R?VLT03G/MC^W65%R/ND(:0AI"&D(:0@>.=(0!R,Z0@<^W?\
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M<4=TK9[)&[UI. 0,9!.,]\*!'L,8%J96RI89P"][W&X>V.F T$4\R;=6H@N
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M>P\+W)?S<%_S;W7B]5 O5$Q:)D>7Y-03A+CXV%;Z4GANI,;@F63A*4/[A*0
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M)14M%+[NEDHDIN3I#J43DK676LG<J)CIWQU*L3IO 14KVNBDV]&>#_RJ)TI
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M-=P"+N,?HQVL=]LQCE"@7#:>C8P[[V/0GY7,@UVE3T;XLZ*Z%)3PEU))R/\
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MO8BUE#<6WQGSBI(4""+['D8VVV'>U&Z@6W N.BO)6Q+; >8W NPY*0/.C/@
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M3>V+[?72$=.?S"E#ZQW<9^NQ1_V:Q:U+T=1;_5YV <%^9QM\<1M>"6XK1?\
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MT6(C"3P9$MQEA.,J<!QC#F52PC4I01+=BI9 2^6<FW09Y/&4BCE)2\S0A*0
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M%U#I9<DG55%72H_O)JN*30"R$]Y3\,E*:P2GP5%2 =U_=T'"D3$Y]QIJ.LF
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M/<CZZ11_TVSRY/'#)C;DDXQPKVSG"1A/;)4 5$[LI(*@!N_#0%BV[D<NF "
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M![I6@E*A^XCO[CG6\'C&H%W (\CZV\H\RF(5*F+EK3I4A12I)V(+$1Q:H+V
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MDEBQ& <ML0=P-B1LQO&S6A*QI4[.#8D7#M<,1G;.\8G6O8EB]!5UZE=#^F=
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M(2/;'&T'N<#&,_ER??6(I9)\GN;\A<'UC- 2 P 2;"UF!W. ;9WCB4,8&=^
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M5[\FNU\N]L78QC36[TPXMUU\H* @I0DY"<!)*<%8.-^TJ2G:E)&-J3VF%LH
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MI3#:UK^[FU9FX93D7EUUU,-I%OUM<20&WUTUAY2'U-/,O%693T4H.I"4BVQ
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M:4J()Y &5<)!W<DGN>VL!2EJ)4LDDWN2<VM?KCELUHZ)$J7)0$2T)EH 'A2
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MJZ;355FIAOG"%S*ZJ5"42,)\QJE1CV*=N5 6#,J5J=51I2Q=$I"47LWC65J
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M"6G4NF15*E*>C4JBI886M3;]9J$) 0T60[(D!I"Z3J69/E*1+EI221XR2 D
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MMY1YK/C/L"7U*Z64]+2VFV:!=\X)\M:4+5*O>J,/O)5MVJ#C]..5).W>H_\
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MEQ7FTRV(ZE15J>53;M;;(.O&IE33RM12\U1))4LZ):23N/;7<_\ L[W96_L
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M#WWSM-?'R,LE94&'G!+3DTU7,I5$I\227*#S&"DOX5-9\'<1!: JQSI(#-Z
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M0A@IW*2^M!6^05$;8S;RA@X"?Q&Y)HYTUB$Z$'\:W MN-U'RN0.D:RKXO0T
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M2R*>4B5)E"6A L D#FQPY+[GWQTG&?Q'C!2>1C.,E6U.X<D[<J)X*2D$'!U
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M$PE,M?,U5NGJB72*>RP#$24/)>=WT\S8<T":M$997K6$#225*[N87(#@D(U
M@NHX2=F%K1(J!*02-0(8$)+LX ;>^QN<%WB__3_IA;**&+L\/_42[+&J,66
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M/;'VE'H+3'R[*FIBD*^0$J6I]*'&BB2XJ*?+=2E*PO75L[NTF2AS,F)<D*4
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M)\:N\F+4'#E*0DFZBI@  ;\HQ:;A<A4]$JDI9<N;-.@S$2T#0@D J4S>$!P
MX)QO&6=3LWQ/])Y56N^T+2O6TKIH2HTVD3XL*M?9;3,>;%C*83=UN/FG0768
M3CTE,\5%4=3[!94@+E-K'@G&*>JXY6U5=5R9BDSE*4B9)0)W<2TD]VA!0RD!
M  !(9;N6<O'L= *3A]+3T%%.IEL-)ESITM)F%3J43+7=2B2S %@&>T;3_#G\
M8GQ$V52:=;76%-&ZRVZJ%%CU6FWI'9J,X'R!\ZPQ7$I1,F)#H6AMZM)J0#0!
M=;"BH:Y9-1QOA<X_<ZY51*!84U<\W0' .F>2FK0PL$JG+0G2/ ;F-E-X3P^J
M"9BI/W&I3F?1*,IU9LA+RB7_ !B6@D#VAMMDZ+_$.\)5]_)MVOU#N/PIW:[S
M_-^J;+BZ1SI+KH68\BB/!ZC0&%NE1?DTQFQI@2L[JJE6[&XI^TE*2H<2HI]
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MI_U K,M4^K7E;]+N>J2EG<J14Z_;M'K-0>4H@>IR;.DN+YW!15NQ[VIJ-$D
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MZ1?7Q=?06S&=(J-':OBDLEB>&4JDI8MI9'LG*B-8-K7<',?JK203'81G>\Z
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M#S\ZN[=C?5&E#I_=U!1$O2WW5P9%/7-7%?:?@[8KQHSBR\V*3)*7),^E@^3
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M9V4220GR_P .0PS\\&-G+F:@U@191Y?(']^A>L4T6T&TH%7I:TIP=XF1U(!
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M23)\NKI"M"3I143?NB%6=N]GI"23LFQ+@#+QE40'%:R31T\N:J9-4$I*996
M<E]+A(M[:F2,DB+G^&7X>'CEJ]4B7C#L&V.@] J+CZ[<J/5"I5&E7P\E"$)5
M&?H]&@5^IQY3:E^6^J;]B)D)0'V("&UA#?S5]I,[BG:1J.NXE.D\.G,*:BI*
M=9I9BK**IDP% GS$E@-14P/A O'TSV"I>!]CY4V8:614\6$A/WF:5RJBIDA;
MA2=1)DR)1#DB42Z@-9*F;=ET'\+GC'L"9$>O^L=,+J@MJVJJ5-JUQHK"LJW>
M63+MV*"R4J2 W(=2"5[@H@$*\>E?9]QBDJ4U%'4H7))+B?*TS!<$I"TJ4I(+
MC2E7A-F&#'2\2[:\ K$JEH7/0O2Y042^[<.'!3,8D$%F<AKYM>KQ9^&3JEXG
M.@E>Z2T*_IW2RNS&VJ@Q46F1+MRNJAI4XB@W3%\N+49=#=>\N4AN!,86W.BQ
M9+\2IM-*ISWK?9^LX[22I-!Q%<Q=!*4)@EJ6DE*4!PE"E.I20;IDD]V"'2EP
M(\?X[V?[*UM8OBU-+0CB"_ 9L@,I4U9;O%R@>Z[QV"II3W@!\:FB:^$/PQ6)
MX1^B-L=';(/SRZ6EVHW?<S[26*G>=Z5!+(K]T51K<XMIZ=(81'A1''GS3J5$
M@4U,A],0.K]?H*R@K)0305$N:B6P6A)_BRU7<3I99:%.[ZDI<X<"WS9VDH^,
MTU<M7%J.?2E9:1K&J29:2K0F1/2\J:D N5(47)U$#4T9/:SE9]S\L;1SD8U>
M(3PF]%_$K1W8?4*UXWV^W%^6I-[TAN/ NZCI25+;;8JOR[IF04K6LJI=3:FT
MX^:ZM$=M]27TVI]/)J)9EST(6/PFVM!_F0IW2>>EM7XK1ON"]H^)\"FA='/)
MDZM4RDFNNFFNP.J5J "B W>(*9@8>)@!'FJ\6_@$ZJ^&26]60T;RZ9./J;@W
MO28;C,6*7EK;8AW+!0[(>H$]8*$(=>=>ID]Q01$GJ?W1F^0XAP:93*,V6#,I
MS^(#Q2A;^\!R'+!:20=P-_=>SG:[AW:!*92"*3B 05KHIJAXV#J533#I$U ]
MHIM-2 24MXCC%T^\0E]=,FT4439-?LM+:HS]N59YUZ/!:6'BMJ"7"XN*P''W
MGVV$$PE/..O(;9>?<DKA239U,Z?:E+;4DDD !_8OX2=V#-D,'%_BG":6N5WB
M$B34H)9:!I"R0S30 -=V99N^"; [(?"/X['.AM480AZ97>B5=G-BX+04_OF]
M/IDQY/S=<MAA8'EM!Q1?J%(:0W JH67FU1:DMMV7GRN(*IYFL JE+([V42RG
M=C,2Y++'XF\*W(]H.. XUV9-;+6DH3+XC+;NYP\,N<D)82YE@2"X"%OJ38,4
MVBY7Q:OB%5NW[<L[I'X>>H#M$/4%ND52M7[:%35'K+EM3(0K=1B4NJPS\[1F
M6Z!Y7SK\53-2=G5:)2UKAEJ2U)UO'>+3JJ>BAX=4%%,A"9U3.E**%SN]23+D
M)FC2J6D.E4Y*2E2[(+)"TK]7^Q#[':3C%&CM'V@I14U-1QA?#.%<)JI:3($N
M@'?<3XC4RY@TSN[0E4FF2IY7>@J(6I<K3J]Z:>);KQT\L^57(/6.^Z!$J8<>
MC4BCUZ;$:J#ZBMQ3BRJ4XI2WD))5+6I2U%U;B5(*FCKE F?2J*:>KJY*EOWA
ME5$^2]G 4):TA1<W40XYF\?9U5]E_8BMI9*^-=F>!UHDAI$N=PNDU2P X0E:
M9:5=V DV?3>X 81@9U9ZNWCU.N2H3+JN6K55#LEZ1-D5&HRILB8XI25NR9$J
M8Z^\\\I!\L*?+CH\H@J<2 HPERI2%&<O5,G+)*IRB3,45.25DJ*EJ5^)1))^
M,94NDI*65+H:"DI>'\-I;2:2AE2J>GDRPY*42I24RT6)<)2/$Y+XBTU2N1IY
MZ/#I\EP0TLM,NH"UME>SS'9"W/0/,?#"5EQX!6Q:TE 2",7]22VDJ9W;1I+M
M9\$7(VN'BW4<0D$I1*F'NP$I+VP%%9).^E+O<.0P BU=<NF55I;TAMPMQRI2
M(K945>3%1M;;"5D?U8!*PD8X7ZRGU9BP!P21M<^GO^,<G5\5-3-64* 0"TMB
M7"/9!)&QRU\L2T8\]4*P9$NE49+N]PM-NR#D$[Y;J"-RN%[?):C<*)X/?;G6
M^X3((1.GE.D,PLUTI+,]\GT;G8>'_:1Q,3:_AW"9:@5&7+7,#C_YYF ESD#0
MA%CG4#$Q@/\ DQI,%*0CRX,=;/J !2VD Y! Y!RH_0'*5 <:P=/>*UJ+^)0-
MGOR;.<^F8[WAL]--2U-(D!*Y=')5)VU"6AC@ 9O;.JU@T46K5,0KEHE24<,U
M2G_*N'>K <9(3RL*'*O*2K'&P+2E7.=V2B69E+.E@!Y*Q,=@]P7V=[J%LW.'
MC1<5XE]R[2<(XB[2^(\/^ZS&42!,01=W RE O@$)9[&I2:VVU)5O;:=3342Z
MFRM9/F-N18C[R$A:"G>V70@*9>RV%@K;2E>X.69<M2D@7'>J3+-LA2PDLXMZ
M>NT7^(<5"9RI@*2:&745J25:M/<29LP.WA/B#:5NEPX&'AM1K F5&SIZF(,A
M/V!AM4EY]"(\V2Z[%+ZFH\Z+(#3+H+BG5+4RD>83N<.!M9$D2Y%:AU =^ 4C
MVE)#JL2DW8#9\;1P7%>+FMXAV6K0N22.$%:5+44IEU4Y:Z=2U!,Q*P@*!6I6
MH@)!+Z@1%\K"Z,W#?52I"(-$<J-+IPJ I46-)@A<Z5!D)-8J<Z7*=5"HM-@O
MO-2JO7Z\\Q1:,VZQ\S\RZ85.E6 M%,*BHFK$KO$E4Q<X]W+ERT)*4I25  @8
M 3XE*.D.I48_$F5/DTTF7WB*+6FEDH/>39]3K>?5*4"7U3/&K6LH2=";Z F-
MR_@J\*-/K4BL=2YDF14K9Z7(DPZ[<4. J#;U0KLVFQS3.EW35^JM/5&34+GD
MSHZKEO%<=N4S2##JE4\Q58H=NP>'X]QY/W1D),FD(/=)NB?7$.'FRT@=S1O;
MNSXUL06+QM.$<(UU*:J:LSZ]*B)]24I,BE2O2II3A1F5*@6[QW#@AW8977GT
M1@2O^%SI7=U3C_SOFWK;5X4&NJ@,,P':G5NG=-D-VY&9<<\NGV_)M6IN6[8\
M!U[<R[:\NG"2V^U!D,Z*FXI,I#PVI$HKEKIE2IJ K2$I^\*)F !].F8'6P!0
M%I\)#B-C6\+E3S74TQ>HF:F;+60""ON$IT[,#+=(U%W2;A028T]=8D5F-07*
M->UL-1ZE36IT>#=$>&J3&N"!3Y#[$:1-*U_>RXTB/.IOS8&YF0&?-C17W7?-
M]+X=.2)FNFGA<M;%<LK_ +I2P'"039G=L6MT\TXI*)29-7(9<DLF> _>)1C4
MJ[V#:B^0&!+G6C6;=^9J:G7Y-*$9:D%#RJ@3.92I2E*;^487)GJ\L;B@1H;B
M %(!PI:!KJDSQI<:U%K@"Q/F6 '-U 9CBITE"9BDLEL@N0Q_E(%W9MK@/Y7U
ML7^8METQN6X^W<$]UPKD!4"=B*VE+*I!54*@&'F%(82ZW%$2*Q."DH>:>8#*
M G#G+FS5>%+ 68L[WY:A<-G'-KF]*")*0HBY+:@["VY-[#D 3T:+;]=;L>FM
M6_&<?;:$B@R9LNG-*2%0G)EQRUAJ5&0^^I#AAMT[Y<R?Z0_$1&6[N2 \[FTJ
M2E/B#%_PNX&YN-\MR9VC#JII4IDD,4W8 #-@6)=FS?GF,<:_4WI"XKV0ISY"
M6%?5+K;@E$D8]14DR-B1Z@E/^;@C- .D7(P]K]<_7*T8:I@)]"^X_IFPM@6S
M%$G5>4_3&5..*6J)$53<N8+99AOL.QF@<*)'R;VU'L E60<$Z  =3G;?)_I%
MG%PXS_3KZY^=]+=O52Z?;DEYIN2TW!FT.KL+=0B--I<V'%M]Z-(2DM!2XRV(
M528<6<HF,L3 OS&4*-@Z@5A)(_E/*[L''O\ TC+"DE""4C/BW=PQ!'H^YSTC
MABUBJV[$D0):$5&D5I4M27"A3SIC5*-!>F,N).UT/+\YBJP_-4WOF18TN*IO
M+^9J\6E3>S;R+9OAQ8^>,1 *8\GY;>0Q8&SQ9RNPUTJ?,AAU,AE;I=8<95_1
MY$)]9=:<8[9;!6AUDXR&'5)2$A3FZ2;@'!;!#$,1[M6][O$%@ F[W-P;7V%C
M;HUO-GD-F2TB3Y34=#]1A0WDB&\A3D:KQ5MN-/Q'@3N_I%*<>CM+;RX),:(I
MD>>M+@BHON4C8\CMTY%@]BUQ:)HMD8%@68AVYX9VW<#>)1+C+MJH0U13Y$=+
M2;BHTS:9J9U+JC<=]$>4TMQ<5;$:(E]F4E+:5+?$F)+3Y\=0BU3XD&SD%KV#
MI8<WV?EZ9JM.E8_E*=0+FZ5@'R/)GR^6BXR+7DW)38%5H:%KK=-1\]'ETI;C
MTQB#"0T4Q0D>:I_[.CD_9[2'-RZ0TJ(ZGS8+;2XNZ2A6EB[@VN3Z .W(>+G>
M(%*@=<LL ;,&+]#FP-LDW.T79M^$GJ!&@U5V(S(NZG)=B7/%>9(@UF@_+L)I
MDY3J"7'7@MN:SYZD9B/Q(+* 7O-:=J+$A2F2/"@C-MMF][GG$T^,>$.L %9Y
M@8?Q-TM8'F3&8MFU";1Z/1*(N4BOVF&&Z,:%5\E^DRGY*TL(@SFW"['=34WQ
M4:3(8<=AR*J]5:<4%NON_:U0@@^$J N78$"P*LM9G?E=A%I12ZAINSG'/;)#
M<SG$=WJ8(<^B(<16GDI8C28"Y$B*RV_'"TN-H3*?0I3AAHD[&)C3RUFF2ELR
M5._+N>;)K;3N+N_-[ MRO^6UY@$J'LD; Y?D^_+ P-FC"%^Z;AHEP5"EU%F5
M$E-@K<B/R/FA5H[+[_R\=+R-L9^5&#LLPI+86'?F); 0F292V\:?*"Y9*5VP
MDAF20#=MQAW-F?:,R2H(4GPXM;)P !@OR_#FUP8R$Z,5>+(K <A'R(TZ0B6
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M]_=:]Q]7BGU]>7T89QS_ +O]NC-8%F.3Y;6;^F8#]?E'ZW #M],_0@=N^?\
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MZ$68O%4+4A04DW%_V/GTVCR/_$$^&CU0\.<VJW)9C<OJ9TP#9DLUJ!$0Y<]
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MEN(UE52A1BIFA+O.E3 %98(2%A.Q.D+(9L6+WCDI,^=64W"="_\ BO#ZN06
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M76I4Y56CR):6%%"5J92X^(^_+JGU-+EASRI"&FLQ(2EV!\OT'P#W\KQ@S#J
M-\'5YO\ (8Y/?<1&:@"68RD%:DI7&62M!Y1\KY!4LX'!3(=0O *2<DY*=3B!
M=O<#;#!K_7Z#H08R5M2XCBDJ:4$/)Y!R6!(8*TJ("\J:4K<$G)+:203MS'<'
MS&#YWQRMY^< #<.&SFSX'/G^4=NW9 0EZC/[G B0L-I3A3@(0I*5(*@H9(40
M0  5#=E*@"!'XL$<S\/F'Z[Q)*F!3F]FO[GY9Y1-IE6FT9##["UOQ6DMS'&@
M$.MO0'5/Q9:4MN!YC#3T5*MA:5]WN4  VTM$6U;,X? -P07]?I[14EM63C!(
M]H,0^?=OTBJ5Q^@7)2*.W(BK@S*9##-.>I27'H3L9Z;,F/JFQI[[CBW2]+\U
M2X]30RTA]<./#9B1(VV*0H:BSE:G+L&M=@ S-C;J8FX4E*3;3@@N<DYNYODG
M#.T1VE4=PKCRJ;42NK17&BRA#<IB46QN WH2T1E4I28Y<:D*+;F'2&TH2=7&
M _#:S6 8B^7S;X;L\0*27OL!Z>@MT/GB+]LVXW>5C0ZS0V'!7;/4XJ=#C^:H
M2+>>?\[$2,M(\@4JMKGN3(;"4^0[7W'6E)@2XD>'; (F%+ )6 >1U7M<D%PP
M##;+YN(!5+=(\2'.;E+=7P039BY;#1<GI6W4*%%17+=B(<3(B&&U#D%$L0JL
ME;SB*9."6FEL1Y@D#[!K*"X&&GY=&E[VYM/2*JE@ZFU.1;!#@NX'I?'N+&"9
MK-J38J9P;B]B?RW<F_+)&MVC0H::/U$Z=?/QDS2ER)09,U+\JE5MO8BZ;?K<
MAKR75P'9#J7J;),<"IQE1%I;156W&6\E ,Y'\1(<>T$N % ^%0.+N"SV+BXB
M!5I6"D%#@[W+V(9W8C8LW)Q:YCZ(%P6Y5;CHZD0:F6_+KU 7%?D1$NC+S\1J
M0A@;HK[2PNFRD!<J.\RN%-0Q5G(Q2)*=F.'#:2+NP!%BYLW*V#$')>Q8;X8B
MP8,1O@6S<V>Q-P795+<BHI\E2YH<:EL.2Y^V9#K,,LM;&9RP&Y+-8IR60PF0
MRRXNH06X\E/S02^J1BE)',#4&<[_ "8[_P!8R4*"]@#8GH!@ ^FV'Y/%@+JI
MT.K4^ER:'443%I,MR(Z9"C-0$NI5(@%"E%:U09"3LBQRXK+S,UAEN.Z5"P2R
M<:07<-Z;!AS+MO&7+2KE?:X)L"YN=3<FS8.(NIT&+Z+G2VZIR.MP(DK8CEU(
MAU!M[RI3<A*%A;!<6W\]#SC<5(+FY*UH<TE>EV+/?22<E)8@@Y=.#UPUHVM(
M0I*_\A) _P#>!#^H(<YO<QZZ>D,V54.FED29RBJ?_-NF-3E%!;4[*;CMI=?6
MV?P+?*?.4!A.YP[1@#7N79B:J;P'AA4^I-*B6=5R=!*0HDDDE2642;N2\1 :
MPM?'E;Y<W:+DZWT5AI"/F!G/OI"/ND(:0AI"&D(:0AI"/@ &<>_?2$?=(0TA
M#2$-(14*.!]K4K\JC"Q_\4M:A,_NYG^17^Z8B1X3ZG\_G&YC7E@-F=M][GE'
M@,-23XG!OFYNV!"+/WE33#J/S2$CR)F70 ,!+O(>22![D!SOC#@P,I(UR'%J
M;N*DK2/!.&L=%L-8PWM'4!U(.'/IG9VO%9P\2EG^-2M)5?,MGE*8_P"$%).Y
M1=0>+<URDM5ND3J:\5)$AE0:>3M+K4A.U<=UE6?2MIU*7$J24G*00<@'6N"G
MR,AA<B_2V<,_YQT&IF;W"WGTOU=KYBR]8J4R$:+U4@L;JG0%JM3J'!:&SYR,
MV\AAR0I)(2%-/;9$9Q?J\B13N[;:@,R2!.E*DJLI-@>H>_/?'+H(BL!![Q.#
M<\FY6(RSBUR[LXC*_I]>,1ERGU>!)^9I%3CMK\UI6X.Q'=BTK"0?ZZ,L!002
M%(<2MA825+Q203*7H4X8D'WV?H Q].L46D3$@BX5=]@!^;6R&+[QE_"E)E1T
M/-*0XE24*WH.Y*DK 6E2"224J00L?D?UUL1]';\_K>,$@AP20 ]N?IZCZ>.X
M??GO@C@_KD?3)TBC-YW&/,&_UM'[2<^^2!^O;]<<=A^_WTB,<R#G&<@_7DCW
MX)[_ )]NY]AC45-C<^0S;H[<LV$5"74[EF;&-WRW[1SA8Q@G!_,<']XQV^G_
M %YB' <GGDDOAL&WO^8B;WR' W!S9\,!BS/'*%!7<'&>"..PQG';\O8XT=FS
M=QFQ]XW)OR^ 'Q,<9OD,/ENSA_*/VE6!^%0'/)_V<=B?[\ZEJ88:V&/S;G:[
M<_.#?MUC\@Y))!P3P,]_^H$XQQSJ/5V-BSFX.W/<LUN8B6D,7LQ\_K.Q^4"H
MXQSG/.<<>W]@^GOJ0!.^[[\K]1=_Z10L#;#;^Y_K?I!*R"$D[N^>.0>3SR<X
MP<\ CC4HC'*DYY'//!_?[8_[="<GUA'.$!U);5SN201SCU \D@Y'UX^GL-1U
M6?RMG/N^OC)'M _6#$-JT$M%:-Q"5 ET)WI1C&"A0)VJ"2%)0E61D$Y&[5T7
M%B ENC:OHY&S",A]62;=-F)\MMQ\ 8C2MS*@6U$>6M#B5-J2E"EH!2E382A&
M"$#*?88W$86<P^O7Z>(MM\/R:-2/Q .D/V%?D#JS2826J+U+9 KY99VLQ;UI
M$=F+.0K9@(%8IK,*IMES[Q^6W4W@G*>=UPR<9B#+5E'LY=KN]NK@V.>=^;XG
M),J?K3=,TER!8+:_0.'+@['(C5C>=LM5&$]Z$*4M"@3WR%*5M&[' 2$J2<!6
MT9& .3LEFP 9@>KO;;D/A8QBH)"DLKPL Q R,,1<Y+NT:^+\M5VB5%]820VI
M0)(SG;GDG Y &"2.#QGWQAE.E6ENIM[GMF^.4;.5,0I/^(-;;?=[CH/@+1>S
MP0251?%KX>'DG;_]=6U8_&>1.G)A$>WXDO@?YO)"D@<FS/\ [J9ST'W#^OQC
M)DEIJ.8/+9N9O=O<;-&\[Q+Q;F\.W5^1XDK5HE1N"P*[;S5H]=[<H<9R96(U
MK4RH3JK;W4&A4IAMQ^J3NGDRKUQJX*5'\V?/LJKN2Z<U)ET)J(]R:Y3%?=C4
MM1"@'TZE?B1BZO9*>=AF\;@%2DA1(8 !CG-C[G<?X27$6;NV^K1ZAT./>-GU
M^E7';M<BIFTNL4F8U+A38SH&UQI]M1&\D;'6SA;"TJ;=0AQ"DIU>H*4_*S$L
M04FX4,@]"V/2+EF WW^&&L1;?>_6,*KQ2%.G9M5N*BG.T<YYXYW>DY&3DXQ@
M)P1?EJ&IWL#=GQ[@?K,6PD)9M]^6?KW7BAVNT6I33SFU#;*PXMQPA#24-[LJ
M4L\)0E*%*W*X'NK R<I:DAB3;>X:U[CR>W[Q%99GNUSU;W]?WC8[X6Y-4\2U
MYV15J9OB>'7H/</\ZJC>;[+S5,ZF=7*&W(A4"C6FZO8W5K6Z>/R9U<N.ML>9
M!EW3&H=#IZGRQ,DQ\Z1(5+3]ZJ'0%(/W62;+4E0*5U"DG" @!$D>$KU%;6#8
M2WUBRBZ=3%F\3ECN^;7#DWM'H2L>8FJT%J<E)0W(><+2/Q*;8;0VS%;)&,[(
MS;;9/N4D_4ZNA14'(8WM^0\L>D339R[[7+/Y/Z<M[1)7!]1^1P1[_N/^#J47
M;'R(]^WQ'JWPZZD \ [3SCC)Y_/(/&@#>N8B4I  P^(ZBF<'&,G\O["!V_QS
MJA4UK>3!SY$LWOO$&N0_QS=HX?)7R-O[OS/'T_MU0D#/PS\(EX@P(&P'/TOD
M;XYQT8TV!+<F,Q9L.0]3Y'RL]J/(9>=A2O+0Z(\MMM:EQGBTXVX&G@AS8M*]
MN% F\B5.6 4RU,;I*O"% %B03EB"+/B+)GRW(UC4E3*"2%%*B 2"Q\)TL6-[
M\C&,OBB\2-1\.-#M6Z&;"J]T6S,N6+!O*N1HY=IMM41Y#B#(D.1I7SL65(F&
M,Q&DN0)%.;*BE]:7'&6U=#P'LVOC-6NE74RJ>9W"UR 2-4Z</$B4 6/,F^V"
M\:+CO'?['I!6"EF5,I,U(J- /\*43XIIN2&\(=F#WW$6LO'J;:'6F!$OJSJS
M"KUH2H+[D*;"DL2F4/PG'H$ZGR%1W7VFI].J$.33ZE%W%<2H194=Q/FM*2--
M7T-3PRIFTM4A4J=()"@0IB<@C4 =)%P<$$&PC;<-XA2\1I9572S1,DSTZD%T
M@YNE0%@M*G2H.64E@[/'G0\9WAGZ0=3+OG.4"#$L:\7UN.OU>@Q6T4RHRW,)
M0NK45L-L.OKR7GIL$0IJE*+TE4K!2; I)=>AYQ\8#)F)]ISC58ZD@-[0<!^8
M(VWWV93%(![Q <K22WA?\*G=\L[@NWEIEZS^&[J_T)DQG[TM>H-T.JO%-"NR
M$#-MNL)2 XE$:JH8V(F%!2I5+J"8E42"77(*62%NZBIX544[J[OO)0OWDMR
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MCY_3 Q'^H:)ET0JBFJ,1)5%BPW$E0R['E/.E9\M4@I\A4>&PTWYKQ<;$UY:
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MN[%F+@[],@9ZQ]"B#C'!^OX1_;QJF&W;SP_4?7OBC$6+7Y[;>G7G'[QA0((
M/8CVY.?K[8[>Y/Z:J=)-K<W]]O=TRT4P0>NU\;A_@?TCZ<X/((R0#G!XP<_F
M,\<#O]-70U@#]"T5*B0VWQ^N;;Q\2"LX"CP,C/Y$?NYSG]?[709_7W=8C'92
M", G)YX'T_0\XSCWQVU7SA'[2<\C'OW_ "_QQ^[5LG46'YW;T]1Y\XK@_'\Q
M',E7/L"...Q_Q_UC5$A+L<\K^^[?/G:*N2?R%Q[KC;X1V=P6@H]\#&X@^H#O
M@^W_ %CWU<2&(/+IU^>/HVJ%7#NS-S]?I^40NJ,+"U)! 2$E7!4%$J  &$C:
M %)4.PX.2L'&IG (%L7;K]#?X1?3<6-W!] .>W3EZQ'#Y[*T/(7A:%C:M.0K
M+:DK2I.[:4C(!W$)W8Q@ISJ"N;M8^70\\_IS!$;$7.>=_?G9\$GS&ISQT]+&
M;6OIOJ;3([;%L]0V7JC,+*3Y=/NV EO^<,5:4CA-1W,5=D$*\]^5/ 2KR@!O
M>'3PJ7W9]I)L-]-AY;-D7Z1S'$J8RYQ6GV%AS<CQ;L["Z2#9F<F-6%WV8BZV
M'7KD:3)B)RN%0%<TQI/XFWJE%_JZE4%@!0^;2[%AJ2$P64NMNRY.=8*4203X
MF<62&P'+>99W\XQ94W0D#'B+K! -LZ3<@<VOL3%CNG-IBV?$=T1J,5OR&(O5
MOIV[AO"&TMMW=1RI(2E*4@)_$  $C\(R< X<]RF83<E*O:(?!<F_NC;TDP+6
MASN&8ONP=^9N1;U>/2EUI;3]\#M)(7N)P,G:HD$]]N,=^.<?0ZXJHSB_7J<;
M_#(OM&^2;.^-P#LWKC?;R$:V;\0?,D#;QN*CW(R =O'Z9)RD$#(_(X:DW')K
M^7J/7XVS#5OS/J^/7].>(Q)O%A* XOT@@JW9!)3G\\ _EZLXY.1QK(E^T"19
MN7U]>31 J(.+CW$'H_Y_*+4THC[12D8)SG:KD]R2., =B"01D$@9SK*U!6/E
MT'SV?=_6-SZ^I^OWC8?X8&PW7(IPG 6GOC<02!GN5<!)PH?4D) U076 ;8/N
M/[GW/BT06"!?.^W/.<\M[7CT3=+%@V;3^WI*A^?*4D_K_P!7UR-;$%P_UU^,
M00<@VO;J_P"FT7!4YG/.2.YQ[?[\?0#G58J2 X#NEO)B4DA][?O'6D2F(49^
M7*?:C1HS+LB3(>6EMAAAE!<=>=<7A*&VT)4MQ:B$I2"20 3II*F !)-@ [D[
M #<DXMY060$%2SI !)-V2 -1)N;,/3/EYY_%15[-Z_\ B)>ZDP%U*MP+:H$:
MRK(75W%FG4J''?G2*Y6[=I93L@3+DDR2T]5GDJJCM/8@Q@(L?SF%>S]C.S<O
M@\A7$JVG2>)5(#*F>)=-3@)[N4'![M94%+7I-RH GPD'R;M-QZ9Q-:N'T<U:
M*%)2F8I!*34K!)42Q!,H!0 20Q(<@@VUR]7O%=T;Z-W9=]D6T]5;QZOVM9=P
M7)3K1M"AR;D/\YJ;#E*IM%JB*=YCK+B*JW!166FV)'V='?\ *D^5(4IC7H4N
MO34RYU,EU+[MRI()49)(UJE!F*@"R7*4J4"D=//)E#,14=Y2T\Y8EGN^\0D&
M1+J%H)EB=-4I*4)!8*NK3EK1J(Z&?#J\5/B@=<N6^)C_ $9LRLS'ZC*F5R.X
M[?-Q+F/+?F2%P5CRXAE.R7G%+>2MP.N%2D[@<8576J04R5S5<-I4R]'W:B[M
M?$5I%@9L]6N53Z@+B25*3_.#:-AP_@]-*2N=5H'%JM1U?Q]<KA$E192D)E)T
MSJO22H%4Y"919/\ "5I>-DE%^"WT!LBE(E3HE<Z@UPMA3U4N.IR7=[Q&2"RP
M662C>,C>QOV\;B2=:5,SAB+R*"69@?5.JU*J)\S/B*YJE7:YP.F'W$Z?Q=<L
M2A4)1)RBFHY**67+'X4)$MB$C&M_9N4N7BIT'P84RP*BD=.[&;HLXN82]#:=
M2V-O)4XXI7D)0E.%JD.$!E"5J4M(!VZ[B'$Y=+(7,G*ET\J6"K6G2@ ,XP1?
M# !^6(M</X?Q*OGIITHG5"YBB"F8K4[%G$Q0LEN9(8681<.X;9M:/'9M_KQT
MGZ9=68)4PAUBX;>M]RK4UE3A0IVG79(B1:U1YS&WS!,H]8@260MKRIN25)\\
MJ_M'IZ<A)F3)\M#@(6H37M98DS=8. SAGN ^?3^']@>,RY:>ZK$RDK%Y#%4H
M!1(*5C$S42S:2 7=K&+*=+/$;(\.'6:LO>%JOWM;G36GN1GG;,N^ZY]Z4BG2
M')4^' F4G^=<-VN/4FH5%J&Q3&:U*N&Y/):DO4.HIIC;C4'F^*?:16\6I9LJ
MHHY/W,?PY>O5][!;PS43QJ,D@ :I(49("=(3+#OTO#?LVI>&U4JLE352*^8H
M+J$TB!(HU!3ZDS*4'NU%1+]ZB7+45EW)O&TGP(^.:[+Y\0=6LOJM<E0JS/6!
MN3'M&=72W'=7=-K(FO0V*;34J:9IM,J="A52ENF-#B1IE=I49QM$F=.FRG^)
MX)5%$^8B;-,S[X=:2I>M06EP-9V*DLD !O"X #QUO&>&HETJ)TB61W"C+6P(
M&E3.6=RRB'-\W-[[V8Q!4@$!8(.4$ @I6,%*@<@@@X4,$8/8CG76"V[1RS68
ML ,^><,^,8?F]HUY=</#STYN^OU**_3I5 F12ZM(HKB(T>I0_0MJ26BG'G*C
M/QF'7Q]Y*J$6LK*=D9+FM=/D29LU7?2]6G#$AP0,L0^6\P;9C)3/FI0"DER7
M<AV+8%B=G8N [N"6C%UOH;;=H)<IU HC-/IY4M3SJ\/SJBXH$*>FR5;W'"HD
MJ\M:E#)R2=1(0 $) 0D.R0&!&!=SRW)-HIJ7,5J4HE1;)Y!K>6\7WZ%)=L:N
M./5!UN'3F4^<X](6EIE#:""Z\5J 0AM21ORI2<!:0,]M0DK"%@*V=CE\69W\
MAYM%9B$J%@HK( ?R]3G;?9R\;!6/&GT@M^,B&7JY6GVD@+72J851@I/<(?F/
M0TK .0%H"D$'(5COL$5Z4.TM:@<$L@?$]<VWS:,=,A8%R ,N3^3<N9BE+\?W
M2\K*$6G=[J,@9+-(25?_  *JCQ^62<_75P5Z_P#H&!QX_P#_ %#_  Z\HD9)
M=@I)]_Z?7K%,J/BZ\.-W-B/=?3ZJ26W,@JJ=L4&I8W<$A3<YQ\?B(W(]7&1S
MC3^T4FRI"ST!0;/R*@#SY&'<K&"&'(L,<OA<10XZ?!S>RP+<O298%0?5Z(<A
M^=!IQ63^%R)<4:;2VT;CA2(<J(,'*5@X4(F?03 ZD*DDWUZ%)OF^C7+L<DBW
M,&&A8N4ZL[WO[CZ%[6(BI/>'VZ:;3ZA*L&NVW?=LU9E3=2ID1R,Y"KL5:2/)
MGT>2]+HL]7EDA$AJI1YC*\KB+CN  51(\7>TE0%&UG!!'\JM)TFQ8BW/E$%&
MS$%)&P_(M@%NAW%K>>OQQ_"?H5[5ZN=1^A,0=+>J[X7*N>Q:NW*8M.\7V@DI
M3+CK0A]J4L(V1ZTRXS5&P</U"OI5Y!V=)Q.93S&F/*G,VOVI:PP8+!)L7=QX
MAL7\,6*F2BHEIUDJ4" E?XDI-BQ8@MZI]&CSU7YTON[I]<DJSK\M6IV9>,-Q
MYHT6K(6IFH%KTNO4"II::AUF,$@K2TTEJJL-JWSJ;$!;4>KH^)2*H]VI2432
ME_:\"]_ ?3! /GF-1/I)M.063,E&Z9J7LYQ,#6+;N19^D2WHMUTZP^'^LFKV
M#<\ZEQ$.)7(H;SK[E'J!2O*PN*HA*" 2E;S7ENJ"L[\)(.14J[I)4^D@ZM;
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MVG)21CT@'!Y_/L2 :4X:M &$H<^9QCG@''SC:<5J2GL>H/>IXB"2G<(2$L0
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M712 GB%.NG( G)U+I_\ .$C5+>UEI39RP4V'+Z^8M5-.1-8=T0$SB; )N4K
M?VDFQ.Z3^)DB-DED74W39$6?%>;E4NI-QW _&=#K3D1X)=BS8[C14V\VE"P\
MVM)*7X[C@2K:M*QJY,P2UE*_#D,007!>XV/3X1G3DE:1I#\CG-FL0,'.^T9:
M0)3<Z*AYE:5@I!.Q25)R<'TJY&U6[(]OIWR<[U8>E[9^?H!ZX)"@"!@;;\_G
MZQWL< 9R>^ ?<\9S@$C'<'^&"=5Z>KM;RB!#;@^7U\'CZ#C(R<<_3!'Y9S_
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MZDVNXTN7(/\ -J2,R+K$6?1/,AJ5("$/.*(0K<IS#N^.\I!(0ILJ2@MDK2
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M/\:0I0!.=)=-B-+) +\[>FVFJ!)6&EK" !:Q'O\ %EVSGEO'IO\ Y.IXJ?\
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MA5,)+J2D#7,47( 87($<G6\0J:Q:I]7-5-4_A%DH256:7+0R4#:R0&S'E?\
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MA4G4%F.@AMM,B=(B1).+-G)#)2-:W9AE+E@2!>YPXO;9VFE!6<Z0/:+8'ZG
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MGL143PB?Q::)*% %5))(5.N_AF302A&!:7K(<N06$8=7VHX=P]*I'#:=-?-
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M!LW_ 'M=N4;28$HIU32 "4$ 7N&M@^;#?>X:(_282YDS>M.(Z7PVHN)_K5Y
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M5K6ESL.Q]94<,K4?QI@IYUC*<Z"5>QJ2X</8_P"8O'$]M:"FXGPV:D24KFR
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M" 9A6E6&<:F3BWLG'MEKVZE4DVU!J#%'<9;>E**437XD.I%QA!*766YB!\[
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M2VE4<272A:$MK6XIQI25+<V>"]N"K^WY\DDHE]U3SBA6F\PI4@34M=P$E(W
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M[8_+(/.CEATW?T8#Y[G,&O\ 3MS'I[XI#S0&2!N5C@$?IG@Y'<<@X!R?;(%
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MDI:9\K)DU2I$M<N4F6A*WU%4M$V80I&E02J8E10",Z-).Y:T63,U%5F*@ 6
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MH,<=]5<X?W,S'R_KTL(H,GZ?'ROL!>*9): .?8GGZ#]Q_CD<X'L.="&9[/\
M+];](JI6X\K9-]G?;K@9B%75;L&YJ+.I$YL?+RFRE+J<%4:2CF/)3E)(4RX
M5#]I!6VK*%$&<I9EK"A[G;R]W/TWBQ,"5ITFZMB&Y]"?=_2-)-4F7)X&?$;_
M #\@Q93O3"_*J:3?=OQ$O)BQ9#[@D2GHZ=J8Z?F2X]<-KN)4,214Z4YY$-U"
M'.VEA''>&*D3"#6TR-4A;#4I+V026R0 KD2#<JCG"_"J[O0%?=:E33$N5!!
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MEMSOLXB!.E)( )P'O=1SY<_Z1L=MN;9%ETB%2J-$:;5 BH2VN7),^4@.@O\
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MNHN)^=:6W)9E4I9CNL2$)>C>W4/%S6\/X?43640ONZE 5D *$QE $@K2 ;.
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MZ3N!B+AU>K!FB3&V5(\UUM,5L<).Z2M+:B<+!4?+W+]6U"=IW ZUDB03/05
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M !Y&- <<@7/U[VZF*BXPU\?KY_GF.A*;*O4!]"<)_/'T/?\ </KGMH1R_KU
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MLW=2EMUBC56ES)$*:S5F%ID#8MEQMT+$ALD-#V0KU+V^BB#+3-EB9)#)(=;
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ME*_MG7U)6):YB'4M@%,VD@#Q @,0" X<CPDN01")<ZHRG J2ZK*@#DJ*\@<
MJ)!_3A1&/WZVLN5)ECP)'N -^6,W/GC ;CZJOKZI>J?.62H#<DD=227Y6Z6C
MCC0'I;J6VFW)#BCA*4I)4H\< #\N^ 1]< '55S D$DA(\Q\]B=G;WF(2*2=4
MK2F6A<Q:B0 $DDW8M@FPY. +V<Q)Q3(M,\L35E^6YC;#BK"E\\%"W4@A.T_B
M"04_L[\D8Q-<R>#W>!E:@6]'/J.8.':-ZJEI.%H2JMFE50JZ:>20I9Q8K L
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M"_ANH@>3Z=][F[##[1O.[$N44 >) 9)+ ML' MM>]F.7C#+Q>1KAA]4>G/\
M-=3C-1N2'?-NSFXU/E5-FI,+HU,D2*<_38K\:5.;?$9M9:2\TMI3GS#KR'&2
MM&XX6M:Y@EH0J8H3$I2A']XHJ"DN!Y7;DPZ1\W?;S2)J.$RIY2DS*;7,U*9P
M4&2R7(NX+:</<]+,6%T1OJM7 FE?9=9%/8G4VI3JE7;9K-L1XS[A4S)E1*94
MY,J8_P"6PR&XL-F4VW4FFF7Y2667=P[&GX573:D4_P!VGRR0@S.]20MCI.E*
M05$J\0TD@ 6)*7$?&\U( 4HJ#M[1&07\5K#>SAP+,#&Z/HS89LRC-M+;<:2S
M3:;2H++ZDJDMPX31(<E!MAA@3)!6E4E<= ;4$M(]/E^6W['V<X0GA\I:U2^Z
M4N6B4B65ZUHEH7,60M5@I:U+*E$ ,-(&DITIU*VU$)65(RD-I <DFV'<GT8W
M>+U:ZF(0TA#2$-(0TA#2$-(0TA#2$-(1\!![:0C[I"&D(J-'_P K4O\ TC"_
MUEK4)G]W,_R*_P!TQ0X/D?E&Y@))[#7F4>$1^@D?M'!_4:0CDP/H/X#2$?=&
MA'4G,?,Q)#. 2ME8!.."D;DGG_I ?WZQJR6)M/-EG\22W^87'3(!C-X=/^[5
MU+.P$3D:_P#(HZ5OTT$OTB QL;2#WSDD]P,8X/?&1Q],Y]]<3@]=]N=@WURC
MUL$MFWGMD?7-X[H'!S^\9_(<X/'Z[OUX[:/@#;'-W^/3&?>CCVA)SC)]L$=N
M,9_AQVR#[=S7I@/N&W/[YY9M$0EL8_8CX_7*/UDDD@'M_#^&/S_V\]P?IMYL
M?R\R&M@Q+RM]?7I'&M!7P.1]#CZ<XY(P."<YX!QCOJM@.O*[9P<X(V-][7B.
M_D&\CY>6_F\4AYH)SQWR!P"!GC..WZ<D9QG5"W[%_P!F(8<_A%;9]_PR=OT\
MK0NZ;?@W'2)]'J""6)C.T.! *X[R.8\IHG:4NLNI"PK)*L%!)2H9DA>A05<-
MEGYGJ&;S/O>(34A:2#=\'D6SSMY&P=HT%]<;-O3PF=<Z;U@L4.T^"Y7@]56V
MDK-.A5N2L&2V^TTIL&V[RB/KW-GT)D.SHH6TY(@M)]#X;42.,T"N'U8"YB4_
MPE. HV 2H$CVI9-V&XPY?CZR1,X95IK9!44$@JED^%U/J"F/LJN=AU L-VO1
MCJ[;/6^P*1?=MN(\N<REBL4LN!R30JTVTC[0I4O\*BJ.M:7(SRD(3,ANQY:$
M)0\ .&K**;P^IF4\X$:"0"19:3[*AS<>[X1U--5(J9,N=)8I6 6=RE3W"@Y9
M0-O-N40OJ59JZ>\Y5X30^4=4%.I2.&G"<IPD#TI)X([ISC*4I .$M L1CHQ:
MX=_K<V,9LM;V((('OR;#+F_NS%I620L9X[@J5G@>OTD]QN[D<D@J_:'JM##;
MEW  #C&^^3;K:+K7Y^>WE[O6Q>T5 *(  7D;0>#QE6$A/ &<#G"CC"L GNFF
MIL&^"7<>@\Q;(O=L16.9!RK*2HCMC<K.3D@D;E$$!*BDDI((V@X(  O9AFUF
M'Q]-N1N;13X?$_G^<#A[/K(W*2,@ \*3VP0!R HJR% *40<JPD78>_;ZY><=
MM#"U^E*22=@YYW!(QCG@$CTY*LD8)4=HU3Z\N5H@I.^,O?Y>?UN(J<>FNK*"
M$\#&20!^UG<,<\ J&<)^AP.=5B(87)%L"]SMRW:)+ HCRD@*'*1QQP"1QC/(
MP",XP20>_(%0"<,WGCZM\8@9A'K\<^_IFW*SW!I-O)&WS$X!3W(Y[\XY(]RH
M C<>3Z1C%U,DD OOU^O4184L WZV'PY>1.X%L1<RCL?(N-/1DX6A604@Y43P
M1P!A)3D'C)!/!SS= 8@8.?2]@QWZL!%O627VL_[_ );8WB>5VY*-;-O5:Z[B
MF?(T.BT]ZIU&8L..?+QHZ"XX4H2E;SS@&QMJ.V"MQY3;*=S[N%Y<I!F*0B6'
M7,4E"4[E2B  %!FN1S'YT7,$M*IBO80DJ)Z &[9Y^E[M&I_JW\01BKSY-/Z3
M],YE3F-E2%7!5W$Q& @@H0J;(?#=+CD-I05I=74E-I'E%Q"<@]YPKL2F>E,^
MOG (R4)+!FNDD*U%B6+ /?(M'%<1[6SD3%2*&1<$ 35JP'+J"" W,9Y[QA+=
M'5/J+=,-UV\KV?B14!*XE LR:A,6 SZM[2JB^?EF0,G;]EPU(0D>A*6QA/9T
MG".%T#2Z6FEI;*C*$L%S9BY4IKDN;GX<G6<4XG5'743UJ+E@5J*0^[8=K:K^
M_.']\]4+(M9UQ]2*+3ZDPW(8%3F.?:MR2$S-B9#;M1D&54%^<D(\WY1##:@
MVD!  3LUKD)#+5+%K(2Q#"WL@6<L]\A[ 1A!-0K4F45LHNH.P)-W)+!P[X!;
MT$;$OAJ>.N%,M:K=+ZG67ZE'HCPNFT:B\\XXI5BS9;%+N.E2&5)+R7+<JDF-
M<+02$,P8:+C0OS"\RI/E7;BA0%RN+TJ4B5-.FI8$ +-@K2"PLD/R(.=3QZ+V
M9J9B9"Z&<Y7+.N2[%I:@24N+-J46=[*& F^TVX^L4B#=L*,'PB-=].G.17?,
M2I*+FM5J$J<E;6 EHU&WYU,F-A04F6]1*U*'K#^O.#,7K227U88VUI.;<TL
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M8J;)"^_6M#:5@H4%2TI\:G0H@]ZE(!"0@:7-S@52FK)GJ04A$XI"$K+_ ,,
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M("5J\P;*;Q.734<J7+4 -("EBP00D.0&8J4IF3^([$D1KUR9DRH42.\*U>%
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ME*3G:/PG.05'D!1&,X)SP,@=CD3'E;;X-Y>46U3=@"^_N=OT^422'0T(2G*
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MJO#H=)ITNDQ:FP%*F4VEQX#3+2$*+ "RR4KD,K4GF>T$NEKZU4Z4OO$IF$J
M;2%@)9*5/<)" 1<Z-:@"SQUO#9DVFHI%),4I:9<ONPHDLLNHJF,0XUK4IGNP
M!L&$9:VU2?YN]8K,K###;:+IMVIT6I/MA"5NNT>/YS ?*0GSG'4OTQII>"H)
MIVTX3M"=SV.G+E]H*0A@F?2SY$TC*M,HJ0#C*@E0:PTQPWVF2$U'8ZO27*Z2
MIIJJ4/PC5.3+61L&ES%[?B9P"8RZU[8P+%P#OTY,/*/E>&CA+A+N=RS0AH"=
M3DBUGMUA#5'!NHG8!FZPAJ@!/]1"&J^R2#R:W5O*$0+J1?E.Z>6O-KTTI<D
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M6EV&0'&WQZ]?A8-5OO0Y;D9UHI6TX4XP!GO@@G! *?P@*3N1[@9&HML<CZY
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M SS.+QQ_%:4RZDN!HFJ<.+,5$G-CY?1TJ1KSKE;I,%4O[1JE30SY;TJ5)64
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M=^7+>;CQ8K+DB0^ZH(:99907'77%'A*$(25*/L =2 4I00E.J8LA ;\14P
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M"0&TJL5 OI)NS1UOV<4?$>Q/%JCAM7.E3J6NEB?3SY<QQWTERL(\025+IS-
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M*0WR$G^K("^QVG=D* ).3P4D^E*02=03/6A3O;=S]8MN,OG.74<'IILJ\LN
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M20M 4@_=NMG.%MKPVZSQ^RXV%(6D\*2K:02<ZY?B%%)XG05G#ZD/(K*:=33
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M:PZO) <=++/_ #A*=EPJA575 07$A'CG*#W3L@'FLIT[,'+QON <)5Q2K2%
M_=I3+GJQ;\*$G^99!&"R0I6PC5Q+E29\J3.F/.29<M]V3)D.J*G7GGW%.NN+
M4>2I:U*4H^Y.=>AI2E*0E( 2D  #  P!T$>P(0F6A*$ )0A*4)2  $I2&2
MP  M'7U6)0TA#2$-(11Z_0*1=%&J- KL)FHTFJQ7(DV(^A*T.-.#\2=P/EO-
M+"76'D8<8?;;>:4EQ"5#&K*2GKZ6?1U<I,^FJ9:I4Z4L.%(78]01[25!E(4
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M &U2TJ<RD$!7*4Y.\@@*P,'(4HZP$U%1/+(2I2LG2D[YLY;./B(Z8\)X-PI
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MX+BE+"<D#!)!YP1R2;GW,I#S:E*18Z=7R##-O=DF,,<=[^9_H'"9E1,R)G=
M,H'!6HJ *BUU$&]XF,85U5-<3<$F/0Z3,4A<I+&%5.6AO"VV4+>#BO)*@%E+
M3$AE>U._:4MK1B%-,)H^[A51-1JTJ4PEI?)9-SU)*6).0\=#)'%YE(K^VY\G
MA-#-4%3D2776STI(4F4%3 H)22'9$N<DD#4 R3$NH58J"XQ@6=#:MNDE6)]Q
M2V0Y6*F4K*@&BZ7G7G  M<=N2_)BQ59<BL0<*S;G%"?%4'O5A/@D2RTI):Q4
MS?[1MJW)C;\,J9ZI7<=GJ8<)HU$IJ>,U:.^XC5@*#B4)FKQ:74@*6N6@AY:)
M&_'5WIM3E,6C1)<N76;@D_\ &U5G2')4YUD[ER9=0J+A6I1"$K+A4=K#+(&5
M% 6*2K@U,U"4RY0\$M*?#KNR4H\[L+E1.Q(B?$UKGJD]GN%3)\[B/%)W^G5L
M]:IU0J4Q,V;/J"5+463<&TN7+2 7 ,3.^&11NGE,M*DMJ,VYJM3Z126E(5YR
M(:6A"C!* %;52&'9CTHMJ4%2:O((V[B-6*5:YM:J?,*@B1+F+F79+Y]3JN.8
M2S"-MVDD'A'96GX)1E2JCB]73\.I$%RM,E32CX<#5*4OO&_'5+8EC&0/API%
M$A==J-<E;'S5L=/*-5+NE1V%)9DUJ'0:6W8-@T&G^:YM%0N&>ZXMOS"68L.4
M[4Y&VGQ9+R,7B"U*HEI2HH5.6E )&'5WTTAL?@'6XC8\"II<CM/0K*=4CAU(
MJH6S$+334J>$<-DA1P9H%1,!+I0A>KV"Y] _@NZ:U5,6Z^N][QF!>O5*6XN.
M$(<":;0&'&D(A0D2$"3&@-KAQ:7!CO*4ZN!18M0?V2JG+:1Z]]F? ?N5 KBT
MY)$ZM2)5/K+D4J"2J8+ #[S-\;CVD(ED6SY7]JO:*9Q7CBZ!,W7+HUZZG3['
MWU:6,I-R=%+**9*06(45N-3QG=KU&/*X:0AI"&D(:0AI"&D(:0AI"&D(:0AI
M"&D(:0AI"&D(J%(.*M2S_P"]&%_K+6H3/[M?^17R,45@^1C=LE./UUY5'B'K
MZ?5X+4EM.YQ00!]>Y_0=S_CG5B=42I(\1=6R1=1_3UC.I.'U-:?X2&1@S5N)
M8YL6=1Z!^K/%'E50)20Q[9]9P5$_^+G Q[YP?;WUJYM=.F%D_P )-W 8J]5-
M;T&^8ZBEX'22&5-'WB8+DK<(!Z2P6(_S$XQ$&JE42D%QYQ14-QP2DJ5C) 2"
MH<\C&.,=N=81)+DG5U<D^1ZQN0D !(2$"S #2!Y#;&WIBUNJA5)4M2D-+4VR
M3@@#!6D9P"??O]>?[=65DFQ##X\OK\XNI2 [W)W%QTV^AZQ28LL19B&R<,2O
M0#GCY@$J!5P<^<G(!/9P([E6T6AX2P]GY*R!AS;K;UBYG%XEC:L@$;O;/' X
M.23@$\XSZ<'/&0H:J0=M\^N+]+>@N8/]?OT^$=A/ '.>WTQR!^>1C@ ?7.<]
MM19F< ]1O@W+-Z\GO%7R^>?UEX_:2 ?TQV(/\?\ &1C'?3=Q8=& +.</9P!?
MET,2! ._I@VR0?G:VPC\*4$C:2?J,XXP.",]^XYQ@<DCC(B?AM\O1[GF^.<7
M'^O1_/X?,/UUKX4"K!&><')! (Y]S^>,<#\AJ,1U..89_F#O^;Q3'9T1+Z(B
MI+ F/(4\U%+K8?=::_&L,[O,<2V<;U@$)W<XSQ72IM3'3AVL#R)P#TS$1.DA
M:9)F)$U:2I$M2@)BDIRH(-U)%G(L'%WM'P\GZY4, _P&?;^/ //;.J1-6W+?
M%QON]N@?E'&I0R #COQD8&/?W.>0.>3@9[Z@JP(VMNY_/ETZ7BC,"#?XO?SY
M ,;-\^J3SDD=P<9 SQV[@>DCOG QR  !JV 3B*]>A'/EFSW%V)WYF. J_7.<
M ]C@8/OW3GL> 2D^W(NH) L?$+Y?+[_39Z0+7MLYZYW][^<:W?&GX7XO42WU
M7#;##46X*>MR709I5L9B5.04JE4.<X "*)7/*0W&=)/V=4$L/)<\A#C$GJ>
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M<F6 1@*/KI>T-.F91"HWIE":[.=.%@,=TER]C[GLQ-<#:G$A258R$K_%DH2
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M/Y< 9)&,G/?)_,@XYU0RF<W]-^?0;\A!%6Y86QZ6MUW][LY$51B8ED;G% Y
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ML7*V])E1I,O[3@//NN.E;).RH4IUQQ2EI2V%O,H0H>B*\P0 =;NG4BIIC+(
M(3H6& 8X2L  9%SAU OB/)^-RZO@?:!/$4JF3$39GWB0N9,*PI!83Z92B_A2
MZT:;@25((8AAE93*K%K%.A5.$O?%GQFI3*E I5L>1NVK_:2M/*5H_9<!3W!
MT:TK1,4E0&I)4EK%NN>H<\H]2IJF75T\BIDG7+GRTS)9(;PJ&I((!8*2;*PQ
M2H;1V%JS@]R.1SCV)(^H(XYQE/! /O;7\]FV?GZ==^D9)Q]?E'7WG<K&/;)
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MP.(<.!(CN!"FW$I42H*0H@+RE6Q:2A/V515LG3**%>!.E)<-I4D"Q#.#RZ.
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MR\M:PF.R\"NCU%W?M96&I$A11!SK@UI[U$N?IU3)!*5![J1[*B+ D@>-.YN
M;B.WD5"::HJ^'*(E4?%D(G4JE%I<BH40J1K420A"R54LU1.E+A:BTLQ;F87(
M;SK,AMQIYAY;+S:TE"VW$$I4%H5@A0(/!& ?R/&:D I<$$* (/UMSY]-^6J5
MJE3)B5I4%H6N6L'(4"1?%MP;MF[VZ0G)'.X#'/MG^[C]<^QQCC52@'Z_?S]\
M8XJE!KW\OK#GUN-G_'S;CZN_I_7) S_M[_IVX&JA"1L/=$%5$R80%*)3N"3L
M_6WE@;6 CLH<:;'*DG\@=V/?V _(X X'.?;4% DL!G=F&/I[]-HR)<R5+W!.
MP >Q8\Q?EGK'"_4BS@(;W'&!G@X.2#P#QGGD\\<CL:"0#E1<\]OGY<ND)G$%
M);1+# ,'!<"^P:SE[GW1^Z8FKUF4&F_N(R%)\]QM.5[ 02VA1Y\Q0X3@@ISD
MD>G5)IDTX*BRE-X;O<O<].9?WF+M".(\3G"4@]W)!3WJD(OH?Q)27!U%RU[6
M)8$/<>!0HT9"6'0HN-.+<BRT>MQ(60XH*4KE: K.4DDC<L *X4G5S*E4QRDL
M" %HP"P8,WT=H[FBX-(D($F<DZY:C,I:E#*6C4RR%G*D@DC2[IU$7LTPC*D,
M( <PM(] =;PM!!(!*CO)2 .P "R5#)/<:V9I)=#ARY!L1BPM?Y$/YQV%'W\E
M 1,TJ #)6AEH(.25:B4MODEP\<REH<Y+6Y1) Y!4<IQC;C]GW/.#@!(4 -0#
MI&>K^5P^?C&2HRUW,O5>UV5<,7 8N PR6+6)81^/NOQ%(R > =RE')(SE')V
MG;N!'L#P-3U'GRVQ:^/+&^6$6WE-=(U7.Y4HY_$D,68.-/A:[-'5=0V-P2E.
MTG&TY//[/.#D8VD@E/?"D@]YI)W)Z'IB_N;'DX>,*<)9L$I2/Y=G+Z<YMH)<
M@[* ) CJ*1SD#G/&,84#C Y_:P>!@$Y.<G!-Y+$7QOR< <C\18VN\:U2+ODN
MX((#B[6-_9N'ZN,&*K!:"#DX2XH$!9YV C&$\>DI)(SR225=AJU,-K.VX<\B
M+[>;6 L(V=%)"2Z@-;64SZ79@+-8O<W>XQ%=B19;ZDLQ@I)5N3D)&Y))3O2%
M<I')R?PA.T8YX%A4Q*0=1=F^'3-^9Z/&XDR)TQDR@0#X1S!)\0U#?5L6:QO8
M1>^R+;@T):*FN(W/K&$J@H>1O9@R$9#<HC<@%UMU.]+;B2DJ!+J=G*L";4+F
M$H"B$EPP<.#U<<[8M@M'>]G^"R>'E-2N2)E8M+2@H.))*6U9TZR;FU\G%Y.:
M;7[UJK=EVES5JDAVH7#79CVVGT*E,H6_4ZM5IRTJ$2*RR?,><4D*)RRTEUYQ
MMMVR@)0E4V:W=H(2F7A2U?A2D;A\_#,7^(_>ZV;_ &1PU9%54 KK*I1>7226
M\<R;,_"H@V+9+ $D ['?"QX6V^HLFAVS0$IB].K%DPZT_4*E&#<RN5V5N+E]
M5F"<^?/>+"A9%ONO/(@PPU5*RMA*8S$S<]GN 57:OBBD!8D4\@2U5\\*?N)"
ME$(D24WUU$W0I-]*$,I1V"M%VHXUP_L+P>CI9%.N>HF:KATA8TIKJU(09O$Z
MXE_X4I2DJDR22LE2,#Q(WTVK:]&LV@P+=H,1,.FTYKRVT?B=?=/J?ER73ZY$
MJ4Z5/2'W,K=<42>, ?1_#^'TO"Z.30T4I,FGD("4(&3_ #+6<K6M3J6M3E2B
M3R$?,G$*^KXI63Z^NG*GU-3,,R9,4=SA*18)0A+)0A("4I  #")%K-C#AI"&
MD(:0AI"&D(:0AI"&D(^$ ]](1]QG]W.D(:0AI"&D(:0@!C@:0AI"*C1_\K4O
M_2,+_66M0F?W<S_(K_=,4.#Y'Y1MQ=DNO.*=41E:\D]\Y/( ]L=N<XY'!XUX
M"5%R2ZB7)46N=W)_=L;1HT2DI2$( 2A"="4I#!( 86\N3<P8ZRY.W*<@8]OR
M)X[\]L#D$\8[8&A^OU^G\MH6U$&[!M^7G^8 Z1T7$^:5 ^Y'OSGC\^ .QP/H
M,'426%O+?Y$<_A\*@ _/IRNW-GR;OZTQ^*E )'U]6<$$CG'L1Q[#GZD>Y*B2
MQ]XZ9Z>[W7BJ@&/,7OU]>C#W6VHDEK!SQSDD''IR>_&3SMY/;.?H-6U /8]1
MS'U\LQ5+M<,UHH[R,\[0 !Q[']!CMS]#[]OK%KO[N7Z=>8YLT2CHL/\ R4]"
MSZ8THH8=YQY3HQY#O/;?A3*SC'J:W<()%#8NSOORV].M_P!WU^WU_66 X/U_
MCV'.,YR/T_0?4:H2"+OZ!G\K_/.U\5M\_P!MOKI K'/Z9P3C)[?7L>W[LCMG
M4&]>GZ>]^0WN6AEK>?YG%OC'"M?[R?R)[XQ@'(';MW/'<XU2WTWP8#YXM$TE
MK8%_WPU^KLVT=1:\%1^N1[$?7'/88XQGC\\8U2))+CEZ6B-7);U&NJF_9E;B
MB3'\Q+S:DK+3\=YO*0\P\G"FE^6IQ"L9"FUJ2H%*L:DB<N0HKEEE,QY$'8V8
MWN!:X>,'B'#J/B<@TU9+[R6%!892@M"PXU2UBZ57*7!\0)24F-*E3ZO=4/"#
MXK:U1;LN.X;AZ:U*HL+73*I)=EQ)%A5B2\[3:G188*(<.IT!3LIAS[/8C)E2
MX%0AO)\N25I]3D\,X=VE[.RIM-3R*>NE2U,M TJ362@RY<Z874M$T:5 S-12
MB8A0/AOM:6@I9%%*IJ.4B1+E)TRT)%DJ<J4[DDZE$J)))).HO&[*%4H56@PJ
MK39+,ZG5*)'J$";%6'(\N',93(B2F'$DAQE]AQMUM8)"FUH4,\9\FF(7+6N6
ML%"Y:E2UH(925I4RDD,&90+VL001=S;(*;$-Y](Y00G/T_">4C/'T02<DD_G
M[C!)U1VMA]CL7SZ!L\\-%(_"LXSQC!['@'"1MXY /MR.Z4ZA]?E"/NW:D#/
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M S)I%TI3,2-'A;Q*NY!/O/V:3*D)JU3E-3U?=F62_P#?R^\"THYDIR-TI#8
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ML0I0&\JWH#G!V 92**B*"55*5%KH#(2JV"6P>FUHZ:BDO=4I 5<@K7K&1=F
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MJJ7B4E5-.'=SBABI3*=1'M)0<,[D.RL7#B-W]V*4K*M/=L=(4G5X2  5.0%
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MD[25<$^P&AGS3-65&Y/PY!P?,M>XQ'JM!12*.G3*EH"0EKASJ+'422,D$DD
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M(GR E4JHI]15*GTLY'=SI:BSA*T.$J7XY:P%I(6AQ;RKL&!,6&R5,*"7HZ^
M%LK)4VK'LK'I6!P%I4 >,:U:T&6M2%922F_3!\B&(._.+D]*4JU2SJE3$B;+
M(4%.A5[EA=)=*A_,E0O%2@UB0M*%H?6W(:;+*5Y.7(X !CO#.U;8QA*5Y24X
M3@@) M=V@@@I!!.IM@KF.1ZB-A35TQ24?Q")LM.E!+-,E"QE3'LH7(&I[,!A
M+=.4Q'E^KY9LODJ4I#7W*\G(/EJ \LY])VK;*QG 6KVN!\.6 LYSYCKYEWBQ
M/1*GDM)2%ER4(="G%V0WA(-O"I.O8%3%E)M#[7FMM;GV6BL>8'4!)0"1W4"
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M=TMSU CZ/RS%Q*!645BDT^:H(8DR(ZC+@AQ*G(DZ&Z8E4A$ [E+IU1;>AO\
M"MKS1"@.$ZPI\DRIBTW*$D:%Z2 I"O%+4]P!,00L!W(59Q>(-=MG%^A_:\5Q
MO.X'.0.V"=V0GZ8_4#&>1GC5C;-_AYPL#S'U]=>D=@J*DGZ [@,__!'(R>YX
MXP 3W &[2+@NY(#;/R>^]F _.^_744 \I/()[ 9 ['C">XQD?QQJK$A_3;SW
M\\;Q$Z7QAW:SGW^?]()!;Y3G&,\). =W;G&=N."3^1/'!(<@?U^7U\HEG<7Y
M6Q[XP^\67AQH76&S:BZ(_P O.;WU%N8PRLR*/6VFEB-<49#2D!YDI6IBM1%J
M\J4PXIU1#FYYGH."<6FT%0A:5>$#3,18";+-BA6V "%9U, ]Q&KXIP]%5**5
M)N#JEJ(U%"RYU!R+/[0PQZ/&BFQ;RZD^&WJNU-8*J1>%H3W(E1@OEU5-K]'?
M4"]%="T)3/H=<B;7HKVW>C=&FM?+SHK"V_2JRGH^.4'\TJ8 I"TGQ2I@%V'X
M5)?Q ^TDWZ<1)GU'"JS64Z9DM13,1E"T.>>4EG21O8/OZ/.CO6.V>M'3V)?]
MFOA"'F7(U6I+SB'*A0*PRVV9M'J*6\@.,[@Y&D8;:G0W(\QD!#VW7D-?0S^&
MU,RGFAE NE8]F8@^RL/8@C(V+BQCT"DJ95=(3/E73@[%"Q8I+EW2;;N;N<Q;
MNK]?>IMB3I"*$8TZ!YJC\C.3E+1SE09=2E+HW'&U*G=I3PE 4,JP$U4Q%@0&
M.&'TS%[6'I&4N4E>D,<!B>=KGI@[,>HBW]<\576ZXBMN+(I] ;/XE, ..C(V
MY3O3GNK!!6, =R2D"BJJ:3>8W^0 ,X-P?$;_ *6B@ID-ASU)&=K$,WKMUBU<
M^O7Y<KBW+AO"L3PX5*4A,E4=GOR$^40 ""1D$^W(QJT9A-_$^"27)V_0-S\C
M$TRD#9(5@$/YXY[C?TSUXEN0TD+=9\UPG*G'BIY9/J(&YPK..^25!/'Y#1W
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M<I>"K.-I"=PX. /2K .4\9.,@%2O4%%-A"& %G&_1S[@,[,WD#LY]0ZU$/G
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M#?ESL=LB+#73 =H54E(1A<5:UJ9<:W+0$J62&U$@XP![[<@ ^XS50&0/#?\
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M\Y]EB:IA]UF.^(K8?<9*<2'D,+RKR@"/)#>Y0VNG(3K94*2*A# E!ES4ZB&
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M*@M!MY_RQL0"IMME'EMI'W;#3;;+*4;&&F1@#<4E*D)3-42M1 -\)L72 <
M=<'F&[6BX=2T<M*9$I*5*NIF*E=5*9[[[>@$6[Z"7&U7>J=O=/ZA.;E2JBJ7
M5I<>4XER7)I=(9,V:^ZPAQ3K<7>AB(7'4H:\V2RVKUJ#9R:W5(I%S4X(*$^*
MP6IADY+.;,;6L\9:T @KPP86>X+,YSESIV-F<1GMU"J1D+<3[!W.!E0"2HJ(
M&!GD%*,8['@\8UIZ.7I#G+ !KOU]7^.(@D"Y..K?7UTC7#XM>GC-]6(_&<;!
M"1*BJD!O?Y*)S"V Z2H*20T7 2G^K'&[9@ Y%3)$R6H*2Z5)*%!G<*%[$L<=
M&Y7\.?03!+GABP4J]RW068W-K&X*A@$GQ,=6NGE4Z+]:JM0'X$BFQX-:36:"
MTX%;?LB5*5)@AEWE#RH*D.4N2XA1"9U/E,J(6VI(\8XY0*HYM71K%B%&6IF"
MY4P'007.QTD;$$.X+[V4CN*R3,2X!6E89M+$N;,,$$>@$;[/"KUB14K'1*??
M6GYB.U#E(&QY7F*;:05^42VH()P%K2VLJ'WAVY3CR"MHERYZTJ&IBD:AZD$[
M"UFVZWCU*2M51)1-)NH ^5O0/T%R1[I?7*JW4JW(DO.$@K*VVU.%TI4K+0RM
M!05'<AO<XV%[2 @)4WO#>(N4-(!NWF-^C[@N27Y7BZ5>R0-+6#;D<P!=R6._
M)Q>*/Y:&VD+"$E2@0ZTQA122G=EPJ4CTE#6"L\*5M*@%(PG!6C2S8+MZ>F+@
MC](R4+)=_P OW%PFP9A8L&CH.7"_'2IO?EE1VH2K<IQ*2%M^AW<=J_5PO:O)
M.'-F[TX2Y9<LQ>YMRWZ;$^F8R4+YCKS]U\M\P#%">N$NR"X'%MJSL/IRV49
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M@) QD$# 4][&UB'QY/T;UY6B<NXS8N+XMTVOF+25%SA7YG_.]SSR3DJX/!R
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MDDEKW\.<;X/OB??#@>IG4"\)?7U#H5/>Z3M6P^C>5?+2ZW<,>H2MN25-K*:
MTVX22I2=N/3N*\;BFI4J7*2-*>^*@!<%DXP 645%S_\ [18GE))8$^+2 [,$
MYM[MQUC9)=54\Z0H!1VGMS@@@G"0<@8*<Y"5  YR0<ZQI,O2GD;8MG.SVQMR
MVMC*L AKERX'+EY<ST;>+1753FZ[1ZA3=A6'XC@5NP4H<3ZDDCDY*DH[<82>
M,C&KZMP0&-A9\VWWN]@[8)O$I14B8E6 +D6?W=/>"8\NOQ3.DS<:FVO>J813
M5J#=4FE.S&V%!3]"NX5*HF)*=VX6JBW70ZK(9 5EJ-=D5"CO>0#Y_P!LZ0*H
MJ:L 9<J<9*RV):TC0^&:8+#_ !$NY,=+1+5-F,Q4E*0I*BY+J)<.=KVZN.D8
MC^'SJA+M6.W3ER5I8<4TE2?,*4*<3Z1SZB%*XYQD'U@*3A!\:K*(3%J+"XRS
MEP21YV)O? $=Y0U<P29<G2"FS[.P?(<C+N+!K!HV 4.ZQ-;0^V\@)>#;NY*@
MM.U0"B=Z5[T%7 PH 8SN2HI*3H*FD(-\:6N-+9(MT=[-R;ENY,Q"DJM?EJU&
MXW\[,#Y1/&*RUE984GUJ4I14VE2BI0(6H**MR7'$JRA:5I4$I5ELD9UIYM,M
MG.W+?SMCH-R(R$JU%D@8.S$<F/[NWPZ-=@AY!7'RII2?-*=BMN"5$C>A:C]V
M4IQR%%1*E@*W%.O6R2?"S/GY@#UW\N1O!12 3GH";=<XML7B B3L46U$@J7@
MI)4!LX;*00<X]*"3DK63N42HG$"DL2 ^^'Q;/D_T\7$K)9V8[V'RM]7O$NI,
M!=3+3;*-JG=J-ZB$(*LH *%* )7R<IX.5;<^H 8RU:"Q&>5^OT7YOB]X)>X9
MN>WTT9K]#.GZ(,V'5WTMNO)=3M>=>P&SRL+0E*,AQ1REIH!!45*.0E*5*DJI
M0@!!!U6+M<#!!'7<O9N9869ZU*!E)40DW.'465:_P8-S$;7Z#6&44R+%2I*G
M%M)2G<1@E6PH&<X1L7ZL X)2,X)VG8) T."&4&8B]P!@O=V9WVVM&M#@O>QN
M1?Z?'RB3!:FF4K*\$1_2D*25I2 HJ5V(+HV[BH@H60,!(&-7J=!0L$YN  WO
M8@N<<^EFB%0=08#)=R/SZ^4:1_BQWJB/TMJ5-23YTUPM[5!85M0UY>TE2@M3
MCJ\>RLC:E&XG<.BH4F9/DRY>HE2DN&<$DE*0G_$2?JT:BI_A(GK/X4A(;;43
MGEMN_(;1YS>C\1BD5RJ_:;GD2)D0R)"'CM0R$[$#TY)44<H61P7VUH._:,^O
M\+H9E,F7+*2)A *A=P[EFP ';#\S:.9I=,N?/6I_&RR3CPC1@XS?:QVO&85#
ME19L9MBCNE#C?WJ&W$%E3QP5%8*T)#B" <*P>$E0 )&ND1(6EG ?+N+\Q;Y%
MN;1D3IX\24 %)N$WV;S?H/A&2GAJZ@RK ZJT"K,%46+*EH6^M14IM2PTINI0
MG-I6E+=1IS#;RBE'FN3*'!826@I2CT'"9P1-,LND3 P-P!-#Z3T!-N1;K&@K
MY:E29BDI]NRA9W9@H-R+/OD/<OOBN&Z+?%NM7(]/C1X+D-J8Y.<DQ8L"*EUH
M+_IE0E/1H41L#<,/O^:K!#33AR@]?+6G2#NK:[NSM;<7P+VZQRA2M*BE5M(<
MD,;#<!GW!;;>-4'B"^*9:'36;(L[I+2Y?5._%K<@Q$4Q^7 MQF>I999#\]IH
M7#7=CGI7'ID2UT.(]#51?V^>K%F5:E'NJ>63,4^G7@9NI(%A8^U8Y/(SER@M
MB2  0D. ZBP-AR!8*U7%["(_T*Z,^)'Q37!3.J?BCN"::-#ELU2SNF45I=)L
M2VI"R51ZD+?CK$>I5YAH^6Q6JTJI51A2PX_-DR-CC=H([@"9/F"HK+GQ)'=2
M.DL Z%&X#M8C#DOEI$F4K6I*M2"QE:G!W"]7\N62DYWL\;?[#Z46O9[+*8L)
ME;JDD+D/M-J62$[5 *<0<#=O"T\C*@<;MP$9A5-8K.HW<.=W)88;;-A&),J2
MM1)R 4I;8.]G)-[/Z1=$ML(1M0C:G(22$%(2I&-R^5@J]:04Y6-H0/<'-4("
M1=S@C=_U]2_.T8ZE/BW._P /B?.*1.BH=2X2T"I2?3N.=Q<"2I8P4%)1L"<[
M=HX QM"110R#\-W\@,7^3-B2=6W-WN,!KG>_J[^<8]=2*+YC2RM&[TN^8M 2
M&@D!Q(3R23L65<;4E)44DX*0"@$ $$"Q4!N]P<@>[K@ M%^4I2E'VCRP;Y!Z
M<\D&-4G72SQ/<E@,G*,I!/N0O:M)4#PD*2VI0!]*TI.PGUIQJQ 6A=]0%VW%
MG&'.PWNW6,^GU$@*<.E1<84H* ZBP&S;6!C7G==ANMR)4@1G&QDI<7L64*>0
MA6Q0S@)44)(]&4K4@DG<-<U44[I/@UJ=R2P+!L9-MA^D;:4M*72=/F5%QEKD
ML>=O<(QFN^UG(4UQQ;6Y*TATJ" I(.[RW.0?2D':H$G.'#G=DJUS$^E5+5,6
MC#W =\WV S%X@E)4SA@QLQ3;DW+SOYM8:[(Q0KR5-!(*4@#!"L>H@X(2H'.[
M&[D$[2@ !(PU73IM;I<<\9_,^L:^K2G0,$GW[@;\^8-MHAD!/G*,-?\ 7)R6
M.^7.1EL#&3C!4@ \C@'D :NJEM_$PUE889OY'<^[G%[A2TS3]U5:8-2I-[K/
MXI;,[BZD@7(U<FBM0G'H2W6BDJ;=X*=VWA)SG],[LC\)&0<<ZU:P%L<$7=O=
M9S]=(WU,N;2F9+OHF )*20/9-[89P7#,0""!M-+:?F/2TQVDJ\K.]_*MC33;
M0*ENN+5@-H;0%94O"0GTD<9.'52TD:G91L+.2_(>=^GK'7=FY]7,J_NTM13(
M7XIZE+TR9,M#E4V:M7A0A*1<DL4C239S-36J='4J/3D#Y99(GRPA/F27"GU-
ML[]RFXZ5%805*WO)]3F$N>2K7=Q-8E9.H>PF[ 7%V-SSLPP!DQV2>+4E,M=/
M0^*0M>FJJ@C2J>26T(!*BF1JU%()*I@8J\*Q+/<^=BJ6GY8HX4AQ1!P$<*&W
M!5SM//\ 5I*>2E0.T&WH7?4"'<!O(<KFU\^D9"JV0M?^BJP4J+%@FQ&BQ<@$
M'*=C@Q]55'WR(L9K<Z[A!46U$'*MN<!*NY4#V5M*<IR1A,N["022S7Y['R],
MF)??ILP=S*0ZUD)#))N5 /8->QN5<N35V934M16XZR"^EM;DD[?0E3GXU*&>
MZD$LYSZ 'B-R7TXM)G7.P)9/7D.MP^,M_+&]512DTA0M(4M$E:YBB' *DDS%
M,' )0#+"A[*==CWD8NVS1U2[FB)",?,,.S<8((\]2WT  8/]6\R,#)YX&,$=
M-5SDHI5$D%E"6^7(8?\ U)(CYL[/\.-5V@ID:;3)<VLTD,PF:IJ0&(RB;*L#
MN[Y,?:5&_IL]D_B,^4/IZ@XX GMG]D#_ #L*'!(&HSRTN4=M",88CZ^$4X?)
MU55=+/M??)Z7Y$+6&:^X;G?WU)$=96OTE.PY.X8& H X]\G( &/KSP=6PL,-
MW89^A@/UOYQGIEJU$%)\.7#,R@"1N[EO?R,5!I  "  >,G=D*2GD')4!D<D8
M&.^0KC43<OOBUW]?+/ISMERT)#) U8-P4D#%U$>R]F<"]MX[[:3D#G.!MR2%
M']K&$C"0 ?Q9Y![9U94+=')-_09^0\HS9:;IO<@:7+%ABS; AB;W<@9-1:0
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M)#GFRI'JG"/LVX9(")U?6S:F<4@SA+"42TDI.M*"ZEZ0^E[%@%ML/F'M!_\
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MBOMNNA8)4ECRR@+2Y[;5%84 01C=P$I./G_B*33S]82TN:-3@>'4/;&"'/M
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M*"I2=IY([XYVC"<>G'N>_P!<#! ]STD:)C]?73$=-QS))QMY^BB0" 4GC!_
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M/ZG-GC(1[+?B&^W6VUSSNUFBYME6C5XJV72TH+4A/E%#1R!D#)W;AG:2K?@
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M!GY-GWQ%2AI*4$ O?5D/N+O=O+EAHQJZA]!ZBEAYYF"\7$E?S+#C/+9R6U'
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M(]Q( 8V'M#,CA4\J0"!A7 !.4E(/!( 3^SG 4,8/(5R2K%4LW'5Q\\/;)O\
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M2*TJ*AYKY&4],]%0:FB6TI+99D(2IS*E+\7A"QI=P- "@Y!U!5E,DEA8@V&
M8L36(8L0H I<$Z;:@0<B_A.Q;=R(N# J4IIM2&5&;+C*D!I+["WJ^\NF/)JU
M.>;B.36J]!9ET]=1B(*&JO32IM2AA2D/OY/\1V2"P<,SDA(*MRX+.EQJ'0$W
MMJ"&LM*740%6 #EF;>^"1?HX$3>AR2\A<. _)*-K*V7H\H3T2DLI;C@?8<]0
M6\KS'J.J0[!3YL=: 9*5/ ES*DS%!)3J(2<:5 .2G2Y"[,Q L'-GY&S.0 S+
M)5S9_0L .7G%P*>0N I#,<F.N8N3%4EDM-)6M"\.R/F77X#KS%*BE:24TQ]2
MY"&FY#JG 44&D.UR23L&.Q)=O9!#VSF\6N\+>RP! -K[NIP.@.UL\XV&^!I]
M'\W+QB,K<5&8J<?RT+2M*4R%R*G)GJ1O*TD+D3 M7EK(2I8*FV"L-(Y/B" B
MJL -22;%W91?+Y4HFUCE[ 1Z+V/F:DUH<%^X5[A,2-SMY.&Y1G=K#CM8:0AI
M"&D(:0AI"&>X^G?2$-(0TA#2$-(0TA#2$-(0TA#2$-(14:/_ )6I?^D87^LM
M:A,_NU_Y%?(Q0X/D?E%YGJXE+I#A4&2EQ#@3D*'F(4G.2?8JR!SVSKQFMI_O
M,A4M+!3@I)9G2<.!NFS^6PC@**;]WGIFJ!*6*5)3R5_FW=K?+(M%/ZE5FRJG
M_1"N?#5O>^40HK>2PTMM#KS"1R CS$!ULX2"I.Y20O<>0G2*JE6$S$%(+L7)
M2K>Q%L7N+;WCKI4ZGJTDRU.0'*2Z5#_,E[W.=]C$NM/Q%],.I'SU&:K5&JM0
MIQ\FL4M,B.]/ICRL>B7#)+S905$!6U2-R5)"RI*PF@G(6&+7QJL">A9CYV -
M^D#+9R"X2UWLW7+;XL+1\K5B4:L)<DVW/;0I6"F(ZL*;X&["5G[QL9/H!"@"
M<YQZ=%24K+HL=QLV"#];6@APQ)ORZ7^?O$64KUK5VDE8G07 VD_]T-I+K>0%
M$#*1P#D$>8D;4]@%'5A<I:6!2^&(+^HN&VM8];1<,P8(9[ $N#<'8MY<XI=,
M!;(2KW42!ZLX*#N YP<D\C&%8.0#@:M!W&>KO[R/IF%X N1?</YO?Z-_=%QJ
M2H#8%>QQP"3G'IX//))/;V. ,9U<2?=SYO<V+['>Q\HDI@I^GY,/I_WN315\
MI"< '@YYQR..0>.,>_!) R#G)!?R]_[?&+>_1K>_\MO.+JTAPA*.<C 'JRK]
M/?V[8[;@2>>=(B4BY/G;ISY[WS%TJ#*5%=;=;^J0I(_YP8.01SE(YY[@#V[Z
MR):M+$,X9]WQ;\_S,1(8$>9O;ECF6;;+WR(G]=@_/PV*[3V]TR(TH/MI "Y<
M,X#K9(QEQ( 4@Y!2H).2 0;TP:T%0R.N1=W]]MG&!%L986<,X%N3$_&(JI2'
M6VY#1RTZG>V>01D]N>0L=BCN#E..#K#;<]?,MG-WWQCK:+R<"[M;Z]/WO'7!
M_:QGN#O[@Y!/))RKD\GE7XCDXT#,KZ.;6Z[W,2C]$A*0<<@9Y]LA(QGCG@ C
M))/?/.8'/1]^CXMNW2V+F+N$N!R/RY-]=(^H7@8)[\\<8' &!@CG.>>-I ]N
M(J'EGRO>_,GZ8Q1!)MZ_*T?DG<G)![ '"3P!CCCD9VCD# SZ>"-0.2QMYC?U
MN.?+>)BXN/0Q^5-H6-BFTJ2H$*2H Y!PE7XC@@@X)]1 /;GF8LWM?A?SZ[CK
M?>  V#?"+'PJM3NC=!L6EW!"J'S=?<IUI5.H4=I<VDPY5N6S4'$W+5TI<;7$
MB2*+0&14ZDW'==9CLQG)S;<:"](9V\R7-XI.K)DA:-,@3*J7+FG1,6B=/0#(
MELX*DSIY,N65 $E00ZE@*N$:BHAF<J8Y\2OU/Z1>_P P;=V_&["OH""K@)(
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M<13+E\15%M%J12NE<=FI5U04TY>U0A;848J1L H%(EH4J6\XM14U/JR$,M*
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M')W9'_P0 ''? P>2223R58&#<BI+'KUY7O\ 7E9WBYE*63MX^AR %'(QDD'
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M'TU%>WK^422EG>/R<J/8 DA)'!SD?M?4;N,;21D$ Y!$!]?7U[GBI!+,6O\
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MT.-1I0AQ5*>729-'=<9E*^U@#2R[2'78R&Y#SJ9M-6MAAJE-0IE3"M2]:"+
M@A1W*0'(#Y<83EC84JJT$*3+"M6EP[%GN'N?_"S@.XY;+&KA90W"MRBMM4R@
MT2.U"@Q6_0AMF&A#:4$I.Q*RD)!61DNE0P@G:<Y9+,U@[  !B,, ;  ,V-A=
MWTH01<J)4<D6=S[[#R&S,([3%<9$EU.]'E-E!942HJ_!M*\95D$* !0"4G(3
MD$JU8N,.^_R^%[OUZ1>"20"Q%MV^0M?Z,5$W 5)(4K8V0V2KU)#1VJP02O<D
M E!].$GD9*D).J%*RSEAL/4$#H2+9%QZ170Q<,3>QW^/N?%N<12K74RPE\^>
M"L-J2@AS WY2OS-NX' 25>I6Y"4A.<A"CJ02PT@%]SM>XQ9M^FW**H2A1#GQ
M/O<G:VQ'KOU:+<5&Z\M@-K"5AO>K<$I*DD;TJR"!C8%*2E)VA25 !(62 ED[
MD!VLU\WQ9[\N;1FIE-=QR)L6R_4?IUM%N+EKKLZ*XXAXJ><2%)2D*4-Z0A*<
M$9.[!"O2H ))3E*20J\E(!#]+O>WJ -GQAMHOI2 D@$/L0,_6UQ?.!%NZ3&E
MU&0I0#NYT*'JR"A()(2G"DC*@%%1VJ!)4KWP)Z@$L&*FM;=C>XV=O=AXJE*0
M1K 3DA\=+7:P?]HN5:'2AZ5/3*#6QHNI6I.T*)4H# Q^$'>L*!'"4J5D+!"=
M6E3--U7)%ARVOA]RUWWB,V>E *1=)NZ5!FSM^7PM&8]E6C)I=2D-D_*1J;$^
M;J+RD*4 A ]*=B>%E>Y 2DY*RI8P5'&K,MU*!%\V>[88C'7R&>>LG3?"P-UL
M 'V.<MB_41>.E_9-QTAF=2)K4Z#,:0MEY !V8QRM)!4TX%X)3GA7&3E*TY:%
M:2S,Q8Y!!  (?(LQ]SV+QBJ!22"+N=[&^1;'UTBC3:%'6ZP\]^!WRVUHPE.%
MN_<Y !!2=Q:3CL"<(P2,75Z?Y>6.9RY^#X9A<1%R6)N?T\]OG&('B#\+=+O^
M!*+<%EQQQITJPTTIP!2"5+23P%8>6 HA)P-X*1A)QUI3-24*#IY."3R()W>V
M"2_/VIRYR@H,0"E8/B3J! !R'!=]W8>9<^;OQ&^$FY[#K]7$:F/^0R^[MQ&5
MD@%Q12M.$D+"0K(Q@);![\:XOC? EJ6)TE.KVE+2;%@ 0 '+/=@5=' CH)55
M)GRDZM"%@$+<G239B' L06Y AKLT820K3JD"3.0XVY&D0%!Q3*T.(=P5J2HM
M)4D$8() QA0"L8XSQ59PF<4S%"6=<L7ED!UA[@,[D7(W.U[1M^$SA35"4JFZ
M 5@REI+*05 7?#$G8^3@D1(H],2IEVM55"FJ9#6EEQ2"$.5&:L%3,".<;"^\
M&RXZ[L*([*77EG^K;<Y91OH#!2B?-( +J(R +9N3Y%O3)='+$K^U>(H*:*1I
MEJ[L!*ZVH4QETTLX*YA1J7,*"F5+"YARA"N!ZH2)\I,QWRVTG8VQ'91LCQ(Z
M.6V&$))P$YRM:EK<<65O/%3CJE&RN5I3I%R-S<E0=R<?TY 1/[_4U50FKGS
MQ(3*E!($FGDI!*),E(4= ENY4"5%9,Q04N82?S7ZJ?D'$M*(44E/8<9"4[<9
MP1GW])(QD>D'5J1+7WGBP[VYO]7QY[4XYQ>;]PFRD3+K3H<; LFVQ!&69QFX
M,2GI(RU1+=NFZ'0$OBGR(L):@"0]* 05-J&-BTH4%$I/JRD<9&;7$EF9/ER
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MEK]&%D-H#3N"ZVH).U2G"X$1VW@<J2Z&P 2I1#,VHM<AF!R+<\)!C%F%S9[
M)?R'([A[O<CK:+F1I 8#:F@=XDQ KD(&08H.?,2X%JW*W^8H%2G%*+H\P$:S
M "X+X4DEK,"P:XZ[ @GE%06!=KI4VI)(=@Q?JW,=-HN'05.JWAQQ+322O?N4
ME(7'DMN .,E*'6Y#S:7)C3:%;4;HS(+:@M;9SY:P$J<$7+' ^&;O:V+ WC"6
MIR'( >X9[8/E9O.XB=?-L178ZW"EM3BXD@MNDTQ =*/EINV CS8+R'?0AQV
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MA#2$-(0TA#2$#SQI"*C1^*M2Q_[T8/\ K+6H3/[N9_D5_NF*'!\C\8C54J6
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M<@GA(]TP9L\O/X$!_+;?K<C]YX[DY]O?/J&!V2!SC!R3N2"".!0YZ?'XW?\
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MA02EK"2VC"2H  *2VI*%'".1A VD3"26 #@X)LUB"!EF<69@,W B\F6E#G)
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M; .Y2MJ4D#C?A Q[^_!R1QR#[:P2BA3GPMD$,S="!U<&+'&9"S)T#VE*TA.
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MTC+G.]K\\1R)X!"@#]<$;3^1/L.#ZCN3V.![QRKH3Y[_ %^\32& $?H%1W
M $ 9VXY/)]R.Y]\ '.2?>1'J-N=A\M^HO NUK&+>WK;C$T.UI$-VHA%)G4FO
MT%#+#[%V6U*0\J71GH[Z4A<A"UN.4PB1' <>D,.K\J6K.?23](3)U!!,Q$R3
M.U*!IIZ2 F:"G8LD3 UV20-0$4"BX2 6=WN&4^7O;R>QM>,#+KM'J+TQK,3J
M [\S>%L6IU1Z6UKIQ4D51,&L5.AWC$<Z>W7;ER,*DJ:DUY$ 6G%769[09J+L
M9NHR)*)M0K05UU-4T/$)2Z).FEJ:CAW$)5>@R]4J5-I%"MIJBG(!*9)6:E?=
M(+H"S+"=$N4V0DI4-+ .E>L$. 0-3@G <*ML[,  8V24V<U4H$*HL)D)C3XD
M><RB0PN/)2S*9;?;1)CNI2]&>#;@#K"PE;+F6W E2%:X-:>[6N6IM2%+065J
M#I44DI4DD*3:Q_$+O&*4E);VM)Y=;[;^?6*NVHJX P>. ,8SC/&/H  <=\\#
M/,4LXY_._EALO^L7/IH[ _#^S]<G/;OP#[$D_F<(2<XSJ9QDELM;EY['RSB$
M8O=6X03/>4$G[Q.1W)(P??V( X2DY'8G)(UCK O_ (2$G]=_5N?*'L '.I1S
M@#Z?]8MS9MAI<)K]PM#Y$_>4RG+V[IVU04F5*0-JA!*R"PV2%3#]XX$Q-HF=
MIV;[-FH,NOKDM)<*DR5 #O+66O\ P;A)8J/M AA',\;XV).JEIBGOBDA<P7T
M V(!>ZA@N&%QDVN5+E^8%!6U*4X;VC:$H21GTH  2$)"=B$[<8PC8"1KU&7*
MTI2D,$A(8; !F#6LU@!Y1Y^I1F+*R7))<X>Y?WW<GUBC%3LAQ##04Y(=<;CM
MMM$K4ZZZ0A#2&T I*EJ5Z1V!*><E1UDI 3G9LX'JQQ;&QLY81=E(,PH0@:EJ
M4 D!G*B[#/4YQ<EHR&9K,*P*)&M>D^4]5WT*DURI-!"VTS'&T%YME8&%I92/
MEVE+1@-H"U(6\ZXL0ETZJE9FS#IEBR 7!-R+C9W?+O9]H]$X?1II*=$D,5ES
M-('M3-SJY!F1C#Y,60KU<?J+\A^5(4HH=(2HJ44>E*G"25;4Y!!*\D J!W [
M<C;RI*920 R0P/T;8M<]'??.!(P&(+ ,"W(8?EY",5*X],ZI^6ZEV1'L%A:"
MVZA:X[M[%EP/>>EQ)W-V82AM+2B0[=H4[O0BU\+N:\2.=F!TE\[:LXR +BRL
MN!EA(0FZ=2C;;P[!B/Q#!?& ";)Z%4I\2+%1&1M0EJ.F.$LI"0B,=@6TREL[
M?3R4_P!63E2,)R0D";ZMA<[W;S\[Y/*\5"= =(W=MW]/C8\K Q!:A&AMM!EI
ME&T%+FX )3N/ W[\#[S(5R!SDJ45'(D#=@=M@V;^[)VW+9:843YNU[[MUNP9
MQOZQ;&O4V*M+RE,AS:G>@*&]/E A22 %$9"QE9[A6>3D:J19P/%??;Y#UWZ8
ME[/A=@6O=[_']@.L8YWE2MOF%*" X#E:$D%1 .$X&59(&,;5!2B"22"HQ8/@
M7OY$-8?$_.+A]D^3?D+;18FJF=#7AKU.NJ<4E(6H>P((5D;%.<!U1!4D'+>T
MGA>S6%\>C?F_1]VB*5%C=]O3S;I^L3#HM<4J%U/ML%6Y4ENKPSE:6P79%$JL
M:.H*7Q_W4\TG<E()VIS@D:NREER X/07R 6],[@781)9"P KQ@$%BY8"^''(
M>6X=HW"U"0E2F'<%/FA+K:$@))\PC:.%)W%*",[\I*MN4GD#-TW/6U[.1;I[
M@6Y9C7A1N#LSL_GRP_U@G],)2Z\E0V%2\>8>X"0%IQG.$$@;\?BP$C/I %HN
M!<;\RS?'S(<$V]) .<E+V?I\MOB><4^Z;HMNS[=J5P7+7J30*%3FW')59KU3
MC4JDQT1T[EJ=G2G&V@-O&UDJ=5^ -[ASBS9DJ2DKF$)2 ;NW3 OFUG\CLN!;
MQ'+#<?R],<WZG$:3O$C\53H);#LVD=,FJQU>K[#SR4R:<MRW+':>*CZ55V6R
MY5:JTRI(VKIU/^7E@JQ)0VL!.EF\78G[O)4M_P#63"4IP6( ))%_:L'ONT22
M0""_-TL"6\\8.;D6R(Q2Z"?%<N:+UCA7#UAMV/3.G[M/>HKD'I]$<C3*0@SH
M,ZFU63+FOS:E57H"VJA'/WRDHAU:HHC04F7)2Y*FXM/EJ*JE!FAM*4,P2" 7
M  =1>V18^9-)B43/ 'E@D**[J!8;@D,"X=A9G +1Z&NF,[IYUZCV]7K*ZB6G
M<%1K4>;4(U!F2&*+7*U3JD&)E,=51RM%-N2;3 )3-6J-O.K=$5#"EAB8W,+^
M=_;-!4G0A12!I2IBY0M+.D.R@[@:5,7U.68BYW4R3+#ZYB4I!"LI Z&Y2GD^
M=Q@"],3PY4RH'Y+J#0#3'TEU(51WWF:7+"4D!U;K*8T]#2\A:HHF;VL^7)^;
MR2K)35H2D*DK$X W!L1=VY"SX#=1F,52YRB>[7I!#A3 M^3\C8<FM'/+\/%;
MI45<&EMQZE0EO(D06F(S*T1-H3M;:&T.)2!^V^''$JX0I>U&LI%?3S I*SW2
MBSI(TW 9]0=RJ_7?G&.4JU:_$5W<N7=QMZ#'RS:FIVH_:;B1+97#:*DMK2E/
ME%"N4IW$!"!A0Y _$,*VJ40#,I264AE) 9[;.Q#-9\['EB*!7>%M2B79BY+;
ML[FW6P:*9U%ZC=-NE%DRJUU$O>V;0#L1:Z6:[58\*5/?::<>^7I5/4O[0JDE
MQ*<H9@1Y#I4HJV=CJQ-FRI*'6H)(M@ESR  ))Y@-N7S$TI*R$RW4QN Q8/GE
MS>_Z1I@ZI]:>B?BLZL64_8EI7'4KGZ1PJG6*EU'FTB%3:+6*?6:<Y0Z9;D5]
M<I5?E.1)<J36(9J," F$*?)\IK<^I:=1W=+75DJ>:<+F4:2J74%*2QF)TI2"
M/$5 *4?%C3@&-S1+FR43)6K^$L!>FQT*]BQRY2SA-ADWB]-C6S4I$Z.Q'I[R
MW%E("O6=H*5A?)"P$M >I:MJ$J47,)7M.MLA!9_9\+&[9/OPVUQML<A2DI1K
M40$NSJ(#L]@^38M]",H*?9-O,%EVI!$R2RIMUQ$92@PO8"5M/.I&7,)*02QE
M)V8;>4/0+Z$ @ZK6L+=3S^8_(1K)E:I3Z$:4DD/IN!L4IVSNQ=W%GBX9JH98
M^7AMLQ6!V2PE#;:0$@C 2,+!0 5+.%9#8R/*5F2@D,[D <RPR;;_ +7V(&"4
M)4=2BI7F207_ $V;\HA%PU%X[$.;E(=W(_:"LJY;1MR1ZU)RD':1N "3A1%$
MLUO"!C%^9(MT>+FD)  8#I?S);&?HM$ E(=PMQ&72C+GEHVH=4%A2U  $*QC
M>?PDI64^D;%G0K& 6V?:_+K@8OB+H%F(N>5\!OZ/OB(](BNJ4T"%+:)*BG:2
M2/6O:0-V>ZCY@!3P,9V@:MZ^9'+/G;XN1[FM% AB[XVB3TRE^2CRCNV H<R<
M^H/*!2I"0E*5)W; "" $DJ'OJVI=@!?.PYGI@WWY1=\+OOU \_Z!O.T2F) :
M?>4MY&760  O:=N4*2HJ(3@@E)4X%!&\;#D9*M6M1(9);R>SXRY\L/ZP*BUK
M-?'5^OP]QB2,4]I(6VM*0/0DC:DI\M2^'!N4G#9)5YA.U6$$$<I2*!]_?]?$
M\^D4"SGGZOYF^+\_7$5^-2FDI6X4)4IE)VH3@ #:$H5@[ $J" 2G&4X6$D%)
M!H"XL6)\SRSCI<VQZN\;<%SR?TM_7X1(+'M--R7*VVXV#$:!>4"24A&_D;<@
M**25))45 J2@$D%)%0"%7Q@L<CIL[%B?<UC$)DTH2Y.7%F_0_3M&4EPTN33*
M:PBD-!H--D$(;!200=J@2,'85)"<JSW&%$XU?ELQ L'+>I)%O7KNT8!5<J47
M)M^F/+)Y-%GW.HM0A99GL+CO,%QI?F I*@4D**!D8  400 KMC&4IU(RO-\D
M @,?6X._KF)D$-9WV%_4@\O7&]XNMTXZAT^I55=->VJ#[#[;B4*&5M/@M.I;
M0K:2Z&E%0V*4$+3D$#DVYDMD@C4%.X*N:2^W07]T46Z2%!+@!BXO<"[/=N?.
M-:G72W#;_B:@Q=A0U(JL&>AQ*_2IK>VXAT%*,D.((6#CD_F2H]!*3WM&F:G=
M+*M@],X/GF,F7,_AE+6(+=6]URP'79HN':U9J4N,S29<Z0GYM]YZ5'EN)*,Q
M_EG'EM D ^89#JBCNORPE1"4A2M?5(+.RB  &#LX<,S;CU.]K15:O$=(!+,%
M ,6(Y^@YYW+QB#X].M<JS;8HO1NU*FB+6KRBIJU].0WD_.4ZUEKVTNB*+9_H
M_P#.%:%R9;:%(>52H;3+O]"JZ_.QI2$K4=:7!2Y#]2 #;?)N]@+/%VGEZM<T
MBR2P>[D W;S?Z9K"^!'J5-Z?]9*(6Y4CY:NLJI,]A*@I$J*\MO?YC94=Y;4!
MLW!02HI5O0 5(R)[E"!I&E(86#AO99[@<[]=K*P*7*<#V0YSX@^_DS^;=1&Q
M+QI]$D]3'K37"84MB;5Y$LDI0M.Q=-DK;.[(&0 YE23^#:4#=QK#FH$^4$,'
M!#[D,]Q\,-UC'H9VD-[+7*@[%TLQ OF_($A]HP/I'@\A"<J+,B+;]>%.K46Q
MD+0@C9M"]NW=N."  EW!!)3A'AZ -0.IQ[! <&V[%B[L7-R/.-I]\6;-9B!J
M(ZG OM@D9V>,]^@7@YL:T:Y3;DFT^*](8RI!+*5-^84*2I1;=!204K "2A0P
M%;B>0K+D2$) *9824FP89;<V!!P6<$/:\8$VJF%)(F*3,2HZ"CPLS@:2#8\S
MEB.=\5?B<_#JL<VE/Z_=+*93;,G6VVY5;]M^C4WY:@7#2&D[WZS"IT!CR*3<
M$8E+DDPFFZ?56@M^6W&F-OS7]#Q;LE2\9*YE&)--6L2LD:43D@$E*@D$]X&=
M!2.BBQ!3UO9WM0E4RFH>.3:B=2IFZY4Q"1.GD@$]VI2E)5I*L*UN&"20&4/-
MS-NNF5VN08SU$*(S09@PT+FJ4&V]R4H*T(8;!<6LE2C^'U8Y",GE*+L93"=+
MD3:J83-F)2L@)=R0/"HL<FQ(#W+'?IN,]O*/B]=)6O@<L2*66F122E5<PH3*
M273K0A"4E1%U %@P2"H"-O\ X8/#?T5NR-4I-^T2;<2Z5(<CTF+,K4VGTB.E
ME2MBC!HCE+4YYP'F/*==4G<$I6#W7Z)_P![.\/61W*ZU:3[54MQ@$_PY>E!V
M <'E&JXEV[XW/$JFI12TDF1*2)$J5)242D.IPD*\*5*>Z@@+)N22S;9^DULV
M18PBL].K9MJTA&6TTXJWJ5#IZW@@J2!*E0V&I4I3@!#XF/N+DJQO45A#BMM)
MHJ.C3W=/3RI" 7:5+0AV&D6";MBY8\[DGCZ[B7%*X$UM74U Y3)JE(&;)ED]
MV/\ 92 P]VH_XLG@_N&K];J-UZH[@8H/52V:7"N1]N I]N'>UGP&*"\C:W(:
M1MJ-LQ+=FLK44/2Y+=84"OY1U6N7XGV8'$J^9/EU*:=T(*DF49I6<!3A: V
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MFHC-J;*5;6F&VY)=0@C:A"76TOMI"'%;7'4%*?\ F\[2IV%G5I&'9-PIFM<
M@,3D%A[.&Z2?".:FP"7(Z;6-NOG);=::8D*?4E*BMDK2UO2$J,F3D)4V$N+4
ME)VI!=6XK)072\ZCRV+LA "M1&79B+ZCR!+MU/F58$%D['Z%OUMTQN9>L_-.
M.,)_YU,IE*@E(]3RS&CME&2A2FU)*0I(5O;;)4ORU.%>20%V=K* ? >PY@M=
MB^V<Q8) ())+*!:WPM^?K:)?2_2K:O<?,:2G^M=2YO"W'D%H@I4@J2=JA]\
MM01Z"<IOI)>RKD!_F!EV87SRBTJP)9P+[6!;SV;/7K$KBK+\LM)*29/F*3Y;
M06E*92&W7'&VV2A;,=+NQZ.4X)+DG>A:64A4CF]WZ;6?>P%B#M>,91UFP*2[
M, 0S6^0:WPB;029(60%;R&FV 'VW0E4V*'2I]])0I"ES('FPP5*6V_L;<6A,
M8OF6L85I(."7_H[BQ/RB(EJ<D*L!ML,O[P-^?E%\:.W'+ 7(:2DBH*2UYA.U
M"W95%D>5\W*?0^ORFIDN0$+JE6*?O%-QVDAT+ME>@,&-PVPRE[FY9SNK).EH
MJ2X*=1<CG>Q?R!)Z;<HR(Z?&.A^A ,)^;4U,5+08<%LK(E*VAUYE^>TZV'G@
MOYAZ$AQ"&O6V,EY,U+ 1K4P+7T@!@"P<7>YRV =[PE  ,Y<A67N2#:Q#W9AS
MY1OHZ543^;W3RU*64E+C=*:E/A6=XD5):ZB^%@E6U0=E*24 D-X#:?2D:TZ5
M%3K/XR5.Y+N21MR:/4N%23(X=22B&4)*5*')4QYB@>H4H@VBX.I1L(:0AI"&
MD(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(=_T.D,_7+]XJ%)P*K2^,@5"%Q_
M^,M:A,_NU_Y%?(Q0^R?(_O&/\V03N]1R0>?IV_=_VZ\;ZG<F_P"H]WTT<,[6
M QF_/E=WRV/R,.GR0G=^_P#//Y\?V\]]"7+P LW+-OUZN1;]X-45^85 \#OG
MWSSW/;O_ !U2)1;.N1&Y 6D@'(4,]\_V>_\ C..470"S8);H;#;RY>>'M8.Y
M[;2%.+2C*5 DGCC^ [#V_+].42\_ZCZS^XBR59H1;*U!.,9/U_W']?KG]#I%
M8@TB&IM7(([_ -G[O\#1H11)5-8DI4V\TEU*LA25I"@0<<$*"A@Y(Y[C]VHD
M=7!R_EG9F9[9)VS$@HCK[[>7+TS&9?@4\0\[PM7\&&7I)Z;73.:%U6XAQQ<*
M*\XI#2J_3(I6EJ+5&4) ><:2GYV,DQY&<1WHV+44R9R=:?#,2'20P"FP%.,'
MF2XYL\9$BH*#I4'EJ8$?R]4\L#T?HWJWIT^D7I;E-N>AS&*G"J$)B=&F15)<
M:DP9#*7&)#:TD@C:L;@?6D$9"2DYU$Q((N#K2X6[$@LQ'/W[<Q&<%%K&Q8AM
MPSC\OS'*@+:$=9(Y!5@<'@*.0,IX.>V .0.#C U8!.XO^FV?=GGB+@.I@VW,
M/;S#OROOG,=IMP!.?4=O."D\8_0CTD\C&-V#@<YU7<_KG^C>L3<=/JT2FAU$
MQGO+6H!ETXV<[02#N/)/?WY_#N..4D7$%BQP3MF_U^<07BS6^#X^LX\XIU=@
M"D3#+;3_ ,5U$_>\^F')5Z4N#D)2EP'8XI0*3A#F=J5YI-E >))L2 S;X'7)
MZ 6M<&*(4; ^X"S,^V[[>?D*6XV$Y)]E8';D\JXR,$' P"=IW<<ZQ5 @M?S^
M'/U?-NL9*&(?-[>Z/RGC/?D9! SG\_S(YR,CNK)(*M63DV\VON"[]>O[1<C\
M*[%0'^<>Q.,$]B>Y"@3D$]AV'&HPCZI0&.3SN]L\!)]O5[!6020!VSNP)@Y'
M-K6NY#\ML#EY/"/PI6W@9&U7J]SC/!&,XXSD$KSGGC&8Y-M]OD(H;!^7]/SB
MPW4&Q42Z'=EMJ=1"LR[XTZH2'DQ%E-FW/$2Q4X-Q-.-NI0U3#4:<S5IK3C)#
M=0:<=1)9^:#"MU15;3:6>VNKI5HE@*41][IU/+73D$%YG=S#*!"@Z&\)"21)
M*SJ#BX;JXQTVM[A$<H77IUKJ7;ECW>P+=GW):\9Z3;\V.ZU,M^Z8UQ5FW52X
ME4 ^0KMIW1,@HCT::RI,F/)?H3KS"HUS,_(9,[@@/#Y]72DSTT]2I(GI4"F=
M3JD2YX2N4_>2:FG2MYJ"G24B<$D&G(7(I\.H7 .01<,#ARQ#W')_Y3&4Z#@G
MW_9&/=60#C@$]N<;@,D#( .N>!(>^-B_3H1GZ:(1V$G([<8/<$@Y!XQGC'JY
M.?;!XR9@N':^W7?/G[CUA%K;OH\*=44R9@2\U'0VI43*0EYP$^6AY(W!3"0
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MONQ[:I+?XVF:3;T93-*I[*4 G[J,EY6"%.+4,G6S*52U$S"J>?\ $<8(9[#
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MI]8/KCTBCOS'IZ<OWBM)IKRDN%L??,I0@!1.-V&ROL"2%#[SA0*CL23@8-&
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MGSBS]5OESU%I\J4@*;6K 4!DD-J\HG<?+)P"KC!5^SG5T(T^+V2U@&>_,/\
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MXH>8JZJHIREM/C9@I)2'P+I5<X!<$79P(M:%:7.AU'4'/.^V]]W\QB,.Z_\
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M5JD+ "\^I64[2$J6%Y/":%<R8:J>2JQ4I1%N@<X"<XV88OF29 E +4H%927
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M&UI+Z:D^[Y@Y9"&E(*2DG,@(:#F-CC"!(+)'4J+ @9)>^"'?]<,+"Y>E5P0
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M(6HK9D3X]2J32FFRJIJ6VO?>E2D)'B&LN%!2F) ')@VVP]7N;9J%)7_#2F4
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ML+QQN-A&>OD V<8OO;ESBPBQ2!DJ\1 OD=,\\W#\A&O^[;X@T"/*JD]UMB'
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MYQ NL%1CU+I;>EE7)'3+MVXZ'/A%N0<*A2/)4Y#6-RAM<CRVVULK3G:M((Y
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M[).20+OR%XTH=!NH\CHIX@;?NXOJB1FZXNW[I:WAM+U$JTA#3[K^[:%(@O\
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M<DR^(S[6F)3,%V!U)N3YD/A_7,YZ:QFK7Z;.5=YLI>K<R=,0KTD^M:H++2"
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MS5*Y:FHO3:O4ZA7*I,)#@>J%5F.U"4Z0X"V\IPD':D (*W$.)26ULI[4*T)
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MDI6GD[L*R.-H.%-!4E1)<#"1_4OT8OYQN*6R27WL<]&VVS;G:+>S&0M2L))
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MO'^.^=5N/JQ^LCWQ3K$8EM@).4GC@#!SR!Q[<<GW_7\Q'+'TWUS!A$9ELC/
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M&"JWR_7/7K&:'+$F]@0?=TYD!QFT0K>IM6,*&#V!'_1QGGLK@;C]?;MK'B9
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M6)+&_P!6%]ST.;1&JK58S3?S"04AM*D84YZG'21E)).2GZJ4G*B-Q](2C55
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M0TRG!"]:2RW#/J%B2;'EC:YYQZ5(VVJVUC^M#L4'' "L_P!6%'=^$JV@8
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M4 0;.>C^O*+^E*M5G:Q#;CP@-?G[NL9@V'>C]7A,JD(+3I2-Z%E V[R?,R%
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MWP2G<@CZ84!M']X!SEAEH8GROS%AR]!%@@H4[69SAM_(^?KTC'Z1'0[YL=U
M6%;FG$J'IP3L(]L^X&?PD#L,:Q3[O-WS\_<.<9!#MTO]/%E;^6ZXJ/1V7ER'
M5.HA,EP@!+8+C@+SBB$EMM#BP^^HC(9\UT94I6O:^QM)]TX1)F*#%:%SUDNY
M*R=( L?8TLDL2]GN8ME)=F! L".H&?=FPQL!&/'42:U5F(=J4R8RW2*>]LD/
MHPER9+<P94Q25*.-^ &!E2D,".V5 (.NJEH)5WJ].M;%G?2D'PIZLP)M[1\V
MNI2&!! (OXK'#CY_"*/2W;5MJ*D.2HZ4H;25$K!4E/IY1MW*0MP*20"K:$9
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M7YB2EP*P4JP@H]"-N0=9#ND!O(XMLQ]WU>+)L2^7OS<1"9E6F(>4ZV#YGF)
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ML@$A@%$J< DV8'\B Q](U6>(7IJ;"O-Z93HZF[<N-;T^G%*<-Q)2EE4ZG#
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M#CSLQPW41 %)2IK:2ZO+<N#^^&M&VOIWMI5DQII&/,B@[SM(_"M.W=RI)4D
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M&Z<AMR)%KL%Y%?F1X[(G1WX5/JDSR&F^&X[V6X]7]K9]=)0J923A)5(FA?\
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M(=$!23\GY\OA<]U#>CG\7IZI:I:)TL24*  F*TZE"Q6Q9P79)#AKO=C.6N6
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M4"=09G<=0[QU,A29B L%W8@C<>74,_FS"XBJ5N@1*[3' 6DG+1\Q*0DEM9X
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MPM"*2\SYB% D[AV.3C']O[_I_;I$DD@CJP8=+?1_I%$>:"24_3N#_=^?'?\
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MJ(4D!/814K/BSL/?G\W_ &B)0!"B$[\R_5FM8[N2.N>D+S<0!ND(QP<\%:@
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M_'/MKR*/.V*2#Y<O5OUM$8E,;BI(2!G]V.PR/W\'Z_O.H*!NX<<^5O(G\OC
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MO<U>W'Z+-5YKGR9BCS3P]&;0M+(*\@X;:'DN(()W)2OL48ZCO9<Y")B2""D
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MQ9_)SM$)-T0ZK5)*$.G^CN)00 I*0D+.]24^HY6I>4*VXX5R G<* :C<7OD
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M\SNV_4MN]W+13NPVH%NH<^;N'ZX,7IMQA#M"AR23_2 X5C&",.;!C!W)Q@@
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M2!CWFYY>EN47(ZK59UBV5TR,L_:-7=0RPTE6%>0@EQY\X22A#:T(VD#^L*<
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MQN2$G#Y_I@XC"CJ):$1XNDL-K2?QY;W$E>,YR5Y'(!.Y2-P*4Y*=:^=+2L7
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M5^HC+EC5+U/?+<K?GGZM>IRWUU&FPY,)UQ*GTX6A(Y2A 5M4LH*B H+.,XV
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MK,^;/_4\SGIOM3GXJB"I/ZC'?'T/T./W_P .%Q8V?/OB8(5<9'U\8HKJ,$\
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MR,$H0K<%+6H E2U^8M(.[7J_">")IY*)( " 'F$I\2EV=;C^9GW8-&V0A$I
M8EP;[:B6;',;@LQW(C4!>M.O6^[B-SSS/>G5&8E4F0\%K<*BZE1<#AR2,*"U
MDG&XG!!6DCH42I4H:0H!G+9L=KLWE;D^QFYMX0 -F-QR?(&=\&[[Y(]*++OY
MR>(4%F1+4WL8?2?.4H9PA2<;2WA0(42I/(2?7N.XT4S6\(SJP/-SR-@< $Y
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M5<K6R-A;DPN""/,"-Q)6DD)6YO9P_P!,0XZ8.!%_+9J+CJ/DI+O]*B(;6EP
M 38RU+#$IM"4AL^:M*D.H;"?)?0Z-H;+2CFI+#20Y%G'D]P#8V+_ -#&6I[@
M$.]FPPZ[8-^>S-%T(,G?C>HJ!!3[@H_$ 3]"K.#GTYP,<#-PEPVXSG;&+#/N
MBWJ*A?:UB_+T]W[1)6%(]:R5(3M2KD83R@I*1SA82DX*4C:,  <+ @S!N?\
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M?4NA=!N*@T20:8TA;3,=U<UE*2 ^@DI?0OE:4^:$+7L"#YBN.,:[Q:%CJ+$
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MVP6<AF>]\&(*2Z?;=3.V2KS;!Z>YS%%N[H72+.NZJ7/8L9$6U+PB5!J\+3A
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M:U2M*EXL%ZB!MM&RX5VW[8<-E*IN']H.(2I$QT)DJG+FRT N_=HFE8EL3^
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M,F*73SA_$2D@D(TB8 6)?V79G*02S6$=E7=FJ:0H5DC49"5/+>8Y1J!4D<U
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M6E(PA0]*"^O>#R""2O&#@$?B!SN/JU$AJ:0X8)DRQJW<( ;X$><;E* 4(RS
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MK^E\YYXP(YFOYPMG+$QYK.P_=E:2K:I&$X !RI9 (SD]@K &9 &[:DEN9O\
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M2(5-12\-LO3-JM+)DI(.@G=;&V0P+%WP8BI12X!&HY) 8/F[9<6 PYS%[/\
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M*2]"A.$E3DL;WG L@;&F/0 I7*4^8 4GU#=D:RJ3@E56KU5$U4N5E0+E:@^
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M6IK5.I_S7]H_8H<.G3>.<*EJ^Y3E:ZRE0E_NDY1\4U"4_P#SO,5<V:7,7I)
M4DGZC^S3MN>*24<$XO._^:5/+2FCJ9BB]=)ECV5J-C52@-SJFH&L!TKC7)40
MJ')D2&D(1)?V*E.AH!Z2E@%(4M26_-?\E)6EK>%EI*7/*].4GQ^9-F3 B6J8
MLH1["%J.E#W5I!LE]VR>=H]CERD)4I:4I"YEUJ  *VL-1%RVSXLV\454WS5
M+* 2DX4G;C)64D$J3D#(SO22%9/)' ME( ?))SD;^N'^(B]' %I!.5;G$>O<
M#A6T H!YV\C<> 2"1QSE)C]?7UTA%39 R7&EJ QG:D+ *N.,'.U.5!.W/?D^
MD82^OJ_URBXD ')^3VS>_P"]Q9VDE,G+;6%(6I02KS$A&%YV+4,Y&\J"MP0I
M&".Z"4@D!I?+7M]'S_8/&2F8#].^>7NL 7-HS Z2W,\VJ,DOC[Q7*BHJ&%YP
M@C_I_P#1;&!P%9!)B/ L-;2^HVO?#M8XSMC,9 .QOJ#^C8Q;H0;^3Q^?$ET#
M56Z-)ZQV1 WSJ>P'KXHT)A9=EQ$'*KGC,,I(+T1M0-;VI.8C(JBB/EIBW/0^
MRW&U3D)H*E0=+B1,46\.>[4^P9D$$EO#'F_:K@:4*5Q"E0RBYJ9:7O<GO@&M
M9]8W]J]Q&OVJ!4BW:S$2<A^F25-!&?ZU*%/M@E."/6E(QG(44I'=.>LJ@>XG
MI#ET*:_($MOFW(M[CR_!U"7Q.@FJ9DU$MWY*5IN?(CT86:+S>"1-VOWE 5;5
M4EMM0WMC\02O*CE+J6@\E:<J2CTEMQ*R4$K:)*]IP/+N*2ES9@$LE,P:5ABQ
M<' Z$._)VR(]YHYJ>YF:P#+ /AW M[(OC.+D7#&UT/C$5B?;/1*%=$J4D3A%
MFVQ7Z:ZXH(F4Z1!D/T^<=KH*GH,]MR,X4MDN(=C-KRF.,4D4BIT^F3,"N^)$
MJV2G4Z7<W9R"%;>L8M3-ERZ"OG -3RI2YZB2&;0HK',>R%,+D^^/,'8/72FT
MQAABKU\0V#6$NAM;A4F/ 7&6Q+=4$ K6J0[Y*_)0E92&W5$*4XD';U' :KOD
MF13K6D()7I3[2E-:[CP@#Q%G-MHXZC[2\-0"5UTB2"ID"8JZ$@,I9!SKL2/$
MS'FYV&V3?%K=0:.],M6X8-4D4],=-012Y'FI@RWDDQR2D@QPZTA:4APY.2E2
M4JWH1KYDFHI5A%1*FR=0.@3I2I>L M8+ =FN0Z=P38QU='6T?$I1FT4^34B6
MPF=Q-3,T$N4ZM).DJ < D%K$ @QF-X>/$!U-Z0770JG2ZQ->H!J<:'5HSR\)
M2U*Q&"BH$!8*4X2!SZ4J4I1SG JJ>8%(JJ:9W4^602H$ *2KVDDL6=M.+ XL
M#&]X?-ESGHZAURU A(4QTD;YSR5A_./2M<7B#GP.F#MS5AU<2%'H[+CDIY8;
M2EE]AO8XVZYAI;YWA"27-IX&T*V[NADU<U5*)DQ2G[L!BUR=P[N'P^1=\1SL
M[A-))KEHEI2!WA58;@_B 9DM9@/5W$8N=&8]$N+K)2;[MMQM;5P4ZH4FHN1U
M)(6Y4%M2V)I""0MQ+[9;47 A*/,2VE1VA0PY4L3JN1.0"5#6E6<3 QYL$AAT
MS:-VN>E/"JF5,(/=)$Q!-O89TM9\-Y/L[7PL'J@W(\6'5JRI2W<6Q M&FAGS
M$;7)57M>DW,%LI.?3Y=8;:VD'+T1:TGUI",RGJ-7%9Z5I\*4I2XYZ0?F;[V#
M'>-!52-7!9'<A+E2E*)+EBH@DXSI&-GC#WIOUIK71OQR>(7IQ>;C;5+K74ZI
M7' 0X%(8-%O],:ZZ XF0Z2AWS:?6F6'?+V-L2(C\-9\QIW7/SITWA/:.<MRF
M363TSB;@ +TJ0K 8!R'9M0.X$;P4,OBW96BF(+S::E,@AR2F9(>6I#'#E)4+
M,S,2"YOOU6MN+;%YU&-3QBE5%+59I0&"E,*H[W$MH()"FVG4NMMJ'!;2C7V#
MV4XJ>+\%I:A9U3I8-//4[ZUR@&7YS):D+/4GU^=N*4GW.MG2@&03K0+A@HD%
M+'&E0*?3:+<:Z.-?#2$-(0TA'PYQQWTA'W2$-(1\ P.^?STA'W2$-(0TA#2$
M-(14:/\ Y6I?^D87^LM:A,_NYG^17^Z8H<'R/RC8)+2$C&,@GOQ^N/W>WY_V
M>.E%[?5V;Y1YR+VYV^O6* \D8_#G).?TSW_@?T[]CJY@6^(.W3<^[UQ >GK?
MZ^MP(I+Z,'/?D_7W]_[,C_JU6#W<9?RBC2&]N2!W[=^ ?\?3OQI%2S<^1OZV
M?GTO=HCTEK*MW;GMC!2<8Y_7_'Y(B"/JS&QB@3&DJ"DX!4.?SP!V!S]<?7L>
M-19B_-AY=.GRVLUZ[=;,?T\O4>37C$J.D9&,YY) ]OS_ .P]OX44&N-AOCTW
M?Z=XNI+CZ^OKTB'3FD;B=O.3GZ'G_9[^^A\@>6+VR3BS;#ESBXESNWOM_4GF
MUCRB-3&,#(&>W'T&/^K_   "!P#L2,V\V].N PL6AN7#D<KN>9_/GO=WBTR.
MG)X..^/X_P!_Y_3G5OWX./K#6SC=K1,8<,^^?UY\AO;))A\^(2K(!"1E7';]
MXYX^O]VCL]LV\GB3C#WB*SHO"B>XYS^7U_/GOV]NV-4BIYQ%)+) Y]L@GG./
MTQC]/SU4%KBWQY\^G7]D41]C\1';C]_\ ,?Q[#/&<ZI"*4^P3R0?H#C_ !VR
M?[_KJOIGJS?6+^<(Z#C Y X/UQ_@_EWU2$?E#8'L<]CV(/<=N=5&UA;\^>UN
MMMC"-Y?@[OPWKT7I\"2]YM1ME3M$DY_'LAAOY3=R<E4)R.HJR.2H8XUAA(1,
M6EF#ZQUU!LWW>S1LDJ,R3++>R-*CU2-_0@L!N\7/J4E4>4XTO(V*(!. G:3@
M 8SVVCG !&L^4D%*2!>_[M\?6T1)+GZN>N/A&L^O]+F+HN^XW)Z%EK[7JN7"
ME>Q334^42"1Z2M?E[0$]B%;02H ^J412*.0;EY<HW8>(IO89#Y\]HVLI7\--
MQXD@?6]G_6T6.OOH>W34NU&WISU,J4=!FM-K"L.!"R$I+*4Y6A>%!6&O25J*
M]H(SM9!2R4D:P?"<$/FS8(9K<^>9!>ER;D'.2+B[EST9WM;$1"T;JN8K?I5;
MI%3<^50X'):8,U<$#!0L_,!HM)+F<(0HYW)]+8.,Y*I"I;*0;./"XU WL19L
M/;PVYV-U2TJ91/B";ABR@[64.A!(PWK'=J8MI\A<IJ.E]!5_2&"XR\VO*5[E
M+0MK8XG()X&"D<$ G4I<^>@,#RU!5P=\*YYL!D-M$0^Q;IZ8 W88^$414>E2
MRMN/7WRDI(2EY:'<)';"CZE$DI )Y!!.20G%]$\B_=2WYIM?R#M9F^>8B=;^
MR2/WVV_J&BC3[=H2&794E<F6H!9'D.)0'$M9(3P1A(VJ)(P23C/^;=^]KPF6
MBV7RP=_7%C^\44H@-IVN6#CS]XMO[XBS<VT 5H33)'GMC8L/ONKR"E.,>KV6
MH @I!.T ))!.J?>9UB AB/Y!ZY).!GYVB#*<*"B7\F%N3M[PT5-FY8,$DMTV
M&RPH*3N2,*4@<?B<)7A0RDA12KTJ2O@IS;=:F*E*)VNS.7M9_?$%!2SI/],<
MK-],\02@VE0XURSK@@(5#<EONN-1TI :<;D(=+FXJQM ;*AY9*B%^6<@HQJ<
MV:LH""01SP0Q!YA\#9L]#%5I(E$/<) )Y-BWG:,(OB-T=B3T$CO.(;*Z/?EN
MU"*L(2"VER%6*0ZV/63ZTU!*N.2$I*E()0#H>/L:%*B':=+8WR0H.1C!W]V8
MU54G5+23<I78ML079K7'/KD/&A=Z.?4=NW*<@XY*?;]Q!&2HIVI^N#GA)AR7
M;EM[L^_UC&1;RM\CCZYQ1WT*2K"1C )'<8.,$%(P..2?Q>W(5P,)0<Y_;T;?
MSOL#81=!(Q'7&X@<DE.1DG=C/8\)[J]B1G!V\@$&W%Q)?\_/R_3>PL(Y$M$Y
M)/985R%*R#P>>-P&1GTDDX3G!T<.V\28#'U]?IRCJRQ]VH%"LJ/&T\84H8'
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M(<FL.OK%T32; ^?EO;US\8NM8TNX+1*J1(K#DEA#?FLI=)):7N_ @JR2WD*
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M148D@EO8M22&@5I(]*<@)2XT%$'<4H)62>#5:2P<8L-L!O<Q;8LXS:)(N6W
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M!@%U7ZFP/[;1F58,AEM3:7E(:;=">5+"0D;0I)&3N*DG<,>D MX'K*=VPDS
MI(R";]?G9\W\HUBP$J8X%B5;\WYY;YB,M+,JR4NM--*&<I)42<YW[@&\E"@H
M A. %C(YR,I-_O'+=,/>_4?39S&"M(03;VS8B^UA@Y/7YQFE8MP,1T16FMN
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M'<HA2N%$J5DC*MH((&,'7"N#B.]\0]KZ^?/GF.%J.<I2>$@@]EG QQPG /(
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MM&"#"M_T7BBU!SWO<S0!L#+";F^X;Q,W(M&1P>0:GA,I,Q#ITSY2E;I,J?,
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M\M!<25 EAT).#N"B0DX3MRGN"%D8R"<T4@M[!SLY.#:P&;XVL8NZD7(4F_\
MB#/M^\7CM:BRH[\92HDCAT;,,/*4.,%0."#Z2,!7 P4I(.5*MI2L6T*93W(R
M/=Y?.*J6A+>-+VP1S'U@7ZQG/82Y<2VZI(3&?&V$(Z%!I8PN5_1T$#'&U*UJ
M'90 ]/ )UW7V=<._M'M1PJ2M)[NGG&KFA26 12@S@"2P\4Q*$79];8SS'::K
M$CAT\A:2I8$E("AF86..2"H[EPUC%$J5$;J\"73*E3E3($YA<:5&>8<+;K+@
MVK2< *2H#E"TE*VUA*T*2M(4/KF=*D3Y4R1.2B9*FI*%H4Q2I*@Q'Z'(-P00
M&\G!9BXLUP=Q>-4]O5*J]!/$VMF/$3(HU-N25$4Y4I$V(A,&;Y,J&_.^5I%0
M"T(8<3N^[4A8<W*;;;<6K7R-VQI!PGC'$J.4-2*:J49*EN2):M,Q#L"%.A8<
MX<!P3'T+V8GRZOA=!.F+2 NE$N8$JPI(,LFS%)"DEKM=W8L-S_CFL>F^([P1
M=0T,TA,UN%9TB]*&BD/-NH8K-O1/MNG+B;D,E+*W833;D;RV6E,O+;#+:' 5
M8B)X5*E5"-*@E2'*78)6=*P4@!O"I5F'B@:>F_\ FA03)JBJII9R)?>!*5+F
M2TJFR66%*2?&E/C*B2 QO:/)'TVZ?4B07JBBG/IDJ;0OF.\H>7Y:5$C<D A)
M"R1R,'@I2"-;NGNI18%A[.EB'WP_0OCS,>4U*B%Z4BQU#S:XP[>_]8N!<%'A
M4QAN6B$^M8<2@[8KJ<G*2%%8:)&2G("?=(/"R3K.7,_@S4*U JEJ2 ]G4DI&
M#YW;>\8U.D_>9"V<IG(5_P"%2599W\.'S\<K/#].DT'J91)**?(2XJ8TDAZ.
MI;3ZG%H;+;J%(#>US<$$E)QPK[S''G"E+*DC2H,I\$.!<A\V9[<H]WE%"IX*
ME)&JSZF]V.?UF-NWQ")DJXOA\=7(YA2TOV_7.EE;AL.PU(*&E=1K5C+<C)3O
M<6WY,]P>8IQP!#I"5I2Z$C>3E#[A5(4%?W<O(LY4GTQ<\C\,6GE2U<9I9H,M
MOXJ5>-S9"@"?%93;.W*X#Z]OAA3ZN.I\J(IJ1%5\B@K5(C/+0&/*)<PG:VZL
M[4%)2V5*V[PI;:-Y&OX6=<V6-*DD+4Y;DD@%MR;#F0;<CG\0,N4F>-2%:B"S
MA/XK7+L1_M!AZBM_$X?K]L>,RQ;GBTF:N56>D'3ZKK<9CO%J54*)=%\T)QTN
MI2E[<J#2Z<I;;I!\E4?(( SE<82O[S2K2@VIPDZ0764S%,]KD @ 6-A;$4X-
M.DR^&UJ>\2K14S%#V6 FIE3-&6(<ER+$OY1FY=G5"G>(7I5TGL.-0:M]J1+B
MMJ\9SCU.D.1Z4*'0ZS3JG-5,?=)=;D*J349H;([JUS$MMH6F.X7NIX'PRJ[0
M55%PN7(6D:T3*B<4^"FIT.F9.4]L%D@W,PB6+JCCN+\1I.%2JNM-0E4Z=+G2
M9$E+%2YBSJ2FP9*4$ G(TI#[@701">:0AM$5Y*&T);0D,N )0A(2E(]/9*0
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4=0F$=W,N/85N/Y3$20QN,'>/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g542432g34o10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g34o10.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X5-,:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](EA-4"!#;W)E(#4N,2XR(CX*(#QR9&8Z4D1&('AM
M;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN
M=&%X+6YS(R(^"B @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @
M('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(*
M(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(*
M(" @('AM;&YS.GAM<$=);6<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]G+VEM9R\B"B @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+VUM+R(*(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@(" @>&UL;G,Z
M<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O
M=7)C945V96YT(R(*(" @('AM;&YS.FEL;'5S=')A=&]R/2)H='1P.B\O;G,N
M861O8F4N8V]M+VEL;'5S=')A=&]R+S$N,"\B"B @("!X;6QN<SIX;7!44&<]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]T+W!G+R(*(" @('AM;&YS
M.G-T1&EM/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1&EM
M96YS:6]N<R,B"B @("!X;6QN<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+W-4>7!E+T9O;G0C(@H@(" @>&UL;G,Z>&UP1STB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O(@H@(" @>&UL;G,Z<&1F/2)H='1P
M.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(@H@(" @>&UL;G,Z17AT96YS:7-&
M;VYT4V5N<V4](FAT=' Z+R]W=W<N97AT96YS:7,N8V]M+VUE=&$O1F]N=%-E
M;G-E+R(*(" @9&,Z9F]R;6%T/2)A<'!L:6-A=&EO;B]P;W-T<V-R:7!T(@H@
M("!X;7 Z365T861A=&%$871E/2(R,#$X+3 S+3$T5#(R.C(U.C0X+3 W.C P
M(@H@("!X;7 Z36]D:69Y1&%T93TB,C Q."TP,RTQ-%0R,CHR-3HT."TP-SHP
M,"(*(" @>&UP.D-R96%T941A=&4](C(P,3@M,#,M,314,C(Z,C4Z-#@M,#<Z
M,# B"B @('AM<#I#<F5A=&]R5&]O;#TB061O8F4@26QL=7-T<F%T;W(@0U,V
M("A7:6YD;W=S*2(*(" @>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#I#-C)$
M0T9!-S Q,CA%.#$Q0D(Y,T4V13A"-D%$,3%"1"(*(" @>&UP34TZ1&]C=6UE
M;G1)1#TB>&UP+F1I9#I#-C)$0T9!-S Q,CA%.#$Q0D(Y,T4V13A"-D%$,3%"
M1"(*(" @>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/2)U=6ED.C5$,C X.3(T
M.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X(@H@("!X;7!-33I296YD:71I;VY#
M;&%S<STB9&5F875L="(*(" @:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4]
M(E!R:6YT(@H@("!X;7!44&<Z2&%S5FES:6)L94]V97)P<FEN=#TB1F%L<V4B
M"B @('AM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y/2)&86QS92(*(" @
M>&UP5%!G.DY086=E<STB,2(*(" @<&1F.E!R;V1U8V5R/2)!9&]B92!01$8@
M;&EB<F%R>2 Q,"XP,2(^"B @(#QD8SIT:71L93X*(" @(#QR9&8Z06QT/@H@
M(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^4W0@,# R/"]R9&8Z
M;&D^"B @(" \+W)D9CI!;'0^"B @(#PO9&,Z=&ET;&4^"B @(#QX;7 Z5&AU
M;6)N86EL<SX*(" @(#QR9&8Z06QT/@H@(" @(#QR9&8Z;&D*(" @(" @>&UP
M1TEM9SIW:61T:#TB,C4V(@H@(" @("!X;7!'26UG.FAE:6=H=#TB,3$V(@H@
M(" @("!X;7!'26UG.F9O<FUA=#TB2E!%1R(*(" @(" @>&UP1TEM9SII;6%G
M93TB+SEJ+S1!05%3:UI*4F=!0D%G14%304))04%$+S=107-51VAV9$<Y>F%'
M.7=)1$UU34%!-%%K;$Y!*S!!04%!04%"04%304%!04%%028C>$$[05%"24%!
M04%!44%"+RLT041K1FMB,DIL04=404%!04%!9B]B04E104)G445"055%0F=5
M1D)G:T="45E*0W=G1T)G9TQ$06]+0W=O2R8C>$$[1$)!341!=TU$07=11$$T
M4$5!.$]$0DU41D)15$5X=V)'>'-C2'@X9DAX.&9(>#AF2'=%2$)W8TY$03!9
M14)!64=H55)&4F]F2'@X9B8C>$$[2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF+SA!04519T%D
M045!07=%4B8C>$$[04%)4D%135)!9B]%06%)04%!04A!445"05%%04%!04%!
M04%!04%11D%W24=!44%(0T%K2T-W14%!9TE$05%%0D%114%!04%!04%!028C
M>$$[05%!0T%W449"9V-)0U%O3$5!04-!44U$06=10T)G8T1"04E'06Y-0D%G
M35)"04%&25))>%%614=%,D5I8UE%54UP1VA">%=X46E00B8C>$$[571(:$UX
M6FDX0U)Y9W9%;%%Z4E1K<4MY63-00TY546YK-D]Z3FAD55I(5$0P=4E)2F]-
M2D-H9UIH2E)&4G%3,%9T3E9+0G)Y-"]0128C>$$[,4]4,%I85T9L85<Q>&18
M;#E76C)H<&%M='-B5S5V63-2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT
M>4YJ;RM#:S535FQP95EM6B8C>$$[<6)N2C)E;C5+:G!+5VUP-FEP<7%U<W)A
M-G9O4D%!24-!44E$0E%514)1645#04U$8E%%04%H141"0T53355%1E523FA)
M9UIX9UI%>28C>$$[;V)(=T9-2%(T4TY#1E9*:6-V17I*1%)$9VAA4U5Y5VE9
M-TQ#0C-04TYE2D5G>&15:W=G2D-H9UI*:EI&1VED:V1&53,X<4]Z=WEG<"8C
M>$$[,"M0>FA*4VMT3515-5!2;&195U9P8EA&,658,5)L6FUD;V%7<')B1S%U
M8C)2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;R8C>$$[*T1L2E=7
M;#5I6FUP=6-N6C9F:W%/:W!A86YQ2VUQ<39Y=')Q*W8O84%!=T1!44%#15%-
M4D%$.$$Y531Q-T9867$W1EA9<3=&56XX-"8C>$$[861E6"]L>3AG<U8U,SA9
M4S5S:W%&-5A&<DET>$-V26Q1=DM32E)5;F)&6&Y&;#5,+TUN4C1,=#E/;7!D
M>$IB>#).,&=T-35I=#$O<"8C>$$[1W X23=I4DEQ;3=#+V)91&I7;%140VA7
M,5!39GIP=711:&UA5TM55U9Y3&DS5E5T26\Q<&%44D5W3UAK9&UB,4]*13!D
M1F-G:FMG3R8C>$$[2U=3-GAO3W)89FUQ>#%"3$IP3TLR0F@Q0C-H1%=9=#5P
M<$QX1T%B;%<T:FM732MK0T<O86]&6$9785E&9&ER<U999BM9;FQJ571C5"8C
M>$$[4S$P.6%N,3)S.51B;45),'DW6&ID.%-3=%0X0V)$1E=+-F)O4#5V-EI"
M6FEY;E=/861Y*W!)>5=S,&)Y>&-,5D=M:V554TEJ5W1U:B8C>$$[<C9)63AQ
M:&=-2V]V4CE-+TY-87AO,F\V;S!L>6)D<FE#+VM:8D=#9C9R3SEO=U%*1DI.
M1'1*135*0C5'34=N1GEU2W-G.'4V4F1X928C>$$[9&1:,4M84TI.3VAL1%)1
M6%AQ45-,9$0Q07I45$US,&LS26YA2D=10TY"5#ER:4%R3#A69&ER<U9E6BME
M9DHO;38U.'@S3W V0V<Y2R8C>$$[3T=$56)596]I97!Q<T1I,S1%37EI:E=D
M5C5(=C-W<6AM,&8X-$Y.175M-E1E375K,F%25S%H-F1T65--;'9$-F%2=$%:
M-3!A4U%O1"8C>$$[-F=N-&=B.%-D<U949GEV<#,U:#)D+W)-;#9K9&(K0DHW
M5C)A15%F<$579'1%-U1R2'IL0TY*2%)F5#)!1#%"<6AX5D]0>3<P;EA.2B8C
M>$$[.'9.6F$P<6DY5SAU-5!513-R;59*<#-L17)0=VDS8FU4,#9B:TM35D%6
M:S)+=7A6,DMV2G1*+TPS>EAB*UER4U-694]K=S-R,C114R8C>$$[2U%U;3)%
M<5AM;4YX1%9R-C9S<%5$=G5-2T5W<V]0>FMA3%1&=G)K1W0R-3%-0T-Y1F)C
M:4-K9G=Y-U)J.2]X9% S:"M(:V]Q94ML428C>$$[:3AS961:+WDY,#-2=%1G
M:V4U<TQM,E<V=%EZ6E,K<EI1=T)6:FE766E":6IC95EN2G$V<U)694=+<R\X
M=%=T,UHK6&1,=$QX1FIU-R8C>$$[93!G:75%4FDV<DEK87%W1$U76G%%9%-4
M9U9-8U936"]!0G(U4"MV+T%+4"]!13-9+UAA.&9Q+S%I3&QY<E1J5&PY<C(V
M-'%N5TMU>"8C>$$[5FI8;FXV,SE3<W94*W4O52]R1"]!1B\Y1V5V.5HT9E9P
M=E,T+U8O,W10<DAP,30O-TPT3U=+;RM'-S%E,#AS,C$Q95)*3G%-3F]K;28C
M>$$[;TEZ*VXK.%-,;$Q1<7)I=DED3VU+;VXQ=&(O-5I,8B]!2U-:4"MQ1TMU
M.6)7+SA!;&MT=BMK;50O<6AI<48Q4S8Q,DQ43'568F5#3B8C>$$[;S1:1U=2
M6C-:;$E1;6]5=U5*2&AI<D5D1SAX-FHK:TQ6:F8O049I13%%:7I3,&I937!#
M<WI+:VQ0:7 P1E!O=V]:=TIT84EQ3%<R<"8C>$$[+W=!>$UN+U9$06PS<F$S
M+T%-<VQT+S!K>68X059$1EAE=')F+TQ*8F8Y2DUN+U9$1EAE=')F.$%Y>5<S
M+U-42B]W0E5-5F0V,G0O."8C>$$[<VQT+S!K>68Y54U69#8R="]W1$Q*8F8Y
M2DUN+T%&47A6,W)A,R]Y>5<S+U-42B\Q47A6,W)A,R]!37-L="\P:WEF.$%6
M1$98971R9B8C>$$[+TQ*8F8Y2DUN+U9$1EAE=')F.$%Y>5<S+U-42B]W0E5-
M5F0V,G0O.'-L="\P:WEF.55-5F0V,G0O=T1,2F)F.4I-;B]!1E%X5C-R828C
M>$$[,R]Y>5<S+U-42B\Q47A6,W)A,R]!37-L="\P:WEF.$%61$98971R9B],
M2F)F.4I-;B]61$98971R9CA!>7E7,R]35$HO=T)5359D-B8C>$$[,G0O.'-L
M="\P:WEF.55-5F0V,G0O=T1,2F)F.4I-;B]!1E%X5C-R83,O>7E7,R]35$HO
M,5%X5C-R83,O04US;'0O,&MY9CA!5D1&6"8C>$$[971R9B],2F)F.4I-;B]6
M1$98971R9CA!>7E7,R]35$HO=T)5359D-C)T+SAS;'0O,&MY9CE5359E22]L
M>'!U=68T='-R5%5%=E0U828C>$$[=49C,C%J<48W2&91>4DY=DM9>GA35TM*
M=W=J67)30BMH239C9U5093A#6%EQ;'9M4'I$<'9L-U)R;E8Y4V-R83)Y,5E)
M3U1S5'-&4B8C>$$[86ER2"]08D966%A0*T]*<4@O34Y.+WEB3TMO,T9867$W
M1E5V,7I1-U16-TUW5$9O-48K2T,U:G V:V)E2S%"2'I",D]+<T\P,WI2<28C
M>$$[6&PS5E)O5W5P,3-T2FA8,#5O>"LS07@W:CEQ26UQ.7%J8VQ$4&)A-6=U
M659M9V-34G0P65E%<6U+=7A6,DMU>%8R2W5X5C)+=7A6,B8C>$$[2W5X5C)+
M=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W9"+WDR;6=M.#4V255M=7!R84)0
M<3%S<W(R,55A,W,W9WAX=6M54W-F4F=U4R8C>$$[2D<U+T1)-%9Q,')H43DT
M=TID:7%6-FXU8W-.4G,Y571:-4QG4C9V0V)E-G!027=60VA3<TUC:&5+23!/
M+T)"53=M=4MR+TU6=D1.;R8C>$$[;#A*541H24I85W9::$<Q1&EQ+SE"-E0O
M04US>69J:7)V,$AP4"],36XT-'$W.4(V5"]Y>DHK3TMU+U%E:R\X04Q-;C0T
M<6=.8CAK*R8C>$$[6$Y:,#93>'4W54MR-WAZ4FMR3$4T*WI*1S,W3$PR>%8U
M:2MO-G0U23%Y3%-V3313-C K63 P-U=86&I&3W8X04I0.$$W-VQ8=6$K+R8C
M>$$[5&-L1# O4V\O3'5P43@T8F1"278Y-45F=$PK3S0Y.%5O-SE"-E0O>7I*
M*T]"6&9O4%-F*U=:4'AX5C,V1#!N+T%*6FLO2$989F]04R8C>$$[9BM76E!X
M>%8S-D0P;B]L;50X8U9D*V<Y2B\U6FLO2$989F]04V8X06QM5#AC5F0K9SE*
M+S5::R](1EAF;U!39BM76E!X>%8S-D0P;B8C>$$[+VQM5#AC5F0K9SE*+W=#
M5UI0>'A6,S9$,&XO;&U4.&-69"MG.4HO-5IK+TA&6&9O4%-F*U=:4'AX5C,V
M1#!N+T%*6FLO2$989F]04R8C>$$[9BM76E!X>%8S-D0P;B]L;50X8U9D*V<Y
M2B\U6FLO2$989F]04V8X06QM5#AC5F0K9SE*+S5::R](1E=!1S(X9THU.6DX
M<&EZ,40V=R8C>$$[-D]Y=VDW;BMO2U)%<S=!,B]R-TEY52]9-$9V:#-)3D-R
M,#-!<G-6668U.'8W>C9I.79(639S1U-:1G1P-T)P4DA-,&M4:FQ),6=:8B8C
M>$$[=%E94V549D%P6F=O2$E6>%9.3# S8V9K.&IK,35,.5(T>E1Z07=33BLT
M4$M2-#)8:W)%-VQ#05)I<4\K=&%T+WEW<"]Y4$@O0412:28C>$$[<G9R5W)F
M.$%,0VXO04-02"].1TMU*W1A="]Y=W O>5!(+TY'2W4K=&%T+WEW<"]Y4$@O
M3D=+=2MT870O>7=P+WE02"]!1%)I<4$Q,R8C>$$[4S(Q,U,U.4PQ5%-O-VEZ
M=49O-D=C5D(W37 T5E9L3S1)>%8U140U:B],8E4W5W<Q9#)F45IN-&%8<DYE
M4F<X25IY0E%Q0C=D3VUW-"8C>$$[9V]E<C9D-7!U3&QO-V1R94TS1'%'4GA+
M1E-534MH;WE!>6M%9$M.=C)X<$MA+U=T5R\U654O-4AJ+VUJ07)V<E=R9CAS
M2V8X:G@O>B8C>$$[4FER=G)7<F8X<TMF.&IX+WI2:7)V<E=R9CAS2V8X:G@O
M=T$P67$W-C%Q,R]!0W=P+W=!:G@O>E)I<G9R5W)F.'-+9CAJ>"]Z4FER=B8C
M>$$[<E=R9CAS2V8X:G@O>E)I<G9R5W)F.'-+9CAJ>"]W03!9<3<V,7$S+T%#
M=W O=T%J>"]Z4FER=G)7<F8X<TMF.&IX+WI2:7)V<E=R9B8C>$$[.'-+9CAJ
M>"]Z4FER=G)7<F8X<TMF.&IX+W=!,%EQ-S8Q<3,O04-W<"]W06IX+WI2:7)V
M<E=R9CAS2V8X:G@O>E)I<G9R5W)F.'-+9B8C>$$[.&IX+WI2:7)V<E=R9CAS
M2V8X:G@O=T$P67$W-C%Q,R]!0W=P+W=!:G@O>E)I<G9R5W)F.'-+9CAJ>"]Z
M4FER=G)7<F8X<TMF.&IX+R8C>$$[>E)I<GIB>DA*-39V4'I$=3=0>2]Q339,
M1'=#15)T.55G63)Q4T-#6GIA4WAG;'E*;7)..%-K24%'24]&6'$K0EA9<6LO
M;7)Z5' O;"8C>$$[<E1F,&IF>'EY5R],:7AH0V9#07)/5UEY3D=O1D5O3C9S
M,4951FE!5E56<E1+,FA8-TMA<3%R2U%2,T)J3TMO-T9867$W1EA9<3=&6"8C
M>$$[67%H9%8P<E0Y5C K9E1T4F=7-7,W;%-K,$QI;TE0-FE/;TDV67$X8G9,
M3R\O3%<W:C O5D1*<5!K4S9L27-T4D%*=4Y0:V-K.$=P,28C>$$[6'52,&)Q
M=$=Q34M(<$=M82LY<DA!=#5-=#-P.7=O87HQ4TDX,&1$,'%25W5+5U-Q>75O
M6E-'5FA65T<T25!H9U9V1EA9<3=&6%EQ-R8C>$$[1EA9<71L;6EI6&Q+-GAR
M5VY*:4%++U1I<31%159'-%!1-'$W1EA9<71A4TY44FU!4&=30FEQ;6(R>556
M831J03A3-B\Q>%948E9D328C>$$[6%IR>4%(,VM19GAX5D%Z*V$Y2&AU5F<U
M;5-T05I9=T=J1F9%,2]6:'!5-'=+-T9867$X>&PP,DEF;F1$94159$U%>DMZ
M2%1W22]R+R8C>$$[04)&:55&5#92:TQ%+T8O96HY,D]M1EAP,D)867%K=7(K
M5F].4DUR<G%&+UI3>DUR4W1B,TQS:%99,FE+96A0-C%U15I8*TE#4&,P8B8C
M>$$[<4LT<74Q6%1,3T1Y=DY:4G%W=#=/,%I)1C5.54-+17%T5%=P,CAC5E)8
M-D8P-RM2+W=$:V),+WI6:7)V,$QP,SAJ+SAJ6F8K87-69"8C>$$[*VAD3R]K
M9B]!2D=Y+W=$3E=+=2]1=6YF>5 X03AJ6F8K87-69"MH9$\O:V8O:V),+W=!
M,5EQ-SE#-F0O22\X07E.;"\U<7A6,S9&,"8C>$$[-RM2+RM2<W8O3E=+<58S
M-6$P4SAT<$Q7-G1Z4&)Z2U5L:6534FQ:5#))3%EQ.&UV.4AV4'EV,4%Y>5)3
M-G0K6#DU3"LX:350-G1G-R8C>$$[=#$R235,."MV<S(W1D1.5BMP,C%R1'%T
M:$M.5#!'-D%A1FML6E-V3&-52VMF:5!9,$]+;VU$5W9,5'AC<&]:;W!+,#1#
M4U9T=D=O628C>$$[67%Q9G!,4D<R:'-B>54K>&MP+WEC>%,W,6DS.3%O;#!F
M.6575E Q-'$W-G1Q,&XY,W!(065,,TPO=T1.831Q-SE$-B]*+W5M0T0U>28C
M>$$[>D@O:F1S5F-03$=T369J=E5J.%%H:V(O04EL5$<Q57(W>69Q8E)Q575X
M8W5$=6HQ54-V8T5L<V)61C(O:SEH0VEZ6#!O641D27I2428C>$$[9F%V8D<Q
M5F@U3W-J.74V=5=0:GI59CA!1W!X=%8S*T1T2B]A85IH-$8O-TUB5F-V;$12
M04XT,V(S3'0O0VU.<7%$>7)O4#A!>7DO."8C>$$[4$HO>E9G=%<O=T1#,F<O
M.'-V.$%W.&XO0416:F%Q56YL1%)8;%=1239+=E=*6%!&=FY7<F9C8TYQ:E P
M3' S.&HO.$%),E@O04IQ=R8C>$$[2S<Y0S9D+TDO=T1Y3FPO-7%X5C,V1C W
M*U(O*U)S=B]!1%9I<GI,>4IB6'-8;5A42$0V;612:TXP+VUE,'57,4%147E#
M27!!-6MN:R8C>$$[84=F:7%P174W.&A2>%1I04-H-C-G4S=&5T9F;51F96-8
M,$153%!Y-W Q-FQW0B]X,&)D<F9M53E.<$LR-D-B,6DS<4MS8F9!1T%*2R8C
M>$$[0FE":7))=&5N:T=G6&)I,VM:<$QE44Y'1$AY4W-B5DQ664PX4&9I5#=6
M>%97+U-&,R\Q8DQN+V=R8B]Q=&ER=C!H9"\Y5WDU+W=#0R8C>$$[='8X07%T
M:7)V,&AD+W=$5G-U9BM#='8K<3)+=2]31C,O=T)7>34O-$LR+S9R67$W.4E8
M9B]6<W5F*T-T=BMQ,DMU+U-&,R\Q8DQN+R8C>$$[04E+,B]W0W$R2W4O4T8S
M+T%.5WDU+S1+,B\V<EEQ-SE)6&8O049B3&XO9W)B+W%T:7%N8UA$,TU%;'9C
M85)03D)+<%-72U$R<DMY;B8C>$$[66AG6G%%67$X9C%E,3%4.'-B<64K=')'
M834X:#9L2T9U=$MN:VHU,CAZ-VAO5U(U1"MZ<U0Q*WDR.4=W;UI6-4,O3DAY
M:G)#5'<V6B8C>$$[6E,R:VM42U!4=4IB6DI*0S10,F95;59M<'@W67!:>4Y2
M=6E!4G!T>5%D=U$Q="\Q5W=+,RMK3'8O<3)84"]"5S,O5F)&6&9P0S<O-B8C
M>$$[=&QZ+T%-1F)F.59S5F0K:TQV.$$V=&QZ+W=!1F)F.$%68D989G!#-R]W
M0W):8R\X1F)F.59S5F0K:TQV+W$R6% O0E<S+U9B1EAF<"8C>$$[0S<O-G1L
M>B]!349B9CE6<U9D*VM,=CA!-G1L>B]W049B9CA!5F)&6&9P0S<O=T-R6F,O
M.$9B9CE6<U9D*VM,=B]Q,EA0+T)7,R]68B8C>$$[1EAF<$,W+S9T;'HO04U&
M8F8Y5G-69"MK3'8X039T;'HO=T%&8F8X059B1EAF<$,W+W=#<EIC+SA&8F8Y
M5G-69"MK3'8O<3)84"]"5R8C>$$[,R]68D989G!#-R\V=&QZ+T%-1F)F.59S
M5F0K:TQV.$$V=&QZ+W=!1F)F.$%68D972FDO,61F>E%.<%!Q<TIS6$@K:399
M;#EB<$E%*R8C>$$[<6-J>G-403 W=#9O6BM1;5@T861H46Q78S1&9&EQ52M:
M=DTQ:#5D<TDW>3A2<$5M;5,S:5)':&I*:VMQ4CAD>$I$1V\K12]A8UEQ<B8C
M>$$[871)6E!,.3=)5DM&-U-6:6I&4U9R1U11;%-Y-V5X27A634U69&ER<U9D
M:7)S5F1I<G-69&ER<U934'IL-5$P,WI:;W)A4G%-<S!6<R8C>$$[,&E3;#=D
M:U8V;V%J9#%K1E!O>%9I5VTO.#0O9FPQ85%44E1W,T]O97%15FMU6G5,>#!"
M2'='05%D83<X<30R<7<O:UIP=&UE9FPO>B8C>$$[0G$R:E-#=D51>C%J2"MX
M06IB-2]&:'17:C52+T]J5$MJ4R]..79Q55,O6FDQ1S-#:R].=W-Z+SA.:7)F
M*TM0>G,P=U8Q2'ER86%R128C>$$[=7AK,"LT.4YJ+W-7859V*T5X5C,O2SA,
M5WDR.'<K5W18,&1Q,$QV0GIJ1D]P-4XV4G X;'AP530P>C@U4'DS,41I23EA
M:6=C.55U5B8C>$$[94-N>F%25E0X8T-P;F9F;4HU1W-6:&4U,7EZ0U1G=$,V
M4W))<D%5<E%X.&@S>%9..4TQ3W<Q4WAI=CA!5#4Q=6)/8T5W>G Y;&=#5B8C
M>$$[3DLK-'A61EEQ-T9867$W1EA9<6<U=%HP:4-6;W W-C-I;%1:;S-L4E=(
M9F-%,7A61UEQ-T9867$X;W1B-U1.4B]/93%U.4]/;%AD<R8C>$$[-E-V.61G
M=FMK;F0Q<WA'2$536$(U3T%':C0K:G-N>&-J53A3<C%F07)S5E-85U!+=&YQ
M87I%,V0U8E-Z3VMH:VEM36=5<$<P5DDT8B8C>$$[9U0R-D)K:V)L>&HS3R\R
M9T1I<3=63DUT3&9Y=DY:46@P=#=/,%I)1E=2,4E72T5Q;UEQ45=&0C!06$95
M6"MH-U0O9FQZ+S!L6% X028C>$$[,55X5C,V2'10.2M84"]35F,O.$%65$98
M9F]E,"]W0BM84#A!,&Q84"]65$989F]E,"\S-6,O.$%35F,O.59-5F0K:#=4
M+V9L>B\P;"8C>$$[6% X03%5>%8S-DAT4#DK6% O4U9C+SA!5E1&6&9O93 O
M=T(K6% X03!L6% O5E1&6&9O93 O,S5C+SA!4U9C+SE6359D*V@W5"]F;"8C
M>$$[>B\P;%A0.$$Q57A6,S9(=% Y*UA0+U-68R\X05941EAF;V4P+W="*UA0
M.$$P;%A0+U941EAF;V4P+S,U8R\X05-68R\Y5DU69"MH-R8C>$$[5"]F;'HO
M,&Q84#A!,55X5C,V2'10.2M84"]35F,O.$%65$989F]E,"]W0BM84#A!,&Q8
M4"]65$95;G8O04UT+TI';T5T9F%41F-U9B8C>$$[,C5':UIV.$%G:3%C8E9G
M6&Y4+VY(;E-T4G5,851Y=S!/:GAQ<D,V:FM-,&]D:5)X2SAM9FI49G!H=%58
M;S,O3U!U:3(K;5<X9#=Q=28C>$$[;TIQ2T$K=%!:5&E+3W!**W=R;SE">#8T
M,G%.+S554F]0+U8O,3,O<$QJ+S9O-#)R6"]+:S%'>65B9&164G-Q+U=U9S=$
M<&IA=2\U528C>$$[,W%%6"LX=FYB6%E!9G1$-GEX<68Y:7E9<30O;$8U:$%R
M2#4K,7=0,DQ4>4U0<$AQ0W5+<F8K5E1E8B\O04,T5W)F.$%$+SA!5F)&6"8C
M>$$[;3-M9CAJ4'I(=4YE=35O;2]3.&)S3T=P6$4P85-Y:FE"5C%D,F%O-F)N
M=&EH.44O;V4P+S,U8R\Y2E9Z+W="5DU#6&9O93 O,S5C+R8C>$$[.4I6>B]W
M0E9-5F0K:#=4+T%(-6,O=T135F,O.59-5F5895)026$V4C4T:3%"+TU/;%AC
M-TQ-+S9/<U97,F1K-'9%4VQV0DEK5D5F628C>$$[;&\R-F5/-$MV6'-#=7A6
M:%@U:"MA<B]4<D]/3%1*;7-:5G5L:79B*V10<3A+4G1B5%1,-F1X8W=Y,C=&
M;FE63F<R-31F0WI!-'%N3B8C>$$[-65Z>F54>F-T1$I,3&,R4$]58U5I9%,X
M0EIM9$=F-&%(<6]*23DX5E(O-E%U+SA!<3)84"]"5S,O5F)&6&9P0S<O-G1L
M>B]W5G0O,28C>$$[5WA6,S91=2\K<EIC+W=$0E<S+U9B1EAF<$,W+T%/<EIC
M+SA!0E<S+T%&5WA6,S91=2\X07$R6% O0E<S+U9B1EAF<$,W+S9T;'HO=R8C
M>$$[5G0O,5=X5C,V474O*W):8R]W1$)7,R]68D989G!#-R]!3W):8R\X04)7
M,R]!1E=X5C,V474O.$%Q,EA0+T)7,R]68D989G!#-R\V="8C>$$[;'HO=U9T
M+S%7>%8S-E%U+RMR6F,O=T1"5S,O5F)&6&9P0S<O04]R6F,O.$%"5S,O0497
M>%8S-E%U+SA!<3)84"]"5S,O5F)&6&9P0R8C>$$[-R\V=&QZ+W=6="\Q5WA6
M,S91=2\K<EIC+W=$0E<S+U9B1EAF<$,W+T%/<EIC+SA!0E<S+T%&5WA6,S91
M=2\X07$R6% O0E<S+U9B1B8C>$$[6&9P0S<O-G1L>B]W5G0O,5=X5C,V474O
M*W):8R]W1$)7,R]68D989G!#-R]!3W):8R\X04)7,R]!1E=X5C,V474O.$%Q
M,EA0+T)7,R8C>$$[+U9B1EAF<$,W+S9T;'HO=U9T+S%7>%8S-E%U+RMR6F,O
M=T1"5S,O5F)&6&9P0S<O04]R6F,O.$%"5S,O0497>%8S-E%U+SA!<3)84"8C
M>$$[+T)7,R]68D989G!#-R\V=&QZ+W=6="\Q5WA6,S91=2\K<EIC+W=$0E<S
M+U9B1EAL,VQ84W9+;&PU=#!+4%%*8BLX9&)I8S-"=3=/928C>$$[0EE9;S='
M5TM(.30Y=D%+25!G<%@T;6-S86Y#:#8Y9U,W1E5$<E=T-F9O=&DQ.7%";%<Q
M:G(V:VM-13%X=U5+5TQU<T-337%"5DY7228C>$$[;U!(1E9M<#-%5GHU8W4W
M:4MV<%178VMK9DI74G5,4D5I<7-&6E11.4-+-'%M3TMU>%8R2W5X5C)+=7A6
M,DMU>%8R2W5X5C)+=7A6,B8C>$$[2W5X5C)+=7A6,DMU>%8R2W5X5C)+=7A6
M,DMU>%8R2W5X5C)+=7A6,DMU>%9*.5DX=GDV;D)C,CAT+TLQ<F145W)T87E*
M13!34E<X<28C>$$[4U-X2G=73U-K-F]6674W57)T-%EQ;48Y6E)8=',Q=DUZ
M<D4T26-2<U5*0D)"0DDW1W5+<5 V2FHO=T-7;34O-4A0.$$Q>%8S-DIJ+R8C
M>$$[04]7;34O-4A0+UA&6&9O;5 O;'!U9CA!:V,O.6-69"MI62\K5VTU+S5(
M4"]!1GA6,S9*:B]W0U=M-2\U2% X03%X5C,V2FHO04]7;28C>$$[-2\U2% O
M6$989F]M4"]L<'5F.$%K8R\Y8U9D*VE9+RM7;34O-4A0+T%&>%8S-DIJ+W=#
M5VTU+S5(4#A!,7A6,S9*:B]!3U=M-2\U2"8C>$$[4"]81EAF;VU0+VQP=68X
M06MC+SEC5F0K:5DO*U=M-2\U2% O049X5C,V2FHO=T-7;34O-4A0.$$Q>%8S
M-DIJ+T%/5VTU+S5(4"]81B8C>$$[6&9O;5 O;'!U9CA!:V,O.6-69"MI62\K
M5VTU+S5(4"]!1GA6,S9*:B]W0U=M-2\U2% X03%X5C,V2FHO04]7;34O-4A0
M+UA&6&9O;28C>$$[4"]L<'5F.$%K8R\Y8U9D*VE9+RM7;34O-4A0+T%&>%8S
M-DIJ+W=#5VTU+S5(4#A!,7A6,S9*:B]!3U=M-2\U2% O6$989F]M4"]L<"8C
M>$$[=68X06MC+SEC5F0K:5DO*U=M-2\U2% O049X5C,V2FHO=T-7;34O-4A0
M.$$Q>%8S-DIJ+T%/5VTU+S5(4"]81EAF;VU0+VQP=68X028C>$$[:V,O.6-6
M4C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMQ1B]C=F$R5GAC<$)*8W9"1S!I,CA)
M0FMK2V=N9V=*04Q.,$=+=DEF3F8U-BM9.28C>$$[3',T6F]V2U8S<'!E5&=:
M9%9I;&II66-394M%0U T='9(<&A6371!+T]N5F)V5#=A-S%$>6YQ2U=R25I,
M<E9)26TK<'!'=%,X<74K,R8C>$$[0E9&9#-X<%9E,"].<E5K,%I*9%$P=4M,
M5UDP=EAU-TMA4U=Y*TLQ5TMA2T-&2EEP6DAM;&EU54MQ44LP6FAT:E-Q-2].
M935I=3<R0B8C>$$[.4M7-E-'33-&=$YA4W1*1DI&1' V6'1X>&LY3VHX5VQJ
M4D=O3V9Q1%IA1W)3;S5F3W5R-FQP9FPW53E+*W%146%T950R:S9Y>'DS2R8C
M>$$[;%E5;F-3=WE"-U$X5RMQ;6Y/3W9X0V]"56=H5TTR=C5W*UER<E0T2E1:
M,FQJ24Y03GID>C-656E&=W,Y=5-K6'%447$Q8E,V4U)6828C>$$[459:,5AK
M3CA.2SE6,#8U1C-P.71D06MI94I*86Q$1V9J54XY:&EZ3#$K>51T9U9,<GIZ
M0F1W4$UI-EAC3TDV9U-C5'=.3SE11'1H5B8C>$$[0S)8;6TY;6=$;E1*<&1Y
M3V-+<WE(.$1J4W-8.'IF;6AR3VIA,6,R,$YT83-C54)%=C%+<%=:8F1,1U<V
M;#EA6DI*9E-M-7A%3$<X028C>$$[<792:G9X5E@S,S5X>'=4-G!"839A;#-*
M<%8P.$4S1S1K46-);V)M9'E3.750,VER6DU/0S%7<$AX-'%M,7@U<C$R-'1.
M1'5R1DQA,"8C>$$[3B]F,T]N,SA%.&-L,7=E,5<T3$=+4EI,8F)L6G-O3$IV
M>4(R<%%H5TM7=C5W*UER<E0T2E1:,FQJ24Y03GID>C-656E&=W,Y=5-K6"8C
M>$$[<511<3%B4S934E9A459:,5AK3CA.2SE6,#8U1C-P.71D06MI94I*86Q$
M1V9J54XY:&EZ3#$K>51T9U9%67$W1EA9<3=&6%EQ-T98628C>$$[<3=&6%EQ
M-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ
M-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<28C>$$[-T9867$W1E@O.6L](B\^
M"B @(" \+W)D9CI!;'0^"B @(#PO>&UP.E1H=6UB;F%I;',^"B @(#QX;7!-
M33I$97)I=F5D1G)O;0H@(" @<W12968Z:6YS=&%N8V5)1#TB>&UP+FEI9#I#
M-3)$0T9!-S Q,CA%.#$Q0D(Y,T4V13A"-D%$,3%"1"(*(" @('-T4F5F.F1O
M8W5M96YT240](GAM<"YD:60Z0S4R1$-&03<P,3(X13@Q,4)".3-%-D4X0C9!
M1#$Q0D0B"B @("!S=%)E9CIO<FEG:6YA;$1O8W5M96YT240](G5U:60Z-40R
M,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@B"B @("!S=%)E9CIR96YD
M:71I;VY#;&%S<STB9&5F875L="(O/@H@(" \>&UP34TZ2&ES=&]R>3X*(" @
M(#QR9&8Z4V5Q/@H@(" @(#QR9&8Z;&D*(" @(" @<W1%=G0Z86-T:6]N/2)S
M879E9"(*(" @(" @<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#HT0C0P04(P
M-S1#,C=%.#$Q.3!&-CE%,SDT,C!%,D0P,R(*(" @(" @<W1%=G0Z=VAE;CTB
M,C Q."TP,RTQ-%0Q,CHU,3HP."LP-3HS,"(*(" @(" @<W1%=G0Z<V]F='=A
M<F5!9V5N=#TB061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*2(*(" @
M(" @<W1%=G0Z8VAA;F=E9#TB+R(O/@H@(" @(#QR9&8Z;&D*(" @(" @<W1%
M=G0Z86-T:6]N/2)S879E9"(*(" @(" @<W1%=G0Z:6YS=&%N8V5)1#TB>&UP
M+FEI9#HT130P04(P-S1#,C=%.#$Q.3!&-CE%,SDT,C!%,D0P,R(*(" @(" @
M<W1%=G0Z=VAE;CTB,C Q."TP,RTQ-%0Q,CHU,CHP-"LP-3HS,"(*(" @(" @
M<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O8F4@26QL=7-T<F%T;W(@0U,V("A7
M:6YD;W=S*2(*(" @(" @<W1%=G0Z8VAA;F=E9#TB+R(O/@H@(" @(#QR9&8Z
M;&D*(" @(" @<W1%=G0Z86-T:6]N/2)C;VYV97)T960B"B @(" @('-T179T
M.G!A<F%M971E<G,](F9R;VT@87!P;&EC871I;VXO<&]S='-C<FEP="!T;R!A
M<'!L:6-A=&EO;B]V;F0N861O8F4N:6QL=7-T<F%T;W(B+SX*(" @(" \<F1F
M.FQI"B @(" @('-T179T.F%C=&EO;CTB<V%V960B"B @(" @('-T179T.FEN
M<W1A;F-E240](GAM<"YI:60Z-$8T,$%",#<T0S(W13@Q,3DP1C8Y13,Y-#(P
M13)$,#,B"B @(" @('-T179T.G=H96X](C(P,3@M,#,M,314,3(Z-3(Z,SDK
M,#4Z,S B"B @(" @('-T179T.G-O9G1W87)E06=E;G0](D%D;V)E($EL;'5S
M=')A=&]R($-3-B H5VEN9&]W<RDB"B @(" @('-T179T.F-H86YG960](B\B
M+SX*(" @(" \<F1F.FQI"B @(" @('-T179T.F%C=&EO;CTB<V%V960B"B @
M(" @('-T179T.FEN<W1A;F-E240](GAM<"YI:60Z0S8R1$-&03<P,3(X13@Q
M,4)".3-%-D4X0C9!1#$Q0D0B"B @(" @('-T179T.G=H96X](C(P,3@M,#,M
M,314,C(Z,C4Z-#@M,#<Z,# B"B @(" @('-T179T.G-O9G1W87)E06=E;G0]
M(D%D;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RDB"B @(" @('-T179T
M.F-H86YG960](B\B+SX*(" @(#PO<F1F.E-E<3X*(" @/"]X;7!-33I(:7-T
M;W)Y/@H@(" \>&UP5%!G.DUA>%!A9V53:7IE"B @("!S=$1I;3IW/2(U.34N
M,C@P,C<S(@H@(" @<W1$:6TZ:#TB.#0Q+C@X.38T."(*(" @('-T1&EM.G5N
M:70](E!O:6YT<R(O/@H@(" \>&UP5%!G.D9O;G1S/@H@(" @/')D9CI"86<^
M"B @(" @/')D9CIL:0H@(" @("!S=$9N=#IF;VYT3F%M93TB07)I86Q-5"(*
M(" @(" @<W1&;G0Z9F]N=$9A;6EL>3TB07)I86PB"B @(" @('-T1FYT.F9O
M;G1&86-E/2)296=U;&%R(@H@(" @("!S=$9N=#IF;VYT5'EP93TB3W!E;B!4
M>7!E(@H@(" @("!S=$9N=#IV97)S:6]N4W1R:6YG/2)697)S:6]N(#4N,C B
M"B @(" @('-T1FYT.F-O;7!O<VET93TB1F%L<V4B"B @(" @('-T1FYT.F9O
M;G1&:6QE3F%M93TB87)I86PN='1F(B\^"B @(" @/')D9CIL:0H@(" @("!S
M=$9N=#IF;VYT3F%M93TB07)I86Q-5"U";VQD(@H@(" @("!S=$9N=#IF;VYT
M1F%M:6QY/2)!<FEA;$U4($)O;&0B"B @(" @('-T1FYT.F9O;G1&86-E/2)"
M;VQD(@H@(" @("!S=$9N=#IF;VYT5'EP93TB5'EP92 Q(@H@(" @("!S=$9N
M=#IV97)S:6]N4W1R:6YG/2(P,#$N,# S(@H@(" @("!S=$9N=#IC;VUP;W-I
M=&4](D9A;'-E(@H@(" @("!S=$9N=#IF;VYT1FEL94YA;64](F%R:6%L;70M
M8F]L9"YP9F([($%224%,350M0D],1"Y01DTB+SX*(" @(" \<F1F.FQI"B @
M(" @('-T1FYT.F9O;G1.86UE/2)#86QI8G)I4F5G=6QA<B(*(" @(" @<W1&
M;G0Z9F]N=$9A;6EL>3TB0V%L:6)R:5)E9W5L87(B"B @(" @('-T1FYT.F9O
M;G14>7!E/2)4>7!E(#$B"B @(" @('-T1FYT.G9E<G-I;VY3=')I;F<](C4N
M,# R(@H@(" @("!S=$9N=#IC;VUP;W-I=&4](D9A;'-E(@H@(" @("!S=$9N
M=#IF;VYT1FEL94YA;64](F-A;&EB<FER96=U;&%R+G!F8CL@0T%,24)225)%
M1U5,05(N4$9-(B\^"B @(" \+W)D9CI"86<^"B @(#PO>&UP5%!G.D9O;G1S
M/@H@(" \>&UP5%!G.E!L871E3F%M97,^"B @(" \<F1F.E-E<3X*(" @(" \
M<F1F.FQI/D)L86-K/"]R9&8Z;&D^"B @(" \+W)D9CI397$^"B @(#PO>&UP
M5%!G.E!L871E3F%M97,^"B @(#QX;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @
M/')D9CI397$^"B @(" @/')D9CIL:3X*(" @(" @/')D9CI$97-C<FEP=&EO
M;@H@(" @(" @>&UP1SIG<F]U<$YA;64](D1E9F%U;'0@4W=A=&-H($=R;W5P
M(@H@(" @(" @>&UP1SIG<F]U<%1Y<&4](C B/@H@(" @(" \>&UP1SI#;VQO
M<F%N=',^"B @(" @(" \<F1F.E-E<3X*(" @(" @(" \<F1F.FQI"B @(" @
M(" @('AM<$<Z<W=A=&-H3F%M93TB5VAI=&4B"B @(" @(" @('AM<$<Z;6]D
M93TB0TU92R(*(" @(" @(" @>&UP1SIT>7!E/2)04D]#15-3(@H@(" @(" @
M("!X;7!'.F-Y86X](C N,# P,# P(@H@(" @(" @("!X;7!'.FUA9V5N=&$]
M(C N,# P,# P(@H@(" @(" @("!X;7!'.GEE;&QO=STB,"XP,# P,# B"B @
M(" @(" @('AM<$<Z8FQA8VL](C N,# P,# P(B\^"B @(" @(" @/')D9CIL
M:0H@(" @(" @("!X;7!'.G-W871C:$YA;64](D)L86-K(@H@(" @(" @("!X
M;7!'.FUO9&4](D--64LB"B @(" @(" @('AM<$<Z='EP93TB4%)/0T534R(*
M(" @(" @(" @>&UP1SIC>6%N/2(P+C P,# P,"(*(" @(" @(" @>&UP1SIM
M86=E;G1A/2(P+C P,# P,"(*(" @(" @(" @>&UP1SIY96QL;W<](C N,# P
M,# P(@H@(" @(" @("!X;7!'.F)L86-K/2(Q,# N,# P,# P(B\^"B @(" @
M(" \+W)D9CI397$^"B @(" @(#PO>&UP1SI#;VQO<F%N=',^"B @(" @(#PO
M<F1F.D1E<V-R:7!T:6]N/@H@(" @(#PO<F1F.FQI/@H@(" @/"]R9&8Z4V5Q
M/@H@(" \+WAM<%109SI3=V%T8VA'<F]U<',^"B @(#Q%>'1E;G-I<T9O;G13
M96YS93IS;'5G/@H@(" @/')D9CI"86<^"B @(" @/')D9CIL:0H@(" @("!%
M>'1E;G-I<T9O;G1396YS93I&;VYT2VEN9#TB4&]S=%-C<FEP="(*(" @(" @
M17AT96YS:7-&;VYT4V5N<V4Z1F%M:6QY/2)#86QI8G)I(@H@(" @("!%>'1E
M;G-I<T9O;G1396YS93I/=71L:6YE1FEL95-I>F4](C0P,#,S(@H@(" @("!%
M>'1E;G-I<T9O;G1396YS93I&;W5N9')Y/2)-:6-R;W-O9G0B"B @(" @($5X
M=&5N<VES1F]N=%-E;G-E.E9E<G-I;VX](C4N,# R(@H@(" @("!%>'1E;G-I
M<T9O;G1396YS93I+97)N:6YG0VAE8VMS=6T](C B"B @(" @($5X=&5N<VES
M1F]N=%-E;G-E.D9O;G1396YS95\Q+C)?0VAE8VMS=6T](C4P-3$Y-C,Y."(*
M(" @(" @17AT96YS:7-&;VYT4V5N<V4Z0VAE8VMS=6T](C4P-3$Y-C,Y."(*
M(" @(" @17AT96YS:7-&;VYT4V5N<V4Z4&]S=%-C<FEP=$YA;64](D-A;&EB
M<FE296=U;&%R(B\^"B @(" @/')D9CIL:0H@(" @("!%>'1E;G-I<T9O;G13
M96YS93I&;VYT2VEN9#TB4&]S=%-C<FEP="(*(" @(" @17AT96YS:7-&;VYT
M4V5N<V4Z1F%M:6QY/2)!<FEA;"!-5"(*(" @(" @17AT96YS:7-&;VYT4V5N
M<V4Z3W5T;&EN949I;&53:7IE/2(R-S<T-R(*(" @(" @17AT96YS:7-&;VYT
M4V5N<V4Z1F]U;F1R>3TB36]N;W1Y<&4@5'EP;V=R87!H>2(*(" @(" @17AT
M96YS:7-&;VYT4V5N<V4Z5F5R<VEO;CTB,# Q+C P,R(*(" @(" @17AT96YS
M:7-&;VYT4V5N<V4Z2V5R;FEN9T-H96-K<W5M/2(P(@H@(" @("!%>'1E;G-I
M<T9O;G1396YS93I&;VYT4V5N<V5?,2XR7T-H96-K<W5M/2(R,S$X,#,P,3<U
M(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I#:&5C:W-U;3TB,C,Q.# S,#$W
M-2(*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z4&]S=%-C<FEP=$YA;64](D%R
M:6%L350M0F]L9"(O/@H@(" @(#QR9&8Z;&D*(" @(" @17AT96YS:7-&;VYT
M4V5N<V4Z1F]N=$MI;F0](D]P96Y4>7!E("T@5%0B"B @(" @($5X=&5N<VES
M1F]N=%-E;G-E.D9A;6EL>3TB07)I86PB"B @(" @($5X=&5N<VES1F]N=%-E
M;G-E.D]U=&QI;F5&:6QE4VEZ93TB,"(*(" @(" @17AT96YS:7-&;VYT4V5N
M<V4Z1F]U;F1R>3TB36]N;W1Y<&4@5'EP;V=R87!H>2(*(" @(" @17AT96YS
M:7-&;VYT4V5N<V4Z5F5R<VEO;CTB-2XR,"(*(" @(" @17AT96YS:7-&;VYT
M4V5N<V4Z2V5R;FEN9T-H96-K<W5M/2(P(@H@(" @("!%>'1E;G-I<T9O;G13
M96YS93I&;VYT4V5N<V5?,2XR7T-H96-K<W5M/2(R,S4V,S0S-#DV(@H@(" @
M("!%>'1E;G-I<T9O;G1396YS93I#:&5C:W-U;3TB,C,U-C,T,S0Y-B(*(" @
M(" @17AT96YS:7-&;VYT4V5N<V4Z4&]S=%-C<FEP=$YA;64](D%R:6%L350B
M+SX*(" @(#PO<F1F.D)A9SX*(" @/"]%>'1E;G-I<T9O;G1396YS93IS;'5G
M/@H@(#PO<F1F.D1E<V-R:7!T:6]N/@H@/"]R9&8Z4D1&/@H\+W@Z>&UP;65T
M83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X
M<&%C:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( 'T!&P,!$0 "$0$#$0'_Q  >  $
M 00# 0$             !P4&" D" P0* ?_$ %00   % P$!"@L#" 8'"0$
M  (#! 4&  $'"!$2$Q05%U97E]77"188(515E)66F-,Q,M8*(S5!46%Q@1DB
M,SAWMB0E)C1"<J$V4E-B<W2"D9.B_\0 %P$! 0$!                  $"
M __$ "T1  (  P<"!@(# 0         !$9'1 A(A46%BH2+P,4%2<9+2@;'!
MX?%"_]H # ,!  (1 Q$ /P#[^* 4 H!0"@% * Q(U/LV57-=CE%C=PGJ=NR
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MA1L9TV)S(I?TFE9Z980LB13&;-@'/K,6)FLJ>V]:KJ7G'RU\88>4/'4'T!U
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MYJ3J:R)-I9D4>SA,7]'@O4U-RGW.#%DYB<8E-M)9F+;,4?SF\ZEO%H3[,I/
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MGDV%??DPQ;;)UQ&[3'VM<.Z+/ <05R::9M6D_P"23:A10"@% * 4 H!0"@%
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M0@.W^'"7)/\ ]=E6X].:"^M>*GA\LS'AWF01/(BZ_P"K>V=FL&_\+@D!H_\
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M+ZN!GJV\FQ3'>:'/+I99N*=3^D3)8#0;L'B$U+)<+<[-U?=%L.>UY@!!M]\
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M 4!I;U0+CY#KSQ$UL>/L>3)G$_X#LID:26%I7 J8P7,UU3PFGBUISK##VXR
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MA?3<,^[)OVM3HW<#KV\C>]0OIN&?=DW[6IT;N!U[>1O>H7TW#/NR;]K4Z-W
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M<U,7%FS@W:-L2)D2<A<.2.:LL&Q0N&ZA274&7%<5QV3)DX220VM>P  #NKV
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>DC7&(H6XMIBYK-<%@$U4 H!0"@% * 4 H!0"@/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g542432g36p86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g36p86.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X4/#:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](EA-4"!#;W)E(#4N,2XR(CX*(#QR9&8Z4D1&('AM
M;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN
M=&%X+6YS(R(^"B @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @
M('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(*(" @
M('AM;&YS.GAM<$=);6<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G
M+VEM9R\B"B @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC;VTO<&1F
M+S$N,R\B"B @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE
M;G1S+S$N,2\B"B @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+VUM+R(*(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @("!X;6QN
M<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E
M<V]U<F-E4F5F(R(*(" @('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]P:&]T;W-H;W O,2XP+R(*(" @('AM;&YS.G1I9F8](FAT=' Z
M+R]N<RYA9&]B92YC;VTO=&EF9B\Q+C O(@H@(" @>&UL;G,Z97AI9CTB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]E>&EF+S$N,"\B"B @("!X;6QN<SIX;7!44&<]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]T+W!G+R(*(" @('AM;&YS
M.G-T1&EM/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1&EM
M96YS:6]N<R,B"B @("!X;6QN<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+W-4>7!E+T9O;G0C(@H@(" @>&UL;G,Z>&UP1STB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O(@H@(" @>&UL;G,Z17AT96YS:7-&
M;VYT4V5N<V4](FAT=' Z+R]W=W<N97AT96YS:7,N8V]M+VUE=&$O1F]N=%-E
M;G-E+R(*(" @>&UP.D-R96%T941A=&4](C(P,3@M,#,M,314,C,Z,#(Z,3(M
M,#<Z,# B"B @('AM<#I#<F5A=&]R5&]O;#TB061O8F4@26QL=7-T<F%T;W(@
M0U,V("A7:6YD;W=S*2(*(" @>&UP.DUO9&EF>41A=&4](C(P,3@M,#,M,314
M,C,Z,#(Z,3(M,#<Z,# B"B @('AM<#I-971A9&%T841A=&4](C(P,3@M,#,M
M,314,C,Z,#(Z,3(M,#<Z,# B"B @('!D9CI0<F]D=6-E<CTB061O8F4@4$1&
M(&QI8G)A<GD@,3 N,#$B"B @(&1C.F9O<FUA=#TB87!P;&EC871I;VXO<&]S
M='-C<FEP="(*(" @>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#HR,D(U,C X
M0C$T,CA%.#$Q0D(Y,T4V13A"-D%$,3%"1"(*(" @>&UP34TZ1&]C=6UE;G1)
M1#TB>&UP+F1I9#HR,D(U,C X0C$T,CA%.#$Q0D(Y,T4V13A"-D%$,3%"1"(*
M(" @>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/2)X;7 N9&ED.D(X138V1D,T
M,D0R-$4X,3$Y1$9&.#4S-3$X,$%!,D)"(@H@("!X;7!-33I296YD:71I;VY#
M;&%S<STB9&5F875L="(*(" @<&AO=&]S:&]P.D-O;&]R36]D93TB,2(*(" @
M=&EF9CI/<FEE;G1A=&EO;CTB,2(*(" @=&EF9CI84F5S;VQU=&EO;CTB,C,Q
M-C8X,"\Q,# P,"(*(" @=&EF9CI94F5S;VQU=&EO;CTB,C,Q-C8X,"\Q,# P
M,"(*(" @=&EF9CI297-O;'5T:6]N56YI=#TB,B(*(" @97AI9CI#;VQO<E-P
M86-E/2(V-34S-2(*(" @97AI9CI0:7AE;%A$:6UE;G-I;VX](C$T-C<B"B @
M(&5X:68Z4&EX96Q91&EM96YS:6]N/2(W-#DB"B @('AM<%109SI.4&%G97,]
M(C$B"B @('AM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y/2)&86QS92(*
M(" @>&UP5%!G.DAA<U9I<VEB;&5/=F5R<')I;G0](D9A;'-E(CX*(" @/'AM
M<#I4:'5M8FYA:6QS/@H@(" @/')D9CI!;'0^"B @(" @/')D9CIL:0H@(" @
M("!X;7!'26UG.G=I9'1H/2(R-38B"B @(" @('AM<$=);6<Z:&5I9VAT/2(X
M,"(*(" @(" @>&UP1TEM9SIF;W)M870](DI014<B"B @(" @('AM<$=);6<Z
M:6UA9V4](B\Y:B\T04%14VM:2E)G04)!9T5!4T%"24%!1"\W44%S54=H=F1'
M.7IA1SEW241-=4U!0311:VQ.02LP04%!04%!0D%!4T%!04%!14$F(WA!.T%1
M0DE!04%!05%!0B\K-$%$:T9K8C)*;$%'5$%!04%!068O8D%)44%"9U%%0D%5
M14)G549"9VM'0E%92D-W9T="9V=,1$%O2T-W;TLF(WA!.T1"04U$07=-1$%W
M441!-%!%03A/1$)-5$9"451%>'=B1WAS8TAX.&9(>#AF2'@X9DAW14A"=V-.
M1$$P645"05E':%521E)O9DAX.&8F(WA!.TAX.&9(>#AF2'@X9DAX.&9(>#AF
M2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9B\X04%%
M46=!54%%04%W15(F(WA!.T%!25)!44U2068O14%A24%!04%(05%%0D%114%!
M04%!04%!04%!449!=TE'05%!2$-!:TM#=T5!06=)1$%114)!445!04%!04%!
M04$F(WA!.T%104-!=U%&0F=C24-1;TQ%04%#05%-1$%G44-"9V-$0D%)1T%N
M34)!9TU20D%!1DE227A15D5'13)%:6-9155-<$=H0GA7>%%I4$(F(WA!.U5T
M2&A->%II.$-2>6=V16Q1>E)4:W%+>5DS4$-.55%N:S9/>DYH9%5:2%1$,'5)
M24IO34I#:&=::$I21E)Q4S!6=$Y62T)R>30O4$4F(WA!.S%/5#!:6%=&;&%7
M,7AD6&PY5UHR:'!A;71S8E<U=EDS4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E)
M;4MI-'E.:F\K0VLU4U9L<&59;5HF(WA!.W%B;DHR96XU2VIP2U=M<#9I<'%Q
M=7-R839V;U)!04E#05%)1$)1545"45E%0T%-1&)114%!:$5$0D-%4TU51495
M4DYH26=:>&=:17DF(WA!.V]B2'=&34A2-%-.0T962FEC=D5Z2D121&=H85-5
M>5=I63=,0T(S4%-.94I%9WAD56MW9TI#:&=:2FI:1D=I9&MD1E4S.'%/>G=Y
M9W F(WA!.S K4'IH2E-K=$U453504FQD65=6<&)81C%E6#%2;%IM9&]A5W!R
M8D<Q=6(R4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\F(WA!.RM$
M;$I75VPU:5IM<'5C;EHV9FMQ3VMP86%N<4MM<7$V>71R<2MV+V%!07=$05%!
M0T5135)!1#A!.54T<3=&6&Y8;3=Y.7)6+S5L=6(F(WA!.W)4.4MV3&1L9T-2
M-GI:6$9T2&-41C%66%):2EIH2D5I4CAG:65N>&%5.&E6<'E*5D$S=FLW>EES
M5VIA=$)B4S,R<S)D<TDW=3)U<FPF(WA!.TA35DEB;U17.&-R<S5D<&%S2EA)
M;#E/<V1",4=+=E1,>5-E3S--:U)5371+:&=71S5P,DLT1F1W=B\X068P6"]!
M0TMB+W%P:7)U1B\F(WA!.R]V-DPO:U4S+U941EAC3"]!4#,Y1B]Y2V(O<7!I
M<G5&+W=$-RMI+S5&3B\Q57A6,T,O.$$Y+U)F.&EM+S9Q67$W:&8O04\O;W8K
M4E0F(WA!.V8Y5DU69'=V+W=$9C!8+TEP=CA!<7!I<G5&+R]!3"MI+W=#4E1F
M.$%65$988TPO+T%(.48O=T%I;2\V<5EQ-VAF+S<K:2\U1DXO,54F(WA!.WA6
M,T,O=T0Y+U)F.&EM+S9Q67$W:&8X02LO;W8K4E1F.59-5F1W=B]!4&8P6"])
M<'8K<6U+=318+W=$=C9,+VM5,R]65$988TPO.$$F(WA!.S,Y1B]Y2V(O04MQ
M67$W:&8O=T,O;W8X06M5,R]!1E5X5C-#+R]W0B]29CA!27!V*W%M2W4T6"\K
M+V]V*U)49CE6359D=W8X02]F,%@F(WA!.R])<'8K<6U+=318+T%0=C9,+VM5
M,R]65$988TPO=T0S.48O>4MB+W%P:7)U1B\X03<K:2\U1DXO,55X5C-#+R]!
M3B]29CAI;2]W0W$F(WA!.VU+=318+SA!=C9,+T%*1DXO=T)6359D=W8O.$%F
M,%@O04-+8B]Q<&ER=48O+W8V3"]K53,O5E1&6&-,+T%0,SE&+WE+8B]Q<&EQ
M4F8F(WA!.SAR0SAT0C9L<G(V<E=N-E$K<%AF,5-V+T%$165L-F10.'%V2#-X
M5FMM2W9.+T](;2LY<W9.6#9/<W9-161S<4<S1V\R>DQA<CE6=#4F(WA!.VYJ
M5C55.55023AY;S=3;&HK-VIJ1EA8=5-Q1'903VYM9E0P,')5-W)51FLP3V5&
M:F-.1D-H=4AI=#<S:#EB0T9&44QC4DY%;&592#<F(WA!.WEQ<'181EAP3W!Y
M371M>%=.<$LP,EAI2V)J<GE+-$964')-,R],3$PY.%@O0418:7)V<DTS+TQ,
M3#DX6"].94MU*W-Z9CAS<W8S>&8F(WA!.S@Q-'$W-GI.+W=!<W-V,WAF.#$T
M<3<V>DXO>7EY+V9&+W=!,31Q-S9Z3B]Y>7DO9D8O>EAI<G9R33,O3$Q,.3A8
M+TYE2W4K<WIF.$$F(WA!.TQ,3#DX6"].94MU*W-Z9CAS<W8S>&8X04YE2W4K
M<WIF.'-S=C-X9C@Q-'$W-GI.+WEY>2]F1B]Z6&ER=G)-,R]!0WEY+V9&+WI8
M:7(F(WA!.W9R33,O3$Q,.3A8+T%$6&ER=G)-,R],3$PY.%@O3F5+=2MS>F8X
M<W-V,WAF.#$T<3<V>DXO=T%S<W8S>&8X,31Q-S9Z3B]Y>7DO9D8F(WA!.R]W
M03$T<3<V>DXO>7EY+V9&+WI8:7)V<DTS+TQ,3#DX6"].94MU*W-Z9CA!3$Q,
M.3A8+TYE2W!,1#4U,%=E.2MP44IC>EA0,6U3>DLF(WA!.U)13R]'8452;51K
M>3%65E542CAB2&IV,7A6<3DX.39*6E18359Z2&12;3!L4T-D+U%C>&E2,#E1
M2TI!0VI5:BM*=4I016)T45EQ;60F(WA!.VIQ.&0O8DQD5VM%<W1U-5E2>6HP
M=W)C1TML;'$T-4M3=G=S3FU'-'%#1&EQ22MS>F8X<W-V,WAF.#$T<3<V>DXO
M=T%S<W8S>&8X,30F(WA!.W$W-GI.+WEY>2]F1B]W03$T<3<V>DXO>7EY+V9&
M+WI8:7)Y9GDS-31K=F1F=$Y5,697>$1"85!,84A31&1'2S5*945/<GHR4W=X
M+U<F(WA!.TA6,SE0-$DP-'-0:#5R.%)+=E@X0W-B,7IZ=F(V4G$P=&A,<#DS
M8TQ&65-8-6QG:DQ'47!.1D-)659.4%5C;6-%,&%G,CAD;%5T8C@F(WA!.WI)
M+W)E;4MU;'EX5T=Q4DDX3CEC>4Q&2$A)6FEK<U5R<4I);&5+3DAC<C9N2V\T
M.%)7=4975V%N3$9(6G5:2%9!4T%#>$%Q86IX=TLF(WA!.W8O4T9H+WDP>&8X
M04)R+UA&6&9P0W<O-6%9=BM$6"MU2W4O4T9H+WDP>&8X1W8X05A&6&9P0W<O
M-6%9=BM$6"MU2W4O4T9H+WDP>&8F(WA!.SA'=CEC5F0K:TQ$+T%*85EV*T18
M*W5+=2]31F@O=T%T35@O0G(O6$989G!#=R\U85EV.$%G,2]R:7)V,&A99CAT
M35@O04%A+S%X5C,F(WA!.S91<U K5VU,+V<Q+W)I<G8P:%EF.'1-6"]"<B]!
M1GA6,S91<U K5VU,+V<Q+W)I<G8P:%EF.'1-6"]"<B]81EAF<$-W+W=#5VU,
M+V<F(WA!.S$O<FER=C!H668X04Q41B]W82\Q>%8S-E%S4"M7;4PO04E.9C8T
M<3<Y25=(+TQ41B]W04=V.6-69"MK3$0O;'!I+S1.9C8T<3<Y25<F(WA!.T@O
M3%1&+W=A+W="8U958GI7.4AS-U=7-W5B>4=+,V=5=DQ)6$9&5F1Y9'-696)3
M878K5D4R;VTK;C@R*W,U,4)D531/3&%G;E%22V\F(WA!.U)X8D-614,R-DME
M1&=S0E)I86Y#<3(U,4@X;F(R-G9,;E4O36M6+TIF2D9(8V5S;'-V2EEN5FA8
M,&)A27-X0V-E8D5S;THT1F-66E0F(WA!.S5",4AY4D1P,#EH-64Q:&(V0T-5
M>7EE<$EP369R5C1Q4&AJ2$@T1#(Y>E5M=4MS;R]31F@O=T%T35@O0G(O6$%R
M=C!H668X04Q41B\F(WA!.W=A+S%X5C,V47-0*U=M3"]!24YF-C1Q-SE)5T@O
M3%1&+W=!1W8Y8U993D0U*W5,:C@P53AV,G$V9%!P=C=Y,VQU56Q2-W-3>#(O
M<D8F(WA!.U%&:S5F0S1:1TAP,$90=&-Q<4-R,$1!<D0O3F5Q*U5$<E V3C%#
M,VUV3E=&;BLW:71M6D@Y3S1V3&%.23%C4U)"2DAU4%-:5S5$:G@F(WA!.S5C
M;$A65DHU=%(O3')51S S>3=0<&0Q23@Q=E,P=%=:=6$K<&5#3V1'651C+U93
M84%V3$I5-TLS>&UP0DMV44PX05=B9V1.=C%J07$F(WA!.TEX5C)+=7A6,DMU
M>%8R2W5X5C)+=7A6,DMU>%9*=$\Q=2]U=&4Q5%1*8D]*24Y/5TIL=6]P,FM,
M=$YY2WAU:E)20DA#2T=90FU(>$0F(WA!.V9&5TLS;C5T4%EW-F9.939/,$5D
M.4Q08E!+6FUE3TMA,W5P3%IW,&E1<W!69E(U<V9T54DT<3(Y1%-V47=14E5D
M34-U>%8R2W5X5C(F(WA!.TMU>%9J6#5M9BM3*SAW+SAW12\O04)!-'$K3CA+
M2%EQ.6TO24=B54E03#-N;6)447@Q1TLP9V5Z16%#5GI-<V0P62M-6C)C.'%5
M6'8F(WA!.VEL;3EZ-6LO349F3'5L=&)26#@K<D<T=4DW;%9S0W)32#%J.54Y
M6G!R949%=#)I+W9*06MB.4YL4$E9<6TO:W95+U!495IB+T%%,WHF(WA!.T9&
M2SEL2$<W,DXV<U%30GEK,W!T5B]2:3-*+W4Q-CA.+VIQ2'A6;D]"6%EQ.'4P
M;GI%3E0O33)#6%-.6'1*9$AU,FM:-T-/,4UD>38F(WA!.TIA165Q-W9B2S=O
M,'$Q179Q.$M!2TMN0W(Q2$%Q5&$S-59S3EAU-&)U86%A1S5T;VI&8GEW;$%5
M2G5)3&Q:04A2=U=74S%3;%%6<%4F(WA!.T5'=4MP3G)(;$AY;F-75G1O9#EQ
M<VM%;'1','-A+U=)56Y,,TYW=DLV64UU-WE3:WAH=5!(-#)50W!&1E=4-FY%
M<C)B06QG0E-N1FTF(WA!.UAU3W1#2S1Q<695;V8U<&8K4C!V+TY72W4K<%$O
M=T$P=B])-E@O;7)&56U45W1.9GI"9#9#:U8P.2]A5R]W0F%O<S9K4THX3WEG
M5#@F(WA!.VMA<F=$,4952'-30EA&56M(-6QE5E9U-')/-&IV<F$V;5(R4TMA
M5E)6-#=P-TXT*U%U1U-O:VI:=61F5#1I=DQT:%9M;C%+2"MA6"\F(WA!.T%*
M2%,O=T1.5T)89E5O9C5P9CA!:V1,+T%-,5EQ-S9L1"].3"]W06IP9CA!;7)&
M6&95;V8U<&8K4C!V+T%$5FER=G%54#@P=B])-E@F(WA!.R]M<D989E5O9C5P
M9BM2,'8O3E=+;V)56#!Z5&)+82MV<F@W93!T,35Z5%!.3'A69D4O1FER16HU
M-"]+07-Z2%9R47,X=C%L;4QY5DTF(WA!.W=14BMQ5"]0=T%8;#%P=&A60TPU
M:2])=&)0-FMT>G!Q,F9X1#9S1DEI;S=+-V9"5&HX5%))5'0Q565!>%906#%B
M5'9-9FQZ5FTX;V$F(WA!.VHY8C%#3S-L:G1P634U84IC=$=F4W%864%(;%1R
M=&=62UDW1'I:2G!/:U<P=6XV;$)E=S-Y;39U-&(X,%<Q5V9N>6%/5R]N36YQ
M4D$F(WA!.TEY=3<X87-6<E)A;%8O-68V2#4S<TPR.70O36,Q>&574E%'>'9*
M3&QY=T-U>%9'451Z2&U1-4QK;F(T5D1-04]+<DXO<550.#!V.$$F(WA!.WE/
M;"\U<7=+-S9L1"].3"]!36IP9BMA<U9D.5-H+VUL+W=#4C!V.$%Z5FER1W9Z
M2G1);#AG*UE'1%-61FI/4E=746HW0C=&<5EQ*U F(WA!.W-+2%EQ.6,O26I5
M<$Y0:#%P-#$U;5IR9%=(3C!P=T5H2#)'6"MF=FER,5@O04)89&8W-D@O23)F
M+W%P:E-U+WA89&8W-D@O23)F.$$F(WA!.S9Q63!R35E,5TM30T]1=$M#-FAI
M0DY,,T9F-7-#5E0V;$0O3DPO>4]L+S5Q>%9)3D,O3#-23D4Q0TLK<W)I+TQW
M4DQB>'=Y,VLX:TDF(WA!.VA137-C4FI::7!34#%'-$MD;$\T,WA6:S)+<%HU
M;3!Y8E9F3"MO86)$=SE3-V=E14Q)>F]J0GA1<7I2+T=O66)%:C=J:7)";2],
M1%8F(WA!.V)A>3!Y6%-"6E=7<39A2FI!4SAS:TM+,3!:<F5#:&HT3TEK;&-M
M6F\K8D]Q;GAW<3E",4Y(87I90U)K27!5<48S,T@X=V)!<7 Y5VTF(WA!.R]W
M0U=Q6#=O=BMA3591=7 S5G9P9&A0<48O<45K1FYB3'IN;4MX:TMV4W1&:DIX
M5C4O9&5D4'EI=7138E5P=DTY=V)X;S)H1').9&\F(WA!.W%X=49$<DA':7%I
M0G5#;'5+:7!!2C,S=W%H2DYD+TDV6%,T.4QM,7@U8D='4#!9635(=6YA3U Q
M1FLT;S=)6%0T:U@W3&1!0C R>%8F(WA!.VU#96$Y23%B>3=F-FQO3W%8;#E&
M84%O5' X0U-82'%!06A)-#5)1S5-86HY:VI!<5<S3W%E8E1995A)<F4X=D1Q
M5GE6:#%A5#E'>2LF(WA!.VE*2F).>7-R1G)91TY&=51(>3)(53%P4G%&5EAY
M3G%0;F$W=3=M,#AX2F11.%E5;'1R;C!O,6E:0WAP>5EW4E9L64U/46]T3T\V
M268F(WA!.W1+<WDK<E1F.'15=C-29C@P649D.5=M+S5A<&9U:2\U;WA6,S%A
M8B]!2F%P9G5I+S5O>%9I9C5R45-R*UAE=D4S16IG5WAQ<$5D1#@F(WA!.U$X
M14)X0W9K6$-H,DMV6&9Y9EIL.'4S9D9I2S-J5F]A9C=Q:G=Q>G8Q<&8U,BLX
M-'$W,7!F-3(K.#1Q.4\K<E1F.'15=C-29C@P6D8F(WA!.TQV<3 S+TQ63#DP
M6"].1TMU*W)49CAT578S4F8X,%EQ>'(X>5E*5CAG*UE#8FU29TQ'97%K4C!0
M=TAW44A&6'@Y:%$W1EAQ2#5.+S<F(WA!.WDV<"]R>&9Q8D-R,%A&6%EQ.4QT
M3&59,G-**W13:CDR=7=%6&=0.$%)>4M68C9T3B]W0715=C-29C@P67%R-'$W
M1E5N.#-F6"]W1$0F(WA!.S$Q.5(Y8C%Q>#@O<79,,2]2.59F6#E(:CA8<65J
M>C0X9#8Y3CA6649E1'IL6DY9-G)B3G$Q-UE+6G<R:VAB:U1',&@Q079B33=U
M5V8F(WA!.S%*23-I57$X9G%'34YY8C=1=W$Y3W99-35B8W!#<6QM<%AM>%5!
M03$W0G-#=34S+T%0=FU,+VMA,R]64$95;#@U84QQ=78X06QF560F(WA!.TAH
M145-=#=%66ML95)Y<6MK1W!P2%AT:7)X3"]!2T9O.#,O.5A05"]!4&=P=BMQ
M94<Q9"\P3%(U=B\V=65N+SA&3B\Q5'AT5V)E4E F(WA!.WEN.'HK5W1/=4Q7
M5RMT;DTP,W%G=W9+0E1I1C-Q9SA-8E%Y8B]#9FU(+VQR:B\U1WDO.$%.1TYQ
M,FYL5'I!<G%X=6]Y05%A97)*+WHF(WA!.U)J87-Q-3,O05!V;4PO:V$S+U90
M06PS3R]W1#DX>&8X:E<O-G T<3=N9CA!*RM9=BM2<F8Y53A64UAZ;&]U<38O
M=T-6.5(P945147DF(WA!.S-S4FE35C5(2W%346%M:V1E,DMV178X06]7:GIF
M+S%C.5 X02M#;2\V<#1B5C,O471(;2\O<34V9B]W53,O5E!',5IT-4@O2U!8
M+TPF(WA!.RML>E=D>F0R:W)Y5&U:5VIA4VQ#:7)4-&M(.'5.;UI&+V=F5E Y
M+U%F92\O0414:F%U+W=0<6XK+V]0=F8O;6Y',5IF>G8X02]F35@F(WA!.R])
M,78K<65"3'5D+R]V;4PO:V$S+U901EAC-R]!4#-Z1B]Y3F(O<6YI<54K83E+
M,517=DQ7<#9417-%570Y8GE12DLX:FQ63')3<' F(WA!.TA81EAH,R]1=$AM
M+R]Q-39F+W=5,R]64$1A=2\V1F\X,R\X059Z,"\O9W!V*W%E3G%Y+WE**U1F
M;4AY-T1E2F18;'!-8FAK6D1%,'4F(WA!.S-!3418:V<X8V)1>6XO02MQ9C<K
M9RLY+RMA8V)6,RM".54O,SE".3<O=T1.3TYQ>7E%6#AC36-F<%)(9V]7=G%T
M=E%5+W=".31%<BLF(WA!.V0O.$$W-6DO-4=T+S%4>%98>%8R2W5X5C)+=7A6
M,DMU>%9"-GEU;U!P1CAU;7EE;'%,5SAO<W!A2S-'8V]F5&)I,W=M:C R3S)+
M=DLF(WA!.W)(.#%037%&.55V-#9A4S!,-G)&1G<T<71N3F-,63(X8VMK8V-S
M9U98-5A$37%L*T\R*W=W;V1Q2#4W=$]K35=M-F1+=#!:3%8O4E0F(WA!.S%(
M;&QI86%)>4)&:V=24%-M4C)J:FLU:"M8-T,W2$=K<VTX,RMB:D):-DI06C8W
M8C9D8S9N2#9L=$-'=#)T<&DS<'0V:VQZ8W%T3&4F(WA!.TYE5WE+<VHQ2$=H
M,GA6;F5"6%EQ-T9867$W1E5(<DLV9RMK6'DV8DHV5V]T8GEI>6QO<F-:>6@Y
M3G5,9D-A4%19-UEQ.'0P,S@P4$TF(WA!.S%:=%5V;VED2U<R;3%M2T)5568V
M1SAO<S=A1C-62%E$;7)4<W="64PT:6=W;U<S,S4W3F124E%A6' X;C%U4C=D
M;WI$-FMR>7 Y8U,F(WA!.T]4,&QL9VI5>%-X:&M2,DMV>5E$9T1V:E-74RM:
M+U!7;S(O;"]13E(P-D)I=7$S1F\Q,V,R,&-T-49$03 P4WEX:&QI*S(O<6-&
M-4DF(WA!.W!0>%4K3V=X5FYE0EA9<3=&6%EQ-T961SEJ=5I,3V5/,6PY1S5E
M3C%G;6]$=VM+:TLQ0T=";V0Y>&ER>6Y19GI'.#-Z,U Q>3EJ6G0F(WA!.T]&
M:DYR2#%:66M6,FAS65IB5S1T-C U8VUV0DA*>3DV9EIW;V1D9FYI3#9X=7)F
M5')8-G1F=EI88S%N8T)P2E!J=#1P;E=E3EIB94XF(WA!.TAG4&]51$]687!!
M3697:E-5>#@R*V8X05=H;T]K86IP<DQP>3-Q,V-L>3-/3C)J;71L*T,P26UJ
M265D;35!=W%&6FY5;W-G*S%I<C F(WA!.W-';T(V5C=(07)S5F1I<G-69&ER
M<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<G,F(WA!.U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)S5F1I<G-69&ER<U9E95@S;'(X>5I0>DU85G)F5F5(;$U3=W,R;B]7
M2$@F(WA!.W=,0W%Y1#!U4$AE444Y8TMR8D,S+TY/1T]C6%EL0S-T*W0V5W1:
M-U=E94,S=4EP<3)Q0S=!:5514W!$>4$U1&EZ8T=9.4963%))4'HF(WA!.VE3
M-&0W>#9X>E%I5GAC=&%%<F-W-F5I96UO:'%Q>'I8:FLO1#!74'-82DMQ6FI3
M9D]'<654.4M45FUU64YE4SEH83E7,W4O<7II,4XF(WA!.S105D1V6G9$134K
M<58K>C@Q06)!<D9R2'DO.$%M.$Q+3T15-7)Y4DQE>$U3;3)U,$TX='DQ>$)D
M8W!7*W,R>$E!3'=%<DER0D9B:3,F(WA!.WA#<%8V>'!W=4)P.7-,;$)(8VE*
M4%AJ1'1+1F9I3U,K;S-X4%$O=$AC-$935V)4=DU(<C9G-75:5&)Y>#-!=#!T
M-4(V>6QW9E0Y35,F(WA!.V-9=S0O6C5';&5U1E=(=U=0-7(R4U)3,G-D,#9#
M,U-#5WIA-W0R:V-Q.30S<D(W>5,O.$%4;5 K:C$K3C%O,T@T9V\T<6]U>6@O
M3T4F(WA!.S-6;%!D5$US42MQ9E<W54-W-$AI=&M,;7!#;"]I3#-B2&DS-TDT
M,'%T5E8O;7IY,S4R9GI$2G%0;#8T=3!J4C=794]*<C94-G4W4E(F(WA!.S-B
M>GA'0C5E0W!,271Q:"M(64=O+V%X5EHU5S!F.'=B9GI22&5A,#DS8U<X,#!S
M,'ET8W(Y5&=393%6*T532F-";4U6>'EI0W9#>3@F(WA!.V%/<%4Y5EAO*T)8
M67$W1EA9<3=&6%EQ-T9867$W1EA9<2\O6B(O/@H@(" @/"]R9&8Z06QT/@H@
M(" \+WAM<#I4:'5M8FYA:6QS/@H@(" \9&,Z8W)E871O<CX*(" @(#QR9&8Z
M4V5Q/@H@(" @(#QR9&8Z;&D^9&5L=&$\+W)D9CIL:3X*(" @(#PO<F1F.E-E
M<3X*(" @/"]D8SIC<F5A=&]R/@H@(" \9&,Z=&ET;&4^"B @(" \<F1F.D%L
M=#X*(" @(" \<F1F.FQI('AM;#IL86YG/2)X+61E9F%U;'0B/C$P-F0\+W)D
M9CIL:3X*(" @(#PO<F1F.D%L=#X*(" @/"]D8SIT:71L93X*(" @/'AM<$U-
M.DAI<W1O<GD^"B @(" \<F1F.E-E<3X*(" @(" \<F1F.FQI"B @(" @('-T
M179T.F%C=&EO;CTB<V%V960B"B @(" @('-T179T.FEN<W1A;F-E240](GAM
M<"YI:60Z0CA%-C9&0S0R1#(T13@Q,3E$1D8X-3,U,3@P04$R0D(B"B @(" @
M('-T179T.G=H96X](C(P,3@M,#,M,3!4,3(Z,3DZ-#DK,#4Z,S B"B @(" @
M('-T179T.G-O9G1W87)E06=E;G0](D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I
M;F1O=W,I(@H@(" @("!S=$5V=#IC:&%N9V5D/2(O(B\^"B @(" @/')D9CIL
M:0H@(" @("!S=$5V=#IA8W1I;VX](G-A=F5D(@H@(" @("!S=$5V=#II;G-T
M86YC94E$/2)X;7 N:6ED.C(R0C4R,#A",30R.$4X,3%"0CDS139%.$(V040Q
M,4)$(@H@(" @("!S=$5V=#IW:&5N/2(R,#$X+3 S+3$T5#(S.C R.C$R+3 W
M.C P(@H@(" @("!S=$5V=#IS;V9T=V%R94%G96YT/2)!9&]B92!);&QU<W1R
M871O<B!#4S8@*%=I;F1O=W,I(@H@(" @("!S=$5V=#IC:&%N9V5D/2(O(B\^
M"B @(" \+W)D9CI397$^"B @(#PO>&UP34TZ2&ES=&]R>3X*(" @/'AM<$U-
M.D1E<FEV961&<F]M"B @("!S=%)E9CII;G-T86YC94E$/2)X;7 N:6ED.C(Q
M0C4R,#A",30R.$4X,3%"0CDS139%.$(V040Q,4)$(@H@(" @<W12968Z9&]C
M=6UE;G1)1#TB>&UP+F1I9#HR,4(U,C X0C$T,CA%.#$Q0D(Y,T4V13A"-D%$
M,3%"1"(*(" @('-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#TB>&UP+F1I9#I"
M.$4V-D9#-#)$,C1%.#$Q.41&1C@U,S4Q.#!!03)"0B(*(" @('-T4F5F.G)E
M;F1I=&EO;D-L87-S/2)D969A=6QT(B\^"B @(#QX;7!44&<Z36%X4&%G95-I
M>F4*(" @('-T1&EM.G<](C4S-BXP,# P,# B"B @("!S=$1I;3IH/2(T,#8N
M,# P,# P(@H@(" @<W1$:6TZ=6YI=#TB4&]I;G1S(B\^"B @(#QX;7!44&<Z
M1F]N=',^"B @(" \<F1F.D)A9SX*(" @(" \<F1F.FQI"B @(" @('-T1FYT
M.F9O;G1.86UE/2)!<FEA;$U4(@H@(" @("!S=$9N=#IF;VYT1F%M:6QY/2)!
M<FEA;"(*(" @(" @<W1&;G0Z9F]N=$9A8V4](E)E9W5L87(B"B @(" @('-T
M1FYT.F9O;G14>7!E/2)/<&5N(%1Y<&4B"B @(" @('-T1FYT.G9E<G-I;VY3
M=')I;F<](E9E<G-I;VX@-2XR,"(*(" @(" @<W1&;G0Z8V]M<&]S:71E/2)&
M86QS92(*(" @(" @<W1&;G0Z9F]N=$9I;&5.86UE/2)A<FEA;"YT=&8B+SX*
M(" @(" \<F1F.FQI"B @(" @('-T1FYT.F9O;G1.86UE/2)!<FEA;$U4+4)O
M;&0B"B @(" @('-T1FYT.F9O;G1&86UI;'D](D%R:6%L350@0F]L9"(*(" @
M(" @<W1&;G0Z9F]N=$9A8V4](D)O;&0B"B @(" @('-T1FYT.F9O;G14>7!E
M/2)4>7!E(#$B"B @(" @('-T1FYT.G9E<G-I;VY3=')I;F<](C P,2XP,#,B
M"B @(" @('-T1FYT.F-O;7!O<VET93TB1F%L<V4B"B @(" @('-T1FYT.F9O
M;G1&:6QE3F%M93TB87)I86QM="UB;VQD+G!F8CL@05))04Q-5"U"3TQ$+E!&
M32(O/@H@(" @(#QR9&8Z;&D*(" @(" @<W1&;G0Z9F]N=$YA;64](D-A;&EB
M<FE296=U;&%R(@H@(" @("!S=$9N=#IF;VYT1F%M:6QY/2)#86QI8G)I4F5G
M=6QA<B(*(" @(" @<W1&;G0Z9F]N=%1Y<&4](E1Y<&4@,2(*(" @(" @<W1&
M;G0Z=F5R<VEO;E-T<FEN9STB-2XP,#(B"B @(" @('-T1FYT.F-O;7!O<VET
M93TB1F%L<V4B"B @(" @('-T1FYT.F9O;G1&:6QE3F%M93TB8V%L:6)R:7)E
M9W5L87(N<&9B.R!#04Q)0E))4D5'54Q!4BY01DTB+SX*(" @(#PO<F1F.D)A
M9SX*(" @/"]X;7!44&<Z1F]N=',^"B @(#QX;7!44&<Z4&QA=&5.86UE<SX*
M(" @(#QR9&8Z4V5Q/@H@(" @(#QR9&8Z;&D^0FQA8VL\+W)D9CIL:3X*(" @
M(#PO<F1F.E-E<3X*(" @/"]X;7!44&<Z4&QA=&5.86UE<SX*(" @/'AM<%10
M9SI3=V%T8VA'<F]U<',^"B @(" \<F1F.E-E<3X*(" @(" \<F1F.FQI"B @
M(" @('AM<$<Z9W)O=7!.86UE/2)$969A=6QT(%-W871C:"!'<F]U<"(*(" @
M(" @>&UP1SIG<F]U<%1Y<&4](C B+SX*(" @(#PO<F1F.E-E<3X*(" @/"]X
M;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" \17AT96YS:7-&;VYT4V5N<V4Z<VQU
M9SX*(" @(#QR9&8Z0F%G/@H@(" @(#QR9&8Z;&D*(" @(" @17AT96YS:7-&
M;VYT4V5N<V4Z1F]N=$MI;F0](E!O<W138W)I<'0B"B @(" @($5X=&5N<VES
M1F]N=%-E;G-E.D9A;6EL>3TB0V%L:6)R:2(*(" @(" @17AT96YS:7-&;VYT
M4V5N<V4Z3W5T;&EN949I;&53:7IE/2(T,# S,R(*(" @(" @17AT96YS:7-&
M;VYT4V5N<V4Z1F]U;F1R>3TB36EC<F]S;V9T(@H@(" @("!%>'1E;G-I<T9O
M;G1396YS93I697)S:6]N/2(U+C P,B(*(" @(" @17AT96YS:7-&;VYT4V5N
M<V4Z2V5R;FEN9T-H96-K<W5M/2(P(@H@(" @("!%>'1E;G-I<T9O;G1396YS
M93I&;VYT4V5N<V5?,2XR7T-H96-K<W5M/2(U,#4Q.38S.3@B"B @(" @($5X
M=&5N<VES1F]N=%-E;G-E.D-H96-K<W5M/2(U,#4Q.38S.3@B"B @(" @($5X
M=&5N<VES1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/2)#86QI8G)I4F5G=6QA
M<B(O/@H@(" @(#QR9&8Z;&D*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z1F]N
M=$MI;F0](E!O<W138W)I<'0B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D9A
M;6EL>3TB07)I86P@350B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D]U=&QI
M;F5&:6QE4VEZ93TB,C<W-#<B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D9O
M=6YD<GD](DUO;F]T>7!E(%1Y<&]G<F%P:'DB"B @(" @($5X=&5N<VES1F]N
M=%-E;G-E.E9E<G-I;VX](C P,2XP,#,B"B @(" @($5X=&5N<VES1F]N=%-E
M;G-E.DME<FYI;F=#:&5C:W-U;3TB,"(*(" @(" @17AT96YS:7-&;VYT4V5N
M<V4Z1F]N=%-E;G-E7S$N,E]#:&5C:W-U;3TB,C,Q.# S,#$W-2(*(" @(" @
M17AT96YS:7-&;VYT4V5N<V4Z0VAE8VMS=6T](C(S,3@P,S Q-S4B"B @(" @
M($5X=&5N<VES1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/2)!<FEA;$U4+4)O
M;&0B+SX*(" @(" \<F1F.FQI"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D9O
M;G1+:6YD/2)/<&5N5'EP92 M(%14(@H@(" @("!%>'1E;G-I<T9O;G1396YS
M93I&86UI;'D](D%R:6%L(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I/=71L
M:6YE1FEL95-I>F4](C B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D9O=6YD
M<GD](DUO;F]T>7!E(%1Y<&]G<F%P:'DB"B @(" @($5X=&5N<VES1F]N=%-E
M;G-E.E9E<G-I;VX](C4N,C B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.DME
M<FYI;F=#:&5C:W-U;3TB,"(*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z1F]N
M=%-E;G-E7S$N,E]#:&5C:W-U;3TB,C,U-C,T,S0Y-B(*(" @(" @17AT96YS
M:7-&;VYT4V5N<V4Z0VAE8VMS=6T](C(S-38S-#,T.38B"B @(" @($5X=&5N
M<VES1F]N=%-E;G-E.E!O<W138W)I<'1.86UE/2)!<FEA;$U4(B\^"B @(" \
M+W)D9CI"86<^"B @(#PO17AT96YS:7-&;VYT4V5N<V4Z<VQU9SX*(" \+W)D
M9CI$97-C<FEP=&EO;CX*(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_
MVP!#  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0'_P  1" !7 1L# 1$  A$! Q$!_\0 '@ !  (# 0$! 0$           <(
M!08)"@0# 0+_Q !($  !! (!  0, P,'# ,!   % @,$!@$'  @4EM8)$1(5
M%A=55I67TM435-<84U@*&1HB-D%U(2,E,3(W.%=WLK6V,U%VM/_$ !<! 0$!
M 0                 ! @/_Q  N$0 " 0,$ 0(& @(# 0       =$149$"
M$B%AH3%!$X&2L<'A,G%R\ ,BXO'_V@ , P$  A$#$0 _ /?QP!P"HO2MG&D1
MJ*$KKFZAQJQ2SH^#;-7B=JEJSKY:4AEN7R\#M2 S)BR$P3*G&:%1+,G- MQ8
MB1;N<18<:\5" 0*+J>[SU9Z1(ER[;I#R,.)O(V[-UK=HFV8L+EKVK.*ZIH].
ML>XR(,G$KHGT3S6+!I4M3M?'L2*V,-1+2&A$!2@+6='FS[&-"K>&V93CM>L%
M;MI]B0;)SCDX19Y,^R6%Z2Y45'J^ =:J4!MF(NILBE6 /'II&LQ5V.;9(]D@
MC -_;L%\DGS@6*!J.4!VQLA,F19C+:I#!3,_,;RF6ZH]AEY"(.<OHPZZC"W,
M);<7A/E9M%2M7C^N^S-75JBXI[W^1D^L[']B4GM0=[H<<7>%)>;++@=9V/[$
MI/:@[W0XXN\*1S99<#K.Q_8E)[4'>Z''%WA2.;++@=9V/[$I/:@[W0XXN\*1
MS99<#K.Q_8E)[4'>Z''%WA2.;++@=9V/[$I/:@[W0XXN\*1S99<#K.Q_8E)[
M4'>Z''%WA2.;++@=9V/[$I/:@[W0XXN\*1S99<#K.Q_8E)[4'>Z''%WA2.;+
M+@=9V/[$I/:@[W0XXN\*1S99<#K.Q_8E)[4'>Z''%WA2.;++@=9V/[$I/:@[
MW0XXN\*1S99<#K.Q_8E)[4'>Z''%WA2.;++@=9V/[$I/:@[W0XXN\*1S99<#
MK.Q_8E)[4'>Z''%WA2.;++@=9V/[$I/:@[W0XXN\*1S99<#K.Q_8E)[4'>Z'
M'%WA2.;++@=9V/[$I/:@[W0XXN\*1S99<#K.Q_8E)[4'>Z''%WA2.;++@=9V
M/[$I/:@[W0XXN\*1S99<#K.Q_8E)[4'>Z''%WA2.;++@=9V/[$I/:@[W0XXN
M\*1S99<#K.Q_8E)[4'>Z''%WA2.;++@=9V/[$I/:@[W0XXN\*1S99<#K.Q_8
ME)[4'>Z''%WA2.;++@=9V/[$I/:@[W0XXN\*1S99<#K.Q_8E)[4'>Z''%WA2
M.;++@=9V/[$I/:@[W0XXN\*1S99<#K.Q_8E)[4'>Z''%WA2.;++@=9V/[$I/
M:@[W0XXN\*1S99<&<E62O02T(#-/!89PDC+@X-**08Y:>VG*L*<A#G7T3)2$
MY2K&5,,N)QE*L9S_ ),\A3-< @W>>T[-J@(+-5^IA+;UV2_!0)(VR17SEA/+
M5$17J+1!4*N6.59;K;ENS_-4=](H&+C!YY*PF1HQMV8P!!J>EA?2%9M!RN:8
M389L6IU#8]-$"+23)3#%$N-BV*!&.V2/$IJI==L&,T"*N?%@Q[ '#.VV.X1,
MI#5BP&D@6.U%MFN;?KTNP " >0F.7*Q<P!Q1HA-@BVRD^-7Y1IA*&GQ1(R*B
M-$I@>4PW*!$')];G_P"EPA-MH#XA]]I<2]W9,FSAF,X@U:/G#DYE.</Q?/S<
MAK_*K_;96K"7$_ZTJSC&>7V7]O\ !C<EJU5=O'!MOK(H7O<!^(,?5R%WZ;^'
M ]9%"][@/Q!CZN!OTW\.!ZR*%[W ?B#'U<#?IOX<#UD4+WN _$&/JX&_3?PX
M'K(H7O<!^(,?5P-^F_AP/610O>X#\08^K@;]-_#@>LBA>]P'X@Q]7 WZ;^'
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M?6% HN\N1Z  OS]V^9>Q^]7%7UA0*+O+D>@ +\_=OF7L?O5Q5]84"B[RY'H
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M#EK]?E^6=5.# X!V=Z.?^Y/7W^$/_P#E)_..O^3^7V1VT?Q7S^[)KYDT. .
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MR6BM"14<!8X/GNM@+M.@2J'&' 6!W[K[I$[.Z*\.D5)B/%V 2H!*+?@5HOK
MJPGK&S3"+ X9!O5- IK[R9=]R,,SG&H%/!V 5$0$)1ZX!+& K(%W(V9"H\=4
MQ#+4O++693<9UQ^.W(RVG+Z([[K,=UYE#OE):=<CL..-X2M;+2LY0D#]N .
M. . . 0'TD:SL(_KA)/4,2)-VS2+-7;CKZ-/G1AT!\I$F9#GHDR3,=8AX8)4
M8Y;!642GFV5+G(RI6,X3P"GHOH^](_5=?N(#6)0GYOJAZBZ_UR6Z]7K)=3NF
M,V"X;/NY0/&LMSIP@48>LFQ1&MID8U;*P555-2/%P<SK<ZMYF@:J4UKX1.UP
M7!)F\Q%E$3-(E1Q,S2M<-46,1J%YZ/\ :)1^= K6X\6-RP@)H#9!^VUH>&BU
MZPY6>  K<8&.:^CPP)NZ0VKMQ;2T[IJ S7[*4-!89*5L*E.$M16(]+M<G5UC
M# R)4C</,NM#T 5=Y;#I68+ABY[<8BFQ4P57CPH6X$ O2'00:$"VRW5?.K8Z
M"@GU%R4]"\X(C-)F]3>FJ7-=B]9PYU=R6M4I;7D*D*4[E><@9'@#@#@#@#@#
M@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#
M@#@#@#@#@#@#@#@#@#@#@#@#@#@#@#@'%?PIO0'Z8_3#O.J+#T8ND"#TT$IE
M4/!K2.+;'VG1W#10D7C3H,UF+KZM'8D]$:(TXPI\BZQ(:4O#;+:VLJ5C2:7J
MJ@MD5U)THH-MI]OJ-HJZ9=!U.*U# A&3)R?#.2Y^O3:[/?Y#3JDCGF'ML/:Q
M(3&C 619Y%?U000,D1<7"3!E9!_6M7=(<Q-,/(M6Q 2K )UWYJ)WX[JRWR*$
M6#3MCPK(5A!00Q5=398[9.IGQTH8/>@DX#;,$C-P0AOP6@-GH(3I<O;(H)_9
M%EAC:A,"3"UOIE7@U,X"#GB!?:LF3425@G$Z[8LC1-?)Z?'U\]7Z_:)1$]4K
M$^177A1B<LV!H^Q.C5?$6.R7?5(L$"M$3I+#MTUIR$8374V*M5GHTI#QJ/89
MD)E3S%9O&\<$X=J%J9DM)'VDY;\1'B#F5K ^?6^AMTTS9]7MAU3EM*/7DW8+
M2<-'!ARD#!5SI]=E7V94AQ&<Q=*397-@,'8U+CUF).K4JFS'*W;H$6)"KQ(8
M!?LW$DD Q:!#>Q'F31D^)$D*6XWAB3)BNLL/9<:2IUO#3JTKRMM*G$X3Y2$Y
M5C&.%ZHCY3712\3T?]FBZ%M #<;2:MR;6$$PAL*EV=#MA0[!+-S92(?K%BPZ
MA(1*83AF8&L*U5^R0.M #^,"B,GQZU:EJI3VJ9TZ:5K0U6JZNZ4]0&60T.F#
M!A6T(%-$J'4YM:B5,6W T[HVFM&JE"+L.3H5D%DZ=<(<&OR+[$K<IAJ&.18@
MC1!FYP<FSZ2FO^FR2J@*1&VJ0$7&%K\:,(Q1RM;,B2%QAZLVLY(,36YU/-J3
M+);<;TWDAU,EYL0"9/QX#+(^69Q/ D3>V@9U]/;"LU7 @T6&P]&O;VO0Y[,A
MH68;V':Q4,%59N"36$3(3D<*X6%H/-/(D#(,MZ,TXAJ0I.0*^6'HX](4IF02
ML\XC<Y0"J3-=5 8/M(<H+L 77MCJ+NIK#M"J768&K%IE7=V'<+3MAI$V(:B0
MS\&!6BZ;#5J_,0!TR#I(H$BTF$06RR1T))1L8Y(=&MD<1FL34#W9B42W8*).
D'4Q')2$2%L8;4^E+N58P!D> . . . . . . . . . . ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g542432g43l56.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g43l56.jpg
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M @(# 0$            '" 8)!0L#! H! O_$ $(0  (" @(!  8( P4%" ,
M  0% P8"!P !"!$2$Q07EPD5%E97EM76(537"AHB6)49(S$YN!@G05%Q<G6W
M)":1_\0 &0$! 0$! 0$               (! P0%_\0 -Q$  @ "!P8$!00"
M P$       $"$1(A46&1H=$Q05)B<? #,H&Q$R*2P>$$%#/QLM)"4X)R_]H
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MQ2Y8<!1YHL1\$4_W]W/\W[W^L<4N6' 4>:+$P+9VK%M<HSQR/;MG,Y@L5W>
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M8!A*'!L5=QUK/;"[":+&'((J&)ES/A@]M',-7V?LRM,BWR1M[/:(!5MV)KX
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MXSPYQS1=YQ289Y <IP!P!P!P!P!P!P")]W[5!TGK*P;,9+?K4"O$UV L3MC
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M<+G(2*''@2:-!E(8;)+"$)AC++CWD27-!/$+!CUW*1)#+A%CGE'GUT!R/ '
M' ' ' ' ' ' ' ' ' ' *6//#='=M9J]=W"U'BSU76FOZ!0;I3Q\5%WH;C6R
MRY5Q9L*O/R\S8<6=GK5Q9)[?53U)U7<UY@YI+V&R5ARY@:C9^[>/]&=%>,R+
MMGL]L-8NV/6VL&P=KKUQH>L'U3F3O9RYV:K(-+3JE96\&7O?_P"/G:;;8?\
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M&F.)&43 !D,[[Z%[N . . . . . . . . . . . . . . . . . . . . .
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2P8. . . . . . . . . ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g542432g51r14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g51r14.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MXB\._9T,LX=IY?# <F'EA\.Y8*_/&-&<:=1T*EW";G&$JL93<OBYG\*V-O\
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MA%*]Y.\I-OK:W/#"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
'H * "@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g542432g54a57.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g54a57.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( %L!&P,!$0 "$0$#$0'_Q  >  $
M @,! 0$! 0          !PD&" H#!00! O_$ $,0  $$ @$!! @"!P4'!0$
M  4" P0& 0< "!(3%E8)$1075Y;4U165"A@9(2*4ER,X=[;6,3,V076TUR0E
M-#4W=O_$ !<! 0$! 0                 ! @/_Q  M$0 " 0($! 8" P$!
M         1$"41*1H=$A,4%A4F)Q@<'P(K$#,M+A\?_:  P# 0 "$0,1 #\
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MB.ZUV&+RU9&(R.K#5D./"FS8M\@CB5C<JPTO/HEA@A")1HLD$X_ -RXK(F8
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MM:V%LIZ"_, RGR3V(I^0V,8]8K,AMB1)C3T)>6G/L_:2E::DWR!51%]-_P!
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M'5@ZIR=*MRP5SUQ$A 4=0M:Z?7+& N[AMV$0M.KX^UX5S*B2%/KK4&KCJ^6
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@;2E#;:4H0G"<8QP#WX X X X X X X X X X X!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g542432g54c76.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g54c76.jpg
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M 0$! 0$! 0$! 0'_P  1" !^ 1L# 1$  A$! Q$!_\0 '@ !  $$ P$!
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M$((L9S =S0%NRN+MTR8U<>=5<B0H5HDPSE,4ELI@[X7E*I)5EX226&/##(D
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M'#;G>4P@\VCJFN5RDX2TQJ4D/D=:W-*G3JEQ1,I2,:,Y/'9 L)EK405'I,\
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M\+]LF?4*- - - - - - - - - - - - - - - - - - - - - - - - - -
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D#;53I%6!\979]85A9DO<D24"=M - - - - - - - - - ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g542432g55p93.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g55p93.jpg
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M(" @(" @(" *(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( 'D!* ,!$0 "$0$#$0'_Q  ?  $  @(" P$!            !P@&"04+
M @0* P'_Q !($  !! (! 0,)! 4&#@,    % @,$!@$'  @)$U<1$A05%A>5
MUM<A6):7(C$Y5=(*&C-!=M08(R0R0E)6=7>2E+.VMR4XM?_$ !D! 0 # 0$
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MB5>%1[<4B/5=[V=?.&22.ELOK\:/!X\\>$%:\LW3[,;BAB+DP"L*Q1XCF#,
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MM26JX J8U0Q5MM&LY<TW$!+0'<-*:]!WB-&))6HJ!&';01P-Q(*DHD1E2FA
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M!N-[ "4:A]KQT=R:\)B'##1C;N80J<6R#BRU*Z?ML(>PZ52.*YB8:CJ>?3G
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MJ6(K.,>QM!(RB<!V7A)**BTNW ?;A@\_$$RH<([(J4-@@8U_='H8EJ[5H_'
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M<L5' /@([?G]I7L_^PFI/_ Q/,8_$^7LCT?\?[2XQ>YI>Y4W' .RP_DV%UM
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M*8^I;YX5;1_!A'FDU:KT92=CN8]2WSPJVC^#"/$U:KT).QW,JAUT:-W?O;I
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M<\UMN>0]\D/PZW%^6QW^'BCO0WB:VW/(F+E21P!P#A\UVOJF$R*@0?) U%3
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M XAVQ5%>*S$V-L8.,51F->E:C;JQ ]52,P*63]JYH?902T5@'Z[E'*M$@NS
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M-5L_KES%<W+ZYDR[\&O301_65>FUYDZ>*".L/PR[7 ' ' ' ' ' ' ' ' '
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M>W[+M_=5-M-+V8&U0& $)- N.M"1P)87!M:ING+<\Y&&NT]B,8LVQK/<[W3
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>!X X X X X X X X X X X X X X X X X X!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g542432g56n78.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g56n78.jpg
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M @(# 0$            '" 4&! D" PH!"__$ %80  $$ P$   0$! (( P(
M'P4" P0&  $'"!(3%!4)$187&%>8UR'8"B(C5EB7F=4D)3$X>+<F,CE!45-W
MMAE487&'N"<H,S4W>;0I-#I"1$5UD;+_Q  = 0$  04! 0$
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M?AIJ/PTT_6+MOIJE/HOS;5+^K=7ZCK43]3:#U!\OZ)CZ0JU];T6.HVO6-5U
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M>';4,%QDIPD$!BDB6)$EKSK_ "==!.G_ !BTW5?_  )U-%ZLU;IGXBW?B/\
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M;3.7%;M2^J7<>7#0X7)0 *Q&AD[9+14I!/VH148_V;4<<^-7N*1,Q')NB!*
MXF.KXHC4M6G$M?EG6_Q7TCH7KCX2]"ZCH^MW;OQ@ZBU[IK0]5H#2SI&DW^G^
MDM9ZQL#6C9U.OJ:+;TW1+D5$Z=IFH1FPO&W+34Q&6=6H26JM^TDD2KI\44TL
M;<^Y(LLZ5QV]D*'B\BEN;H=ONAO.T9ZUM6])3K>][WK6M:U^>][W_AK6M:_Q
MWO>_\-:U_P"N?J1(4%F(55!+,2   -R23X  \DGP!D'/-YEV.ZZP^TXP^PXM
MEYEY"FW676U;0XTZVO25MN-K3M"T+UI2%:VE6M;UO660S0V(8K%>6.>">-)H
M)X766&:&50\<L4B%DDCD1E='1BKJ0RD@@Y4@@D$$$$@@C8@CP00?((/U&23S
MSEQ7HXWI)(47"C]<QH!'HQ>$3V33-* QA(4(DMAOI!LN"Y,:(&Q:'&B,X;KY
M$E3\=4G;#S:/S'XD?%;2/AEJ?PQTS5]'UO43\5/B)IOPTT:]I8TMJ.E:]JFE
MZOK5:76_6:G4OQTI=.T'5GBETRAJ9]162"RM46(96FTJ$EU+SQR1)Z&F]V17
MY\I(HWCC81<49.0>6/<.Z>&W7EL0//E_)[!UF5:8=<(@8+].IQZ_&='))"*E
M-5JT-9"Q$HRX0PBE]0F$C4AV%K:9\M+B4#8TUU+J&[/BM\7NG/@_4Z3N]3:=
MK]Z#K3K7I[X>:(="JZ?;9^KNK+J:=TUI=E+NJ:<U==7NN:\5XAM/J-&SZG:H
MQ-%)(HZ?-J#6%A>)36K2VY>ZSK_-X%Y3.O&-]^VNQ*_?;?V*QWVC#>M:WO6M
MZ5K6]ZTK7Y_DK6M_^NOBTE7Y;_\ 77Q)UO\ +_UUK?\ AGZHI) )4J2 2K;;
MJ2/NGB67<?0\68;_ $)'G(.?F5QC&,DD3R:\&>=6SJL48RBDTQT$P7)RI\./
M(<?L9=804@<+6]]SGLOSV)S2R#,3[8TL:0C+FZFQ_I5?F.K_ !@Z#T3XE='_
M  CMZK,_776\.OV-%TNKI]VS72OTSH\>NZN^I:JD/RO3YH-/L4)4T^>V-4FC
MU/3K,=$T;(M+.CTZW+2L:@L8]+5,0ED9U4[SR&*,)&3W'#.KCF%[8,;J7Y+Q
MSF#.2&"//)_2'K3SD,-B)F.1*Z>O8 5>ST:$^F&N;7*9(D_?3,)TAJ4/CRHD
M53+LP:3;^+28+ZTP]4^,.BZ;\1]/^&4/2GQ+UK5+AIQV^I.G_A_U%J_0'3]F
M[7>ZE+J7KBM5/3^B7HM/-74;%2Y;2>*GJ>E2<&;4*R/<FG2/3:Z;%*)%Y%89
M;<4=N55/$M#6)[LJE^2!E78LCC?V,1%6?K6:_)QLOGOH%:H0GHNW:K80)&U1
MZ+.8I]I$V@Q6;E.@OD1U:LHP2](=@$R$2++7$0PJ8PIZ,[#=?:F?!'7^#=,?
ME&_#OJ?XAZO\,Q%U;TYU#IO2-GKZA8ZSZ3UCI31>J.BJ-^OIFI=3=,:IK$%:
M+4=+TVY;J)<>=:<ZPVHKL,$U'G93:SZ/<@J1W":\T3V!59:UB.Q+!99"Z03Q
MQEBDCJK%0.0W4J2'V4\.X<(OM,A$YDQD8777;K'YM;H-<FK+SZCT"7%E2HE2
M-,-QFTNDI7VXO#C20CA@.^2"E1C1-<Z(IC<WHOX__#WKB]I-*C/JNCKU-T+8
M^)_1M_J2@FCZ?UC\.JENI4M]8:'8DLR-%IM7YGHURS4UR/1M:KZ9KFD:G-I:
M4;B3BVUI-NJLC/VY##:%*PD#]QZ]ME9EKR@*-W;A(JM$9(B\<B"0NI&?I;@7
M4 URYUSZ4"CO7#J82O6"H!X!@3/^J'6DA/'A7)A&+,<$P5/['/2Y.WY^FAL)
M2723L1;<IJ/32/RA_A3K71/Q+^(M77[,/1GPEUWJ3ISK36K^BZO0])J?26G:
M?J.NQT]-M4H]7OK6&I04ZPKZ>9=3O*T.F17$DJRV$FCWX[5*DT2FSJ$4,U:-
M)(WY)8=TB+.K&--^!9MWV1/+E=F U.UT I5!5=L*B 8[6[4X;C!+ !DRWH$H
MA6Y,6,>&N,DX(LI%FC-D!K[B90YIB3#)P)D%^7&D)=UU_2/Q$TGJ[5^I.G%T
M[6] ZGZ2BT*UKO3O4-6I#J%73NIZURST_JD<^EW]6TJW1U0:;JE>-JNI33UK
MNEZA2U"O4M5VB,>Q3DKQP3<XIH+!E6*:$L49X&59HR)$CD5X^<9/) &61&0L
MIWS1<[[(F,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,
M8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,
M8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8R] Z
MT<J!\G35[-SFBUJU%.)$RM=/D*+:K;>CY@G M(^-/BV!RT.UT.DK*V+."2RZ
MZU$K()@[%0RR:&@B9#X(U/I/XMZ[\73U5TM\3.O>INDM*^.NE:5U+T[IO7_2
M/1_0/3VBZ7J'2>HV=/N=/1=)1=3:R^E5/FNA:QH\?4T]SJCJ"?0;,D\NA:IK
MVEZ9UB6-/BT\03TJL%B32Y'AF>I/8MRR.EA%99C8,,?<?MRQR&$+!")5V$L<
M4DE,ZY\]LR/G-/2830J</)3"L89HOL-%8(1$**NCU[2Q*;B/.L;U'DN-1Y3R
MV8CCB=R$_G]M=2&"31=1H2P5;LVK4=0TREI-K5#HXUNW/IUMUTB+44#3U9;D
M,4X-BK'+8J0I-<CC85VVYB'?NHP+*(V1VD6/N]I5==Y"A\,%)'M8A6.RD^<[
M"?4UH(EJ5?4*[#^LAI7H \C!!!/,<3E3$F"DB=<9FVN]IYS3Y!=^)J7$5!3H
MK-T1GO2)#L![:TS(?G'^2;TIIVC]<_#YU^"[]%:GI/PZU'3+^O:]^5/>^+DU
M.^^F]/QS:?T?T!)\3.M:VB5[C4[:WG.D4&TW3Z]>I%?A"O2N=EK]AY:MS_QE
MZI)+B2)#%H2Z>"G.4A[-OT-8RLO)>/VK\W8L4._)>MK/3G.(QC&=@_:.SRZI
M6>%L\QL-&G%YGD2M<.O!D:9#GCE;5+L5LGVVI:907DC16B8HF,C$33HIUU$6
M3*@#S,1>R#6><OP0^"%/J[JGX_3?%3IOKRCHU/\ +(ZH^//0>B:GHNM=/Z#U
M.M/IKI#3NC^L#.VCU=3U8Z7JVEZK9TS1(=6BB>W6JZAJ&BW%73I1V&IZFU>#
M2A1FJ/(_3M?2[4J2132P;RSM8K\>XR1\T=%>0QD[%D25?>,WVQ7'E]F[[9ZF
M@UQ 12&.1-2>)EF1=(K]#$=AG\MYT)+.6*TTJ$/G"DJ) ;6/%RS))N)6;&H6
M=#Z@Z;'3,_/>F>BOBMTM^3STMUA+HGQXUKKJQ\99ZWQTT:?5NO.H_B#K/P6T
M[XL?$K5M&BZ:Z4ZXO:E1U9ETK7^C]1U:EHNF27.J.F(]5T#63>9]0I"9/:HS
MZO/7$NEQU1IP.ER*E2&I'J3T:4<AFGJK&T0YQ64C>1PL$Q26/A[6SAB+U4"5
M:DP+:1X1"GO^P?/EDL]:K)$+)HI"GU6@6"JWJQI&6J<08.PGY11AZTD6OKQ1
MHX2+E@ZI0[XI#,[6.@>L]-ZHJZAT?IOQ_O:?!^1C^4?TSTOU1U3INN5>OM.Z
MSZO^(?3G5O0731U7I.AIMC0+]>KI4\/26F2?+M7T/0=+T;2-92IJ06O-9':K
MO 5L2:2KGJ/2)IX8'B-5ZU>I+7M3]N=G$JLS@V' >.65Y)$+(2PW>@7;C@&T
M5=4F?PML3/\ ;'69-JD3QW+"#CWGHR,$K#JFS)<.5.U6'GG+.P,90\F9'0ZF
M!&;:8>&QU\+\0^A/C5U#TIU6*^G_ !\EUG3_ ,A?X05ND8*&I_%G3D@_*0T7
M4]:36EHTZ=ZK1/5<,,?2L^JS20M3M/$U^U)-/#J=A)52UIT-B$E])$;]3Z@9
MBZ:>Y.CRQIV^3,K,(">\$&X8 A% 4HN:Q2;3RDA*\UR[M-XDN4!@>IZ]?MR(
MO+H[$(4H)*_9=!"-"CM0E.LV#\EU,K%:7-B;<V^W-:B/K<<ZCKOI/XO:=4_*
M?I]"T?CHM3J"_P#DE=2?#T5[GQ6LV;VK)KU/_P .#Z99O69;RPS=.@IU?I%F
M9*-Q4[$E*:W L<>"I8T]SH;6VTOE"-?AN<EH!5B[/_BWFJJ$)$Q;T\BCDO@A
M@IW/#KEJYBUS:IU27.XJPDGXT[&&M3.XG+HY1[LC1:V2>:))&&HS99%NTP]4
MY$&>N>E]4C2GY\G<R.36U.ZGZ1^*<WQ-ZOZNI4?CC.^F?EM_!/6^DIA<^*]C
M28?@G+H_1E7XI-INBS69-&?HWOP]8U[^GKI[5U@*P:=6%.QI4<MM>Q1%*O7=
M], DZ:U..<<: D.I<IS1YR "06?^CE&+ABV[.>8D(Q33'-AWGRR5U-LX8;LL
MFO\ F^\TB+%>Y[ <A6!DI'A=(&R8E@?GV%^S184A";]JX%8D:P;?GZ#TX=4Q
M#6M;:6Q\4-4_*,Z8ZD;I#X^:%TQ4ZB_*;Z"ZZM6X?B+?AO=/3:38O?#'5*UO
MIZ#3NFX>E[=ZL[?#Q^C-(N6>G>S0^==:ZEUCK,Y:P"BNC30^HTF2<PZ):J*#
M30K*'"WD99B\QL!2/5^ID59@7[=9*\8 S)/I7/[/ZQZ!S"3OF*N"WN+T?GE#
M/U.G4/0ZAP;A#=EU.["Y]8"-S4O5ZQ0X+TB20D[G"@4PXVO<>+)D-.Z72OA?
M\1.E?R0/AS\4ZB_%0?E!?#^U\,?B1U_T[U=UM\06U/X@7^C+D-3K'H35-/ZJ
MUV6BT/4G35W4(*]73JJZ?J_4-/095%FU5KS19'O5)^H+=%O0?*K2W:=2:O6J
M=NFME"T%J-Z\0;E#.JDL[<XX6E'A"5-"+"=B6_I2)XQ$,<'48$"@7U>A@-ID
M"'^D$B)1E_:XHYDE('0V)UA*R7D:F%GR!.8_MV0ZYOT'Z=T"WT;\+Y-/U-KN
MHZR-&UG5]>%,ZKKTTW4&M"YJ^LU-$KA;FIS:97U*[8H=.:36BE-'1X-.TNE
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MNM_@O20:A2J7)H=-^/?5%F>C\2-%29U].E1([?5R+5ZK4K7T^=#VW4/=2I/
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M2Z/YGNI+JE)ZC!],<XG=0K<N@CK1& CJVE810A29]Q%5H].DDXAIM^3'G5,
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MI:=>JLL@@%^H)84KREN ]97GDE*H6\23)(HA^K0\.3),T[JMI)E@U&&.+DW
M3Q!E5'WV'=C=F(7?PSAAP/U3;<K\HV]?E_AO_#>O\-ZW_P#(S]VSM<^IKP)_
MH[D;JO+ZUV?V7?[ESV'<!$2RU_D= ^S![4,KLV.B<-(WZTV44?B!II&$MN7(
MJD !]P$0G6DE#L RJ:(%?A_57Q<-&[-IO3M6O;:O(T,NH6^Y) \RMP=*D$+Q
M-(J,"JV&EX2,"8XGBXR2<9J?51AF>OI\4<IC8HT\O)D9@=B(D0H6 /@.6V8_
M=4KLQM]T+_1S/$W4*44F>9>\]!KML@ID1!YB=:Z?UFA.%F&_CU!L(\0&#&([
MJU_+:>>'6:.Y ;>5)V((*0B,OGZGQ?ZDI6476M*J2P-LSQK!8H6A&3MRA:22
M2,@>2 \)#D<>XOWA!BZKU&&11;K1.AV)4))!)Q)^J%F93_=NA!VVW'USY9['
MY*N'$O9E8\H>CX;M0FHZ]S^DW(F*(QV8+]-MUD#0]W.JV E"7!<#DJV3V9#%
MYX_;<5*M(,#8\R'/&L?N$6O5]2Z<GU[1V%A?E]NU61T)86*\,C>FGB1@PD29
M.W+&C[M_YMRK(Y[-+T=B@]VJ>8[$LD88;D2(C'MNH._)7'%E!\_U3L0<^_7\
M/3Q9YD\5TKH55\Q]%LG10%TM(ZP6:=9+Q2[P^.,01.AL6+&ETNNUV+!9=A:T
M\J--8D2'%_[5MU+?^IGRIU;U)K74EFI/K5.&G+6@>*!8:MFJ'C:3FS%;,TS,
M0WC=2 !X(W\Y^8ZIJ%S4)(GN1+$T:%4"1O&"I;<DB1F)\_B#MG3A^)5^%1X#
MATSV=ZKC]QO;G?EQNO=C51U=;Y6L%KI,Z66LLJO:J**0FU:'-FY#T- 79O[R
MAE.HJR"I*5/;_0^C>NNJFL=.:$=,JC2N6GZ=ZKT%_N^C58X%F]0;78YF,!C)
MVNV3[@G'QF^TC6M3,FGTC7C]+O!!W.Q-R[0 0-W.YPWXC?EQX[^=MO&=*/X.
M/@KC?X@7=NG<S[4=Z*  4WDK]Z%2>;&J\$+/&&[C5J^EB=(L=4MT5T?N$:EN
M;98@QI'U*&%ZE:;0XR[^D_$/JG4>D]+I7=-BIRRV+XJNMR.:6,1FO/+NHAGK
ML'Y1*-RQ'$D<=]B.AU[4K&EUH9JZQ,TDXB83*S+Q,;MN CH=]U'XD;;^/S:I
M^+UXFY/X*]0UWBW&S5].U0MQNJ=!DS.BEP)H\@V<M5Z"2X[,NO5FJ04C41*S
M 7'86,<DHD.RUN3'6W&FF,_P_P"I;_56B3:EJ,56*>/49ZBK3CECB,<4%652
M5FGL-S+3N"0X78+LH().30M0GU.F]BPL2NMAX@(E95XJD; [.[G?=SN=]MMO
M&3A^%C^#/=??8R5V#HMK)<H\ZC#$D)#-"1\:9=ND%QR]-F(-);)H<%"Q =W>
MX9*X%(A:(@NAP,-"EI40TX%UG7'Q%K=*NNGTX$OZN\:RM%(Y6M3C<$QO9*$2
M/)(-F2NC1L8R)'DC5HQ)&UG7X],(@B19[94,58D1Q*?NF3B>19AY" J>.S%E
M!7?O-L_X0_X(/&W$4+K75*]5;KMEIG7[H^LP5*N[CK[:=LR/L+IVK#MOO)4E
MUI**SJ.Y\2=HC[;WI.?F,'7_ ,2]1'JJ%&:>MN3_ #'09;-8 $[CNB*=]AL1
M_3;^/)WWSG$UWJ*<=V"%GCW/]#2:2/\ PY<7.PV/]??Q]<^:7\1'Q51///M$
M/YS\OV$_UBM=&#<U*<Q=(%Z]829<MTV:Z,#U\?8*_%%A3<=\KJ/&%$41H_S&
MI3+<IUYQIR8]^S=(]26M6Z<DUC6XH:$U22XET)'-%'''24/)*\4K221D1[M(
MA)V()4 $*.NTK49+6GM;N*D#1-,)ME=5581R9BC%F4A=RPW/T\#\,^A#C'^C
MY>,>"\G:Z/[M[%,-EX V)-N\Y=_'<BXG3GY7RDJ&LGI:1]@(_33'M#VSQ*RA
M63#GR5QZV-=>TQO\FU+XL]1ZK?-/I?3UBC=V6LOI'U#4K &_O,2\XDW4<^TD
M,IC\AIG WSEY^J-0LS=K3:X4$D1CM&>PX'X\1NH\#<J$;CYW8_7*B^Y_PQ?P
MQ?X5NR>D_#GH>$<L'%P@T^6HU0Z_4^R5N= EV0*!>CE8?U<NZ5F7O[NE^*3D
MG'X7^HAO8B1J0V\WONF.M>M?GFG:-U-I+11:C*\*6K&GSZ=,KK#)*#&W%:TR
M_9[,@B#>2>X-MC-T[6-8];7J:C5*K88HLDD#P."$+^T^(W'CR NXW^OC;/EY
MS]NSLL8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&
M,8QE]7>#5FP\*"]0UR[M@L@*Y&3(3#P6OU!KE9 D%38%1;.4-2+)NR.MS$('
MN$7F!GYJEH3 :C)2E2->?4?Y075'3GQ^USX4M\5O@7JFG:O\8=)TZCT]KG4G
M6$OQ;T[2];_DXMOI72M"K=+CIF*2F[ZE'ID%C5O%.1M0EM%G5SUQTF";28K_
M *#54>/3G9I8H*PT]Y(N\5GDE:?OD, A<B/R1P"C*(Q94F#)C384E^',AOLR
MHDN*\Y'DQ9,=Q+K$F,^TI#K#[#J$.LO-+2XVXE*T*2I.MZ^_;=2K?JV:-ZM7
MN4KE>:I<IVX8[%6W5L1M#8K6:\RO%/7GB=XIH94:.6-F1U96(/)*S(RLK%64
MAE920RL#N&4C8@@C<$>0?(SL?]7'.@'>9L.VHEV!JL).0)-5LMX]&1>G5CM#
MCBI"-'P_.H:&H=?7J$Y(L$(@ VZ J\)2ZM/TZ3)BI.O,S\D30OAUH'Q2LQ=)
M:9\&).JFT#4:O5O2_0/Y,]SX6=4_!&.,5I#T[K7Q+O22W>H4-Z*OT]>T[J)8
M>H>J[R1]5Z?V=+TK5:N=KU!);EH@SMJ(@[R-7L6M:2]!JGE@)8Z2 )$0I:97
MB)AKKO7?>22-LZV<].\XG&,9=JB=3\G\RM7#>T5.A]B?Z3RB-1+#8.8&S%;D
M<RN?6Z([#GM7-OHD>6W<0E+/V$;#/F^;LT>1/3'<(5T-T,2S(B%A_-6J.O78
M-3TV>UIRTK[6H8;T4<PNUJ%H,AK&FRFM+9BB=HH[ALA">,TE-RK1OKI(;TR6
M:\DE<0SF14F0.)HX)-QV^T5[;2*A*K+W-M]G:)MBIF[PGTFE=B]\DNN>ON-C
M/0M,Z<:M]D[41.S- :1RI-^L,5T_VZTK>^$%"J-!02G:0++3AL%AF;#C@Y7Z
MAB@(DC6]44[.G=*I0Z?U%](L4HZ\.FI$O=LWO2Q,(=,@ WE:Q;*)[XU=F*L9
M5[+2L(^I0R0:8L%"<U9(5C2N%'*2;M*>-=/ZQ>78>0"?!+#@6.:O6?5G(*M0
MO7/D(C7[>5\C=FZ\_P!'XZ;KBXLKHG'S]1LLEJBW$>$M$L; MS-AH,835+O7
M39ROD9<)EB3 L8J?&?U,S3Z%J$]K0.H$EKQZ_IVGBGJ,4P9:FH16(5-JL\L"
MR/7,-LR3UIHHI45B0\,B$<;WI3O)1O!T6]7KB*=7W$4ZN@[L;,@8IQE+/&ZJ
MP!\%2#XUWLGMR<1"^1.:^?QQWGW,O$SCMEY3.L<@?+N=GZV8N4?H-IZQ;(PS
M2PXZ80M,2(H!58THY&JXJ.Y"0?*[GR7-9M.Z:5)=?N:L\5N[U)M#>6)66O#0
MCKFI!0@9_M'5(&;NSD1&>0AC$G!<O@TX!KTUDK++J&R3!00B0+'VD@0M[B%4
MGDY"\V\\5V RQ+7XBW'*QZ>Z%[ZY]RNZA?55YI]C;"TN?*KTGB_->RWFH+I5
MT[$%L.Y3]OM$.;!G'S(CG)>L"]#S1^2F=>2T",PPK4'I#49M$J=*V[U:30ZM
MB'NV465=2NZ=5L"S6TZ2'B*\#*RQ1R7(YY.<<2\:L;,QR)\JL/3BTR:>-J44
MB;R ,+$M>-^<==DV"(00JM*KMNJC:-2?%9N1^L*XGR]U3QSWL;;C?+;STX)W
M2D7JG?;#%WY9V,4/57RY]NNV0F%&70'<JJZ\$-!Y%IK$N$^M1B"57(D2V']U
M?T&;YW1ZATIZ\=ZM2DTNS5L<XZM[3G?NQQ&:%)7K2UYP)8Y!!.K "-HP%5A,
MGI/ZR&_6,:S1PM6DCDW6.>!CR5>:AFC:-QR5@C[CVD;;')"MWJL'W'I7B?DE
M4X#9.C><?)T815Z1Y_EE'Y=U[+HA88EMZV<M$VKC9+8VP=4G#MOD!@* 1%5L
M7$8B)>*(:(3YD.OH4NF4NI+]C58:>L:\9)K.K*@6MIQ2%J^GQ0+.ZEX:*OLC
MRNDDSL6VC)15Q)2:M#J,[V4BMW2SR6@H$<&RE(%0,1NL(.P+$,[$GQX GSJG
MJ_SIY7]\^D5^<.<#S'DCMW'W>$=FY#5;)$C"'AE^Y^ C].B<WL\?]1!(1>F7
MM,]P"9@(+5MXE!-PJ[(;JQ>!.9U=#0M8USI71_G-MH]?TW4!JFG:A/"S2+)5
MMRM2:Y">U(T=BKP$L3\)@C1-,._&ZF+!2MW=,J>KE*WJ]@6:\[H2V\4K&$RH
M>#%9(]N2GBX!7F.:D94:W>I*%3_)1_QYYZ&7C=5Z;U0=U7M/2^D1@(2TW356
MBL1Z!SD74ZP7L@H+4:G,8_4DTG*LA8M8[,MN6S&K@V/]J?WU?0[=C7HNH=7>
MKWZ5%Z.FTJ9EE@K&=B;=Q[$\<,DEB=3V5C$*1PP;J6F=NX)\=.62\MZT8^<,
M+0UH8BS)'S/VLK.ZH6D<;( $543<$N3N)BF>XN)==L'DSKGI'GG1K#V+R93Z
M70GX=*G5I%-]%5?DYE\_RV/?#!M]HUSPM#?D+#WLV)!]">N(CXG(4:M3%-;B
MZ]>F=2T^+7M/T>W3BT[7K%FTK65F-C1Y[\8BO&K'&#%<C8#N58I):8KR>&:9
M=^4<:=8@2]!4EA2O=DDE!D#]RJ\ZA)C&J[K*IVY1*S1",^"7'@ZQSS\1ZX:[
MWZNZ;W*N.= H?MVHW.A=ZI->))!3AP.R)VBIF.=D",<K'@G^2I;A,TILXP0B
M2149\42>0_-28A9[?1]?Y5H5+3)O26NF;%:UI5F9.ZKRP^9X[B(8V:'4-V-D
MQ%&5V$B JO::^724]+2AK/VI-.DCEK2.O(,R??64#B2L^Y[G$@@GD =N)CWH
MOJ2EB?)8SQAP,5<6>?%NMR>W]<Z+T&.%#7#I-N8#1JY4:Y%JE<+6,75J33Q,
M1J7]&[:[),L%F7]\4H&W'2.>ET]#LR:_)U'JLE<VTH+IFGTZADDKTJYD::Q,
MT\R0O/9L2,5Y"O L4([7VO+D,L5*1KS:A9:,R+ *\$47)DA0L7=R[A2\DA.V
M_! J>WW?7*^\ O\ 0><=&9,]4HD[I'."]7O-,N%5#FXE:L#@V[4\U68Q^LGI
MX:P0AMFII8D-N0!<P1,ARB@&,/F::B3'WVMMJM2W<IF.C:6G<CGJV:\\D331
M!ZUB.9HIXDDB9X;,:/6EXR*RI*SKNR@&5:BEEBXP2B&57CD1V4NN\;JY1U#(
M2D@!C?9@0K$C<C;+8A_6W*>!>;_17G[S$)ZJ4F^JVZ:#ZCT?KRZL$<K]!I4T
MN0C5"F4>G3C\*26/.GB,$_=3EDW_ .3*7"#U05*E.$6=#)H%_5=8TC5M;>A&
MNA&Q+1IZ>)Y>[:LK&C6+-JPL++'$(D>*M%#_ $FS2SR*H0P6HS6K=2U<:%12
MYM#%!S;G+( #)))($(5.(*1JGWO+.0-C+_3_ ,0'B'02'X=3T?G/51D/P0.I
M0#X7CE1DR>F":1, 'XDK\T0V6JN1)':D)BR&?R.1H@DD1>:=D3(,9J;KZ72F
MJ5$ZO!N4';JE[,OB*P%I26EEB9?+$SHD4[LI^S9I$4$!7)7##IEB)=5!FA)U
M-I7^XX$)E#*1][WA5=B/NDE1] QXR<$_$V\XR_5'M3O%QXKU>$+]@<IETN$?
MI=EIS'9>&GR(C=?-2><6J>/9&MP; *9@*FE5,02<9V(W#<@E!_SVI4*7HO6!
MH?3>EU]1H-)T]>6PT5F&R=.U.))!+&+D",7+1.7XQ[LC!MP\;[%<+Z1;]%I]
M:.Q 6H3"0K(DGI["JW)1*@/+=3]%\J=R=P=LBGK?NKS/U3S'X[X&UR#M-2F^
M2>AW<F"*,W^G6**9H]LM2+3(=-2)E5%R35V).0!D:;]% J->%S7BI4>Q*@+@
MUJ+.H=,:U1UKJ'53J&FV%U^I625#4L0M'9@@,"B-5G<15D#N5Y/8ED4)&Y5^
M4YS0Z=<AMW[/?KR"]%$'!BD0K)'&8QQ =@(P"2-R[L-E.QW<Q-[A]N@O2OLI
MGVCR>MVSF=Z4<YY94 ++/"V"!7SW*@=-$U(@')CH\!V?I^35ON9&//'QDL.K
M98CNR&]N*1/Z9Z:ET;IT].7YJ]VKVK<!EA62)I8K\MF2PDB.6"[+/P0JQW&Y
M(!VWSZ=IS5*'R^=TFCXRH60,I99FD9PP).WA]@0?S[Y,'LGVMX<]4/G>Z1_(
ME\K7K>_@68-Y?7U-+/ FK;]F:"O]&B5L5$9MU@/1V6&98P2LC4PCI5B(1MC=
MN4@PQ8=?T[TWU-H8BTL]059M J2EJH%'?537[IE%-II&->*(DE7D"6)1&62N
M:_V9ACT-/U&D%K>NB>C$V\?V)]5PY<NUR8F-4)W!;9VX[A.'MX8KD?X@%#\]
M<2[WSODT3L\F'Z(\V[XG8>&W$J$E\%I'0K'4P=7Z'W6MS/O!,V6.F?I+&1 U
MA52K*1KEG5".V:RP0XUI&34.E+6K:GI5R^VFJVD:S\SAU.O'(NJV:D-B6>GI
M<R]M(HXHN4*2SBQ-S[ :*"%I')NGTN2U8JRSF#>K:]0ME%869(DD9XJSCB%5
M5W0,_-]^&ZQH7.W4WG>9N\8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QG<%X0\
MZ_IL4UVBX0/A/GHBT4B#);_V@D!+;^%TZI"]?FW..M*VW!5K6ELA5*<2XI)=
MQMG\MZSUWU$ATFJ_V,+;W'4^)9U/B $'RD)\N#]9AML.T"?-W\K3XT?.M0D^
M&'3=LG2=)L*W55N"3V:CJT#<H](#(=GJZ3( ]M22LFIJ(V16TY7D[)LX'/B'
M&,9W]_A]^8F>74ICK-LAMKOU_%1Y EIU*%KJ].G):EPHS>_];Y9,^W].1)K_
M #^9'B:@#?A8>:(ID?GG46J&U.:<1(KUW(?\.[,NZL3^=8SNJ_G/)O(*[>@O
MP!^%G\D-(_E/K=;AU+K==>S#,NTNCZ5)QDCK%6&\=RYLD]S?WQ((*I6-X[(D
M['<YK/HO/3)DQX<=^9,?9BQ(K+LF5*DNH8CQH["%.OOOONJ2TRRRTE3CKKBD
MH;0E2UJTG6]Y4 L0J@LS$!5 ))).P  \DD^ !Y)P 20 -R?  \DD_0 9_/C_
M !GOQ(9/N/O"J3SHP\OS7Q8D1%<^;CN.-P[_ &;7QP3W4YC'^K\YHAI+@NEI
MDZ4Y JJ-SD-#Y]F.1,^L?AST<.F=+]3<C UG4D1[9(!:K!]Z*BI_ IXDL[?>
MG]I+K#$V?J'3^D_+JW<F7:W8 ,N_UB3ZK"/S$?>DV^K^-R$4YTPY^C9T&,8S
M^AWU;_XQ*0__ $:E3_\ @  L^2:'_P!]!?\ \<K'_P!M9<_+(?\ RD7_ -[O
M_P#--GSY_@(?B3?P[]1;\E]@/_(XGV:P-;H1DI)_*#S;K)/;,.*RM]Y6DP:M
MT):(HHEK>]Q!=H0&+[3!B$;,07^L?%/HWYO1.OZ?%OJ6G1?SJ.,>Z[03=F.P
M^]/4'*1/ZSP=R/WLD"#J.IM)]5";T"_SBNOVJCZRP+Y/C\7B&[#\2G)?)"#)
MD_T@K\-3]!629[JXL ^"EW0K'C>@Z^+C?DQ6+N4?1&'=,9883\M@/=YCC0ZU
M.;0TF-='895UR6_;Y6X&N^$_67JH5Z8U*;>S60MI,KGS-60$O2+$[F2LH+P#
MSRK!D'$5UYX.E]7[J#3;#?:1J359C]^-1YA_]:,>4_/'N/'#SW>_CL?_ !JO
MU-_]I#_[HWD.?FGPP_\ +G0__P!)_P#VGU#.=Z;_ .NJ7_YQ_P#*3Y\[W^C2
M<Z"6;VATZ^E8S$J?S/A)EZLZ=0E2QYNWVJLU^07C*WKXFWVZW^H ZE)WK\XQ
MR0C?Y_%K/USXS6Y8>G*56,E5NZI&)MCX>*O!/*(V_.#-VI/_ %HAG5=72LFG
MPQJ2!-97GM]"J([<3_\ E\&_Q4?FSL[_ !@?PT??GOWO0$IS2T\MB<"H%1%"
MZ14[7?SX5S=IG:?FW&USP,*IEH*2\Z1)C V)NYCSFPH. EM,?;TE+O%?#[K/
MI3I32Y4N07FU6W.[VIX*D4@["$+7@25K$;=M5!E*\0.[*^^^PVT^A:OIFF5F
M$R3&U*Y,CI$K>P>(T#%U/$#=B-OO,<LQ^#-XM]K>&:UU7E7HZST*P<G,/@['
MR\34[H9M#E/L_P TDQ<(\2*5KH5 P/9(KPB>_&BO.1DEA;TQJ*S**$9$G2_$
M7J3IOJ>:C>T>"U#?C$L-Z2Q6B@%B#9#7+-'-*7DA(D0,P![;A2Q5$"P]?U#3
M]1>":HDBS+R29GC5.XGM[9)#-R9"& )\\6VWV  ^7/\ %6Y6&Y%^+9V"OUV(
MS!"6'K'->D18S"$M-HG=,#4Z[V7:6D:TAI*[8;/+;0C_ %--*1O6D?G\"?VW
MH:])J'0.GRS,6EAH7:;,3N2E*2Q6AW/X_P WBBW/Y]_)^N=CHL[3Z' [G=D@
MFA)/GQ"TD:?_ -"KGT:_Z2S_ .P)0/\ WI>??_ U[)GY#\&O_*JW_P"X[?\
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MOWMM/7KK*W+?DR+8E=6.Y67A(-G4$<'TM EC4VDE',P023+R]WVI>- YW^I
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M\^=*<=E3)DN0XX_)E2'7'WWG%NNK6M2E;^KD1(T6.-%CC10B(BA41%&RJJJ
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MR._])4_]OZD_^[#SS_X(77,E_!K_ ,E+7_ONW_\ )Z?F7I+_ *LD_P#;)?\
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M51I;\=4==FJ',!V["G2T? MUE5K(6D-'D*3O?PO,!FULKW\R/MEQ*%)Y*O\
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MK!4A,C!I#%7C6*/FP50S\5'(A5!.Y 'TS800I6@AKQ\N$,:1)R.[<44*.1
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MWF[T'HOIWIQS-IE!5M%2IN6'>S:XMX94DE)$(8>&$"Q!Q]\-DREH^GZ>>=>
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M9/0*;EK*4ZPG6TQ&2;B!L^5O7R!D]6H9%R+(_P!GFAAZGT&?4AI":A&NIL6
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MX/YCDD<?\Q=T[N-L-@YG0I)2H5%;+5MZ#8#59H',JK(D_+W&B67IW0C56Y^
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M7;<FX1WZ5N(/C/DI#=K9#NLC&]D7$)@[3(WH+W4^AZ9;2C?NFK;E95A@DJW
M]AG8*HK;5RMGD[!%,!D!<\ >7C(,VHTJ\H@FF[<K$!$:.7E(6.P[>R'N;GVC
MARW;V_7QE5RPR2$*DPTU<%R8((31DMP64&'!KDF!)<BOK'&@DP@&,05.M+5$
M*")\X80C[;EP)DF*\T\O>1NLL:2*&"R(KJ'C>)PK@, \4JI)&VQ]T<B*Z'=7
M56! FJ0RAAOLP!&X*G8C<;JP#*?SA@"#X(!S'Y?E<8QC&,8QC&,8QC&,8QC&
M,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&
M,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&
M,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,VBES:D.LHV;>@1:S55C
MZQ10$$-MUPH1^(?*1!9C''AQ=L;\))4-Y^0H7/\ RC-O)3%=4K2=\IUO1ZPU
M+I?4Z70.OZ1TOU;8]&NDZ_KVA2]3:3IO'4*CWIK>@P:IHLNI\]-6Y#!675M/
MWLRPNUJ)4+9GK-72=&MQ23UQR[D44HAD?V,%"RE) FS\23P;P".)WR\35JIR
M*Q9Z)S6C]4"RS' +59GXL+TV:L5=K].DBB-TF![+76.0509+:0C2;21!)L$4
M-+?(I@N3II\C(KTOX.EZ3ZU?JGI;K[XH]>?"+7*6C?E$=(],5[5W\EC1NF^I
M>HNM:VK:;T/1UOI?J2S\:>K]3I3O(6Z2TWJ%NG+6M4Z^FM?BHT>G=-J]1T^K
M]16[$]2C4U")I-'L3E4UV2:&&LT;V7CGA&F5T8 'OR1"98V+\"[3.T+=>N>C
MF<;ETNMWKFB>4S:%2>M7.YSBYP5=3*);Y!BMR7HF]5BM5=8XGSFMD21^O4D4
M*)V^W/EQPR;8OI!XT3:/E[L(SX?^#G07Q1D^+E+XA==_!_HGH>CHN@ZOT-HC
MTZ^G3]3P0W-^J>I^K$U/2OB7U/IFE]/=1]<:MJVE=&]&P:-J>JT>FO5ZEJFL
M=*]Y>F]3Z?4;=+Y>]2KJ%FRTDT=F4,7$+%?L(("DE*!WEAJQQR6;!E1&G(1(
M[']-'2W/N#.8QC&?1A^'O^(+"\/>2O.0;IE9A7SS7WOT5[ H/>*M,$QC4IJM
MQ*'Y19&V 7!E-NH)L@T6VRI-51Y*Q]H"&B\-R/LK]JF1/R'JWI-NIM>UB2E,
MU76=*TCIZUI<ZR&-3,UK7B\3LI!0R^GA[<X(>"6.-M^'-6Y35-,.HWK;0N8[
M=:K0EK.&*CF9+A921].7!>+_ %1E4[[<@:S_ (J/X;T'RP8KOI?S.2U??%?;
MG(5BYO< $YTU&YV0/-;+#J@1,H6Z[(!S&=KDT.Q2W?JY4-AT"9=6?$*GFMUT
M-UBVN1S:-K*>EZDTWE%<KRJ(C;6(\'L)'L )%.PM0J.*L1+&!%(%CF:+JQNJ
M]2V.WJ%?=)8V 4RA3L9%78#D/I(HW /N7VMLLH5-YY__ $B*4MYUQU:??%T9
MTMQ:EJTS'M1Z.PUK:M[WIMEAIMEI'_Q+;2$-IUI*=:U L@#X1J  !_):J? V
M\F&$D_XDDDG\223YS%( .EAM_LN(_P"\QH3_ -I.^;_^()XTM'1?Q&O8/5H?
M;^%56-30W1NX0  SMW/)G<$3N,\%5?Q8L?R6*:=NS!B66J41<C4@7&6*K[DN
MQN*U'B(T[%Z3ZC@J=(=/T&TS59S8DIZ8\SZ9;73"NHZH*CNVH-%Z4QK'8;;9
MR))0L(]S>,.F:@D6E4(#7LN9#%6+FO**VUBSVF)G*]OB%D.WD\F 3\<QG^CR
MV4S<OQ,;Q<+%+3.L%LXKV"R'IJ(T6$B:8.W2C%"<I,."S&A14R)TEYY,:)'8
MBL:5IN.RTTA"$W_%N&.OT95KPKPB@U+3X8EW9N,<5:TB+R8LS;*H&[$L=MR2
M?.7=4HL>D1QH-ECL0(@^NRK'(H&Y\^ -MSYSHMZWO>^K=-WO?Y[WT*Y[WO?^
M.][W8R7Y[WO/T^A_T"E_[)6_[E,Z.#^@A_\ J4?_ -@,N9[Y4K],_A[;^)7Y
MH_#SY+\._P ]_FG\NO\ >]Z^'?\ \C\M_P".OR_+\M_XYSO2O]/U;_\ C;>_
M^UVE9 TW[^J?^])O_EZN?0-^,?XR].>K/Q+?-[GG0)IR;6N$<XFDKFQ;:R#D
M\Z2%[ATN?(NTJ#,-P[,F!7-DADYJ>(%37)4_; T3J884B%GY/\/.H]$T+HS6
M!K$NRSZI<5*QKSRK<[NF4D%966)H>4W!T*22(%3=Y"L>[YR^@WZ=+2+?JFV#
MV9@L9C=A+RK0CM@A>!+;$%68;#W-LOG.H_\ &O\ 2W(_9_NT-(X,YHD&I](J
MO$9MSE#9@6/;[A N5LG3R$>.0BQ"2A 9VTQJXQ/(069$M8>9(B?4!]BGW.^^
M&VC:ATYTO(NJCA)8LSZDM8.LC5Z[5X$1"59D[D@@:8HC$*)%#;2=P#>=/5)]
M/TUA9\-)(]@1[AC&A1  2"1R;@7(!V'( [-RR>?QZ:\/\SN^.?"?+FG /$N3
M\'C]#2,AHU"CW'HEFM5IJ1J\6AJ/M+)BU26Z=*).3Y>GGH<BV'$PU,,$GFU:
MOX6S/K(ZBZHND2ZE?U0U.;>XUZD$$%B.M 3YC@!LJG!=@PKQ%N10$1NFG-OU
M^I3>ZQ/9,6Y.YCB1$D6-"?H@[@78;;B-=_H,K_\ @2]RL?.?>-&Y*MW97E?I
M,5:>6]0I!%"2%=L,9=2L!BN39X26EX;,E#C4!J I^3&<7^GC5D&:W],5E-N[
M7XH:7#<Z6M7]N%[1G@O4;*'A-"?40QS*LB[.JO&Q;92!WHH7^L:D2NI*R2Z;
M)/\ =GJ,DT,HW#H0ZAP&'N *DGZ[<U1OJH(F.I!7O 'XIGO9C@<B*&3PGAWI
M.\<RBRF-%!8:.J@".CUNM38DE:ON8D!]RA@W&);JGY$8<E3TCZO_ ,1K76)!
MU7T1TH=5#2?--4T>M=8'A)(?4S4YIE90.$DO!I05&P9_ X^,CR-\ST;3/4@M
MZFS3CF.^S-]HT3N"/HS[%QM]"?I^&67]1<0Y5^-#YND^Z_(U>AUWV5S / &^
MF> CEMN&+GH<.5IJ6,CITV\9.H@0)$CGEB0S\^]5R$]3)WYVZMQ!,'3:)J=[
MX<ZPO2^OS--T[=D=]%U5]Q'6YON5<^1'$7<"W#OM6F865_F\S.T.G8FZ?MC3
M;SEJ$S%JED[\8]S]#^"KN=I5_P#-N1)X1R3TH]B<G-^!O%XZ4N4VF'W/VNCZ
M&0IU&HKZ87E[3R-QW/R^2ZEU3NG$;0E27%.?%K2E+_/])T\*>JNHW4*>6E]-
MGD-O<.>N;'<?4;;;'\VW]V=#!M\SU C;S6TX[C\?-W\?Q\;9W:^[>)&>U?A6
M_A,0 ]\XS15@^81I+\CL?7Z)R.#/3.Y]3F4-!9MZ,AXYF3'VQM<V,/6^]#9<
M9=?0A#S>U?FG2^IQZ;USUX\E74K7=O,H73M/M:@R<;=@DRK5CD,:G?96?8,=
MP-]CG/:;86OK6MEHK$G*8^*\$DY&TLA)81JQ7??P3]3OMG1=Z='=)\R=0=\Z
ML]1BVP?RKF8RF03M:=$D:^Z%[C0@72>EAJF?BQMK+THT?OMB8$%DO:46 3-S
M&M14EYC"_P!/T5Z6M4AJYI- UZZ]EHIA(DHDTRU+3I26(6;:.S'#5A,D>VT<
MJ\3R,:G.DIM%<A%HPE#-,SE'!#AJ\KPQ-(I/MD58TY+_ %6&WU4'.VK_ $>3
M_P#+WO7_ -U:=_\ KA3.!^+G]'TK_P"^Q_\ 8Q9H^J/IIG_MH_\ @N?/6#MU
MDK8VWB 1B6,&WVNQZG<(<;:--'ZY%M-:NL<3-^-"U;BM6FGUHTGY2FG/JA$;
M6W-L[>:=_6Y:\,SUY)8U=ZLS3UV.^\4S035FD7S]XP6)HO.XXR-XWV(ZAHT<
MQLR@F)^<9/U5RCQEA_?P=U_P8Y]'/XHH%VU?AV?@B5=B0W$?LG+Z^!9E/:VI
MF,Z8YKQ4<W(=3K:=[;97)TXO6E:WM*=ZUO7_ *Y^/]$2B#J_XE3D%A#>FE*C
MZD1W=2<@?WGCL/[\Y31FX:KU"YW(29V('X\9K!_[?S9JOX_SL3SZ7\G>">31
MG:EP+DW!Q?18E9'[^DB6:X6.VW.GKL]H1'TTV?L34>DS23AB<AV4HM;;+,VY
M\\I*4K/\*0VK1Z]U3?86-5OZH]-IG]S0UX:]:P(82=S%"395!&NR]NO NW&-
M<OZ8!M+=U.?9[4]EHBY\E(U2.3@G]A-Y .(\<40?11G1?QGN-YX:0OLRF3$I
MB=,Y)T_B]V#2G9>A9^F]1IQ6J$69\>)(C;D2 <J?!M@#;JUL1;, #RY#,F,R
M_$?_ $[4=,JZHE5;*^ZEJ%'4JTBA>Y%9HV(YT*%E8 2JCUY=ANT$LB@JQ##H
M[%:.R(Q(/,,\-B-@!R22&17'$D';D 8V_$H[#QOOGT>"O(=6_%>_#+\<5ORO
MU6CU_NWC.HW.K77B-F(?:VB9:WD!$BQE2.H;<N8!GV@G6H]DK%G<%2ZY8%V$
MB++%AA =.<&_C[]03]"=:=13:[1M3:7U'/6GK:E G<*)72001IR*K*L"3M!/
M")%FA$*/'&Z.O/E&O/HFKWWN02-6U"2-X["#D0(PP4#?8,$#E73<.H52H((W
M^=#T/2>X\RZB4YCZ)"'JWT_FPFM4.<#L;4/4X97ZJ 'B*?#BS!^W()<''J\8
M4S73,&60@D0:![\ A+A;CN[_ %[2+.F7:*7=(EBFI7))K2RPEN+RSRO)89E?
M9XY6F9S-&ZHZ2EPZ*VXSJZLE::%9JK*\,S/*&3?8L[%G)!\JQ<DNI (;?< [
MY"&;/)&?1[^$?_\ &P_QEO\ YR$C_P"!)V+/Q[K[_P M?AU_[S7_ .V&G9R>
MN?\ 7&@?^T#_ +^#.O/A?X<C?8/&_3?:9KTWR/G7/.7V>NU*RAB=>Z:?.5XN
M8N%3K\J/;&P]2^**[L+;()^MMTF/T+5AE21@"6Y7WY1*:$Z[4^L#I_45+IN/
M1=0N6[T$UB"1)J444T<=>Q,# 9+'N^TKM%-ZDU.RH>51*JHLNULZMV+\.GK4
MGEEF1W1@T*JZK'(X[?*3S[HRK=PQ<0"PY; -^^Q_P^*WYQ\^>>_4_(/10GT=
MP[T#,. A%E:YP:Y:6#68!N>U-&.UTV?L,V5%1-!V0:_*DN"9<,B$>CO#%-2(
M\E=.G>K)M8U;5M#U#2)-'U/25BEDA-R.]')#+P*N)HHHE!*RPN  ZLDH(?<$
M933]4>W:M4YZK5+%4*S)W5F5D;;8\U51OLRGQN"&&Q\'/94_!7*:STWGG$/7
M?J5ORSUKI53!7!@=/Y7%N5%Y?"MXI9JFBN[7TMU/G*>>V&P#-P)SL$6 N JL
MPS0Q5O/ )B20\?2?JJ]/2MZGT_H9URA3L2URZWFKVKK5Y!%9?2ZD=&X;<,3\
MU#22UWF:-_3Q2KP=TFIS-#+8HTO6P0NR%A,8Y)C&W&0UHEAE[J(=QR+(7*MV
MU<;%NNVY@(E5N%KJ\"Q!K?!K=D.@(5LKCKK]>L\0.4E#HUB!/OMLOO!C3,=!
M(6Z\TTZY!DL+<;0O>TZZ^O*T]>"=X9*[S0Q2M!, )8&D17:&4 D"2,DHX!(#
M*=B1FUC8O&CE&C+HK%&^\A8 E&V_K+OL?[QFMYFR_&,8QC&,8QC&,8QC&,8Q
MC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8Q
MC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8Q
MC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,9^I2I6])2G:E;_]$IUO>]__ "?\
M-:_QW_AEK,J*6=E51]68A5'G;R3L!Y\?XXR^M>.CE>=)U<C=I(5FHLT.X:L'
M-F;E9IMJM5]TU ,UV!&I;0-@>,J.[-LHX:2S,EU?]*MNGR4[=MD/,P//KJ/0
M=17\I.CU)9^!VF]5=9S?$#HUNG?B?/T3TK1Z3Z1^'IEOZ)U+J%KKB77I]2U;
MK!>EAI<>A-+2J=5CJR:+I[3:'\CJ\4]_KH9D.BM"NJ/!66I9[U$6K#6+%SBD
MD*K5$02.N9^?=XLU?L RR-ZAB$H3GH/G(Y=;T7P*B<_KBNEUM'6P0B\%V9%!
MKEJXL=I%-8$3U+G)BC+P?O\ =C!MZ**3IT;%-P L\S!VZ:3)0W%^WROAO\FK
M\H7K[XB=2K\+^IIO@YU!K706C35OB%U)TA\<M!Z\ZWGUK3ECT][6K]!]/_#G
MH;1M!AMZLSQZI;T+4=;T_1=16+0S5>2UZ^KT^LZ15IP^NA&H0Q6Y :<-C3):
MM81ON_&.U-;LR2%8_,:RI$\J;RAMEXFE.?<F<QC&,[/^N<?ECOP\/-\!KIOG
MTQ;Z3V;TUTFZ\Z >B^''>AUFI])JW!!-1FRJ>)O\PU/ED%\FL3[P<-%(FH")
M0EF<.CRY:H[7%4-1#]6ZPQI:M'7LZ=HM.M<ETC4XJDUBE/JLEA18DJ+&BIZ^
M("21DB;BY5RHWS303@ZK;/9M*DM>G%'*U6PL3R0O99P)#$%  G3W,54D-L2!
MOD_?A7?B-U#D8NP>)_8\./?O$/;]2P)2)8DOSV.0&;"_K;Q^!\"OK(E-($E-
M$K P,6Q/JYQICH-7=AFHIAD]J>N>C[&H/%U+T\S5>IM,XRQM#LAU".(>(FW'
M%K*)ND1?=)XB:DX>-HS%&UK29)V74*![6HU]F!3QWU7^J?P,@&ZKR\.I,4FZ
ME>.R<^G5J=^.[=NM/] Y8!Y?2_9-ZZ">Z!;^J\ZIE234%V>P2HQ<2;M=G#PK
M(W,:6SN&Q7'2LI_4B.M#'RG4N9AN).OPOK4!4O2WK/3M2I%4KT;EFQZ@0P@Q
MR1002-"5(/(S"-1L=SX.6S!QTW'!VIFFDT^*%8DAEDD[G;0%61$8KL=]^0 &
MQS"_B'\3N77_ ,0'O?9^ =\\EF:3THTVNOWH1[G\G5C?V&P<]%TZSCR0T]V@
M';(C;L)TV#-0_L;J"(]^4S$T1B2=?-R=(ZG7T_I32M.U72M>CM4XB):K],:]
M/]K#;>Q"Z/%ILM=B&$4L;=T&-PI;@R^*Z79C@TRK7M5KRR1*0\3:=>?W)*SJ
M0R5V0['BRGEN#MOL1F/_  ]>T\/_  W?Q.XJ+7T@-<N1QZ3^SUXZ_4I\>WU"
M'9[13:>6M-FK9&OQE:/<^$]6&2P@XK#8>FJIJ4&GV9,QEZ,[?U;INI]8]%$U
MZ<E>^;7S"MI]A#7L-!!8L1P0S)*WV5N2BZRO&Q"^H^R!"D,*ZI7LZMHYX0M'
M.9._' X[;E$D=41PY]LIA(9@2!W/:-AL<AST;^'1TI7<.BV#D?2/-_2>#VF[
MV*T4SM4+T_P 14&::?,RR\&1;-V'HHHP )@ATMN/8(;HIY2Y\64V#490J.I[
M8:/UA2&F4X=0IZQ3U6"K#!9TUM$U62P;$4:QN(.S3>.5)74M$P<>QE,HB.X$
MBIJT7IXDGAMPV4C5)*YIV6?F@"GM\(BKJQ&ZD$;*06"Y%/J@I7N[=HXOQ/BU
MOJ5JKO">"\U\Y@NEV.T5_FE'NI.C1SMFO=RBV'I)*JB0=1FWFUVY-6D6"= E
M$*[$$R?DIF3VX6I^A)-I>FZEJ6I5[$$VJ:K=U>6E#!+=M5DLF*"I6,-))Y);
M"U8*_?6%7"S-(-^*ELS4PU:O/8L(Z/9LRVFA5&FDC$G%(HRD0<M((HX^80$!
MRPW.V^=Y7XI7M*-QW\1;S1[K\O=>XIV>A\\X\ YCT ;S7NG+;=+L$%_HW1B5
MRH9FLURVE+&W%+5FT#98LZH#-%"#S, O\?UH1"-?F70_3C:CTAK72^MZ?J6G
M6KFH2W:CW=+O0+$PITTKVHIIH$A+1S0.LD0E61XF:/[LN^<[HVGFQI5S3;D%
MBO++.TT1FK3(%(BA$<JNZ*GAT(*\@Q4D?1LHE^+]RCS)T2YA?=/C/M?%#=>[
M2%&WOK7(1O5^<!>M4*_$_HY#EIURV1:(UTU*L[\M+MO!BPTXS7KI!.F)Z-CS
M'S1W4?#Z_K5.M)TQU%INI13:;(]6AJ#T+DE"U43=1!ZX0-6XPA2*\KR)'+6:
M*-??'L^QT*>W%&VFWZ]A7KL8X)S!*T$L2[CAWN!CV3;9&8A6C*J/*^94]?=7
MY=^,+YZX/TFI]$YUSWW=PJM2:1T[C73KA6N91^Q@9FHDIX]RFW70B%IY:9'.
MQ"%A&5%XW!*Q(ECL@Z9IQT6 DV&#T_1O?#W5M4IST[=OI?5)ULTM1I5YKK:=
M*O)1%>KUTDL(IB9(7L"-T9H877823+#AH03Z%:LPO%++IMEQ)#8AC>8P.-QQ
MFCC#2 %=D+A2NZHWT9N%<?!5+J?X?W<H'L#U_:J. UQD':R/+>%5'HM"Z%U_
MKG1SU:+58'";K-$L%FW2*F)9,SR\RZ7J17AFB,(7'%MFM+FMQ]QU39L=5Z6W
M3_3T%F;YE+72]JEBI:J:?I].*9)Y6,]J*'U-B0QK&M:JLTG!I#)VCP+2]3D?
M5*QHT$D;U#1B:R\4L4$$2N'8\Y$3N.W$*(X@QXDEBOC? ^:[#9O4G9O='I3I
MO2^%<X*]HX7ZB!CH_3NX\KYCLUTOIE<98J'.JD(OMP"''Q[,<G%%"C\J$W6(
M4$3N*3L#$YE;>\NLPP:)IW2^CTJ>J7(]-U31)7-+3+UWMTZ<K>HMV)*M>2(.
M2C221*QG9GY1PE3N+KBI3KZ;4ABLRBO9IN3#7FFXPPN2\KM%&R[^TDJ#S).X
M7;*;^7/3_:_ /HD9U'FA<:FQ5:8L'<:Y#L(NQTCH%6=?8<-5$P4JY$J".!2*
M66G8181/F_:RD> ;$2D$!\=U/0ZYHFF]5Z0]&[&_9G7NUYFA>&S4G (CL1I.
MB2Q2)N0T<B+S0M'(O%R,V%RG7U.J89E/!QRC<J5DB?8A74. RLN_E6 W&ZL-
MB<[.OQ@>R^:?5-!\1].\JQ*W6_W?MGHRU].HJRP8&1IO9[:KSZ*LK%XCS9\,
M/6)A.4)CSY5A?4*KEC1N5=DRG$$R)!?%_#[3M9T*UU+2UUIIOE]?1Z]&UVY)
M$L:;7^;/ :Q56DF5%<JL([DT)XUN(X(F:?0:]NE+J,-TNP@CJ)#+Q9EDKQ^K
M9#&0"SA0Q 7W,GB/;V@9//OJI5SMOX<WX<7'>:]\\CG>K\#I4 5U"A2_8?F*
MN%@$PC0ZX.=;:(V?JX>ME%"R0E^ 2;&')3R7W&5PVID;Y\AG5=*SS:9U?UAJ
M%W2M?BH:K9>2E:7I[6IHY52U,X)2"C),G-'#H7B4; ABK; QM,=Z^JZK8FJW
ME@M2$PRBA<=6 D<[[)"SC<$$;J/'UV/C.ECO/ 2/+^5T^^]0[-S"_=<N=D@4
MX#2>8]TY?W-^G<PYE2!H-B9>C',K-=1 GYS+U)K'.!;%B2W% U6PQWHBT,CT
M#_TC2]56[>L5:6G7JFGUX6L2V;NEWM+%B[=LO*5JQW8:TDFQ%F:XYAW:6>)@
MWEB^_K6A-/)%#7FB@C0R-)-6FK=R::0MM$LRQLWTD>4E/+.I!^N_;5^! 8H'
M)XWJZX==[1P+D@3K/#'N?4']S.\<CI9DY9'2IZ*ZQNKG+C$M R+%=B_$[-+!
MH,9]B5#E05RXTEMW? _%&*W?;08-/T[5;\M#4O56O1:7?LQQ0\(6![\5=H'8
M@^%21B"&#<2I&:3J023&BD$%F=H+/=E[-:>150*AWYK&48D'Z*Q(V(.Q!SH$
M,\^L(&\)YY/?JKMB43%B4OB;]1#]25+,ZB;@K3T$#9"5!V/_ "G,;FE_U-]I
M%?E(^Z38?T<OY'ZM';BEK>K43B'@\FTE2U#8XQ\N7\TEA2WS]IXQ]GN2>."M
MR7?IUE1H^Z.839F]T4B/LN^_V3HLF_@[#AN?&P.XSZ#/Q0C=/M7X>7X:=6YW
MVG@=ROWF/F H/UVL4'T/Q:U6ZD']\[YH)::CAJ[?)Y4^]"-UXE#>?JD<TB,_
M%0_\SZ5UF2O\FZ)BL0=6]9SW--U6M5UJ]))0FMZ1J4%>S%ZR[(2TDU54B#12
MHP%@Q[@D;<@0.7T=735=7>6"S'%<F8P/+5L(DJ]V9OO/$%7=6!V<J3OMMN"!
MZO8G1N/?C%\,X;URC].YCS/W7QFH*H?4>)=7N=;Y;&ZR'<<00^Y<JN-TGA::
M3?CV-1DZ$KL@["F1QUE-P"[D62($/':]/4]1^'FIZG0M4KMWI?4;'JJ.I4*\
MUYJ$@!3A>K5DDL(&A[<4LPB92\,;QAEDD$2A%/H-FS!)#--IMA^[#8@C>8PL
M/'&:.,-(-UXJS\2"44KN&;AUC5KQ',H=3ZST7T[=>4<S#TOF=ZDT*@;[5S(]
MT[JW4Y-=(#.?A:G3J1;+)8%!0]KFB+)939"###R PMX3&E.N$G),#M9NI5MS
MT*FB5KUV2S=JK:MC3;L=&C169'MR6+-F"&'N20))#!&CM()'$A4! 'W#ZAW'
M@BIQS2M)-&)9?3S+## '!E9Y)$5>10%$4$GDP8C8>=YHOFOKU5LO">^^*.V<
M^&MDZ'S,^:N37HKE?/K+P_IR*T'B]6KW58%LMU:+@*^U<(9TU$22#3ZV;HI0
M<+VX<?;GPW(MK6=/GAU32NI=,MN4M78HJQTB];AU2D9I&HRT'@KS1RS&LT43
M<)%FBM([[1 HV8Y;<#I:JZA7E/&295C]+-*EF'DQA> I&ZL_;*J=F#)*I;VC
M8Y?/V8=\T?BI_BN<ZY]%]"T_F/.QO':YR$SWEL:PJM='Z;69=PL*V*2DT0 0
MY;=A/6R%2*P2+D8T8HD+I819IN6 CD^7Z=BUGH7H6Y;;2;%VV^H3:A'I9<B:
MG2G6O"&L]M964PQ0-9GCC5F3N;2=HK,R:R@MS1=%EE-62:4V'G6L6]T,+A%^
MTXAB.*H9'"CP6\A?<1TE^IN$3O,7HGL/ "-AA6R3RB\F*CJS0(RH,<[%@NI6
M/)J'JD3%#)4N ]&=GB]S9OVR<J3 U-F:CZDN_I.AZHFMZ1I^K)"U=;]:.QV7
M8.T3,-G3F O-5<,%?BO-=FXKOQ'14[(N58+00H)XUDX$[E2?J-]AN =]FV'(
M;'8;[9W??A9DJ/2OPZOQ):1>>Q^?Z+=?2/*9]?XS3[OZ$XI4;1;RT?G'2@FH
MBP5@O@\G7-R"YX7 C.VJ,$9>=D;>TYJ(R](1^:=<):L]7='6:NG:M:K:/>2;
M4;%;2=2L05XS=IR%A+%5=)N,<3NP@,A &VW(@'G-:$DFJZ3+'!9ECJ3!K#QU
M;$B1KWHFWY+&5?PI)X%B-MOKL,CW@KM8K/X*?NG@Y_J7"Q/9;]WBF6.E\UF]
M_P"),VZS Z!=^,;LY,.(5?\ ZB;%C-TJS2!JFM;58X@Y,RMI+19XUZ9+U43S
M_$CI?5(:.J2:=4TNS%9N+I.I&O#):JZCV$DD])Q4DV85??\ H6<K-VV1PN2S
MS?J'3;*0V&KQ5I$DF%:QVT:2*SP#-VM@3W$!_LD[-Q(.W*[U<*2,_!O_  ]Z
M'!Z'Q&V]/X3VZY='Z3R01V[D5@NHBM6+HO6#E?V2J(:Y$STE!:#9Z_\ 7P!X
MR>1#L%%?>H,'<2<B-;I5>R_Q#ZMM-4U.O2U33*].G?DTS4(JTDT-.A%+PL25
MDB7MM#+P=W1)"@[;-R7>M9'.OZI(T5A(;->*&*9JTZQLZ10(^SM&$&Q5MBQ
M;;VD[C)C_$Z\W\G]_="!^^/,_JSS$+H70N>U%KK@'KW6Q%"MW-K!5A#(A#Y>
MN+9)G%OIKT84+FU:(,?M"S(M2P VQ13@]3>NZ*UB_P!*5)>EM:T+6WM5+=@Z
M?)I^GR6Z]R&>0R$1S I%Q[QD=9V<0"-_M7A,;Y'T>W/ID3Z;<I7&DBED[#00
M-)'*KG?97\+MS)(<D(%;W,I4YU=TSQ;PFW^./2GIUGV%1A]MXUT:54N>\?,A
MH8*U=3KC$@"@38TAR-HU9P\JZQ34N371L "?BP':X4BER:?@*/U_N+/4>J5^
MH=&T4]/6GKZC36Q;U".1I8*,Q$O<A,B0&"1:K1J)G::)G$T;1IY03;E]0LI?
MJ4S0D*6(1)+.K%D@8A^2<@G!NV5 8EU)Y J#NH;K>SL,VV,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8S9J=<[3SZR#;A2CI"M6<,J
M4L4<%/?3D!ZYD*2.DN17]:VIEQV%,DQ_F)_):$NJVA25Z2K7+=:=$])_$;IG
M5.C.N= TWJCI76EJIJV@ZO +.FZBE*]6U*K';KDA9HXKU.K8$;[HSPJ'5DY*
M<]:S8ISI9JRO!/'R[<J'9TYHR,5/G8E&8;_7SX\Y=.5[(+6KFUD&]#Z=Z%LU
MK,4 I1-45=C&.<D*R9X%ZN,6X].?(ZL;DJ*V\FQR >PT_P"YVB*EYRPQA,G8
MN+\/5/R*='Z2^)W3&I_#;X5_DW]+](:/\1-*Z_;K].F=3B^,6CU=/ZA@ZEL=
M&].T*^F-TU%4N20-TW6U\:[IWRKI6V]>+IJSJ]8:M:Z<]2-/2G2[=UB>S)3D
MJ"KWH_ETC/"8%LS,7$Y90W>:+MOW9U!,RQL8UH-GH5G(Y87I'7ZA;@IAH%S4
MG5KM<B,8CTBS%.B&;9!,3(LM1!UBNUF>*@:K<=XM\$K:RI6U%H49K[3 *184
M@BF?\X_#'X-=9]':WHTNO_%#2>K.A>B]-LZ;\,^EM(^&VB=(7M&IVJB:=%/U
M+U1I^KZB>I[,&D<ZBII&D=(Z/=LR_-]0TFW=KZ8VG;F]J5>Q%*(J,E>U9=7N
MSR79;"R,K%RL,#QIV%,ONWDDL2(H[:.JF3G7K/H[--C&,8QC&,8QC&,8QC&,
M8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,DODW27.27*#?(5/I]O/@
MM-3JFF[1"Q,/6K3"G0IX:W-!!QD2./D0<B)MV"&MK)^GS'7=Z/UHU&1J+N%?
MI#4*SU7L6*\,NZ6/3-&DDT#*R25S*\<CQ)*&V:2N8K"@?931GW9AGA[\9C,D
MB(WA^V5#.A!#)R*L5# [%D*N!]UU/G-4MEKLE[M-CNUQ-$+);;<<*V6S6 M(
M7*)FSQN:^2+%2$E?^L_,GSI+\F0YO\OB=<5O6M:_+6I$$$-6"&M7C2&"O$D,
M,48XI'%&H2-$'X*J@*!^89D1$C18XU"(BA451LJJHV  _  #89K^9<NQC&,8
MQC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8
MQC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8
MQC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8
MQC&7IC\RY&GA@^RQ*S1R%FG<O-V"0=->FZJ-N,>R1&3[4C8_B,6)][FMP)H[
MX!0[YSCTQAIN7.=1_P"*0U\#V?BG\8F^/>H]+7>J.O-.Z7H_%30NGJO3^A_D
ML=8:GT79Z8N3=/S5QJ'QXLW#T_2DU"EJ1?5]3,,4-&Q++2HP.?2R3=6M'3OE
M*SK!4>=J,LIEEUVM'9$ZB4-PTI5[S\'3[--]V #/M[@*+9]\9RF=B?I\+**
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M5.V/T=3N]]*E4^;7N-4?D7/^V1*S&LYV7"'2;K?[3V;F_'5#X]7KCIN<!"@
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M4G^P=/\ W\_^CX[VH_J,'[<?X3'[9^*_^++L'])0_P#S'X];U)_L'3_W\_\
MH^.]J/ZC!^W'^$Q^V?BO_BR[!_24/_S'X];U)_L'3_W\_P#H^.]J/ZC!^W'^
M$Q^V?BO_ (LNP?TE#_\ ,?CUO4G^P=/_ '\_^CX[VH_J,'[<?X3'[9^*_P#B
MR[!_24/_ ,Q^/6]2?[!T_P#?S_Z/CO:C^HP?MQ_A,?MGXK_XLNP?TE#_ /,?
MCUO4G^P=/_?S_P"CX[VH_J,'[<?X3'[9^*_^++L'])0__,?CUO4G^P=/_?S_
M .CX[VH_J,'[<?X3'[9^*_\ BR[!_24/_P Q^/6]2?[!T_\ ?S_Z/CO:C^HP
M?MQ_A,?MGXK_ .++L'])0_\ S'X];U)_L'3_ -_/_H^.]J/ZC!^W'^$Q^V?B
MO_BR[!_24/\ \Q^/6]2?[!T_]_/_ */CO:C^HP?MQ_A,?MGXK_XLNP?TE#_\
MQ^/6]2?[!T_]_/\ Z/CO:C^HP?MQ_A,?MGXK_P"++L'])0__ #'X];U)_L'3
M_P!_/_H^.]J/ZC!^W'^$Q^V?BO\ XLNP?TE#_P#,?CUO4G^P=/\ W\_^CX[V
MH_J,'[<?X3'[9^*_^++L'])0_P#S'X];U)_L'3_W\_\ H^.]J/ZC!^W'^$Q^
MV?BO_BR[!_24/_S'X];U)_L'3_W\_P#H^.]J/ZC!^W'^$Q^V?BO_ (LNP?TE
M#_\ ,?CUO4G^P=/_ '\_^CX[VH_J,'[<?X3'[9^*_P#BR[!_24/_ ,Q^/6]2
M?[!T_P#?S_Z/CO:C^HP?MQ_A,?MGXK_XLNP?TE#_ /,?CUO4G^P=/_?S_P"C
MX[VH_J,'[<?X3'[9^*_^++L'])0__,?CUO4G^P=/_?S_ .CX[VH_J,'[<?X3
M'[9^*_\ BR[!_24/_P Q^/6]2?[!T_\ ?S_Z/CO:C^HP?MQ_A,?MGXK_ .++
ML'])0_\ S'X];U)_L'3_ -_/_H^.]J/ZC!^W'^$Q^V?BO_BR[!_24/\ \Q^/
M6]2?[!T_]_/_ */CO:C^HP?MQ_A,?MGXK_XLNP?TE#_\Q^/6]2?[!T_]_/\
MZ/CO:C^HP?MQ_A,?MGXK_P"++L'])0__ #'X];U)_L'3_P!_/_H^.]J/ZC!^
MW'^$Q^V?BO\ XLNP?TE#_P#,?CUO4G^P=/\ W\_^CX[VH_J,'[<?X3'[9^*_
M^++L'])0_P#S'X];U)_L'3_W\_\ H^.]J/ZC!^W'^$Q^V?BO_BR[!_24/_S'
MX];U)_L'3_W\_P#H^.]J/ZC!^W'^$Q^V?BO_ (LNP?TE#_\ ,?CUO4G^P=/_
M '\_^CX[VH_J,'[<?X3'[9^*_P#BR[!_24/_ ,Q^/6]2?[!T_P#?S_Z/CO:C
M^HP?MQ_A,?MGXK_XLNP?TE#_ /,?CUO4G^P=/_?S_P"CX[VH_J,'[<?X3'[9
M^*_^++L'])0__,?CUO4G^P=/_?S_ .CX[VH_J,'[<?X3'[9^*_\ BR[!_24/
M_P Q^/6]2?[!T_\ ?S_Z/CO:C^HP?MQ_A,?MGXK_ .++L'])0_\ S'X];U)_
ML'3_ -_/_H^.]J/ZC!^W'^$Q^V?BO_BR[!_24/\ \Q^/6]2?[!T_]_/_ */C
MO:C^HP?MQ_A,?MGXK_XLNP?TE#_\Q^/6]2?[!T_]_/\ Z/CO:C^HP?MQ_A,?
MMGXK_P"++L'])0__ #'X];U)_L'3_P!_/_H^.]J/ZC!^W'^$Q^V?BO\ XLNP
M?TE#_P#,?CUO4G^P=/\ W\_^CX[VH_J,'[<?X3'[9^*_^++L'])0_P#S'X];
MU)_L'3_W\_\ H^.]J/ZC!^W'^$Q^V?BO_BR[!_24/_S'X];U)_L'3_W\_P#H
M^.]J/ZC!^W'^$Q^V?BO_ (LNP?TE#_\ ,?CUO4G^P=/_ '\_^CX[VH_J,'[<
M?X3'[9^*_P#BR[!_24/_ ,Q^/6]2?[!T_P#?S_Z/CO:C^HP?MQ_A,?MGXK_X
MLNP?TE#_ /,?CUO4G^P=/_?S_P"CX[VH_J,'[<?X3'[9^*_^++L'])0__,?C
MUO4G^P=/_?S_ .CX[VH_J,'[<?X3'[9^*_\ BR[!_24/_P Q^/6]2?[!T_\
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M_BR[!_24/_S'X];U)_L'3_W\_P#H^.]J/ZC!^W'^$Q^V?BO_ (LNP?TE#_\
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MD;EE29TBD#1LR_;QJLRIOS0.$<!U8"Q&8KNZ=L\F4*65B0&(5MU)'O4!POU
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M7FM+4WMQI2M:TXWIQ"T?&C>T_&A2?S^).]:VP(.X!!V\'8_0_78_F\9*W_\
MK>,?(?\ D[D_)=^GT[IC<CY:_DZ>VG:],[=_+X-.[1K:]-_%\>TZVK6ORUO>
M-QOMN-]M]M_.WTWV^NV_XXW&^V_GZ[?CM^?;+4!_,SD_]! IIP]"O%LY7;?0
MAD8Q6!DP#7>$4SGMZZ<3/13#EN@S#=XFU"@DBHBIO"0863]Q#0)%QB394I$#
M1R:T%]7*L435J]ZOI$<AFD66;5;-NK2CB:,5V6*JMBVD<E@22R+PD9:S*JEX
M+7 .XP53&DZ5%/,AGLR2Q0JI7@0L8>4!GY,WAB$( WK=88H5DR955)!PC46S
M$^-7BMA$Q IF:*0^YL:Z9&#2IX8,,/0/DO3QT$X6C17U.-QR$QE*)"]S$93'
M'WUC2<QJ94BD:2-9-AS$;O'$[QAMPKM%&6&Q**? F(6XKW HDX@NJ,64-^/$
ME5)7?Z$JI/X@9[PP89-CV!TR>;KKPVOOE0,:4)+SE6DLP6&P/T]#='17VAKZ
MX4DH3V4*JCBFD!)$)V2B;*AM.6R2.K1".(S!Y1'*5DC7L1F-W[K!V!<<E1."
M;R'N!@"JL11F(*A5Y[L%8AE' %2>1W()\@#9=V/(';8$C [8>TUM[;+NF=+0
MWMW;:]-:<<1MQ#>W/R^'2UMZVXA/Y_$I&MKUK:=?GF7<;[;C?Z[?CX\'_L/C
M+]Q]-_/_ .PPZP^Q\OYS+K/SFD/L_-;6W\UAS\_@>;^/6OC:7\*O@<3^:%?E
MO\M[_+> 0=]B#L=CL=]B/J#_ '_W8W!^AWV\'_'\V>*6G%(6XEM:FVOA^:XE
M"MH;^/>](^-6M?"CX]ZWI/Q;U\6];UK\]ZRNX\#?R?H/S[?FQGEIA[;2G],N
M[91M&EO:;7MI&W=N:;TIS\O@3MS;3ND:WO6U[:<TG\_@5^5-QOMN-SOL-_/C
M;?Q_=N-_\1^?&_X?C_\ M_\ K'_;DU\_XXW=^1]\Z@Z>F"7>+ :(=A!M =38
M-L1;^CUSG\^,LZHO#V%D ]V6$40VT),Z(H^..ZL7\+3TC6V]0-;4-*I")9!J
M4MJ)I.[Q:#T].6VI$7;;N"7LLAWDCX>" _D"-+8[<]6'B&]0\B%N6Q3MPO*#
MQXGERX%?++M]1R\[0HTP\^M+;#+KSBUI;0VTVMQ:W%_G\*$I1K:E+5\*OA3K
M6][_ "W^6M_EO-D2 -R0 /)).P 'XY)WV_\ CAMAY[3JF6774L-[>?4VVM>F
M6=*2C;KNTZWIMO2UH1M:_P DZ4M*?S_-6M;$@;;D#<[#<[;G\P_.?!\8W_\
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M1Q1+)!%N1+&Y9GL2PQA0JG?W\OILIR[4XI9Z-B&%#))(H55#(NYY*?J[(H
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M=,M/IRT?1W>JIM0M)+1BD@TV_)J<]0M/#-(YC59ZK]N,3&NT/+M;Q)O9#4>
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M-IM"O_/#Q'G)R#)HB.;P"M/$!K0/%V,':BXBQL?,*O&HQ*PR(KENG:=JBV]
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M7AEJ20A I<#9YF,O",$()"-AMDB]0[?Q7H1OKMOYIZFC\:[(QUCEW4:]U>8
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MT^QP.L[M-$EKMEK)C;!2G:REN1!B_H/GR2TRWI&HS#6(^P6N7=8I7=-U7N0
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M:Y#ZT_5H$ M4(Q3:+[&G:M#>GU"I0:;3GU6G8ET)9:D4MF*/3+52S;C62=*
MD-N:I96M-/'WFH"=GCL&/>LE>RLSV(H2\!M0R-2#1*TB+7EBDE4,XAY=UXI1
M$[J',',D2%<SO'?1G&PW/K=5^R>@C]BZA8.Z0RM5]!5F!U4E=.8R(''/V]KW
M>1#=BJPYZWB*],;;KLH,:=#=013IDFXU$<!Z(%KS36+4-'U%[E>QIVDPQ48M
M+:.?29GHI7NJVHFW+I<ABG<5Y)E/>62/N4O4*M:P\M.28FV>I8:5'@JJD*UB
MKU7, CF!G,K5FXN>#,/=R7E#W-D=GB+$]:UOKM7CUMFUL]@#7R\%[[<11ZM0
M@E\1/0$'1PLX3TAZT6H &BE85X)%#;$<8]IBTCW0CLPZ.B_<V$I[.O-.9C =
M/DJU8ZM>2*9I:I3NN9%DIB""61D:JB1$R#>!Q*%B=N!S;QNY?@8&BC6*-E<M
M'MR)8-$$1F(,8526^X>0"D['(OR;F;&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,9?SS?Z!C<H\]VNK"^TE>97V
M=Z\\O]0"PP[W18,QJB\_IO?:]T<XDK4@4X;';W,Z#0MR1.R&BQZ$$E?+&3-B
MAT>7RFL:4U_5H)GTU+M5>G]<I2/(*;*;5NQI4M.(I/*LA/&I:XR<.W$TJ[NO
M<<KK+=4S6DD-=9HA1N0L6$1!DEDK/$A61@3XBD\[<5+#R-R18RY^A^.=/.EA
M%B]'(A5R+[]Z1U7FQ@I1[Y<&.>\/MH JT+F5H!:^=&A-:$NE(]5B2*_$!SR%
M<<'Q;#!I1EX#!B2=17TC4:4220Z.6F;I2G1N1QVJE<V]3@E0NL\T%R*2:3@T
M["9I464.T368A*S+$CJV(55DJ[O\KBAE59(X^[91E)#LDJEVV,AYEE#\BIE7
MD2.4OT_S:)=N:W>'Z*:U9@WX?';_ #\;M;R>W'K.QU:98>Y-<O02M)'FL0R9
M<T.M/-B8>UQXC$6OH!L?+BU=T"'$LVC1+IK7:S:1]A+U;IFK15Q\LBA-!8=,
M-WA EQHXOM(+B20%BTW=.[3B65R%.8QRQFK[&U2M:5/YNJ=D+6,VR"4JOE)E
M9/);D?+\F.:OS_TQRP[YZ UGIO=+56_25@OGK:WK[W&_<XW:^<G>N N&M0Y]
MUEQJ[,?LU>[.USFX5"Z':80+]$IS)H,:CQ" R7:JX0S6]%O1:M+-2TN";1H:
MN@5_E1]#'7NQ4)=4++65IE$,NG&Y7L5HK*1U+)BDC9D=8)DNEISK:=X:T;5%
MCHIZ8]E4E6!K.XC'(!'@[L<D:R!8I"K*2&",(WNG>ZV*\\<\$<=ZW3*]-:Y!
M"YKT[F#U0Z*KHDB^@^N3;^YT2J6*365<Z3%L16'5+N-O&[0!Z97'8I"N)&M-
M#Q\8E-K:5,^KW)-0H6)D.H-<I718IBH*LE!:@J3PK,+G*&-IZSU>Q+2F#),7
M)=V3-'5<VY6G@D9>^989A)#V1$T C[3H'[NZ O&8^#0MN'W\DC2_:W9ZGUWV
M_P!"Z\_T<AWWCY_KA:XUMK<V_1GQW)C=]*6N+S")&Z$&KY*L/BPQ.2/=%!HK
MM:%$)S^Q!"6GYSV2>F].L:?TS4T]:::5J$6GQUYO;48/?CJ1P-=8U))DF#R(
MK<Y2)G5!W$7P,R:=7>#38H.T*TZP!'\1G>=8PAF/:9@_)@#R8AV '(#QEA87
M:.94OU6R:A>OV[OYSO)7T-. !V*OVD4-XS [5R*\<_!,WNBDJ/"'!I0%9^I@
MC GCK71@J0596Z,DN1A8&!-U+:==L:$8VZ>]-K%5-(65S/ILCZDVFZA5MRFK
M:2TSR++VIY8WU$TY.[,.:[O*ZQ37FDI<30[=N-:H=B]=FL&O/'*_;D$A+<N,
MC*T_9;F_D>YB/VF^AN8TG7GY$7T0-<.<U\$>M^ F[3 !]C^&%T>\VSTS/XZ*
M'R)7/6B\@3&8Z-S.>#+(@MQ*PP$3]0D-.!P8>Z6-(NV?FV^D.(KG56@:M% T
MFG>ZG5@T1=1D95MF-9&]'=25"W*<R^.XLCME'JS2>I/I6XS:G1M*A:O_ $,<
M=19R0)=@V\4H9=]W+';D&)R/8GK^4KA_#@UZ[7;^AEI'J3MO0/4?/W2W0'C7
M5>0WR7Y@*10%K/&!<6NV^)8SG*^A%YH.?9);<><2'$YT5,^<\F)+;IY?F6IR
M5=,K5$&AZ;4T2WVZ@BHZA576T,L$43M-7:&*]4C65(5)1'C1N"CEE- >HLM'
M7CB7T=:*G)M'QAGB%U2R*K%TX)-$H*J-U!5? \RWOU)60/<+@M?IRBV'F+W+
M/=\7G=JJ%"[.#-0#?HK@UDI'/@%JD&Z U;X4QR[)Y\7?K091GG%!+!#5C"&-
M$9;LDK ^232Z97_\2VHKPO=+&W!8M:;)&\6D:I#9MS0"*V:[**QMQB:3MW+<
M<L<,L?!0J8/1.]=/YG*DPFTTRI)+78%:EE))63C)VR!%W5#GC+(K*C+L-EX]
M8]9UM+H0FCTV8J_1#WX<IGAUIZ4^_P!K9+PNTBNSFKS5Q5EL@2IS[45?:H.@
M=9"V40S8!8Y^)&#J)PAD5J3JL^@3$2H=%CGJ1=81:I!3 TTQMIKZ=%5GDAAE
ML+!&#:[LTD,AA=PQDX,[%<N:D^S TUDB755L1P@5^/IVKK$S*C.$7[7D[*2K
M'<ML6.8#E?<ZP]<_(53B7DQ:*=+\C]4\W^M=UJ!<VIE3JW3NX^E[O9[B5D'1
M "*:;YM6NO5+J39B(1EBF[%4I<0@01&;6N=FO:7,*^OSM5C@L+K]'6- [SUB
ML\]+3-&K05XQ%)*T7K9M/GH]MD60PV%94Y$!;IZS]N^YC5)/70VZ/,QD.\5:
MG$D8XERO>>!X>)7EQ<$#\U%9760]I[[4.B=$@&KASJMVZ@1'*D9F[+$GN.T&
M8&%":(J1-D*:D.-T0.P"<6Z^EJ7+6_+D.;<E/O*Z=:$D&DV*=1HJ]R:O;;OQ
MKP0:C;6222ULHW -J0R@ ;JNRJ-E &R[#)6DAB*I*\<I#@<5$\H9FDV'D#NL
M6V'D#P/H,O/9/4TRH^BJ=<*3ZDYT=HW/+[U?IE6-5[G/7(,\Q5KTH X7Y-<X
MMMH48Q+<Z*$KPZNSZ#]20Y#6)[YXC'L4596:0(<Q#H:V-'L5[.AW(K5NK0I3
MQS6]/*1SU>Z([]=J]IHU])),\R6N*ZA.@B1HB(T1-:E(259(Y:<RO+%##(CS
M0$*\7+C-&8Y.([3,767Q,P"@K[0!PSO<>)(M/9IU,[5(%<HZ/XS/\^YGQPK!
MZO/3Q6S6*133+G VY*J:Z)-#0%C#%I$#H3+[L*WIU$M5N)LVXF6WNZ/3-2,&
MG+9TT27Z?4<%N[J,;4$^90P]^/YJ5%D21O+!(@:F5#5SR@KH:Z1Y5:U@I7$E
M?E/#J"2S6 81ZA%#KZG;N<E+HP!BV';\I&O;"Y*M3]8\8@](XC=&^PR>;W09
M3_2?-+@?H)#M:>/CAUQ\MHY9RCIK%+GU:1;N86HS=6:[&OE4YHNWU& NE"[+
M7Q5?C# \>=!L:#J3TM2K'3UN5I+&C7:\-M=-^8.U;7#?OTC92<5[L"5C,:L]
MWT\[^I>&9Y2\C+A>E8,5A#7$T9DJ31I*M?U!,=WO30]P/VYHUCY=IYN#GN,K
MLV[$5D/]MH%H\IVZ@= Z.[9.N#XI.12[533/662_0RICT%%M-CK_ '4%<ZXB
MG7D5, K+]1JO56B-<Z2,(,5*AV*$;AP%0*]NHM-MP:[7MU*8@H.4%J"S'0,=
M2./26@AETN6M-ZBK(LHCHST2DU)T:Q:A:-VY32UKRI=CEBBX0$CN1R+ 5B"U
M3&CUFC?G&P;C"\.SQ$&252I.\FL<,[N!YUY1[%S8GT(M%F77T?YMNL[DHTA?
M1370N542H]\#=< SR(44NILP[4Y>>>CI0LR884::#:D2XJT@!GS,VIZ7+<UW
M3[B5(V6OHVLUDU!TJ2&G?M6-*DT^5$DD%@M *UQU>.,]LR<58=Y]K[-9I;L$
MRQ*1'4MQB<B(F*:5ZK0, S<]T[<I!5?;R\'WG)^/^E>3;MO>)[W546\#TKU7
MR'K7"/G5V[0'>#U2IWH]9B1Y8U=;^32)P7GTL1R?]%<T^_#IR8K:1[DBLT^H
M$2&JBT:_Z?2T%$UY:>A:A0U0B:LXU2>>K%"D7,3;V5DMK)?]3=[3IN>0$UBP
MJ1DJ3!*P['!HJ4T-D\XV]2[H$5>7/>3E*&G[DO$KOY][N%IEZT[(3[1Z"Z!;
M9G1#'5*5&NEP:YA,)3;.F"'Y@5O%CMX"IUP;9X(PG500[]23=,5^.*'P1,N5
M,2/C?3[;<<Z/0-.33=)J5UIQT;+5JYNJBP<I+J58:\MB9X'=)Y7[*[RF1VD5
M5YMON!/I0"O5C01+#(8X^]L$W:81(C.Y0L'8\![BQ+ #<Y;3L'ICDQ*;[#,U
M>Y/V*G=H(\M+^9^7QA%E%$?/Y"L='J-P"RF=$!<"N5&3R#EH6T\-@KI)DA]]
M;M3#HIV77$3IT?0Z=HM]%Z>CGKB*QIR7H]:O&2&1-62>G8KRJ>,CS6%U"_)!
MJC"U&G;,!#A9N*F%!3G H*Z<9*XF%N8E"+(DB=&'@EG$\QCL$.HX\/=[]ADP
M]%]&<%<Z3U.RUST.#+!+K^*;1?8M1CP*MVB&FK\IED.Q&[*[(BD><PFQ]N$H
MN55&V(*';F((282-"2)Z/!VN-KZ>D:H*="&;2)8Y*W0]KIZP7GTUN_>5-.BA
M"LEQB]>3TT[PR2%2BM]HD1?9H\52SVH4>JRM'HLE"3=ZYYS@0*GE93R1NVY5
MB1L#[@I.QZX^\=<,=7]!%+;8>GD.@5H7<94"C64\S8+$,KW--7(K8P($-6;7
M$&3XE6KS1R<J+2=#1HR-\R6-'Q&H;K:E]?I6GQT-)CKQ4DJ3O75[4,1BA>:[
MZ>.*:62:!G5IYC$O*SS=SLKLQ8>-K5@6"JL:PB)S&#(B\5+3=M5=F="P+L5&
M\F[$^"3OE^[)ZCXM+N%]Z2 ZB[2NC7/S+W2M%(E9+]LL_.0O8[GT" :KRN)E
M;=3$=&H8>TQH4JV/UX[+D@Z(7(-:%V>/-F$1(/EH-$U):]6G+2%FI7UK2YD:
M:/38+DFG5ZK1S?,HZ]CT=J2 LL FB42VHU/. JJ22:Q*=@1Q1/#W(DMUG!=:
M\<K01Q%6%A4D[4C)N(^2@-*J^Y" &?AZ]$\KF]7!=M5Z:D#>@5_DGC*/8#40
M'TT7:NAWOFM=$5WK.BW38_,2G0720I8 >X2'0B%<$]98EL3S%_3(J\2'.J=(
MO+0ETP:*KU);_41AB,M)X*E6Y+)-0[=)KB5 DAE<([+-)0*E(ZA68LE15F6!
MZ_I-XFGO\%Y0LD44SEX-H3,(P#R.S$.T&Q BV<D:#TGTE6ZUS;U-5>-=W<B+
MZ5[)N5X% Z*UU&G-WG@ESK-_J]E$_62:: AP@-G'60%"-U(](&;(0Q:%2Q,A
M8H4A<JGHTTUW0Y]1TL,*73U:M))9-&P:NJUIZD\,G%;,K-+"\,C16(1)P9_;
M( [G,T51GEIO/6W[5&.,M)V7[=F-XG1MA(Q+(48JZ@[$^&\G-_Z7ZIHT?O\
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M8CQ6H++[DA]YIII*W'$)W'6W5>.25;-=HH0QFD6:-HX@H)8R.&*H% )8L1L
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M!E+IQ+J&!9.6Y7DH.Z\@"5W WV.WTS YER[,_8ZI:*>:=K=MKAZKV%A@9*?
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M,2IH(EMK_%X.?A(D!S$1:5M2QLV5'=;6VXI.^SU33J^K:=<TVTH,%VO+7<[
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MAN7D[Z<[38P['X>=W]!CP35_ 1W 5FHG:^O5J12*Q-,4,_&K?-RJJR4/QPK
MB9.$V2RE";L\K\^4Q)N?5;L4MZ.K%IL,IZNK:0TIJRD2P6M+T^=;,ZQVHFFN
M1B9(3(9%62*&.,)& I6K6ID:81K70G58ZI;M-[EDKP,)'"R*7E'(*6) 954
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M6W,ZQ7XI$L*W>@JP1JZ$(TRMNN1;<DLLD1,;124YYD,:O[3%(L9 E8\9E82
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M:8 =ZUS 4<]7^WQ$@N"Z*+WT(,8_;/R0[%*UZU0Z$!CB&V?A&1YT%0"5)?\
MD&=LDH>B<9D3%OSV:=WJZS**%UX]!Z9D6.2F_I)(O6Z^"DL#6Y3(3[RK]T*-
MX]T;@QDQ3/)%/JLC=B9A1TUMFB/:9>]?\,AE;E^.QY;?=W!V.\,\Z\P\.MU'
MXKLC^ZS5Y[/YB];=C9,P[G46:K5KCYL$]U/"8BZN]S:47/UNV1N.1H!&#JWA
M"8EX](FQC$]$)J&]LKFM:G7LZEP]":VG:WH&G&-JU@SSU]9DTN*1N^+JQQ30
M-J)9']/*CB(*T:\RPD37+,<EC;L=NO=HURICD+O';:LC'GW0J.AL;@]ME/$
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M*+M-/'<>0U:[-+9B4+#:9^!+SQH%$<Y)D10 K  8]/78EC!"Q9UE+=M"6D4
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M^AH7X:X^3)):=5NS,@G?Q#G>10;"J3K\YNC^O-:QM$VY\Y4G]G2#2E-)#_\
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M3QG)3FSJ9XF[0,<RK"&#%@I &:15O)/->J5CC=KY]^XX5-D_C5_7-9,V2NW
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M:3(V[LY+MJFM@G=V.PV55500J*JJH55 $R-0NK6=M_=I]5CY)W)LW!^).W@
M >   !L!DV^R>%46L">Y4?CG4"C5<\>WGG/-+!RR516:]7N@3+(@E7'.S!;[
M!NI>5U&^6JTBYQLLS9:36% ZD:@!^?D2-&J4*)&UG3NJ6II-,LZC1C,W4-6Y
M<BO+9,LU182DWRZ6J]:-:-2"!TBC,-F<26(VDMHEJPS-&H696:O)/ .5^*68
M3]SD\039^P\1C40Q(C!5*2/R=290)')R/.1Q+/0>&\'G42,6!]=G?B#$JQ>8
M#$>7!L+3]+IW&)'%Z\<@J0U,;2_8[9VIJ,'FM:1,EQ"K3L9UR$I+4R^T%K4]
M46TT<NGKTFD]9BRO"5LV-1&HS1-N5.T-?329%/M5HR& 8;Y9RDMFRLI5ZXTL
M/&=P5/<DL"PRG_U$K[L/H"NQ\Y;[[30:EZ;\C@>$Z%[Y#=/Q*O3%:L\8<ZUN
MKV6CP^Z<^HS52M:D*U!(TF#YR.B]+'DE."!M5O\ :9;:8T:R&'I7/\[4^B:_
M+JG/YA7Z,T:: MOWX;+Z7;LFQ /O)9?6(I-G3[1YZD"DDPQA8.\KT[S60WJ(
MM(J.F^_-)#6EE+IYW$AMJ?<H#%XD'G@NW69P'EO+>L>@+113CUM7SV/2_1MR
MKLJIEQ@DXZWR?D?2.I5)M^6=K]ACN02VZ5"%E4;'M3/IB#LF/)9?8TV[V>K7
MKU#2H+,0KBV;6CUIA/&\D0-_4*=&<A8I82&3U+.AYE=T *D'QM[4TT%5)%X"
M7N58WYJ64=Z>*&38*R>1W"5\[;CZ;989CRGP2X\XC=YIAWHE7H _SX=ZM;.9
M72R"[->QE@K?H"G\"D2X=UIW+(R)O-2DNXMVB/8$<F^J&S*\=I<_>M-JN$+4
MMKNJ5[ATNQ%4GM/JT5""[6A>&J\4VDV=5"M6L7CQN1K7[!B-_C(LL=E//\V:
M*;MF.7TTBQ/*UH0)-&C)&4:K):&\<DQVE41E"O?V(*N/KV\C\_R3RT"XQTSK
MHR1W*XP$=>G<KY1K[W4*4VPV=Y"]>:A9;I!)4 [//1P-F:T.-01"JBJZUQQL
MJ+E4J7M,)Z7%?UR74:>GN-,KO\OCO7_LK%G<QZAZ6Q#69+42Q&6'WQM)ZCTT
MP[;BRON&19[KV(8#Z:,]@33^UY=^,_;=(R)$"ED\@MW.V^ZD2#R-3\R>?*AW
M6O7R,LO*F=7&RAZ^><R;MX;GLWH0*)7K65O4BE'K35#U8N%YJ;\6GRXW,)!V
MFF[0)*3FJZ1($ULMP<^M:M8TN:JW!5H.K"W=->2VM25IH(ZJV8H)XIZ]6P&L
M*;PBL1021J9D1-R^2Y:DK/$=@(&![LQC:41,718Q(J.KI&^[[S!75&4<P%^M
MH^H\SYIU'E]+27:O4'I7,?PV>=]>JUB@6,#JD/1JQTF2#(5$]2Y-0D'9SA,/
M8I\J#9A]]$(&$(T&([62474B2YHJ%V[1NV2AK/3N]9W=/GA:*7U(,]021V(K
M(L")1')"BO ]60NC,PG1ME$.&::&:3CVS#-JTT#H5;N;O%R#K('"CBR %#&W
M($GFI &147\I\U$\XJ=@GQ^J ;7$].<CXE?15BL-&8)SJUU"EG;4Z3:HXH$6
MG\EM@B15R4-@!;K9=)\B*0A3"P@&]%5"G;"/7;KW+$2FC+7.BZAJ55X8;119
MJ-F* (;4DL:7X)%G1C+7KUD#(RQR2AN2YENS--(H,+(:<]B(JDA4-#(B;=PL
MHG1@X/)$C ((#,#N,Y8_-/FH:4]#6"//ZV(YMYDZW2>%W5)ZVA"EGM-BMUX[
MA"5T,5,JG&R<:IU6-5.2P!#5:, #7Y7NTC_J+YN"Y%$S,<6LZRZ:3$5H27=:
MH6=4K=JO(D$$->MIC>DD6?48VGG:>^TAFCFC_FL#[5>0:1;5MW"*J$0--<@D
MLQ\48(B1QUSV3SG4R2%YBQ=2OV2G:+<<A0.[5R*".FEUY-CG415HM BE6:Q5
M]ZO2[$* D_IV9$J#MV5%A&FQ\D7(.AHQ"<H++GMQ'GUZ4TZ[U5:9I8HQ+V5M
M"""2S##*)5ADE3<A6V5FC+AQ%(R+W%0L /(&SC<LJ\N DX(TB(P<(S+OL#X)
M7<'BQ Y ;[9IV2,R8QC&,8QC&,8QC+A\5\^4_J_%>C6\:6E&^LTF-TFP*YBS
M< U&*2.>T/G#%TE7RGL6:J$AO5]UAYH\3Z71P%KKUUKE)#1CH<4?;,NO@^=U
M+5[%#4J==XQ'0LM2B]::TEJ-;=JX:RU;+0V$>AWP8DI69:\M::S(8I)(C&!+
M L6I(+$494+!(84[QC:11+)*8Q%(4<&'F"@AD9&C>5N+,FWND.Z^<^(5UGA]
MK%?N=.Y_Z/B\.D<PE/WBH++-2)1,E5O3PDL_&YIJ+)G\VZ &D4ZLZ^B"JW$-
M5VVSXQJ-)D!&XM;6-2F.J0/Z);>C-J8N@5K C(5$GT1XPUSD%NU)!9G]TH#1
MS5T:-@)3BBM67-E&[(DJ&R)@(WV.P5Z;+O,2!+$PD??EY5D4C;EDT#_)7E61
M?:U47X'?]19GOFP>*3$IKJ7/-2'ACI<,,K?31NE\06W"GB4S)SIFF24D(Y]7
MT>H=JKNFG]2-:^OZZM6:PKZ46'2L74D2FC;XAUC=YZ3[:GNRR;(([*\3%[BT
M$VX"QS>NB)G!K;C3$U!089-@P5B\)VL;D-L.,GCCY]C;^'.N9<FNW(O%O"^O
M)Z0L=?O8_K/D==N//CE>$/5$U88_D>IC+<5K=AJEF3< @\Q-A$"M8'G*?.?'
M,D6HMB;F/,.-+EV_6U#J/5-/]&'J].Z!J$U>W%+(+$4+=06'KQS0SP^GE>-6
M1)WBL*'*%H>(.Z2:=+%^S 8MXZ-&=XY59NXJ^N<QJRNO;9@"%<K( VVZ$;Y%
M]9\=<XFW3@')C%LL<JS>@N%WSKHKJ( J&US6JS TSK\:MPWP<JNR"5BJT+7)
MG=="L2;97Y(1TT3W%':31WV[9.GZAN+6U6_'7A6#2=4JZ?)2FCD]9.LBZ>T[
M+*LRI#.WKQZ2$P2B01)R?^=#L9GOS!+4X1 E6S%7:%E;O.&$!<A@P"N3..TO
M!@W$;G[0=O%=T U _6. NW"7?([P#\/>LG:C^B:K#M3,BW0NN7^&*B7AV::#
M[J]#5!F$=%;3$T6EC9S8>(P&F)GKVS?I<MB*;5176J1+U;/%8]3.T!%=M/JL
M[5@L<G?M<U3A W!70R,9%X>;Z[.KV>V(_=J;J_<<ILA@C+&/96YR;@<4/$$<
MB6&WFKG&^P_M"]>W5<_I/06KQ27*?N)=D6)48#(;LU;M8ZQ#=5P_7W9<R$4K
M$)F2&-NE*J>%29XJP B<.1IM&\U'3_F J@6[-0U;(L<JW9Y2@P35WA?O12A5
M>.=B)(PD\3A'BE1AYEV(.^(QW9(NW('WCX[L.+(5/-6V!#G9EV=6 96!&72X
MSU?D7:"O8^?=8"V[SN+]/=SYM=.<=@X\U9;J+Y7U2E:MT*%6+4-N5HFW:Y\Z
M(/=5:L9;0V\JN-9.C@!X;$,L-,#8W.:C0U#38].MT)(-7?1-+N5KFGZ@8:TE
MZC9].S3025X5K5K:"B88^=7TTT3RQ.T9W<Z^Q#/7$$L#):-.M-'+7G*1M/#(
M8R71D01QR@0\5WC$;*60E=]\V[SZ5Z[2+Y^(7S&Y='-'3/(?)7IJCJDB+.4D
MUU@U3^G5 80(U;:'(S#4*48V7)PIT:+%=D[)2)RTI?F/[5'U9-/M5>DKM>G'
M%%J&O:-:"R0(LICL4;+HDX()+K'VT969@O!4'A1M9:$$D6ES1Q*BV+U.39D
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MB2'F5YI889U59HHIE22*9%EC214F@D66&50X(62&5%DB<;-'(JNA# $7LB.
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M'L.368*)+C,&&VIW:(S*49A3IK9:XM2LMMD$;6A!$++1@L0C3A>Z4!=R%+;
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M>OOZB.,?Y7L=GJK_ &AT_P#N?4?]<QPU+]8H_L=C^.Q^H/ _\I/7W]1'&/\
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MJ;56+- VRG3C\UE;J&M_+7P__*S^$W5MK4="DU6CI]SI?3Z4W4NM]/SOU?\
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M6_8]34LTZ-1S8[EI:^G5ZTYE1G]LTJ)W3Q=VWYN6+'W$DG>LN?4N:'&,9/\
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M+I=<A]X[+[4Z'YP@7(C8;G%9)P1U"X,;HXN7!=/SJB+D3[5U<D,G&FZU';3
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MFW>S++IPD4IWF59%M"92JL)'M$%I0#L%DCVXQ,0X2,E=MSRST4OV?NB&N.F
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M]!E&GC1,,^@J>T9I8$9$5'%!1+%<9DQ9 J:;E*L*=E+I=BR--:S?[TVGWQJ
MD]+'&DDBU9ZBQ"-) 8XNW9E=MWED,Q#*ZQJ(LD-6>3TYDGYO!/WPW;"AF$3Q
M!>*L-E D9CNS,6V]P4<<VPAZS^NK5NKFN?I93;?*]&\J/R_U2IQ4.LT'H5#Z
M:*M+3/Z>1IP]+L?-ZU'(QU.I'.!73D2,Q%FSX!,1@30>$\$WJR3!KMK70O8
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M8GNN[$$$ 4S"W$ FUV0[<*.*L0BU,V!$VOAY6ZDD))-2%3HA&FS8T,FQ7I0
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M]5RKT\M.AB[381$R0VVJRQU)IM6-9+#21;PRV61A%W%J12M";7#O;RQ2,K-
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MM.TB:UK<"K/VS+'#6U*S## >T6C^QC18U[;,I"@AFWY&S3Y9)89FD+LRW+B
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M>FA66#V&*-7#?8=Q4?C$HW.<,,<IF:9XII%D9/$HAD*OQ(\%TY)X*J&W'#D
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MH9H]R>6_!U!(S?+9Z_A]#)=E_4G+PBQW>^O\3ZE<8!*V6#0*&YQ^-:!;%?\
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MG"AAN4>)U=#MR1XY&4@%2#LP8$9*G+/7\OCD !!I/,ZXU'KO<&^QQA98R:+
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M@<R&W=05Q);U*7-J]F=H:)4^OF?5TMRKDN1?&7/&1!FR6P/?R_2@+LH-$$C
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MG3V4KG/[9=D/(<>^%:'EZ>1T%FLL].>FA$*35Y*P*H"(XY(S%[$!4>U#[1N
M-AX(&V3Y(P\+P@\ \;1@@;\59>/@;@> ?'X?3ZCQE@X_J$1,;]" +CR<=<*#
MW_H8'L$NN2;:5$&:3U&L/WAT-8:U:!4!C;HKZ3I=Z E !,-)T2KYB(S]QC'
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M^F\_WT<C7.(R>/46Z=#OEE/=-"SMWV1<@W0;1=PR*LYT4]4Q)$GSZKBK0*=
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MS/\ -/S[_P [J'_W3'SB+]1U?]UW/\O'JU_0VOV:7_EQ_#N9_FGY]_YW4/\
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M-K]FE_Y<?P[F?YI^??\ G=0_^Z8^<1?J.K_NNY_EX]6OZ&U^S2_\N/X=S/\
M-/S[_P [J'_W3'SB+]1U?]UW/\O'JU_0VOV:7_EQ_#N9_FGY]_YW4/\ [ICY
MQ%^HZO\ NNY_EX]6OZ&U^S2_\N/X=S/\T_/O_.ZA_P#=,?.(OU'5_P!UW/\
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MM/\ 3:M^_P#7?]1QZ.+^W:_;KO\ $8_B8Z-_NWY^_I,\K?V:Q\EI_IM6_?\
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M0H$N+T?FU1Z3 ;8C$$HFHW!@VV,/>5(;:6Z_%=>TRREQ+2(VDZBNJT4NI"\
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MG,\C$R#B;CW VQ[H+U36[!_#@-]^6_F,"/AO]IDQS??G$W[?ZNN#=&[4]/\
M25H]=SF625U#RA5=K?J#E+]8@0% 4?*$N$J'='OJ/K5LSI1:K1P;(TA6G@I(
M9:]<O2FI"OH-<VM-":-7Z?0E*TBO-/HE\3LXE.\@2U6&W'=5CG,I=)A*DE?
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M<TT/UVWW[,D?+Z#;EOM^&VYR6_XU.Z?_ %/PC^DGR=_9/-?_ ";TO\^J?O\
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M.B;#4ZG3)$7*<CNJ@%A[LH8193]1 ER8ZDNJQ5+E6] EFG/'8@< K)$P8;D
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MX&@2>>&%K,H@K++(D9GG*/((80Q!DE,<;N$3=BJ,0-@<O:2-"@=T4RMPC#,
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M>[B]KCOMR[F_'8GP#OL3XS6@=*N%F%6L[7*K8CP6B"(Q^ZEPX8@2&U(',+0
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MU9@&D8*6(0$[L0H+$#<@ D^,.4NX,TZ)T-VJV)JA3['.I\&ZN!B*:I+M@P;
M,$:S&L"H^A3Q^")*#B<H0W*5/8@3HLMQA,=]MQ06:YL-4$\)M)"MAJPD3OK
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M.,ZA0%-=0-VH*#I'(MTV(A49)65(G%@OVBLCNB(0^S,RJ-R0,L-B 0BP9HA
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MD!+:I>T#IS#BE.,RX>F7VEJ4I#B5;WO*BM6!<BO #*I24B*,&1&&S(YX[NI
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M,C!B9#KFH ]J9-F2FX<7349$F7)?2WIU]U2RQQIS*1HAD<R2%55>Y(552[[
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M0^IQ+J]*L]/ 817,,)@5558.VG9"H0441\> 5"JE0%V4@$;;#+>VG 1\$X
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MVE;KBE%CC3GPC1.XYDDXJJ]QV #.^P')R% +-N2  3L!@*HWV '([ML .1(
M)/YSL -SYV SG:MMJU89%NU9K!JURI,V9*L^C)'5ADRR3;S)&5(-?4_<GI,]
MF3(:FON25.RFY#R'U.)=7I5GIX#"*YAA,"JJK!VT[(5""BB/CP"H54J NRD
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MRF4*LJ]F5H6,L,L09E56+1&15[L7O 6:/E$S!E5B5;;(K!N6P8<6*GDK+N0
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M^^;KZC]RJOV%%W;H.P^[97]7C9=T"[8DDDT7Z_\ 5*JKJ&RJ*NV:%_I]!=2
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MK]Q%]1"5E 2:'G&[JZHQ*G*)*LG=V60=J1HVY1NG)E56)CY =Q"& #INK$$
MG;-O;X1;'.VS."IL?+M6R";+@7;(YU.BL\N<E!H$PE)DL=2>-MT=P<^Q"=:@
MSOO.F9D]Q@8UO9%Y$7<<ZI -,75>S>-=HHY1"*-HWN,C*@4T1'ZD."P++V]U
M0%S[!RRSU*>G%GC-P*JW'LR][9B!L8>/<W!/D<=P//T\Y"N;+)&,8SN%[<3K
M/1_#KY;T%&Y[^^G*B@VL<#[+SNV"52^XAA#? Z8BNV^OAB<X9>9 [C:I!*5T
M5 D'::L[S&LTZ_2?U&96/G?GNFI/3ZG6/23;^5WXWGU73[D$FVF22-JUDRUY
M9$5ZJMJ/%%I\Y8)_73V:B]F/FNAKJ\.I<:IE-:<%[,$J-M78FTY>-V4&,&QL
MO9Y,C]YI(_8O(=/6?H6;[&,8QC&,8QC)M\YV>^TKLM-MW,3=4 WFMJ/F@3]X
MD5]BJ%5#ZN;DD*B9;M2D5\E'O0EN?2V@)1:8]DE'V*_I2723>]:W6(*MG3K-
M>[%8EJS=J.5:HE,Z<YX@EB/L?:H:LA6R94!,*Q&78A",C6TBDKR1SJ[1/Q5N
MV&YKNZA77A[E,;;2<AY0+R_#+5_B0"^.IZ@ M=!K@CGO2;DYT>?V_F-9LDFR
M5FMV47TJQ!JY8Q[<\B9)4R9T&NQ&K*1YY/+255Q*X4X;&' CPF&WH>CGU'T,
ML%N:2W3K"FFFW9H5@FFA>E#)- W!8TLK4E8PI<2-1,>2LSRQ2-D+238[+1RN
MTL48A%>9T".R-"C,A( $@B8\1* .?D$EE8YUSYV&;;&,8QC&,8QC&,8QC&,8
MQC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC.S^
MH7MBI\-$Q[%:.1D)A'DM@^912'5^T2+9,JTZH6FIL0JM4XM2F\LIEE)5,M8X
ML]:+'(T\:EQ3DR"P2AS 17RJZR^']GK#X]:Q:Z;Z4^,.FT=.^,/3?;Z^T[X1
M? VKTA3ZLT[K/I'K">]U9U?<ZPH?%SK?I?3.L=%Z9LT%/3-8Q:)2N:#2OV-+
MN4M?TCNZ]P5]+C6:;3W9]-F'I9+^IM.T#U;%=5KUUKM0K3O7DF#[3,#*R2LJ
MR(\4G7P75N]';E8A[8@!#B1I!]L46L4%J7]L:GCA<46.EE%P)%LL3;4V,_):
MA1E%BK<8L;^A0S'F?)]&M'4=!:!T5TWJ,FL=0W;EJMT[)JVD=-:A-4^:RZ?J
M6K6]6U*GI2:A7Z1Z;DFHVH:TU^TND:3+:TC0_F$D]FEW^.D_G<MF9.W"JJTP
MCDG0-VPZ(L:-(4:Q, ZDA%[D@627@ K;78]%NQW.96(M*CT"?=;8:Y\Y=2,7
MT1S_ *H6$)IPPJ%"BZ;S^HB8!RH"V&"2H$N39I1#8 3&@U)I_3KVG9?PO^35
M#8B^*G3FCT[7Q"T[H;I#0OB-%T/I=O\ )J^)'PDTC67ZTU71];UW5NM?B/UI
MJVH:#UIK$]C2TU&I6Z6JZ:.H]8M:EUC-!V83#4ZG6BIH32,M-[5B6D;4BZU3
MU"2(5HY8HHZM*M&DU:("3@3.TG8B5*X.YW;KOSTCSC,8QC&,8QC&,8QC&,8Q
MC&,8QFT4FYV?G5OK5\I99T';*@:'V&O%V68LE8\L+DMRX<C<2>Q*@3&D/-IT
M_"GQ94&8SMR-,C2(SKK*\%FM!<KS5;,8EKV(WAFC)8!XY%*L.2E64['PRLK*
M=F5@P!%DD:2QO%(H:.12CJ=_*L-B-QL1_<000?((/G,G:.D6FV#F I!P,. Q
MBDDVV J]9KE0"+,RV$17BLD96!8F)-GIC(W&AR)K<A0R(Z_!%_10GW8ZK(*<
M$#F5!(\K(L7=GFFL2B)26$:O/)(RIR/)@I'-@&DY, 1:D*(2PY,Q 7D[L[<1
MYXAG)(&_D@?4^6W/G-$R5F7&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,
M8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,
M8QC&,8QC&,8QC&,8QC&,8QC&,8QC//;KFVT,[<7MIM;CC;6UJVVAQW3:75H1
MO?PI6XEII+BM:UM>FF]*WO2$_E38;D[#<[ G\3MOMN?[MSM_B<;?C^)SPRN,
M8QC&,8QC&,8QGFXZX\XMUYQ;KKJE+<=<6I;CBU;_ #4M:U;VI:E;WO:E*WO>
M][_/>_SP  -@-@/H!X&-MO \#/#&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8
MQC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,[-*?:6"/FPC58O6>
MFDTA>(VR;(K*S/)*]S^(Q)B6Y3X944I]9T$F@,>^2%7%::2:*$BM<2):A5LM
M +P_+3K/I*QIOY3^G=76_A#\*],?6_CMT?1K=4QZ'\8NI/B-;GJV^CEKZTES
M2O1?#O27UGIT3ZVMN69M!TC2])ZF?5YK_4VCZCHUWNJU@/H;UUU&]((M*L.T
M!ETV&FH9;.\160-;D[<VT?$?;2/)!VU6"1)5Z[:XV/2_.)32HL?(!0FC(D>7
M%32\.SDXA48VBN*CQ8<R*W]3$?F3G7#'TPEV*.D0GY*9$N*T[Z3]2R:BU>AI
ME'2-5U"OK]Z71-7U'1]6HZ/<Z6TJWI.J22=2K8M7*=N3TMRO2T^&/1?4ZO#;
MU*M>@K&M3MS0\7"$W=WDC0Q*)8TDC:19Y%D0"'9591R4LY,O&,JC*3R90;R>
MG[/5' %YK\>?PH9=YEWA$K=5*7Q;J]'OK)6+-*.3&BAWHJMC6M#91.2DBP)U
MHC/=>TIKXAGU:L^"_P E7I7JZ/J+H+J&UI_Q^U3H2CT'=TSHSJWKGXW_  AZ
M\^'MG2;='28Z,VDZ#\-!\TF;5*>EUGTRSK!?3:$$+K*4U5J:MU>O6*YAMPJ^
MDI:>TKV:]73-1JV^XKR%A++=^S 1G;F(O>Q(V^SY9U\YZ,9QV,8R]I+P^3<K
M0DG4NE"#UD+^3IOLJ+5"U>G5U<OE $C:(-P&#S+9$Y"?O-5B4VQ6*8&GMBA!
M*O0%+"6(B=>8 .\O'U,G>D2>E)%#'KR].M8CF28+?E2!J[O&4B<59VL0PK(G
M<D29OM84B!F&M741S8/$RHMX:>7#AMIF"%&*[*>VY=$##=@Q]R!06RCVA\_?
MTV]09F]37M1X>]1GM_5R-HC.:8C?ZG^W>VW,B.:::^->T2HROA^%]K:NFYK[
MO<OM&[>1[1Y&[>? W5O)_LG\QS8\AY\CQY/D>/K]?S?0_7\Q_-GEH82V0^TZ
M'SME?J/I/MFHC^R'U?Q?!]+]'\OZGZCX_P#4^3\OYGQ?ZOP_G_ACFG#N<UX<
M>7/D.'';?ERWVX[>=]]ML;C;EN-OKON-MOS[_3/'0^?MN:[J#,VT-4A!%S49
M[Y<!;KNV&T35_!\,53C^MLH2_MO:W=;;3K:];UCFNZCDN[[E!N-VV&YX^?=L
M/)VW\><;CP-Q[OIY'G\?'Y_'YL];D.6S'C2WHLAJ),V]J'*<8=1'E;C+2W(U
M&>4G3;^V%J2A[32E?*6I*5_#O>M94,I)4,"R[<E!!*[^1N/J-Q]-_K^&-P20
M"-QMN-_(W^FX_#?\,G:V<.>K7!^)]@;)&91?KO1>ST%RFRJRL>H2OE@?BQH6
M2$D=$YDFQL6R)V"/\O6PXC<)\4IF/]S;D(E:U<&IB;5-2TXI&J:?4TZUZA9N
M?<]=)J43QR)P40M VGMO]I)R$@)X$%<C)9#V;%?90L$5>7N!]^7?:PI5AL I
M0P'^LVX;\/ID)0PY<B7B !XLC..SR+ >"%API,DM,+2I*(487%',M+F2",B8
MXB(Q":97)=DK2PVVIU6D[V321I&TK.BQ*AD:1F41K&%Y%V<D*$"CD6)XA?).
MV2"RA2Y8!0I8L2.(4#<L3]-@/._TVSVN@3;)$B)<$$=$Q&YFBD!,-]R5 T/6
MIN<J6RVA2V&XBTJU(=<UIMK\OS6K6O\ '*"6,HCB1.$G'@W(<7YC=.)W\E@0
M5 \G\,!U(#<EV;;8[C8[C<;?XC\,V3F%0@] Z)2J(1.KK,>YV8-5D'TBEFVQ
M,L_/8%P)LL:U-@2'Q[,V5'415$>=F,0=2'X<(A)::@R,-ZPU2G9M)$)C6@DG
M,1D$7-8D,CJKE7 8JIX<@%+;!F0$L+)I#%%)*%Y]M&?CRX[A06(!((WV'C?Q
MO]2/KD[63RC8>=]]C\,Z=9(@!@V-^_T?I=8&[N]%Z'4"(^26J-[II",2$Z-4
MNX#8CJAQ:&X])@$=+#&1L E ,L"]9#KL5O2CJ=&%IC&_:LTIG]-:J6$<1V*M
ME&23M6:[L.<; *Z;21NZ/&SQTNK-5]3"A8J>,D+GMR1.#Q>.0$'BZ'Z@@ CW
M*2"N]7'X3J6G9T=F:Z)U-<A,$GX:H[3KJ4[>;9=VAR3&9FJC?"^Y#1+D*:2K
M>TN.MZTZK=AAN%)4/Q#% VY ^A(W )7?P&XC?\P/C)FXWVW'+;?;?SM]-_S[
M;^-]LX>T[U^?YZWKX=_#O\];U^6_\?\ #?\ \K?^&_\ #?\ C_AO_P"5EV5S
M(MAR[TIB R*).SI2''(T-N#*<E2&VMO)=<8CI:V\\AM4:0EQ3:%)1MA[2MZV
MTOX;#)&%+%T"KMR8L J[[;;DG8;\AMO]=Q^<9;R78GDNP^IW&P^GU/\ O'_:
M,X\6#-G/(C0H<J9(<=0PW'BQWI#SCSGQ?+90TRA;BG5_ OX&TIVM7PJ_+6_A
MW^5695')F50!N2Q &P^IW/C;^_*D@#<D ?G) &?C4.8^U*>8BR7F8+:79KK3
M#KC4-I;J&$.2G$)VF.VM]Q#*5N[0E3JT-ZWM:M:V+*"H+*"WA02 6(&Y"C\?
M W\?AYQN/ W'GZ>?K^/C\_C-QA4A^-,1'N[I.BL$*07N==DDZT9F+L"&ZZ0-
M52-"B1F4R$#[C*B18$&Q.)V(@PY[9Z4ZH2TIY4=[(*[U@EHI9CK2JDT:]K>9
M([#,Q)!>LK%VA'VC,O:4"0@9C,H(^SXR$2"-P'4<?>%<DGZF/?<K]21Q'NS3
M_H9WT>B/T<K[>J3]$F?].]]'N9IOYVXFI7P?(W)TU_M?D:7\WY?^O\'P_P".
M2.:\N')>87D5W'+COMRX[[\=_&^VV_C,FXWVW&^V^VXWV_/M^;^_/R9"F#Y+
MD.?$DP9;.TZ>BS&'8TEK:T)<3IQAY"'4;4A25I^).OS0I*M?GK>MX5E<!D96
M4_1E(8'8['8C<'8C;_' ((W!!'YP=Q_VC)WYOPYCH'&.^]@7;_LK?!!]&($J
MYNOK(OV5'0[5'I8%L8227AL0UQ3LEMPWN;&UJ('TJ:/^[3M:%;U=S4VJ:EI6
MGBOW/FC6D2;O<!":D!LRET[;%N40VBXM[I/:_;7[3(TUGM6*L'#D;1E ?EL$
M[2&1MQQ).ZCV[?5O!XCW9!*X$YN-J:Y#E-PU/)CIEKCO)C*?6PB4AG3ZD::V
M\N,XW)2WI?QJ86A[2=MJTK>TY*3Q#*6V)X[C?8'B3M]=@W@G\_CZY)W&^VXW
M^NV_GZ[?3_$;?X^,2(,Z(W%>EPY45F<S]3"=D1WF6YD?XU-_/BK<0E,AGYB%
MM_-9VM'QI4GXOB3O6@96+!65BIV8 @E3MOLP'T.QWV/G; (.X!!(\'8[[?X_
MFSBY=E<G3NG&F^0%J9$&FB5I$6SD?'.FJ-2Z]H"@?,ZSST/?=5IQE@J<C;>"
MI*.C6I>R6G"[<!9/4* EY4*-J]+U'YA'99XT@DKZAJ-(1K-W2ZT+<E7O F.(
M[2\ Y7@1&6"<WVY&-6L=]9"RJC)//#Q#\MQ!*T?/RJGW<=]MO;OMN=MSJW*^
M4VGK72N<\P 1E13/3+*&KH&819?9@)26))'.%W'/@^)\8,UJ3)FNQ=.JTU#D
MH;2MY'R]R+UZ"A2N79FWBI0R32JI!;[-.8C'G8._M50VWEEWV!WR^:=((99F
M.ZPHSL!Y/@;A?_6;P!O^)&8.SB06C!=5 W;S-2%QA2E%;/7H80PR\\/AH).%
MQ@4Q91@F,H]LA&%:V<EJD#T0W'UMS'7XS.2"27MQ^K]/'8=I/LX)6EC(#MP$
M;R1PO(PBX&3[)=GY  J 3<C-Q7N]M7;E[4<LO@G;BS*A;V[<O:-CN/IL3K"8
MDI;#DI$:0N*SM.G9*67%,-;4I*$Z<>TG;:-J6M*$Z4K7YJ4E.O\ '>M;S\EW
M"[CD?H-QN?Q\#Z_3SE^XWVW&_P";?S_V8E0Y<%WY$V+(AO\ RV7ODRF'8[OR
MI#2'V'?ENI0OY;[+B'F5_E\+C2T.(VI"M;V5E8;JP8;D;J01N#L1N/Q!!!_,
M1M@$$;@@C\X\C/)<&:AB-*7#E(C3=OZAR%QW4L2]QE:1)U&=VC3;^XZU:2_\
MI2_E*WI+GP[WK64Y*2R\EW7;D-QNO+Z<A]1O^&_U_#&XW(W&XVW&_D;_ $W_
M #;_ (?GSP1%DNN-M-1GW'774L--(9<6XX\I6TI9;0E.U+=4K6TI;3K:]JUO
M6M?GK*E@-R2  -R21X'YS_=C<#ZD>/KY^F>Y0T@B3'A*@34S)B8JHD145_4F
M4F<E"X2H[&T:=?3,0ZVJ+MI"M2$N(4U\>EIWNG--BW)>*\N3<ALO'?EN=]AQ
MV/+?Z;'?'(;$[C8;[G<;#;Z[G^[\<_61A*3*W"CCYS\Q+^XJHC,20[*3)UIY
M6XVV$-J=T_I,=_>V=H^9K3#V_A_)M?PBZ <BRA=N7(L -O'G<G;;R//T\C\^
M"P W) &V^Y(VV\>?\/(_[1GJ;A3'8LB<U$DN0HBV6I4QMAU<6,Y)^/4=N1(2
MC;3*W]MN:90XM*G?@7\&E?"K\A90P4LH9MRJDCDP'U('U.VXWV^F_G&XW W&
MY^@W\G;\PSVZ%DMN0&=#IVWBB6UC&M1)&W"*77E1VE0$?+^*8EV0A;#>X^G-
M+>0II.]K3M.G--F/-=DW#GD-DV&YY'?V[ @G?;8><<AY.XV'@G<>-OS_ )O]
M^<5UIUAUQEYMQEYEQ;3K3J%-NM.MJVAQMQM>M*0XA6MI6A6M*2K6];UK>MZR
MH((!!!!&X(\@@_0@_B#E<]>5QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8Q
MC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QEN.S^9A7$:!7IUKO4MGJA2((,R:7NL
M.)K4D39*)Q[H8F&!MNB6Y,XV-K?7A<HPN2 B@9KPXY'!&)K L<0LN@T[6GU.
MW,D%531C9XQ9[X[PDAM:C3D:6OPV6-Y]/D6,+*TJJ\32QJ9'2&#7N-8E=4B'
M94LO<Y^\,DD\1+)ML%+P,!LQ8;KR7=F"5'S?Y.QC&,8QC&,8R7N)<@+]KN4V
MKC)FAL4#2;_T>RDDPW2<J#3^:5 Q=K.\,$,.,O%S+@D+(BAQWU$*)()2(NRA
M0,(00,0-?J6H1Z;66=UYM+9J4X4Y!%>Q=L1UH \AW$<8DE#2/LS+&&X)))PC
M?!8G%>,.1N6DBB0;[ O-(L:<F/W5Y,"QV)VWXAFV4^OMU$J?-^D66GTRW3+D
M&"%C8OZXH$U7S(^8%L1D#)%&![4\I!5,:V*3-:F#2$B'.'SX,KX(,EV2,A-,
MM3W:4%FQ76M)+'%)Q27NQNLL,<JO&_%&XGN<2KHK*Z,/<H5V5I7FB222,1LR
MJVP;DI#(K!E.P.WNV((W# CR-F,2YL,SXQC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC-GIHNLF;*-&W&T/
M4NMR/J]DK*P!D6=X8EB!*D1OE@HDT?(GJF36HT#26YC'R/JOJ5J4AE2%<KUO
MJO5.B=,:GJ?1?2</7'4];T8TOI>QU!6Z5AU1I]0J5K0EU^W1U*OIRTZ,UG4"
M\E*?O^D]*BJ\ZR)GK1P2SHEFP:L#<N<XA,YCV1BNT2LA?DP5/##;ER^@VSL#
ML<KEP'EJ:?4CE0D3%\5-%1VB/CX(.O5QAN0#S+EOC=2G&2MT$I(?+=>638D2
M(HZ%"EOZ;9KK3VV?.OIFK\5]?^*YZTZPT#K"O37XXZ)I.IMIOY:/4&I=!]%7
M8M0Z?EBZ,L?";3]#T?H;6'TX/% FE6:U>YJ=Z]4B:2QU'- )NPG.GPT/3UYJ
MY;Y7+(@DZ<B2U95DF!LK?:62S'S\GF"RQJK'VP*>/6KGI]G$9V:^EQY&?R.X
M6/;$9U;5OJS!DFKQB(\^S9_W>09D:G?N(T4?/V=I^<.97)%EOJUSW9,8K.1]
M;$:DQ_+;\EW4M-H?&+HWIE9IX8YNB^K+&BZ6GY;VN?E&4M/&CPZ% :!^&L^E
MUNG>E)8*.I2I6U;1Q6CT^*M9TB@_H;DM>QW.NQNVGV)]MSZF 3.>F8]'8F0R
MGEZP2-+8!=!R1]^199&]P!'65GJ3G#8QC.P3T7Z(@S*)YUIW&^I#)4<?Y"J7
M!.S*"58X$--31/1[[<355?M-BI0:PRZ84BV4!LD.K)B0%.R1<R.7'R6&(:YO
M)Z/I#+:UBQJ-%U+]0V-5T[N3Q21%9*E6O%.((;,D2V$:&7@\\8DB#J8W!+<=
M74JD26WGA;S?DM5^3JRD-%$BOP21E$@*-L74,H((().TV7CV#5K7VZ^J-=LL
MEFH!ORQKG'';4_\ N-+ <2[69X?RJCW6Z0ZJ7"Q#(9Z[$J%9*A;+53Z^0.S
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M7E@H(>R_>JZI\6E!U(C:]D!LS6T$MB1[2S5&KI#/VZTAFBD%R'LQ/ZA5C):
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M=T">WH=$4DG=Z)!(0J_9Y\A;:B#Q%I1@Y.E(3-;A2B!PJ^Y$^&6IO4$Z?59
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MA)(2>XK$CW*-MCYREFL9WB/(*$692P^^.[&8PR'8@%-^8)_K ?3ZY/8CV:%
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MVGGKW7H-@=L(L?HKX^)N3[&<#P1ZV?(_E7H_!2U<^Z$TEQX=_MDBW+FC2LY
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M; CJ)9M%(3V4DF\[*C% SJO([G8[A1]YMOIN=LT,KRKHX@M< TJD6AR902)
M7<-PP)69&K\H8F6[+V4E1XBV83"(T&5-2_)6TTY 8<FI5N,A3FI27J<D=>1;
M, 6VB/7Y2HK2J_$+P4L"QY.J[+N0Y"_>.V95FB81L)$VE ,>[*"P.VW$$^3N
M0-A^/CZYS.0<>Z/WCH%?YARJK$;=<;).C0X(Z U_L(K<B7'AK*F9[GPP@@*
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M*%914DJU6$81C.%%JQ($Y1@31P.77CR786(I9)Z;($,4,LDLG)B#R[31QD*
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MU')#I=:!$K^^G6@LS0R$M$><4%DB5XUCS"*$\;12(L)D62[:8L2 EB562LB
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M;S4?69,M1Z>2B7JP3:B7#JKY>37T:ZD.EU9.'_B[4KNIV[1E!?4IIEU (J;
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MB>0J6).TXD0L %\+]"=LXO%N#%;U3NE]HL55O13C/&80>9<I=-C.02!XD8L
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M.6:"2&#AOR7OSM&D:'BP)&\JABI]IW'EE915J5SV_0C0FMS*-<(=AL R&;
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M<93M"M:R/>I1B-I+E5%EC$L3/8B42Q$ B2,LX#QD$$.NZD$;'SE3-"O$M+$
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M3U,';ED6&*3O1\)9F8HL4;<N+R,X*+&I+%@5 W&V7=R/96[B<78(K<EV9B2
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MRF.6:DX GW;BD:)$AD:3,=Z"W8]1&B1-')#%"C/*5(620K; 4(W%GA/B3=B
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MI_1'IZ[<%V.[#2ACN:[I]DFO(6:#2=,K0]BM7_F\?!FGK=C<<'[%RU+]D>,
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MFW&7T\-V\\90>IC9$:1&$IJ:,DD@>7CQ:Z]QT#$E0L"00PJ2!MR*)-,R[?:
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M$(#Q)JKV(05+Z^(4,*!"4 @33]UF@OB'PI<9J3-U][&$@WYQFW=?=1\T=_\
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M,P55!9F8@*J@;EF)V   W)/@#R<R$@ DG8#R2?  'U).69Z_Y\E\VK_F\0T
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M(R0^PP1V-D2=0GGFFI/REN(3N4EBO)+-#'/#)-7X=^))4>6#N M'WHU8O'S
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M#B<_@QW"/HR^-=%"\CZ;.,M7C;4R$""V&IEZ[3G%2X5+M>[[/=LDZ.5D1K;
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MI=-7=<F@^$M+J;2NIDT:OH-BWH,O3%E*6J79>N%G_P 7"GW]2:?Y6\@TR*Q
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MW8ZVZ2HLKZ<)3>4,\:JK51#+W0Y7CP/]V]$O59#&%F4F5I5C\,.30<N\-V4
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M46B;7&.I5U2A7CMVG8LL:59BRQ68Y&4)8KR,I1)J[2QL_L#<R 8QOTQW2;"
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M"[36Z=T^ZV2!8+W1Q6ZS!X^ 18+Z&M"G+ XJKW &Q)&0B%0L*!E@$S"T)PY
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MUM-ANU6I31BM)IT30!M,CBL=N*&:%N(KS,P@8+('E]Z/*CIV8++RPRUQ#/'
MLT9A8=MH%* UU20*J,AV[;$A".6[;D&9>M^\N'],YIVJM1>;=5!7;T%PSR#R
M>Z&W[)42E6JY/R\JCQ5EZP ;$#BQ:#8Q]%B/(9*V$<^B61D,*^E:C-R']9I_
M2NITKFFS-=HRUM(U3J"_6B$-A)YTUL6B$GE,CQQM"]I@3'"XXH#[B2!@@TVS
M#+7;O0M'5LWIXUX.'=;G</%VY%5*&0_=0@@#\^PUZV^ZN=V?TU[1[VBG72&-
M]9<)Z-R6%7%*!OSJ,4Z(*K0EPO*(:(LL6& %16&93<=J,&D%%$G8JE#=#T2B
M$BOTQ;@T7IS2O45V?0=4IWVF^U"VDJ/,XC5.!,32=\J26D"< WOY\4N3394I
MZ?5[D9-*S%.7]P$@B9VX@;'B6Y[;DL!QWV/+9<I(]W\BDD(=B30>D0["2_#>
M8\)VO2BM8(!D&X/+P'+!O0:]&TT-G:%L0 ;AZ:%)3E2R,LB@4Q,%,CMDB6)>
MEM05'A]73:)>L3U1!]G.DG;:])>>I*V[KS9I!$LB)QC5#(5D+\$H--G *&6$
MH-6.I+LKAMC.TYB;R1N2P0,!L .6S$[#BWKWU5K/:.0=6J,STORCK%;%\ACW
MJ+4>H@9O&Q=IXM2!U(K/0^><Q* ?D3I\W046>E4ZTDV*_$>>L874PA%L*IX^
M^KTI-!!J%"PFBWZ$SZ@:K6*,JZB\&I67LSU+=U)=U5>X\2V8$:9@(9>*M"$=
M%ICHD\#BI- YG,9>%A.R6)3*\,LH.X4<BO-!S/M;8%=C4[TKW"E=O[O^[(#F
MXFDC)@V@HM@BIBQ7/F+K:Z^!$0;W?&*Y6-3*_P _)]%.PR=A=#5Y1&"!E$M;
M3,,34RB$W>Z+IEG3-+]!+<DM.KVS ]AY+9K032R/5J&:;C-;CIQ,D(DFX/*J
M?=C7BBSJ=:2M6[#RM(0TI1G9I>VCNQCBY/[I%B4J@9]BVWT V [#XWXD/G.K
MV#DK]!XSTT-6./>[)/L.OAYABENS)X8A3:T'DT N79@Z-FC48E41D+]PK<:M
MUK/Q)T^R6(E-G1XE>WR1Z/UB>&^+6HTI)]1Z87I^:18[(1)$L32"U'&7[4<9
M2Q(WI:\5>O$RI##&B%I<U?RFTZ3B6>%GGTT4&8+( &#NPE52>*KM(3VD5$4@
M*@ );(VYS[_Y51A'#:F6YM<[;5>?3_<0.^:U-!5\X>H'MFLC*>9>IL[3YQJL
MW*AB [3\)Z8T3@6%PI/'NOA([*94R9<Z4OV9-3L1W:U>>VO3,M7VRS116^FI
MGL1BPNT1GK6I)-F"E'AX*X$I/%<LNES2-8=98T>5=-:/<,RK+ISM(O<^Z6CE
M9MCML5V!'(^!5GT?WGG/3^6^8.3<XK5V$BO.--Z73$G;L3!2B%JC7?L-QZ;"
M(;' H3484_&9M/TDJ-J;.;;<;^G:?E)8^X3-YH^EW*5[6[]R:M))K%BE8[59
M)52 U=.KTF3G*Q9PQ@Y \5W'D@<N"S*E:6&>Y/*\;&W)%)QC# (8X(X2-V/N
M!X;@[#\^PWV$M="]0\%Z71_*5./ .TP6?-_')W(3Z0!.K"V>I!RMP/7$I'=?
MU+=F5. 0=L,T)*;2JR.+'(9E(TW*UMO>OJ:)JM*SKUB*736;6=06_"94G<T9
M(Z\=>,\>/&PR")95)[(#[CR,PQ4K,4MV17KDVYQ.G)7)A98UC7QX#D!>0^Z-
M_&VV<<=ZSY8OQ\>\;VJL]"LU,CR1/2N96IR9"BV'G?>USS#=N-0H;E@FB9'+
M+)5Y T)*YXVQ%4LM]9<FBL*R:>F%+GT&\.H8NHH)ZD-@K)2NP!6:&YI06,UX
MF81*XO0SAY1<);9.-8QM![4J:,WKEOQO$DA!BF38E9:P"\%)X@B9'Y,)?/MV
MC*E/"R63]O>=I_KGAOM2'R+J03J%4MG)+MU6F0;94GN;3CG**^%$2-<[84!C
MGX,2]R*V)?<:.$=LTA,DMN)&M:78$:!"3IK6%T#4^FVU"C+1GKWZU&PU>P+B
MQ7YI)!ZLB4Q.U59I #$F]DB/DT!#L^$:=:%*SIYGA:"1)XX',;]X+.S$=T\R
MI,?,^57>38;E/)S!@O8_ G*WY_HU^YUTFT53CEK]E'BFQQ,2"DG=>H@P>'79
M&A[!=V+/9Y^2JX::<J!R;*K'1() F#/:0":E"[!EEZ>U43:M9JVZ<$^HU^G8
MDYI)*L7R221IAS,89#;CFD6*Q$BSTW5)8CW2KPW-0L\[4D4L*//'01>2LP7T
M;,7&_'<=U78*Z@/$0&7W;%=IZ'[^Y+=ZOT '!Y_?@,F]>%N.>/MN*<I$B *(
M<DO]<N+%QCCP,.ICDC2D.EAQR@0X:(8AOG"+T)N-$ 0H1S!4Z4U"M-4D:W4E
M6KU/J/4&VUD/(E^K-7-<O*UA^<;69'$KO(6$2!BS2L\=D6F3QO$S2Q,(M2GO
M_P#G 2)XW0QDL7)*F0GD2=PHWW+$K;+FWL'D74R'>>RG*]U-\=.Z1X?-T;G=
M-,<B+WRB=&\U\8*<]&]G?JG08J@JZI%16H)*9<E$E A)(U$HMXJYRNR='']%
M<Z?U"BFEZ=%-15UI]316;EB._'6M4]9U%+;::)ZA[OJ&,Q1:P02R+&UJI-%,
MIB$&:A/ *T"O"-HM162619UCDBN6!*U?N1'ES/,J$V#,%[D;J^ZY4_MWJOC(
MZF7CA(*X>AKD8Y=U7ODOD_<.>=-"4,5V6K]MGL$[*SW82/%FV+#(&V-)9>CM
M+FH'7FNE" 9I0D;,'&(V]TW0M1>S6U26OI%>.]1TI;^F6Z4MI].FTQ2D!TN1
MWB:$20\-XK*%ZLR))]HZ/&TVO3LM)'99*L:S0UA/6EA:0UWK@A/3$E2NZ;>V
M0;QN WD@J:G^8O3D#BE8[SR*_4Z5T#AOIFD!:;T^MB#3-<M PG3SZ+7SKH5.
M-2AI@>U9J#94K)PQA@9,#'(LF<+GZB;D,$86^UK16U*?2M0JV%J:GHMF6S2F
MDC,T#I8A,%RI8C5XW,%N'9&>-UDB*JZ<MBC3KE,V'K3Q2"*Q3D:2%V7FC+(O
M"6*105/"5/!*L&4@,-]MCNW O1'#O,-VA6:D5+H?2UV +U&A]$-W!5>H)1KF
M74>:V+F\X'0@H4G>X@VT#46B79';88.3&2\L0%"QP%?@.F9)*-JND:GK=9H+
M,]2D(I*-JG'7[MM#=HW(;B2VI98ZK/ Y@6$5XXE*+))(TLSB)4QV:MFY&4D>
M*'BT,D2IRE'>AF24/(S+$60\ G;51Q#,2[GCQE?GGO&D<]H]"XZU6+@<YYS/
MS?['XJ#L4B,#&VXU:?9$24.LENGA$&B(P)7Z3!^S:#U*-83<@Q.%%)[Y\3^I
MU1P4"WTO9MVK.HF>O%<N:ST[J4L(,KUXX.G6#PUUE[:22RV7[ADL-#&(UD1!
M%)V.4N"739)9)9R\:RS6Z%AE'(HJ4""B!N(+-(>7)RJA0RCBW#=O-_W7S=VN
MF@Z:?>-2"GX;M>\$H=5]AVRT3!] KM^5TY?Y$_CW DNUM@0FIZ3N0RU.=(;L
M+JHB(,J@Z7N":*0V*VR=8S=5$?:[E):DU44ON;<E$QD,_P!#Q"=H<N2AILP=
M6[D>PU9]3V]WT:)XNS]/J.?+G]#MMQ&^X]G6/='+^E5[TS7V*G?1"?0G%_'G
M)8\UUJO3=U1WRNW1HLDZ]$0:C:--W:-1(KT<>B4+57WS$AER89;&MOD:4.E[
MM*7193/5D.D:EU#?*[RKZ@:YZHK$&[1[7IC:(+<9.\(P0L9<A$&FS0M38R1-
MZ6>_/M[O?ZTRD)OM[>V9/)\\^(\+OXVSJGXC%"Z#9.]6@-6>I4DIV3UAYJ]*
M"2(,I76CU#1P("6!.#!!M3KC;ME(KLA$T!L*A3<4*0""6Y(HBV1DNB\%'H^U
M4ATJ"2:C9CT[0=9T:1)8YC%:.JRI+SDB &T"=E(Y8>9:1))")%**'LATJ2)*
MJ,\,BUZ5NHP96XR^I96Y,O\ 9 0*R<CR#'9AL-^8*_$JH\;M1WIIGF40V OG
M.N?4WT30T<PY:+H'KXE69]R+VRR]-YNTY+KG+KG:9YRL*#] H$PZ6J4^KDK
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MIS%^Q>E7W<2T\!KB*,[;@(A4ER-V<,>"A@%V7J'O[F'19'J5UJEWT2WZ1/\
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M-7!<  [7^JK\G7NC[,.SL0PC41A&?>4CM[H'4L.>X!W(^N:[?^57WF&JT[=
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M<C>SGA/UI66ICEBXK8@;HZJVN[D!Y4C6H)J!5*-2 '2+8;F@9)QLU%B Z1:
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MVO4]^-5),1B#[%2 0Z<GS"F45^^NSR/"HXOS,J EX^WQ[G-0-RO'?Z>/(R;
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MW'?Q4@3ZSD@O*W2O,+-?^\L&NQ)Z%R^_DMIB'^= +/7"E6Z^$'QV),SZ5?4
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M-6E;3TKZ?)9J/O EZL(S"MBN6FN&1%9$)8/&M:>85O3Q-P5Z-J)XD>1O5,T
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M"2D$"(,<6Q_RGT8_*NU::==9DLQ46@KV)0[5%E-GN!8N</9>)H9%D42)+X9
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M_/<Z34J4>G-JQG5M/6IZ[U,:O*C5#%WA,BQJSNK1$.O%22#X&9FL0K7-KF#
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MM%8.AKAU;T+R+LH>;&DP3(D'6N*<7/<*J%*+D)#XLD:,2JD8@D#=R;&PDRC
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MSV999GU-B=K,\D[K&C2-R*0H(XE\ <8XUV6-!M[44!5'M4  #+D$N_\ J6M
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M6E8ELQ-))$D8$L\:\9"_(0SRPDD%$XG[,'ZG?<GV_3)BOGCBHA3\J!3^JFS
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M&,1NB<26*]P%E8I[02&)V4P+YVX ?]$VBTU6L.E))NLT>==XE4JH6):NB7I
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M[L<O+R[B1G1H]99ND02X%J]:I[\XU8GK$-?GSS "&)K2T32+H74TM;M6ETZ
MTH1J%[2SJK1+:85HJP%=%+3FLSB2>:P%BA6&0(D<K23 J@EBPW)9! AA3OS5
MO4E1*1&L?L ]YC+<G=]E7B0 K%G\#EJC?GVU\Y]@U3SL<.U%%FC]?Y[4X%K<
M!MW:ASD6PO7Y51M;]9/#VTV.HF1AP,<DU\\(2Y.#3'!AD/IY4H?F<ZM!<Z>G
MU>**QV#I]N=X!*:UI3!'*MB 31.>S8C>*2(312$+(H>.3;B^7^J2:@]I4?@8
M)7,?+MR#@K"1 ZD\'4JRAE;PPW4_0Y+U.\51.BD^<Z)=@%@K'W/O_?N T\0(
MYLZX-B=*Y$SS8DTL[J(9 ":U2;1^ZM?9;EUR&:?JVG&F(M9*Q6IOVK7V.I&I
MQW.&GR2PZ9I.DZK8DDNCFU+4#<0]HM'-)/:@]#,2LS1"?8EIXV*=S!)J!A$V
MT#,E:K6M2,THW,,YE'M]K%I$[+>'*A_Q=?'*'6?.0MSD-%[2N_RMTZTU[KTB
MQ28E/;EZHUXY5+J$!N@%5?JIE<R=;9?0^>;%$V&66(D.]UV;*B[;0?2"V)UA
M_F%K3?2KZB"73Q"&L<?55KPL,;4?V!"K M.V9$))9JLR*V_:[L@VV[\E?M#N
M(T 4&38R1S!SW5' [!!%+R!.Y[3@?U.<F/\ AJ9"N8/F)7LG-@W49%YJ-#L-
M%)V&G,E(A:U4X]:76ZYIN[O/$I%=)@V>?&6;K$YM&<OMHJ$ //*@BA"Q!X0Z
MG5Z\MV/3KDE%:MBU#:2&P49(+$4 [V]8!!,DIMQFLUQA5@L/*D<J+#)A^8@Q
MM,L$K0]MY5E59"I5)%3=_L_ 96,H,?>(B20L RA&X)WR;5J5S/T;:^@7'I]+
MNG#>B<0YQ%H-FXP_7#\VP]BYOU2[L#;<',W"-/JS@XIS$A7ESX:ST)<13-D&
M_>QI0>A-T6O6+-W1X*M:E9K:G4U.XUJ#4A-$D.G7*-8O7DCKE)P\=U)@K")@
MV\+]IT?"WGDFJ)%'#)'9BLS&5+'-0E>6&/>-ECV?DLP?8\-CNA*D$YBKIXY*
MU"=Z%JF[X-F]%\IP*\6[C6' <J*,%#)MTJ?-;A)IU@8($'[:OG'0+Q6J]9&9
M(&O;G-29A>MK-#X6UO9*W426$TB?TKK4UUIDTR;NJ9'=:UB[7%B$H@@]94JS
M2PE99N)"QS=MVV%T=]7%5^V1%=+"L_(%F(C>9!(FP"=V.-V3W-ML%?B3L)(G
M^!&E=DZIP^E]8F=4OW%&K=^OZMSGEQ4G<YLFJ= &T^3&YG3SEFKI/IJX@2>[
M<K%' K;*!!@LHW$&'(T7[HN$O5>VG4-3LT%HU-2-?TD]R\B5E6Q4>RK7;$4$
MR4@TBBM"91PE=T+/$3PS$-3_ )O#9DA$,5@IVWEF41@/$9 9G5&$.[#MH6!#
M,5W*[[95#D_%RO6+W9*D,,1!HJE4_I/1;?:)D*=MH51.55DQ;;.5C!741"4T
MK*&AE00 %[0]Z<>(C!I&6'C.S",'?7]2CH58;$D;/)9L4Z=>!63=[5Z:.O!&
MT@+(L:O(&FE7F$B1W19"%1IL]@01HY4LTDD42("/,DSJB MY 4,V[,-]E!(#
M'8&=JKXV1;ZW7^@P.I#X7-[1QON75Q!LG4R*;$V1\\N1_P!P^?E:P-*%(L(^
MF!.%'01*/8R (D%-B5/SH!A1(,+U<_41KS2U'HLUR#4=,H21)80PE-7!]';C
MG>-&:(NLD4J-"DJ2Q2;*T?"1XSW^V[Q& F5+%>!E5QQVM?T4JNP7==^2L"H9
M61O!7BS0?W;D$3CUAJ$,1:7;C6>@<QHW5:F;F /TL86!NXQ4MJ >KJ#-CBB3
M0DA&(#9C$"Q'(#^HK4V(1=:E)0UM-+U!M0AL-) *\U6[:HSQ++WX^[6?B7BF
M[<+21R*4=2\,3CD59 5W,FM.9T<LG;>*:2%U#<UY1ML2K<5+*1L1NJGSL1XR
M8+AXY+U2?WVH;O(Z7TSS!6:];NS5-T))ABQX>=9Z92;@FHV5!":[:"7-[;T"
MM";-#E :^W/9T<)U>4>@BF72.NK]0I872K'I76EK<TU?3K E5I&D6"S9KFQ!
MP40)<KU)I(6668H>U'.L3R$)'COJXJR=LB&X[I7?D"Q8)))'W$V' 3)$[(0S
M;>T.%+;"/_37#*WYWZ&6Y; ZG#Z5;JD>LM<O*!=0.5L0"(!9[3 W[:1-O[=/
MM%X3JI+ZVX,#0N6P_"W]<S]//D2]%U.;5ZD=YZ+4J]B*":J7L1322K(A,G-(
MAM$8V'$;LW<4AO8=U&6G9>U$LQA,*2*CQ\G5V8,/.X7PO$^!Y.X._CR!O;?G
M1VF\QIGH 5=4GD"NW\NY\6'*I1.#6WBEXK=BOU>*4FUEWEQ+\+%MT6PURY)?
MKP..+L<5F.*W:0,Z.;=BG6%L7K.D25^T9-,NVT<68WF$=::&I,EF",;U7<VH
M9J^TTI>%B9!!*C1#%ZON2R5C'PWK32JW<4OM&ZQ,)$7S$Q,BM'[F)4GEP8%<
MM/W7Q=KN_IKT9,XAT,#-/M^\KYQV]T2PUF73(?.$]!OG5R]5N(<K#F'6+9SP
M6,H5JBV-R )"V4#+$L,0JB5'D1I!_1Z7U'\KT31EU.I,(CTM5U&K:AF%EKAJ
M5**3UY$98F@N2/:@:$/))!*LC%[$;HZ"'6U#TU2H+$+\?EL5B.17$AE[4<"O
M&P(4I*6E3CN61@Q)=2",K3S3QVWV&-0;!S_I295-NW4+=QR45/U!88Y6;P H
MDGHH!9*O1;,8CRJQ=*]%F:%&(!YXE (!S\4L BHB"7SNYN]1?+C:BMT^-BM1
MK:BL<5CN135IK:TY0DS0QE9ZTS+W(VB".DD+1RL6D$,N:^8#(DL.TD<,<X"R
M<E>-Y1$_%BBD/&Q&ZE0"&4AO)XY/D?D&J7:!SVR7#J92O5;H/GGT_P!L86#I
M#9DX&(^;Z_=B)&NR(4JS#X,^(4DTZ3.C$62$5V6.TW 5&%SIOU0ZR_U!8K/;
MAKT4EGJ:OHFFD2VNW%)'K,U9$F5EA=E9!8560H0K[ORD5>+TGOO&94CA#/':
MIU_=)Q5A;>,!P0C$$"3;;8['SN0-C2 HR/CDR+ B;()"F9TMD81EP4C)4\>W
M(<1"FR1J)A! ^1*C);?>@IGSDQ''%1TS).F]/+Z9"Y1#(H20JI=%;FJ.0.2J
MY5.84[@-P7D!OQ7?8;%=R 6 #$#D >0!V\@'8;@'QOL-_KL,X.797&,8QC&,
M8QC&,9DPQ%L06'%'1@PT@?+9E[%&6I#XF?MA>G$QB+$25"??B.*3K3[")36G
MD?FTYO;:UI59(ADC>,.\?-2O<C($B;C;DA96 8?@>)V/D>=LHPY*0"5W&W)=
MMQ_>-P1O^8[>,[3QH7FG9.C>5:]>*#SD5UBK>>_175NYAJ%1JES6M6M[F-!Z
MYV_B-,N=,YX(K-28MQFK4D!"N+@,./)DJW;J^+/R-W"$81#X=Y;FG4]<EK6K
M;T)]7T>AIDEJS/<F@%ZUI^F:E9K6+<DU@UXY[,KUQ+*R)/7F>("N\9;2EIJ\
M5UHY)3"]JI!6,LLDKIWI8*UB1))6>3MJ\CLG)B Z.RC@5)KAU,=5]^>O*?=Y
M5/IKMQMUJ]$\\N00>#CT^NVD=RZ5S0Q3[.3!4)54CQR.]=7*5Z1,$:%[*QJ4
M+20W+D-$'I>WHO/\VUW2UL6!7KP:1<K2O*;,T#WENQV(4EMBP2G\P28+)W.#
M69"O$%0LN$OZJ[6$D@C1*LL;%N;(TW>61%:3F=OL ^S;[&4[;#;+.7/EG&A'
MXEOK'F<VL :5S&L/]_#U0JBJ0C?-^'28%;(P*?T&XU-UE^).HM1*.0D$&$0B
MQ1,R= F@P=GM#0H 6TM>]J+]&:#=6:6S=F729)X^^T=S4P\J-8J5Y]PRVK"<
MBAY1IQ5EDEAA,DJ0XY[#:31F#M),_I6=>966P&<&2*-]QM)(-]B2J[ AF1=W
M6H7M&B_MQVMNI;K%=!.#^:<C<?/4O8']!]2?F<YKLI[L-!35MZKB:9TEQW=C
M ."VH+DN')3.-AZ_991H ,Z#IRR+>FF<3S2AKNH 16>[ZJB%N3*-.M]_[;U-
M(#LRB0MQ9>$<DT*QS/.T^7NU^8=F!FG'&3EW(=I6'8DY^_N0_<8'< C969>+
M&IN;[)V,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8Q
MC&,8S+@1X\H7@CRIV#61\EU2)1TE%*SH0YM+:UZ>?B X!,J^E:TI92B' D.?
M&XE2TI:TXXC3]0:CJ.DZ-?U'2= O=4:C5B5ZN@:9;TFC>U*0RQH8:]O7=0TO
M28&1&:9FNWZT92)E1FE:.-\D2))(J22I C'9I761D0;$[E8DDD/YO:C'<_FW
M(OH$NSCGG)8 =U/GPI\E0[ ]:*D*I_=9%QN3==J]AK5;KENL345_FK,2JCON
M!0$'B%0U9:+S6;D:%EK K3DGSZU[H6-/RF(^H=1^$WQ'U>'3.O\ IR'I3K+5
MNL_@!!T3T2_4?573G4_4_4G1W34MVO\ %":YU;J/R[2>H-:NZ-KG5,NC4)NB
MM"U71^FU*5NNBM[Z*84OTHV>I.9ZT=;5C:L]FO-!##8G"-1"P1\Y(HDDB@$C
M"S*DDWEJ%BT@=LFOO;I=N0D0M5>T+8AO,NGOKQ^FVC6Y<AA; C8O952WX.I$
MQ,](]"8ZHZY*V_0756Z@$^B?(XM'DK-K"+U&=5GNPSQ=/_+]1,DNB+3KSQSZ
MP-5&DJD%]JU)M/?49&L+9CK1R\C'V=I>Z9 W;^Q[84@S<TV$O(@B/M]P[IR;
MF$&W$L1V)>H*Y;8O+M'; '[X,1%CURK07.D<XY)1*DR+EFI=GE0AK%.^G.,&
M3AYYVQ%E/"1\^R36%%;8_(GCH;;?FS^2EU+T=;^*S:!TWK7Y/6J/<GZEZNU&
M+X9?$[XP?$'K&?5:NBT>EJE_4Y^M1/H<^B:%T_%!TUI*0:QJ.G],49X](Z1@
MK:=J-Z67L]>@L+0[TT6KQ@"&!#>HZ=4KJC2O.R)Z4B42RS$S2[QHTS@R6"SH
MNW6MGI]G$8QC)>&=KMXGBUHX)%BUU5 N%UK71#B7PZ73K]PIXRPA*R78.;?U
M+B?: ]LLPUF!'^6-D,&YKDV'*E:CR&->^FUY-2@U5FF]57K34XMI"(A7L/#+
M-&8MN+=R2O Y8[N#$H5@NX. UXVL)9)?NI&\2^[VB-V1G7C]#R:-"3]?:-B!
MN#N==]3=+J\.A01L6HJ8YOR7J_$JQJ6!5(6USSMK5U8Z6+FN;FI5-EV%CI/0
M&4%7-Z(B6[;/T&D#]P &P\:;0Z4[6V=K -V_0U*?C* #;TPUC2=1P(5832J$
MH/9(:Z=T/RE[F-Z<+F0L9/M9X;+[/M]K7[?:8>/ 7LQ>W[IX#D#NV^O=%] 7
MGJE8J==ND"DD9]1J]8I,:\M4L#%Z&7J-'&QPE) V"VL14SR;%5 PA]?&SMZ9
M,2 0P4),$B<$6/9C9J>DU:,]B:L]E%L3SV6JFS*U2.Q:<RV98JY;BC3RL\KK
MYC$KR21HC2.6NBJQP.[QF0!W>0Q=QC$LDA+2,B;[*78EB/N\BS  L2=GX[ZP
MZOPX331-*12WT\Z[(-[US^=9Z6#LQ*F]*@L5V'*,A))1AY+;)J'4:O&*PI;4
MMGX@(V<,T-*1]3MX=0T&AJ<EB2SZD&YISZ5;6"S+ EFDYF98I1&1N8FL3F-E
M*G[:17YH>.63TH++2-)W!W:YK2A)&19(26(5@/Q4N^Q&Q]Q!W!VS\K/JSIU0
MUS?0.)3HVN3JZ;ND)57=.-C4]?B2(%[;>:5,^5.:)PI3L:(W+0ZD0WM*A6HC
MB$N:I/H5*QZWNM8/K_1>JVEVY_+R&JD'CNI1E!8@^_\ K\AXRKTH7[O(R'O]
MKN>_[W8(,?X>""!N1L3^.^9X)[1[*"K-7K;$?G9!VE\UZ)QBM6@YSNLF[F/Y
M%TX%;:_8^<+LA*'(G3ZU&@7BSIK^B6YA0"V3?'#B;052A:L<O3FG2S3S$W%%
MF[3U&:"*Y/%6?4*,M>6&YV8V55F9JL'>X<4E,8=D,OVF6-I]=F=OM1W)HK#H
MLKJAGA9'27B" '+1H6VV5B.17EYS E/5G33D_F!XT-YZ3N'*(]"A@[W)H8)-
MV-0.611X_F\*W6*.RQ,L#=/&" XF'(?VU/+B0XD;:)AZ&.B,LY$T*E$MV**2
MY'7O&TTE5;4OIHGO,SW&KPDE8C8>221@-TCDDD>!86=B;Q2A43*IE6.8R%HQ
M(W;4S;F4QJ=PO<)9B!X5F8H%).:M7/0?3*;U&U]@IY.'6+I=!E^%'7Q<%"AS
M['2P)4#:W61T]<YAF2]]YE&Q;J?ST!L;(TR%1!DB1OTN>;2:5BC7T^Q&T]:L
M]1XE=MG!I2QRP N@0E1VUB<?^=A+QR<ED?E>]6&2%()%+QQF)E#'SO"RLFY&
MVX]H5A_60E6W#'?+C?4'8!UUX!T!9R$2LGF.#5(/('R@J+)B@M42Q2K13)9&
M&C3+%@G5PFZ/9@OF4S-/A:[6JZ11. A8H[5CZ)I[UM6J"-DAUI[#Z@(W96E]
M5"L%E4;R8EF0.6$?':6::9"LLC/EK4ZYCM1<2J7"YL!6(+]Q DFQ\\ Z@[\=
MO<S.-F8G,$#[K<ZQ5[A4*W$KH4-=;[0NEDDQA;LF3"MO,E6)5)F"9)*;.<B1
M@WZOM2=P7?J8L])V3HDW+W#$;'9)=+K3S5[$S3225JENDA+@!J]WL^I60(J\
MC)Z> \AL4,2\./)^=S5HW>.1R[-'%+"N[; I-Q[@(  );@GGP1Q&VV[;R04]
MC=3-RNNJ, .4E@_:+E$Z5:JF4YI7"=6']-A*/.1^AU<5/8D[!V=:K18FYZFY
M#P@S +.!38DB"@B1@^&G3M&)=/$<M^.33J[4H+"79DG>DW:WJ3R*1W(?L(2G
M@21-&)(I$E:1WQ"A"O8XO.&KQF%'$S!S">&\3L-N2^Q2-_<I')6#$DQU/[M;
MB@GE 0B)ITX;QN&8%U&)+KK4B,\&L=A.6JR!C\1U]<,R/.G[*<GRT2(Z7XNI
MZH8F0-'QX<6/,72ZZ27Y4DL(^HM&]AEEXD20Q100R1,%#1O%%#$JD'8\.3AW
M+,<HK1J9V5I ;!4R$.=^2(B(RGZJ55% V_-N=R2<P=_Z[=>BG*J<,S]0G*%5
MJU2:'#$+FL1Z=5*AMU=<#!I<V;/-*:%R)$F6Q-)EB)3<F0XXY.7I+26\M33Z
MU.*>*-.0M3S6;32<2;$]C8322*JK&"X55*QQI'Q  0>=[HH(X5=5&_<=Y)"V
MV[N_WV8 !?.P&P4+L/IDBW/U'>[]T9GK%DJW*G;VHC,L1@V+YT" .V>[D?R6
M0OUA0"0.1+M4N5I153T;4,2P>>DV*&(C'I,@BY#K:'5JTS0AFO"KP6&.)[DL
MH@K)]RI"92Y6!5^SV;E(8@(6D,2J@PQTHHHNRCS]O;@JM,[A(Q](EY;[)M[?
M.[<0%+<0!DU<4];N+O(ZP]QEU\LBE^6NW>?ZH6)5@H9+V2-?.0WCG=%"] )B
MWMFK&!KY&W,LOEI\MPX I430*M.*A!JX!B:W4M 'I7ATQ98S9US3-6GC2=(X
MX35U"K<M2U(W':AEF2N2(U412V6[LP#232M@L4?LRM8,I>[7M.H<*JF.>.65
MHU8<49A&2 %XO*2S^7=S"];]5=/JZ3(B-&IA:@&Z!$Y=*Y58ZO&L'.&:2+MD
MF^A1X\,4=>(020>]32%RA6IDLBWNV(L<(DCLYP^<21V4VA4I^W(6LQVH[;7A
M>AG,5PV7KK4E=I$ 1DDJJE=H#'Z<0QQ(D2"&+AG:E"_%CW%E64S"97*S&1D$
M3%F'@JT8$93CVPBJ%4<5V]#OJ3IDWEBN/FAO-+'4X1FSFJ@[8.5T(F:YJ]=G
M6W[@/YJ2=!:W3@1^2TU.< C&$B Y5'WNM1 AI;A%=1H=);PU"-[L,[1PQ6!%
M>M)%=%8%:[W4[I]1+$I*B5SW)$^SF:6,!!7T4(F[ZF97*HLG&:0+,(QLAF'+
M[1E'MY-[BOM8LOC-%ZMV"U]E)5LU<HU=^\UNDTJA)+!0,(-/-A^?U(%1*O)L
M3T36ON96!4JR #;E_"RVZT-3+5'^XS24R;*H:?!IR31UVF[<UFS:[<LK2+%)
M;L2VIUA#?<C:Q-++Q\D%^/+@L:IE@@2NK+&6XM))+Q9BP5I9&E<+O]%+NS;>
M=M]M]@ )"E>L.LRR0@F\JI_.A\2#^=["TU5AS+'0^2 *M7:4&K%_2UI#AQ0J
MLT^HP1)9AT>7"SZP$LP:</ML)![<1=!H*DB#O[-J<FKPDSN33U":::Q)-4WW
M$0>:Q8>2,AXY%GEAD5Z[=K,(I0 ,!S\V&MK[R3%.[M(SQ?V>3NY9?*L'9&!0
M\<B>_=)M'1WJSJP/QFQ=(JL&C4BOC(^X@.HU ?/*%V 0:,MQ]_3+QLX</$IT
M^5.+&CYLP=,D"!8E,F/3ZM.&F)NT&+V9VLV97/*6Q8=(XS+(=@-Q%%%$BHJ1
MQQ1QQ1HD:*HSQ0I%SX[\I',DCL=V=R O)CX^BJJ@  *JJJ@  98*U^X^[W")
M:/N4BCQ+'>A?/Q]ZOP:@5H5?[C.Y@6$FJ;:#=GB0T3-W ?/!BWY5E'I@$B\F
M+HB6=FEG7R#FHK],:77: H+30U9+;U:DEJ:2I72[')'9@B@9BOIG65P('YI&
MIX1A8P$$5--K)P $G"-I3'$97,48F!61%0G;ML&8!#NJ@D* NP&%(^O.FD>K
M.]HU7^6"[].A7EDZ1K_-Z_7HUF)],KI2JWZQ'H(5J"Q*,68&;,QWVV-10HN6
M5(%Z^'$&);Y!>5.GZ24!IO>O255:L8DFN2S-#'2F2>K#$TA8K'#)'&03RED5
M$CFDDC4*+Q1A$(K\IFB4Q%5>5FXB%Q)$BEM_:C*OUW9@H5V91MFL#_2W3PUC
M\_6P')"!COF49!"\JF00[2D0A$&^67I>AIZ)-=EQ+)#FW.Z7$F38+,/H)1;,
M2!S-/ $#Q<',^C4I(=6@E$DD6M2-+>5I#[I&JPTN<+*%:%DKUJZ1F,@HT*2K
MM*7=KC4A9+2,&9;C%IP6/EC&D.ZD;%"(XXPI4@J4##9MV/JJ7H_HU6JE\I,E
MNI7>M="M$*_&!O1ZB%NZ(/11S)6+$OX-9N.^X-LJH9LI")J^)X18X4E$2S"3
M,>'!;BUL:/3GGJV5-BK-4@:K&].Q)6+4W,9:I+VB.</*)&3Z20LI:"2,LY:K
MU(GDCD'.-XD,2M$[1[Q'8F)N)\INH*_1D(W1EW.^IW'K%EO%,YQ13<4&D/RH
M47"4]Z /<B$8HP_9#-P-1ILE,I;9#1"T6 L96[(84]%=E:A0'(@IB/ :D5Z$
M-:S<M1M+W+SQR6 SAD+PPQUXRJ\04X011Q[ [,%Y,&<EC?' D<DLJEN4[*TF
M[;@E46-2!^&R(J^/K]3N3OFS5+T+?*=0:MSB!$J<^OTGK4GM=2>-5N(0,@+R
M1@4D<9?'%]K:EM##D?G%&T5&J4MI_P#3L=MI3$>:68(8+&D5;%J>X[3K+9T\
M:;8$<S+%+51[+QAX_*EXC<M=M]MQWFW!*QE+'JQ22O,2X:2 5Y KD*\0:1E#
M+]-U,LFQ_P#3/X@;;T)]G=MKY:*=K\RKAR\7M5E[\F9'J\"6F1T2YBM@+>X0
M@%=D19*LV8 MX&9IQ"#)K,L5)F0_MB6YDK3L63IS3)HS%,L\D9TV'2N)G==J
ME:3NUPC1\'2:&4"6.PC+,KJK<]U7;$VGUV!5A(P-=*VQ=AM%&>2 $;$,C^]9
M 0X8 \O R [U='[V?=.NUVGU1O;6F(H&BUN#6 $!G3STE26(432Y$AU<B2^X
MJ83F$)VFE,P6Y2!T(?#B;6K6%6(1":Q.=]VEM3//*YV"[EF\#95 XHJ*2"Q!
M=G9I448B7CSD?\2TCEV/@#ZGP/ 'T !/D^229V9]@=8AHC0AT6FBP$,+W(-%
MJL&ON-UJ&KTI71]1[>3&C7"+OV:7>ZP+A!G(05X< K49A+],"UR=^<O-8>GZ
M#;L[69)6ETR5IWF!F;Y-,]C3(W<(.ZM6=VDY2AY9F.UF69?;D;T$!\DR,Q:L
MQ<ONY](YDK G;W")R6W;=GWVD9QXSAM^LNGIKFZE('4,C7M\@K_$?MI.H0IS
M6Z34KTWTNKI<4^ZIQ\F&O*73WU4A;L8PN2Z.L<(R';BCHUWR&EWO4![22_,)
M=3YI893ZFQ5-*?Z#Q')5VBXC9H^(>%HY-W-?0P\^8:4-WVL;B0C[1X^R_P#N
M:/V[#8KL&4JV['A]#]3=+ZBUVMNW1*?(7Z!Z> [)TM\?76Q+I+HU9@W2"&L4
M#0^4PR+<C_N/?YDB'$93 (SK:1D$HLSZ0*@5=4T.E2.FFNUA1I-&73J2M,9
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M3%#8D9(TBC)/;$2B.)%1$2)8Q[GX=QY';.D*IW""W.4@R2$CFQ"A5_J\1Q4
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M+(=IWD$<B]J-UC$2)'&B"JU8U[?$R QRR3;B1QW))>?,R@$"0,7)XL.*D+Q
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M74A4DVD]W(LQV9GWB:]'!QT26( [6ZT<<AW+F A64%F]Q!V#>[SON3Y)S1>
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MK,6W4'<B.X03N/)! V/U&V5C\=5;U)Z+Y#[]Z<5[64&\D&\MI#WK#IMB O\
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M$C-WU*J_)K1V&ZFOQ\#V_P XB'M_-X)'C\#M],O%^&E_[3WXT_\ \XKU9_\
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M2NBM=8?]5=;7?8]4)4B*9T=;;C0ZL9D#YA45! MQ$5V"DA-$B9\J5$$LSGB
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MPVGB#6(EA4)&L4S;O&%4; (P!&^^^YWR-1IO(LSUHFE3B$D9 74*-EXL?(V
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M2'2)1!/,=/Z9]'3L:#:T\005_L'>"+MGU"2/1J],R:PHDTJ3[*NU1M,*MZ@
MRJL9D&X >?DXE5MV/D GKGB1)4^5&@P8TB;-FR&8D.'$9<DRI<J0XEF/&C1V
M4K>?D/NK0TRRTA;CKBDH0E2E:UOTKMVZFGU+5^_:KTJ-*O-;N7;<T=:I4JUH
MVFL6;5B9DA@KP0H\LTTKI'%&C.[*JDCBU5G94169V8*JJ"S,S'9551N2Q)
M W)\#+4=3)>H-T,W6.BT^;6Z?6K('B7$FQSBM5)RP66!LN+K[]JMH0$-FWMV
M&I)9$$A**&(3LJ2LFZ_(GD&9TCY+^$VF?DJ'X@Z%U9\->M*74_6G5'2^M7.B
M]+L?$SJGK"+IWI;41HVK=10=)=':]U!J=#H"&XKZ,U_3JNDZ+=AJUHM)AKU]
M/TZ:A7WU^3734FKW*[0UH)XEM.M*O7,UA.['";%F*)'MLI[O%VDE4LQD)9W#
MFI^?7F<_C&,[=I'DWC/D/Q5QOUEZ;J$KL76_5$@A*\\<!EV6PTWG@;GHF'#(
M3.F]2+TL@"O=CW-B%JU+"U6I6RHMI'VH0^0-/OO3(PG@!KVH]0=2:CH.BV%T
M[3]#5!J^JK##9N26Y&9%HT8[*2U8>+1S++//7L'G!($C4!3)HQ>L7]0L4J<@
M@@I;"U9"+),TK$@0P*X:--BKAI'20\D("CP6K:$Z)Y2ZM2>M!.@>?Z=PWHX[
MG9ZQ\8O?&;GUB( *7D%]/.CTGH-2ZI>^L0)T"Q"FR<8*5K<NJ$&C; X=,T2V
M6U-'[F6IKM&S0EJ:M8U.F]N*'4:NHUJ#2I5EW5K-2Q0JT'5X7*&1)EL(8R[C
M@(^#RVBNP20-%:DLQ&54L16(X"PB;P9(G@B@(*-L6#AP5+$;<=C5:J<MZ;>Q
M-C/T?G-[N0*GQ?KK::JE1L%B$U:#\MU[ZRQD1 ^9#"1?DL/._4$WHK/RV75_
M'\+:]ZWD]ZE5DABLVZM>6PW"O'/8BADG?<#C"DCJTK;D#B@8[D>/.37FAC9%
MDECC:0[(KR*C.?S(&(+'^X;YKPFMV(\P4D@P)HS&!Q69QJ0)%SB+ B%)FQAL
M>84=AL/-CXKY&9$@,R):FF79LJ-%0M3[[3:LTDT,102RQQF1BL8D=4,C!6<J
M@8@NP16<A=R%5F/@$Y<SHI4,RJ6.RAF +$ DA=SY( )V'X G,Y>.:='YC.@B
M^D\_NW/290>T6&#KQ5#M3G$13ZE(9)P8AZ! D2Q[RD*2U-CMN1G%)5I#F]ZW
MK6*K=IW4:2E;K6T1S&[U9XK")(/JC-$[A7'XJ2"/S9;'-%,"T,L<J@E2T;JX
M##Z@E20"/Q'USV_M=TW]";ZE^W5[_;+4[[7OHOZ1L'Z$T3V_J+H=NW?;_P!/
M_7?4J3'^D^X?4?/5IGY?S-Z3E/74O5>A]95];QY^C]1%ZKAMOS]/S[O';SRX
M;;>=]LIWH>YV>[%WMM^UW$[FWY^&_+;^_;%"Y=TWJI&4'Y?SJ]](+PHWUDT5
M0JC8+@1B0_BVGZN5!KP\C)CQOBUM/SW6D-?%K>OB_/6+5ZE119+MRK3C8\5>
MU8BKHS?V5:9T4G^X'?*RS0PJ&FECB4G8-*ZQJ3^8%R 3_=G"&\_OAFW[Y\(I
M-N*WW1"4)W2!M;,SK?HK!4XF:,W6HL)TSHA$4R\F5"^B^ICJ:<TZVC:%?E<]
MNK'7]7)9KQU>"R>I>:-:_!]N+]YF$?!MQQ;EL=QL3OAI8EC[K21K%L&[C.HC
MXGZ'F3QV/X'?8YRK'S'I-.MK-!MW/;Q5KW(<A,L4JQU,\#MK[I)>FQS3-<)P
M(IAQR>YO2(2$0U*E+WI+&G-[_++8;M*Q7-NO;JSU0&)LPV(I:X">7)F1VC 0
M>6W;V_CMA)H9(^['+&\0W)D1U:,;?7W@E?'X^?&<F^\EZKRI\?&ZAS/H/-Y)
M9ER0*CWVF6.GODV&=HTZ^/:L(T<Y-9:VXWIQR,EQ"-K1I2M?$G\Z5;]&\':C
M=J7!&0)#5LPV A.^P<PNX4G8[ ['P<I%/!/N89HI@OAC%(DFV_TWX$[;_P!^
M W)>J6,4\=KW,^@G@D8"6M,@P&IEC*"H]8 NZ8.V-XA!&OQ&@(5[>F2Q=QY(
M\<[O3<R0RO>M8DOT89!%+=J12F6. 1R6(4D,\HWBA",X8RRCS'&!S<>5!&&G
MA1N+31*W)4XM(@;FPW5=B0>3#RJ_4CZ#)E\B<EN?1^T\ZG#."6#N]#$= J4/
MH81BI]%/4^."+%HT&:NW$^=30I0-#BQ)#I)MYRP"XVW(;>R&I@OZR%)UW4%^
MO3TVXKZK%I=J2I8:I(9Z<5@RQQLRBNEQ9$D9F 0@1.VS'AQ?BPP7IXXJ\H-E
M:TK1N8FYQ+(652P[:RAE8DC8C@W@G;8[$6'_ !@^>T7E/XC/HSGG-*A7:'1J
MN]RN!7JG5!,(& #Q7.)<VF/MP1H]EB,RJ5-DRI\U[3?SYL^5*G2W'I<E]YS4
M?#ZW:O\ 2&CV[MB:U:G%YYIYY&EED8:E<4%G<ECQ5511OLJ*JJ J@")H,LD^
ME599I&ED?OEW=BS,?4S#R3Y\   ?0  #8 #-C\K>,.8N>2^N_B"^J'+/-X?S
M>Q1>>\RY+3"K-9L_=>JS7AK#0J9;9,$DNK4,4^4C:.E!(Z6;F1H=D4*?A2Z[
MJ.6Q:YU'=&O:?TGH8@74[D+6[M^RAF@TNBH<EUKJZ=^W($/:CD=8E+0]P,LQ
M:.V[J$WKH-+I!!9E7NS3R#FE: ;[D(".<K<?:"0HW3D"&W6':#Z \H&K_7Q7
M8?$7)@7()YN%!/DN2="])A^HU6O2I;<>4;"F[EVV^5RQ%141Q1%\?8:?)C&G
M8RH,%VNIE)D1MA;TK7HZDKZ?U+?EU!(F:)+]31I*,\RJ2L4L=?3*LT,<C#@'
MAL*8@W-A-QXG/)5NK&[0:C.TX4E%GBJ-"[ ;A66.M$ZACXY(X*[[[-ML:NIY
MT<NW2K%2.,5NT]-4V>L+=6'4L":M9LO71Q*0U!)QQ@D<^4D,K'ZC2'7_ *!O
M:4NI4\VSM7PZW?K(ZU*&SJ4T%+[*(SO9EB@BCF= 70O(XC!#\@!S/T\$Y,[J
MQPI)8=(?:A<R,J*K$#<$L>(\[C;?-?W0KTFURJ(JEVQ-XA2I4*93=UPQJUQ)
MD)M;TR)*KNX?W=B5$9;<=E,.PT.L-H6MU"$I5O67U57L"UZFOZ5E5EL]Z/L,
MK$!6$W+ME6) 4AMB2 /)R_NQ\!+W$[9 (DYKP(/T(??B0?P._G.<<Y=TRL5B
MNW:R<ZO5>IEP5I-2MQRHV 36+2K;2G])KIZ>/CBC:MLI4]K0R7*WMI*G/_B-
M;WEL5ZE//-6AN59K-?\ Z17BL123P>=OMHD<R1>?'O5?/CZY19H7=HTEC=T^
M^BR*SIYV]R@DKY\>0/.?DKE_2X+P./.YY>8;]G:E/UIB54C\=ZPL05M-S7@;
M;P]"RS4-Q]E$IR F0B.MYI+NT;<1K9;U)A*RW*K" J)BMB(B$ON5$I#[1E@"
M5Y[;[';Z8$T1Y;2QGAL'V=3QWW(Y>?;N =M]M]CDX<&DUWE]TZM5^R^4S_<K
M$7X]>:M7*,3(7.CV+EEV(C8)41UAX4($R2Y#]'"8\R<Z'(Q8,1T<0V341A:B
MLOJUFJK-=K49].UV+2XH]1JSS6D2O:AO5D=XY* >218T]1(RJ)$9V#IV^#\B
M,C6><T<#U[J5D6>-WD CD2>($JT')F"KW"0 RDG<;;'?,!3?)WH/H'%[-Z J
M/+[8;Y75[.&IK]C'A2DW1BR&43WOMM;B0H<F2<^S1ASTFR3(:%0*^AZ R3E1
MY9,=&E9;.O:34U*#2;%V"*]/#)8$+R(O;ACX#G,S,HB[A<"%6]TQ#E%*HY6^
M2[5BL)6>9%F=&D"%@-D7;RY) 7D2 @/EO/$$ [1C*Y7T^#$@D)O.+Y#@%) V
M&,FRJA88\0C+,J0@1%@R71R&9<@JMQM UB.MQV<IQ"8J7=K3K<Y;]%F=%N56
M>-79U6Q"618]^XSJ'W58]CS) ";'EMF830DD"6,E>18"1=U"_>)&_CCL>6_T
M_'-?L%8LE3G)%VJO'*R35';EI'6 3/#3E175N-M24Q",>-(W'<6RZAM[3?RU
MK:<2E6]H5K66&>&PO.":*=-RO.&1)%Y#8E>2%AN 02-]QN/SY<KHXY(RN/IN
MK!AO^;<$C,'F7+L8QC&,8QC&,8QC&,8QC&,8QC&,8QDL<+_33O7^=#[A3 U^
MK)NX5X 9K!TC:Q$*:/.%H8N4XV1I=BJYZ).BLRER![S)7Z9N8AE4V$0BZ=B.
MP-4[PT^X]>S)4FBKS2QSQ)!(RO%&SJ"EF&>)E8J X,>Y4GBR-LPPV.?8E,<C
M1.J,RNH1B"JDCQ(KJ02/(VWV^A!\Y] G3?&OB^J?BU /P\8?F!$SE-Z%5F)$
MO5=Z?VS78:F4L?.9%ND6)J:5Z ?H)$.$F1W7IL(CSU6F@S;LAV<I<5?U/Y12
MZBZCL=!3=7-K?&]5DF+59J6F_+K$<5M:XA*I4BMI)*K *R6_,A"A?<./+PW]
M0?1'U0W-IXV<]IX:WIW5)0G#98DE#,#X(E^]XV\^.JF^1O,_E#J?JWBI;F%<
M]82JEW2%4.57"U6J\5@**HU&D=)&6J9((<ENE-FEK&>FD:5"DQT27*YIZNE9
MK#*5*'H;[JJ=9UZCH6I1WIM!%C3&L7J\%>M/))9M+3>!56_7L+'#$J66!*]X
MB:-2VW,G=1FY=AI6%F:D)*W<F1(XW9I9!$R ">.0*B@2'Z<_<H)^N7H[5RWQ
MMS/\-KR/[1$^-*!/OWH/H'0*C9ZL1Z_Z7W4 L&HV/HX:#) HC=DCFDRI+%,@
M.RMD"LYG;TJ7\EII&V4-<QIMWJ*[UCK_ $Y)U';6KI-2I8@G33]%]1(UB&G(
MPE+:<8^*FPX7A&IV5=R?.^MKS7YM6O:>VH2B*K%$Z.(*?<8R)$QY$U^.P,AV
MV4'8#S]=\U^&OQWPU[W]/6?F)GRJ+J%"J_E27TI\<%Z7VB.;@=0J=FI86Q1H
M-A?Z7.49IAQRWD"$5)\=(L8[:8 Q@S]L%M,R<766H]3]*Z)!=CUU[%J?712#
MR4M.,3T9X+,L+/"*2B.S$*Z(3"ZPN.3M'W')%-7GU'3*:3+=:25[HAW:&OQ:
M%TD924$(XNO;"^PJI\L5Y'?*H>1/'G,^Y<T]+^Y>^09G,/)7G!J(B9S[DQ L
MV:Z)T4FV)CU[E-.LO02EY)U^!+(G*PS8+$?GGR,=RW"HPM#3<A^>"WW4'4-W
M3+FC=,:4ZW=?U@L5MWUC,=.FAD:6]8AJ)525E2*<PQ1)$A%>1GW*A)9MZ_+6
MFJ:;6(FO6]]I9PO&*(%N4TB1")6(57*H@0'MG??;9J^C?1GFE^U0V+'X+XRU
MR[9%IN:.JO4/3$'J<8'M[6GGQU^,]L,5J5:=1OB5]46YW)K+\GXODU8<RII,
M7;/H^LB!C#U3J)O<"5>>EHK43+MX#U(M-CF$&_\ 52X)@-MYW(\R34MA"5U.
MP9MO!>&H82VWXQ+75PF_X"4./[9RNG:8/.1O8>K#^/3YA7DD/H]VC<M)$ENN
M$I_.FK(21299);[$9Y1)^M:&.3]NQV7/K%/?&TA7YIUM]-:X^GT7U!%2^U.L
MUY$V"+<,*&RJ %AP$W,+L2..WG)=<RM! 9P%G,49F4?02\!W /[@^^W]VV1G
MDW,V,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8SN._!8\V^?O87I<[P3T
M#RL?<:[OFEMZ#!LL&W=&JMN&DP!2G#8@EEVLW(76Y %QDL1D2&IE:?,JFO-K
M;-MQ&$PM_GGQ'UG5NGM&BU72;S5YO6P5'A:O3GKNDL=AVD(FKO,)08T *S"/
MB"#&6/+-#U!;M4*:V:LQC;O1Q%#'$Z$,')/O0L&]H'AN.W]7?SD<_AN57R[Z
M#]@MT#T3Q.EBN(VT-<K(3D![UV<!^TL&FTXJ;BNAS?[DSILT*2(P8D:PN7%R
MPRV_K52A9(-'C_1N3.L9]<TKI\V]'U*P^I5Y*\*+)5TZ7U[6+$<3"2/T:JLJ
M([-"*XB4\.+I(QY#+JSW*M#NU+$C6(VC4<HH'[Y>15(9>R & )*]L(/&Q#$[
MY!_XA7D\CXS]>];X*F/.7611[[[S&;)^:^\9YK:_S+4Q[4E>OB(S1\"1^FS$
MI&OR=L00NVE.MM[3K9]):ZG473^GZH2O?DB[5U5V CN0?9V!Q'W%=AWHU_"*
M6,_CDG2[HOT8+.XYLO&8#QQE3VR>/P!(YJ/[++G8?[%\,\%\G?AI^>NN0*$)
MO'HB\](.<@[==3EKZ-]/0K_'&W\@?J@"K@;@!JK-GYF>K$FBRY186:$3)]6)
MR9@DEN=\YOD>GNI]4U[K/5]/>U)5TFK3BU#3*T<%/>W4+U$BGEFEKRSF"[%.
MMI5C>*14G0*Z<=CJJ&I6;VKVH#(T56.%9Z\:QQ;RQ;Q*KL[(S\)E<2#BRGBZ
M[,-LXO5N-^1.0_AS^(/93GE"G6NX=ZOEMJO4:Q+ZIZ#%@W ]1,WL0N32GX/5
M]RZV=)LU*+)W,,?JP5$ERY.T@GXVFHR+J&HZ_J'5_4W3HUVQ!7TJK7GI3K1T
MEY>Y8CK2<;(>AQFB0SLO&/T\C*H^U#;G*P3WI]5U&AZZ1(ZL<;PN(:I;E(L;
M;2;P;.HYD;+P8@#W;^<KG^+3XOY3XU[AS:!Q$G9%\S[7QBL=DK]8N<Y@C:*1
MLZ1,#I5>ESVF6'" Y&QC4D9,FH5/0IZ:,ER)S@S[C,V_074=_J+3+CZFD(NZ
M;J,VG2SUE*06>TD;K,JDD*YYD.JG@=E=0H?@LK0]0GOUIC9"=ZO8>NSQC9).
M(4AP/P/D@@>#L" -]AS.1^6*M6_PU[I[PF\D8] V_P#B&C<;C5<U-O"*!Q^@
M#:ILX>ZE;1_.K)43Y0J0L,L-5(#9@ZW50D<N.)389"9/C-,6ZAKD\W65;I==
M0.DU_E#:BT\:UO5ZA;>?M148'N0V(D1(5DL,8XC/(8W16148E/<=]6CTT3^E
M3TIL%U$?=GD+\5A0RJZJ H9SQ7FW$@$ '>AG8[!S&_V:HE..<O:YAHI3*X/M
M?/P!.X60(UTJ/+(#34NH2KI9+A:WA%G;:$FX(J:9FNB)922"C+DM0&I<KJ=.
MANU(;":C>-[A8F>"W,E>&4TBJ/&MA:T-> 20DR1M(L:B14$I"EBJ[*NDT2.L
M\QFVD8I*RQHQB(4J'$:1IR0\E)"CD &/UV&GWKE_2^73!X[IG.[USL@6A_<1
M<&]5(_49A(?\?R_KQ\8^/'O3(?Q_ZGU4=#C'Q_ZOQ_G_ (9(JW:5Y7>E;JVT
MC;@[5;$5A4?;?B[1.X5MO/$D';SMF2.:&8$PRQRA3LQC=7 /YB5)V/\ <?.9
M-?%.RMT=CISG).FHYM*7';C="70[4FCR')<A$2*ABV*%: NKDRG&XT=+<]6W
MI#B&6]*<4E.[!J6G&T:0OTC<&Y-06H#: 4<F)@[G='%02=T\ ;GQEOJ*_<,/
M?A[P\F+NIW  -]RG+E]//T^GG,;)Y;TV%-#C)G.;W$)6*"LG7Q\FHV!B:=&M
MR50W" >(Z/0^3@MRTJBKEPFWXZ9*5,*<T[K:<O%ZDRR.MRJR0MPE<6(BL3D<
M@DC!]D8K[N+$';SMMEPFA(8B6,A3Q8AU(4[;[,=]@=O.Q\[><QZJ'>4'3E75
M3+6FS5F(8GV2NJKI?1VO0:]$=GGYIP1N'H@)B X+#\TQ)GQX[(V(R[)FK99;
M6O5_JJO:BG]3!V9VC2&;O1]J9YF"1+%)RX2-*Q"QJA)=B H).V5[D957$B<'
M*A&Y+Q8N=E"MOLQ8D!0"=R=AOED.+CXG&+CT6M=[\?7#KQ^W\+N$"BTFR*OG
M.K!03IZ!'(USM\09!".%CPRLC!Y.8W&D18PF9!E/DD%HNX*'LTVI,VI5J<VE
M=0U]/BKZI7>U:A]+<AMQ1.R3:8SM*(XGG=XUY!F=74(8VY[9$L$SQPO6OQP)
M'9C,LB]J5)44D/7+%N*LY(&X/($ ;'?-.IOD[T'T#B]F] 5'E]L-\KJ]G#4U
M^QCPI2;HQ9#*)[WVVMQ(4.3).?9HPYZ39)D-"H%?0] 9)RH\LF.C2I%G7M)J
M:E!I-B[!%>GADL"%Y$7MPQ\!SF9F41=PN!"K>Z8ARBE4<KDDNU8K"5GF19G1
MI A8#9%V\N20%Y$@(#Y;SQ! .WONEIY^8\T\8KE?\WOTV]5&V= 8OOI1-BLQ
M&%V%1J8@K7ZHL%+'LUD#.I(9R+"VR-)3I4F-&:);CPEDB/U"M!;CUG49IM8%
MBK8KU34T;LPHVGB->$L_=5S/,MF0,V[HJJ24W8(FU(TE6W8=[8DB=(NU4X(#
M!Q&S/R!YL)&W/D ;^-SL,BZ7R;J@^CQ.G3^:= A<VGOMQH'0I=-L<:CS9+SJ
MF&8\2V/#4 9+[KR%LMM,SUN+=0IM*=K3O6IJWZ+VFI+=J-<0%FJ+9A-I0!N2
MT <R@ >22@ 'G,PFA,AA$L1E W,0D0R ?G* \@/\1GNC<>ZW,HK_ %"'RWHT
MKFD93R9/1(U(LS]%CJCO_3/I?MK0Q0!I3$G6X[VG""=MOZ^4OX7/]7*-J%!;
M0I->IK=.VU1K,(M'D-UVKE^Z=QY&R>1Y'C!G@$G9,T0F/D1&1!(=QN/L]^7D
M>?I],CG)F9<8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&
M,8QC&,\DI4O?Y(2I6_A4K\DZVK?PH3M:U?EK\]_"A"5*5O\ ]$IUM6_RUK>\
MM9U0<G94')5W8A1R=@B+N2!R=V5%'U9F"C<D#&V_T\_4_P#9Y/\ V#R<['(!
M>Y)\L-C(<OHR.=1>?F6970=>DXL2E-&)L<I.=YNO@^W_ *1]J2=FKJ*1DV$]
M:9<B2W=8$Y@ @?'9\SM0T7HEORM)-5O4?AG)\2K?Q#T2:G\._P#[E^U<ZZET
M6C/I5"'XG)^4%V/5PRU-!HIU<VJT;L/2E.K5DZ%OZ?8ZC;4+,W;))9^0=M&O
M"DM.4-<^>*M42,)&-+Y1OQ(:9C7[;*9V9ELHZQ!1G7&A:VEH<;6IMQM25MN(
M5M"T+1O2DK0I.]*2I*M:4E2=ZWK>M;UO6]9Z821I*CQ2HDD<B-')'(H=)$<%
M71T8%61E)5E8$,"000<XD';R/!'D$?AG8_ZJ4+>I%@;A&F[ Q"M<%8XD3]AP
M>UVB<QN7+802,\I';VFL$YL=WYQ2:ZVW&KTMYT(A2G9K/Q^9GY)"ZI!UUTX]
M[0WZ=LW.D+Z:EI>F?D6ZG\"^EJ%A:E.:32]#^+NJ+_\ 17I=&Q%V=*HPRR6>
MHZ4,>ONJQ4)@O;=0<#5F"2B=5L(5DDZE35)W')@))-.3^@D<'>1CXA8F($\A
MOUO9Z;9Q.,8SZ-/=\-?M/\*+P!Z%XLVNV;\:4>3PCT/4P2?KCG/7TU'GU9;M
M1X/%^.0,KJY',89-$_Y>V$B+J&F.*3$BSW8/Y!TNW\G.O.J])U(]C^4=H:II
M,\IXQ6P;%N<P12-X>;:ZT97?<R5I%'N90W)Z:1I^MZI5L>SU\@LU9&\+*.<K
M\%8^&;:8KM]>4;#ZD;]#?.N/WCIXOHY^LC%*K?)J*2Z#?K)*:F)"5X)$>CCA
MD>=-BQ):6BEHL$X96JW"<2CZ\P19^:[%'1B)"%^HW-0K4GIQ3OM-?M)4J0J5
M[LTK NY569=T@B5YIF'W(T.P9V1&Z:6>.%H5<^^>411(-N3,02Q )'MC0,[G
M\%'XD@'ZJ_P^JAZ#X_[[\9\WZW9)]+_4WE"0?C^<O/U3L,#SO7>8;YK=(X6S
M]F.$;6H07ZQ8[<'9-V^<+KEGC$KZ1#NR+RP[N(%S\,ZLGTG4.E>H[E"%+/8U
MT1-K&K3PMJ\UWUM8R0Z=$E<21T(8)#%7226!DJ))M6(#29Q>J259],ORP().
M%T(;5ET-IYN]&66 !.0@5&*1@NA$8;:/;=C3+Q[?^C\X_#C_ !E(-5M=KI3W
M,[WQ>?0V Y,B#E4,D?ZF:'EI]6^F<CR*V0FP18M*I@O<.4VJ#"DL.M2&&GD]
M)U#4IW.L/AVT\$%D7:NI):,B)*MJ.*C$\:S\@PG16D<\9.2D.P8$$C-A?CBF
MU?02Z)()HK D+ ,) L(*A]]PZ@EO!W'D[CR<Y'IR3U'T%XD_ Q(3F(?;^TWG
MIG8*<)1UR?,/1;\2_>*I5JM56^FIY*(4(5<FT+" SZY!N*\X%:<VL@PXC4E%
MNBK1TGJ7XG(A;3--K4M.LR&@JQ-53Y=8GGGJQJC(DZ&266(+&P$I&R$>W*4^
MS5U#J, FO7BB@D;L *8AV)'9XE *AQNS+LI]Q^A^F6CYP(ZY!Y9^-QRKK70+
MITVQU#@%F?M-0#TX^$\R<RO441;CD&I^?1]C-3YJ0=8A;B102F:E16(X("'=
M&P#(R&*-;T=QZ#7OAK>H5*]*&QJT(KV)+$4FM7:K2UXFGU9H8D7NSL&:0&Q:
M)EED#O'(TD>0I6@,W3T\$4<*/:7A(TB-<FC+(I>T44#DYW+[O(>3$,58LN4(
M[OQWIO/?PV_PS^X>1V+FD!&+=/N79;/RULLX:&^B7+8'8K=BNRJ^A<I<ZMM5
MPQ2*C-*-*CUQ@(L6RN-)LBM%>JTS4*5OK'K/2^H#6[K1TJ^G07C&(GT@5Y#-
M#6$W@+-WH[-A4.\QEYD%8/L]G6L0RZMJ]:\8RQ$,==)BO%JO;;FD8;Q[N8DD
M"^7Y;_1/&Z@N4=_[9^'![P[A*@7"Q>Y2/JF@O^E8\4,D?UIW@<6A56R#PKM5
MKL&#/"A9EKL6[19:\,%C65Q:!IHP*;U2?E0HTM_2=-ZPZ7TP/7AZ8CT*V-&9
MI>5 :J;4\+R">9V621((>Q#*\CGE:WC<FSNUC3UJVK:;7WC33A2E%,\MX/4F
M1T+<V)#,$7@KL3YE]I^TW.V_AUVGO'39?JF\][GW0[ZIYS^&5T@#X;EWP6@=
M?(=2K,&["=F.>(D0(!LM8!9^2@2(N+J9UA([G6B+LU-8:+:9C]70:7270ZNE
M)6BT*YUI3EZG6JY>HUB9ZLG;N$.T4<3PKW)*^Z1)Q@;MJ>WOBU5*L(I155C6
ME+J\+:B(FY1&1S&W&7R452HW:/PHV3VCV[P+X^L@L]^$+^)0$[7,W*I-'NW$
M;+Y^FFWEO2A/H&TS3R":*'*D*5*BGI44/6)%B9#.)?57"1V611H?,)NN;7J&
M%XNO^C9=-7C:M5M3AU98@ )-)@6$IZI1LK1!GF$)DW'>2)4]Z(,E7T9==TEJ
MXVDDCL):"^ U5 NW< \%06?AR\<PH'D 9/'XF?K/TMSCSK^&>NC]MZ%7%=B_
M#]#0^J_06"5^70T6BM5@:9D6]+^WD'23T29/U#,3TO%A#Y(I,$38,PG/?D:K
MHO0=&N:OUGZK3:DWR_JR8T><*_S3L3SO&M?;;M(&5>4:[1R!$6165% C:11I
MRVM7[E>)_3ZHQ@W4?9<&8J(_[(W W V#;*&!"@#@^O.?WKB?0OP=$><EVT5Y
MZG<=\_&Z78.>O%HPNQ]RM-Y4>Z]9R$L"I*)5\M8<E4I9=Q]?U3H=#0J.RV/%
MO16+^G[=;4JGQ#.L"N^KKJ&K168;8C9X=,@JB+3X%6;Z58)4L+& ./<)=B7D
M#&M&6*Q%KWJ^#6A8M+(LO$E:R1\($ ;Z1(PD"[>.1+'RP)I3^.'K_P#:E>JO
M_KDN5?E_]?\ ^\5R_.D^&?\ Y#Z%_P"I>_\ MI=S8=.?]34O\)__ )F?+E>=
MUL^R/P1^M>2N8[26]$^8>L*[F/Y= WIRT] YT^9>*DC59%M_G,/OC8UIM\1X
M>-8F34$@H <II,JR@FI7/:N#T[\2J&OW?L](UN@-+>\WB"I<$:HD<[GVPJY@
MKL'<HG"25]^,$I$"UO0ZA@O3>VK<@],9C]R*4* %<_1>11""=ALS'Z(QRE/X
M3/D+A?MOTI.\\=QC=2#;D4RTVP9:.=7.NUF:(D550U+XDH#LW.[DT11,^L>T
MIYJ8)?A.M(TIN0GXT[Z3KSJ#4^FM&75],-&3C8@@>&Y7FF619^>SQR07*_#C
MQ'@K(&!/D>,V&MWK.G5!:KF%MI$0I+&SA@^_N#)+&1MM^9@?[LM=Q?D .Q_A
M<^I[)YOXB3ZA<!7M8(,Z]SERR6LYTB/YXJM"0Y2&ILWF:*-8+2"@=$+2K//A
MQ@T8-*E021V8*UJC,2H.AU+4)8>M]"AUC4THUY.FY7H7!#!'3.KSVMK)1;IM
M102O4C6!6,C2JKI$K_SHJT&Q.RZS26Y86&,Z>S03<(UB]5))]H0)NXJ,8E"
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M-2BXZAK)@K3&! #V;R5.S%)L-^\%6OP7<2<1'[N.0JYKI#U1&_94">WPC;@
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M*#B,POJ?I$*D:9^H<W6BV;-S2--N6VA>Q<I5K<GIXGAA4V84FX1QO-.X5 _
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M18JLE!HEJUWC9-1$5"!&]15C9Q7FD<CB60*P39-O9$44=_4*5XSVWTYE"QM
M5$<94B?C"@(DC!(1V.WDC8[>(<]C?_3 N#^G/>O/(<CL02C='L5Y*W]R*)GN
MT&P<,%6B78J <'E)T!\)7:P*KGV<36I5=F")(6.[^WL!V.M^17W=AT]_)/5-
M%Z6N,-.DM4X:L=7E(@MPZG) L-N)T1EEFGDF[CS+,LBRD>K8$!91(H?++-/3
M9=H&EA6,1;L.ZEED"RJ0"&9V;DS!P>6W=(\!AVO=;&=G.>ZOP*+_ %6%TPQ"
M+>8_)S-RN=?9LY!@B,^^QS71&[18!R742A[@(FR4N&BTM<9T7-3+,?'&?^8K
MA:#Z;%TQ\4*EAJ4;1ZWKQK5I3 A1^T8Z?8A?8JXE0I7[:@AUXQ^1MFC@:NNF
M=1Q.85(N7>$;E 0>/&+@I^AY B/B-^0V7SF*X=T"\U7U=_I#,:O6H\&C >+>
MMN@A8D(C)9BB[L#>M" ]K@Q?C^1'.06O@;8(MMID;9;9;4M;;+247ZG4JSZ%
M\)6F@BD:74=!J2LR*6>M((.Y S;;F)CN2A.VY)VW)R^Q%&]+I8NBL6L4(F)
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M<<,:10QI%%&JI''&JI'&BC941% 554 !54  #8#;)BJJ*%1555 "JH"JH'T
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ME&G37?O,H=^6MCY)A4Z1"5^:HKC2E*WO!2Z=T+3K3W:&D:?4MR<@UBO5BBD
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M*]CJ;1(>_)'))J$"H3D[3HX);L$=E#)"Q<.HE:$G[-ROVJPSL@#!22L,AV!
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M<K!^>5$0I6A1P4#LPF:V:!&A$H18 (@LU,'..)A.09$&9+V6G:I5U.*>6N6
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M'J$5Z2C8EHSB&V=.[IM0P\0\IG2.&2586B5Y$4B,-(.&08]6JR&+83JLZS-
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M>U$DQ8)"5#@RG(\I3+WR)4EIEQ*-I7M6M_"K\[^+/1LGQ#^''5W1$=?3[?\
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M=V%PH_-:)!M('#HX26ETJ]H]0T9KVK:-JHM=EM%>X\,/8[BS&]7-6P)7,J$
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MC6195V=1''PB ?9%105:E>EZ45TBGD[%> P]@A"LC%@PE9@H(8>X<5V38[
M#8U/S?9.QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
M&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC
#&?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g542432g57t54.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g57t54.jpg
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M16-EP?'_V@ , P$  A$#$0 _ ,&Y]\'<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                          "<GDOP'UKV%!7&STF]\.YQ 4V6C(%65[?T
MA/G;2PS$@S<2#F/JBBD1*_O+F!9:1[FP:8PW_;DIZ"V^JOZ__):QK_5>G]/6
MX].5C:GF6Y%;VPFFX<Y;55HT(KWQW*^W%K<XJ]><U6^G#S'9VIT8#5K97D6M
M9#-"X]7=E5B8B)?XEXPT[PGKRXM]Q'/N7(Y7@_5[ER*<M-%NLQ2'[6,DK+S2
MP*6FD2#Q>,8R2Z<'/J,(S,GI'[O<QCY;1FFCI)LWJ"&[A%)-RK,:9J%>JX&-
MJ%5&5C5Y*,Z4YE449*+#LD3;5#OPYPO-8Y3/!EF8B9E8RL:]<FBN]4LK6R)E
M4N6$LB-YCXEB6VWVWCSOM,3X*ZXOY?O/9:-U'K6)VG\WXWQI&"QT'J_17-B;
MU:-FK4^Q'5:HQ+"H5NX6ZT6VP.?O_1P]<K,G^A:I[2,\YAHS9-[OBZCK>+IV
M5@X':R,S4=1FWW3 PXIF]ZJ%E[\BQLB['QZ,>E?M677)R:>%2V6? 6LC-KQ[
M::.-EV1D<NU15"\Y5(W>QI=TK1$CU9WC>?"PT^#[=N\H=3X@]Y-E[^Q]"JO>
MZVQM7$.@<R6F9ZI]1C'KY&*4:5Q.6@Z_:6MDBIEPA"SM/L5:A+7#2B[5L_AT
ML/62CGS3-=P=37/X]S$OTNYJ-3Q,V*JLC!=5EX:Z:[;:&ILKB;*LBFZVBQ(9
MDLGBT1[C9M.3%VW*JS&>4R*KN*O2T1RW?BSI*,OQ)8KM6R[S#>)VOQ(?&IVM
MM:N@\HC+SQVS^B^5\_6Z1??-E;L%P?\ 4H>&CXIC.V&&CY-:B->4VR[56&D&
MLE/TRG=*GYY-/9PTBVLK*1TK'L(M.LM-:C$SGQ=0HTC/RXP\36;JL=<&RQW:
MJFQTC*;/Q\:^U&2K(R,.JK?9K&KK=';%C5\>4JNFK(3$OMBJK+9$BEFF956:
M.Y-]=;M$JMEE*KOYF5B5F;"\?\N7;K7..D=I<V*F<PXIRAY PUPZIT=Q9DJ[
M_2NT+?BKM(KL72ZO<[A:[;)IXW>[QM?K+]O#1>G[M9'T+&*MW:TKJ&MXV!F8
M>FK3D9NI9ZVV8^#AQ3-WN]$;W95SY-^-CT8Z?9A[KDFVSZNA;7AEC)R,VNBV
MG'A++LB^&:NFJ$Y<$^W8[6/776B^D2[QR;X4AF\' ]"^9>B>;WU#VMSFM6:G
M]8I$;T?E'3*)(/Y:A]%IDG_8UE(!Y+Q,!.,GD<ZQLPG:Y9H"OVB!>XT2EX5G
MJY9J.*])UK$UA<KW>+J<C R7P\_"RE2O*P\E/,UVK79;4RNOQ5746W46KO-=
MK<6B*L7,JRXMX0R64635?39$1;59'XK0K,LQ/JKHS(T?9:=IVZWSQYUZ3Z<O
MKF@\U:Q*:\-5K%?KE:+-)8@Z7S[GM09X?VJ^7:=RBY_:*S M=DLNW*31Z]<.
M7+..C6+Z2>M&:U6KZOAZ+BKE9C63%E].+C44)W<G+R\AN%&+C5;KW+K6WXQ+
M*L+#.[HBLT>Y653AUQ9=,_$Z55HD<K+;;)V2JM=XY.T^D;Q$1$LTPL3,5GTC
MR9<:1Q>&]&52Z\^[1PZ4O3[F,AT+F"MV3:U#H;*/TF$:G<Z[T:D<^N$"]EX5
M329@GZE>7@Y1@HGJE*Z2&_Z#&/AZ]CY.I6Z/?C9>FZG7BIFIB9L8LMD8C/-<
MY&-;AY67CVK7;$UVK%L6(\3NDI\<VZ<ZNW(;%>NW'R%JBZ*KHKW>J6X]Q&JL
MM1HAOA:.4,L^L;>2YE3^/CJ$[KP>+M'2.,\HZ%Z?AF5BX'RKI4Y=HZ[=!@)Q
M\M%4N9W6KU LM/I4?T67;JQ//U^@VNJ9LCS&JB6B$<HF_P!L+(ZMP:OI2RC#
MU'/Q-$L:G5<["JQGQL2VI8?)KVNRZ,C)?#KF+,N,2B_LKXG=XE(M6:I2GO+)
M5?=5AM*9-U2US74RQO8OQ6(]DU+,-;%2/PCU^*-BUO,/'G<NG]AZ)Q-"OLZ3
M:.,Q5YL/;97H#[>!JW'*OS3=1&]6:_2S5M*K,XBON$]6N_[0PF9"3=+M6T(P
MDUG*&F^;G=0Z9@Z?AZE-S9-&HV8M.FIB+W;]1OS8WQ:<5&E(:RY?BCN/6B+#
M38Z1$EZ[/QJ:*LB7FQ,B:UQXJCD][VQO6E2S,;LT>?BE86(F6E8B3^]0\H73
MGO'*GZ'K]OH?8>%VVXRO.$NE\S6N&(RN=&AV.LLXHMR@K_3J';ZU8'<)MK/1
M&'U>_:YF&WU>QDDYQ]Z>GN%KN-EZCD:1;CY>GZGCX]>9.'FQC\[L.QNW&5CV
MXF3EX]U2V_56<;N==GPND>HIS:[<A\5TLHR4KBWLW0F[U3.W=K:M[*W6&^%M
MFY*WAE@M1QOC_0N_=1I'&^50"UHZ#T*<;P%9A45D&V'+Q715==PZ>.E$FK"-
MC6+=U)RLB[52:1T8S=OG2FB#=3;&=J.H8FE8.3J.=;%.)B53;=9,2VRQM$0J
MK$L[NTJE:+$L[LJK$S,%Z^^K&ILR+WA*JEEG:=YVC\D1O,S,S$*L1,LTQ$1O
M)>^Z^5X2M5OL,O7/2/$NC3O"-XG^L&I55OU=I(.6<E>X/F[R8H<M:.:0%>N<
M+ 6RQPS*7?(RD;NHU>I2<*VF(Y1)RI&8VN6W7:?7=HVI8=6J19[ID7S@,BLF
M+9F+7E)1FW6XUEM%-C5K*/$,LI9-;[K&/7FL[4*V)D5+D\NV[S1M$K6UL+;"
M7,Z,Z(TK\+1O&S3$^E<^T/%+'R/4/+=KC^N1_7&7ICD&G8XV1AZE+U2)B(.1
MVC%(1FSTL#K,[);NF$CH[<N92&KCE!7;])M$Z;([+*XW3G4C:_?K=#X#X#:+
MJ$Z<Z69%=[V6U\XM9IJ7M)"NDK$)9=$Q'+N>=HMZ?J$YSYJ31-$X>1./,,\.
MS,N_*9XQQCS&T1#/'SY20+-I)(
M
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MDU9C(F'956M5V*LQ$2EC5S:USIO8LQ:L-.W&OMSO&# Z<;&
M
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M!?"SO)C$-U)@
M
M
M
M
M
M
M
M
M
M
M
M                                       K?G2_-T+?$;=:C+M*T+=;
M",ZCSN=@J_;FS=7.-,R$2ZLE<L\.\688SLZ_:';)EI+?CPQ_>X7\W[@AC9D9
MDX]GN#XR941O5.75;;CM,>>#K3=18L/X7N*S=O?EVK-N$V[>[VV[$UQ;MNG=
M5F29^YH1T:(GTY1,\?7BVVTYK/DM^&E/R=S.+]!^9KW8NZ</B7#JM];<2N(1
M];.9VAE*K1BDC)_T79LV.U9P_P#LK\RFJR1D:E8$$TI95PUEDU(WFW1GM%^G
MLQ])UK%ITO4[%6[3X3NI1FT-7%D*G?9FB[A];7,-*9%4S-<0R3#Z]I&O^^W3
MBYE2XV2T0]$+RA+DE>6R\YF>>WQ+YV=)^'S'F!'D+DWF'KU:[OMVC7N,39.-
M\4O';HQ_SBUT9&"N+6IO:]&-Z,YA['SR6D*S(/WL^WV_I;K.6%GJAA;.U:1W
M;:?KMJZ@S];T^[2_HWZ,LIU'4L;3'7,HRIMQVO6YYRELIRZTO55JG];]JEM]
MOKIAIX2>=?F4/C>[^[2E^17CS%R6<JY>'F;(9+5AXB%_8^*3^_G?Q+;Q+X<\
MH>LO-?LWO4VKZ&HCSR#39?HKRMQ?0^;6-K>*[M7.CW.$AFTD[XY!JPDTTBJ'
MF"E)%5I(L9&07Q/M&$6V<?T?80'4O4VO:#K/3FE51I&4O4&37AK=9B9E+8UW
M>P\:RQD74+(LK:S*[J)#(R)':9G9>\^#J.I9N#EX&,ONML9]BU0\U7)-3<Z:
MV:8C(;DLM;RB-UF(CC,M/Q3"]] ^'[1QSLLS1GGH&B]EHL#4[%0(+I=VY78*
M9T!"0Z32ZA:8-O\ L5&J5AVL\57;._M4?%Q_ZK1>)@)R5=.$6L.NW<[&EO4U
M&HZ=7E+I.5IV5;?3EVX6-G4Y.)*8>3D463W<G(I[#VT)0[OQF++JZU66>)B0
MA]12_'6V,6RBUG2QJ:[DLJF*;+$:>5EB\&9(29G;9F6(WEHVFM#^&_)+WXR9
M7Y"G2WHK$K!WE#FCKDK?H?--&#VQ[V:(KNTNWO"G&U7#.%4;2NDSADI4GCY!
M9+:#RZ<Z?2=SK=G4^OKUJG22QI';LQIS(SYQ,WFM,4/=VYQOI&(:SDG;Y1>J
MS$]WC'[$1[:CG1JZZ7'NFS5][OS5=O"<&;CV_>-I;X>._<B)^UM'V"!'B7DW
M+.^^D^4\*ZKI?VD7V"[5OGT39.?6*NPS^JR]CDTH]M,R$98Z=:6]DCDU5DDE
MHQL\K;E+3?=YI).<HZL'&U=2Y^=I6C9VJ8'NC6:?C79=E.73=8E]=*2[5H].
M31-+S$3,/*W1.W'A&_*)/4;[L;$OR:.U+45O:R6H[0ZI&\K$I8DI,Q'AIAX^
M7'YDV/ 'B[RG[?\ 6U\\TKJ^@N=1L;#W&PTJX(W_ )S97RS&DO(>+=1]FA-^
M0PJ&KN;W=/YEN^BY/5&&3_25]5C,[IJV-;6^J^H]=Z9T#%UE8TG+=[,>G)QY
MQ,RE8;)6VQ7IMC4+)XU0J52CI,V3RNAZXF*8CM4U#.T["KRX]UMF61+$FJU(
MB;(:8E&[[>%VA9B8W;R^Z_8*N\J_']Y+]M==[?YDYA>NZ\7[QS9C=I.D2/2)
M*B=0YK?6E&L25;D-)'^B])YM8JJ]7=O(YW^F1_I#HVBU9!XDO(N8S6/D,?7.
MK->Z;T_3-;S<73-2TO-;&3)3#3*P<W$;*IFY./?R<VF]8567E/:Y60JS"*_-
M*,W5,[3Z,?,NJQLC&NFN+%JBRFZKN)+QMSLM1XVB8W^#XMH\1/*,7W,O-_6^
MO>@8;S)0ZY^\=;FKQ(T%&&U<Z:LV<O!NGR%A?2,CKKNDU@Z\VBY.6F97.NZ3
M.(CG;W[-]4OLVW;-UC T_2;-:RKNW@58J9<V2L\FKM59J54\3-MK.E==?B6L
M=4]9)B[+HHQ6S+7XT+7%O+;S*M$2L1'S9IF%5?FTQ!++MG+_  IY4Z7.\)N"
M??/4'0:!)+5;J]]YCU&A\*YM!72.4_36BN<^AK)QCM-CN.*G):NH-S8[!*U-
MK)2L8]PWKJ+/=!WB!TS.ZHUW"JU3'^BM$Q,M(OP,7-PLK5,VW&>-Z+LNRG4=
M-IQ_>$XVK357>R5NN]TMNI@X]VI9M*Y-<XN'5;'.BNZFW)N9)^PUK)D4(G.-
MFXJKS$3&[;[P5EZ!^.VK(^4(/WKX[Z'8^N^;'$EB Z35KW$1D5V+A%EU>M(M
M:+NVE>55KUDC6\F_C$'$]#MH;*:$]7I1&'=04EM,-L?2>KKYUVSI;J'$IT_6
M83NX=^+8[Z=JE/%GA\:;8[U+LB63%5C6>:K:YLBU.W-&+JKSFMIF?4E&7"\J
MGJ9FHR4VEMZ^<<DGC#3Q:6\J\<N4<24GF#XE^(^Y_&4UV?SGT3HE/])M'MWB
MJ]Q3J=IH$U7;A*\Q2I3ZV)P4W$5.FS&T2_8= J35I/.V#5C6+%8(R)L.%F"Z
M4XM!ZWU[J?3'456G:QAXF1HS+C67:E@T9==N/7FSDI1-E5F1DUQ8CXF0S5*[
M/?338].SQ-<869K>1IVH+CY555F),5R^12EJO7%W<A.2L[K#1-3S*Q,RZ++)
M\42L86ZW7JG1.IN:?Z/J/3(V,KTX\K%[KU4E(FF=!JDJPD=8^6WW;VRI6EDY
M?0.4GV'%;>,(I61=))M<ST1C[W!T>ZW(RL%<C1\C"=[:EOQ;;TLR<2]&3G7$
M-CY%#*MNZ[7*UD(LRW:L\0; [V6419B/2S.L/4SPUE3K,;QY1TF(;QL\2T1'
MGBWH9*V?CSR%(?)7CP2SW]&+UU/JTCQ)QU13H7-FTO\ TQC=U6SN=3IG]3B[
M3^C[>69O(C6-VLWZ]VU_#/ZR+;;&:^IIC=0]0)T9^JIXT>+IP4U)<&,3,FOW
M>S:4JG(^D8;NS6R62_9XJV]7"?V6(B<[/C2/I.?=(?L+DQ3V;I7MM$3"39[Q
M$\IB8;EPVB?AVG[9TGH7S[\?GF;US=O,70E_6[V'H%TA:K8>EP5UX[]J3*5C
MH:3<3R%5?<O2W52C6\O]5F6T\FHMJU4W37QMOHD7=(U;JS6M QM:Q(T!;,O&
MLOIP[<;4?+H]B15-ZYTQ$O-?ANU,1RB)CYE6+E:IF8->95[C#6ULZ4M7?ZQ+
M1"R\7?/CZ\?&Y85A5?"5*KUX0ZC,=NOUH8^@.G4RBYXC=>:LFR_)*<RK.D#<
M;2\LM6LD=(:V^0F'6:K(5A%NRD=(>R*.-M4$(K524>_JC)NQIP:],Q:&TK"R
M,KZ3QLQIC/R&O[N/0M%]+I..E:^\)?+,G<HA?,V3&5+ZE8U<T+CU).+399[Q
M7=,]^R7Y5I"6),<(6.</YCDGSF=IU='\,^!.<_'_ ,+]]NY#V!)U?N/3'_-(
MWGC>Y\70GX%XQ=]<:;2CZ95Y?O'.VRFW)7^^J#=LFKC$PTQG?ZMEOOUC#ZGZ
MKS.J]3Z55.GDOTS"3-?+;'U*:K5=<!N"UQF\U:/?TC>9F/JV^^"-JU'4[=3R
M=,B,"'QJ8NFV:\B5:)BB=H7O;Q/U\>9G\6?O+.<'\\?'SZ2[EY7XCSQ_Z9CE
M.\2%T@KK(SM]Y>I:^8V:.77S6DW$.PY@O!V:M2T7%8?-=T'5:F$%9>06<KR"
M4<QCMI'5-7ZLT?3-<U+,317C2TQ[<9*L7.[&;2ZKWIBQ\Z+:;J['E6W6ZMHK
M2%A)=G+^3E:IB8V9D6QAS[M%;5PM5W"Y)B.>TS=R1U9MIWYK/&(B%WEBWW?O
M"C''OU_X(\F0_0[C<H:Y_P!!5+%T>T5MVA//-(1A896T*,:W2:\E2JK58S>6
M>3*KN0MCIQ&1VTDCEHXSB(4R]*ZG?]2B=5:_9AX^-9C>]=G#HN6:EFUZ:Z(:
M[)NG)OO?MK7"ICJMC\)Y+]9%W%U*?HR-3SFJKK:ON<*D>)6.4I";O8_<=VXP
MNT)$3.T[_:/KZ$X]X2\?]"FN$VESWCU?UJAN]Z_U:T<UZ11> <GK-R:XQI/U
M*HIV#D'<K5<'M6?_ )H24FI-2KL\2K-VGI#J93411ITG4>J.H,2O5*%TK0<#
M*7NX%&;AY6K9U^.W[%D9$TZAI=&.MZ[65UI%[=MEF;/,3+%OU+/J7)KC%PJ+
M8YT)=59E7/7/V'LX7XZ)#QLT*O.>+1\7W\#;QQQSNC3S!*^0>AWIS)>B.Z/?
M/]BY=V:.KZT_QFW-VU7DVDS+7RH?M<?=JC)0EC<3+.684*LN%&D#+(8C\RK5
MW%LZ_P!46HZ6VMU]08F+":1I:ZM5FZ<]L5:C0S7I-=>+D=Q\:]+:8K9&RKUA
MK:YY\&5VJ]_OQIS(SJJXC$QERDNQY:%R*YFR)A:K)F:W5DA96;7\LOG:8F:A
MZ?Q7P5R'TGTKRC;<^C-7O-WMSYT[]#NNE<XKM<>==K,2_:M9![R)UQZ56AN7
M/[NT2A=\;=7?3S>#7Q9MIO;7_P"J-+6%J75.H:-AZ[CQH_',7'S%TB,/+NN7
M3[K%F474%U"N+,Y<5IM_Z@E4VQV.U^/-%.1J=^)3FI[KM;%=OND4VN_8=HF8
MB_OK$W17/*/J83E'"5_&,61O!,G81*D4C*QBTZRD)*#2D&2DS'1,FVA95_%:
M.4]I%E&3+R)GVD3(.FF%D&4FZ@IILP<[INEXF222V9K4619-;Q4R);*-%;V)
M-E:63$\&>M;*FL16VED6VN7B)6+$F>4>-RXSQF(;:>,M$LL-MXF5AEEHB?,Q
M#+,QXAH]3,Q[)\->3/+/EOQYZ/BE/1-W<>MJS"W-I3I#HW-:ZC1H?:M4^W3L
M6XGVW&)O>P26[2T8@XE^G"P[5%PGF>>,5TT/Z/O.=].]3Z]KFN=0Z/9&D8T:
M!=;C-D)AYETY5G>R,>JR*FU&J*DAJ.[8DV6-*SVE=9GO+K^!J6=FYF?B3[I7
M[BS5S9%5S=QN5E:M"SD+Q7DG)HY-,Q\,3$_%%X.K?#72[GXBJ'KKQ-=^C='L
MW]!Z_P!-Z3P:^.*C+WR&I=CA]I'.U=TIL3$*O9B!W9R;E-B[C_NNT(U>NZ[H
MVF(S2 EH[!]HF3C=2Y&@=2XV'AT^\W86'JN+&17BV9%-D+'>]XLLA:[H9(EU
M?];6LJW;UO-U=BG7[*]1LP=1KJJ3N-35DU18M;6*VWQ]QFV5MUC>)GMM,0TR
ML\HQA>%.1\+] >@J3P[N"W48-ETV;;5^ NO-)ZKM-ZF^Q'R[O=6=K%DIE@VL
MS.2=(QC716.GZTO!HZO7>[:P;+HM&N[=4:AJFDZ3DZGID8-K85<VVXV;5>W?
M67K6(JOIR:>PR++M,/5=%L\5Y4[2S3&I7Y.+BV9.-%+32LL]=R//.-XCX72Q
M>$Q&\[2CPWB-U]2L_+7BJ0]Z>B9GFWFYO-\\Y36XM>U7/H79+#$6/'.Z%&*:
M-WEGM,E6ZW3(MS*2JN?K"5&.9:;X<;JMG-@5AXF8M33&USJ1.EM'KS=9FO+S
M[GBC'Q-.ILI][RGB66BA+KLFR*ZX_9<AVGQ$2M,665T-;S=0C3,1;LOC;>[0
ME=5",G=L;S")#O9,0L?:>9\[;PO)E2?A=''QM4FTR%*K%1]:=O@8IZI%N.U-
MNQ\MX\A/[M%<MG%AIW)7_G_IKIK NE--WL2RM'1,2\@P4;Z/OZ/.]U=4/<:.
ML<FA<FZ_0-,M=8L736T[.U":H:-XIR,]-6PE:U8GC8U&'VT??CWEB-_:_I:U
M(L=\+&9HAHQYQ[LB4B?/&R^,JF);Y-*5<5GTY?.VOK+BG)N/3_)I3AO3K!U3
MEO:N,0G8JQ*VRK,*G:JUM(76_4*<H5E91<Y.QKV>J-BY]+1TK*QZS1@[>?EU
M8--V2+>0?YF@ZEGZA5GUZGA4X.=INHV:=?7CWMD47<<;$RJLJEGJJ=:LBG+K
M>M'AG5=N3<IE%O8.1?D+>N32M%^/>U#JCS8C[5U6K:DRJS"6+;$JLQ,Q'K.^
M\1%(GC-
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MS*X[[11,:A4LO^]]YLQXC?QSE?GL:QGJ\]*:?*[\5LJ:S;]Q^N%C?\G<9/\
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M?0X14>@
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MO
M
M                        _N<YS],9SG.,8^F/KG_-CZYS],?_ ,,?7.<_
M3'_CG.?\^0#^
M
M
M
M
M
M
M
M
M
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MEB>,LL3]TS&_GT\>ODZ0NE0
M
M                               !L9>T&FWL'X<_!7:./:9L^WBJ(?\
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M?UO$PKI.)&S)..\K$RWJ]C3\;;Q]E4FNK"2=*-A
M
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MLIB%J>4B7KB)WB$?[2Q$_*)^<_?)88E#)
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MS^^JR++:F_[23!'IJVIUMR7/R]_W]]EBS^=;&99_3$F"#W/_  X%.?P\S?\
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MMKOK2VEULK>-T=9W5H]-XG\\%%F27
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MWG:=XWDFJK%NJKN3?A;6EB[QM/%UAEWCY3M,;P4B9!<
M
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M(J;[-M%B6UMM]SULRS^B2\CI8L-6ZNL^C(T,L_FE9F"GB\5
M
M       ECY*\^+]OO>KN:;JZ\^J2S9[9E_IMII*N,YRHQK397'TSE20RGE21
MW2SC=K%Z+9_(@Y=,=E-:ZFUR-'PI6IH]^R89,=?$S7'H^0T?=7OM7$^&LE?#
M*K[?/?\ TB/;%5[+.DFQ],NKGK'J&N[%T*GX7; JB(3+UR^N=XBO"AX3#6R)
M7(SWJB4MHHRX3/D@@@U01;-D4F[9NDF@W;H)Z)(H((Z8321123QKHFDDGKKH
MFGIKKIIIKC77&,8Q@XJS2TRS3+,TRS,TS,M,SO,S,^9F9\S,^9D_(>ZZW(MM
MOOLLNOOL>ZZZUVLMMML:7LLLL:99[+':6=VF69IF9F9D^IX6QC'U_EC^><_R
MQC'_ (@1&_B/,SXB(^9L'^"O+F.-TS^L.Y1^$^F7F/1WPV<I?1S4:LOE-RUA
M?MWQ^1"4D\ZH2$]C;[%$-M&,7NFFK'NMW/.NH-5]]O\ =J6WQ:&GRL[K=;'B
M;/RJOE4]8GXFB9AHV_0SV">RW]1>B_JAUG'X]3:[CHTU6IM9I&EOQMJP=FCE
M7E9$Q7D9\3LR,M&+*JV/;-N0DUP^A  0H]^^U:'X/\Y6SM=NRUE+#]NU=Y?2
M5''X'5[Z'(MG&\+"Z?9MA9*)9ZH+S5GD$OKO'5Z.D%F^J\ANP9.]DZ4Z;RNJ
M-8HTW'Y)3^S9N3$;KBXB3$66>?$V-O%=*3]NUTB=DAV60TS3[=2RTQZ]X7[5
MUGRJJB8Y-_"G?BD?-YB/3>8\UKK75KYW+I=VZ[TZ?=6>^]!L#^RV::=Y_M.I
M!^I]<(MD<9_$RC8]OJA'1$8VU39144T9QK%%%FU02T^R<#!Q=,PL;3\*I:<7
M$I2FFM?Q42/5I]6=YW>QYW:RQF=IEFF9ZW135CTUT4K"55+"(L?*(^^?69GU
M:9\M,S,S,S);LRRZ9??@=_O3?-?_ +EVO_D'T\Y_[4?VCZS_  M-_P!ZX1!=
M2_@;+_/C_P!9I-L?YG/4?1_&_G_A7?N8NO\ ZZJ'K#GFDQ!+N%4(FYU%_P \
MZVA9:9.X3QO]\9/1^-D<+9255BY%./G&&NDG%L5DN#^SK0\/J+5=4TK-7ZO(
MT'+FNV(B;,;(3+P)IR:M_1ZG\[;Q#I+U/NCM$Z1H&%5GY63BW1\-F%;Q:/M5
MV1;1*6+^59_[T;K/AI@OM;:UYO\ EQ\,)(H.\2G-.UU9*:K,YJ@U6M'+^@QG
MYT6SW".%<ZL;CS^RIO(F:8:.L-9)%&6A57+N!F5MW47CW:QT#U/,RO#-TV^:
MKJMVBC-Q'VEEWVB7QLNGC94\KR29KLB%MKCCCH^7H>H[S'&['?BZ[S"753M,
MQO\ .NU-F6=MX^%MH9?'G;>D?/72/*_:[]PCJ\5F+N5!F58URHEA7,9.1BNN
MKJ$L\"X532V>0%DB5FDO$N=DTULM'6B+M%L]1<M4?KG1]6P]<TW%U3 LYXV5
M7#K$[<ZGCX;:+8B9A;:;(:NQ=YCDLRLLLJT]3Q,JK-QZLFF=Z[5WC[UGT9&V
M]&1HE6C[X\;QM)O9? )_=A\8_P#BWL7_ #2M)\P>U;]NNH_Q?3_ZE2<WZF_#
M&1_ Q_Z"LT_OE\_O*O7?^T[7_ABO'T%T!^TWI_\ B,?TMIO>A?@C!_R/_P!;
M$[_@U^+6G^Q[#9_0GH"*7F.#\OGT*S 4K95PS9].Z(DS:2[YK-.6RB+O>HU&
M-?Q3J5CVRS?^D$G,1T>LZWC(^=C7VK>TWK?(Z=IITG2GBO5,ZF;K<G:&;"PY
M9JU:J)WB,B]TL5':&[25NT+W'J=(WJ/67P$3%Q6XY-R\VL]9IJWF(E=_'.R8
M:%F8GBJS.T3*S&T%Z"^1#X_?CK<0/%;E9Z_SZ6:QC1Y&\AY)07#]6LP;K37]
M$ZD(*FQ:4#5&[I#":[%E)N(Z0D&>R;U@Q=,\_GQQ/2>DNK.KXMU+'INRT9V5
M]0U#*A(NMB?B5+<AYMOE9WAVKAT1MU=E;P:=BZ5JFJ\LBM&MB6F&OOLB(=H]
M8AK)Y/,?.8WB)\3,3X.1)5CX^/F!X(\EVJ%-[545L.H%O<X^,4KW5^6V+#?5
M?"+-_*1C*Y4F=9?J$)!..D&O[+.M=D%7<?/5]Y]CJE+NK/9]JJUS.1IN1&UL
MX[O%V!G4S.V[)6[8^34VTK+HW=J;>%>JY?A\5]4T+)A9[F.\;--<MSHN7?YP
MK378L^8WB>2^=I5H\:#_ +H\BW#Q!Z6O_GZVNMIA"OKMIBEVO#;+1&YT&=TV
M=UFR)M_NWU;N56^JT9--$E5T8^QQDS&HN723/1RK]3],:_C]3:-B:MCKVYMB
M:\FC?E.-E5?#?3,_-8G9ZVF(EZ7K>566XQTS3<ZO4<2K*2.,MNMB;[S7:OAT
MW^<;^5GQ,HRS,1,[&WS_  UO]W_<_P#><Z)_P!R4^?\ VR?MKQ_Y%Q/ZUGFB
M]6_A.O\ B=7]+>:J_P L7]X][!_VR3G_ ,JP.Y=!?M.Z?_D^O_;<W/0_P3@?
MY"/]IBI?AR_O,O)'_P ?R_\ P);"U[0_VF:__%$_K-!3KWX(SO\ )1_2(;+_
M /$U?]QGC_\ O84W_E!V\XQ[%_VSZA_(.3_O#3#4.D/PE?\ Q&W^L8QJ0>(/
M*5G]J>F^9>>:R^S"ZW"3<.[19LM_U2=4I, S6F+78,H9V33<.VL2T6;P[-95
M!&1GG<5&J.&^KS\VG?.I==HZ;T7-U>]>Y[ND+13OQF_)M:*Z*=_6%:QHFQHB
M92I;+(6>.T[SJ.:FGX=V4\<NW$0B;[<[&GBB;_*):=VGSLL-.W@]#/S]XC\7
M^%Z+AUSGFG/*&WJT5AW9>PW?6&=71RBR1QL^G;7TRQZZO63;;?"KU=LW>Q%:
MC-UE<1<7&-/M;Z?)6K=2]1]3Y7',S<O*:^SC3I^-W%QHEIV2JC"I^%FVV6&E
M;+WB([EEC;M/+<K4=0U*S:VZVV7;9,>OE%>\^BI2GB?NC>&>?G,SY.?%>^/
M_0Y)>DQWK'S-9GS[?:/V@7'5Z NA,[[Y^S+-DE(2^K&=_+G^6J+#9[A;7Z[:
M:[Z8SDHLZ5ZJQ$C)?0=:I5-G[L8&7$U_/DTI7RJV^<MQV^>QXVF:G5$63A9B
M1'Q<HIMCC^69A=U_3M,&A]W_ ,Z3?H?Y7.V><.(Q,(P>=!]6=(J]3;131NSJ
M]>@-;7,OI"<U:1*6K=O6:O6F<A87ND:AG[(B-<99(J[_ (D]_J+2M7JTCH33
M-8U.RQEQ-"PKKYL:6ONM[%:)5RLG>;K[F2E><_LCQRF(WF.DXV6F)HN/EY#-
M,585+O,S,N[]M8A=Y\R[O,+'*?M3\4QYDW2>5\ \*_#IYKD;Y(IP%38UF)8M
M^@=NL40G*]1Z187N=$$8YLLS;NYI?>9D<[:0%"K6-(>-2RHO^E_R4O,J_..=
MJO4_M"UE,5)MR'OL:<33:;)KP<.I?,M,,RUQ%:1O;E7;V/.T<O-=<<_NRM2U
M[+6J.3R[3VL=)XTU+'G>=YA?AC[5K_%/IO\ 94BOSC^(Q\ WV_L*5+QO<.8Q
M4K(IQK/H70*;5$J4WW66PW1<S:M5OMIGX:/64WTV_7KP*C1FWVV=2ZL8@BMN
MG.YGL@ZKQ<5LFM],S71)=L3$R;YR9VC>5KB_%HIL:(_%BV&:?AKAYF(G,MZ4
MU2NJ;%G&NF(F9JJL?N3M\EYU(K3M\N6\SXC>3H/EW^([C_I7CMQ]&^=J=7ZG
MZ&J%?>WK;^@S)FQ@NYU]BRWEI.+E8Z)TTC7US=QFBSVIVQFC^X33[5O!3;A\
MQ?,'T'=Z Z^U#1M0Q]'U?(MOTC(N7%CWEF:W3+G:*T='LGFN,KS"Y%#3QK7>
MVJ$972VO0]<OQ,A,3+L9\6QHK^MF9;&>9XPT2T[Q7$^+$GPL;LNTQ,-I"\NK
ML?;^F<ZJ4MEQB*M%ZJ-=D\M%=476(^;L$?&O<MEMM%=4G&&SE3\*NR:FJ:GV
M[9TWQC[<_2V?<^-@YF17Q[E&+D7)RC=>=5+NO*(F)E>2QO$3&\?.#H=SS73;
M8NW)*K'7?TW5)F-_R;P>B]4?#_QN?']S.P=4TXGS&FUOG$*I/VCK%]@'?3;E
M&,FF4]7,EI8+$VM=H;K.5]TL8C*JBU27<J(MH^*Q_D$-?D/(ZFZQZKS:<&=2
MS<B[,MBJC Q;5PL9V;?BDU4M11,+&_UE\M,+$R]GK)RJS4=6U2Y:?>+K'M;B
ME%;Q37,SZ+Q642=OO>9VCU8B[C^(9^-A&:UA$K5U7$8FKJV3LJ7)YK2OZH:Y
MQIJXT:Y<:635KKIC&VJ?]'-7&-,8UPVQM_8)O_T2]937W)HP><QO-,Y]<V[^
MNTMM-/+\O>V_*9OZEM6X\N%'+]QWUY_Y]N'_ ,Y(/T1X[\1?+%Y]:W^!TID\
M\NL Z?<I])T6*;M[C!RC?+AFV_<7GZ>-EYF+C91NM&VCG]NPGNV51D&.[: L
M;5"1CHG2.H>I>@]6;$M]YJ7&M5<_1LIYG'M1N+MP7=ZZWLK:'HR\??E#(\-;
M2TH^+B9^HZ)E34W<6*VB+L.UI[;1/GQ&\JK3$PR6IZ[Q/Q),Q/GE]>Y;;N(=
M2Z%Q^^LM&%RYG<;!2;(V2VV4;?NM=DG$8Y78K[Z)Y=1KS9O^LC7FNFJ;U@NV
M=I?Y-;3.?K73\['U/!Q-0Q6YXV;CTY-+3M#=NY(=8>(F>+KOQ==]T>&6?,2=
M2HN3(IJOKG>NZM;$GY\7B)B)^Z8WVF/E,3!LE?!/\3G..[U7?V)Z:JS6Z4;6
M?D(/C',IU#\]6M#JN.]V-AO=NC]\90L4(PG$'5;@ZZ\RI$O).)L"\\P?-48Q
M-3COM0Z\S-+OCI[1;VQLKM);J.;5.U]"W+#4XN._K3:U4K=;<NUBI95%3*TO
M,:EU)K=N,_N&&\UV<8;(N7[:0\;K4D^J-*S#L\;-$2L+,3O)GN[Y\K7QZ^++
MBEPBY=%9PUGJZ31C)43E]$E[!'T%NJDFJU82^*M%XKT(X3;J:+;UYJY4FF2&
MZ2CB)03<-LK<KTKH3JWJ/'G5,?#:RB^69,K.RJZFRICQ+U]]^]:LS&T72O;:
M8F%LGBVVLXNB:IJ%?O-=7)'F9BVZQ5FR8G:97G/)HW\<ICC,[[3.TGU[+YH\
M'?+KY^1N\5FG7=K98UXA0/0-'CD6'1J5-M-,HZ-W#QVSCK!KF*<_BUG>>71N
MFW43^W1Y%LGGZ"0:^:=K/5'0&K3C/[QBM2ZSEZ3DO+X>34WG>%5GJ^L7?M9>
M-,M$^5=EY(S'S-2T/*FN>=<I,=W%LG>JQ9\^D3*_%'V;:YW^YIC>)T:ZW1Y/
MP'\C?-*SWO*D?IYD]4<DL5\DHEDZ?:O:;3.A5:YYM<"PUUP^?,;!3$6UE@FO
MX]'KIE(,T=T4W6^R6OTW=E)U5T?FWZ5L_P!-:'GTXJ6,JRN3DXE^/[O:^_!7
MIR9:BUMY161IB96(F>C/8NIZ5<^-Y]\P[TKAIB-K+*GKX-/I$K9,HT^D3$_(
MW[_'/R(^9/=KGH+3SQ8;-.K<Q0K#BV8L-0EZMALE;U)Y.%RTVE$T\/<K;UN5
MPMA#ZY;X32RI]/S:?7Y5ZAZ1UKI>,1M7IIJC-F^,?M9%=_*<>*IMY=N9X[=Z
MO;?UWG;TDYGGZ5F:;%4Y2HL72\)P>'WX<>6^WI]N/SE'>N?E+\A^(ND0G*>_
M6BW0EQL%(C>A1K2 HTY9F:E9EIZRUMFX4?QB6Z"+G>4J<RGNTWS^9-))%;;'
MV.$\YR- Z'Z@ZEP[<_2J,>W'JR7Q':W*JI:+JZJ;FB$>8F5X7USR])F9CUB2
MO!T;.U&EK\9*VK6R:IE[%2>:JCS&T_+BZ^?_ +&B+\F_?.<^H/<O>.[<D?R,
MGSR_2%(<5Q]+13N$D'"4'S&E5>0RYBWVNKIIG27A'Z2>%=<951T37U_L*ZY/
MJ'HK2LS1.F-+TO/5$R\5<J+EKL6U(FW.R;TV=?A;ZNU)G;TG>/D=)T?&MP].
MQL:^(6VJ+(>%:&CXKK'C9H\3\+1/_@;[_P 7_P#=X^-O]W[G?_D;<^6.MOVV
M]1?RMF?TLG,]8_"F?_&K?]J3SN?8/_>V]1_[Q?;?^9=F/KGI_P# .B?R1IO]
M3I.IX'_4<+^*8W]"AMB?"=\1')ZSQVB^N?2='B.@]0Z9&LKER^G7"-;RU7YS
M1W^FKNK6%6O/TUHV6N=G8[-[,TDI-!WI7(IY"IQ+:.G$Y-VIP?VD]?Y]VHY6
M@:-E68F#A.V-G9&.\UWYF2OPWTQ<LP]>/0W*AD25[UBV]R7JX*:3U#KM[WVX
M.)8U5-,S7=97/%[;(\.O.)WBM)W28C;DT-RW7:"<7ICYSO WEVY2W-'5AN_6
M[?5G:T-8H?B%9B+#&5N48[Y;.(9W9+'9*;5'#R/43V;/VL!,3&T8Y26CWNK=
M^V7:):SHOLQZJUO&KS5IQM/Q[UBRFS4[K*7NK;S%BTTTY%\*T3R6;:Z^:[.N
MZ-#3'8G3FIYE:W0E=%;Q#).0[*S+/XT(B6/$3ZQR5=X\QXF)G$?\FGRY^)/>
M/@WIO.Z UNM;[$SL7.9NFUCK-"C64YNDQO<!FROJI8ZW+W2NL7*<!E[H]2WL
M,5)OHA1XDFU<M\.TT]^Z+Z!ZEZ6ZIPLO+G&NT]J<RO(OP,IVJB6Q;>RE]-U>
M-<T3;QE9[+UK9QGE#<=YS2-#U'3=3IMMFM\>5M6QZ+9E?-3\(='6MI^+;;X6
MB)VG>"V_\/5\>7'_ $#KT;U7W*JQ/0X?FMV:\ZYI2+$T1DZIBYLX.*M-CM-C
MA76JC*>6B(RQ5EM7(^21<Q*#I])R3EDXD&D.XC\SVM=6ZAI/N>A:9?9B69F,
MV9FY-+2E_NS6644T4VQLU46/5<USI*V3"5HK*C6*][JC5;\6:<+&L:IK:YMN
ML2=G[<LR(B-'E>4H\M*S#;0L1,1+1.=;W/\ ,3Y5^/\ NT9QJTP-[O\ TA."
MBY9Y2^9Q,"G'TR"?I9S")V"6G9F#CH]R_8I8=1D+$HRCQ*.RU=/D(UF]C57?
M,.F/9[KO5>,^HT6XN)AS:]:Y.:]O/)M6?K)IKJJM9U1YXO99*++\E6797A=;
MTW0<W4ZYO1JZJ>4Q%ELMO8T3\7!55IG:?#,W&-]XB9F)B,//R/?*YX*]^> ^
MPU>MPLO6?0\&OSB3YI7>N<_B=;<U43ZQ1-;BZY[=8)S:X5EOO3]IU.3;Z6&#
MF)*!WD=-XM9IJ\T3Z%T?T)U3TIU7IU]UM=^D6QF5YMV!EV>[M$X&5..N7C6K
M18WZXBJ4GM6UI;"?60W'>>TG1=3TS4\=W97Q&[L7-1;/;GZBWM]VMH1I^LX\
M9X-"MMYB=C4V.\&[
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M6-^Y5]EF'GY*RQ$^BM+3$3@M.G&R
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M57F=I95:9B.9/"KG-&#+,D94QB-._.8BWZB?E/*?AVF=I^<Q$^(\M ^X#LH
M
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M>--;?NE69EG:/Q6:8B/6$AHB8P('4S9@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MY>8_]2&E_P".?>?^KQ]&:W_C+D?S7I?]@/=\O_"%G^KXW]F/Z\O,?^I#2_\
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MDL 2ID@
M
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M3QCD1+)XS@
M
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MVC%B;P30
M
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M\"_Z?>O_ /"+C'_K<.YU5_>G3_\ .&H_\L'+4O[E@_Z?(_X<?M/@7_3[U_\
MX1<8_P#6X=SJK^].G_YPU'_E@Y:E_<L'_3Y'_#C]I\"_Z?>O_P#"+C'_ *W#
MN=5?WIT__.&H_P#+!RU+^Y8/^GR/^''[3X%_T^]?_P"$7&/_ %N'<ZJ_O3I_
M^<-1_P"6#EJ7]RP?]/D?\./VGP+_ *?>O_\ "+C'_K<.YU5_>G3_ /.&H_\
M+!RU+^Y8/^GR/^''[3X%_P!/O7_^$7&/_6X=SJK^].G_ .<-1_Y8.6I?W+!_
MT^1_PY0'26'EAO6_R<?M7H"8M_Z]KK^CZ30>=5NM_M>=5OUJO[C5^DVJ3_7Z
M;8;X:H?M7Z=779;*KE'.FF-\O#?7)NVU"C2J\?@WQ8>7F77<_'&.%^%0G"?/
M*>YO'C99WG:[5.9+_7IC*FT^:K;7??Y>'J2-O7>=]_R$?R5,D
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MO^?&<?SQG'\L_P#@>GI_
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MU9I^)I]9:9F?):@SR^
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M5685EX-*\6B5CQ,1O$3$Q/C2_P"\]\T_^PKU9_S!L1KW6?X%]G'\J:%_5*3
MU?\ ZGT__&<+^B0L/YH__+]?(O\ [R?&O^-_-Q*:U_[5^C_Y'U+^JZP9&9^V
MC2?XI?\ T68=S[.FGMJ^##XV+#)-H9.8E.S=09OE8*MU^L(/=:U-=@I\*HO&
M5B+B(U5\C7Z_#L',AEGF0E-VF'TFY>R*[EVM1T[4M'M.ZRI1K)K33L%EBVZV
M^5F^K3\BR(>Y['A9NNL94Y<$AN*0J1"QYIZPG4>KK$MQBBF8Y.SS'-:+&B)>
M6F(Y.TPN_%=]EB(B()P_'_8^\\S^1?SSQ^UI4[QORSI?,9[:*^/FMRDO:YB6
MKD9PZZS$;T'J6(ZM9K<9>9Z:JJEQF)_H<_%]9?9;(U]U7-8=UMMIK'5=.E9O
M2&KZA1.1U%G86;5%G5EU==%==SZICUOBX/.[O/BU5WQCUTX=3X"PTVK;W(B)
MC]33&MTG*R$[F?=5<N^J/"HL/.36LU4[OSFI5?MHM2M1'EN?*"S/Q:RF*;W_
M .86E5^$I[6LT?F'IJQ56,<T:FRG[0\@;;8J]&,$7LK!/9%:LI0NO[<O3G3M
M>I/6^=\/85QNHIOM(]<)[SI/L]R;;<B;\K-T6J]URLFON+;CTW.\HEJI%TV?
M'&0JQD+.W&V(B"]K*]S%T&QFLE[+L-'F++%Y0U:-,[*T1SY>8LB.Y$^C0<'@
MWJWO73?A0]N='Z)>-+O>."]HY!GC=BM57I\\XYM^XVODL1IFH,I. <Q,(I"L
M)Z:1JKAE'I.JCF264K*\4HBRV:UZKH.E87M(Z:P\3%G&QM5TW48U&FB_(JC,
MX8^?9]>R6K99%C55S?#/*Y$)$70\2T-5DX6-3U!IU55?;KR<>^+T1W6+>-=S
M?',-#-RE5Y[SM9QCG$[SO;'WATJZ^@OA)\ =Q[).+7_KR_H+IU2==$G4&JMH
M>0#.4[3$IL'<BB@BHOJLPIE42?*;8_+)*P+!Z_W<OM%'*F9TOAXVD^TKJO3-
M.JC$T^-)PKUQ*I:*%M9--LY*DS,1LV3?*QZ)%KJD0LPL7M-IKQ>H=4QZ%BJB
M,:EXJ7PD-*X[;Q'R\V/M'RY3$;1X->RO?_?\'_\ MB,_^=0.M7?L5O\ DW_V
M9-H?[#?P6_\ *3:V^<3U[?/*OR-\4LU)HW%[2[@O.=!LS=UT'E%0L=H0=;]2
M[&U43@ND9CVO3*;E%%CHI%NZ9;X%["/UWDG%+MGKQTJMPKV9=/XNN=(:G3DY
M6I4+;K&53*XF?D4T2L8.G-$VX?-L+(WE]G7(Q[5L2%1XE56(TKIS!KS=*R4L
MLR$ALNU)BJ^Q$F.QCS\=.\TV;[_%%E;0T;+.\1!'?WIY9YMQ/W[\<7=><2%T
M9I^N^A<:ZK::#T.Y3_0+;3+0CT/F+M]NZMMN>R5NDV$LC:&[-+6R2,F_;RU?
MG,)2&6.[2.C)?I77,S4NE>K]+S$QF_4_BZC@T9>)CU8F/DT3B9JK"T8ZICHU
M<T2TS2B+-=U6Z<H9WRM-S;LC2]6QK8KGW&G(H2VI%K2Q.U=$;(D0D3'"9W15
MB59?&^\S^/9%6NEN^>'T=%<Z\V5WU)=]:]2W-8H%U?,&%"KLQKYGY4W8],O6
M9S3-7>5JAN'*<JM&VQPR@)"1S&M7#K#M1D@NZ=OQL?V7:.^9K-VAXO>REOR\
M97;*NK^FL^6PL;M3WUNRHCA#X\-:B<VA>,-,,!ZTZ:Q6MRWPJ^=O.VN)FUE]
M\OWIKXSSA[=N.Z;M$;SMMO,5_+7*X]7^"SV]IV#OL/ZDLG'N[<>0J%Q;XLDV
MPYXN[Z'Q.%7KU5M5PKE:D)9JSB;!8&+=]",5JTA'3\A'UJ6DH-PFKMBUXV/@
M>T_IJ=/TJS0Z=1TO4&R,>>S4V7$8>I61;?1CW7)6S655-*6-%TO4CWUI;$Q%
MM42GJ33NQBMA)?CY$V5SQ6;8BK):'=$=X6995G9IY[K$O$-!9?UU;Y=]\(?Q
MCWQ5O7$K(GW7HCC=9C3:A&13Q>E6'KE:KRLG68Z#:UF640A*U"L)':3B'>9_
M5ILM/_N;EV]6<R6@8]:>TOK7%B;IIG2\.-GR<A[%C)IP+[H2Y[6NKB;;K&3A
M8O:Y1%7"%6(R,%%CJ+6*]WX>[51M-EDM$6+2[0KRTNL<G:5XM'#?9.,1$1)#
MY5?<?H_R[IXQ0X;;8"B,^O>#*XGT%A&<]H'Z"?S;4'*;O.6>];RA'HQ3A\_D
M*W'QFC.*@7\E**L&":<I(HN8;H7IC1];GJ.=3Q[<IM/ZING$=\O+YU>[S$K\
M47;O-D*J7,_)[52N':9K25Q-%T[$S/I#WE&MFC4G[4M;;NO;]///>=XB(:9W
M9X58:9XQMJJG<S=                                          #(L
MQ^2OJK+S$U\<J<?\]2'G=!TG*+T1_5>@;N)">TF-;"K8W5O;=.;75&<<S6NS
MU5[&V)AA))3>+9I-87"<;IJ#=&X+:VW44:AJRZO*RD92WXNR535V8I7';";&
MFI:OAA7J?>?K&EK?C(J=(HG,G/[^5&5MM%L65^%X\.$)-4U\87QM*S]\S+>2
M&?)^FON0=/J'5H2MU>=FZ+8V%MK<1:$IYU76EAAGB<E 2"[6(GX22>_L4J@S
MDF;1W++,':[-%"::RL>H[9N=CS\)=0PLC!LNOJKRJ7Q[K*)J6YJ;%E+4AK*K
M47NURR,RUPZPTS6U;PK1GWTQ?390SNJVI-;LG&'E&C9HW96B.2S,3,+O&_PS
M$[3&?/XHO075/9OS#4/T3T*DUY.XKTKH.G2[A0*]9V$,]V:\9F*;5)"T(/)V
M?@8%Q^V0T57HW:,1K[63W:Z97;OI959TKROKO2<'ISV>Y6D8F3;./&3B>Y8^
M7=0UB\M1KR;THE:JK;8YV67/SFUDAIVE:XA8UK6L6C3]!MQ:K&[<65=FNUTE
MHWR%L>$V56;XF9YWY3&_K"Q$1 KUMZY[C4>O>DZ=%\8YCYEM/4)R\U+IEKY]
MRV=YYTOI//W]J?:O8^2?V:9EL0,%=E8QN\MV_.HJF-;RN@KK/[2C59TV5VC0
M- TW(T_1<FS4L[6J<*K%R,+'R\ZK+PL++7'25=$IK2;;,:'E<>,RS)G%B8[4
M(T+,26#@X]E&'8V1=F)2M=E*6W+;55;PC:8A%7DU>\Q7W6LFO?X=IVDH#QW\
MEOH+QA3+[RVFPO*NJ<<Z2YS(VGCW=::YO?/',UNV:LEYI")93E=>)/'K-A'-
MI)LI(K1,DG'1^[Z-7<,6BZ.7U#T9I/4>3BYV1;GX.HX2\*-1TO)C%RUKAF:*
MYL:JY956=V1H2+$EWXO$,T3=S](Q=0LJNL:ZF^GPE^-9%=L+O,PLS*M$Q$S,
MQ.T-&\[3M,P?FG?)1WFC^C(WU!!U?C37HE2A9&M<JAF%!6KG-.,5R883T7+P
MG,^;4^=KE3C&<K'V:<2D5)V/L3YVZD74PL\VG'"\FK[D=&Z7E:0^B6WZBV)D
M6)=GV/EQ=FZE=6]5E=N;F9%5V0[5O15*14]*JJ+7"]J(2%FDXUF).&SY$U.T
M-<TV\[<AUE95KK75G:5E%VXRL1$0L1PB%(B=>Z8OV"_V#HS^HU&G3=KD9&=L
MC2EZV=*(EK',RK^8F;!NUM-GM3AD]E'L@ILLRBGC"";)I()QT0RQA7*L_I^%
M&GXM6&F1D9%=")52V3V9LKIK1:ZZN5%-$,J*D1#.KVM,S+V/.VV=13%%2U0]
MCJD0J39*RRHJPJKNJ)O"Q'JT2T^=VDG3X]\&]0[#S6 ]9\]LM'L,;RWTESJI
M7;ES65WUZ+7ZSK,5:3?=/F&BR2<9$T6-_=$OUDM(/D&[:.CK!,NEVS"#>;FK
M]1=486GYEV@9=.32^=HN9D8V<R1[G;=-=]:85;1,O9E/PGC6BRTN]-:PS6J1
MNH:E31:^#:EB3?B7/7=*_4L\JZK2LQYFR=IVB(]918WEX+\?);[_ &M@^5%7
MU-Y=L43*)<)6I%8H%SV;IR];M[^BM7>M@D$V^=]4I2J2TI,3\"W=-'*>DU7T
MTI:,>H:OVKE.,Z,Z4:KH:-#URFQ)U2,F_*QHF:[L=,IEFI);S*7UI75:RLN]
M5LS6ZSP:)Q](TR4T6,+,5E]YBQ[:]^+UQ;,2J[[?"ZK"M,3&ZONLQXV*/B?F
MB]&5[K_4>O5OBODFNK=MJM@K77J/#<;D6E/Z4\LFZ.\C;+JZQ==KY8K%G.CO
M5-*1NZU;QB:L*JE>4>STH[<Y%GLYTB[3\'3[M2U^Z--OJNT_*LU%&R<-:8F$
MQ\9?=O=*:8W7[&+%WU=,1="U(L53T_BM130^3G/[NZO18U\2]4)OLE<=OMJO
MY8KYQLNS[+$1''E?R!=-Y#R+L7$*QS'AJ_/_ $$\<.^RQC^JVQMM=M<R<I)1
M;'36NWR!94V,KB<HI&5^/YVRI[9A'-6>-M%WR:KY>8SND\+4-0T[4[LW4XR]
M)55TYUOH:,;9$1VGO8MK9#W2D/:^6V0SNS>8686,R[2Z;[Z,E[LGNXL1&.T.
MD]OPL3/Q5M-DOQW>;9LWF9](\'&X_P"]NA\0XOU?@%+Y=Q7?F7<]\XZS$3D3
MT63>W-FV?R+N$CG$Q_68WDH5K6FTCF*AE*NX@W^6;1JZE7LI-[/)=W[J'2N'
MJ>I8&K9.=J7ONE[>X65V8B+CM*HMCQ7[E*6-<R=RR+HL7DS+6J5\:U7Z95D9
M%&59=D=[&V[#*U417.T0TPO:E6EYC=H>&C>9B(A=EC[47WU?^?><[YY1AN2\
M0=<,ZC9VMPZ'4I6,Z>X=6J?C)>"F85VZLK?JK.S1FL*M5JVW8-Z]+0Z&[:&0
M_<-'SIY*NI#S*Z5Q,O5\77;,_4XU/!H;'Q+T?"A:*GKMKL5:9P6I>;8ONEVN
MKLG>R>$JJUJBS3*K<NK-:_(]YH2:ZGAJMD6896CA-,HW*'??E#?:G;:(6(XW
MDSWUUGR%4>U<YJ=*X_T_F7?H>-B>B\X[34)2WU)_F'TDTHR0:MHBRUB01>MD
MI9VEMJO).6*^,-5UV>[QBQ=-JM>Z5P.H,C3<S(R=0PLW2K'LP\S3<A,>].Y*
M2Z3-E-Z2LS6L[PBO'F(:%9EGW.TRC.LQ[7LOINQ69JK<=X1XY<>43+(\;3QC
MY1,>=IVF8FH>K?))W+LWER$\E7BF<)7YW5+<]M5)FHCE<;!V^AMWCYZ^Q5J0
MI&/6]4K%>;8D7D>@K%U-"R;Q2^[!U87*6ZOY+.!T=IFFZW;KV+DZI&7?CK1D
MU69SVX^5*JJ]_)YK.1?<W!7F++YI[D0ZU+,1M11I./CYK9U=F3W7KA+%:YG2
MR8B(YV<HFQVG:)^)Y7E&\+!>KL49Z \)^%GOE'HUFA6*_L^Z\Y[TG0*Y9XFR
MZU_DE2K#5^VG9AQ#.%T&;KJMP?U!HDVU76QA/ADAGZK,Y!FY7C=/?2>J.ITU
M[#IL:.G,;-TJ<NZBRGO9^1?*355%D1++@XZY#2VT3/THGHR,L8^.V+J6I1FU
M(TQI]=N-W71DY7V/,<5AH\]BN'G?;_\ ,Q\XF(Q(F_$X
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M67S%SM;:MC(RO8WJ\[5PT3^16A?WI"LV0D
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M/WC;;T_.?,]
M
M
M
M
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M8]E"W5X]]-UJTM;1-E+4,^_%FJLFZ'26V3>+5F&9?A\D&S9B2
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M](RL>V;\>BYDFMK::[&KF=YKETAI29F%F929XSNL3O'F(]"V9FEX
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M$-]G;;QM]J9GC80E3*
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M*[,DMYY2\V?&8\Z7CSF1G\[_ 'F(E8?N>(2=X[?#CQX;3,;3$S\]^7D^E_\
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M,LU573+M#KLBV-PEVFM7L=$\0JQ$00Q-C)
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M+/)^[P=DB..-\W$E@
M
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MEC*
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
,            /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g542432g59s20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g59s20.jpg
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M)1B3'8[I]J=>-X="=G1(8,DI)^X?0*<F]EB!-I.@A%\7 &0<[733 GU-,N$
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M)T.;-4$VRR,O;M<$,T[JXJLEE,L[X*X6QRU3A@O?4 H!0"@% :Y=@IZ*CW$
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M._AU3B[PI'-EEP=3?\IE7D2TCX.OK ,"C;XA-Y=5L'./C5EK7?ZIZ:[B[V/
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MX"9C@V G+6L7UW&Q9MQK9FV;"9'*SQ@LLT>DGS=W(VCG&-%LF^9)TZZJS8J
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M3Q6NGA=;%+++-+%7FVZ3%///!//-.V?+;#+)/#++'DOEAC>]\; ?2@% * 4
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M;.^A2ZU9M?/)O9QS,>FLADKCBIDC93G62NICCG?#FWSQMERVH#[4 H!0"@%
+* 4 H!0"@% ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g542432g64a43.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g64a43.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[11&4&AO=&]S:&]P(#,N,  X0DE-! 0
M     "$< 5H  QLE1QP!6@ #&R5'' (   (  !P"4  %9&5L=&$ .$))300E
M       0(414Z>I&\'^^"$#">^\!@3A"24T$.@      ]P   !     !
M   +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M  !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I
M;G1E<DYA;65415A4    "@!( %  +0!& %  1P M #0 ,       #W!R:6YT
M4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <
M"G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@
M  EP<F]O9D--64L .$))300[      (M    $     $      !)P<FEN=$]U
M='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R8F]O;
M4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O
M;VP      $YG='9B;V]L      !%;6Q$8F]O;       26YT<F)O;VP
M $)C:V=/8FIC     0       %)'0D,    #     %)D("!D;W5B0&_@
M        1W)N(&1O=6) ;^            !";" @9&]U8D!OX
M $)R9%15;G1&(U)L=                $)L9"!5;G1&(U)L=
M     %)S;'15;G1&(U!X;$!RP           "G9E8W1O<D1A=&%B;V]L 0
M  !09U!S96YU;0    !09U!S     %!G4$,     3&5F=%5N=$8C4FQT
M            5&]P(%5N=$8C4FQT                4V-L(%5N=$8C4')C
M0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T
M0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P         -8W)O
M<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N9P      .$))
M30/M       0 \     !  $#P     $  3A"24T$)@      #@
M   _@   .$))30/R       *  #_______\  #A"24T$#0      !    '@X
M0DE-!!D       0    >.$))30/S       )           ! #A"24TG$
M    "@ !          $X0DE- _4      $@ +V9F  $ ;&9F  8       $
M+V9F  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $ +0
M  8       $X0DE- _@      '   /____________________________\#
MZ     #_____________________________ ^@     ________________
M_____________P/H     /____________________________\#Z   .$))
M300(       0     0   D    )      #A"24T$'@      !      X0DE-
M!!H      S4    &              &-    ?          !
M              $              'P   &-                      $
M                        $     $       !N=6QL     @    9B;W5N
M9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,
M969T;&]N9P          0G1O;6QO;F<   &-     %)G:'1L;VYG    ?
M  9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2    !W-L
M:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU
M;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU
M;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M  !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M $)T;VUL;VYG   !C0    !29VAT;&]N9P   'P    #=7)L5$585     $
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M96QM=;0QC &L8T0 !HUK6A23E8H+0-62222C7*22224__]DX0DE-!"$
M %4    ! 0    \ 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '     3
M $$ 9 !O &( 90 @ %  : !O '0 ;P!S &@ ;P!P "  0P!3 #8    ! #A"
M24T$(@     !0DU- "H    (  @!$@ #     0 !   !&@ %     0   &X!
M&P %     0   '8!*  #     0 "   !,0 "    '@   'X!,@ "    %
M )P!.P "    !@   +"':0 $     0   +@   #D "W&P   )Q  +<;    G
M$$%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,3@Z,#,Z,3 @,30Z
M,#8Z,S( 9&5L=&$      Z !  ,    !__\  * "  0    !    ?* #  0
M   !   !C0         & 0,  P    $ !@   1H !0    $   $R 1L !0
M  $   $Z 2@  P    $  @   @$ !     $   %" @( !     $
M     $@    !    2     $X0DE- _T       @          /_A 41-30 J
M    "  ( 1(  P    $      1H !0    $   !N 1L !0    $   !V 2@
M P    $  @   3$  @   !X   !^ 3(  @   !0   "< 3L  @    8   "P
MAVD !     $   "X    Y    \     !   #P     %!9&]B92!0:&]T;W-H
M;W @0U,V("A7:6YD;W=S*0 R,#$X.C S.C$P(#$T.C V.C,R &1E;'1A
M  .@ 0 #     ?__  "@ @ $     0   'R@ P $     0   8T
M!@$#  ,    !  8   $:  4    !   !,@$;  4    !   !.@$H  ,    !
M  (   (!  0    !   !0@("  0    !              /      0   \
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M 0 " P$! 0$             ! (#!0$&!PC_Q  V$0 " 0($! 0% P0!!0
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MP9;5'1%X[?\ BI^6\N=^5^&HJJ[<X+K\QM,Q-[3R%_Q._P"^,WB&@J ^UK_
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M9U8&/,(SE/,H5[5KKUUK!?.J-2J4R0/+)76!<%H@VWZ3!-K'JQI$"!&W^_\
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3/N8[_(=A;XXW?Z0PQB>C!C__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g542432g67h10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g67h10.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[1^<4&AO=&]S:&]P(#,N,  X0DE-! 0
M     $$< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<< 5H  QLE1QP!6@ #&R5'
M' %:  ,;)4<< @   @  ' )0  5D96QT80 X0DE-!"4      ! < _VD632U
M&LAT_L&6\3 /.$))300Z      #W    $     $       MP<FEN=$]U='!U
M=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $EN=&4     0VQR
M;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&5R3F%M951%6%0
M   * $@ 4  M $8 4 !' "T -  P       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0&&T,2         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #P
M  $  0/      0 !.$))300F       .             #^    X0DE- _(
M      H  /_______P  .$))300-       $    >#A"24T$&0      !
M !XX0DE- _,       D           $ .$))300*       !   X0DE-)Q
M      H  0         !.$))30/U      !( "]F9@ ! &QF9@ &       !
M "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    ! "T
M   &       !.$))30/X      !P  #_____________________________
M ^@     _____________________________P/H     /______________
M______________\#Z     #_____________________________ ^@  #A"
M24T$"       $     $   )    "0      X0DE-!!X       0     .$))
M300:      ,U    !@             "$    V,          0
M               !              -C   "$                      !
M                         !     !        ;G5L;     (    &8F]U
M;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M3&5F=&QO;F<          $)T;VUL;VYG   "$     !29VAT;&]N9P   V,
M   &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S
M;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N
M=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N
M=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
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M;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M"W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M.$))3001       ! 0 X0DE-!!0       0    6.$))300,     !3Y
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MTW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H
M# ,!  (1 Q$ /P#L.I];ZAAWVUV?8J@\[L0Y-U;'&K::]SJ[+:_I9'Z:O_NO
M^B?^G5,?6K)K@N/3K6@ ./VJ@&0VQSWLV6V.?N?Z/Z/T_P!'_P /_/LG]9/J
MUC=3ZC1FNONKN;CLH+:646 -#WVM>_[:/;N>[\S_ *XLL_4O%#B\9627$ $_
M9L+@%S@UNYG_  C]VU.!CU_)+J?\Z[PUI'[,=[;"X'+I:06M::9;ZUC?T]KG
ML_G+/2_TO^%4Q]9LBW(;3CCIUCGN+6-&52XN.\MJ:S;=O]2^K9LK]+Z?Y_\
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MM;=K9@DDR23)\W)7?S3_ .J?R*:A=_-/_JG\B2G_T_0LNLV/8!2,B&,):Z0
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MW>W=X2)UT3>O1N#/4;N+=X$CZ/[W]5 _96!K^A'NYDN,]OWE*SI^%8W:^II
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M %  : !O '0 ;P!S &@ ;P!P    $P!! &0 ;P!B &4 ( !0 &@ ;P!T &\
M<P!H &\ <  @ $, 4P V     0 X0DE-!"(      4)-30 J    "  ( 1(
M P    $  0   1H !0    $   !N 1L !0    $   !V 2@  P    $  @
M 3$  @   !X   !^ 3(  @   !0   "< 3L  @    8   "PAVD !     $
M  "X    Y  5G'8  "<0 !6<=@  )Q!!9&]B92!0:&]T;W-H;W @0U,V("A7
M:6YD;W=S*0 R,#$X.C S.C$V(# Y.C4P.C,Q &1E;'1A      .@ 0 #
M ?__  "@ @ $     0   V.@ P $     0   A          !@$#  ,    !
M  8   $:  4    !   !,@$;  4    !   !.@$H  ,    !  (   (!  0
M   !   !0@("  0    !              !(     0   $@    !.$))30/]
M       (          #_X0%$34T *@    @ " $2  ,    !      $:  4
M   !    ;@$;  4    !    =@$H  ,    !  (   $Q  (    >    ?@$R
M  (    4    G $[  (    &    L(=I  0    !    N    .0   /
M 0   \     !061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C Q.#HP
M,SHQ-B P.3HU,#HS,0!D96QT80     #H $  P    '__P  H ( !     $
M  -CH , !     $   (0          8! P #     0 &   !&@ %     0
M 3(!&P %     0   3H!*  #     0 "   " 0 $     0   4(" @ $
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ME=/7X2A$97*"A](X0TAC='6%AJ.EI[*SQ<;'4Z:V_\0 &P$!  (# 0$
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MQP =A$F1K^8 ,&^Y1VLVVX=-P\!W\0TO>09,BVHRA9::=5ZU57U$A_[?N/\
MA#O_ /G-J5$6G34WZS)E'J)#_P!OW'XOTP\@=_\ *;\O=HD'ZU(\KQ\E3&D0
MA?KI*W@.X!^R)D#H(B  &_K..X\VP=0 1W[NNH)#1)M]3"7Z.1X$?+Q4HT>&
MZ;2-O]K;;],;('7?W?5(/S?BW'6!+'6>?!QS%#'J,E$',^XKK0^8HJH46'Z#
MY_<-NG=D3( [AM[_ %E_+O\ BUL'6?KFIBE]:]:9:*/J)#;_ *ON.WN^$3(
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M$C8J7CWGJ\XCY)5X03K-4^["[#?A/VMFU8N TX&SN<",4AN'BN#78;GD"=R
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MBN@N+5G18,</'E0$.("]2"#7AFRA4L%.#9""H\1DC-UV3I+U'&)S!;'=\8,
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MM6X"Y42<+$4*W(JL=--,H&/AB86TX3L(.V9X&+AMQ6N=+ 6N<YOP;S0'?$"
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M6(9\HX JC<&<G,OV;1V=PFHFHDFV564.55+V=C]*O PL?:'8K6[/B3AXCF0
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MN^$7RD>(>&;-_ 9AO'."[_ANS_".XH&=;+>W\%;6U5O\P]LTO5Y>EJM#F?9
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M*E!5Z(34-*KQ[M-V#>Q*I\X_G2%4>'6=)HJ$(<":87:C&XO:Q-MNV;$:V02
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M'O,(AWZTK&\Q>U%:J*8ZLQD$QR !B7=PF [B/,1*)AR%,;PYN0W9[#L $3(
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M:P?K97H?H@_RP?G9&'TBU(%\=D,D1G\%>9O.E(\KD68ODD M J&9@Z &QG
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M$A]A$8<795UD_FIZT_54BM!+W<@%Z;;@/,3<XF.4#%V_,]P()" )?K *8W*
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M98IS 2D'$0$U(,:FNHNWM!)YFW0$Q%XDSLX.!R/;?9['-(+10DW,F2:DB8K
M@ VFLSCWC,B.<\:4U=77E1*#(WE'^'NV9BPY?X2R6>%;5J_\3,C?%8^N6)IZ
M6AKC3QJ>,I8R*+= '#F89P]="29<BIXMXGYZ]Y3I&*32_MO8SA%K"QKBP-;
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MN^DUI/Q_5?E/K\OU>:@XCW&2YT\_HHCB>I^OH$#Y"3R30_\ P-:0'R6[*?\
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M)HV4>/WZJ931];54YWLDZ>/5S&.<3"9==0?:[,.0I=%$=>,]:P)62VBE&B*
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MHB-$1HB0U$_4UF^WFW?SLKHH&?/6>N62ME%#]%<B?;N]^;]#8G\OGUT8O\'
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M:U(2+/9!BD3MXP)P[-$TJ6/24564*R3?&63:]HJ=04")F.;G,(:KGN8TG(3
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MDVC)FB=A7'!TT&Z0 FF3SA==0")@4I>;E  Z;%'7AUSO/!9*:*5 P\H"8>X
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M9>(%%15--P)VASK)M5![-VJD1J<!*J(:HMHQ=X$8+C.IH+9&HUI\ZC%[W/\
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M6^/!G$AA7B1JY+?A;(=>OD/L0KL8ASM(1#@P%,+.:B'/92D6Z+VA"F2>-4A
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MUL((J-%#@J83 KR[EUU;/@=\6LB7/>&-B9K ID:FE+W4@3  )),==46LV/\
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MS8_R^L6-_>*J>[?6GL(I-9/***UJ_1%WE=4; ^J2_"ICY*T1L.%AD*Z?#&6
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M,WCA,(?+7-<)!W2&@Y%@TB8CXJ*2_!)^!Q.H)%AE:DTKSI-%B)QG<1.$\TX
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MK-2:Q,C*%K.-@N<"7;I%ZR"?(SGJ/=)W+?E ,-7%CD5S4K?>*NXNO!//X_\
M1$3%3<:T:9YLN5"W63!D5LJ@@V0%NXEW*$_L0B"3TD>FN/:N!6UXO:FQO86[
MV$/B!:0XBU)-)@9Q6A(BD07X)G=<2Z)$N$3-[:&IXQ=8N\;_ !(8DSAC##T=
M5;=:K?DN%=M%KK(#6IZAU)U#,*17JU&N9VE/;'/P!LHMG,>YCIJ<J!&\3)0+
M9D*Q3]JL1.K[9VW8=HV<8;<22#,->"1))-2V0 #05B8%(F-X$Q05J:9 ",I-
M)FQJOHL^2FW#R;7 ]N&P_2SXIW#IN ^J[#<!VZ?<Z=^VOGYX67 3\1TKZGKS
M\M@6B(T1&B(T10\0^0?Q:*,_#7Y?./+-BJD(#-9,WW'],!3W!^X^G_+^7AJQ
MCX65 ^%NOR"H&[I?CR8/?.M_2W@G$HGV$??;ED7^D&SZKEZ!-;98N-E.).@)
M2<<QD4D\*Y1532?M$':::OKMB<O:$(X34*13D$2\P !N41#?;IHL28(Y_(_.
M.23[',O#TM/Y.AY9*M5OX)I.'A[%+66!C(F%=NISM4V@5V2<HF2FB)2S%[75
MTX\QU"6&/=QO8"[3%,'7762201Q,'QMY>NDE*-QD# )XV-E8I[C>=;RSZ&C8
MPL2>JN%73F:!BJQ!),ZS<3@#!^A)G1YNV&/(91),P[%$II?QRZ^23HYUX4C6
M"N59*U8Q=RMJ?S<5#IMFL2Y;.)&O)Q2\DS.[2:F;)*D+.19VW:J$3>B]2%H=
M;FT2:"*BE3^?1TK(?"-B,?S2;I:*AZE(HM'SR*=J,XR)<)H2$>L*#]@L=) Q
M2.6;@AD'3<P@H@L0R2I2J%$H%/7GFKAZGU+<1]5JYN;?F'T)&;CN&P[_ )UZ
M[AT'?PZ:(H^J%2WW]5Z[N&^P^A(W<-^_KYMOU\??HB/5"I_P7KO_ $)&_P"+
M:(CU0J?\%Z[_ -"1O^+:(H^J-4_@Q7O^A8W_ !;1%#U0J?\ !>N_]"QO^+:(
MCU0J?\%Z[_T)&_XMHB/5"I?P7KO_ $)&_P"+:(FAP&T:,C9I:LFS9FV1SO=B
MI-VB*3=!,!C*T<0(BB4B9-SG,80*4-S&$P^T(CHBR T1&B(T1&B(T1:>O+TV
MMI5O)3\6(/"@(V*LU2IL ,0IP/(3U^JZ"0E P@ &12374 1\0#E]H  =F&TN
M>V!/Q D< 1)2I('+W\K>5#5?.K>\-^2:_P .%-XFGT:1/'E@L<O6V0IIN?/&
MZR" >8S[H#D*FE"R4@DZBF;KF GGC(_,)4U4S&]>S8=I=A#%:P'#:)DO8.-B
MX$Z 1PR"VC!Q#^$4O\39YFLQZ"]Y6*(F$P\YA]HX\YMO 3^T(>&XAOL/7O\
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M5(--"=:F,YM(TGE7R10F)(-A* <H* 50!$ +V9_9/OOL&W*(]=^_;66"YIQ
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MV[^=E=$5LHG26R)[QN[WK_\ 1T3[QV\/'[P:WXW\+ _TW?[SI55^R?WG;_\
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M3RD_JH_ZB!Y*?80^DLQAM[O.[AL'R?51\0?%T#W!IWV)_-:U!3T3=''S*/\
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M"R7T1&B(T1&B(T1<W_T41:Y6 \G#'PC$P^8W3.^/H:9(4N_.QCV%CL*9#&W
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MX9JR2W@"7$M*GNU1=TJ94?8COK?]"7:T,=1PW2B<9QR9986T!%M5I9P1P]?
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MQ5>XRYQXF]TW=M5KLGDOB4I<S;H"J.;KA3'->8NYF2CF@HC))9?BQ>I-GCA
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ML[> B\3*?:D99 \*99YK:+\)F./XP*1U[OJK@?\ ']%*/A,QQ_&!2/Y5P/\
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MFZ B903(BH)C@<BABKJCMS]P& 1$1#QWP &F *187 %P01;U&JR^BS8B.$6
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M)@;FZ;<WCOOMX;> C\FMFZ=#Y'Z+.306%M<X$'.1PI<Z+R]"H'*5/F4#8""
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M1]IV_P#UV_\ B9\O0)RR^'3O+_WC^'^OPUH5@IM$1HB\D@ BP>@58S8PM'(
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M#IU&2R*PA.V"4GS("FWB"I%(T4DS-41*4!,BBF8^YQ,(E*<'Z:KA]_C,B/\
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M7**ZISFYD6Z29"@)=]4.-C/Q2X.=3?>X9B7$DQ>YXQ7*ZUN))DF30=>=]%D
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M5F4INSW0,L8"IARB"BRP[E(41$1*&_( &$?VH!N.L,7:7N8.\.]K&LFO(TY
MTJA;[ ]9#/GD;+Z 7T,!PIAB7@JL?$7,L.QM/$];UWL>Y7*'G!,>8UDYZJUY
M-'83"FU?SXVJ4  %/SM!RT7/VB9&VU'CO#G4%NNO6ML;^'O>V5*>:YC?HA2E
MMJ7Y5_B-(R#LTK2SQ?=%0 VP^=3^-:PJ^4 -Q#<SYJL?<-@#G4Z>&K#8<9K6
MEL.FTB@]ZQ(T6UKQ N8@4M33KA6I6HY(YU&BQ@-]<BV?%*;J4#'/YJL&VX]1
M'E,/00VW[AWU806-=/!_],PTWO:;CCQD&02!68J;T%8L/?1;!/)%8M-FCRE'
M"+5U&OGK*+RY%7F2(7E!,K''::]S,<X'V 42K0S4%2=XE5 H!N(AJOVK&!PR
M*W:;B)F#G3.D:RI?]T^'0_+DOIQ7[.^+\6H7EQ>;.C!-\<TA#)5Q5582SGT1
M273R58-YP",F#D7Z:KR"E&PLXT'3XCA%)-1J47K,7%6,-SX#6SO4%JGA.=)6
MMC'/M' SX^U:9"5>X[+^.I68GX-G9X\S^KPM2L,\+@RK-C'Q%Z+*&JCM26=I
M(12@S)(=\=NW1>J.DTRHG<HH%<MNUGNGM !:9J(%3\, T'&B%CQ^$^%?;]%=
M#9"K*3JP-GCM2++6EXUM(OI=NM%Q:BTJV1=-2Q\H\(DPDBE*N1!R=FX6(U><
MS)P9-R0Z98W'G\)K;Z]?13W;Z?":\.?E8W2>K^:\=VBVVBD0T\W=3]1+7#2J
M/.FFU6"U0JUAB!B'JARMYKFBD1<NPBSNQ8E.070)D$3EDX;P)+3GE6G7G2Z=
MV^GPFN:5]2NM6O4<M+U&=B[#&H/WT6L]B7B+UNE(QCI5E(LE#I&'LW+)X@LV
M<HG #I+)G3, &*(!A!%P1S6+@6G=-^I2IT4(T1&B)#43]36;[>;=_.RNB@9T
MBOGQ5KH@AZ6R)\5X?>[^YL3OM[_G\=]];\;^%@#/<=_N,5G],EP;)_>=O_UV
M_P#C9X_*OFY8> AW"7\?Q=/$?^[6A6 ^ONIM$1HB-$4@%V,)NG7XO:_XPCU^
M+IT#< []#.7JF?7!3Z(I3EYB&+_9%$ ^(1#H/3J&P]=PZAX:(1*Y.O+28V-"
M\6<3<2)G3;WW'$$].J.P(*O8!:0A7?(&_55NQ:,E%=R[B"A=M]>__9?:&G8S
M@?B;CO,Z!P81G.6EI7;LSH;NYDG.!-*1?CG6)M34@9IWE(0H<@AVO*  (["
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M[Q= %Q$FM,\JGT@<NT?=M^(>=09CC]5T@AU !VVW !^[[]>+:! (S 7&HZF
M)XW1&I1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B*'B'R#^+18_
MB_Z?G^28JIC^C>3=P#]D!3W_ ,#Z?\GX-6(/PMC^47 /N%0AI.)M%/\ CO\
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M<5U1YR&!-G-L(PB8!N'Y_6[39,3 -]V!M!PMJ[O+$@@:D$2/$7X!=. X6/\
M,#>)RX='@N9G<NW,'*81 ?';FWWZ"(CT'?KR[[==N[7U+#JS>DF<-^6K-">(
MU^:MF$%GA2OCGKI0>B?#A;; 7B0P0<WL&-F#'HE( B83%]96)>;8>NP@H8#=
MP=0$=Q -JWM2G86TSGO5Y"@UL:"LQEGRXU'F^0MIQR,^697=$KRB3V@ Q3$$
M! P;@8.@[;=W7P\-QU\>-'M/4U^H54/+CHN&SBSQR?%G$UFRB-DQ8Q\/?Y=2
M-;D "II1$N",S% F0!, I'8R""R>_-R%/V!.5-(A"?7.QMI^T;%A.+@"&M$3
M4RV: VK^EU9LEP.YH:BM2 ;@1-(J0X:43!"Q-V1CH\NXEY=Q$!$1-T*<-]MA
M*/M[!]< <HAMJYPXWP"8O<P;'7)9UFQB)F(U%0>/R72%Y#FF@UQ;F2_G2*4)
MV^1U8:G QN8[>O0#.17.<HFY2AVMA I1Y ,;<WM"!2@3YG^T^,<3:VX9%&!Q
M!.<F/&U[:+CVAV6IN-!:E34DFGS6]0 V  #N#H'S:\R* #1<J-$1HB-$1HB-
M$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$1HB-$4/$/D'\6BC/P^?I\_!,35! )
MS)G7]WZ@]/=ZGT_W?)JQ ):VY^$9=96X0J  '$VC[O\ >'Q)(INLM!LG%HOV
M$??;ED7^D&SZKEZ!,3DM_<V'$-CI2E5V%LD@;#V42.6LU:5JL@V:FMV+?STD
MY0@9\SA8JH%)V)FR:?((F[4!+IUUUFL36EO#G^OZI$M,/3$:6PIQ_"I@%FE;
M&+N/LO)=]SS+20<D?O6;I0V,>U\S6D$D7QT$E$BJ/$TG@E*\;-7"13E4W_/7
M]*6"JDQ%,E4C5#\*F U31$2O"1XJWD%10BW7G)W#,Q5<8*)N"JG?/0.X<D4=
M'!X^5,J*K]R8Y!P,BO&L\Z^_%>B<Q;9+'(3TK-\+^#))_9FK9M.R#O(+@\A)
ME9*MEV9UWGP;=J15)TR9.?.$1(Y,=DV(=8XI)*I$\=<_<GYT&E)5J:82>,5'
MIV7"7P^-?/X]U#NB-KJ""*L4\,OYPV,@CC!-,5'";E7MW0@+I7F%'MRMBHI(
ME*]C;$<TT=UV21X5L")R50,V-6'H7T_G$*=J_-+M5FBQ\8G5([92YU9-F]$X
MN4WZKAXF=%PX6.8HM2F="=;>'SU,JY7:@9 R#2;ACRS\/V(W%5O@2AK.Q0R:
MX1._?3"!4'LX"AL8J%+/E J2K:5.11RDLV;GY_8*!"4X:>.0]\\[52&^EU<#
M(UV1#A=PP'JPQF&<5'CDUT>*(:P2%>D)=ZZ8'QD9%^]<GJT&B59T!R)L6:<=
MV1F92IZ*+YWM&8RCB+R-$LB8OLH/)9_]+#@PSR<E6TU+.O7TXK/I5FJZ7:OU
M1'&>Q'*2SQPNH=/E,Y<.7;AP8ZCE43$FE",LY KT J/P46$'S"2+PNX)3?1<
ML,[&K$ORB0LY7D8I [0*CC-)$J@)Q$.*?Y@()+Q[1R)57+9-8SKKKQ4QUKSI
MYD:\ 4[OK-Q#E H$Q/CD0 "@(FRY)]3=XB&V-_VV_<(B/3<3#S;%(*7(O2OA
MF;_-1]:.(CK^E-CCXOTVY/[_ .EQ[]*_6GY_53(U4/6?B($/V)\< /3NRW)B
M'O'K\'/XN[??1%8^&UQ/.V.7E[+%LH6;/G2[^?QT;**3+!!3T?73%*VD5F$:
MJX)V8EW.=BW]L3\A0  ,)1T?+U628B ;;^.L28+>)Z]U*UR9-SSG6H67B8ND
M*OC)YBKAPDH->9H\I6)Y"YVNN?!G5L@6D\9>4+<I$L+$8LR[0KS!S2EVKI9E
M'M7*P^>F<H=6'@AY8TFN+.[PC49C70571A88>*UF1G06F,XDW$5NKI \7JJ=
MMB:6XK$K-FM>4\@5!I8I1W3J/!PS.L7D]5;0C5Q+V+EM%F05<-G+2#9';V.4
MAA5?EB2O4 C3;CL3=W?!%&-<0T;SJLWYH*-K$P:B:"5N^R8<&3 BTG*#83_^
M5C:H-7'7&#=K:WQTVE\"V)C.9&>9->1Z<=<*FYAXJE8RMT16Y>U3+UV^;JM3
M<D^EV4(BU>R[U]'KE2;HMS-U@P=L^&"YO>1N[L? 3.\V8@'.E: 3%:+G?@D/
M+6F0(SK83,6J<^"058\ICCF[5ZX6&FX\MTPV@&E5FH=5M*54(>2KENL05EO,
MV2>2D%XK'R$8Z4:2%D):3)KQ40_:/E0*!796FS$[..$&%SF?%(, RTQO6!EU
M)B(ES30C[T'!<,P "*W/SRKRKQ60E2XI6=JRI6L8IT5]&GL--A;@WL;^X48\
M9(H342K*AZF(-9I5UD*-C#)%C9J>IOI.,C'KEL5R!&RZ;DW,=F:UCG;[2&DB
M TW!@@DU;G .0HH[MPF8H)O>+QZ^4)N?*L62,JGDW>-F6ESE(T/PXY/B$P,;
ME%60L-:>P,8@4?[)>1D6J9=NNYN@"/36K"/[]LY$7Y@]7]EK'4+Y62*"399,
M2]1\V%<>O,(E,0YB["  )N8J?:$$P!N4Y1'8=P+Z<""VM-P7K<&UARL9ODMK
M#\,Z=</H-;E9Q^3.PVKG[CYX3,7^9B]9R&6*C/3B!B%42]7J4\3ND[YPF8/;
M;&BX1PBN&PB!%!$VQ0$0X]NCN6Q6"WD0&&EB-*&A(GD<#%_3VO\ I<TE?5I)
MU)L).S^N#EZ= W$ [NG4-AV\-]43H@RM(L/R^5/)< WT5%1%(7CJP_?.S(5M
M>^'R(9@<A _-7M/M]J:.3'. \PG!K*Q:>X ;V"$ >7E #=^QT,BAGPRMX*=>
M=*QIY^'CFN:]J<Y&YC"'^Q[C8/$ [9( Z#T ?DZ]_P NK5QG'$1_=P!7_.3^
MH'GKN9;GPX#J5W\_0M,,Q:^3TO\ -I-TRR$[Q09!!^X H JHG&4C&;=DDH8
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MBTQ ?-\BP<PKM]?V, J>9. CMT*8&?* =PG$NXE 1,%3VNX#L':BZ8AP!XF
M*5\<]+!:\>DUL)RTKQS'D3*[7!#F -A#IMX[>[W>_P!WS:^0.AQ;8P9ZUL?=
M52Y8_+&XL4J_$O&WU!N*;+)]-CGAU-@*5:7J9$81Z( 4-N8K#T6=;?J!SC^U
M$@F]_P#LOBE^#NDR</$W1P!%*4L#[>-EL/W'G_,,O\NBU)E%5,Z:>P@9-0.8
M0 H@&P["&YA .X1\=AZB&_3?VYKBX?\ U2;#[IRJ?H;KKQ9.&3.AUS%.=/*X
MI3IQ\B5-,7G#AD6);_JN)R^_5>$ 0W*G(U&JF;G$!'< ,9HN4>XO,0P )@+O
MKY=^TIG;_P#I/^XGGG'(>51CQO#Q^5#Y<%N;UYY:4:(C1$:(C1$:(C1$:(C1
M$:(C1$:(C1$:(C1$:(C1$:(C1$:(H>(?(/XM%&=J1>.-OR3$U7;TYDSV=_J_
M4[^7^!]/Z>&VWY#JQ &ZVH'PC6^>17GP3WFT3_CNN!_*W@G%HOV$??;ED7^D
M&SZKEZ$?7W3:SA.TXDZ20%#(F-@W*0%63$ 43,-WQ24IR\P&(82<PG*4Y#EY
M@ 1*(!L)0;CF?&G75L9665\M8UG;F9[:9S,(%X@7.%H*"L2%3K+&(@FF'V67
M)"R><U:E(2TM-MBM)B)CX\!.UD"NT4!(DX0\Y(3/\_EY=72+'CWO\O&/G$+B
MBONWT=CUQEE5%];I"-1<5(2U15I!I"M6RN$+4)K.#519PV+7# R7=-I9T*3I
MJU)KU7UX9<4M%>-&WQ\I>HN5HE32=8HL$= 7=DVMSP\G859Z[2-/BEL91CF%
M;NK #$K-O(3R<@#!1J=UYD@55;LQT]^N'T2O4]>\\)67^%KI8LC8OIE\M,)%
MUR4N$&PLA82)E%YAO&QLVW3DHEJXD'#&.,M()QKIL$CV34K8KOM0;&41Y#B0
M?7W\$Z.BE&B(T1&B(T1&B(T1&B)A,%[>=9N[MPSS=OE']"ZUW_$ #\N_?HFO
M7FGZ$ 'OU! ,3EQA%C19.$G#=NR%,Y%L;*V2KVQ3$!8I^IN+]< QK.6"KQ\/
M&04W,8V2F$Z;*2,>S@8HA%'\0X3649(+N4EETR*%Z6;3BL9N-W1\);O;C2_=
M=<!Q!(\"LVXCFB&P!:U?#H+T3/"GB&>?Q[J0;6[T>RN\QD1S5V=\MT?3I^VS
M5C"V.9*TU5C+-X6R)M[  2+%A+M'4>V4 "%;&2 "!B-HQ!8B=T-G=&\ ! @D
M3IR@1"GO<3^8BU>7Z#RI"OE)X<L68_F2SE<C)@KI!:[GC&TI9I^;C()MD22@
MYBV14!&2S]VSA821E:]'R!(>/20CVCL7:S5!([Q<3ZR]Q)<7&3!)U($ IWKZ
MUOP\?7/\RDS'\)N+X6!M%8KLSERL0%G48\L56\TY/AF54:1[U9^E%4%!E:$T
MZ/$*N'+DKB-K98]JHU6\P!,C!!HV;[G;3BO#0[NW$?B.&S?=2/C=$NIFXGT$
M3WV)J,LADO=!<*^(JY9:+9HQG:RCC./;,J-6W-[M[VDUURUC'L.6=94YU,*U
M\;,M'2<D@[L"[%64=#(/%UW!W"PJZUG%>002*W,"2-";Q] H.*\@B16]!;2W
MY\5K'^B)+FXJ7DM\R-FIRE/<K1C>G*[F$O.TDK:P>NTP, @(=HWC5 -_N1'6
M6S]V,5KL0%P:+#\1D4,>-EK'KESY9_6%\VDJ^ZZQ1'F[)D($'N+R'$44 #P*
M0O:B4H=P%Y0\.M^']Y\; 1A@!H!B:4K76\99F@6UH&[Y\?03IG>#K"Z$OH;7
M$<E=O*60UX(R57A<-8GO]EDW:91%NTDY^+"C1#94XE$ ,]4FY$[<!$!,FS6'
M<=C ')V@0,  3)<V<Q&ZX&XUCUC.6):]9%,XK^FMA<4^B,7< V$=QZ]=]]^O
MXAZ;>&VJ4B:%:EP]_18M/LB.9>$:_J,%PJ4I0;]36<H( #8MAC9^/F73 PA]
M:Y4CY%JXV,(\Z"'-W[AKJV5Y:^D7!MQ]:Q=1KX:'CX=:E<G:QBMFX*CW>C5"
M=_01!PGOU^,P#\?>&VP:O/O8@>:GN0*4%\Q%P3E><JK=ASN^/T!]B+2N_#Z%
MF7=*^3\R054@E9)\45Z%B<1Z*'4Q_BX[TH!X=DJ)2CW==46V$G'BF<BFI]+>
M$9+%]P.'7LNEK7,L%C)*<(F%I:[*7A5A;VB[JUQU[DJG%Y#NT7C:8NL4]:2;
M*TRN.&,XC3'<T64CV$JZ=FABC(RC-"2DBO'H'7/U-VS':T-#FF&E@<6-.(&G
M\(Q(WP!E6BW#:,4 !K@(@3NB8 B]#;C]59:AP1</5([/T+7+$L5JYHJD62<O
M=RL1(-AC.Y%OU#K\"2<FGX0U;K-F*9['04>"$>1-51LHDH@8" =MF.\02T3)
M.ZQK9)!:28 !)!J2)-- LAM6,!$MH21\#9$B-*FIJ4[5.P?CBA+4M>L0JS%7
M'U9LU0JQCR4@Z\P@KA-0M@GVI_.7"GG1GDK7XUP59SVJC<$U$T!(14Y1T.Q'
M.WI/WB'.XD66MV*]X(,5B8 $QUXYIV]8+6C1$:(C1$AJ'^IK-]O-N_G971/5
M6RB?9;(?O]>'GAO_ +&Q6WQ_AW^;71C5P<#^A_JYULK1\\HK]D_O.W5_XPD?
M_;9'OU*<HO<'?N >/R_=\/ZO'7.N\6Z]>.O%3:*4:(C1$:(C1$:(L:.,A=VV
MX5^()=B0RKI+$MV,DF4=A'>"?%4,'_F)B8X[=Y2B'<.NK8/[[L\FG>,(YUCG
M4!9X?WVS2XGF"/U7$V@W*L)^T'LS%ZE+OT 0WW$H=  !Z;B ;].H[:^P8+W=
MPP2!+0TT%6NB36,IK6QA6^"32YF>=C$>^<<1"SI\F_"OG_&7A96.34<&8RDO
M(/>S -DHYI R2CM=3?ZU)(HEZ^)C@ [=-4_[2XO<]E8F TAK7W!-9D&AS6K'
MB'3FTWD4CPJ)US/AV(% -@$.H" #O[_$!U\K #;9]?-52T8>6XHKV2HV%LAM
M$%#H5>QVBN2*P#LDF2RL(QY'%<" ;E34=P)T]]]CB?LQ 0/KU'[+[5N;0_")
M@/?AN BI !!B9K5O,'@N[8W[N^W4@QK0C2D1ZKG422 #D Z.PJ;F'F$1$"B&
MY2^X-NGCWAUU]+Q:8F&YGCPEI\[F:"*Z0K-VZ[!<34P!<C\0 I3(>-.:WX>1
M(G#-Y;.M4 _(DNTJUE(@  !.<J[Z,<*\@ 'MF 6Y!,&_0@!XZ^??M7L[,-V'
MC,$%SG-<2<RTD4-HW3G7,*HVC#:!OB9D6F*R<O UOXKH++W!\@=WR:\<+#D%
MRJ.I1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T1&B(T10\0^0?PAHH
MS\-/G\I3$53I-Y,ZB'U?J=P;]?4^G]_0>OSZL0/A;_2+D#R'4F2J &,3:* G
MOWS-?PMXIQZ+]A'WVXY$_I L^JY7X^9]RF'R6I>$N(?'@T6-K$G('PYE+SU.
MTS$K#M$V1;ABSE,W7B8F6647%<2_F2B*9.S$YNU P  D.7/+D?DK\+?.RBW:
M!0,'"J5X,FFJI;K4909#S?S89(##0MRNSM%#,3K@8S@6IC(G6.B():(+TSJ:
M_+G?H*S1U/RS#I.T8G$G#I%I/U7:[U*/FIYFBZ5?]D+P[E)KCY$KDSDZ*1G9
MERF,[%)N*G5LF(DY]>@55Y5,LOI)C-OL4\/;J9C5W;EA*.IZ></V+A\"8O'#
M)\?'?GB"[LR0&?J$7 SX! BAMB^V2.IOK-/SXA*-FKQ",FJ#1E3,,-FC=(B+
M9LC=;@W1;H)E B+=%!&B)I(HH)%(BBF0A0*F0H<H#OH@$>->IX47H&0XC^GU
M)X>';_?U<0^;]8_7KXCOHD<_/UF_L@9#B/V_6GA[?O\ U]7'YOW#?=[M^F^^
MB1S\^,]<+0CTAQ'_ ,$\/?R[N/O^T;^OW>(Z)UG^754>D.(_QJ6'NONO=QZ=
M_P#O&^3N'1/?KJU-(HCTAQ'_ ,$L._RZN._N#]P_3Y0Z[]>NB1Q/GU]."/2'
M$?O^M/#W=_#JX]^^_P# ?Q^YX;;:)7UU_++3S-T>?\1_\$\/#M_O[N77QV':
MC!X]-%/777R1Z0XCQ#]:6'-]P[[W<^X/'I1OR[]^@!HHCB?,^G7SE/<-AI]9
MEF%2TM8EG.&SI=A?MH-X]?Q22Q6%= A6;J0;,W2R?8D0.<ZC5MNL8_YB4"E$
M2GKKTJLE=$1HB-$1HB-$1H>%T7+G]%$9:*SX:>'WAHBI*&C;+G?.,:^<JRT@
MUCF<=5J.Q7*I)2#MX=)LPC/6&=A0=OE5"$1:MU0*!A-V8VG8V%A8VTM9C@PX
M-$ !S9D7+BVT0+DS8FJ+D-XR.'C$.$)#'KO"F3Z?E"K6.L5Z'M3B M<//OV]
M^@TBDLSTK2/?/%T8:R"S0EFP;BT:'<J,^T$B!55?5]I;+@[(YS<(G=&'AGX3
M#?B:TD;MFG7,YS"VL^Z.B36_YQ7P7:K]#=<)R.$^#:1SQ-QA4+MQ06%6U(NE
MT2@];8VK2[R(I4>14VZA6CYT>=L0I$$J2AY9$W*8$4CCXO;,8XN(1DTG*":Y
MZP,^)4/-2,AY]5713KD6M<W/T4'C1*X^3SA+P0C;S[%><J--(+JI)F<%965M
M+5%\U:N#?FC4CE:38+N.S_UWS!,# (@371LP)Q( F<@)-QUXRC028_0>,>ZX
M"9&'D&!1824<Y8O&[-[YRW?(J-W:(H*-E"'69N"IJ(@HDLFX*!O]<*<3DYBG
M PWK 0X X9!&'F!8.FXUX9&%TMPG-;4@WSDT .D#B-=%] GZ&!N$38?)OO:Z
MSCV+"4H&?\DU^=,S A5Y5>0B*?9&$W(D* '%TXCIE"+256$YCMH5,H" $*!:
M7;F.&."8J)IXZUFTZZW6AQEQZ\ET9ZY%BC1$:(C1$:(C1$:(C1$AJ)^IK-]O
M-N_G971%:Z+]ELB=1_7P]W[A#[&Q0[^_H [ &M^+_"P/Z'?[CX<UP;)_>-O_
M -<36TX6'EQCJB<LO< ?%^7^G6A=PMJIM%*-$1HB-$1HB-$3/Y^>Q,;A7+$C
M/-4'L*SQU<%95FN8I$W;(L!(]LV.<P"! 6((I;CN&Z@=-;]B#G[;@,;(<<7!
M@P#'QW@T.=]"L\,2]M8KG3URT7$"X:D%0O9F,4O/N !UYB'-N!!$1 1V =@'
MQZ= U]EPFG#PL-K@#(%JQ;A0Z&*S>+6V&X#XC-CI>H%*4SX4S6WWR-]22>\0
M5^L0MTS%K>,'+=!0Z93G1>3L[$)E614'HDIYK'NTC;=3$6$-]M>1_;-Y&SX3
M6F-Y\1G1CCH8BA%Q2X7/M#QNFXD@95$@ZY@>(G)=, =P?(&O "8'(?*O7Z5R
M8CB6Q#'9TPID#&<@W154GX!V,,NLD548^PL2"]@WR.X")%$))!L)S%#F,@*J
M'UJYMNK8MH.R[5@XWX6N&]!K!(!@&!:MQ6+B9R8XM<"/',>2XHIF!D8B4>13
MYLJVD8I\YCGS=??M6KQDJ*#I%??_ -\25(=,^P#^:E'Y=?:,,C&V?9]H;(;B
M-$ WJ'7O2 9,GFK?"#GLF9$&I/E0\($BH\IVB>21R&G2N*)>I/NQ(PR929.
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M6 JHEDRJ,"C\N.G7JIF?'Y>G*;X%L?41FZ-%+-:^V<WQL 3MF9N6*#I8KT#
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MB!=-%&#J:X?'+%=%1NX9+XNMRK5PW5$.V0515R"HD**H%(91(Z2Z:AP_-"B
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MC1$:(C1$:(C1$E[=7VMJKEBK3XI#L;#!24*[34*!R&1D6;AJJ D'?FV*H!A
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MU& !B-<YD&:1.5LC'ZGJQVD,WR!NP8KJ0 ,HIR^G:0F  0@%#8H%* !MML
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MD+%OS@00^#C&NY3\H&Y3;0'01+L8.;;V3D$.AR<Q3U'7U\%$,=Y>,;8O$?9
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MFU,TS;G+7'4WK9E4(*YO)I-HC.LRH4I%=LO;6R<.>Q8\=E6QBW6<0/:NI!:
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MP$Q7A@/)KM6I2(M0Y'T%OJLG,$;^<YN]H#?I\W7<=@#<?1=:W$ #WC\W0=%
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M3#054%@#H=,Z:NXE'<!.FF;;H :MNPG;O:VQ.@&,1U#,?PL09566$=W$:?\
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MD!.)1/L(^^W+(O\ 2#9]5Z] FXG!_P#"2H?M<O+A;*!^80]@H!<\6!SF$>@
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M'X65CX12O&M O/C^)M'^NZ9UW6<!E'5 XM$^PC[[<LB_T@V?5:O1)8B4H]1
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MX%55$S@W/N&;MOVUV&["=M6T'#?]YAQ<0M=(@RTN@^7)#B8AG>>YQ.9<?+.
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MOT4$QE*AS"&^Y1V\-AW$?FZ;?=T0F!8DZ=>JE.<2]"EYC;=-QY2_()MC;?\
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M=6DIU1PE9H*$6E%(-QV=HK<_Z$LL&E-R[2(LD,9H]:M7QTU$W!F[,[8BN+7
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MV?\ ^T[\OP$FL=9?5'F&2OX64?IW_I>S_N ?XSOCT2\:% ,,DCM]5E'ZAO\
ML>SWQ?WS?CT4J(L,DA^ZRC^'[WL]XCM_&=HBD\QR5N >M='ZAO\ L?3_ $[_
M .^=_5\V_0HGW \X^JB##).^WK91_P#!]/CW;>_)W3H/7OW'KOHD^X]21[A'
MF.2=P#ULH_7?][V>\/\ UFZ(#4B+1GJ.2!89*#]UE'Z]WZ7L_P"\ _C.^/YO
MCT2:3PE L<E!O]5E&Z '[WL_XCM_&=^7=OXZ)/S]#" 8Y)$=O6NC[[;[_!]/
M>.W3;X3?C[]_FTZZJITX_0GY*(L,E;!]5E&[P_>]G_'I_&<&BQGUMXS$BFFJ
MH'B;VY_,9*ZQ;= >4#GK-1/$O#$-U. +S=DM29#>R )G3;IF( G$1,82"F2?
M]Q%>%<N7ZI3P\%&PJ"B;%%3G<J X=NG2Z[QZ\7Z#VSMVZ4676.'[4#*=FD'L
M(D3( % IBTBWRMHKSHI7G5014 _:$ X#WE,(\HB(;;[;[;B!MA-MOMT[NFI!
M(LL2 \%KA(GY?FFR?TERR<'=T^==U=5PH*RS4"%DX594Q]U530[O=-JJJ8QC
M*GBG$=VYQ[5?M%?:UN:0YM1\_?+JM%58^SXC' X&,["K$0'M=E5IBTR-UPT-
M)GQ]CEXFY"7.@F( F HK8[GC*;>'.9/)291$OB)2$ VV_*7?;3<:9IIPT!H/
MJ%(Q-K:2.]PR;SW9&4S =$^G!411S& #O=\?#L&_[&T_\?A\)_7?;WAM\H[A
MEN,D0V_]6@/\W$([%VRH[W"R!_=G.H_$/'5 )9C$0^K?'NP &_Z6U@Z[]0_?
M0'Y![OB^*=S#F-V]JG4C^8+$8VUBV)AC_P"V?_EIUD@4<R==KOC[Q']C6P?M
M=@V_90\=1N89!(;:-<_^KGU>>^VL4&+A1_IG.O\ -QO3Z )9B$0*%VQ]S;[;
M_!M8-ON?"AO]_3=P_P"777(3_.@QML_Q<+.?W1TG^;ZZ44.SS%T^K;'W=O\
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M3=$=R(-TDP*0-3G3$" ?&:\9M"[L'9F,$N^)Q@R7.)F/YJ$WM  R2N3  3(
7   !0  #N  Z  =_0 Z!K6ND6&2__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g542432g79m05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g79m05.jpg
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M 0$! 0'_P  1" !7 1L# 1$  A$! Q$!_\0 '0 !  (# 0$! 0
M  <(!08)"@0" __$ $(0  $# P$#"P,!!00+ 0    4#! 8! @< "!26$1(3
M%A=45I?5UM<)%548"ADA6+4:(B,V)#<X5W)U=G>4E;8E_\0 %P$! 0$!
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MTB_5?DOI^697]M7Q]C=M0T- - - - - - - - - - - - - - - - - - -
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M9WE</S$W5F>9H06&0J.R*2DB ">.UD<LCIAF&^9 <0M%WD<=$PWV!I U (B
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M)1C$9>8E%@:<O,O(O7;=RY$NFC0&2;GV(=VF!TGC:9=&.@49 D+0/)!1:9M
M'>[4"(E[&*%I)(.H_I:^O%IO:+6#[WE*.[FE$:N*46K?30&:T T T T T T
*T T T T T!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g542432g79s79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g79s79.jpg
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M@D+_V@ , P$  A$#$0 _ /OXX X X X X X X X X X X X X X X X X X
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M*DOV:W]T 05J\*[2_-6CLJ%6^;+^&29HCQ#Z2!"_!*V[:[NC]V>8_1?I=_\
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M_9UOK09?3:^9JV8.NY[C+VXJF];RQ'(4< < < < < < < < < < < < < <
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MG_37\.ES@X'>]KZE@."#@#@%5_77JU2\>ZUJ[5>@1HVL=DR8NY$ K$[YJ8A
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MI?X[._\ V9IJX/0< < ^Z?\ (X_^1_?7ZU^=/^T;EX.;U[[.Q]3[4>#P' '
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MJ<&E0\L^)$7?KUQ"/M\?].L_UXU+_%E(Y5?N?1D=V]=43%R%' ' ' ' ' '
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M!NB3"6I8BXDE2J 1SOC_ *=9_KQJ7^+*1RJ_<^C([MZZHF+D*. . =) Q_\
M,)W_ /<E/_[T_(KEL70[U<MBZ'#<I1P!P#M(_P FQ_,W^5O_ -OZ _\ ]&[7
MX./U?\EK=_JC>KP>8X X X X!\HWY7E_4 \^?MAJ_P#!7=W![>A];_ZOJCKP
M.#J' ' +^_"F_.:> ?VP?//\45G@QZGT6MAV_?!Q#@#@#@#@#@'5.?E!?YX;
MVI^M.LOX%:NX.STO\=G?_LS35P>@X X!]T_Y''_R/[Z_6OSI_P!HW+P<WKWV
M=CZGVH\'@. . . . :Q/C0_FJO=O[/CA_A.#?I_79VG4A<':. . . =SQY-_
MJL>:/V?]-?PZ7.#@=[VOJ6 X(. . . . . . 4%WN.85+TV-VT23VUZU[>\>
M[OU6.'*:L=<IZFQ+KUK=MA5+ H"/)6J4NV 0G*F.)6X*X*6Z@8"BY.G>O+U8
MB+AO7SOI\D6)7D#\#><O**6S"R!CT@(TGXVTBW,-6Y9+J/3GY4$679+V>[5_
MJV1I6OH9\LO>R$;YBP-HN[Y85%1BNDL"*]V*%;KI+<;;^*HR9/*C_MVVP3:O
M9-.SH6O5%7=,*=NV";QA-9-K&YFQ(5@!]M:+]VAML_LI %4]JDG-9BJ0X3V\
MC124M4?5LE((XPTZ5+';0UZT;"K0BQKYBJA<;  A8H8JM$W/8*KC'391]OJ_
M:(5<X8>[8T?%-4QARQDAAE^B7'N?OZE32O4WXQ>H,M-XQ=ADY/!^#]P_IF'_
M +L1'^O\4R?%=A7-<'W'X/W#^F8?^[$1_K_%,GQ785S7!]Q^#]P_IF'_ +L1
M'^O\4R?%=A7-<'W/G%M_DFOA"[:LW)]J;R[FMV)K,W>)(-CC]K/)E+)]7'Y7
MOZN/U\^_HZ^GOZ.OZ.5.RJ>WFSU7J^HJ39_3^YZ_\TL\%_I4WI_>8;_*<39^
MWFQ^-ZF=G]/\A_-+/!?Z5-Z?WF&_RG$V?MYL?C>IG9_3_(?S2SP7^E3>G]YA
MO\IQ-G[>;'XWJ9V?T_R-U7D#P]/X@\^I'FC1VX2<.L]?SM-E?C;$H0P'L9'!
MN..ICYTMT4H_,X]FV$AW6Z^6C^PJ=P5_]_[+Z^4ID^/['G:=JTVVU+TTC,LQ
M^#]P_IF'_NQ$?Z_Q3)\5V)7-<'W'X/W#^F8?^[$1_K_%,GQ785S7!]Q^#]P_
MIF'_ +L1'^O\4R?%=A7-<'W'X/W#^F8?^[$1_K_%,GQ785S7!]Q^#]P_IF'_
M +L1'^O\4R?%=A7-<'W*.^]/ACK?Q'M6*NGO2&WV2=.3G^ELH-BCJXA6)],M
M!=9%>OE:O=WR7V]'[K:BO6=3['#ZUCNO-]KU]C]3.S9RG?V2-6;5NRY35T?3
MLUT-3_\ -+/!?Z5-Z?WF&_RG$V?MYLW^-ZF=G]/\A_-+/!?Z5-Z?WF&_RG$V
M?MYL?C>IG9_3_(?S2SP7^E3>G]YAO\IQ-G[>;'XWJ9V?T_R)2T?^3&>._/NY
M-6[TU[M?<,;WI]_5-DI^9F4.3$8LJ8;IGPV1,=]E7^>H]7Z,'=JI]O#]O#]>
M/[7#ZWUNDV?MY_L1^IZEI--V8?\ Q_<WX?@_</Z9A_[L1'^O\E,GQ78\ZYK@
M^X_!^X?TS#_W8B/]?XID^*["N:X/N/P?N'],P_\ =B(_U_BF3XKL*YK@^X_!
M^X?TS#_W8B/]?XID^*["N:X/N/P?N'],P_\ =B(_U_BF3XKL*YK@^X_!^X?T
MS#_W8B/]?XID^*["N:X/N:0/5/Y.+Y8]C;^V+Z4W)MC:TNRMH70Q!HD6, X(
M%E8!+(53H?=XKZ+GR>'0D /ZFQ^9E^TL]33?3C]I]3&S9^WFSTL^IZEE))V8
M7_'?]Q7S^:6>"_TJ;T_O,-_E.)L_;S9?QO4SL_I_D/YI9X+_ $J;T_O,-_E.
M)L_;S8_&]3.S^G^0_FEG@O\ 2IO3^\PW^4XFS]O-C\;U,[/Z?Y&R_P"'[\([
M7WPTANT17F?;K?7J;?O*1!PZ>U\.V296$JNPU@G8S/JV,^1PZC9B?S6/T3?,
M9=U^_IP^Q^C)-G*-_=,Q:M6[<-M4_P"/[FQ/\'[A_3,/_=B(_P!?Y*9/BNQF
MN:X/N/P?N'],P_\ =B(_U_BF3XKL*YK@^X_!^X?TS#_W8B/]?XID^*["N:X/
MN/P?N'],P_\ =B(_U_BF3XKL*YK@^X_!^X?TS#_W8B/]?XID^*["N:X/N0SZ
M'\L,OI[2&S?/VT-QSR:^VTJWTUMP (0@09R#$OL_F>AI/LO:^2M=_9X_4G^7
ME^I_3_N=_3Q3)\?V*G:3334K3]S1'_-+/!?Z5-Z?WF&_RG+-G[>;/3\;U,[/
MZ?Y#^:6>"_TJ;T_O,-_E.)L_;S8_&]3.S^G^0_FEG@O]*F]/[S#?Y3B;/V\V
M/QO4SL_I_D/YI9X+_2IO3^\PW^4XFS]O-C\;U,[/Z?Y'T,(NG]D:\24Y 7=R
M0XKZ,JKR>"QNZX$6KG0=9$U HSJW9^_(_F+75*E!U//]G']M+]>3ZF/UOJ]2
MF3XKL>7YLUP_<RK\'[A_3,/_ '8B/]?XID^*["N:X/N/P?N'],P_]V(C_7^*
M9/BNPKFN#[GZ_"&W_P!,@_\ =D)_U_B5DN?<I,'(!P!P!P!P!P!P!P!P#\Y?
M6ZQR[PZQRSZQ[^KCEEWACEE]'^[UEEUCGWCCWW]'7>76&?>/7]/6.7T?1V!0
MS3_K][VLHGW:SK'4Z2!4]K>KM5L\['Z)GIYB,O++QLW6I9WS^\M-B*\J2<<4
M 7&6(]6<+J4NMU4_?'E/NJT/G&H6;PPSC6^_;!9&EOK4D,RL 9]K:> OK(O"
M#D2=7VFKD+=K$FK%G#*9;[NS!"S*"R7UMH/BST0&C&66%PNQ]4JE >0^3&8X
M>=UQ.,*^HO-P0L@ BF^-1U"NU#)=>US4SV L9Y.1P#C6[,BP,L1*2"[<'37A
MU&S#'+]; H5$"?Z298=4LBP\G0QOT3Z -Z-8O-@(4B"W./T'O\1H>2X0=+:E
MFGVBZ$_[ A9<*M9+;,6.O$,UT:I2"\K0"3N];%]87>X)K<U,$I3T4\TODE!K
MV.,47!< F#6NPP<BJ/C:>NM.Q*2RT#!27@ EE+ E&X)FC9%BG"5N3.K+880%
M-)CA#9SQ%NCO_P"-$/77MZ:2;:;205=Q:L9AZ/ ,M.MY>V$I&J:?5-UI;@:R
MTV1I>S"OP%JD$]H9,6SJ1WZT,L]7*6*//+H#.E]C7FT138%4Z&9@)#[?N@;7
MRE$R(O=5;,U*SW3)#I[-*S\O<KV*D_V,V?V5F":"3ZLL6>&(',\ < < @'9.
M]*ZCM/6.BE4'7;]N;4 OCN*!WC>:X"7M;ZQF5:#J]M9RL'8[U$=5/OB.J QX
M\ 4(GF5IHPX1T0H]B/ Q8HW@J;W,='Y!@J7ZW4I-B[DT[NJ)<TCLC2M+73,:
MZ./ ^R@-6N=O7#8C6S\E.YX:F9WZ!EH6&9$,!RP ,7!/0"X&CA+"R"T?/A%T
M5GJKUS)FH;QTJ44K#\,W!JTBBTS-Y<MNM#8"G<4JK",DDB) ;#'7+2!X#(^6
M&6*\+EN8WJDD4F%B"/+#+KH2'D<3O3;O\D?G[;&]P <:_5]::H<-L4PN+)]Q
MC6P2H*]YNEJTVBD&:(ZG146/E^["$0<G6EFEK=Y8XUI<K$8*K2S(!U'[?5VU
ML;$C;H=:TD86]4>=]SU3I+9 TSKXPH>EY7H6A">F\X"0\Q;_  LVMFL,03R
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M9< < < JSJ7SB3U5:]47H7VH<L^F]MF]QR_;I\E&!*8S.KT/5'8V&.%KGD8
M58!K55O8P2SB",I;-@ER)XTR0ZD$%;HM*;:M_)%8[Q(16%7Q_13-MUQ3GY!U
M(1T&#8S^MJ#6M/\ J(\NZV7SX=I2;311SIL]F73^MF48TA6>I&+9 %G+,'?7
M#)!;S";Z7N>O?(Y=B\@,S+OK7>ZBV\29BKJ?=PK<>OU1@2ZI&1;JY>:W#S6X
MZ\&E1[(%$"E-F&/3+L:#( HAB538I/.ZQ67$ /7P 0)I&D/6LGJIOC$HH#M"
M!NML0$Q?G7TQMOT.CQSH'5>X0K[57=_J\J4RVX'+[*](#%^CG7[)F'5!/5^R
M%3YI%^KC1/1L@3?JDN$=C )OAP+YI'7=<MFT2A)6$^:O7_F0CV#6,%TZ15O8
MCKKMY;F2@5E8S5<.RIY/5ZS"J9Y#"0[*O,9[*TKLMRCF+%]W%VE:X3W)G_V9
MWHW'Y[OONWP3&U:&W''MW[W ZA&)(IQN0:EV+ISH?<7Q;=:^Z;5]>V:P&RY2
M$I>K2M4(VP'"@EVO(LSB3?JHYI_!C>LO&5_5['Y\9@^U<+=W1\'IH*0AMHF'
MRSHI^H-FJ.VFH9%CBVY2K)D TI 2L#.]2G:^8#,E1N Y2%FN7I"S1K/V_P#E
M-9:Z%Z>#(X X!7KU9H7#U!Y[VEY_L-<J2/VLM6%,NS50T9Z^,%798<[L@RA.
M1&5?O#..+[.M8MRV*U?++N26E:ZZZCX+9?M:>1YM@Z6*[ V!YPV);<!X\KH%
MK9'":E65+,H]P*-FLFC5IF"/&1JZL+E#$,Y'B R+*P?L5">(C*U:(5:5RL4!
M8ZK]_@AE<\@N"0K;Z1$/?YA/6-J'-WN.O28E! 8[*U X[\;F'8C?9@V'V3ZM
MM:X%?6MB-I0K$4KL8"B3^YIW0G",!6103C>Z;(2A4_?<8E2\(E1@9W@';>&T
MV%J]8ZH]?#B.&LI9 85]UXF:N2S:[<"3["E+L*JW5-9QWNI[C96;QM\[>NEF
MIJOQYW;;/7^B^[3!J_#AYH9C>\;V;KPUNN6S<.IFOV!KOUY9I9)7UNJYW7FC
M=?Z#IIV%F-LAQD%DU76P M<*?*QVHF*T8GKU<1EFB*&C,W:4YM_)ARSX0*H[
M,ENR?N> >U+[#ZGF8Y"^K1+*NM*;ZQ] W?23:$@7RK/GDOM2'L A;AUJZ0%"
M%.F!L3C'11=^I<I>AJ;Z?;G@HYX\H,R,>-I2KD]MO6RL(.WKUOIWUG8HY)?4
MO= [IW5&KM1#%"*S&U5L)A1D!J)6(WR/R<%F Q;/R5:V-&Z.HAP]W^KL\6W\
MDR>>]*WM#KCNH=N6+<OL.YMX[;6XY%S &27,-[;B>]WL2Z3OQ&"4+)D*;=B'
M: DQ#07^OP[4#4[0N8G6OF"@S^W*A/G ' ' ' ' ' ' ' ' ' ' ' ' -4NZ
M-D[6Q]Q[6TH&==\U$:WXQU-L)>IZA'(A*?7.R''<.Y-=$]AY_BD7/-*-JA51
M;OW!%[IB"8=A"-_!>DGNW<+PU"]J=)]S5<DD_GH8CZ6]-[93V?X@+&O).R<[
M7E+32+2U&:#/((8A]L&T%BJ0-'#B')LT8/;VBO*Q5BZ_==DLF/7Q:!;KAK0<
MN?FI-0B2<*;W6_SRNED0/KC6NM;UW6<FOO0M<!JLK&L[@>&6!OV^.THPD]2P
M^A2-7:VU)F78LMT6M)+$N8L+/BY,@L 0<% $-L7 T92RM![72ZN$UO@Y39'L
M1J1%_7;'2\R[38A^U-B:32D>2)JT\+R-U=Q8'[>5CJ IL6K8%GU"B BQ-!#L
M8H9-=:5>,6RWX,6F98"+ZJGG,N[7DDFKP32UY:DLL,4DE6?*#.>M))ACEG7F
MSJS6*V4L.7?<<F5>Q/!EGCWW%-+'WCGD(>;@#@#@#@#@&O'VALG8*#O'P2!3
MV'8E5<VYO7::#LE0UW$O3EW);#>5=\[/#5Z_W]7ZRI6@SJA+1O.Z,*B;68V@
M0H3R7*EN6E,-)*+6B37ZK*Z,R:;U(,TJO:"#O:UN]@[W"T:C6H6EYH( -@5S
M'HMRM!D)59J,II6D:#:$6+KZD_U]?A&0BJ"I!C"Q]6)+4T]@2_32N"G7(B$O
MN\FS[W\RUD]FW#2'U_B'>E=&;!7&HPNT*#'13?%7I1TP6Z(M,N1!36N:S:I*
M#8A].LEQI'W:4-TQ*-(=25*HL4_^9YK,DVK\0O5]M("OL>N-O8B&#R/N+V,+
MKYT===7["%HPNFAGI,[BQV1E!#L2*=\7K RI/8B3B%6:QW@YX6*TM?$/:_\
MTK.]SV9Y[GNX8-B%5K_GCT3FUDE&39N:"L* /93C5U-98:BZL/>8[53*\UNL
MG>24L15U6U=IM$M%2:ZY8:(-U X<Z)&JZ;>&/]E\N"#@#@#@#@%>/7+"QI_E
M7TDY)Q\BK-R9HG;#DJL8GY/(@%9%-%.,(,C7C(U+X^Q\J4&U9):E^C;HVX>I
M*MNM-7FDCR%5ZVHKMH'<S=5U:"V8UCO1#61-:>TQ>N@W8=K\:LDFEA5V%E-.
MP%GZLA@BD"FPHV(VLFWLHM;'88K%(2-IF2$%(\#75[;\5V72F [!]@KNW-2
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M;]+,85:HAX,]A8?0T+5Q5,9.(TIV,JPUX8\U:^URSP02"0YC5K@9+U[-JUW
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MM)OX X X X X X X X X X X X!7+U<TEE72I#$+:LCK[SL'1VE^S%&:2N1
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MYKY>TJ(@6<P1GSRG(%<[ER;/*6?/+L1W[ES2+)\$' ' ' ' ' ' ' ' ' '
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M7R.I1+-=85 ("NEI]77RC7%#:U*!81Z>(O"LJ 88(\(A0&/ &%P^[:6$-;/
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5@AQMEB=VSU#%U+]3$"2^ . . ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g542432g91q20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g91q20.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[2"H4&AO=&]S:&]P(#,N,  X0DE-! 0
M     #$< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<< 5H  QLE1QP"   "   <
M E  !61E;'1A #A"24T$)0      $%P:QTKN"NZ!IDAZK DDTLDX0DE-!#H
M     /<    0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O
M; $     26YT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E
M;D)I=&)O;VP     "W!R:6YT97).86UE5$585     H 2 !0 "T 1@!0 $<
M+0 T #        ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q :'5HX         IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ /      0 ! \     !  $X0DE-
M!"8       X             /X   #A"24T#\@      "@  ________   X
M0DE-! T       0   !X.$))3009       $    'CA"24T#\P      "0
M         0 X0DE-)Q        H  0         !.$))30/U      !( "]F
M9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M       ! #4    ! "T    &       !.$))30/X      !P  #_________
M____________________ ^@     _____________________________P/H
M     /____________________________\#Z     #_________________
M____________ ^@  #A"24T$"       $     $   )    "0      X0DE-
M!!X       0     .$))300:      ,U    !@             "6    >T
M         0                         !              'M   "6
M                   !                         !     !
M;G5L;     (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4
M;W @;&]N9P          3&5F=&QO;F<          $)T;VUL;VYG   "6
M  !29VAT;&]N9P   >T    &<VQI8V5S5FQ,<P    %/8FIC     0
M!7-L:6-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M        !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE
M<F%T960     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
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M='-E=&QO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H
M   ,     C_P        .$))3001       ! 0 X0DE-!!0       0    #
M.$))300,     !8D     0   (,   "@   !C   ]X   !8( !@  ?_8_^T
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M &@ ;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "  4 !H &\ = !O ',
M: !O '  ( !# %, -@    $ .$))300B      %"34T *@    @ " $2  ,
M   !  $   $:  4    !    ;@$;  4    !    =@$H  ,    !  (   $Q
M  (    >    ?@$R  (    4    G $[  (    &    L(=I  0    !
MN    .0 '=M3   G$  =VU,  "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN
M9&]W<RD ,C Q.#HP,SHQ," Q-#HS-SHP. !D96QT80     #H $  P    '_
M_P  H ( !     $   'MH , !     $   )8          8! P #     0 &
M   !&@ %     0   3(!&P %     0   3H!*  #     0 "   " 0 $
M 0   4(" @ $     0              2     $   !(     3A"24T#_0
M    "           _^$!1$U- "H    (  @!$@ #     0     !&@ %
M 0   &X!&P %     0   '8!*  #     0 "   !,0 "    '@   'X!,@ "
M    %    )P!.P "    !@   +"':0 $     0   +@   #D   #P     $
M  /      4%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I #(P,3@Z,#,Z
M,3 @,30Z,S<Z,#@ 9&5L=&$      Z !  ,    !__\  * "  0    !   !
M[: #  0    !   "6          & 0,  P    $ !@   1H !0    $   $R
M 1L !0    $   $Z 2@  P    $  @   @$ !     $   %" @( !     $
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MX?$E0T1RHA@F-&2R_\0 ' $!  (# 0$!              $# @0%!@<(_\0
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M]D%/+A7%'<085I5S(LZ*P^V113C;*]<FWR?N#:WJXVRS##8X:CTZ^IWIVO\
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M913H?+:\,J'MS!@=DQ$MOK$=+:+2W\'JD1<2Y;5/TU,U!MFHE)-N,KW3-HY
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M<09I^N+:3*@R$L[B;,R:Z0X!QZUC@F5*3W**N$EY$#)(;8X//I=H4$]J2=_
M/AU<&,K:+J@UN[2#_M@3M?=<_%":C2=FVTT!_?\ 9/CLEO#L]D&;'9&HRZMG
M[GXOBT2\OL2:;G*G5]2^(99F.R5PVZUSN%C7*<AQIS\^.Q8PI<F,RPZ".7Q1
ME>GA&XHL'RZCBZ8,<C!.PZR2KL(YCG%KS#H)@$:6Y]01I?P5O.%0!6XM2PP
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M>^E+MU&B@*[5=CS?=9.H/DA$8_+'Y3X"Y':I)//H*XX.0%H/.3-YL/SW^J)
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MLZ1(9AU^-;>9?89O@^]&*MOJ<C0*K'U;@9Q15R1&BT.*0F0B.I<0'-<"1:1
M]]/[J6M<_,YAS!GU1)RB3-P;:;SRTE+V/GO7S#IW)\_;_HAMHD1"_B<G1U![
MUXE7%*$\F2[1RNG+*ONU"?!5&7E4Y7"@#)2D^IJ<CR<C?\0V B;]P/=NHSMR
MYI&4 DDVT[_S"8[#\@WSZK+N5BDOKMV%PRF;CF?>8'T5T[%QN:]2I>2P]W;T
M[GW^4NU$%]:T1W;/&=G<<O(ZG>^JR"IDI9D-[-?!8W"TVU<1A*K&/ +7%I8T
MYA((S#0B[;WD7NJJ6)P]=SFTJC7.:2+.!B#!TGNV*E(WT^[4=/NR698WM;B_
MW,F\FQ[[++^RLK7)\VSK)I4^$B7E.?9QDLVVRS-<DDI ;7<Y+<6<UN,AF%'=
M9@QX\9K2>XM9F O:QVGN5I:.UN3W>EMU6)LWT,8':;WO]2&UDBYVYW4V[L['
M*)-+BT@5V([DJ*U(<JLFIV4-F.N<7'/B)58[&%BI0%G&E%YQ_71H<<X@_!5.
M'U*K:F'(R@/;F<QMH:TS RBPD&UCNM-_#Z+L0W$AU5E1I!ACVAI/,C(29WN%
M>GB>0Q,JQNER&%R&+6 Q*"%<=[3BD]K["QR>%L/I<:6#Y"D$$ ^-:0]RMY;F
M7*CP8LF;*=2S%B,.R9#RR$H:88;4XZXHGP$H0E2B?R&B*L?-MUJO=>QO\CII
MT2;2M1;BD@?"2&Y#33->Q+8>:=6TI24RENK6_(;Y^3UFTCN2 I6;&AQ(.D3J
M 9O$R#R\TT4.<QO<_P!K[V+ W#SW8W&8=NR;#'H-Y.L:ZQE5"DLEI*9TAZ)
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M\%%+&XQC751B#3LT_+[#@0,LS,WU@P;:3]+P_$<%Q(XG#X N&'<]V0O<'/\
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MW?.1V\\G@GW4.>?*223YY]4VD757$&6!Q$; B01TO.D6]/+M<RG18 T-,N=
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MDKUW<6*](0PB8+A*FW08CC:Z!,R![\.8"D]5T_U[C[L5M<@$.*'D'_S^O/\
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M(@EHOW$@QISWO,JS6[1F;!=(V]R):$ E*$I9DN>_RGNCJ*5)XYY[1SX)X!/
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M[WW[[3<)E;G[#3H?L%K<JZK/<;<5Y2JHS.UY;///*/BW)*1Y^8]R5<G\M,Q
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BB(T1&B(T1&B(T1&B(T1&B+ ]OW/]3HBSHB-$1HB-$7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g542432g99i17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g542432g99i17.jpg
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M)VE#=$2R1K.\RU--L74.LL=()F>*LLBS[*&W)\[ 1!9S+2P1EBQLPR]Z@S.
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M*<*Z\-,?M+%R>UQO3FOU<LT=<:?_ +]*<*Z\-,?M$7)[7&].:_5RS1UQI_\
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MAZMF,Y*KL8L:Q=/9^MC"$CPIE;3^.R5>&[E$I8CR%#S9! )BF(.+:);'C32
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MT@51\UD@K#D&4,4PEK-&^:HXTO:IO<7J+QNZ0N6/<G,8&YD1M$<-:&P2M*I
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M)^^CF)?WF78;2;@D<UWD]G$3%PN5$<IY?9JN%PN'D7*>(Y/>U^5<1QG\EQE
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8B1>H;"W 8%\4 H!0"@% * 4 H!0"@/_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
